Citrus Sinensis ID: 020720
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 322 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.984 | 0.305 | 0.496 | 2e-85 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.981 | 0.305 | 0.495 | 9e-85 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.878 | 0.296 | 0.531 | 3e-83 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.872 | 0.275 | 0.539 | 6e-83 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.863 | 0.274 | 0.555 | 6e-83 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.860 | 0.268 | 0.532 | 2e-81 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.866 | 0.273 | 0.519 | 3e-80 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.860 | 0.268 | 0.525 | 1e-79 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.869 | 0.274 | 0.510 | 4e-74 | |
| O23081 | 665 | Cysteine-rich receptor-li | no | no | 0.878 | 0.425 | 0.448 | 2e-66 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 315 bits (808), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 159/320 (49%), Positives = 216/320 (67%), Gaps = 3/320 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L DG IA+K LS++SKQG +EF+TEI MI ++HPNLV+L GCC+E
Sbjct: 675 IGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIE 734
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+LVYEYLENNSLA AL G++ + + LDW TR IC+G A GL++LHEE+ IVHR
Sbjct: 735 GKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHR 794
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+NVLLD + + KI DFGLAKL D TH+STR+AGT+GY+APEYA+ G LT KADV
Sbjct: 795 DIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADV 854
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFGV+ LEI+SG+S++ ++ + L++W + L+E+G LLE+VDP+L T F +KE MR
Sbjct: 855 YSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMR 914
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASS--SET 298
+ + L CT RP M VV ML + + + G+ + A S+
Sbjct: 915 MLNIALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPLVKREADPSGSAAMRFKALELLSQD 974
Query: 299 SSSQKHKGKRSVDHEVPTSA 318
S SQ R+ + ++ +S+
Sbjct: 975 SESQVSTYARNREQDISSSS 994
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 9e-85, Method: Compositional matrix adjust.
Identities = 158/319 (49%), Positives = 215/319 (67%), Gaps = 3/319 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L DG IA+K LS++SKQG +EF+TEI MI ++HPNLV+L GCC+E
Sbjct: 673 IGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIE 732
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+LVYEYLENNSLA AL G++ + + LDW TR +C+G A GL++LHEE+ IVHR
Sbjct: 733 GKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHR 792
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+NVLLD + + KI DFGLAKL + TH+STR+AGT+GY+APEYA+ G LT KADV
Sbjct: 793 DIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADV 852
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFGV+ LEI+SG+S++ ++ + L++W + L+E+G LLE+VDP+L T F +KE MR
Sbjct: 853 YSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMR 912
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASS--SET 298
+ + L CT RP M VV ML + + + G+ + A S+
Sbjct: 913 MLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVKREADPSGSAAMRFKALEHLSQD 972
Query: 299 SSSQKHKGKRSVDHEVPTS 317
S SQ R+ +H+ +S
Sbjct: 973 SESQVSTYTRNKEHKSSSS 991
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 151/284 (53%), Positives = 197/284 (69%), Gaps = 1/284 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L DGT IA+K LS SKQG +EFL EI MI + HPNLV+L GCCVE
Sbjct: 630 IGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVE 689
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+LVYE++ENNSLA AL G + + LDWPTR IC+G A GL++LHEE+ IVHR
Sbjct: 690 GGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHR 749
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+NVLLD +PKI DFGLAKL ++ TH+STR+AGT GY+APEYA+ G LT KADV
Sbjct: 750 DIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADV 809
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFG++ LEI+ GRS+ ++ L++W LRE+ LLE+VDP L +++ +E M
Sbjct: 810 YSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMT 869
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYR 284
I++ + CT + RP+M +VV+ML + + L E V+R
Sbjct: 870 MIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEEASVHR 913
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 6e-83, Method: Compositional matrix adjust.
Identities = 152/282 (53%), Positives = 197/282 (69%), Gaps = 1/282 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V++G + DGT IA+K LSA+SKQG +EFL EI MI ++HP+LV+L GCCVE
Sbjct: 678 IGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVE 737
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ +LVYEYLENNSLA AL G + + L+WP R IC+G A GL++LHEE+ IVHR
Sbjct: 738 GDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHR 797
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+NVLLD +PKI DFGLAKL + TH+STRVAGT GY+APEYA+ G LT KADV
Sbjct: 798 DIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADV 857
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFGV+ LEI+ G+S++ + D L++W LRE+ LLE+VDP L T + ++E +
Sbjct: 858 YSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLLEVVDPRLGTDYNKQEALM 917
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGV 282
I++G+ CT RP+M VV ML +N + L E V
Sbjct: 918 MIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLEASV 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 6e-83, Method: Compositional matrix adjust.
Identities = 156/281 (55%), Positives = 200/281 (71%), Gaps = 3/281 (1%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L +G IA+K LSA+S+QG +EF+ EI MI ++HPNLV+L GCCVE
Sbjct: 684 IGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVE 743
Query: 62 DNNRILVYEYLENNSLANALLG-SKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
N ILVYEYLENN L+ AL G +S + LDW TR I LG A GL+FLHEE+ IVH
Sbjct: 744 GNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVH 803
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIKASNVLLD + + KI DFGLAKL D TH+STR+AGT+GY+APEYA+ G LT+KAD
Sbjct: 804 RDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKAD 863
Query: 181 VYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVM 239
VYSFGV+ LEI+SG+S++ +D + L++W + L+E G LLE+VDP L + + E+E M
Sbjct: 864 VYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDPTLASDYSEEEAM 923
Query: 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEP 280
+ V L CT A RPTM QVV ++ + E L++P
Sbjct: 924 LMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQE-LLSDP 963
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 149/280 (53%), Positives = 194/280 (69%), Gaps = 3/280 (1%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG VY+G L DG ++A+K LS S+QG +F+ EI I ++H NLV+L GCC E
Sbjct: 699 LGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYE 758
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+R+LVYEYL N SL AL G K+ + LDW TR ICLG A GL +LHEEA IVHR
Sbjct: 759 GEHRLLVYEYLPNGSLDQALFGEKT--LHLDWSTRYEICLGVARGLVYLHEEARLRIVHR 816
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+KASN+LLD PK+ DFGLAKL+ D TH+STRVAGT+GYLAPEYA+ G LT+K DV
Sbjct: 817 DVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 876
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
Y+FGV+ LE++SGR +S D+ L+EW W L E+GR +E++D +LT+F +E R
Sbjct: 877 YAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRM 936
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPG 281
I + L CTQ RP M +VV MLS DV +++ ++PG
Sbjct: 937 IGIALLCTQTSHALRPPMSRVVAMLSGDVEVSD-VTSKPG 975
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 298 bits (763), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 147/283 (51%), Positives = 198/283 (69%), Gaps = 4/283 (1%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V++G L DGT IA+K LS++S QG +EF+ EI MI + HPNLV+L GCCVE
Sbjct: 679 LGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVE 738
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ +LVYEY+ENNSLA AL G S + LDW R IC+G A GL FLH+ + +VHR
Sbjct: 739 RDQLLLVYEYMENNSLALALFGQNS--LKLDWAARQKICVGIARGLEFLHDGSAMRMVHR 796
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIK +NVLLD + + KI DFGLA+L TH+ST+VAGT+GY+APEYAL GQLT+KADV
Sbjct: 797 DIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADV 856
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT-QFPEKEVMR 240
YSFGV+ +EI+SG+S++K D + L+ W L++ G +LEIVD L +F E +R
Sbjct: 857 YSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEAVR 916
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVY 283
IKV L CT + RPTM + V+ML ++ + + +++PG+Y
Sbjct: 917 MIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQ-VMSDPGIY 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 147/280 (52%), Positives = 191/280 (68%), Gaps = 3/280 (1%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG VY+G+L DG +A+K LS S+QG +F+ EI I ++ H NLV+L GCC E
Sbjct: 700 LGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFE 759
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+R+LVYEYL N SL AL G K+ + LDW TR ICLG A GL +LHEEA IVHR
Sbjct: 760 GEHRMLVYEYLPNGSLDQALFGDKT--LHLDWSTRYEICLGVARGLVYLHEEASVRIVHR 817
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+KASN+LLD P+I DFGLAKL+ D TH+STRVAGT+GYLAPEYA+ G LT+K DV
Sbjct: 818 DVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 877
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
Y+FGV+ LE++SGR +S ++ L+EW W L E+ R +E++D +LT F +E R
Sbjct: 878 YAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRM 937
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPG 281
I + L CTQ RP M +VV MLS DV + + ++PG
Sbjct: 938 IGIALLCTQTSHALRPPMSRVVAMLSGDVEIGD-VTSKPG 976
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (711), Expect = 4e-74, Method: Compositional matrix adjust.
Identities = 145/284 (51%), Positives = 190/284 (66%), Gaps = 4/284 (1%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V++G L DG +A+K LS++S+QG +EFL EI I ++HPNLV+L G CVE
Sbjct: 687 IGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVE 746
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+L YEY+ENNSL++AL K K + +DWPTR IC G A GL+FLHEE+ VHR
Sbjct: 747 RAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHR 806
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+N+LLD + PKI DFGLA+L + TH+ST+VAGT+GY+APEYAL G LT KADV
Sbjct: 807 DIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADV 866
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFGVL+LEI++G ++S D + L+E+ + E G L+++VD L + KE
Sbjct: 867 YSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRPEVDRKEAEA 926
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYR 284
IKV L C+ A RP M +VV ML + E + PGV R
Sbjct: 927 VIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPE---STPGVSR 967
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 130/290 (44%), Positives = 185/290 (63%), Gaps = 7/290 (2%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG VY+G L G +IA+K LS +S QG EF+ E+ ++ ++H NLV+L+G C++
Sbjct: 350 LGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVAKLQHRNLVRLLGFCLQ 409
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
RIL+YE+ +N SL + + S + + LDW TR I G A GL +LHE++ IVHR
Sbjct: 410 GEERILIYEFFKNTSLDHYIFDSNRRMI-LDWETRYRIISGVARGLLYLHEDSRFKIVHR 468
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVSTRVAGTMGYLAPEYALLGQLTKK 178
D+KASNVLLD +PKI DFG+AKLF + T +++VAGT GY+APEYA+ G+ + K
Sbjct: 469 DMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYGYMAPEYAMSGEFSVK 528
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF--PEK 236
DV+SFGVL+LEII G+ ++ + D L L+ + WK EG +L IVDP L +
Sbjct: 529 TDVFSFGVLVLEIIKGKKNNWSPEEDSSLFLLSYVWKSWREGEVLNIVDPSLVETIGVSD 588
Query: 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGN 286
E+M+ I +GL C Q A RPTM VV ML+ + + ++P Y G+
Sbjct: 589 EIMKCIHIGLLCVQENAESRPTMASVVVMLNANSFTLPRP-SQPAFYSGD 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 322 | ||||||
| 224140401 | 385 | predicted protein [Populus trichocarpa] | 0.981 | 0.820 | 0.769 | 1e-143 | |
| 449483711 | 383 | PREDICTED: probable LRR receptor-like se | 0.959 | 0.806 | 0.733 | 1e-135 | |
| 449440265 | 383 | PREDICTED: probable LRR receptor-like se | 0.959 | 0.806 | 0.733 | 1e-135 | |
| 225440666 | 380 | PREDICTED: probable LRR receptor-like se | 0.944 | 0.8 | 0.773 | 1e-134 | |
| 147806197 | 470 | hypothetical protein VITISV_011889 [Viti | 0.953 | 0.653 | 0.768 | 1e-134 | |
| 297829432 | 393 | kinase family protein [Arabidopsis lyrat | 0.881 | 0.722 | 0.785 | 1e-132 | |
| 5923666 | 383 | putative receptor ser/thr protein kinase | 0.881 | 0.741 | 0.778 | 1e-132 | |
| 18398327 | 393 | protein kinase domain-containing protein | 0.881 | 0.722 | 0.778 | 1e-131 | |
| 356523296 | 380 | PREDICTED: probable LRR receptor-like se | 0.940 | 0.797 | 0.75 | 1e-131 | |
| 357505993 | 380 | hypothetical protein MTR_7g068190 [Medic | 0.953 | 0.807 | 0.726 | 1e-128 |
| >gi|224140401|ref|XP_002323571.1| predicted protein [Populus trichocarpa] gi|222868201|gb|EEF05332.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1320), Expect = e-143, Method: Compositional matrix adjust.
Identities = 244/317 (76%), Positives = 280/317 (88%), Gaps = 1/317 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IGGG FGVVY+G LRDGT +AIKCLSAESKQGT EF+TEI MI I+HP LV+L+GCCVE
Sbjct: 55 IGGGGFGVVYKGVLRDGTPVAIKCLSAESKQGTDEFVTEIRMISTIKHPTLVELVGCCVE 114
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+NNRILVYEY+ENNS++ ALLGSK K+V++DWPTRA IC+GTASGL+FLHEEA P IVHR
Sbjct: 115 ENNRILVYEYMENNSISTALLGSKGKHVAMDWPTRAAICIGTASGLAFLHEEAKPHIVHR 174
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASNVLLDGN PKIGDFGLAKLFPDNVTH+STRVAGTMGYLAPEYALLGQLTKKADV
Sbjct: 175 DIKASNVLLDGNLRPKIGDFGLAKLFPDNVTHLSTRVAGTMGYLAPEYALLGQLTKKADV 234
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFGVL+LEIISGRSSSKAAFG+D+L+LVEW WKL +E RLL+IVDPE+T +PE E MRF
Sbjct: 235 YSFGVLILEIISGRSSSKAAFGEDLLVLVEWAWKLWKEERLLDIVDPEMTGYPENEAMRF 294
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASSS-ETSS 300
+KV LFCTQA A+ RP MKQVV+MLSKDV+LNEKALTEPG+Y+ TS G SS ETSS
Sbjct: 295 MKVALFCTQAVANQRPNMKQVVKMLSKDVNLNEKALTEPGIYKAQTSKHFGGGSSYETSS 354
Query: 301 SQKHKGKRSVDHEVPTS 317
S K+KGK+S++ V ++
Sbjct: 355 SHKNKGKQSLNTSVNSA 371
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483711|ref|XP_004156667.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1257), Expect = e-135, Method: Compositional matrix adjust.
Identities = 228/311 (73%), Positives = 269/311 (86%), Gaps = 2/311 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G +GVVY+G LRDGT +AIK LSAES QGT+EFLTEI+MI NIRH NLVQLIGCC+E
Sbjct: 52 IGAGGYGVVYKGVLRDGTNVAIKSLSAESTQGTREFLTEINMISNIRHQNLVQLIGCCIE 111
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+RILVYEYLENNSLA+ LLG+ SK+V LDWP RA ICLGTA GL+FLHE+A+P +VHR
Sbjct: 112 GTHRILVYEYLENNSLASTLLGTMSKHVDLDWPKRAKICLGTALGLAFLHEDAEPSVVHR 171
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASN+LLD NF PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADV
Sbjct: 172 DIKASNILLDRNFDPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 231
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFGVL+LE++SG SSSK AFG+++ ILVEWTWKL++EGRL+E++DPEL +P+ EVMRF
Sbjct: 232 YSFGVLMLEVVSGSSSSKTAFGEELSILVEWTWKLKQEGRLVELIDPELIDYPKAEVMRF 291
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSL--GASSSETS 299
I V LFCTQA A+ RP+MKQVVEMLS++VHLNEK LTEPG+Y+G+ L +SSE +
Sbjct: 292 ITVALFCTQAAANQRPSMKQVVEMLSREVHLNEKLLTEPGIYKGHKISKLNGAGTSSEGT 351
Query: 300 SSQKHKGKRSV 310
SS H+GK+ +
Sbjct: 352 SSHGHRGKKVI 362
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440265|ref|XP_004137905.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 228/311 (73%), Positives = 269/311 (86%), Gaps = 2/311 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G +GVVY+G LRDGT +AIK LSAES QGT+EFLTEI+MI NIRH NLVQLIGCC+E
Sbjct: 52 IGAGGYGVVYKGVLRDGTNVAIKSLSAESTQGTREFLTEINMISNIRHQNLVQLIGCCIE 111
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+RILVYEYLENNSLA+ LLG+ SK+V LDWP RA ICLGTA GL+FLHE+A+P +VHR
Sbjct: 112 GTHRILVYEYLENNSLASTLLGTMSKHVDLDWPKRAKICLGTALGLAFLHEDAEPSVVHR 171
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASN+LLD NF PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADV
Sbjct: 172 DIKASNILLDRNFDPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 231
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFGVL+LE++SG SSSK AFG+++ ILVEWTWKL++EGRL+E++DPEL +P+ EVMRF
Sbjct: 232 YSFGVLMLEVVSGSSSSKTAFGEELSILVEWTWKLKQEGRLVELIDPELIDYPKAEVMRF 291
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSL--GASSSETS 299
I V LFCTQA A+ RP+MKQVVEMLS++VHLNEK LTEPG+Y+G+ L +SSE +
Sbjct: 292 ITVALFCTQAAANQRPSMKQVVEMLSREVHLNEKLLTEPGIYKGHKISKLNGAGTSSEGT 351
Query: 300 SSQKHKGKRSV 310
SS H+GK+ +
Sbjct: 352 SSHGHRGKKVI 362
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440666|ref|XP_002274657.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430 [Vitis vinifera] gi|297740219|emb|CBI30401.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1249), Expect = e-134, Method: Compositional matrix adjust.
Identities = 235/304 (77%), Positives = 275/304 (90%)
Query: 15 LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74
LRDGTQ+AIKCLSAESKQGT+EFLTEI+MI NIRHPNLV+LIGCC+E +NRILVYEYLEN
Sbjct: 65 LRDGTQVAIKCLSAESKQGTQEFLTEINMISNIRHPNLVELIGCCIEGSNRILVYEYLEN 124
Query: 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134
NS+A+ +LGSK K+V LDWPTR +IC+GTASGL++LHEEA+P IVHRDIKASNVLLDG+F
Sbjct: 125 NSIASIILGSKGKHVILDWPTRVSICMGTASGLAYLHEEAEPHIVHRDIKASNVLLDGSF 184
Query: 135 HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADVYSFGVL+LEIISG
Sbjct: 185 LPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGVLMLEIISG 244
Query: 195 RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAH 254
RSSSKAAFG+++L+LVEWTWKL+EE RLLEIVDPELT +PE E+MRFIKV LFCTQA +H
Sbjct: 245 RSSSKAAFGEELLVLVEWTWKLKEEERLLEIVDPELTDYPEDEMMRFIKVALFCTQAASH 304
Query: 255 YRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASSSETSSSQKHKGKRSVDHEV 314
RP MK VV+MLSKDV LNEK LT PGVY+G ++ + +S E+SSSQ +KGK+S++ V
Sbjct: 305 QRPNMKLVVDMLSKDVILNEKVLTRPGVYKGRPTHHVESSPQESSSSQGNKGKQSINPSV 364
Query: 315 PTSA 318
+++
Sbjct: 365 SSTS 368
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147806197|emb|CAN65479.1| hypothetical protein VITISV_011889 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-134, Method: Compositional matrix adjust.
Identities = 236/307 (76%), Positives = 275/307 (89%)
Query: 12 RGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEY 71
+G LRDGTQ+AIKCLSAESKQGT+EFLTEI+MI NIRHPNLV+LIGCC+E +NRILVYEY
Sbjct: 152 KGVLRDGTQVAIKCLSAESKQGTQEFLTEINMISNIRHPNLVELIGCCIEGSNRILVYEY 211
Query: 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD 131
LENNS+A+ +LGSK K+V LDWPTR +IC+GTASGL+ LHEEA+P IVHRDIKASNVLLD
Sbjct: 212 LENNSIASXILGSKGKHVILDWPTRVSICMGTASGLAXLHEEAEPHIVHRDIKASNVLLD 271
Query: 132 GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEI 191
G+F PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADVYSFGVL+LEI
Sbjct: 272 GSFLPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGVLMLEI 331
Query: 192 ISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQA 251
ISGRSSSKAAFG+++L+LVEWTWKL+EE RLLEIVDPELT +PE E+MRFIKV LFCTQA
Sbjct: 332 ISGRSSSKAAFGEELLVLVEWTWKLKEEERLLEIVDPELTDYPEDEMMRFIKVALFCTQA 391
Query: 252 GAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASSSETSSSQKHKGKRSVD 311
+H RP MK VV+MLSKDV LNEK LT PGVY+G ++ + S E+SSSQ +KGK+S++
Sbjct: 392 ASHQRPNMKLVVDMLSKDVILNEKVLTXPGVYKGRPTHHVEXSLQESSSSQGNKGKQSIN 451
Query: 312 HEVPTSA 318
V +++
Sbjct: 452 PXVSSTS 458
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297829432|ref|XP_002882598.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297328438|gb|EFH58857.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1230), Expect = e-132, Method: Compositional matrix adjust.
Identities = 224/285 (78%), Positives = 254/285 (89%), Gaps = 1/285 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IGGG +GVV++G LRDGTQ+A+K LSAESKQGT+EFLTEI++I NI HPNLV LIGCC+E
Sbjct: 52 IGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVNLIGCCIE 111
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
NNRILVYEYLENNSLA+ LLGS+S+YV LDW RA IC+GTASGL+FLHEE +P +VHR
Sbjct: 112 GNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHR 171
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASN+LLD NF PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADV
Sbjct: 172 DIKASNILLDRNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 231
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFG+L+LE+ISG SS++AAFGDD ++LVEW WKLREE RLLE VDP+LT+FPE EV RF
Sbjct: 232 YSFGILVLEVISGNSSTRAAFGDDYMVLVEWVWKLREEKRLLECVDPDLTKFPEDEVTRF 291
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLS-KDVHLNEKALTEPGVYRG 285
IKV LFCTQA A RP MKQVVEML K+++LNE ALTEPGVYRG
Sbjct: 292 IKVALFCTQAAAQKRPNMKQVVEMLCRKELNLNEDALTEPGVYRG 336
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|5923666|gb|AAD56317.1|AC009326_4 putative receptor ser/thr protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1224), Expect = e-132, Method: Compositional matrix adjust.
Identities = 222/285 (77%), Positives = 254/285 (89%), Gaps = 1/285 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IGGG +GVV++G LRDGTQ+A+K LSAESKQGT+EFLTEI++I NI HPNLV+LIGCC+E
Sbjct: 42 IGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVKLIGCCIE 101
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
NNRILVYEYLENNSLA+ LLGS+S+YV LDW RA IC+GTASGL+FLHEE +P +VHR
Sbjct: 102 GNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHR 161
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASN+LLD NF PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADV
Sbjct: 162 DIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 221
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFG+L+LE+ISG SS++AAFGD+ ++LVEW WKLREE RLLE VDPELT+FP EV RF
Sbjct: 222 YSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELTKFPADEVTRF 281
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEML-SKDVHLNEKALTEPGVYRG 285
IKV LFCTQA A RP MKQV+EML K+++LNE ALTEPGVYRG
Sbjct: 282 IKVALFCTQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGVYRG 326
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18398327|ref|NP_566341.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|21537226|gb|AAM61567.1| putative receptor ser thr protein kinase [Arabidopsis thaliana] gi|332641187|gb|AEE74708.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1222), Expect = e-131, Method: Compositional matrix adjust.
Identities = 222/285 (77%), Positives = 254/285 (89%), Gaps = 1/285 (0%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IGGG +GVV++G LRDGTQ+A+K LSAESKQGT+EFLTEI++I NI HPNLV+LIGCC+E
Sbjct: 52 IGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVKLIGCCIE 111
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
NNRILVYEYLENNSLA+ LLGS+S+YV LDW RA IC+GTASGL+FLHEE +P +VHR
Sbjct: 112 GNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHR 171
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASN+LLD NF PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADV
Sbjct: 172 DIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 231
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFG+L+LE+ISG SS++AAFGD+ ++LVEW WKLREE RLLE VDPELT+FP EV RF
Sbjct: 232 YSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELTKFPADEVTRF 291
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEML-SKDVHLNEKALTEPGVYRG 285
IKV LFCTQA A RP MKQV+EML K+++LNE ALTEPGVYRG
Sbjct: 292 IKVALFCTQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGVYRG 336
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523296|ref|XP_003530276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 228/304 (75%), Positives = 265/304 (87%), Gaps = 1/304 (0%)
Query: 15 LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74
LRDGTQ AIK LS ESKQGT EF+TEIDMI NIRHPNLV+LIGCCVE ++RILVYE+LEN
Sbjct: 63 LRDGTQAAIKSLSVESKQGTHEFMTEIDMISNIRHPNLVELIGCCVEGSHRILVYEFLEN 122
Query: 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134
NSLA++LLGSKSKYV+LDWP R IC GTASGL+FLH+EA P IVHRDIKASN+LLDGNF
Sbjct: 123 NSLASSLLGSKSKYVALDWPKRVAICRGTASGLTFLHDEAQPNIVHRDIKASNILLDGNF 182
Query: 135 HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
+PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADVYSFG+L+LEIISG
Sbjct: 183 NPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILMLEIISG 242
Query: 195 RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAH 254
+SSS AAF DD L+LVEW WKLR E RLL++VD EL+++ E EV RF+ V LFCTQ+ A
Sbjct: 243 KSSSIAAFEDDYLVLVEWAWKLRGENRLLDLVDSELSEYDESEVYRFLIVALFCTQSAAQ 302
Query: 255 YRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASSSETSSSQKHKGKRSVD-HE 313
+RP+MKQV+EML K+VHLNEKALTEPG+YR +++ G S +ETSSSQ K KR+ + HE
Sbjct: 303 HRPSMKQVLEMLCKEVHLNEKALTEPGIYRWHSNGKRGGSLNETSSSQAIKYKRTENPHE 362
Query: 314 VPTS 317
P++
Sbjct: 363 APST 366
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357505993|ref|XP_003623285.1| hypothetical protein MTR_7g068190 [Medicago truncatula] gi|355498300|gb|AES79503.1| hypothetical protein MTR_7g068190 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1194), Expect = e-128, Method: Compositional matrix adjust.
Identities = 223/307 (72%), Positives = 257/307 (83%)
Query: 15 LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74
LRDGTQ+AIK LS ESKQGT EF+TEI MI NI+HPNLV+LIG C+E N+RILVYE+LEN
Sbjct: 63 LRDGTQVAIKSLSVESKQGTHEFMTEIAMISNIQHPNLVKLIGFCIEGNHRILVYEFLEN 122
Query: 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134
NSL ++LLGSKSK V LDW RA IC GTASGLSFLHEEA P IVHRDIKASN+LLD NF
Sbjct: 123 NSLTSSLLGSKSKCVPLDWQKRAIICRGTASGLSFLHEEAQPNIVHRDIKASNILLDENF 182
Query: 135 HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL QLTKKADVYSFG+L+LEIISG
Sbjct: 183 HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLRQLTKKADVYSFGILMLEIISG 242
Query: 195 RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAH 254
+SSSKAAFGD++L+LVEW WKL+EE RLLE+VD E+T + E EV RF+ + LFCTQ+GA
Sbjct: 243 KSSSKAAFGDNILVLVEWAWKLKEENRLLELVDSEITDYDENEVYRFLVIALFCTQSGAQ 302
Query: 255 YRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSLGASSSETSSSQKHKGKRSVDHEV 314
+RPTMKQV++MLS+ VHLNEKALTEPG+YR N S S +E SSS + + ++
Sbjct: 303 HRPTMKQVLQMLSRQVHLNEKALTEPGIYRWNASAKTSGSLNEISSSSQVIKHKKYENRC 362
Query: 315 PTSAQLA 321
TS Q +
Sbjct: 363 QTSTQFS 369
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 322 | ||||||
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.881 | 0.722 | 0.778 | 1.1e-119 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.872 | 0.720 | 0.563 | 3.2e-81 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.822 | 0.256 | 0.560 | 2.1e-77 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.878 | 0.292 | 0.529 | 1.9e-76 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.878 | 0.296 | 0.531 | 2.4e-76 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.860 | 0.264 | 0.528 | 2.4e-76 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.860 | 0.268 | 0.525 | 1.2e-74 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.866 | 0.258 | 0.510 | 5.1e-72 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.869 | 0.274 | 0.510 | 3e-68 | |
| TAIR|locus:2033577 | 425 | AT1G70740 [Arabidopsis thalian | 0.863 | 0.654 | 0.452 | 4.8e-62 |
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
Identities = 222/285 (77%), Positives = 254/285 (89%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IGGG +GVV++G LRDGTQ+A+K LSAESKQGT+EFLTEI++I NI HPNLV+LIGCC+E
Sbjct: 52 IGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVKLIGCCIE 111
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
NNRILVYEYLENNSLA+ LLGS+S+YV LDW RA IC+GTASGL+FLHEE +P +VHR
Sbjct: 112 GNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHR 171
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKASN+LLD NF PKIGDFGLAKLFPDNVTHVSTRVAGT+GYLAPEYALLGQLTKKADV
Sbjct: 172 DIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 231
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
YSFG+L+LE+ISG SS++AAFGD+ ++LVEW WKLREE RLLE VDPELT+FP EV RF
Sbjct: 232 YSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELTKFPADEVTRF 291
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLS-KDVHLNEKALTEPGVYRG 285
IKV LFCTQA A RP MKQV+EML K+++LNE ALTEPGVYRG
Sbjct: 292 IKVALFCTQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGVYRG 336
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 3.2e-81, P = 3.2e-81
Identities = 160/284 (56%), Positives = 203/284 (71%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L+DG AIK LSAES+QG KEFLTEI++I I+H NLV+L GCCVE
Sbjct: 47 IGEGGFGSVYKGCLKDGKLAAIKVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVE 106
Query: 62 DNNRILVYEYLENNSLANALL--GSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
N+RILVY +LENNSL LL G + DW +RANIC+G A GL+FLHEE P I+
Sbjct: 107 GNHRILVYNFLENNSLDKTLLAGGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHII 166
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIKASN+LLD PKI DFGLA+L P N+THVSTRVAGT+GYLAPEYA+ GQLT+KA
Sbjct: 167 HRDIKASNILLDKYLSPKISDFGLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKA 226
Query: 180 DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ-FPEKEV 238
D+YSFGVLL+EI+SGRS+ + L+E W+L E L+++VD L F +E
Sbjct: 227 DIYSFGVLLMEIVSGRSNKNTRLPTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEA 286
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGV 282
R++K+GL CTQ RP+M VV +L+ + ++ K ++ PG+
Sbjct: 287 CRYLKIGLLCTQDSPKLRPSMSTVVRLLTGEKDIDYKKISRPGL 330
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 149/266 (56%), Positives = 196/266 (73%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L DG IA+K LS++SKQG +EF+TEI MI ++HPNLV+L GCC+E
Sbjct: 673 IGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIE 732
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+LVYEYLENNSLA AL G++ + + LDW TR +C+G A GL++LHEE+ IVHR
Sbjct: 733 GKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHR 792
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+NVLLD + + KI DFGLAKL + TH+STR+AGT+GY+APEYA+ G LT KADV
Sbjct: 793 DIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADV 852
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFGV+ LEI+SG+S++ ++ + L++W + L+E+G LLE+VDP+L T F +KE MR
Sbjct: 853 YSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMR 912
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEML 266
+ + L CT RP M VV ML
Sbjct: 913 MLNIALLCTNPSPTLRPPMSSVVSML 938
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 152/287 (52%), Positives = 205/287 (71%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L DGT IA+K LS++S QG KEF+ EI MI ++HPNLV+L GCCVE
Sbjct: 646 IGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVE 705
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
N +LVYEYLENN L++AL +S + L+W TR ICLG A GL+FLHE++ I+HR
Sbjct: 706 KNQLLLVYEYLENNCLSDALFAGRS-CLKLEWGTRHKICLGIARGLAFLHEDSAVKIIHR 764
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIK +NVLLD + + KI DFGLA+L DN +H++TRVAGT+GY+APEYA+ G LT+KADV
Sbjct: 765 DIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADV 824
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLI-LVEWTWKLREEGRLLEIVDPELT-QFPEKEVM 239
YSFGV+ +EI+SG+S++K D+ + L++W + L+++G + EI+DP L F E
Sbjct: 825 YSFGVVAMEIVSGKSNAKYTPDDECCVGLLDWAFVLQKKGDIAEILDPRLEGMFDVMEAE 884
Query: 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGN 286
R IKV L C + RP M QVV+ML + + E+ +++PGVY N
Sbjct: 885 RMIKVSLLCANKSSTLRPNMSQVVKMLEGETEI-EQIISDPGVYSDN 930
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 151/284 (53%), Positives = 197/284 (69%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L DGT IA+K LS SKQG +EFL EI MI + HPNLV+L GCCVE
Sbjct: 630 IGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVE 689
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+LVYE++ENNSLA AL G + + LDWPTR IC+G A GL++LHEE+ IVHR
Sbjct: 690 GGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHR 749
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+NVLLD +PKI DFGLAKL ++ TH+STR+AGT GY+APEYA+ G LT KADV
Sbjct: 750 DIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADV 809
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240
YSFG++ LEI+ GRS+ ++ L++W LRE+ LLE+VDP L +++ +E M
Sbjct: 810 YSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMT 869
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYR 284
I++ + CT + RP+M +VV+ML + + L E V+R
Sbjct: 870 MIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEEASVHR 913
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 148/280 (52%), Positives = 196/280 (70%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG VY+G+L DG ++A+K LS S+QG +F+ EI I ++ H NLV+L GCC E
Sbjct: 716 LGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFE 775
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
++R+LVYEYL N SL AL G KS + LDW TR ICLG A GL +LHEEA I+HR
Sbjct: 776 GDHRLLVYEYLPNGSLDQALFGDKSLH--LDWSTRYEICLGVARGLVYLHEEASVRIIHR 833
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+KASN+LLD PK+ DFGLAKL+ D TH+STRVAGT+GYLAPEYA+ G LT+K DV
Sbjct: 834 DVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 893
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
Y+FGV+ LE++SGR +S + L+EW W L E+ R +E++D EL+++ +EV R
Sbjct: 894 YAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDVELIDDELSEYNMEEVKRM 953
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPG 281
I + L CTQ+ RP M +VV MLS D +N+ A ++PG
Sbjct: 954 IGIALLCTQSSYALRPPMSRVVAMLSGDAEVND-ATSKPG 992
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 147/280 (52%), Positives = 191/280 (68%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG VY+G+L DG +A+K LS S+QG +F+ EI I ++ H NLV+L GCC E
Sbjct: 700 LGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFE 759
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+R+LVYEYL N SL AL G K+ + LDW TR ICLG A GL +LHEEA IVHR
Sbjct: 760 GEHRMLVYEYLPNGSLDQALFGDKTLH--LDWSTRYEICLGVARGLVYLHEEASVRIVHR 817
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+KASN+LLD P+I DFGLAKL+ D TH+STRVAGT+GYLAPEYA+ G LT+K DV
Sbjct: 818 DVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 877
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
Y+FGV+ LE++SGR +S ++ L+EW W L E+ R +E++D +LT F +E R
Sbjct: 878 YAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRM 937
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPG 281
I + L CTQ RP M +VV MLS DV + + ++PG
Sbjct: 938 IGIALLCTQTSHALRPPMSRVVAMLSGDVEIGD-VTSKPG 976
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 5.1e-72, P = 5.1e-72
Identities = 145/284 (51%), Positives = 201/284 (70%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG VY+G L +GT IA+K LS++S QG KEF+ EI +I ++HPNLV+L GCCVE
Sbjct: 683 IGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVE 742
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+LVYEYLENN LA+AL G + LDW TR ICLG A GL+FLHE++ I+HR
Sbjct: 743 KTQLLLVYEYLENNCLADALFGRSG--LKLDWRTRHKICLGIARGLAFLHEDSAVKIIHR 800
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIK +N+LLD + + KI DFGLA+L D+ +H++TRVAGT+GY+APEYA+ G LT+KADV
Sbjct: 801 DIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHLTEKADV 860
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLI-LVEWTWKLREEGRLLEIVDPELTQ-FPEKEVM 239
YSFGV+ +EI+SG+S++ ++ + L++W + L+++G EI+DP+L F E
Sbjct: 861 YSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLEGVFDVMEAE 920
Query: 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVY 283
R IKV L C+ RPTM +VV+ML + + E+ +++PG Y
Sbjct: 921 RMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEI-EEIISDPGAY 963
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 696 (250.1 bits), Expect = 3.0e-68, P = 3.0e-68
Identities = 145/284 (51%), Positives = 189/284 (66%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V++G L DG +A+K LS++S+QG +EFL EI I ++HPNLV+L G CVE
Sbjct: 687 IGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVE 746
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+L YEY+ENNSL++AL K K + +DWPTR IC G A GL+FLHEE+ VHR
Sbjct: 747 RAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHR 806
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA+N+LLD + PKI DFGLA+L + TH+ST+VAGT+GY+APEYAL G LT KADV
Sbjct: 807 DIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADV 866
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT-QFPEKEVMR 240
YSFGVL+LEI++G ++S D + L+E+ + E G L+++VD L + KE
Sbjct: 867 YSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRPEVDRKEAEA 926
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYR 284
IKV L C+ A RP M +VV ML + E PGV R
Sbjct: 927 VIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPEST---PGVSR 967
|
|
| TAIR|locus:2033577 AT1G70740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
Identities = 128/283 (45%), Positives = 185/283 (65%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V++G L DG IA+K LS S+QG EF+ E ++ ++H N+V L G C
Sbjct: 68 LGEGGFGPVFKGRLPDGRDIAVKKLSQVSRQGKNEFVNEAKLLAKVQHRNVVNLWGYCTH 127
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
++++LVYEY+ N SL L S K +DW R I G A GL +LHE+A I+HR
Sbjct: 128 GDDKLLVYEYVVNESLDKVLFKSNRKS-EIDWKQRFEIITGIARGLLYLHEDAPNCIIHR 186
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
DIKA N+LLD + PKI DFG+A+L+ ++VTHV+TRVAGT GY+APEY + G L+ KADV
Sbjct: 187 DIKAGNILLDEKWVPKIADFGMARLYQEDVTHVNTRVAGTNGYMAPEYVMHGVLSVKADV 246
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
+SFGVL+LE++SG+ +S + L+EW +KL ++GR +EI+D ++ + + ++
Sbjct: 247 FSFGVLVLELVSGQKNSSFSMRHPDQTLLEWAFKLYKKGRTMEILDQDIAASADPDQVKL 306
Query: 242 -IKVGLFCTQAGAHYRPTMKQVVEMLS-KDVHLNEKALTEPGV 282
+++GL C Q H RP+M++V +LS K HL E PGV
Sbjct: 307 CVQIGLLCVQGDPHQRPSMRRVSLLLSRKPGHLEEP--DHPGV 347
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_XVI1054 | hypothetical protein (385 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | CRK4 | CPK related kinase 4 (535 aa) | • | 0.428 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 322 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-32 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-23 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 8e-55
Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIGCC 59
+G G FG VY + G ++AIK + E E L EI+++ + HPN+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
++N+ LV EY E SL + L K L I L GL +LH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 120 HRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL-LGQLTK 177
HRD+K N+LLD N K+ DFGL+KL + + + T V GT Y+APE L G ++
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 178 KADVYSFGVLLLEI 191
K+D++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-51
Identities = 83/276 (30%), Positives = 128/276 (46%), Gaps = 34/276 (12%)
Query: 1 MIGGGAFGVVYRGSLRD-----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G GAFG VY+G L+ ++A+K L + S+Q +EFL E ++ + HPN+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+G C E+ +V EY+E L + L ++ K L + L A G+ +L +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLESK- 121
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG---YLAPEYAL 171
+HRD+ A N L+ N KI DFGL++ D R G ++APE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKLPIRWMAPESLK 176
Query: 172 LGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230
G+ T K+DV+SFGVLL EI + G +++L + + G L
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-------KNGYRLPQ----- 224
Query: 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
P + L C RPT ++VE+L
Sbjct: 225 ---PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-51
Identities = 81/273 (29%), Positives = 131/273 (47%), Gaps = 27/273 (9%)
Query: 1 MIGGGAFGVVYRGSLRDG-----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G GAFG VY+G+L+ ++A+K L + S+Q +EFL E ++ + HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+G C E+ ++V EY+ L + L K++ L + L A G+ +L +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
+HRD+ A N L+ N KI DFGL++ D+ + + ++APE G+
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 175 LTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
T K+DV+SFGVLL EI + G ++L + ++G L
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL-------KKGYRLPK-------- 225
Query: 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
P K+ L C RPT ++VE+L
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 7e-51
Identities = 87/268 (32%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G G+FG VY+ + G +A+K L S + + EI ++ + HPN+V+LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ ++ LV EY E L + L S+ L I L GL +LH I
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL--T 176
+HRD+K N+LLD N KI DFGLAK + + ++T V GT Y+APE LLG
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPE-VLLGGNGYG 177
Query: 177 KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236
K DV+S GV+L E+++G+ D L L+ R G LE +P+ + E
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-----RILGPPLEFDEPKWSSGSE- 231
Query: 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
E IK RPT +++++
Sbjct: 232 EAKDLIK-KCLNKDPSK--RPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-50
Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIGCC 59
+G G+FG VY + G +AIK + + + +E L EI ++ ++HPN+V+L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+++ LV EY E L + L K L S L +LH + IV
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K N+LLD + H K+ DFGLA+ T GT Y+APE L K
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 180 DVYSFGVLLLEIISGRS 196
D++S GV+L E+++G+
Sbjct: 178 DIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 7e-49
Identities = 88/279 (31%), Positives = 138/279 (49%), Gaps = 34/279 (12%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G GAFG VY+G L+ T++A+K L S++ K+FL E ++ + HPN+V+L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVS-----LDWPTRANICLGTASGLSFLH 111
G C E+ LV EY+E L + L S+ + S L + + A G+ +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAPEYA 170
+ VHRD+ A N L+ + KI DFGL++ ++ D+ T + ++APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 171 LLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229
G T K+DV+SFGVLL EI + G + +++L + +G L PE
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLPK--PE 230
Query: 230 LTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
P++ E+M L C Q RPT ++VE L
Sbjct: 231 Y--CPDELYELM------LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-48
Identities = 86/281 (30%), Positives = 125/281 (44%), Gaps = 45/281 (16%)
Query: 2 IGGGAFGVVYRGSLRD-----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G GAFG VY+G+L+ T++A+K L S++ +EFL E ++ + HPN+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+G C + +V EY+ L + L K L + L A G+ +L +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLESK-- 121
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL-----APEYA 170
VHRD+ A N L+ N KI DFGL++ + G L APE
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 171 LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGD---DMLILVEWTWKLREEGRLL--EI 225
G+ T K+DV+SFGVLL EI + G+ + E L + RL E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMSNEEVLELLEDGYRLPRPEN 228
Query: 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
EL E+M L C RPT ++VE L
Sbjct: 229 CPDEL-----YELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
++G G+FG VY G +A+K LS +S++ + EI ++ +++HPN+V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 58 CCV-EDNNRILVY-EYLENNSLANALLGSKSKYVSLDWPTRANICLGTA---SGLSFLHE 112
E+ N + ++ EY+ SL++ L K+ L P I T GL++LH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPV---IRKYTRQILEGLAYLHS 119
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR-VAGTMGYLAPEYAL 171
IVHRDIK +N+L+D + K+ DFG AK D T T V GT ++APE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 172 LGQLTKKADVYSFGVLLLEIISGR 195
+ + AD++S G ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G FG VY+ R G ++AIK + ESK+ ++ + EI ++ +HPN+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
++ + +V E+ SL + L KS +L A +C GL +LH I+
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---II 120
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIKA+N+LL + K+ DFGL+ D + GT ++APE KA
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYDYKA 178
Query: 180 DVYSFGVLLLEIISGR 195
D++S G+ +E+ G+
Sbjct: 179 DIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 71/195 (36%), Positives = 105/195 (53%), Gaps = 12/195 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V G R G ++A+KCL +S FL E ++ +RHPNLVQL+G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
N +V EY+ SL + L S+ + V + + L G+ +L E+ VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVD-YLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A NVL+ + K+ DFGLAK + S ++ + + APE + + K+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 182 YSFGVLLLEIIS-GR 195
+SFG+LL EI S GR
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY DG +K LS S++ ++ L E+ ++ + HPN+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVS------LDWPTRANICLGTASGLSFLH 111
E +V EY + L+ + K + LDW +CL L +LH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYLH 120
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE--- 168
I+HRDIK N+ L N K+GDFG++K+ V T V GT YL+PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 169 ---YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAF-GDDMLILV 210
Y K+D++S G +L E+ + + F G+++L L
Sbjct: 177 NKPY------NYKSDIWSLGCVLYELCTLKH----PFEGENLLELA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 70/200 (35%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G+ T++A+K L K GT + FL E ++ +RH LVQL
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
C E+ +V EY+ SL + L + K + L P ++ A G+++L
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESRN---Y 124
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN--VTHVSTRVAGTMGYLAPEYALLGQLT 176
+HRD+ A N+L+ N KI DFGLA+L D+ + + + APE A G+ T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182
Query: 177 KKADVYSFGVLLLEIIS-GR 195
K+DV+SFG+LL EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-33
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 13/198 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G + T +A+K L K GT K+FL E ++ +RHP L+QL
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
C + +V E ++ SL L G + + L P ++ ASG+++L +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---Y 124
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD+ A NVL+ N K+ DFGLA++ +++ + + APE AL + + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 179 ADVYSFGVLLLEIIS-GR 195
+DV+SFG+LL EI++ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 67/197 (34%), Positives = 109/197 (55%), Gaps = 11/197 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG GAFGVVY+G +L G +AIK +S E ++ K + EID++ N++HPN+V+ IG
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++ ++ EY EN SL + K+ A GL++LHE+ +
Sbjct: 68 IETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQG---V 120
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRDIKA+N+L + K+ DFG+A D V+ V GT ++APE + +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 179 ADVYSFGVLLLEIISGR 195
+D++S G ++E+++G
Sbjct: 180 SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-32
Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ G ++ ++AIK L ++ ++F E+ + +RH +L+ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
++ E +E SL L + + L + ++ A G+++L E+ +HR
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLEEQN---SIHR 128
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTRVAGTMGYLAPEYALLGQLTKKAD 180
D+ A N+L+ + K+ DFGLA+L ++V ++ + APE A G + K+D
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTFSTKSD 186
Query: 181 VYSFGVLLLEIIS 193
V+SFG+LL E+ +
Sbjct: 187 VWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 70/241 (29%), Positives = 118/241 (48%), Gaps = 28/241 (11%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG+V+ G + ++AIK + E ++F+ E ++ + HP LVQL G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ LV+E++E+ L++ L +++ T +CL G+++L ++HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N L+ N K+ DFG+ + D+ ST + + +PE + + K+DV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 182 YSFGVLLLEIIS-------GRSSSK------AAF--------GDDMLILVEWTWKLREEG 220
+SFGVL+ E+ S RS+S+ A F + L++ WK R E
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPED 244
Query: 221 R 221
R
Sbjct: 245 R 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-30
Identities = 77/219 (35%), Positives = 116/219 (52%), Gaps = 14/219 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G+ T++AIK L K GT + FL E ++ +RH LVQL
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E+ I V EY+ SL + L G KY+ L P ++ ASG++++
Sbjct: 70 VSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERMN---Y 123
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
VHRD++A+N+L+ N K+ DFGLA+L DN + + APE AL G+ T K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 179 ADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216
+DV+SFG+LL E+ + GR ++L VE +++
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 6e-30
Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 24/277 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHP-NLVQLIG 57
+G G+FG VY RD +A+K L+ + + + FL EI ++ ++ HP N+V+L
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
++ + LV EY++ SL LL + L I S L +LH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 118 IVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTR-----VAGTMGYLAPEYAL 171
I+HRDIK N+LLD + K+ DFGLAKL PD + S GT GY+APE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 172 ---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGD-DMLILVEWTWKLREEGRLLEIVD 227
L + +D++S G+ L E+++G + ++ +L L +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASPLS 240
Query: 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
P + K +K L R + +
Sbjct: 241 PSNPELISKAASDLLKKLLAKD---PKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G+FG V +D G A+K L + ++ + LTE +++ I HP +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 58 CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
+ ++ LV EY L + L SK S + R A I L L +LH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEER-ARFYAAEIVLA----LEYLHSL 112
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
I++RD+K N+LLD + H K+ DFGLAK + +T GT YLAPE L
Sbjct: 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGK 168
Query: 174 QLTKKADVYSFGVLLLEIISGRS 196
K D +S GVLL E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-29
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 8/198 (4%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIK-CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G FG VY+G L+ T++A+K C S ++FL E +++ HPN+V+LIG CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V E + SL L K++ L + L A+G+ +L + +H
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-MGYLAPEYALLGQLTKKA 179
RD+ A N L+ N KI DFG+++ + VS + + + APE G+ T ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 180 DVYSFGVLLLEIISGRSS 197
DV+S+G+LL E S +
Sbjct: 177 DVWSYGILLWETFSLGDT 194
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 82/271 (30%), Positives = 123/271 (45%), Gaps = 30/271 (11%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS-----AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G G+FG VY G +L DG A+K +S ++ K+ EI ++ ++HPN+VQ
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+G E++N + E + SLA L KY S P GL +LH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLH--- 119
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL-LG 173
D VHRDIK +N+L+D N K+ DFG+AK + S G+ ++APE G
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQG 177
Query: 174 QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
AD++S G +LE+ +G+ G V +K+ L P +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL-----PPIPDH 226
Query: 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
E FI L C Q RPT +++E
Sbjct: 227 LSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG GA G VY+ + R G ++AIK + KQ + + EI ++ + +HPN+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ + +V EY++ SL + + + V ++ P A +C GL +LH + ++
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVI 138
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIK+ N+LL + K+ DFG A + ++ V GT ++APE K
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKV 197
Query: 180 DVYSFGVLLLEIISG 194
D++S G++ +E+ G
Sbjct: 198 DIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 43/224 (19%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLS-----AESKQGT----KEFLTEIDMIWNIRHPN 51
IG G+F V + + AIK L E K KE LT ++ HP
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPG 63
Query: 52 LVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
+++L +D + V EY N L + KY SLD L +L
Sbjct: 64 IIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYL 118
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA----------- 159
H I+HRD+K N+LLD + H KI DFG AK+ N + S +
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 160 --------GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR 195
GT Y++PE K +D+++ G ++ ++++G+
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FGVV+ G R +AIK + E +F+ E ++ + HPNLVQL G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+V EY+ N L N L K K + ++C + +L +HR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N L+ + K+ DFGLA+ D+ S + + PE + + K+DV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 182 YSFGVLLLEIISG 194
+SFGVL+ E+ S
Sbjct: 185 WSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLIGC 58
IGGG FG VY +L G +A+K + + KE E+ ++ ++HPNLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
V + EY +L L + LD L GL++LH I
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG---YLAPEYALLGQL 175
VHRDIK +N+ LD N K+GDFG A +N T + V G Y+APE G+
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 176 TKK---ADVYSFGVLLLEIISGR 195
AD++S G ++LE+ +G+
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 2 IGGGAFGVVYRGSLR------DGTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G GAFG V+ G D +A+K L S K+F E +++ N +H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRA----------NICLGTA 104
G C E + I+V+EY+E+ L L L P I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--- 161
SG+ +L A VHRD+ N L+ + KIGDFG+++ D T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 162 -MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+ ++ PE + + T ++DV+SFGV+L EI +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 1 MIGGGAFGVVYRGS---LRDGT--QIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G FG V L D T Q+A+K L+ +Q +F EI+++ + H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 55 LIGCCVEDNNRI--LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
G C + R L+ EYL + SL + L + + ++ G+ +L
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLGS 127
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--MGYLAPEYA 170
+ +HRD+ A N+L++ KI DFGLAK+ P++ + + G + + APE
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 171 LLGQLTKKADVYSFGVLLLEIIS-GRSSS 198
+ + +DV+SFGV L E+ + G S
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQ 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 66/198 (33%), Positives = 106/198 (53%), Gaps = 14/198 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKE---FLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G T++AIK L KQG+ FL E +++ ++HP LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++ I + EY+EN SL + L + +++ ++ A G++F+ +
Sbjct: 70 VTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIERKN---Y 123
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD++A+N+L+ KI DFGLA+L DN + + APE G T K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 179 ADVYSFGVLLLEIIS-GR 195
+DV+SFG+LL EI++ GR
Sbjct: 184 SDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G+ T++A+K L K GT + FL E ++ +RH LVQL
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E+ I V EY+ SL + L + + + L P ++ A+G++++
Sbjct: 70 VSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIERMN---Y 123
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD++++N+L+ KI DFGLA+L DN + + APE AL G+ T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 179 ADVYSFGVLLLEIIS-GR 195
+DV+SFG+LL E+++ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 52/286 (18%)
Query: 2 IGGGAFGVVYRGSLRDGTQ----IAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLI 56
IGGG FG V RG L+ + +AIK L A S + +FLTE ++ HPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G + +++ EY+EN SL L + K+ + G ASG+ +L ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFT---VGQLVGMLRGIASGMKYL---SEM 125
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG------YLAPEYA 170
VHRD+ A N+L++ N K+ DFGL++ D S T G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED-----SEATYTTKGGKIPIRWTAPEAI 180
Query: 171 LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW------KLREEG-RLL 223
+ T +DV+SFG+++ E++S +G+ W K E+G RL
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS--------YGERPY----WDMSNQDVIKAVEDGYRLP 228
Query: 224 EIVD-PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+D P ++M L C Q + RPT Q+V L K
Sbjct: 229 PPMDCPSALY----QLM------LDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 1 MIGGGAFGVVYRGSLR---DGTQI--AIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY+G + +I AIK L S + KE L E ++ ++ HP++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYV-----SLDWPTRANICLGTASGLSF 109
L+G C+ L+ + + LG YV ++ N C+ A G+S+
Sbjct: 74 LLGICLSSQ-VQLITQLMP--------LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLA 166
L E+ +VHRD+ A NVL+ H KI DFGLAKL + G ++A
Sbjct: 125 LEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMA 179
Query: 167 PEYALLGQLTKKADVYSFGVLLLEIIS 193
E L T K+DV+S+GV + E+++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEF----LTEIDMIWNIRHPNLVQLI 56
IG G +G VY+ + + G +A+K + E + F + EI ++ +RHPN+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 57 GCCVED--NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+ +V+EY++++ LL S + GL +LH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHD--LTGLLDSPEVKFTE--SQIKCYMKQLLEGLQYLHSNG 120
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALLG 173
I+HRDIK SN+L++ + K+ DFGLA+ + N + RV T+ Y PE LLG
Sbjct: 121 ---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL-LLG 175
Query: 174 --QLTKKADVYSFGVLLLEIISGR 195
+ + D++S G +L E+ G+
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 36/279 (12%)
Query: 2 IGGGAFGVVYRG----SLRDGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLI 56
+G G+FGVV RG S +A+KCL ++ +FL E ++ ++ H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G V + ++V E SL + L + + T + + A+G+ +L +
Sbjct: 63 GV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESKR-- 117
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST----RVAGTMGYLAPEYALL 172
+HRD+ A N+LL + KIGDFGL + P N H +V + APE
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRT 174
Query: 173 GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE--- 229
+ +DV+ FGV L E+ + +G++ W ++L+ +D E
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT--------YGEE-------PWAGLSGSQILKKIDKEGER 219
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
L + PE V L C RPT + E L +
Sbjct: 220 LER-PEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 73/219 (33%), Positives = 114/219 (52%), Gaps = 14/219 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G+ T++AIK L K GT + FL E ++ +RH LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E+ I V E++ SL + L KY+ L P ++ A G++++
Sbjct: 70 VSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERMN---Y 123
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD++A+N+L+ N KI DFGLA+L DN + + APE AL G+ T K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 179 ADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216
+DV+SFG+LL E+++ GR ++L VE +++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 1 MIGGGAFGVVY------RGSLRDGTQIAIKCLSAESKQGTKEFLT----EIDMIWNIRHP 50
+IG G+FG VY G L Q+ + +SA SK + L EI ++ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
N+VQ +G ++ ++ + EY+ S+A ALL + Y + + N GL++L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVA-ALL---NNYGAFEETLVRNFVRQILKGLNYL 122
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA-----GTMGYL 165
H I+HRDIK +N+L+D KI DFG++K N T A G++ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIISGR 195
APE T+KAD++S G L++E+++G+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGC 58
IG G+FG VY+ R +AIK + E + E + EI + R P + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++ + ++ EY S + L K LD A I GL +LHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGK--- 119
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRDIKA+N+LL K+ DFG++ ++ +T V GT ++APE +K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 179 ADVYSFGVLLLEIISG 194
AD++S G+ +E+ G
Sbjct: 179 ADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 25/213 (11%)
Query: 2 IGGGAFGVVYRGSL-----RDGTQ-IAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLV 53
+G GAFG VY+G L R +AIK L +AE K EF E +++ +++HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQEAELMSDLQHPNIV 71
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALL------------GSKSKYVSLDWPTRANICL 101
L+G C ++ +++EYL + L L+ G ++ SLD +I +
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 102 GTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL-FPDNVTHVSTRVAG 160
A+G+ +L + VHRD+ A N L+ KI DFGL++ + + V ++
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+ ++ PE L G+ T ++D++SFGV+L EI S
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G++G VY+ ++ G +AIK + ++ +E + EI ++ P +V+ G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++ + +V EY S+ + ++ +K +L A I T GL +LH +H
Sbjct: 69 KNTDLWIVMEYCGAGSV-SDIMKITNK--TLTEEEIAAILYQTLKGLEYLH---SNKKIH 122
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIKA N+LL+ K+ DFG++ D + +T V GT ++APE KAD
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKAD 181
Query: 181 VYSFGVLLLEIISGR 195
++S G+ +E+ G+
Sbjct: 182 IWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 1 MIGGGAFGVVYRGSLRD----GT---QIAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNL 52
+G GAFG VY G+ D G+ ++A+K L + Q KEFL E ++ N HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS---LDWPTRANICLGTASGLSF 109
V+L+G C+ + + ++ E +E L + L ++ + L +ICL A G +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHP-----KIGDFGLAK-LFPDNVTHVSTRVAGTMG 163
L +HRD+ A N L+ + KIGDFGLA+ ++ + +
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222
++APE L G+ T ++DV+SFGVL+ EI++ G+ A ++L V GRL
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV------TAGGRL 232
Query: 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
Q PE + ++ C RPT ++ E+L
Sbjct: 233 ---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCC 59
IG GA VVY L + ++AIK + E Q + E E+ + HPN+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
V + LV YL SL + ++ S LD A + GL +LH +
Sbjct: 69 VVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVSTRVAGTMGYLAPEYALLGQL- 175
HRDIKA N+LL + KI DFG++ D V GT ++APE ++ Q+
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE--VMEQVH 182
Query: 176 --TKKADVYSFGVLLLEIISGR 195
KAD++SFG+ +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE-SKQGTK-EFLTEIDMIWNIRHPNLVQLIGC 58
IG G +G+VYR G +A+K + + + G L EI ++ N+RHPN+V+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 59 CVED--NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
V ++ LV EY E + LA+ L + + + L GL +LHE
Sbjct: 75 VVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE---SQVKCLMLQLLRGLQYLHENF-- 128
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
I+HRD+K SN+LL KI DFGLA+ + ++ +V T+ Y APE LLG
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPEL-LLGCTT 185
Query: 176 -TKKADVYSFGVLLLEIISGR 195
T D+++ G +L E+++ +
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-24
Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 29/202 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEF---LTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY +R +AIK +S KQ +++ + E+ + +RHPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVS-LDWPTR----ANICLGTASGLSFLHE 112
C + ++ LV EY LGS S + P + A IC G GL++LH
Sbjct: 83 CYLREHTAWLVMEYC---------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
+HRDIKA N+LL K+ DFG A L + V GT ++APE L
Sbjct: 134 HE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 173 ---GQLTKKADVYSFGVLLLEI 191
GQ K DV+S G+ +E+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 70/207 (33%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 2 IGGGAFGVVYRG--SLRDGT----QIAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G GAFG VY G RDG Q+A+K L + S+Q +FL E ++ H N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYV---SLDWPTRANICLGTASGLSFLH 111
LIG E R ++ E + L + L ++ + SL A G +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 112 EEADPPIVHRDIKASNVLLDGNFHP----KIGDFGLAK-LFPDNVTHVSTRVAGTMGYLA 166
E +HRDI A N LL P KI DFG+A+ ++ + R + ++
Sbjct: 134 ENH---FIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 167 PEYALLGQLTKKADVYSFGVLLLEIIS 193
PE L G T K DV+SFGVLL EI S
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 31/262 (11%)
Query: 21 IAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79
+A+K L A+ +K +FL EI ++ +++PN+++L+G CV D+ ++ EY+EN L N
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-N 105
Query: 80 ALLGSKSKYVSLDWPTRAN------------ICLGTASGLSFLHEEADPPIVHRDIKASN 127
L + + T AN + + ASG+ +L A VHRD+ N
Sbjct: 106 QFLSQREIESTF---THANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159
Query: 128 VLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGV 186
L+ ++ KI DFG+++ L+ + + R + ++A E LLG+ T +DV++FGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 187 LLLEIIS-GRSSSKAAFGDDMLILVEWTWK-LREEGRLLEIVDPELTQFPEKEVMRFIKV 244
L E+ + + + D+ +I E T + R +GR + + L P ++M
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVI--ENTGEFFRNQGRQIYLSQTPLCPSPVFKLM----- 272
Query: 245 GLFCTQAGAHYRPTMKQVVEML 266
+ C RPT ++ L
Sbjct: 273 -MRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-24
Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 7/191 (3%)
Query: 2 IGGGAFGVVYRGSL-RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+GGG +G VY G + +A+K L E +EFL E ++ I+HPNLVQL+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ ++ E++ +L + L + ++ + +S + +L ++ +H
Sbjct: 73 REPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RD+ A N L+ N K+ DFGL++L + + + APE + + K+D
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 181 VYSFGVLLLEI 191
V++FGVLL EI
Sbjct: 188 VWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLIGC 58
IG G +GVVY+ G +AIK + + K L EI ++ + HPN+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ LV+E+++ + L + K + L + GL+F H I
Sbjct: 67 FRHKGDLYLVFEFMDTD-LYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSHG---I 119
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTH-VSTRVAGTMGYLAPEYALLG- 173
+HRD+K N+L++ K+ DFGLA+ F TH V TR Y APE LLG
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPE-LLLGD 173
Query: 174 -QLTKKADVYSFGVLLLEIISGR 195
+ D++S G + E++S R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 8e-24
Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FGVV+ G R ++AIK ++ E ++F+ E ++ + HP LVQL G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+V E++EN L N L + + L ++C G+ +L + +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N L+ K+ DFG+ + D+ S+ + + PE + + K+DV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 182 YSFGVLLLEIIS 193
+SFGVL+ E+ +
Sbjct: 185 WSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+I G G Y+G S+++G Q +K E +EI + ++HPN+V+LIG C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVK----EINDVNSIPSSEIADMGKLQHPNIVKLIGLC 752
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ L++EY+E +L+ L L W R I +G A L FLH P +V
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
++ +++DG P + L L D +S+ Y+APE +T+K
Sbjct: 806 VGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL---TQFPE 235
+D+Y FG++L+E+++G+S + A FG I VEW + L +DP + +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSI-VEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
E++ + + L CT RP V++ L
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 1e-23
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE------FLTEIDMIWNIRHPNLVQ 54
+G G +GVVY+ + G +A+K + + +E L EI ++ ++HPN+V+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALK----KIRLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+ + LV+EY + + L L + L +I GL++ H
Sbjct: 63 LLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
I+HRD+K N+L++ + K+ DFGLA+ F + + V T+ Y APE LLG
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE-ILLGS 173
Query: 175 L--TKKADVYSFGVLLLEIISGR 195
+ D++S G + E+I+G+
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 84/295 (28%), Positives = 132/295 (44%), Gaps = 50/295 (16%)
Query: 1 MIGGGAFGVVYRGSLRD------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNL 52
+G GAFG V + + +A+K L + +++ + ++E++M+ I +H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 53 VQLIGCCVEDNNRILVYEYLENNSL-----ANALLGSKSKYVSLDWPTRANI-------- 99
+ L+G C ++ +V EY + +L A G + P +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD-DPRPPEETLTQKDLVSF 137
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G+ FL A +HRD+ A NVL+ + KI DFGLA+ ++ H+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRK 190
Query: 160 GTMGYL-----APEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213
T G L APE AL ++ T ++DV+SFGVLL EI + S I VE
Sbjct: 191 TTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG------IPVEEL 243
Query: 214 WKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+KL +EG +E P+ +MR C RPT KQ+VE L +
Sbjct: 244 FKLLKEGYRME--KPQNCTQELYHLMR------DCWHEVPSQRPTFKQLVEDLDR 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G + T++A+K L K GT + FL E +++ ++H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++ ++ EY+ SL + L + V L P + A G++++ +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---Y 124
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD++A+NVL+ + KI DFGLA++ DN + + APE G T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 179 ADVYSFGVLLLEIIS 193
+DV+SFG+LL EI++
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG V+RG L R +AIK L +++ ++FL+E ++ H N+++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G + +++ EY+EN +L L ++ S + G A+G+ +L +D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGMKYL---SD 125
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG--YLAPEYALLG 173
VHRD+ A N+L++ N K+ DFGL+++ D+ T G + + APE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 174 QLTKKADVYSFGVLLLEIIS 193
+ T +DV+SFG+++ E++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-23
Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 2 IGGGAFGVVYRGSLR--DGTQI--AIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V +G G ++ A+K L E G KEFL E ++ + HP +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G C + +LV E L L + VS + A G+++L +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVS----DLKELAHQVAMGMAYLESKH-- 115
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--MGYLAPEYALLGQ 174
VHRD+ A NVLL KI DFG+++ + AG + + APE G+
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 175 LTKKADVYSFGVLLLEIIS 193
+ K+DV+S+GV L E S
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-23
Identities = 69/254 (27%), Positives = 130/254 (51%), Gaps = 24/254 (9%)
Query: 21 IAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79
+A+K L ++ K +FL EI ++ ++ PN+++L+ C+ + ++ EY+EN L N
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-N 107
Query: 80 ALL--------GSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD 131
L K+ V++ + T + ASG+ +L + VHRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 132 GNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLE 190
N+ KI DFG+++ L+ + + R + +++ E LLG+ T +DV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 191 IIS-GRSSSKAAFGDDMLILVEWTWK-LREEGRLLEIVDPELTQFPEKEVMRFIKVGLFC 248
I++ + + D+ +I E T + R++GR + + P L P+ K+ L C
Sbjct: 225 ILTLCKEQPYSQLSDEQVI--ENTGEFFRDQGRQVYLPKPALC--PDS----LYKLMLSC 276
Query: 249 TQAGAHYRPTMKQV 262
+ A RP+ +++
Sbjct: 277 WRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-23
Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 2 IGGGAFGVVY---RGSLRDGTQIAIKCLSAESKQG---TKEFLTEIDMIWNIRHPNLVQL 55
I GA+G V+ + S D AIK + + LTE D++ + P +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
N LV EYL LA+ L SLD L +LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLL----ENVGSLDEDVARIYIAEIVLALEYLHSNG- 113
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAK-------LFPDNVTHVSTRVAGTMGYLAPE 168
I+HRD+K N+L+D N H K+ DFGL+K + ++ R+ GT Y+APE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 169 YALLGQLTKKADVYSFGVLLLEIISG 194
L +K D +S G +L E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-23
Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 29/276 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ----IAIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG V G L+ + +AIK L A +++ ++FL+E ++ HPN++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G + ++V EY+EN SL L ++ + + G ASG+ +L +D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL---SD 124
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG--YLAPEYALLG 173
VHRD+ A N+L++ N K+ DFGL+++ D+ T G + + APE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 174 QLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232
+ T +DV+S+G+++ E++S G D++ +E ++L P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-----------PAPMD 233
Query: 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P ++ L C Q + RP +Q+V +L K
Sbjct: 234 CP----AALHQLMLDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-23
Identities = 64/266 (24%), Positives = 124/266 (46%), Gaps = 28/266 (10%)
Query: 21 IAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL-- 77
+A+K L + +K +FL E+ ++ ++ PN+++L+G CV+++ ++ EY+EN L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 78 -------------ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIK 124
N + ++ + + ++ L ASG+ +L + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 125 ASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYS 183
N L+ N KI DFG+++ L+ + + R + ++A E L+G+ T +DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 184 FGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFI 242
FGV L EI+ + D+ +I + R++GR + + P E+M
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEF-FRDQGRQVYLFRPPPCPQGLYELM--- 281
Query: 243 KVGLFCTQAGAHYRPTMKQVVEMLSK 268
L C RP+ + L++
Sbjct: 282 ---LQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 9e-23
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 7/194 (3%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
++G G FG V++G+L+D T +A+K + Q K +FL+E ++ HPN+V+LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ +V E + + L + K L L A+G+++L + +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+ A N L+ N KI DFG+++ D + S + + APE G+ + ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 180 DVYSFGVLLLEIIS 193
DV+S+G+LL E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-22
Identities = 55/204 (26%), Positives = 109/204 (53%), Gaps = 19/204 (9%)
Query: 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG V RG L + +AIK L + +++ ++FL+E ++ HPN++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G + +++ E++EN +L + L + ++ + + G A+G+ +L ++
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---SE 124
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG------YLAPEY 169
VHRD+ A N+L++ N K+ DFGL++ D+ + + ++G + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEA 182
Query: 170 ALLGQLTKKADVYSFGVLLLEIIS 193
+ T +DV+S+G+++ E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-----FLTEIDMIWNIRHPNLVQL 55
+G G + VVY+ G +AIK + ++ K+ L EI ++ ++HPN++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANI---CLGTASGLSFLHE 112
+ +N LV+E++E + ++ KS + L T A+I L T GL +LH
Sbjct: 68 LDVFGHKSNINLVFEFMETD--LEKVIKDKS--IVL---TPADIKSYMLMTLRGLEYLHS 120
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
I+HRD+K +N+L+ + K+ DFGLA+ F ++ +V T Y APE L
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL-LF 175
Query: 173 G--QLTKKADVYSFGVLLLEIISGR 195
G D++S G + E++
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQL 55
IG G FG VY+G +A+K + +E FL E ++ HP++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
IG E+ I V E L + L +KY SLD + ++ L++L +
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKY-SLDLASLILYSYQLSTALAYLESKR- 127
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHRDI A NVL+ K+GDFGL++ D + +++ + ++APE +
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 176 TKKADVYSFGVLLLEIIS 193
T +DV+ FGV + EI+
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-22
Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 7/192 (3%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FGVV G R +AIK + E EF+ E ++ + H LVQL G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+V EY+ N L N L + +C G+++L + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N L+D K+ DFGL++ D+ S + + PE L + + K+DV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 182 YSFGVLLLEIIS 193
++FGVL+ E+ S
Sbjct: 185 WAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-22
Identities = 85/288 (29%), Positives = 136/288 (47%), Gaps = 35/288 (12%)
Query: 2 IGGGAFGVV--YR-GSLRDGT--QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G FG V Y DGT +A+K L E +Q T + EI+++ + H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 56 IGCCVEDNNRI--LVYEYLENNSLANALLGSKSKYVSLDWPTRANICL---GTASGLSFL 110
GCC E + L+ EY+ LGS Y+ A + L G+++L
Sbjct: 72 KGCCSEQGGKGLQLIMEYVP--------LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYL 123
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--MGYLAPE 168
H + +HRD+ A NVLLD + KIGDFGLAK P+ + R G + + A E
Sbjct: 124 HSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 169 YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD- 227
+ + +DV+SFGV L E+++ SK + ++ RL+E+++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 228 ----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
P P+ EV +K C + A +RPT + ++ +L K++H
Sbjct: 240 GMRLPCPKNCPQ-EVYILMKN---CWETEAKFRPTFRSLIPIL-KEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-22
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRH---PNLVQL 55
+IG GA+G VYRG + G +A+K ++ ++ + E+ ++ +R PN+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGS--KSKYVSLDWPTRANICLGTASGLSFLHEE 113
G ++ ++ EY E S+ + KY+S+ I L ++H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKV 120
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
++HRDIKA+N+L+ + K+ DFG+A L N + ST V GT ++APE G
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176
Query: 174 QL-TKKADVYSFGVLLLEIISG 194
+ KAD++S G+ + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-22
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V G R G ++A+KC+ ++ + FL E ++ +RH NLVQL+G VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 62 DNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ + +V EY+ SL + L S+ + V L L + +L EA+ VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVD-YLRSRGRSV-LGGDCLLKFSLDVCEAMEYL--EAN-NFVH 125
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RD+ A NVL+ + K+ DFGL K + + + APE + + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 181 VYSFGVLLLEIIS-GR 195
V+SFG+LL EI S GR
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-22
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
++G G +G+VY L +IAIK + + + EI + ++H N+VQ +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
E+ + E + SL+ ALL SK + + T GL +LH+ IV
Sbjct: 75 SENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IV 130
Query: 120 HRDIKASNVLLDGNFHP---KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ-- 174
HRDIK NVL+ N + KI DFG +K + + GT+ Y+APE G
Sbjct: 131 HRDIKGDNVLV--NTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 175 LTKKADVYSFGVLLLEIISGR 195
AD++S G ++E+ +G+
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G GVV + R +I A+K + E K+ L E+D++ P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLHEEADPP 117
+ + + EY++ SL L K V P R I + GL++LHE
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGLTYLHE--KHK 121
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
I+HRD+K SN+L++ K+ DFG++ +++ GT Y+APE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQGNDYSV 178
Query: 178 KADVYSFGVLLLEIISGR 195
K+D++S G+ L+E+ +GR
Sbjct: 179 KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 69/204 (33%), Positives = 98/204 (48%), Gaps = 29/204 (14%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLS----AESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G+FG V + + A+K LS + KQ + L E ++ +IRHP LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
G +D+N LV EY+ L + L KS R A + L L +LH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQVVLA----LEYLHSL 120
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR---VAGTMGYLAPEYA 170
IV+RD+K N+LLD + + KI DFG AK V R + GT YLAPE
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEII 170
Query: 171 LLGQLTKKADVYSFGVLLLEIISG 194
L K D ++ G+L+ E+++G
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 16/238 (6%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEF-LTEIDMIWNIRHPNLVQLIGCC 59
+G G + VY+G R G +A+K + ++++GT + EI ++ ++H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+N +LV+EY++ + + + +LD T + G++F HE ++
Sbjct: 68 HTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K N+L++ K+ DFGLA+ F V S V T+ Y AP+ LLG T
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD-VLLGSRTYST 180
Query: 180 --DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235
D++S G ++ E+I+GR +D L+ + R G E P ++Q PE
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI-----FRIMGTPTESTWPGISQLPE 233
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFG VY+ ++ A K + ES++ ++F+ EID++ +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+N ++ E+ + +L + +L + L P +C L+FLH ++H
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSHK---VIH 126
Query: 121 RDIKASNVLL--DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK- 177
RD+KA N+LL DG+ K+ DFG++ + T + GT ++APE
Sbjct: 127 RDLKAGNILLTLDGDV--KLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183
Query: 178 ----KADVYSFGVLLLEIISGR 195
KAD++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK------CLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG G F VVY+ L DG +A+K + A+++Q + L EID++ + HPN+++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIK 66
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+ +E+N +V E + L+ + K + + T + S L +H +
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
I+HRDIK +NV + K+GD GL + F T + V GT Y++PE
Sbjct: 127 ---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKAAFGDDM 206
K+D++S G LL E+ + +S GD M
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFY---GDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-21
Identities = 85/279 (30%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI----AIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG VY G+L D A+K L+ + ++FL E ++ + HPN++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 56 IGCCVEDNNRILV-YEYLENNSLANALLGSKSKYVSLDWPTRANIC---LGTASGLSFLH 111
+G C+ LV Y+++ L N + PT ++ L A G+ +L
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL- 114
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN---VTHVSTRVAGTMGYLAPE 168
A VHRD+ A N +LD +F K+ DFGLA+ D H T + ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 169 YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228
+ T K+DV+SFGVLL E+++ R + D I T L + RLL+ P
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDI----TVYLLQGRRLLQ---P 224
Query: 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267
E P EVM L C RPT ++V +
Sbjct: 225 EYCPDPLYEVM------LSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 5e-21
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G+ GVVY+ + G A+K + ++ K+ L E+ + + P +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA- 67
Query: 60 VEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLHEEADP 116
I +V EY++ SLA+ LL K P A I GL +LH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD-LLKKVGK-----IPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
I+HRDIK SN+L++ KI DFG++K+ + + +T V GT+ Y++PE + G+
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-RIQGESY 177
Query: 176 TKKADVYSFGVLLLEIISGR 195
+ AD++S G+ LLE G+
Sbjct: 178 SYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
++G GA+GVV + + +I AIK S + + K L E+ ++ +RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
LV+EY+E L LL + L + +++ H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE--LLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHN--- 120
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QL 175
I+HRDIK N+L+ + K+ DFG A+ T T Y APE L+G
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL-LVGDTNY 179
Query: 176 TKKADVYSFGVLLLEIISGR 195
K DV++ G ++ E++ G
Sbjct: 180 GKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 59/185 (31%), Positives = 95/185 (51%), Gaps = 14/185 (7%)
Query: 19 TQIAIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77
+A+K L S ++FL E+ ++ + PN+ +L+G C D ++ EY+EN L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 78 ANALL--------GSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVL 129
N L G SL + T + ASG+ +L E + VHRD+ N L
Sbjct: 107 -NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCL 162
Query: 130 LDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLL 188
+ N+ KI DFG+++ L+ + V R + ++A E LLG+ T K+DV++FGV L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
Query: 189 LEIIS 193
EI++
Sbjct: 223 WEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 8/201 (3%)
Query: 2 IGGGAFGVVYR-GSLRDGTQIAIKCLSAES-KQGTKEFLT-EIDMIWNIRHPNLVQLIGC 58
IG G+FG V + DG + K + + + K+ L E++++ ++HPN+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 59 CV-EDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH--EEA 114
+ N + +V EY E LA + K + ++ I L H +
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
++HRD+K +N+ LD N + K+GDFGLAK+ + + T V GT Y++PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMS 186
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+K+D++S G L+ E+ +
Sbjct: 187 YDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 26/269 (9%)
Query: 2 IGGGAFG--VVYRGSLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G GAFG +YR + D + + K L+ S++ ++ L EI ++ ++HPN++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
++DN ++ EY +L + ++ K + + S +S++H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKAG--- 121
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
I+HRDIK N+ L K+GDFG++K+ + T V GT Y++PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNF 180
Query: 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237
K+D+++ G +L E+++ + + + L LV K IV T
Sbjct: 181 KSDIWALGCVLYELLTLK---RTFDATNPLNLV---VK---------IVQGNYTPVVSVY 225
Query: 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
I + Q RPT +V++
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-21
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ + T++A+K + S + FL E +++ ++H LV+L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ I+ E++ SL + L + L P + A G++F+ + +HR
Sbjct: 73 EPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D++A+N+L+ + KI DFGLA++ DN + + APE G T K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 182 YSFGVLLLEIIS-GR 195
+SFG+LL+EI++ GR
Sbjct: 187 WSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-21
Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G+FGVV++ + ++ A+K LS +++ +E + E ++ + +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLD--WPTRANICLGTASGLSFLHEEADP 116
++ +V EY EN L L + + + D W I LG L+ LH +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHSKK-- 121
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
I+HRDIK+ N+ LD + KIGD G+AKL DN +T V GT YL+PE
Sbjct: 122 -ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYN 179
Query: 177 KKADVYSFGVLLLEIISGR 195
+K+DV++ GV+L E +G+
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 2 IGGGAFGVVYRGSLRD------GTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FG+VY G + T++AIK ++ S + EFL E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS---LDWPTRA---NICLGTASGLS 108
L+G ++V E + L + L + + + L PT + A G++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAP 167
+L + VHRD+ A N ++ + KIGDFG+ + ++ + + + ++AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 168 EYALLGQLTKKADVYSFGVLLLEIIS 193
E G T K+DV+SFGV+L E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 17/196 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G +G VY+ + G +AIK + E + EI M+ RHPN+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V EY SL + + L A +C T GL++LHE +H
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIY---QVTRGPLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR---VAGTMGYLAPEYA---LLGQ 174
RDIK +N+LL + K+ DFG++ +T + GT ++APE A G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQ----LTATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 175 LTKKADVYSFGVLLLE 190
K D+++ G+ +E
Sbjct: 181 YDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-20
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 2 IGGGAFGVVYRGSL------RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G GAFG V+ +D +A+K L S K+F E +++ N++H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 56 IGCCVEDNNRILVYEYLENNSLAN---------ALLGSKSKYVSLDWPTRANICLGTASG 106
G CVE + I+V+EY+++ L L+ ++ L +I A+G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYL 165
+ +L A VHRD+ N L+ N KIGDFG+++ ++ + V + ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIIS 193
PE + + T ++DV+S GV+L EI +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 36/284 (12%)
Query: 2 IGGGAFGVVYRGS------LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G GAFG V+ +D +A+K L + K+F E +++ N++H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 56 IGCCVEDNNRILVYEYLENNSLANALL--GSKSKYVSLDWPTRANICLG----------T 103
G C + + I+V+EY+++ L L G + + P +A LG
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTM 162
ASG+ +L A VHRD+ N L+ N KIGDFG+++ ++ + V +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 163 GYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRL 222
++ PE + + T ++DV+SFGV+L EI + + +I + +GR+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ECITQGRV 243
Query: 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
LE P + KEV + L C Q R +K++ ++L
Sbjct: 244 LE--RPRVC---PKEVYDIM---LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 2 IGGGAFGVVYRG------SLRDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG GAFG V++ T +A+K L E S +F E ++ HPN+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS------------------LDWPTR 96
L+G C L++EY+ L L + L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 97 ANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVS 155
I A+G+++L ++ VHRD+ N L+ N KI DFGL+ ++ + S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
A + ++ PE + T ++DV+++GV+L EI S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS---------AESKQGTKEFL-TEIDMIWNIRH 49
+IG G +G VY ++ G +A+K + ++ + L +EI+ + ++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 50 PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
N+VQ +G + + EY+ S+ + L Y + GL++
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD---NVTHVSTRVAGTMGYLA 166
LH + I+HRD+KA N+L+D + KI DFG++K D N ++S + G++ ++A
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWMA 178
Query: 167 PEYALLGQ--LTKKADVYSFGVLLLEIISGR 195
PE + K D++S G ++LE+ +GR
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-20
Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 29/269 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V +G G ++A+K + + + FL E ++ + H NLV+L+G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
N +V E + +L N L VS+ L A G+ +L + +VHR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N+L+ + K+ DFGLA++ V + V T APE + + K+DV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDV 180
Query: 182 YSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240
+S+GVLL E+ S GR+ + L E + E+G +E PE +M
Sbjct: 181 WSYGVLLWEVFSYGRAPYPK------MSLKEVKECV-EKGYRME--PPEGCPADVYVLMT 231
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269
C + RP+ ++ E L K+
Sbjct: 232 ------SCWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIK-----CLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY D G ++A+K S E+K+ EI ++ N++H +VQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 55 LIGCCVEDNNRILVYEYLENNSLAN--ALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
GC +D + EY+ S+ + G+ ++ V+ + TR + G+ +LH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY-TRQIL-----EGVEYLH- 121
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS--TRVAGTMGYLAPEYA 170
IVHRDIK +N+L D + K+GDFG +K + + V GT +++PE
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 171 LLGQLTKKADVYSFGVLLLEIIS 193
+KADV+S G ++E+++
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 21/198 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY +R+ +AIK +S KQ ++ + E+ + +RHPN +Q G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + ++ LV EY + A+ LL K L A + G GL++LH
Sbjct: 83 CYLREHTAWLVMEYCLGS--ASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALL---G 173
++HRD+KA N+LL K+GDFG A + P N GT ++APE L G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEG 189
Query: 174 QLTKKADVYSFGVLLLEI 191
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-20
Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS------AESKQGTKEFLTEIDMIWNIRHPNLV 53
+G GAF Y+ ++ GT +A+K ++ +E ++ + EI ++ + HP+++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
+++G ED++ L E++ S+++ L SKY + N GLS+LHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 114 ADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLFPDNVT---HVSTRVAGTMGYLAPEY 169
I+HRD+K +N+L+D +I DFG A T ++ GT+ ++APE
Sbjct: 123 Q---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGR 195
Q + DV+S G +++E+ + +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG GAFG V RD ++ A+K ++ + K + L E ++ + HP LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
++ N LV + L L L K K+ + + IC L +LH +
Sbjct: 68 SFQDEENMYLVVDLLLGGDL-RYHLSQKVKFS--EEQVKFWIC-EIVLALEYLHSKG--- 120
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
I+HRDIK N+LLD H I DF +A + ++T +GT GY+APE L Q
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE-VLCRQGYS 177
Query: 178 KA-DVYSFGVLLLEIISGR 195
A D +S GV E + G+
Sbjct: 178 VAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 2 IGGGAFGVVY---RGSLRDGTQIAIKCLSAESKQGTKEFLT---EIDMIWNIRHPNLVQL 55
IG G +G VY R + +DG + AIK + +Q T + EI ++ ++H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 56 IGCCVEDNNRI--LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
+ +E ++ L+++Y E++ ++K VS+ ++ +G+ +LH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 114 ADPPIVHRDIKASNVLLDGNFHP----KIGDFGLAKLF--PDNVTHVSTRVAGTMGYLAP 167
++HRD+K +N+L+ G KIGD GLA+LF P V T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184
Query: 168 EYALLG--QLTKKADVYSFGVLLLEIIS 193
E LLG TK D+++ G + E+++
Sbjct: 185 EL-LLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIK--------CLSAESKQGTKEFLTEIDMIWNIRHPNL 52
++G GA+G VY G G IA+K L+AE + ++ E+D++ +++H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY--EKLQEEVDLLKSLKHVNI 64
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
VQ +G C++DN + E++ S+++ L +++ L P G+++LH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK---LFPDNVTH--VSTRVAGTMGYLAP 167
+VHRDIK +NV+L N K+ DFG A+ + TH + + GT ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISGR 195
E +K+D++S G + E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 28/280 (10%)
Query: 2 IGGGAFGVVYRGSLRDG---TQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG G FG V G G ++ +K L A + FL E+ + HPN++Q +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRA--NICLGTASGLSFLHEEAD 115
C+E +LV E+ L N L S V+ + ASGL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKN-YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYLAPEYA---- 170
+H D+ N L + KIGD+GLA + +P++ A + +LAPE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 171 ---LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227
L TKK++++S GV + E+ + D+ ++ +RE + +++
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL----KQVVRE--QDIKLPK 232
Query: 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267
P+L K R+ +V FC RPT ++V E+L+
Sbjct: 233 PQLDL---KYSDRWYEVMQFCWLD-PETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 2 IGGGAFGVVYRGSLR-DGTQI--AIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G FG V +G + QI AIK L + K E + E +++ + +P +V++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL---GTASGLSFLHEEA 114
C E +LV E L N L K D T +N+ + G+ +L +
Sbjct: 63 VC-EAEALMLVMEMASGGPL-NKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--MGYLAPEYALL 172
VHRD+ A NVLL + KI DFGL+K + ++ R AG + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 173 GQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211
+ + ++DV+S+G+ + E S G+ K G +++ +E
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-19
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY +R +AIK +S KQ ++ + E+ + I+HPN ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + ++ LV EY + A+ LL K L A I G GL++LH
Sbjct: 93 CYLREHTAWLVMEYCLGS--ASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL---GQ 174
++HRDIKA N+LL K+ DFG A ++ + GT ++APE L GQ
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSA-----SIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 175 LTKKADVYSFGVLLLEI 191
K DV+S G+ +E+
Sbjct: 201 YDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G G++G VY+ L D A+K L + S++ ++ + EI ++ ++ HPN++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++ N +V EY L+ A+ K K + I + GL LHE+ I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD+K++N+LL N KIGD G++K+ N+ GT Y+APE + K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRPYSYK 181
Query: 179 ADVYSFGVLLLEIISGR 195
+D++S G LL E+ +
Sbjct: 182 SDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-19
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 2 IGGGAFGVVYRGSL------RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G GAFG V+ +D +A+K L S+ ++F E +++ ++H ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 56 IGCCVEDNNRILVYEYLENNSL----------ANALLGSKSKYVS-LDWPTRANICLGTA 104
G C E ++V+EY+ + L A L G + L I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMG 163
SG+ +L A VHRD+ N L+ KIGDFG+++ ++ + V R +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
++ PE L + T ++D++SFGV+L EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-19
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 29/202 (14%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY + ++ A+K +S KQ ++ + E+ + ++HPN ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVS-----LDWPTRANICLGTASGLSFLHE 112
C ++++ LV EY LGS S + L A I G GL++LH
Sbjct: 89 CYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
++HRDIKA N+LL K+ DFG A + + + GT ++APE L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILA 191
Query: 173 ---GQLTKKADVYSFGVLLLEI 191
GQ K DV+S G+ +E+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 23/201 (11%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFG VY+ ++ G A K + +S++ ++++ EID++ + HPN+V+L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+NN ++ E+ ++ +L + L P +C T L++LHE I+H
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 121 RDIKASNVL--LDGNFHPKIGDFGLAKLFPDNVTHVSTRVA--GTMGYLAPEYALLGQLT 176
RD+KA N+L LDG+ K+ DFG++ N + R + GT ++APE ++ + +
Sbjct: 127 RDLKAGNILFTLDGDI--KLADFGVSA---KNTRTIQRRDSFIGTPYWMAPE-VVMCETS 180
Query: 177 K------KADVYSFGVLLLEI 191
K KADV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 22/201 (10%)
Query: 5 GAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-F----LTEIDMIWNIRHPNLVQLIGC 58
G +GVVYR + G +A+K L E + KE F L EI+++ ++HPN+V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 59 CVEDN-NRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
V N ++I +V EY+E++ +L+ + + + L SG++ LH+
Sbjct: 73 VVGSNLDKIYMVMEYVEHD--LKSLMETMKQPFLQ--SEVKCLMLQLLSGVAHLHDNW-- 126
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--Q 174
I+HRD+K SN+LL+ KI DFGLA+ + + T++ T+ Y APE LLG +
Sbjct: 127 -ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYRAPEL-LLGAKE 183
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+ D++S G + E+++ +
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQI----AIKCLSAESKQGTKEFLTE-IDMIWNIRHPNLVQ 54
++G G FG V++G + +G I AIK + S + T + +T+ + + ++ H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+G C + + LV + SL + + + SLD N C+ A G+ +L E
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL-FPDNVTHVSTRVAGTMGYLAPEYALLG 173
+VHR++ A N+LL + +I DFG+A L +PD+ + + + ++A E L G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 174 QLTKKADVYSFGVLLLEIIS 193
+ T ++DV+S+GV + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 1 MIGGGAFGVV----YRGSLRDGTQ--IAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G FG V Y L+D T +A+K L + + ++F EI+++ +++H N+V+
Sbjct: 11 QLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 55 LIGCCVE--DNNRILVYEYLENNSLANALLGSKSKYVSLDWPT----RANICLGTASGLS 108
G C N LV EYL SL + L + + LD + IC G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQIC----KGME 122
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--MGYLA 166
+L + VHRD+ N+L++ KIGDFGL K+ P + + R G + + A
Sbjct: 123 YLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 167 PEYALLGQLTKKADVYSFGVLLLEII--SGRSSSKAA 201
PE + + +DV+SFGV+L E+ S +S S A
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 2 IGGGAFGVVYRGSL----RDGTQ-IAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G AFG +Y+G L D Q +AIK L + Q EF E ++ + HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 56 IGCCVEDNNRILVYEYLENNSLANALL--------GSKSK-----YVSLDWPTRANICLG 102
+G ++ +++EYL L L+ G S SLD +I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 103 TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGT 161
A+G+ +L + VH+D+ A N+L+ H KI D GL++ ++ + V +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+ ++ PE + G+ + +D++SFGV+L EI S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS-AESKQGTKEF-LTEIDMIWNIR---HPNLVQL 55
IG GA+G VY+ L G +A+K + S++G L EI ++ + HPN+V+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 56 IGCC-VEDNNRI----LVYEYLENNSLANALLGSKSKYVS--LDWPTRANICLGTASGLS 108
+ C +R LV+E+++ + LA L SK L T ++ G+
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQD-LATYL----SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE 168
FLH IVHRD+K N+L+ + KI DFGLA+++ + T V T+ Y APE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPE 176
Query: 169 YALLGQLTKKADVYSFGVLLLEI 191
L D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIK------CLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG G F VYR + L DG +A+K + A+++ + + EID++ + HPN+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLNHPNVIK 66
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+EDN +V E + L+ + K + + T + S L +H
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
++HRDIK +NV + K+GD GL + F T + V GT Y++PE
Sbjct: 127 ---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKAAFGDDM 206
K+D++S G LL E+ + +S +GD M
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP---FYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTEIDMIWNI----------RH 49
++G G+FG V L+ ++ A+K L + L + D+ + +H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD------VILQDDDVECTMTEKRVLALAGKH 55
Query: 50 PNLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
P L QL C + +R+ V EY+ L + + D P GL
Sbjct: 56 PFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQ 110
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLA 166
FLHE I++RD+K NVLLD H KI DFG+ K + T + GT Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIA 164
Query: 167 PEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
PE L Q D ++ GVLL E+++G+S
Sbjct: 165 PE-ILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 26/243 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G +GVVY+ + G +A+K L E++ + EI ++ + HPN+V+L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+N LV+E+L + L + S + L P + GL+F H +
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCHSHR---V 121
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ--LT 176
+HRD+K N+L++ K+ DFGLA+ F V + V T+ Y APE LLG +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE-ILLGCKYYS 179
Query: 177 KKADVYSFGVLLLEIISGRSSSKAAF-GD---DMLILVEWTWKLREEGRLLEIVDPELTQ 232
D++S G + E+++ R A F GD D L + R G E+V P +T
Sbjct: 180 TAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRI-----FRTLGTPDEVVWPGVTS 230
Query: 233 FPE 235
P+
Sbjct: 231 LPD 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQ 54
+G G FG V+ + T + +K L + + EF E+DM + H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWP-----TRANICLGTASGLSF 109
L+G C E ++ EY + L L +KSK L P + +C A G+
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK------LFPDNVTHVSTRVAGTMG 163
L ++ VHRD+ A N L+ K+ L+K + + R
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------ 183
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+LAPE + K+DV+SFGVL+ E+ +
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-18
Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQI----AIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY+G + +G ++ AIK L A S + KE L E ++ ++ +P++ +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS---LDWPTRANICLGTASGLSFLH 111
L+G C+ + L+ + + L + + K S L+W C+ A G+++L
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 126
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYA 170
E +VHRD+ A NVL+ H KI DFGLAKL D + + + ++A E
Sbjct: 127 ERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 171 LLGQLTKKADVYSFGVLLLEIIS 193
L T ++DV+S+GV + E+++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-18
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 4 GGAFGVVYRGSLRDGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCCVED 62
GG+ V + GT +A K + +K K+ L E+ ++ R P +V G + +
Sbjct: 18 GGSVSKVKH--IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75
Query: 63 NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRD 122
NN + E+++ SL K + I + GL++L+ I+HRD
Sbjct: 76 NNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRD 129
Query: 123 IKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVY 182
IK SN+L++ K+ DFG++ + + ++ GT Y++PE G+ T K+DV+
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 183 SFGVLLLEIISGRSSSKAAFGDD 205
S G+ ++E+ G+ + DD
Sbjct: 187 SLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIK-CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G FG V+ G LR D T +A+K C +FL E ++ HPN+V+LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ +V E ++ L +++ L + A+G+ +L + +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-MGYLAPEYALLGQLTKK 178
HRD+ A N L+ KI DFG+++ D V + + + + APE G+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGD 204
+DV+SFG+LL E S + A +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 60/201 (29%), Positives = 81/201 (40%), Gaps = 23/201 (11%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES----KQGTKEFLTEIDMIWNIRHPNLVQLI 56
I GAFG VY R G AIK L Q T M+ P + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTAS---GLSFLHEE 113
+ LV EYL A+ L + DW A G+ LH+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS--LIKTLGGLPEDW-----AKQYIAEVVLGVEDLHQR 116
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
I+HRDIK N+L+D H K+ DFGL++ + + GT YLAPE L
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGV 168
Query: 174 QLTKKADVYSFGVLLLEIISG 194
K +D +S G ++ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 2 IGGGAFGVVYRG---SLRDGTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V +G + +A+K L ++ E L E +++ + +P +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANI---CLGTASGLSFLHEE 113
G C E + +LV E E L L K+K+V T NI + G+ +L E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL--QKNKHV-----TEKNITELVHQVSMGMKYLEET 114
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT--MGYLAPEYAL 171
VHRD+ A NVLL + KI DFGL+K + + + G + + APE
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 172 LGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211
+ + K+DV+SFGVL+ E S G+ K G+++ ++E
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 2 IGGGAFGVVYR----GSLRDGT--QIAIKCLSAESKQGTKEFL-TEIDMIWNI-RHPNLV 53
+G GAFG V G + ++A+K L + +E L +E+ ++ ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
L+G C +++ EY L N L + +++L+ + A G++FL
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAKGMAFL--- 157
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDN--VTHVSTRVAGTMGYLAPEYA 170
A +HRD+ A NVLL KI DFGLA+ + D+ V + R+ + ++APE
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPESI 215
Query: 171 LLGQLTKKADVYSFGVLLLEIIS 193
T ++DV+S+G+LL EI S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 67/209 (32%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTEID-----------MIWNIR 48
++G G+FG V L+ + AIK L K+ + E D +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK-------KDVVLEDDDVECTMVERRVLALAWE 54
Query: 49 HPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
HP L L + V EYL L + S + A I GL
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI----ICGLQ 110
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE 168
FLH++ I++RD+K NVLLD + H KI DFG+ K + ST GT Y+APE
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPE 166
Query: 169 YALLGQL-TKKADVYSFGVLLLEIISGRS 196
L GQ + D +SFGVLL E++ G+S
Sbjct: 167 -ILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCC 59
+G GA G V + L++ I A+K ++ + K+ L E+++ + + P +V+ G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 60 VE--DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
++ ++ + EY E SL + K + + I GLS+LH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--- 125
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
I+HRDIK SN+LL K+ DFG++ V ++ GT Y+APE +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTSFYMAPERIQGKPYSI 182
Query: 178 KADVYSFGVLLLEIISGR 195
+DV+S G+ LLE+ R
Sbjct: 183 TSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 2 IGGGAFGVVY------RGSLRDGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQ 54
+G G FG V G G Q+A+K L ES + EI+++ N+ H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 55 LIGCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
G C ED L+ E+L + SL L +K+K ++ + + G+ +L
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLGS 127
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR--VAGTMGYLAPEYA 170
VHRD+ A NVL++ KIGDFGL K + + + + + + + APE
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 171 LLGQLTKKADVYSFGVLLLEIIS 193
+ + +DV+SFGV L E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 36/217 (16%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQI--AIKCLSA-ESKQGTKEFLTEIDMIWNI-RHPNLVQL 55
+IG G FG V R ++ DG ++ AIK L S+ ++F E++++ + HPN++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 56 IGCCVEDNNRILVYEYLENNSLANAL-LGSKSKYVSLDWPTRANICLGTASGLSF----- 109
+G C NR +Y +E N L KS+ + D P A GTAS L+
Sbjct: 69 LGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETD-PAFAKE-HGTASTLTSQQLLQ 123
Query: 110 --------LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161
+ ++ +HRD+ A NVL+ N KI DFGL++ V T
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKT 176
Query: 162 MGYLAPEYALLGQL-----TKKADVYSFGVLLLEIIS 193
MG L + + L T K+DV+SFGVLL EI+S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCC 59
IG G +G VY+ + Q+ AIK + + +E E +++ HPN+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 60 VEDNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
++ N LV E S+ + + G + K L A I T GL++LHE
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR---VAGTMGYLAPEYA 170
++HRDIK N+LL N K+ DFG++ + R GT ++APE
Sbjct: 133 K---VIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTPYWMAPEVI 185
Query: 171 LLGQ-----LTKKADVYSFGVLLLEIISG 194
+ ++DV+S G+ +E+ G
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFL-TEIDMIWNIRHPNLVQLIGCC 59
IG GA G VY + G ++AIK ++ +Q KE + EI ++ +HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ + +V EYL SL + + + +D A +C L FLH ++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VI 137
Query: 120 HRDIKASNVLLDGNFHPKIGDFGL-AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
HRDIK+ N+LL + K+ DFG A++ P+ + ST V GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 179 ADVYSFGVLLLEIISG 194
D++S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQI----AIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY+G + DG + AIK L S + KE L E ++ + P + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+G C+ + LV + + L + + +K + S D N C+ A G+S+L E
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL---LNWCVQIAKGMSYLEEVR 129
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP-DNVTHVSTRVAGTMGYLAPEYALLG 173
+VHRD+ A NVL+ H KI DFGLA+L D + + + ++A E L
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 174 QLTKKADVYSFGVLLLEIIS 193
+ T ++DV+S+GV + E+++
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 2 IGGGAFG-VVYRGSLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G+FG + S DG Q IK +S S + +E E+ ++ N++HPN+VQ
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVS----LDWPTRANICLGTASGLSFLHEEA 114
E+ N +V +Y E L + + LDW + ICL L +H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LKHVH--- 118
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
D I+HRDIK+ N+ L + K+GDFG+A++ V T + GT YL+PE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRP 177
Query: 175 LTKKADVYSFGVLLLEIIS 193
K+D+++ G +L E+ +
Sbjct: 178 YNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 2 IGGGAFGVVYRGSL-----RDG-TQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQ 54
+G G FG V + + R G T +A+K L + ++ L+E +++ + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKS---KYV---------SLDWPTRANICLG 102
L G C +D +L+ EY + SL + L S+ Y+ LD P + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 103 --------TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTH 153
+ G+ +L E +VHRD+ A NVL+ KI DFGL++ ++ ++
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
++ + ++A E T ++DV+SFGVLL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 4e-17
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG GA G V+ + G ++AIK ++ + + + + EI ++ +++PN+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V EYL SL + + + +D A +C L FLH ++H
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIH 138
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ NVLL + K+ DFG + ST V GT ++APE K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 181 VYSFGVLLLEIISG 194
++S G++ +E++ G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK-CLSAESKQGTKEF----LTEIDMIWNIRHPNLVQL 55
+G G FG VY+ ++ G +A+K L K G F L EI ++ ++HPN+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPL 72
Query: 56 IGCCVEDNNRI--------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGL 107
I VE ++ +V Y++++ + LL + S V L L G+
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHD--LSGLLENPS--VKLTESQIKCYMLQLLEGI 128
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV----------THVSTR 157
++LHE I+HRDIKA+N+L+D KI DFGLA+ + T T
Sbjct: 129 NYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 158 VAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
+ T Y PE LLG + T D++ G + E+ + R
Sbjct: 186 LVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIK------CLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG G F VYR + L D +A+K + A+++Q + + EID++ + HPN+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLNHPNVIK 66
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLD----WPTRANICLGTASGLSFL 110
+ +EDN +V E + L+ + K + + W +C S + +
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHM 122
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H ++HRDIK +NV + K+GD GL + F T + V GT Y++PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 171 LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLIL 209
K+D++S G LL E+ + +S +GD M +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLF 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 40/215 (18%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRH-PNLVQLIG- 57
IG GAFG V + + GT +A+K + + ++ K L ++D++ P +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 58 ------C--CVE------DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT 103
C C+E D VYE L++ L I + T
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEIL---------------GKIAVAT 116
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
L++L EE I+HRD+K SN+LLD N + K+ DFG++ D++ TR AG
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRP 172
Query: 164 YLAPEYALLGQLTK---KADVYSFGVLLLEIISGR 195
Y+APE ++DV+S G+ L E+ +G+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-17
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFG VY+ ++ G A K + +S++ ++++ EI+++ HP +V+L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
D ++ E+ ++ +L L P IC L +LH I+H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMK---IIH 133
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA--GTMGYLAPEYALLGQLTK- 177
RD+KA NVLL + K+ DFG++ NV + R + GT ++APE + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 178 ----KADVYSFGVLLLEI 191
KAD++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-17
Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 22/204 (10%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQI----AIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY+G + +G + AIK L+ + + EF+ E ++ ++ HP+LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS---LDWPTRANICLGTASGLSFLH 111
L+G C+ + LV + + + L + + K S L+W C+ A G+ +L
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEY 169
E +VHRD+ A NVL+ H KI DFGLA+L + + G M ++A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIKWMALEC 182
Query: 170 ALLGQLTKKADVYSFGVLLLEIIS 193
+ T ++DV+S+GV + E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG GA G VY + G ++AIK ++ + + + + EI ++ ++PN+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V EYL SL + + + +D A +C L FLH ++H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIH 138
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ N+LL + K+ DFG + ST V GT ++APE K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 181 VYSFGVLLLEIISG 194
++S G++ +E++ G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESK-QGTKEF-LTEIDMIWNIRHPNLVQLIGC 58
IG G +GVVY+G + + G +A+K + ES+ +G + EI ++ ++HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++++ L++E+L + L S K +D + G+ F H +
Sbjct: 68 LMQESRLYLIFEFLSMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---V 122
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QLT 176
+HRD+K N+L+D K+ DFGLA+ F V V T T+ Y APE LLG + +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPE-VLLGSPRYS 180
Query: 177 KKADVYSFGVLLLEIISGR 195
D++S G + E+ + +
Sbjct: 181 TPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G++GVV++ R+ QI AIK S + K L EI M+ ++HPNLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVS-LDWPTRANICLGTASGLSFLHEEADPP 117
LV+EY ++ ++ N L K + I T ++F H+
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNEL----EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVT-HVSTRVAGTMGYLAPEYALLG 173
+HRD+K N+L+ K+ DFG A++ D+ T +V+TR Y APE L+G
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LVG 174
Query: 174 --QLTKKADVYSFGVLLLEIISG 194
Q DV++ G + E+++G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG GA G VY + G ++AI+ ++ + + + + EI ++ ++PN+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V EYL SL + + + +D A +C L FLH ++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 121 RDIKASNVLLDGNFHPKIGDFGL-AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
RDIK+ N+LL + K+ DFG A++ P+ + + GT ++APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 180 DVYSFGVLLLEIISG 194
D++S G++ +E+I G
Sbjct: 198 DIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 2 IGGGAFGVVYR-GSLRDGTQIAIKCLSAESKQG--TKEFLTEIDMIWNIRHPNLVQLIGC 58
IG GA G+V++ G +A+K ++ +G + L EI + +HP +V+L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA---SGLSFLHEEAD 115
+ +LV EY+ + L+ +L + + A + G++++H
Sbjct: 68 FPHGSGFVLVMEYMPS-DLS-EVLRDEERP-----LPEAQVKSYMRMLLKGVAYMHANG- 119
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ- 174
I+HRD+K +N+L+ + KI DFGLA+LF + + + T Y APE L G
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL-LYGAR 176
Query: 175 -LTKKADVYSFGVLLLEIISGR 195
D+++ G + E+++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 54/195 (27%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFL-TEIDMIWNIRHPNLVQLIGCC 59
IG G+ G+V + G Q+A+K + KQ +E L E+ ++ + +HPN+V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ + +V E+LE +L + + ++ ++ A +CL LSFLH + ++
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLHAQG---VI 137
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIK+ ++LL + K+ DFG V + V GT ++APE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEV 196
Query: 180 DVYSFGVLLLEIISG 194
D++S G++++E++ G
Sbjct: 197 DIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 42/291 (14%)
Query: 2 IGGGAFGVVY--------RGSLRDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPN 51
+G G FG V + ++ +A+K L + +++ + ++E++M+ I +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANAL-----LGSKSKY----VSLDWPTRANICLG 102
++ L+G C +D ++ EY +L L G + Y V + T ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 103 T---ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
T A G+ +L A +HRD+ A NVL+ N KI DFGLA+ +N+ +
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198
Query: 160 GTM--GYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR 217
G + ++APE T ++DV+SFGVL+ EI + S I VE +KL
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------IPVEELFKLL 252
Query: 218 EEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+EG ++ P +MR C A +RPT KQ+VE L +
Sbjct: 253 KEGHRMD--KPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDR 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 42/275 (15%)
Query: 19 TQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76
T++A+K L ++ +++ + ++E++M+ I +H N++ L+G C +D ++ EY +
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 77 LANALLGSKSKYVSLDW-PTR-----------ANICLGTASGLSFLHEEADPPIVHRDIK 124
L L + + + PT+ + A G+ +L A +HRD+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 125 ASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG-----YLAPEYALLGQL-TKK 178
A NVL+ + KI DFGLA+ ++ H+ T G ++APE AL ++ T +
Sbjct: 168 ARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQ 222
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
+DV+SFGVLL EI + S + VE +KL +EG ++ P +
Sbjct: 223 SDVWSFGVLLWEIFTLGGSPYPG------VPVEELFKLLKEGHRMD--KPSNCTNELYMM 274
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273
MR C A RPT KQ+VE L + + L
Sbjct: 275 MR------DCWHAVPSQRPTFKQLVEDLDRILALT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEF-----LTEIDMIWNI-RHPNLVQ 54
+G G FG VY ++ G +AIK + K+ + L E+ + + HPN+V+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L E++ V+EY+E N L K +I GL+ +H+
Sbjct: 63 LKEVFRENDELYFVFEYMEGNLYQ---LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAGTMGYLAPEYAL 171
HRD+K N+L+ G KI DFGLA+ P +VSTR Y APE L
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPE-IL 170
Query: 172 L--GQLTKKADVYSFGVLLLEIISGR 195
L + D+++ G ++ E+ + R
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 35/213 (16%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI-- 56
IG GA+GVV R G ++AIK +S + K L EI ++ ++RH N++ L+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 57 ---GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA---SGLSFL 110
+ N+ +V E +E + L + KS L T +I GL +L
Sbjct: 68 LRPPSPEDFNDVYIVTELMETD-LHKVI---KSP-QPL---TDDHIQYFLYQILRGLKYL 119
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF------PDNVT-HVSTRVAGTMG 163
H A+ ++HRD+K SN+L++ N KI DFGLA+ +T +V TR
Sbjct: 120 HS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW----- 171
Query: 164 YLAPEYALLGQ-LTKKADVYSFGVLLLEIISGR 195
Y APE L TK D++S G + E+++ +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 1 MIGGGAFGVVYRGSLR--DGTQ--IAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G G FG V G L DG+Q +A+K + + + +EFL+E + + HPN+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 55 LIGCCVE--DNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRA--NICLGTASG 106
LIG C E +I ++ ++++ L + LL S+ + P + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-MGYL 165
+ +L ++ +HRD+ A N +L + + DFGL+K + R+A + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIIS 193
A E T K+DV++FGV + EI +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 47/287 (16%)
Query: 2 IGGGAFGVVYRGSLRDGTQ--IAIKCLS----------AESKQGTKEFLTEIDMI-WNIR 48
+G GAFG VY+ ++ Q +A+K ++ E + + ++E+ +I +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 49 HPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLD----WPTRANICLGTA 104
HPN+V+ +E++ +V + +E L K K W + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY 164
L +LH+E IVHRD+ +N++L + I DFGLAK S V GT+ Y
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILY 179
Query: 165 LAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
PE +KADV++FG +L ++ + + +ML L +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMC---TLQPPFYSTNMLSLA------------TK 224
Query: 225 IVDPELTQFPEK----EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267
IV+ PE +V I C A RP + QV M+S
Sbjct: 225 IVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 68/208 (32%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
M+G G+FG V+ L+ Q AIK L E K L+ + W HP
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS---LAWE--HP 56
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
L L N V EYL L + D P GL FL
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAPE 168
H + IV+RD+K N+LLD + H KI DFG+ K + D T GT Y+APE
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPE 166
Query: 169 YALLGQLTKKADVYSFGVLLLEIISGRS 196
L + D +SFGVLL E++ G+S
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-16
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQI--AIKCLSA-ESKQGTKEFLTEIDMIWNI-RHPNLVQL 55
+IG G FG V + ++ DG ++ AIK + SK ++F E++++ + HPN++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 56 IGCCVEDNNRILVYEYLENNSLANAL-LGSKSKYVSLDWPTRANICLGTASGLS------ 108
+G C +R +Y +E N L KS+ + D P A TAS LS
Sbjct: 62 LGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD-PAFAIA-NSTASTLSSQQLLH 116
Query: 109 FLHEEA-------DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161
F + A +HRD+ A N+L+ N+ KI DFGL++ V T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 169
Query: 162 MGYLAPEYALLGQL-----TKKADVYSFGVLLLEIIS 193
MG L + + L T +DV+S+GVLL EI+S
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 2 IGGGAFGVVYRGSLRD------GTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FG+VY G+ RD T++A+K ++ + S + EFL E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRA--------NICLGTASG 106
L+G + ++V E + + L + L + + + + P R + A G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE--AENNPGRPPPTLQEMIQMAAEIADG 131
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG--- 163
+++L+ + VHRD+ A N ++ +F KIGDFG+ + ++ G G
Sbjct: 132 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 164 --YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-LREEG 220
++APE G T +D++SFGV+L EI S L E ++ L E
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 229
Query: 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
L ++D P+ R + C Q RPT ++V +L D+H
Sbjct: 230 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 68/222 (30%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCL---------SAESKQGTKE-FLTEIDMIWNIRHP 50
+G G FG V + ++ AIK L ES K F T RHP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE----RHP 62
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSL-----ANALLGSKSKYVSLDWPTRANICLGTAS 105
LV L C +++ V EY L + ++ + + A + LG
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA------ACVVLG--- 113
Query: 106 GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMG 163
L +LHE IV+RD+K N+LLD KI DFGL K + + T ST GT
Sbjct: 114 -LQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPE 166
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD 205
+LAPE T+ D + GVL+ E++ G S GDD
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP---GDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 34/216 (15%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQI--AIKCLSA-ESKQGTKEFLTEIDMIWNI-RHPNLVQL 55
+IG G FG V + ++ DG ++ AIK + SK ++F E++++ + HPN++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS---FLHE 112
+G C L EY + +L + L KS+ + D P A I TAS LS LH
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETD-PAFA-IANSTASTLSSQQLLHF 129
Query: 113 EAD----------PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM 162
AD +HRD+ A N+L+ N+ KI DFGL++ V TM
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 182
Query: 163 GYLAPEYALLGQL-----TKKADVYSFGVLLLEIIS 193
G L + + L T +DV+S+GVLL EI+S
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 1 MIGGGAFGVVY------RGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY G Q+ S E+ + EI ++ N++H +VQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 55 LIGCCVEDNNRILV--YEYLENNSLANAL--LGSKSKYVSLDWPTRANICLGTASGLSFL 110
GC + + L EY+ S+ + L G+ ++ V+ + TR + G+S+L
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY-TRQIL-----EGMSYL 122
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTR-VAGTMGYLAPE 168
H IVHRDIK +N+L D + K+GDFG +K L ++ R V GT +++PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 169 YALLGQLTKKADVYSFGVLLLEIISGR 195
+KADV+S G ++E+++ +
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G +GVVY+ G +A+K L E + + EI ++ + HPN+V+L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 59 CVEDNNRILVYEYLEN------NSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFL 110
+N LV+E+L+ +S L Y+ + G+++
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY-------QLL----QGIAYC 115
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H ++HRD+K N+L+D K+ DFGLA+ F V + V T+ Y APE
Sbjct: 116 HSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE-I 170
Query: 171 LLG--QLTKKADVYSFGVLLLEIISGR 195
LLG Q + D++S G + E+++ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES-----KQGTKEFLTEIDMIWNIRHPNLVQL 55
IG G+FG +Y + D IK + K+ +K+ E+ ++ ++HPN+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLD----WPTRANICLGTASGLSFLH 111
E+ +V EY + L + + S D W + ++ GL +H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118
Query: 112 EEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
D I+HRDIK+ N+ L N K+GDFG+A+ ++ ++ GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEIC 174
Query: 171 LLGQLTKKADVYSFGVLLLEI 191
K D++S G +L E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQ--IAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G+FG V++G + + TQ +AIK + E++ ++ EI ++ P + + G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++D ++ EYL S + L LD A I GL +LH E
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEKK--- 122
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRDIKA+NVLL + K+ DFG+A D +T V GT ++APE K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
AD++S G+ +E+ G +L L+ + P L K +
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------KNNPPTLEGNYSKPL 229
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264
F++ C +RPT K++++
Sbjct: 230 KEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G+ G+V + + G Q+A+K + +Q + E+ ++ + H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V E+LE +L + + ++ ++ A +CL LS+LH + ++H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ ++LL + K+ DFG V + V GT ++APE + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 181 VYSFGVLLLEIISG 194
++S G++++E+I G
Sbjct: 201 IWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ-IAIKCLSAESKQGTKE----FLTEIDMIWNIRHPNLVQL 55
++G GAFG+V+ + + + IK + E Q TK+ E ++ + HPN+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+ED ++V EY +LA + + LD T + + L +H +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL--LDEDTILHFFVQILLALHHVHTKL- 121
Query: 116 PPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
I+HRD+K N+LLD + KIGDFG++K+ + T V GT Y++PE
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYT-VVGTPCYISPELCEGKP 177
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKAA 201
+K+D+++ G +L E+ S + + +AA
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGCC 59
IG GA G VY+ R G A+K + + + + EI+++ ++ HPN+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM- 140
Query: 60 VEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ N I ++ E+++ SL + + A++ SG+++LH I
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADE--------QFLADVARQILSGIAYLHRRH---I 189
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE---------- 168
VHRDIK SN+L++ + KI DFG++++ + ++ V GT+ Y++PE
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGA 248
Query: 169 ---YALLGQLTKKADVYSFGVLLLEIISGR 195
YA D++S GV +LE GR
Sbjct: 249 YDGYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
++G G++G+V + ++ QI AIK S + K K + EI M+ +RH NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 58 CCVEDNNRILVYEYLEN---NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
LV+E++++ + L G LD G+ F H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSHN 120
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF--PDNV--THVSTRVAGTMGYLAPEYA 170
I+HRDIK N+L+ + K+ DFG A+ P V +V+TR Y APE
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL- 171
Query: 171 LLGQLT--KKADVYSFGVLLLEIISG 194
L+G + D+++ G L+ E+++G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 57/215 (26%), Positives = 85/215 (39%), Gaps = 35/215 (16%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G FG V ++ G A K L + ++G + L E ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA- 59
Query: 58 CCVEDNNRILVYEYLENNSLANALL-GSKSKYVSLDWPTR-----------ANICLGTAS 105
+E ++ L L+ G KY + A I G
Sbjct: 60 ---------YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG--- 107
Query: 106 GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL 165
L LH+ IV+RD+K NVLLD + + +I D GLA AGT GY+
Sbjct: 108 -LEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYM 161
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIISGRSSSKA 200
APE D ++ G L E+I+GRS +
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 48/194 (24%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G+ G+V +++ G +A+K + +Q + E+ ++ + +H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V E+LE +L + + ++ ++ A +CL LS LH + ++H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ ++LL + K+ DFG V + V GT ++APE + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 181 VYSFGVLLLEIISG 194
++S G++++E++ G
Sbjct: 199 IWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 2 IGGGAFGVVYRGSLRDGT---QIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V G L ++A+K + ++ ++FL+E + HPN+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 57 GCCVEDNNR------ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT--ASGLS 108
G C++ +++ ++++ L + LL S+ PT+ + T ASG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-MGYLAP 167
+L ++ +HRD+ A N +L+ N + + DFGL+K + + R+A + ++A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 168 EYALLGQLTKKADVYSFGVLLLEI 191
E T K+DV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G+FG VY+G R +AIK + E++ ++ EI ++ P + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
++ ++ EYL S + L K L+ A I GL +LH E +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK---I 123
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIKA+NVLL K+ DFG+A D +T V GT ++APE KA
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKA 182
Query: 180 DVYSFGVLLLEIISG 194
D++S G+ +E+ G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 46/194 (23%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G+ G+V + G Q+A+K + +Q + E+ ++ + +H N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++ E+L+ +L + + L+ A +C L +LH + ++H
Sbjct: 89 VGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ ++LL + K+ DFG +V + V GT ++APE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 181 VYSFGVLLLEIISG 194
++S G++++E++ G
Sbjct: 200 IWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAESK-QGTKEF-LTEIDMIWNIRHPNLVQLIGC 58
IG G +G V++ R+ +I A+K + + +G L EI ++ ++H N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 59 CVEDNNRILVYEYLENN--SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
D LV+EY + + ++ G +D + GL+F H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD------IDPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
++HRD+K N+L++ N K+ DFGLA+ F V S V T+ Y P+ +L
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 176 TKKADVYSFGVLLLEIISG 194
+ D++S G + E+ +
Sbjct: 178 STSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 50/295 (16%)
Query: 2 IGGGAFGVVYR----GSLRD----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPN 51
+G G FG V R G + +A+K L + + + ++E++++ I +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALL------------GSKSKYVSLDWPTRANI 99
++ L+G C ++ ++ EY +L L +K L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G+ +L +HRD+ A NVL+ + KI DFGLA+ V +
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 160 GTMG-----YLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213
+ G ++APE AL ++ T ++DV+SFG+L+ EI + S I VE
Sbjct: 193 TSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG------IPVEEL 245
Query: 214 WKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+KL EG ++ P +MR C A RPT KQ+VE L K
Sbjct: 246 FKLLREGHRMD--KPSNCTHELYMLMR------ECWHAVPTQRPTFKQLVEALDK 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES----KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G+FG V + G AIKCL KQ + E ++ + HP +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM 84
Query: 57 GCCVEDNNRI-LVYEYLENNSL------ANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
C +D NR+ + E++ L A +K+ A + L +
Sbjct: 85 -CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH------AELVLA----FEY 133
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
LH + I++RD+K N+LLD H K+ DFG AK PD + + GT YLAPE
Sbjct: 134 LHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEV 186
Query: 170 ALLGQLTKKADVYSFGVLLLEIISG 194
K D ++ GVLL E I+G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 44/303 (14%)
Query: 19 TQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76
+A+K L + + + + ++E++M+ I +H N++ L+G C +D ++ EY +
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 77 LANALL-----GSKSKYVSLDWPTRANIC-------LGTASGLSFLHEEADPPIVHRDIK 124
L L G + + P A G+ +L A +HRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 125 ASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYALLGQLTKKADVY 182
A NVL+ + KI DFGLA+ N+ + G + ++APE T ++DV+
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 183 SFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFI 242
SFGVLL EI + S I VE +KL +EG ++ P +MR
Sbjct: 221 SFGVLLWEIFTLGGSPYPG------IPVEELFKLLKEGHRMD--KPANCTHELYMIMR-- 270
Query: 243 KVGLFCTQAGAHYRPTMKQVVE-------MLSKDVHLNEKALTE---PGVYRGNTSYSLG 292
C A RPT KQ+VE + S D +L+ E PG +S S G
Sbjct: 271 ----ECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSSG 326
Query: 293 ASS 295
S
Sbjct: 327 DDS 329
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 71/282 (25%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 2 IGGGAFGVVYRGSLRDGTQIA---IKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG G FG V + T +A +K L +A SK+ EFL + D ++HPN++Q +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNILQCL 61
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G CVE +LV+EY E L + L + + + A+G++ +H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
+H D+ N L + K+GD+G+ + ++ + +LAPE L+G+
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE--LVGEF 176
Query: 176 ---------TKKADVYSFGVLLLEIISGRSSSKAAFGD-DMLILVEWTWKLREEGRLLEI 225
TK ++V++ GV L E+ + + D ++L V +++ + +++
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-----IKD--QQVKL 229
Query: 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267
P+L P E R+ +V FC + R T ++V +L+
Sbjct: 230 FKPQLEL-PYSE--RWYEVLQFCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGT 161
A GL FLH + I++RD+K NV+LD H KI DFG+ K +F T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGT 164
Query: 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR 195
Y+APE K D ++FGVLL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 26/265 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G+FG V++G R +AIK + E++ ++ EI ++ P + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
++ ++ EYL S + L D A + GL +LH E +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIKA+NVLL K+ DFG+A D +T V GT ++APE KA
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKA 182
Query: 180 DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239
D++S G+ +E+ G + +L L+ + P LT K
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------------KNNPPTLTGEFSKPFK 230
Query: 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264
FI C +RPT K++++
Sbjct: 231 EFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-14
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGC 58
++G G +G VY+G ++ G AIK + + +E EI+M+ H N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 59 CVE------DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
++ D+ LV E+ S+ + + +K + +W A IC GLS LH+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQ 129
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
++HRDIK NVLL N K+ DFG++ V +T + GT ++APE
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 185
Query: 173 GQLTK-----KADVYSFGVLLLEIISG 194
+ K+D++S G+ +E+ G
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 32/209 (15%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIK-CLSAESKQGTKEF----LTEIDMIWNIRHPNLVQL 55
IG G FG V++ + QI A+K L K+G F L EI ++ ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 76
Query: 56 IGCC-----VEDNNR---ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGL 107
I C + + LV+E+ E++ LA L +K V + +GL
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKKVMKMLLNGL 132
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP----DNVTHVSTRVAGTMG 163
++H I+HRD+KA+N+L+ + K+ DFGLA+ F + RV T+
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188
Query: 164 YLAPEYALLG--QLTKKADVYSFGVLLLE 190
Y PE LLG D++ G ++ E
Sbjct: 189 YRPPEL-LLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 2 IGGGAFGVVYRGSLRDGTQ-IAIKCLSAESKQ-----GTKEFLTEIDMIWNIRHPNLVQL 55
IG GA+G VY+ +A+K + ++ + T + + + HPN+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 56 IGCCV-----EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
+ C + LV+E+++ + L L K L T ++ GL FL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD-LRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H IVHRD+K N+L+ K+ DFGLA+++ + T V T+ Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVL 179
Query: 171 LLGQLTKKADVYSFGVLLLEI 191
L D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 26/279 (9%)
Query: 2 IGGGAFGVVYRGSLRDG---TQIAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG G FG V G + G Q+ +K L + S Q +FL E +++H NL+Q +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 58 CCVEDNNRILVYEYLENNSLANALLGS-KSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
C E +LV E+ L L K++ ++ D T + A GL LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKL-FPDNVTHVSTRVAGTMGYLAPEYA----- 170
+H D+ N LL + KIGD+GL+ + ++ ++ + ++APE
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 171 --LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228
L+ TK+++V+S GV + E+ S D+ ++ T+ +RE+ L++ P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TYTVREQQ--LKLPKP 233
Query: 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267
L + P + R+ +V FC RP+ ++V +LS
Sbjct: 234 RL-KLPLSD--RWYEVMQFCWLQ-PEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCL-----SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY D G ++A+K + S E+ + EI ++ N+RH +VQ
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 55 LIGCCVEDNNRIL--VYEYLENNSLANAL--LGSKSKYVSLDWPTRANICLGTASGLSFL 110
GC + + L EY+ S+ + L G+ ++ V+ + TR + G+S+L
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY-TRQIL-----QGVSYL 122
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST---RVAGTMGYLAP 167
H IVHRDIK +N+L D + K+GDFG +K + T V GT +++P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSP 178
Query: 168 EYALLGQLTKKADVYSFGVLLLEIIS 193
E +KADV+S ++E+++
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 31/284 (10%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRH-PNLVQLIGC 58
+G GA+GVV + GT +A+K + A + Q K L ++D+ P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ + + E + + SL K +++ I + L +LH + +
Sbjct: 69 LFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--V 125
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK- 177
+HRD+K SNVL++ N K+ DFG++ D+V T AG Y+APE K
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKG 183
Query: 178 ---KADVYSFGVLLLEIISGR---SSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231
K+DV+S G+ ++E+ +GR S K F ++ E + +L E E D
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD---- 239
Query: 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEK 275
F+ C + RP ++++ ++HL++
Sbjct: 240 ---------FVNK---CLKKNYKERPNYPELLQHPFFELHLSKN 271
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 31/278 (11%)
Query: 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
++G G FG + RG L + +AI L A S + + FL E + H N+V+L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G N ++V EY+ N +L + L + + V+ + G ASG+ +L E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYLSEMG- 127
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL--APEYALLG 173
VH+ + A VL++ + KI F +L D + T ++G L APE
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 174 QLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232
+ +DV+SFG+++ E++S G G D++ VE ++L P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA---------PRNCP 234
Query: 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270
++M L C Q RP Q+ +LSK V
Sbjct: 235 NLLHQLM------LDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G +G VY+ ++ G AIK + E + EI M+ + +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 61 EDNNRILVYEYLENNSLANA--LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ + E+ SL + + G S+ A + T GL +LH +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSES------QIAYVSRETLQGLYYLHSKGK--- 127
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL---GQL 175
+HRDIK +N+LL N H K+ DFG++ + + + GT ++APE A + G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGY 186
Query: 176 TKKADVYSFGVLLLEI 191
+ D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 66/228 (28%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCL-----SAESKQGT-KE--FLTEIDMIWNIRHPNL 52
+G GA+G+V++ R ++ A+K + +A Q T +E FL E+ HPN+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNI 69
Query: 53 VQLIGCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANI----------- 99
V+L+ +N++ LV+EY+E + L + RANI
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETD-LHAVI--------------RANILEDVHKRYIMY 114
Query: 100 -CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---------PD 149
L L ++H ++HRD+K SN+LL+ + K+ DFGLA+ P
Sbjct: 115 QLLKA---LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 150 NVTHVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
+V+TR Y APE LLG + TK D++S G +L E++ G+
Sbjct: 169 LTDYVATR-----WYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAES-KQGTK-EFLTEIDMIWNIRHPNLVQLIGC 58
IG G +G VY+ +D G +A+K + ++ K+G + EI ++ + H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 59 CVEDNNRI----------LVYEYLENNSLANALLGS-KSKYVSLDWPTRANICLGTASGL 107
+ + + LV+EY++++ L+G +S V + GL
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQLLEGL 129
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAP 167
++ H++ +HRDIK SN+LL+ K+ DFGLA+L+ + T T+ Y P
Sbjct: 130 NYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 168 EYALLGQ--LTKKADVYSFGVLLLEIISGR 195
E LLG+ DV+S G +L E+ + +
Sbjct: 187 EL-LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 46/218 (21%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG GA+GVV R G ++AIK + + K L E+ ++ + +H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNII----- 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDW-------------P-TRANIC--LG 102
+ D IL K YV +D P T +I L
Sbjct: 68 AIRD---IL---------RPPGADF-KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY 114
Query: 103 TA-SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL---FPDNVTHVSTRV 158
GL ++H A+ ++HRD+K SN+L++ + +IGDFG+A+ P + T
Sbjct: 115 QLLRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 159 AGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEIISGR 195
T Y APE L L + T D++S G + E++ GR
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCL--SAESKQGTKE---FLTEIDMIWNIRHPNLVQ 54
++G GAFG VY D G ++A+K + ES + +KE EI ++ N+ H +VQ
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 55 LIGCCVEDNNRIL--VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
GC + R L E++ S+ + L Y +L G+S+LH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST---RVAGTMGYLAPEY 169
IVHRDIK +N+L D + K+GDFG +K + T V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEV 180
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGR 195
+KAD++S G ++E+++ +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 43/102 (42%), Positives = 59/102 (57%), Gaps = 11/102 (10%)
Query: 106 GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMG 163
GL FLH + I++RD+K NV+LD + H KI DFG+ K +F DN ++ GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPD 161
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD 205
Y+APE + T D +SFGVLL E++ G+S GDD
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH---GDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 5 GAFGVVYRGSLRDGT-----QIAIKCLSAESKQGTKE-----FLTEIDMIWNIRHPNLVQ 54
G FG ++ G L D ++ +K + K E L E +++ + H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 55 LIGCCVEDNNRILV-YEYLENNSLANALLGSKSKYVSLDWP----TRANICLGT--ASGL 107
++ C+ED V Y Y+ +L L + + + P T+ + + A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLA 166
S+LH+ ++H+DI A N ++D KI D L++ LFP + + + ++A
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 167 PEYALLGQLTKKADVYSFGVLLLEIIS 193
E + + + +DV+SFGVLL E+++
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIR-HPNLVQL 55
++G G+FG V L+ G A+K L + + +TE ++ R HP L QL
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 56 IGCCVEDNNRIL-VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
CC + +R+ V E++ L + S+ D S L FLH++
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDKG 116
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
I++RD+K NVLLD H K+ DFG+ K N ST GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEML 172
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKAAFGDDML 207
D ++ GVLL E++ G + +A DD+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGC 58
++G G +G VY+G ++ G AIK + + +E EI+M+ H N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 59 CVE------DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
++ D+ LV E+ S+ + + +K + DW A IC GL+ LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAHLHA 139
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
++HRDIK NVLL N K+ DFG++ V +T + GT ++APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 195
Query: 173 GQ-----LTKKADVYSFGVLLLEIISG 194
+ ++D++S G+ +E+ G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
++G G G VY+ L +A+K + + + + K+ ++E+++++ P ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+N + E+++ SL Y + I + GL++L I
Sbjct: 68 FFVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK---I 116
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD+K SN+L++ K+ DFG++ V ++ GT Y+APE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 179 ADVYSFGVLLLEIISGR 195
+DV+S G+ +E+ GR
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 18 GTQIAIKCLSAESKQGTKE---FLTEIDMIWNIRHPNLVQLI--GCCVEDNNRILVYEYL 72
G ++AIK L ++ + + F E + + HPN+V L+ G V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL-- 130
+L L + L + L L+ H + IVHRD+K N+++
Sbjct: 62 PGRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 131 -DGNFHPKIGDFGLAKLFPD----NVTHVS--TRVAGTMGYLAPEYALLGQ-LTKKADVY 182
H K+ DFG+ L P +V ++ T V GT Y APE L G+ +T +D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 183 SFGVLLLEIISGR 195
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G +G VY+ R G +A+K + E + + + E+D++ P +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ + EY++ SL + L + I GL FL EE + I+
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL---- 175
HRD+K +NVL++GN K+ DFG++ + V ++ G Y+APE G
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 176 --TKKADVYSFGVLLLEIISGR 195
T ++DV+S G+ +LE+ GR
Sbjct: 183 TYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 43/100 (43%), Positives = 59/100 (59%), Gaps = 9/100 (9%)
Query: 97 ANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156
A IC GL LH+E IV+RD+K N+LLD + H +I D GLA P+ T +
Sbjct: 109 AEIC----CGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG 160
Query: 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196
RV GT+GY+APE + T D ++ G LL E+I+G+S
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 66/231 (28%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAE----SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG GAFG V+ +D Q+ A+K L Q E D++ + P +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHE 112
+D + LV EY+ L N L + + R A + L S +H+
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVLALDS----VHK 119
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK------------------LFPDNVT-- 152
+HRDIK N+L+D + H K+ DFGL K LF DNV
Sbjct: 120 LG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 153 --------HVSTRVAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISG 194
+ GT Y+APE L G + D +S GV+L E++ G
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTEIDMIWNIRH--------PN 51
+IG G++ V L+ QI A+K + E ++ ID + +H P
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED----IDWVQTEKHVFEQASSNPF 57
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
LV L C + LV EY+ L + + A IC+ L+FLH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH 113
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAPEY 169
E I++RD+K NVLLD + H K+ D+G+ K L P + T + GT Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEI 167
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGRS 196
+ D ++ GVL+ E+++GRS
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 4e-13
Identities = 67/204 (32%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 1 MIGGGAFG-VVYRGSLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V+ G A+K L E +K LTE ++ N RHP L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
+ V EY+ L L S+ + S D TR A I S L +LH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSED-RTRFYGAEI----VSALDYLHSG 114
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST--RVAGTMGYLAPEYAL 171
IV+RD+K N++LD + H KI DFGL K + +T +T GT YLAPE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 172 LGQLTKKADVYSFGVLLLEIISGR 195
+ D + GV++ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 2 IGGGAFGVVYRGSL-----RDGTQ-IAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQ 54
+G FG VY+G L + TQ +AIK L +++ +E F E M ++HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALL--------GS----KSKYVSLDWPTRANICLG 102
L+G ++ +++ Y ++ L L+ GS K+ +L+ +I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 103 TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGT 161
A+G+ FL +VH+D+ NVL+ + KI D GL + ++ + +
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+ +++PE + G+ + +D++S+GV+L E+ S
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 41/104 (39%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 97 ANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156
A I G L LH E IV+RD+K N+LLD H +I D GLA P+ T +
Sbjct: 109 AEITCG----LEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRG 160
Query: 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKA 200
RV GT+GY+APE + T D + G L+ E+I G+S +
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-13
Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 43/282 (15%)
Query: 2 IGGGAFGVVY----RGSLRDG--TQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FG+VY +G ++D T++AIK ++ A S + EFL E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS---LDWPTRANICLGT---ASGLS 108
L+G + +++ E + L + L + + + P+ + A G++
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG----- 163
+L+ VHRD+ A N ++ +F KIGDFG+ + ++ G G
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223
+++PE G T +DV+SFGV+L EI + ++ ++ + EG LL
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL------RFVMEGGLL 240
Query: 224 EIVD--PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVV 263
+ D P++ E+MR C Q RP+ +++
Sbjct: 241 DKPDNCPDMLF----ELMR------MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 2 IGGGAFGVVYRGSL---RDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQ-- 54
IG GAFGVV+ S+ RDG ++A+K + ++ K E+ M+ +H N++
Sbjct: 8 IGYGAFGVVW--SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 55 ------LIGCCVEDNNRILVYEYLENNSLANALLGSK---SKYVSLDWPTRANICLGTAS 105
I E I V L + L ++ + S +V +
Sbjct: 66 DILQPPHIDPFEE----IYVVTELMQSDLHKIIVSPQPLSSDHVKV-------FLYQILR 114
Query: 106 GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGY 164
GL +LH I+HRDIK N+L++ N KI DFGLA++ PD H++ V T Y
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170
Query: 165 LAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
APE L+G T D++S G + E++ R
Sbjct: 171 RAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 1 MIGGGAFG-VVYRGSLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V+ G A+K L E +K LTE ++ N RHP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
+ V EY L L S+ + S D R A I S L +LH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED-RARFYGAEI----VSALGYLHSC 114
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST--RVAGTMGYLAPEYAL 171
+V+RD+K N++LD + H KI DFGL K + ++ +T GT YLAPE
Sbjct: 115 D---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 172 LGQLTKKADVYSFGVLLLEIISGR 195
+ D + GV++ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 1 MIGGGAFGVVYRGSLR--DGT--QIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQ 54
M+G G FG V L+ DG+ ++A+K L A+ S +EFL E + HPN+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 55 LIGCCVEDNNR------ILVYEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASG 106
LIG + + +++ ++++ L LL S+ + +L T + ASG
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYL 165
+ +L + +HRD+ A N +L+ N + DFGL+ K++ + + +L
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIIS 193
A E T +DV++FGV + EI++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-13
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 1 MIGGGAFG--VVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
++G G+FG ++ + D + +S ++ E ++ ++HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVS----LDWPTRANICLGTASGLSFLHEEA 114
D + +V EY + L + + K L W + +CLG + +HE+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLG----VQHIHEKR 120
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
++HRDIK+ N+ L N K+GDFG A+L + T V GT Y+ PE
Sbjct: 121 ---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKA 200
K+D++S G +L E+ + + +A
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQ-IAIKCLSAESKQ-----GTKEFLTEIDMIWNIRHPNLVQ 54
IG GA+G V++ L++G + +A+K + ++ + T + + + HPN+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 55 LIGCC-VEDNNR----ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
L C V +R LV+E+++ + L L K + T ++ GL F
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
LH +VHRD+K N+L+ + K+ DFGLA+++ + T V T+ Y APE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGR 195
L D++S G + E+ +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 2 IGGGAFGVVYR-GSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-----RHPNLVQL 55
IG G +G VY+ + +DG+ A+K L S + EI+ +NI HPN+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 56 IGCCVEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
G + + + LV E S+ + G LD + I G GL L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H I+HRD+K +N+LL K+ DFG++ +T V GT ++APE
Sbjct: 145 HNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 200
Query: 171 LLGQ-----LTKKADVYSFGVLLLEIISG 194
Q + DV+S G+ +E+ G
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 56/166 (33%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAG 160
A G+ FL A +HRD+ A N+LL N KI DFGLA+ PD V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP- 239
Query: 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG 220
+ ++APE T ++DV+SFGVLL EI S +S + I E+ +L++
Sbjct: 240 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----VQINEEFCQRLKDGT 294
Query: 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
R+ + PE ++ L C Q RPT +VE+L
Sbjct: 295 RM---------RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 2 IGGGAFGVVY----RGSLRDGTQIAIKCLSAES---KQGTKEF-LTEIDMIWNIRH-PNL 52
+G GA+G V+ G G A+K L + K T E TE ++ +R P L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG-TASGLSFLH 111
V L D L+ +Y+ L L + ++ + + + L LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHL--YQREHFTES---EVRVYIAEIVLALDHLH 122
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
+ I++RDIK N+LLD H + DFGL+K F + GT+ Y+APE
Sbjct: 123 QLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 172 LGQL--TKKADVYSFGVLLLEIISGRS 196
G K D +S GVL E+++G S
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 60/206 (29%), Positives = 83/206 (40%), Gaps = 29/206 (14%)
Query: 2 IGGGAFGVVYR-GSLRDGTQIAIKCLS----AESKQGT-----KEFLTEIDMIWNIRHPN 51
+G G FG V A+KC+ E+ Q KE L E + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN------HPF 54
Query: 52 LVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
+V+L +D I ++ EY L L D T +L
Sbjct: 55 IVKLY-RTFKDKKYIYMLMEYCLGGELWTIL----RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTHVSTRVAGTMGYLAPEY 169
H I++RD+K N+LLD N + K+ DFG AK L T GT Y+APE
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEI 163
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGR 195
L D +S G+LL E+++GR
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEF---LTEIDMI-WNIRHPNLVQL 55
++G G+FG V L+ ++ AIK L + + +TE ++ +HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 56 IGCCVEDNNRIL-VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
CC + +R+ V EY+ L + S+ D P L FLH
Sbjct: 62 H-CCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRHG 116
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAPEYALL 172
+++RD+K N+LLD H K+ DFG+ K + T T GT Y+APE +L
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPE--IL 168
Query: 173 GQLTKKADV--YSFGVLLLEIISGRSSSKAAFGDDM 206
+L V ++ GVL+ E+++G+ +A DD+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V G ++AIK LS +S K E+ ++ ++ H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL---GTASGLSFLHEEAD 115
++ + L A L + K L + +I GL ++H A
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL---SDDHIQFLVYQILRGLKYIHS-AG 138
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALL-G 173
I+HRD+K SN+ ++ + KI DFGLA+ D +T +V+TR Y APE L
Sbjct: 139 --IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWM 191
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
+ D++S G ++ E+++G+
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQ----L 55
IG GA+G+V G ++AIK +S Q + L EI ++ +H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDII 72
Query: 56 IGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICL---GTASGLSFLH 111
E N + +V E +E + L + K++++S D +I GL ++H
Sbjct: 73 RPPSFESFNDVYIVQELMETD-LYKLI---KTQHLSND-----HIQYFLYQILRGLKYIH 123
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS--TRVAGTMGYLAPEY 169
A+ ++HRD+K SN+LL+ N KI DFGLA++ H T T Y APE
Sbjct: 124 S-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 170 ALLGQL-TKKADVYSFGVLLLEIISGR 195
L + TK D++S G +L E++S R
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 61/206 (29%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
++G G+FG V + ++ AIK L E K L D + P
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-----KPP 61
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
L QL C + V EY+ L + + P + GL FL
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV-AGTMGYLAPEY 169
H I++RD+K NV+LD H KI DFG+ K V V+TR GT Y+APE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI 172
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGR 195
K D +++GVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAFG V + Q+ A+K LS + + F E D++ + +VQL
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKY-VSLDWPT--RANICLGTASGLSFLHEE 113
+D +V EY+ L N + S Y + W A + L L +H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLA----LDAIHSM 161
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYLAPEYALL 172
+HRD+K N+LLD + H K+ DFG K+ + + T V GT Y++PE
Sbjct: 162 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKS 217
Query: 173 ----GQLTKKADVYSFGVLLLEIISG 194
G ++ D +S GV L E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 1 MIGGGAFG-VVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
++G GA G V+ + DG A+K + E S+ E+ + N ++V+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 58 CCVEDNNRILVY--EYLENNSLANALLGSKSKYVSLDWPTRANICLGTA-----SGLSFL 110
C ED N L AL+ + L ++ +GL F+
Sbjct: 96 -CHED----FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 111 ------HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMG 163
H ++HRDIK++N+LL N K+GDFG +K++ V+ V GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
Y+APE +KKAD++S GVLL E+++
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 1 MIGGGAFG-VVYRGSLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V+ G A+K L E +K +TE ++ N RHP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG-TASGLSFLHEEAD 115
+ V EY L L S+ + + + RA S L +LH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEE---RARFYGAEIVSALEYLHSRD- 115
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST--RVAGTMGYLAPEYALLG 173
+V+RDIK N++LD + H KI DFGL K + ++ +T GT YLAPE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
+ D + GV++ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEID-MIWNIRHPNLVQLI 56
IG G+FG V + DG A+K L ++ K+ K + E + ++ N++HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 57 GCCVEDNNRILVYEYLENNSLANAL------LGSKSKYVSLDWPTRANICLGTASGLSFL 110
+ V +Y+ L L ++++ + A I AS L +L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYA------AEI----ASALGYL 112
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST--RVAGTMGYLAPE 168
H I++RD+K N+LLD H + DFGL K + + H T GT YLAPE
Sbjct: 113 HSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
Query: 169 YALLGQLTKKADVYSFGVLLLEIISG 194
+ D + G +L E++ G
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G +G VY+ +L G A+K + E EI M+ +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 61 EDNNRILVYEYLENNSLANA--LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ EY SL + + G S+ A +C T GL++LH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSEL------QIAYVCRETLQGLAYLHSKGK--- 127
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL---GQL 175
+HRDIK +N+LL N K+ DFG+A + + + GT ++APE A + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 176 TKKADVYSFGVLLLEI 191
+ D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 64/200 (32%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 1 MIGGGAFG-VVYRGSLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V+ G A+K L E +K LTE ++ N RHP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG-TASGLSFLHEEAD 115
+ V EY L L S+ + S D RA S L +LH E +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED---RARFYGAEIVSALDYLHSEKN 116
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
+V+RD+K N++LD + H KI DFGL K + + T GT YLAPE
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173
Query: 176 TKKADVYSFGVLLLEIISGR 195
+ D + GV++ E++ GR
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 42/195 (21%), Positives = 83/195 (42%), Gaps = 20/195 (10%)
Query: 10 VYRGSLRDGTQIAI---KCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNR- 65
+Y+G + ++ I K K EI + I N++++ G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 66 ---ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRD 122
L+ EY L L K L + T+ ++ + GL L++ + P +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 123 IKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL--LGQLTKKAD 180
+ + + L+ N+ KI GL K+ ++ + M Y + + + T K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 181 VYSFGVLLLEIISGR 195
+YS GV+L EI +G+
Sbjct: 205 IYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRH--PNLVQLIG 57
IG G G VY+ + G +A+K + K+ K L ++D++ H P +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLHEEAD 115
+ D++ + E L + L K + P + + L +L E+
Sbjct: 82 YFITDSDVFICME------LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
++HRD+K SN+LLD + + K+ DFG++ D+ TR AG Y+APE
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDP 191
Query: 176 TKK----ADVYSFGVLLLEIISGR 195
K ADV+S G+ L+E+ +G+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 2 IGGGAFGVVYRGSLRD---GTQIAIKCLSAESKQG--TKEFLTEIDMIWNIRHPNLVQLI 56
+G GAFG+V S RD G +AIK + K E+ ++ ++RH N++ L
Sbjct: 18 VGMGAFGLVC--SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+ I V E L + + LL S+ L+ GL ++H
Sbjct: 76 DIFISPLEDIYFVTELLGTD--LHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAG- 128
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQ 174
+VHRD+K SN+L++ N KI DFGLA++ +T +VSTR Y APE L Q
Sbjct: 129 --VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQ 181
Query: 175 -LTKKADVYSFGVLLLEIISGR 195
+ D++S G + E++ G+
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 55/167 (32%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAG 160
A G+ FL A +HRD+ A N+LL N KI DFGLA+ PD V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 238
Query: 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG 220
+ ++APE T ++DV+SFGVLL EI S +S D E+ +L+E
Sbjct: 239 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRLKEGT 293
Query: 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267
R+ + PE + L C RPT ++VE+L
Sbjct: 294 RM---------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 39/94 (41%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL-FPDNVTHVSTRVAGTM 162
A GL FLH + I++RD+K NV+LD H KI DFG+ K D VT + GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTP 165
Query: 163 GYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196
Y+APE K D ++FGVLL E+++G++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
++G GA+GVV + ++ +I AIK S E+++ + L E+ M+ ++ N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
LV+EY+E N L LL V + R+ I + + H+
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-KVRSYI-YQLIKAIHWCHKND--- 120
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
IVHRDIK N+L+ N K+ DFG A+ + T T Y +PE L K
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 178 KADVYSFGVLLLEIISGR 195
D++S G +L E+ G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 2 IGGGAFGVVY---------RGSLRDGTQIAIKCLSA-ESKQGTKE--FLTEIDMIWNIRH 49
+G G+FG VY L+ +I + L+ E+ Q +E L+++D H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD------H 61
Query: 50 PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
P +V+ +E + ++ EY E L L K +L + G+ +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
+H+ I+HRD+KA N+ L N KIGDFG+++L + ++T GT Y++PE
Sbjct: 122 MHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPE- 175
Query: 170 ALLGQ-LTKKADVYSFGVLLLEI 191
AL Q K+D++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 27/203 (13%)
Query: 2 IGGGAFGVVYRGSLRDGTQ-IAIKCLS---------AESKQGTKEFLTEIDMIWNIRHPN 51
+G G FG V+ R A+K ++ + K L E+ HP
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV------SHPF 62
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
+++L + ++ EY+ L + L S S + I L +LH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI----VCALEYLH 118
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
+ IV+RD+K N+LLD H K+ DFG AK D + + GT YLAPE
Sbjct: 119 SKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQ 171
Query: 172 LGQLTKKADVYSFGVLLLEIISG 194
K D ++ G+L+ E++ G
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTE---IDMIWNIRH------- 49
+IG G++ V L+ +I A+K + KE + + ID + +H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK-------KELVNDDEDIDWVQTEKHVFETASN 54
Query: 50 -PNLVQLIGCCVEDNNRILVYEYLENNSL------ANALLGSKSKYVSLDWPTRANICLG 102
P LV L C ++ V E++ L L +++ S A I L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS------AEISLA 108
Query: 103 TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAG 160
L+FLHE I++RD+K NVLLD H K+ D+G+ K + P + T ST G
Sbjct: 109 ----LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCG 158
Query: 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196
T Y+APE D ++ GVL+ E+++GRS
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG GA+G+V + ++AIK ++ +++ K L EI ++ ++ H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 59 CVEDNNR------ILVYEYLE---------NNSLANALLGSKSKYVSLDWPTRANICLGT 103
+ +R +VYE ++ + +L++ +Y L R
Sbjct: 73 -MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSD----DHCQYF-LYQLLR------- 119
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
GL ++H A+ ++HRD+K SN+LL+ N KI DFGLA+ + ++ V T
Sbjct: 120 --GLKYIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRW 173
Query: 164 YLAPEYALL-GQLTKKADVYSFGVLLLEIISGR 195
Y APE L + T DV+S G + E++ GR
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G GVV++ S + G +A K + E K + + + E+ ++ P +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
D + E+++ SL L K + + + GL++L E+ I+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 126
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K SN+L++ K+ DFG++ D+ ++ GT Y++PE + ++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 180 DVYSFGVLLLEIISGR 195
D++S G+ L+E+ GR
Sbjct: 184 DIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 54/166 (32%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAG 160
A G+ FL A +HRD+ A N+LL N KI DFGLA+ PD V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 244
Query: 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG 220
+ ++APE T ++DV+SFGVLL EI S +S D E+ +L+E
Sbjct: 245 -LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGT 299
Query: 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
R+ + P+ + L C RPT ++VE L
Sbjct: 300 RM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 49 HPNLVQLIGCCVEDNNRILVYEYLENNSL------ANALLGSKSKYVSLDWPTRANICLG 102
HP LV L C ++ V EY+ L L +++ S A I L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------AEISLA 108
Query: 103 TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAG 160
L++LHE I++RD+K NVLLD H K+ D+G+ K L P + T + G
Sbjct: 109 ----LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCG 158
Query: 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196
T Y+APE D ++ GVL+ E+++GRS
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 41/100 (41%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 97 ANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156
A +C GL L E IV+RD+K N+LLD H +I D GLA P+ T V
Sbjct: 109 AELC----CGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRG 160
Query: 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196
RV GT+GY+APE + T D + G L+ E+I G+S
Sbjct: 161 RV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 41/274 (14%)
Query: 2 IGGGAFGVVYRGSL----RDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G++G V SL DG Q IK L+ S++ K E ++ ++HPN+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 56 IGCCV-EDNNRILVYEYLENNSLANALLGSKSKYVS----LDWPTRANICLGTASGLSFL 110
ED +V + E L + L K K + ++W + A L +L
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYL 118
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
HE+ I+HRD+K NV L K+GD G+A++ + ST + GT Y++PE
Sbjct: 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELF 174
Query: 171 LLGQLTKKADVYSFGVLLLEIISGRSSSKAAF-GDDMLILVEWTWKLREEGRLLEIVDPE 229
K+DV++ G + E+ ++ K AF DM LV R++E P
Sbjct: 175 SNKPYNYKSDVWALGCCVYEM----ATLKHAFNAKDMNSLVY---------RIIEGKLPP 221
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVV 263
+ + E+ I + + RP++K ++
Sbjct: 222 MPKDYSPELGELIAT-MLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G GVV + + G +A K + E K + + + E+ ++ P +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
D + E+++ SL L +K + + + GL++L E+ I+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKHQ--IM 126
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K SN+L++ K+ DFG++ D+ ++ GT Y++PE + ++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 180 DVYSFGVLLLEIISGR 195
D++S G+ L+E+ GR
Sbjct: 184 DIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 53/171 (30%), Positives = 83/171 (48%), Gaps = 23/171 (13%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-- 161
A G+SFL A +HRD+ A N+LL KI DFGLA+ ++ +V V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 162 --MGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE 219
+ ++APE T ++DV+S+G+LL EI S SS D +K+ +E
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKMIKE 332
Query: 220 GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270
G ++ PE ++M+ C A RPT KQ+V+++ + +
Sbjct: 333 G--YRMLSPECAPSEMYDIMK------SCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 39/104 (37%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 97 ANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156
A I GL LH E V+RD+K N+LLD H +I D GLA P+ + +
Sbjct: 109 AEIL----CGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRG 160
Query: 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKA 200
RV GT+GY+APE + T D + G L+ E+I G+S +
Sbjct: 161 RV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 40/210 (19%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR----------HP 50
IG G F V + S + G AIKC+ K+ ++ + N+R HP
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--------KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 51 NLVQLIGCCVED-NNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
N+++LI + R+ LV+E ++ N L + G K + L + L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMN-LYELIKGRK-RP--LPEKRVKSYMYQLLKSLD 114
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAGTMGYL 165
+H I HRDIK N+L+ + K+ DFG + P ++STR Y
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYR 165
Query: 166 APEYALL--GQLTKKADVYSFGVLLLEIIS 193
APE LL G K D+++ G + EI+S
Sbjct: 166 APE-CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 1 MIGGGAFGVVY---RGSLRD-GTQIAIKCLS----AESKQGTKEFLTEIDMIWNIRH-PN 51
++G GA+G V+ + S D G A+K L + + T+ TE ++ +IR P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG-TASGLSFL 110
LV L D L+ +Y+ L L + ++ I G L L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLS-QRERFKE----QEVQIYSGEIVLALEHL 121
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H+ I++RDIK N+LLD N H + DFGL+K F ++ + GT+ Y+AP+
Sbjct: 122 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 171 LLGQL--TKKADVYSFGVLLLEIISGRS 196
G K D +S GVL+ E+++G S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQ-IAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G +GVVY+ R + IA+K L E + + EI ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANIC----LGTASGLSFLHEEA 114
+ LV+EYL+ L K S D+ + G+++ H
Sbjct: 70 VHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122
Query: 115 DPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
++HRD+K N+L+D + K+ DFGLA+ F V + V T+ Y APE LLG
Sbjct: 123 ---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPE-ILLG 177
Query: 174 --QLTKKADVYSFGVLLLEIISGR 195
+ D++S G + E+++ +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ----IAIKCLS----AESKQGTKEFLTEIDMIWNIRHPNL 52
++G G +G V++ G A+K L +++ T E +++ ++HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL-GTAS------ 105
V LI L+ EYL L L R I + TA
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSEI 109
Query: 106 --GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGT 161
L LH++ I++RD+K N+LLD H K+ DFGL K + VTH GT
Sbjct: 110 SLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGT 163
Query: 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
+ Y+APE + K D +S G L+ ++++G
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 1 MIGGGAFGVVY---RGSLRDGTQI-AIKCLSAES-----KQGTKEFLTEIDMIWNIRHPN 51
++G G+FG V+ + + D Q+ A+K L + + TK E D++ + HP
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHPF 59
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTAS---GLS 108
+V+L + L+ ++L L L SK V T ++ A L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMF---TEEDVKFYLAELALALD 112
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE 168
LH I++RD+K N+LLD H K+ DFGL+K D+ + GT+ Y+APE
Sbjct: 113 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 168
Query: 169 YALLGQLTKKADVYSFGVLLLEIISG 194
T+ AD +SFGVL+ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 21/200 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G +G V+ +D +I A+K + + LTE D++ + LV+L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 58 CCVEDNNRILVYEYL---ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+D L EY+ + +L N L + R + + + LHE
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH------ARFYMAEMFEA-VDALHELG 121
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
+HRD+K N L+D + H K+ DFGL+K + + V G+ Y+APE
Sbjct: 122 ---YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 175 LTKKADVYSFGVLLLEIISG 194
D +S G +L E + G
Sbjct: 175 YDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 38 LTEIDMIWNIRHPNLVQL--------IGCCVEDNNRILVYEYLENNS----LANALLGSK 85
L E ++ N+ HP+++++ I C V + +Y YL S + AL+ K
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 86 SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145
GL +LH + I+HRD+K N+ ++ IGD G A+
Sbjct: 165 Q----------------ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 146 LFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
FP +AGT+ APE + KAD++S G++L E+++
Sbjct: 206 -FPVVAPA-FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 40/126 (31%), Positives = 57/126 (45%), Gaps = 17/126 (13%)
Query: 106 GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL 165
GL +H +V+RD+K +N+LLD + H +I D GLA F H S GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 166 APEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
APE G AD +S G +L +++ G S + D E R+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------EIDRMTL 212
Query: 225 IVDPEL 230
+ EL
Sbjct: 213 TMAVEL 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 2 IGGGAFGVV----YRGSLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIR-HPNLVQ 54
+G GA+G+V + + +AIK ++ K K L E+ ++ + R H N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 55 LIGCCVEDN---NRILVYEYLENNSLANALLGSK----SKYVSLDWPTRANICLGTASGL 107
L + N + +YE L L + + + + S + +C GL
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI---LC-----GL 118
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS---TRVAGTMGY 164
++H A+ ++HRD+K N+L++ + KI DFGLA+ F +N + T T Y
Sbjct: 119 KYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 165 LAPEYALLGQ-LTKKADVYSFGVLLLEIISGR 195
APE L Q TK DV+S G +L E++ +
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 31/77 (40%), Positives = 52/77 (67%), Gaps = 1/77 (1%)
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLT 176
++HRD+K++N+ L K+GDFG +K + D+V+ V++ GT YLAPE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 177 KKADVYSFGVLLLEIIS 193
KKAD++S GV+L E+++
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 48/149 (32%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 106 GLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL 165
GL +H +V+RD+K +N+LLD + H +I D GLA F H S GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 166 APEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
APE G AD +S G +L +++ G S + D + T + E L +
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE--LPD 220
Query: 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGA 253
PEL E + R + L C GA
Sbjct: 221 SFSPELKSLLEGLLQRDVSKRLGCLGRGA 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 51/194 (26%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 3 GGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCCVE 61
GG V++R S G +A K + E K + + + E+ ++ P +V G
Sbjct: 14 GGVVTKVLHRPS---GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
D + E+++ SL L K+ + + + +I + GL++L E+ I+HR
Sbjct: 71 DGEISICMEHMDGGSLDQVL--KKAGRIPENILGKISIAV--LRGLTYLREKHK--IMHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+K SN+L++ K+ DFG++ D+ ++ GT Y++PE T ++D+
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDI 181
Query: 182 YSFGVLLLEIISGR 195
+S G+ L+E+ GR
Sbjct: 182 WSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-- 161
A G+ FL A +HRD+ A NVLL KI DFGLA+ ++ +V V G
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNAR 275
Query: 162 --MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWT-WKLR 217
+ ++APE T ++DV+S+G+LL EI S G+S ILV +K+
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG-------ILVNSKFYKMV 328
Query: 218 EEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+ G + D F E+ +K+ C RPT Q+ +++ +
Sbjct: 329 KRGYQMSRPD-----FAPPEIYSIMKM---CWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 2 IGGGAFGVV-YRGSLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V R G ++AIK L +S+ K E+ ++ +++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
D + +++ LG K+ L + GL ++H I
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---I 139
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYAL-LGQLT 176
+HRD+K N+ ++ + KI DFGLA+ +T +V TR Y APE L T
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYT 194
Query: 177 KKADVYSFGVLLLEIISGRSSSKAAFGDDML 207
+ D++S G ++ E+++G+ K G D L
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFK---GHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ-IAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+I GA+G VY ++ Q A+K ++ ++ + ++ E D++ +P +V +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
C E + +V EY+E A L + V + A L L +LH
Sbjct: 68 -CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA----LEYLHNYG- 121
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT--------HVSTR------VAGT 161
IVHRD+K N+L+ H K+ DFGL+K+ ++T TR V GT
Sbjct: 122 --IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
Y+APE L K D ++ G++L E + G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G++ VY+G + +G +A+K + + ++GT + E ++ ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL-GTASGLSFLHEEADPPI 118
LV+EY+ + L K+ P + L GLS++H+ I
Sbjct: 73 HTKETLTLVFEYVHTD-----LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGL--AKLFPDNVTHVSTRVAGTMGYLAPEYALLG--Q 174
+HRD+K N+L+ K+ DFGL AK P +H + T+ Y P+ LLG +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPD-VLLGSTE 180
Query: 175 LTKKADVYSFGVLLLEIISG 194
+ D++ G + +E+I G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIW-NIRHPNLVQL 55
+IG G+FG V + + A+K L ++ K+ K ++E +++ N++HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 56 IGCCVEDNNRILVYEYLENNSL------ANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
+ V +Y+ L L ++++ + + AS L +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----------IASALGY 111
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST--RVAGTMGYLAP 167
LH IV+RD+K N+LLD H + DFGL K +N+ H T GT YLAP
Sbjct: 112 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAP 165
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISG 194
E + D + G +L E++ G
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 38/93 (40%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGY 164
L LH+ IV+RD+K N+LLD H + DFGL+K L + T+ GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEY 162
Query: 165 LAPEYALLGQ-LTKKADVYSFGVLLLEIISGRS 196
LAPE L + TK D +S GVL+ E+ G S
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI-- 56
+G GA+G V + G ++A+K LS +S K E+ ++ +++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 57 ---GCCVEDNNRILVYEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFLH 111
+E+ N + + +L L N + K +V + GL ++H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIH 137
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYA 170
AD I+HRD+K SN+ ++ + KI DFGLA+ D +T +V+TR Y APE
Sbjct: 138 S-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 189
Query: 171 L-LGQLTKKADVYSFGVLLLEIISGRS 196
L + D++S G ++ E+++GR+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G + V++G S +A+K + E ++G + E+ ++ N++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANI---CLGTASGLSFLHEEADP 116
+ LV+EYL+++ L + +S+ N+ GLS+ H+
Sbjct: 73 HTERCLTLVFEYLDSD--LKQYLDNCGNLMSMH-----NVKIFMFQLLRGLSYCHKRK-- 123
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--Q 174
I+HRD+K N+L++ K+ DFGLA+ S V T+ Y P+ LLG +
Sbjct: 124 -ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-VLLGSTE 180
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+ D++ G +L E+ +GR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 1 MIGGGAFG-VVYRGSLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIW-NIRHPNLVQL 55
+IG G+FG V+ DG A+K L + +++ K + E +++ N++HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
V +++ L L + S P AS L +LH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSIN- 116
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
IV+RD+K N+LLD H + DFGL K + +T GT YLAPE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 176 TKKADVYSFGVLLLEIISG 194
D + G +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTK----------EFLTEIDMIWNIRHPN 51
+G G F +Y+G LR + + I E K F ++ + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
LV+L G CV D N I+V EY++ L + L + VSL W + ++ AS L +L
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPL-DVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 112 EEADPPIVHRDIKASNVLL-----DGNFHP--KIGDFGLAKLFPDNVTHVSTRVAGTMGY 164
++ +VH ++ N+L+ + + P K+ D G+ P V RV + +
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVE-RIPW 170
Query: 165 LAPEYALLGQ--LTKKADVYSFGVLLLEIISG 194
+APE GQ LT AD +SFG LLEI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
G+ LH IV+RD+K NVLLD + ++ D GLA D T T+ AGT G
Sbjct: 105 TCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNG 159
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSK 199
Y+APE + D ++ G + E+++GR+ K
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAFG V + ++ A+K LS + + F E D++ P +VQL
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKY-VSLDWPT--RANICLGTASGLSFLHE 112
C +D+ + +V EY+ L N + S Y V W A + L L +H
Sbjct: 110 -CAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFYTAEVVLA----LDAIHS 160
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYLAPEYAL 171
++HRD+K N+LLD + H K+ DFG K+ + T V GT Y++PE
Sbjct: 161 MG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLK 216
Query: 172 L----GQLTKKADVYSFGVLLLEIISG 194
G ++ D +S GV L E++ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 2 IGGGAFGVVYRGSLRDGT--QIAIK----CLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G+FG V + ++ +AIK + KQ F +E ++ I HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G +++ LV E++ L +K +P C A +
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKR------FPNDVG-CFYAAQIVLIFEYLQS 149
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR---VAGTMGYLAPEYALL 172
IV+RD+K N+LLD + K+ DFG AK+ V TR + GT Y+APE L
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPEYIAPEILLN 202
Query: 173 GQLTKKADVYSFGVLLLEIISG 194
K AD ++ G+ + EI+ G
Sbjct: 203 VGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY 164
SGL LH+ I++RD+K NVLLD + + +I D GLA D + + AGT G+
Sbjct: 108 SGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGF 163
Query: 165 LAPEYALLGQLTKKADVYSFGVLLLEIISGR 195
+APE + D ++ GV L E+I+ R
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+IG G++GVV G ++AIK ++ E L EI ++ +RHP++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 58 CCVEDNNR-----ILVYEYLENN----SLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
+ + R +V+E +E++ AN L + L R L
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR---------ALK 117
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL-FPDNVTHVS-TRVAGTMGYLA 166
++H + HRD+K N+L + + KI DFGLA++ F D T + T T Y A
Sbjct: 118 YIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 167 PEY--ALLGQLTKKADVYSFGVLLLEIISGR 195
PE + + T D++S G + E+++G+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 32/77 (41%), Positives = 45/77 (58%), Gaps = 1/77 (1%)
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
+++RD+K N+LLD H + DFGL KL + +T GT YLAPE L TK
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTK 172
Query: 178 KADVYSFGVLLLEIISG 194
D ++ GVLL E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIW-NIRHPNLVQL 55
+IG G+FG V + DG+ A+K L ++ K+ + E +++ N++HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 56 IGCCVEDNNRILVYEYLENNSL------ANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
V +Y+ L L ++++ + + AS + +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAE----------VASAIGY 111
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAP 167
LH I++RD+K N+LLD H + DFGL K + P+ T + GT YLAP
Sbjct: 112 LHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAP 165
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISG 194
E + D + G +L E++ G
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 2 IGGGAFGVV---YRGSLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G GA+G V Y LR ++A+K LS +S + E+ ++ +++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 57 -----GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
+E+ N + YL N L A L + K L + GL ++H
Sbjct: 81 DVFTPATSIENFNEV----YLVTN-LMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYA 170
I+HRD+K SNV ++ + +I DFGLA+ D +T +V+TR Y APE
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIM 187
Query: 171 L-LGQLTKKADVYSFGVLLLEIISGRSSSKAAF-GDDML 207
L + D++S G ++ E++ G KA F G+D +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKG----KALFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 45/189 (23%)
Query: 26 LSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG--------CCVEDNNRILVYEYL---EN 74
+ A + GT TE ++ I HP+++QL G C + + +Y YL N
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN 178
Query: 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134
++ + L +S + +LHE I+HRDIKA N+ ++
Sbjct: 179 IAICDILAIERS----------------VLRAIQYLHENR---IIHRDIKAENIFIN--- 216
Query: 135 HPK---IGDFGLAKLFPDNVTHVSTRV---AGTMGYLAPEYALLGQLTKKADVYSFGVLL 188
HP +GDFG A FP ++ + + AGT+ APE D++S G++L
Sbjct: 217 HPGDVCLGDFG-AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVL 273
Query: 189 LEIISGRSS 197
E+ + S
Sbjct: 274 FEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 54/266 (20%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSA-ESKQGTKEF-------------LTEIDMIWN 46
+G G +G V + G +AIK + E + L E+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 47 IRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASG 106
I+H N++ L+ VE + LV + + ++ L ++ K + L I L +G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD-LKK-VVDRK---IRLTESQVKCILLQILNG 131
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF--PDNVTHVSTRVAG---- 160
L+ LH+ +HRD+ +N+ ++ KI DFGLA+ + P +S
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 161 -------TMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAF-GDDMLILV 210
T+ Y APE L+G + D++S G + E+++G K F G++
Sbjct: 189 EMTSKVVTLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTG----KPLFPGEN----- 238
Query: 211 EWTWKLREEGRLLEIV-DPELTQFPE 235
++ + GR+ E++ P +P+
Sbjct: 239 ----EIDQLGRIFELLGTPNEDNWPQ 260
|
Length = 335 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 32/81 (39%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL-- 175
IV+RDIK N+LLD H + DFGL+K F + GT+ Y+APE + G+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGH 184
Query: 176 TKKADVYSFGVLLLEIISGRS 196
K D +S G+L+ E+++G S
Sbjct: 185 GKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLV 53
+G G F +++G R+ T++ +K L + ++ F M+ + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF-LHE 112
G CV + I+V EY++ SL L +K+ +++ W L A L++ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL-INISWK------LEVAKQLAWALHF 115
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT------MGYLA 166
D + H ++ A NVLL K G+ KL + +S V + ++
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLPKEILLERIPWVP 172
Query: 167 PEYALLGQ-LTKKADVYSFGVLLLEIISG--------RSSSKAAFGDDMLILVEWTW 214
PE Q L+ AD +SFG L EI SG S K F +D L W
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G + V++G S +A+K + E ++G + E+ ++ +++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL-GTASGLSFLHEEADPPI 118
D + LV+EYL+ + + +S+ I L GL++ H +
Sbjct: 74 HTDKSLTLVFEYLDKD--LKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRK---V 125
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QLT 176
+HRD+K N+L++ K+ DFGLA+ S V T+ Y P+ LLG + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-VLLGSSEYS 183
Query: 177 KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILV 210
+ D++ G + E+ SGR + +D L L+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRH-PNLVQLIG 57
IG G +G VY+ G +A+K L + + L EI ++ + +V+L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 58 CCVE----DNNRI---LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
VE N + LV+EYL+++ + L T + G++
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
H+ ++HRD+K N+L+D KI D GL + F V + + T+ Y APE
Sbjct: 127 HKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPE- 181
Query: 170 ALLG--QLTKKADVYSFGVLLLEIISG 194
LLG + D++S G + E+
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 2 IGGGAFGVVYRGSLRDGT---QIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G G +G VY+ +DG + A+K + E + EI ++ ++HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 59 CVEDNNR--ILVYEYLENN--SLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLHE 112
+ ++R L+++Y E++ + SK+ + P ++ G+ +LH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 113 EADPPIVHRDIKASNVLLDGN----FHPKIGDFGLAKLFPDNVTHVS--TRVAGTMGYLA 166
++HRD+K +N+L+ G KI D G A+LF + ++ V T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 167 PEYALLG--QLTKKADVYSFGVLLLEIIS 193
PE LLG TK D+++ G + E+++
Sbjct: 184 PEL-LLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAFG V + ++ A+K LS + + F E D++ P +VQL
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKY-VSLDWPT--RANICLGTASGLSFLHEE 113
+D +V EY+ L N + S Y V W A + L L +H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLA----LDAIHSM 161
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYLAPEYALL 172
+HRD+K N+LLD + H K+ DFG K+ + + T V GT Y++PE
Sbjct: 162 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS 217
Query: 173 ----GQLTKKADVYSFGVLLLEIISG 194
G ++ D +S GV L E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL----- 55
+G G+ G+V+ D ++A+K + Q K L EI +I + H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 56 ---------IGCCVEDNNRILVYEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTA 104
+G E N+ +V EY+E + LAN L ++ L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLL 124
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRVAG--T 161
GL ++H ++HRD+K +NV ++ + KIGDFGLA++ + +H G T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 162 MGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGR 195
Y +P L TK D+++ G + E+++G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 2 IGGGAFGVVYR-GSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-----RHPNLVQL 55
IG G +G V++ + ++G++ A+K L + EI+ +NI HPN+V+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 56 IGCCVEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
G + + + LV E S+ + + G + ++ P A I GL L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H +HRD+K +N+LL K+ DFG++ +T V GT ++APE
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 171 LLGQ-----LTKKADVYSFGVLLLEIISG 194
Q + DV+S G+ +E+ G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLT---EIDMIWNIRHPNLVQLIGC 58
+G G +G VY+ +DG + + + +GT ++ EI ++ ++HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDD--RDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 59 CVEDNNR--ILVYEYLENN--SLANALLGSKS--KYVSLDWPTRANICLGTASGLSFLHE 112
+ +R L+++Y E++ + SK+ K V L ++ G+ +LH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 113 EADPPIVHRDIKASNVLLDGN----FHPKIGDFGLAKLFPDNVTHVS--TRVAGTMGYLA 166
++HRD+K +N+L+ G KI D G A+LF + ++ V T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 167 PEYALLG--QLTKKADVYSFGVLLLEIIS 193
PE LLG TK D+++ G + E+++
Sbjct: 184 PEL-LLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 59/230 (25%)
Query: 1 MIGGGAFGVVYRGSLRDGT-QIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC- 58
+IG G+FGVVY D + ++AIK + + + +E L ++ N+ H N++ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYY 128
Query: 59 ---CVEDNNRIL------------VYEYLE----NNSLANALLGSKSKYVSLDWPTRANI 99
C + N + + V++Y++ NN L Y +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY---------QL 179
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLF---PDNVTHVS 155
C L+++H + I HRD+K N+L+D N H K+ DFG AK +V+++
Sbjct: 180 C----RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 156 TRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEII------SGRSS 197
+R Y APE +LG T D++S G ++ E+I SG+SS
Sbjct: 233 SRF-----YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276
|
Length = 440 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAFG V L++ ++ A+K L+ + T F E D++ N + + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKY---VSLDWPTRANICLGTASGLSFLHEE 113
++NN LV +Y L L + + ++ + I + + L +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFG-LAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
VHRDIK N+L+D N H ++ DFG KL D S V GT Y++PE
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 177
Query: 173 -----GQLTKKADVYSFGVLLLEIISGRS 196
G+ + D +S GV + E++ G +
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V R G ++AIK LS +S+ K E+ ++ +++H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 59 CV------EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
E + LV Y++ + ++G + + +C GL ++H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG---TMGYLAPEY 169
I+HRD+K N+ ++ + KI DFGLA+ H + G T Y APE
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEV 185
Query: 170 AL-LGQLTKKADVYSFGVLLLEIISGRS 196
L + D++S G ++ E+++G++
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 34/86 (39%), Positives = 43/86 (50%), Gaps = 10/86 (11%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK- 177
VHRDIK NVL+D H K+ DFG A N S GT Y+APE +L +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE--VLTTMNGD 181
Query: 178 -------KADVYSFGVLLLEIISGRS 196
+ D +S GV+ E+I GRS
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G++ VY+G R +G +A+K +S ++++G + E ++ ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 60 VEDNNRILVYEYLENNSLANALL----GSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
V+EY+ + LA ++ G V L GL+++H +
Sbjct: 73 HTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQH- 123
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-- 173
I+HRD+K N+L+ K+ DFGLA+ S+ V T+ Y P+ LLG
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGAT 179
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
+ D++ G + +E++ G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 2 IGGGAFGVVYRGSLRD---GTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG GA G+V + D G +A+K LS +++ K E+ ++ + H N++ L+
Sbjct: 29 IGSGAQGIVC--AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 57 GCCV------EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
E + LV E ++ N L + ++ LD + + G+ L
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------HMELDHERMSYLLYQMLCGIKHL 139
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN---VTHVSTRVAGTMGYLAP 167
H I+HRD+K SN+++ + KI DFGLA+ N +V TR Y AP
Sbjct: 140 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAP 191
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISG 194
E L + D++S G ++ E++ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G + VY+G S +A+K + E ++G + E+ ++ +++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL---GTASGLSFLHEEADP 116
+ + LV+EYL+ + L +++ N+ L GL++ H
Sbjct: 74 HTEKSLTLVFEYLDKD--LKQYLDDCGNSINMH-----NVKLFLFQLLRGLNYCHRRK-- 124
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--Q 174
++HRD+K N+L++ K+ DFGLA+ S V T+ Y P+ LLG
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPD-ILLGSTD 181
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+ + D++ G + E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS-------AESKQGTKEFLTEIDMIWNIRHPNL 52
+IG GAFG V +++ Q+ A+K L+ AE T F E D++ N +
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE----TACFREERDVLVNGDRRWI 63
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG-TASGLSFLH 111
L ++NN LV +Y L L SK+ A L + +H
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFG-LAKLFPDNVTHVSTRVA-GTMGYLAPEY 169
+ VHRDIK NVLLD N H ++ DFG +L D V + VA GT Y++PE
Sbjct: 120 QLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEI 174
Query: 170 --AL---LGQLTKKADVYSFGVLLLEIISGRS 196
A+ G+ + D +S GV + E++ G +
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL-----LG 173
VHRDIK NVLLD N H ++ DFG + T S+ GT Y++PE +G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 174 QLTKKADVYSFGVLLLEIISGRS 196
+ + D +S GV + E++ G +
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG G G VY ++A+K + +E+ K FL E + ++ HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT--------ASGLS 108
C + + Y+E +L +LL S + SL +G + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAK---------LFPD----NVTH- 153
++H + ++HRD+K N+LL G F I D+G A L D N+ +
Sbjct: 128 YVHSKG---VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 154 ---VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+ ++ GT Y+APE L ++ D+Y+ GV+L ++++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCL-SAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
I GAFG VY G ++ +++ A+K + A+ +K + E D + + P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
NN LV EYL + + L Y D A L +LH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRHG--- 124
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKL 146
I+HRD+K N+L+ H K+ DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 44/210 (20%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 3 GGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEI-DMIWNIR---HPNLVQLIGC 58
+ + T +A+K ++ +S +KE L + I R HPN++ +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVS-LDWPTRANICLGTASGLSFLHEEADPP 117
+ D+ +V + S + L K+ + L A I + L ++H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLL---KTHFPEGLPELAIAFILKDVLNALDYIHSKG--- 121
Query: 118 IVHRDIKASNVLLDGNFHPKIGDF---------GLAKLFPDNVTHVSTRVAGTMGYLAPE 168
+HR +KAS++LL G+ + G + + S + + +L+PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPE 178
Query: 169 YALLGQ----LTKKADVYSFGVLLLEIISG 194
+L Q +K+D+YS G+ E+ +G
Sbjct: 179 --VLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 38/95 (40%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
A G+ FL A VHRD+ A NVLL KI DFGLA+ ++ H S V+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGST 299
Query: 164 YL-----APEYALLGQLTKKADVYSFGVLLLEIIS 193
+L APE T +DV+S+G+LL EI S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 27/196 (13%)
Query: 5 GAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG------- 57
G+ G V+ + Q + A + T EID++ I H ++ LI
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG--REIDILKTISHRAIINLIHAYRWKST 160
Query: 58 -CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
C V + ++ Y++ + L I L++LH
Sbjct: 161 VCMVMPKYKCDLFTYVDRSG-------------PLPLEQAITIQRRLLEALAYLHGRG-- 205
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLA-KLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
I+HRD+K N+ LD + +GDFG A KL T +GT+ +PE L
Sbjct: 206 -IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 176 TKKADVYSFGVLLLEI 191
K D++S G++L E+
Sbjct: 265 CAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 20 QIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79
++ +K L + + F M+ + H ++V L G CV D I+V E++E L +
Sbjct: 34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-D 92
Query: 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL-----DGNF 134
+ KS ++ W + + AS LS+L D +VH ++ N+LL DG
Sbjct: 93 LFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGEC 147
Query: 135 HP--KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEI 191
P K+ D G+ P V V + ++APE + L+ AD +SFG L EI
Sbjct: 148 GPFIKLSDPGI----PITVLSRQECVE-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKE-----FLTEIDMIWNIRHPNLVQLI 56
IG G FG V+ + + C A S +G KE + E++++ ++H N+V+ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFF--CWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 57 GCCVEDNNRIL--VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+ N+ L + E+ + L+ + + ++ +I L++ H
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138
Query: 115 DPP----IVHRDIKASNVLL-----------------DGNFHPKIGDFGLAKLFPDNVTH 153
D P ++HRD+K N+ L +G KIGDFGL+K +
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--GIES 196
Query: 154 VSTRVAGTMGYLAPEYALLGQLTK----KADVYSFGVLLLEIISGRS 196
++ GT Y +PE LL TK K+D+++ G ++ E+ SG++
Sbjct: 197 MAHSCVGTPYYWSPE--LLLHETKSYDDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
+G G++ VY+G S G +A+K + E ++G + E ++ +++H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRA----NICLGTAS---GLSFLHE 112
LV+EYL+ + +Y +D N+ L GL++ H+
Sbjct: 73 HTKKTLTLVFEYLDTDL---------KQY--MDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGL--AKLFPDNVTHVSTRVAGTMGYLAPEYA 170
++HRD+K N+L+ K+ DFGL AK P T+ + V T+ Y P+
Sbjct: 122 RR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVV--TLWYRPPD-V 174
Query: 171 LLG--QLTKKADVYSFGVLLLEIISGR 195
LLG + + D++ G + E+ +GR
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG--- 160
A+G+ FL A VHRD+ A NVL+ KI DFGLA+ ++ S ++
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR----DIMRDSNYISKGST 301
Query: 161 --TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
+ ++APE T +DV+SFG+LL EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 60/238 (25%), Positives = 91/238 (38%), Gaps = 57/238 (23%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSA----ESKQ-----GTKEFLTEIDMIWNIRHP 50
+IG GAFG V +D I A+K L E +Q ++ L E D W
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW----- 62
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
+V++ + N L+ E+L + L+ K +L T + +
Sbjct: 63 -VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAI 117
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA--------KLFPDNVTH--------- 153
H+ +HRDIK N+LLD H K+ DFGL F N+TH
Sbjct: 118 HQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 154 -----------------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
++ GT Y+APE + K D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 58/238 (24%), Positives = 91/238 (38%), Gaps = 57/238 (23%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSA----ESKQ-----GTKEFLTEIDMIWNIRHP 50
+IG GAFG V +D G A+K L E +Q ++ L E D +W
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW----- 62
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
+V++ + N L+ E+L + L+ K +L T + +
Sbjct: 63 -VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSI 117
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL--------------------------- 143
H+ +HRDIK N+LLD H K+ DFGL
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 144 -------AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
A+ + N ++ GT Y+APE + K D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 52/217 (23%), Positives = 81/217 (37%), Gaps = 37/217 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGT----QIAIKCLSAESKQGTKEFLT-----EIDMI--W---- 45
+IG G FG VY Q K + E++ E L +ID I W
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 46 NIRHPNLVQLIGCCVEDNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANI 99
NI H + + GC R+ L + + K + NI
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK-------NI 131
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
+ L ++HE I H DIK N+++DGN I D+G+A F + H+
Sbjct: 132 MKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 160 ------GTMGYLAPEYALLGQLTKKADVYSFGVLLLE 190
GT+ Y + +T++ D+ S G +L+
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 2 IGGGAFGVV---YRGSLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG GA G+V Y L +AIK LS +++ K E+ ++ + H N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 57 GCCV------EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
E + LV E ++ N L + + LD + + G+ L
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHL 135
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H I+HRD+K SN+++ + KI DFGLA+ + + T T Y APE
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 171 LLGQLTKKADVYSFGVLLLEII 192
L + D++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 55/235 (23%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G G V+ L+ G A+K L + + K LTE +++ + HP L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEEA 114
+ LV +Y L LL + + R A + L L +LH
Sbjct: 69 SFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLHLLG 123
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS------------------T 156
IV+RD+K N+LL + H + DF L+K VS T
Sbjct: 124 ---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 157 RVA----------GTMGYLAPEYALLGQLTKKA------DVYSFGVLLLEIISGR 195
GT Y+APE + D ++ G+LL E++ G
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPE------VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 2 IGGGAFGVV---YRGSLRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG GA G+V Y L +AIK LS +++ K E+ ++ + H N++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 57 GC-----CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
+E+ + + L + +L + + LD + + G+ LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 143
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
I+HRD+K SN+++ + KI DFGLA+ + + T T Y APE L
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 172 LGQLTKKADVYSFGVLLLEIISGR 195
+ D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 34/113 (30%), Positives = 46/113 (40%), Gaps = 37/113 (32%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAK--------LFPDNVTHV--------------ST 156
+HRDIK N+LLD H K+ DFGL F ++H S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 157 RVA---------------GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194
R A GT Y+APE L K+ D +S GV++ E++ G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 93 WPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152
TRA I + ++H D ++HRDIK N+ L+ + +GDFG A F
Sbjct: 267 KQTRA-IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS 193
GT+ +PE + D++S G++LL+++S
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 35/210 (16%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS------AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG GA G+V G +AIK LS +K+ +E + ++ + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIG 79
Query: 55 LIGC-----CVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
L+ +E+ + LV E ++ N L + + LD + + G+
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMDLDHERMSYLLYQMLCGIK 132
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVSTRVAGTMGYL 165
LH I+HRD+K SN+++ + KI DFGLA+ + +V TR Y
Sbjct: 133 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YR 184
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIISGR 195
APE L + D++S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 25/183 (13%)
Query: 20 QIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79
++ +K L + F ++ + H +L + G CV + I+V E++E+ L +
Sbjct: 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-D 104
Query: 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL------DGN 133
L + V + W + + AS LS+L D +VH ++ A N+LL +G
Sbjct: 105 VCLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGT 159
Query: 134 FHP--KIGDFGLAKLFPDNVTHVS--TRVAGTMGYLAPE-YALLGQLTKKADVYSFGVLL 188
P K+ D G++ T +S RV + ++APE L+ AD +SFG L
Sbjct: 160 -SPFIKLSDPGVS------FTALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTL 211
Query: 189 LEI 191
LEI
Sbjct: 212 LEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 50 PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
PN+V L V +++ LV ++ E L + + SK++++ L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDA 100
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
LH E IV RD+ +N+LLD H ++ F V A Y APE
Sbjct: 101 LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDGEAVENMYCAPEV 153
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGRS 196
+ + T+ D +S G +L E+++G++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 42/119 (35%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLF----------------------PDNVTHVST 156
+HRDIK N+L+D + H K+ DFGL F + + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 157 R--------------------VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR 195
+ GT Y+APE L T+ D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 4/87 (4%)
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VTHVSTRVAGTMG 163
S + ++H E I+HRDIK NVL++G +GDFG A + T +AGT+
Sbjct: 271 SAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLE 190
APE T D++S G+++ E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 49 HPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
+PN ++L +L+ +Y+++ L + LL + K L I L+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGK---LSEAEVKKIIRQLVEALN 123
Query: 109 FLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAP 167
LH+ I+H DIK NVL D + D+GL K + + GT+ Y +P
Sbjct: 124 DLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175
Query: 168 EYALLGQLTKKADVYSF-----GVLLLEIISGRSSSKAAFGDDM 206
E ++ SF GVL E+++G+ K +++
Sbjct: 176 E-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 33/123 (26%), Positives = 47/123 (38%), Gaps = 46/123 (37%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFP------------------------------ 148
+HRDIK N+L+D + H K+ DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 149 ----DNVTHVSTRVA------------GTMGYLAPEYALLGQLTKKADVYSFGVLLLEII 192
D + + R A GT Y+APE L T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 193 SGR 195
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 32/123 (26%), Positives = 50/123 (40%), Gaps = 46/123 (37%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFP-------------------------DNVTH 153
+HRDIK N+L+D + H K+ DFGL F D+V++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 154 ---------------------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEII 192
++ + GT Y+APE L T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 193 SGR 195
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 18 GTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75
GT + ++ E +++ K E+ + RHPN++ + ++ ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 76 SLANALLGSKSKYVS-LDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-- 132
S AN+LL K+ + + NI G GL++LH+ +HR+IKAS++L+ G
Sbjct: 85 S-ANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDG 138
Query: 133 --------NFHPKIGDFGLAKL---FPDNVTHVSTRVAGTMGYLAPEYALLGQ----LTK 177
+ + + + AK+ FP T V + +L+PE LL Q
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV-------LPWLSPE--LLRQDLYGYNV 189
Query: 178 KADVYSFGVLLLEIISGR 195
K+D+YS G+ E+ +GR
Sbjct: 190 KSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 15/29 (51%), Positives = 20/29 (68%)
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLF 147
+HRDIK N+L+D H K+ DFGL+ F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 322 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.37 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.34 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.3 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.8 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.68 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.68 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.6 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.58 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.56 | |
| PLN02236 | 344 | choline kinase | 97.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.4 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.35 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 97.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.23 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.09 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.93 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.83 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.75 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.51 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.14 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.74 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=376.45 Aligned_cols=267 Identities=53% Similarity=0.921 Sum_probs=233.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-eeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-NRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|...+|+.||||++.........+|.+|+.++.+++|||+|+++|||.+.+ ..++|+||+++|+|.+
T Consensus 82 ~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d 161 (361)
T KOG1187|consen 82 LIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLED 161 (361)
T ss_pred ceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHH
Confidence 589999999999999988999999887554331455999999999999999999999999998 5999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC-Ccceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD-NVTHVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 158 (322)
.++..... +++|..+++|+.++|.||+|||....++|+||||||.|||+|+++.+||+|||++..... .... .+..
T Consensus 162 ~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~-~~~~ 238 (361)
T KOG1187|consen 162 HLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV-STTV 238 (361)
T ss_pred HhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce-eeec
Confidence 99876544 789999999999999999999998888899999999999999999999999999976554 2211 1111
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC--CCCH-
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT--QFPE- 235 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~- 235 (322)
.||.+|+|||++..+..+.|+||||||++|.||++|+.+..............|.+.....+.+.+++|+.+. ....
T Consensus 239 ~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~ 318 (361)
T KOG1187|consen 239 MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDE 318 (361)
T ss_pred CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChH
Confidence 6999999999999999999999999999999999999888876655566688898888888899999999985 4443
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
....++..++.+|++.+|.+||+|.||++.|+...
T Consensus 319 ~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 319 KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 68888999999999999999999999999995544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=352.35 Aligned_cols=243 Identities=28% Similarity=0.460 Sum_probs=207.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-eeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-NRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L 77 (322)
.||+|..|+||++.++ +++-+|+|++... .+...+++.+|+++++..+|||||.+|+.|..+. ...++||||++|+|
T Consensus 86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSL 165 (364)
T KOG0581|consen 86 VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSL 165 (364)
T ss_pred hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCH
Confidence 4899999999999887 6889999999655 4556689999999999999999999999999999 49999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+++...+ .+++...-+++.++++||.|||. .+ |+||||||.||||+..|.|||+|||.+....+. ...
T Consensus 166 d~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 166 DDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 99996553 69999999999999999999996 66 999999999999999999999999999876544 445
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccC--CCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFG--DDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.++||..|||||.+.+..|+.++||||||++++|+.+|+.||..... .+-..++ ..+.+...+.++
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------CAIVDEPPPRLP 303 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------HHHhcCCCCCCC
Confidence 67899999999999999999999999999999999999999987522 1111111 122233333444
Q ss_pred HH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EK-EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~-~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. ...+|..++..||++||.+||++.|+++.
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 43 66679999999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=368.13 Aligned_cols=241 Identities=25% Similarity=0.409 Sum_probs=207.6
Q ss_pred CcccCcceEEEEEEE-CCCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSL-RDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|||+.||.++. .+|..||+|++... .....+.+.+|+++.++|+|||||+++++|++.+..|+|.|+|+.++
T Consensus 25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s 104 (592)
T KOG0575|consen 25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS 104 (592)
T ss_pred eeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCcc
Confidence 699999999999987 68999999999764 45566889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..++ ++++++++.++.||+.||.|||+.+ |+|||||-.|+|++++..|||+|||+|.....+. ....
T Consensus 105 L~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~ 176 (592)
T KOG0575|consen 105 LMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKK 176 (592)
T ss_pred HHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc-cccc
Confidence 999997554 8999999999999999999999999 9999999999999999999999999999775442 2335
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
+.+|||.|.|||++.....+..+||||+||++|-||.|++||+...-.+.+..+. ... ..+|..
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------~~~----------Y~~P~~ 240 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------LNE----------YSMPSH 240 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------hcC----------cccccc
Confidence 6789999999999999999999999999999999999999998664333333221 100 122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+..+||.++|+.||.+|||+++|+..
T Consensus 241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44557788888999999999999999963
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=359.53 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=206.0
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCC-eeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-NRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~ 78 (322)
||+|+||+||+|.++....||+|++..... ...+.|.+|+.+|++++|||||+++|+|.+.. .+++||||+++|+|.
T Consensus 49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~ 128 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLS 128 (362)
T ss_pred cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence 799999999999999434499999976532 22569999999999999999999999999887 799999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++++.. ....+++..+..|+.+||.|+.|||+++. ||||||||+|||++.++ ++||+|||+++...... ...+.
T Consensus 129 ~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~ 203 (362)
T KOG0192|consen 129 VLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTS 203 (362)
T ss_pred HHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccC
Confidence 999874 22379999999999999999999998763 89999999999999998 99999999998654332 22333
Q ss_pred cccCCCCCchHHHh--hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 158 VAGTMGYLAPEYAL--LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 158 ~~~t~~y~aPE~~~--~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
..||+.|||||++. ...++.|+||||||+++|||+||..||........ +..+...+ ..+.+ +.
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~-----~Rp~~---p~ 269 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGG-----LRPPI---PK 269 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcC-----CCCCC---Cc
Confidence 67999999999999 56999999999999999999999999987654211 11111111 11222 22
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.....+..++.+||+.||..||++.+++..|+....
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 355568888888999999999999999999986654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-52 Score=347.67 Aligned_cols=196 Identities=34% Similarity=0.616 Sum_probs=178.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||.|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++.+++|||||+||+|.
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs 97 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS 97 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence 899999999999887 6899999999876 5667788999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC------CeEEEeeeccccccCCCcc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN------FHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~------~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++.++ .+++..+..+++|||.||++||+++ |+||||||+|||++.. -.+||+|||+++.....
T Consensus 98 ~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-- 168 (429)
T KOG0595|consen 98 DYIRRRG----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG-- 168 (429)
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch--
Confidence 9998776 7999999999999999999999999 9999999999999865 56899999999987643
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCc
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM 206 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~ 206 (322)
......+|++-|||||+++..+|+.|+|+||+|++||+|++|..||......+.
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 334668899999999999999999999999999999999999999986654443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=348.84 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=201.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.|-+|..+ +|+.||||+++.... .......+|+++|++++|||||+++++++..+..|+||||+
T Consensus 179 ~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v 258 (475)
T KOG0615|consen 179 TLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYV 258 (475)
T ss_pred eecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEe
Confidence 3899999999999655 799999999975411 12234579999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---CeEEEeeeccccccCC
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN---FHPKIGDFGLAKLFPD 149 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~ 149 (322)
+||.|.+.+-.++ .+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+..+.
T Consensus 259 ~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 259 EGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred cCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 9999999998776 6788888999999999999999999 9999999999999766 7799999999998763
Q ss_pred CcceeecccccCCCCCchHHHhhCCC---CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQL---TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
...+.+.+||+.|.|||++..... ..+.|+||+||+||-+|+|.+||.....+..+... + ..+++.
T Consensus 332 --~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ-----I-~~G~y~--- 400 (475)
T KOG0615|consen 332 --GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ-----I-LKGRYA--- 400 (475)
T ss_pred --ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-----H-hcCccc---
Confidence 455678899999999999987653 34789999999999999999999877655422110 1 111110
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+..-....++.+++|.+||..||++||+++|+|+.
T Consensus 401 --f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 401 --FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0112234456678999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-52 Score=359.06 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=211.5
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|-||+||.|.++....||+|.++.. ....+.|.+|+++|.+|+|+|||+++++|..++.++|||||+..|+|.+++
T Consensus 214 LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yL 292 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYL 292 (468)
T ss_pred hcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHh
Confidence 8999999999999997779999999854 344578889999999999999999999999988999999999999999999
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
.... ...+.....+.++.|||+|++||++++ +|||||.+.||||+++..+||+|||+++...++.........-+
T Consensus 293 r~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfP 367 (468)
T KOG0197|consen 293 RTRE--GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFP 367 (468)
T ss_pred hhcC--CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCC
Confidence 8632 237889999999999999999999999 99999999999999999999999999996655544444444457
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
..|.|||.+..+.|+.|||||||||+||||+| |+.||......+....+ ....++ ..|..++..
T Consensus 368 IkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l------e~GyRl---------p~P~~CP~~ 432 (468)
T KOG0197|consen 368 IKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL------ERGYRL---------PRPEGCPDE 432 (468)
T ss_pred ceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH------hccCcC---------CCCCCCCHH
Confidence 78999999999999999999999999999999 88888776554443332 222222 234455667
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
+.++|..||+.+|++|||++.+...|+....
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 8889999999999999999999998877654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=333.02 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=206.4
Q ss_pred cccCcceEEEEEEE-CCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccce-EEEeCC-eeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSL-RDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIG-CCVEDN-NRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~-~~~lv~e~~~~~~ 76 (322)
||+|.||+||++.. .+|..+|.|.++-+ +....+.+..|+.+|++|+|||||++++ -+.+++ .+++|||+|++|+
T Consensus 27 IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GD 106 (375)
T KOG0591|consen 27 IGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGD 106 (375)
T ss_pred HcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccC
Confidence 89999999999955 47999999998754 4455678999999999999999999998 344444 4899999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA-DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
|..++...+.....+++..+|+++.|++.||..+|+.- ++.+.||||||.||+++.+|.|||+|||+++.+.... ...
T Consensus 107 LsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-tfA 185 (375)
T KOG0591|consen 107 LSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-TFA 185 (375)
T ss_pred HHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh-HHH
Confidence 99999877777779999999999999999999999831 1239999999999999999999999999999876543 334
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC-
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP- 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (322)
...+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+. ..+.+-. + ... -.....+
T Consensus 186 ~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~---K-I~q--------gd~~~~p~ 250 (375)
T KOG0591|consen 186 HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCK---K-IEQ--------GDYPPLPD 250 (375)
T ss_pred HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHH---H-HHc--------CCCCCCcH
Confidence 5578999999999999999999999999999999999999999976 2222211 1 111 1233445
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.-+..++..+|..|+..||..||+.-.++..+..
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 4566778888999999999999996666655544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=329.94 Aligned_cols=234 Identities=26% Similarity=0.342 Sum_probs=197.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||+||.++.+ +++-||+|++++. .....+....|..+|..++||+||+++-.|.+.+.+|+|+||+.||.
T Consensus 32 viGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe 111 (357)
T KOG0598|consen 32 VIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE 111 (357)
T ss_pred eeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence 5899999999999665 6999999999765 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|...|+..+ .+++..+.-++.+|+.||.|||+.+ |+||||||+|||+|.+|+++|+|||+++...... ....
T Consensus 112 Lf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~ 183 (357)
T KOG0598|consen 112 LFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATR 183 (357)
T ss_pred HHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC-Cccc
Confidence 999997665 7999999999999999999999999 9999999999999999999999999998554332 2234
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.++||+.|||||++.+..++..+|-||||+++|||++|.+||...........+ .. ..+...+.-
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I-------~~--------~k~~~~p~~ 248 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI-------LK--------GKLPLPPGY 248 (357)
T ss_pred cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH-------hc--------CcCCCCCcc
Confidence 578999999999999999999999999999999999999999876443322221 11 112222222
Q ss_pred HHHHHHHHHHhcccCCCCCCC
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP 257 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp 257 (322)
...+..+++..+|+.||.+|.
T Consensus 249 ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCHHHHHHHHHHhccCHHHhc
Confidence 344577888889999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=316.95 Aligned_cols=256 Identities=25% Similarity=0.324 Sum_probs=205.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.+|+|+||.||+++++ +|+-||||++... ++.-.+-.++|+++|++++|+|+|.++++|.....+++|+|||+.--|
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL 88 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL 88 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence 3799999999999887 6999999998644 344457789999999999999999999999999999999999987444
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+-++.... .++...+.+++.|++.|+.|+|+++ ++||||||+||||+.+|.+||+|||+|+..... ....+.
T Consensus 89 -~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTD 160 (396)
T KOG0593|consen 89 -HELERYPN---GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNYTD 160 (396)
T ss_pred -HHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cchhhh
Confidence 44444433 6899999999999999999999999 999999999999999999999999999977642 233466
Q ss_pred cccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH--------HHhcCcccccc-C
Q 020720 158 VAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK--------LREEGRLLEIV-D 227 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~ 227 (322)
.+.|-+|+|||++.+ .+|+...||||+||++.||++|...|.+..+.+.+..+..... +......+..+ =
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 778999999999987 6899999999999999999999999998877777666543321 11111111111 1
Q ss_pred ccCCC------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQ------FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~------~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
|.... -.+....-+++++..||+.||++|++.++++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111 11222335789999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=325.45 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=203.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhc-HHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||.|..++||+|... .+..||||++..+.... .+.+.+|+..++.++||||++++..|..+..+|+||.||.+|++.
T Consensus 33 ~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~l 112 (516)
T KOG0582|consen 33 VIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLL 112 (516)
T ss_pred EEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHH
Confidence 4899999999999664 68999999998775444 488999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee---
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS--- 155 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--- 155 (322)
+++...-.. .+++..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+|||.+..+........
T Consensus 113 dIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf 187 (516)
T KOG0582|consen 113 DIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF 187 (516)
T ss_pred HHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee
Confidence 999754332 5999999999999999999999999 99999999999999999999999998876543332211
Q ss_pred cccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC-CC
Q 020720 156 TRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQ 232 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 232 (322)
....||+.|||||+++. ..|+.|+||||||++..||.+|+.||....+-..+.. ...+......-..+ .+
T Consensus 188 ~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-------tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 188 NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-------TLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-------HhcCCCCCcccccCChH
Confidence 44689999999999664 4799999999999999999999999987654433211 11222111110011 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
........|.+++..||+.||.+|||++++++
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22233446888888999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=326.34 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=197.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC--eeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--NRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L 77 (322)
+||+|+||+||++... +|...|+|.+...+....+.+.+|+.+|++++|||||++++...... .++++|||+++|+|
T Consensus 24 ~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL 103 (313)
T KOG0198|consen 24 LLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSL 103 (313)
T ss_pred cccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcH
Confidence 4899999999999765 58999999987664444677899999999999999999999855444 68999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCC--Cccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPD--NVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~--~~~~~ 154 (322)
.+++...+. .+++..+..+..||+.||+|||+++ ++|+||||+|||++. ++.+||+|||++..... .....
T Consensus 104 ~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~ 177 (313)
T KOG0198|consen 104 SDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS 177 (313)
T ss_pred HHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence 999976653 5999999999999999999999999 999999999999999 79999999999986653 12222
Q ss_pred ecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....||+.|||||++..+ ....++|||||||++.||+||..||..... ...+...+... ...+..
T Consensus 178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~ig~~--------~~~P~i 244 (313)
T KOG0198|consen 178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLIGRE--------DSLPEI 244 (313)
T ss_pred cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHHhcc--------CCCCCC
Confidence 3346799999999999953 344699999999999999999999987411 11111111111 112233
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
+.....+..+++..|+..||.+|||++++|+..
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 444445577777889999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=335.73 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=202.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+|++|++|... +++.||||++.+. .....+.+..|-..|.+| .||.|++++-.|.++..+|+|+||+++|
T Consensus 80 ~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG 159 (604)
T KOG0592|consen 80 ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG 159 (604)
T ss_pred eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence 4899999999999665 7999999999654 233345677899999999 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce--
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+|.++|...+ .+++..++.++.+|+.||+|||++| ||||||||+|||+|++++++|.|||.++.+......
T Consensus 160 dll~~i~K~G----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 160 DLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred cHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 9999997665 7999999999999999999999999 999999999999999999999999999876432211
Q ss_pred ----------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 154 ----------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 154 ----------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
....++||..|.+||++..+..++.+|||+|||+||+|+.|.+||.+... +...+.+..+.
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l~------ 303 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQALD------ 303 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHhc------
Confidence 11347899999999999999999999999999999999999999986532 22222222211
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.++++.......+|+.+.|..||++|+++.+|.+.
T Consensus 304 -------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 -------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 12333333557788888999999999999999775
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=352.67 Aligned_cols=252 Identities=28% Similarity=0.501 Sum_probs=214.1
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||+||+|+.. +...||||.++..... ..++|.+|++.+..++|||||+++|+|.+++..++|+|||..
T Consensus 494 LGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~ 573 (774)
T KOG1026|consen 494 LGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDH 573 (774)
T ss_pred hcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEeccc
Confidence 799999999999754 2457999999977655 678999999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCC----------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 75 NSLANALLGSKSK----------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 75 ~~L~~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
|+|.++|..+..+ ..+++..+.+.|+.|||.|+.||-++. ++||||...|+||.++..|||+|||++
T Consensus 574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLs 650 (774)
T KOG1026|consen 574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLS 650 (774)
T ss_pred ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccc
Confidence 9999999754321 224888899999999999999999998 999999999999999999999999999
Q ss_pred cccC-CCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 145 KLFP-DNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 145 ~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
+..- .+.........-..+|||||.+..++|+.+||||||||+|||+++ |..||++..+.+....+ ..+
T Consensus 651 RdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i-------~~g-- 721 (774)
T KOG1026|consen 651 RDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI-------RAG-- 721 (774)
T ss_pred hhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-------HcC--
Confidence 8543 333222224445789999999999999999999999999999998 89999988766554333 222
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+-..+..++.+++.||..||+.+|++||+++||-..|+.+..
T Consensus 722 ------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 722 ------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2234566677789999999999999999999999999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=331.01 Aligned_cols=241 Identities=26% Similarity=0.397 Sum_probs=198.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc----Ch-hcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE----SK-QGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||+|+.|.+. +|..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++......++||||+.
T Consensus 24 ~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~ 103 (370)
T KOG0583|consen 24 TLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCS 103 (370)
T ss_pred eecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecC
Confidence 3899999999999665 7899999977653 22 23466778999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 152 (322)
+|+|.+++...+ ++.+.++..+++|++.|++|||+.+ |+||||||+||+++.+ +.+||+|||++.... ...
T Consensus 104 gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~ 175 (370)
T KOG0583|consen 104 GGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GED 175 (370)
T ss_pred CccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-CCC
Confidence 999999997743 7899999999999999999999999 9999999999999999 999999999999774 222
Q ss_pred eeecccccCCCCCchHHHhhCC-CC-cccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQ-LT-KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~-~~-~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
......+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||........+.. +. .+. ..+
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k------i~-~~~------~~~ 242 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK------IR-KGE------FKI 242 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH------Hh-cCC------ccC
Confidence 3445678999999999999877 75 899999999999999999999987322211111 11 110 111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.... ..++..++.+||..||.+|+++.+|+.
T Consensus 243 p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 243 PSYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11111 556888999999999999999999983
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=324.76 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=205.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|+.. +|+.||+|.++.+. +.......+|+.+|++++||||+++.+...+. ..+|+|+|||+.
T Consensus 124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh- 202 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH- 202 (560)
T ss_pred HhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence 3899999999999654 79999999998775 44457788999999999999999999999887 689999999987
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.-++.... ..+++.++..++.||+.||.|+|+.+ ++|||||..|||||.+|.+||+|||+|+.+........
T Consensus 203 DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~ 276 (560)
T KOG0600|consen 203 DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY 276 (560)
T ss_pred hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence 7877775443 47999999999999999999999999 99999999999999999999999999998876665556
Q ss_pred cccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc-----cc--cccC
Q 020720 156 TRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR-----LL--EIVD 227 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~--~~~~ 227 (322)
+..+-|.+|+|||++.+. .|+.+.|+||.||||.||+.|++.|.+....+.+..+.....-..+.- +. ..+.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 777789999999999875 799999999999999999999999998766555544432211111110 00 0111
Q ss_pred ccC------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PEL------TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.- .+.........++|+..+|..||++|.|+.++|.
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 100 0000111234678888899999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=330.88 Aligned_cols=242 Identities=28% Similarity=0.448 Sum_probs=205.8
Q ss_pred cccCcceEEEEEEE-CCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSL-RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+.|.||.|.. .+++.||||++........+-+++|+.+|+..+|+|||.+++.|...+.+|+||||++||+|.++
T Consensus 281 igqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDv 360 (550)
T KOG0578|consen 281 IGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDV 360 (550)
T ss_pred hccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhh
Confidence 79999999999954 47899999999877666678899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..+..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+..... .....+|
T Consensus 361 Vt~~-----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVG 431 (550)
T KOG0578|consen 361 VTKT-----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVG 431 (550)
T ss_pred hhcc-----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccC
Confidence 9554 5999999999999999999999999 99999999999999999999999999987654433 3345789
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
|+-|||||+.....|++|.||||||++++||+.|++||-.......+.+ +...+. +.+ ..+......
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------Ia~ng~------P~l-k~~~klS~~ 498 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PKL-KNPEKLSPE 498 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH------HhhcCC------CCc-CCccccCHH
Confidence 9999999999999999999999999999999999999986433322222 222221 222 223344555
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
|.+++.+||+.|+.+|+++.|+|+.
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhcC
Confidence 8888888999999999999999974
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=326.29 Aligned_cols=242 Identities=27% Similarity=0.427 Sum_probs=205.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|.||.||+|... +++.||+|++..+.. ...+++.+|+..+.+++++||.++|+.+..+..++++||||.||++.
T Consensus 20 ~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~ 99 (467)
T KOG0201|consen 20 LIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVL 99 (467)
T ss_pred hccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchh
Confidence 4899999999999665 799999999987744 44588999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++.... .+.+..+.-++.+++.|+.|||..+ .+|||||+.||++..+|.+||+|||.+.......... .++
T Consensus 100 ~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf 171 (467)
T KOG0201|consen 100 DLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF 171 (467)
T ss_pred hhhccCC----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence 9996554 5588888889999999999999999 9999999999999999999999999998766554443 668
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
+||+.|||||+++...|+.|+||||||++++||++|.+|+....+-..+..+ .....|.+.. ...
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~~---~~S 236 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLDG---DFS 236 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCcccc---ccC
Confidence 8999999999999889999999999999999999999999876553322221 1111122322 344
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..|.+++..||++||+.||++.++++.
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 457788888999999999999999863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=333.08 Aligned_cols=250 Identities=27% Similarity=0.518 Sum_probs=203.3
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|.||+||+|.|. | .||||+++.+. ....+.|.+|+..+++-+|.||+-+.|+|..... .+|+.+|+|.+|+.
T Consensus 400 IGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~ 476 (678)
T KOG0193|consen 400 IGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYT 476 (678)
T ss_pred eccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhh
Confidence 899999999999877 2 49999998874 4456889999999999999999999999988876 89999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC-Ccceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD-NVTHVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 158 (322)
+++.... .+.....+.|++||+.|+.|||.++ |||+|||..|||+.+++.|||+|||++..-.. .........
T Consensus 477 hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp 550 (678)
T KOG0193|consen 477 HLHVQET---KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP 550 (678)
T ss_pred hccchhh---hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence 9987764 6888999999999999999999999 99999999999999999999999999874321 111122334
Q ss_pred ccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 159 AGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 159 ~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
.|...|||||++.. .+|++.+|||||||++|||++|..||.....+..++.+ - .| .+.+.+.....
T Consensus 551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV------G-rG----~l~pd~s~~~s 619 (678)
T KOG0193|consen 551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV------G-RG----YLMPDLSKIRS 619 (678)
T ss_pred ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe------c-cc----ccCccchhhhc
Confidence 57889999999983 47999999999999999999999999933222222211 0 01 11233333344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+...|.+|+..||..++++||.+.+|+..|+.+..
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 556678888888999999999999999998877765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=323.92 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=206.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCC-CCcccccceEEEeCC-eeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDN-NRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L 77 (322)
||.|+||.||+|+.. +|..||||.++... ..+.-.-++|+..|++++ ||||+++.+++.+.+ .+++|||||+. +|
T Consensus 18 lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NL 96 (538)
T KOG0661|consen 18 LGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NL 96 (538)
T ss_pred hcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hH
Confidence 799999999999665 68999999987653 233344578999999998 999999999999888 99999999975 89
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..+. ..+++..+..|+.||+.||+++|++| +.|||+||+|||+..+..+||+|||+|+....... .+.
T Consensus 97 YqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP--YTe 168 (538)
T KOG0661|consen 97 YQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP--YTE 168 (538)
T ss_pred HHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCC--cch
Confidence 99997763 38999999999999999999999999 99999999999999999999999999997755433 355
Q ss_pred cccCCCCCchHHHh-hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH-----Hhc-CccccccC---
Q 020720 158 VAGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL-----REE-GRLLEIVD--- 227 (322)
Q Consensus 158 ~~~t~~y~aPE~~~-~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~--- 227 (322)
.+.|-+|+|||++. ...|+.+.|||++|||++|+.+-++.|.+....+.+..+--+... ..+ ..+...++
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~ 248 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF 248 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence 67899999999876 567899999999999999999999999887666555443211100 011 11111222
Q ss_pred -----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 -----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 -----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+..+.+....++.+++.+|+..||.+|||+.|.++.
T Consensus 249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 12233334567789999999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=297.55 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=206.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|.||.||+|... +|+.||||.++..... ......+|+..|+.++|+||+.++++|.+.+...+|+||++. +|
T Consensus 9 ~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dL 87 (318)
T KOG0659|consen 9 KLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DL 87 (318)
T ss_pred hhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cH
Confidence 4899999999999654 7999999999866322 246789999999999999999999999999999999999976 89
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..++.... ..+....+..++.+++.|++|||.+. |+||||||.|+|++.+|.+||+|||+++.+.........
T Consensus 88 e~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~- 160 (318)
T KOG0659|consen 88 EVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH- 160 (318)
T ss_pred HHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccccc-
Confidence 99996554 37888999999999999999999999 999999999999999999999999999988755443322
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc-----------
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI----------- 225 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 225 (322)
.+-|-+|+|||++.+. .|+...||||.||++.||+-|.+-|.+..+-+.+..+..+.....+....++
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 3578899999998865 7999999999999999999988777776665555555433222111111110
Q ss_pred c-CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 V-DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+ .+.+...-+.+..+.++++..|+..||.+|.++.|.+++
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 011122333455667999999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=329.68 Aligned_cols=236 Identities=27% Similarity=0.464 Sum_probs=200.9
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||.|+.|.||.|+.. ++.||||.++.-.+ .++.-|++|+||||+.+.|+|.....+|+|||||..|-|.+++
T Consensus 132 lGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL 203 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL 203 (904)
T ss_pred hccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence 799999999999988 78899998864332 3678899999999999999999999999999999999999999
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
.... +++......|..+||.|+.|||.+. |||||||.-||||+.+..|||+|||.++....... ...+.||
T Consensus 204 ka~~----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kMSFaGT 274 (904)
T KOG4721|consen 204 KAGR----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KMSFAGT 274 (904)
T ss_pred hccC----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--hhhhhhh
Confidence 7654 7888899999999999999999998 99999999999999999999999999987654422 2346799
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC-CCCCHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMR 240 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (322)
..|||||++.+.+.++|.|||||||+|||||||..||...+....++- .=...+ -..+..++.-
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG---------------VGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG---------------VGSNSLHLPVPSTCPDG 339 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe---------------ccCCcccccCcccCchH
Confidence 999999999999999999999999999999999999986543322211 111222 2445666677
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
|.-|+++||+..|.+||++.+++..|.-.
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 88899999999999999999999988543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=301.43 Aligned_cols=229 Identities=28% Similarity=0.359 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||.|+||+|.+++.+ +|..+|+|++... .....+...+|..+|+.+.||+++++++.+.+.+.+++||||++||.
T Consensus 51 tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGE 130 (355)
T KOG0616|consen 51 TLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGE 130 (355)
T ss_pred eeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCcc
Confidence 4899999999999877 6999999999765 23445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|..+++..+ +++++.++.++.||+.||+|||+.+ |++|||||+|||+|.+|.+||.|||+++..... ..
T Consensus 131 lFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 131 LFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred HHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 999997665 7999999999999999999999999 999999999999999999999999999976543 34
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
+.+|||.|+|||+++..++..++|-|||||++|||+.|.+||........+..+ .++. -.+|+-
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI-------~~~~---------v~fP~~ 263 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI-------LEGK---------VKFPSY 263 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH-------HhCc---------ccCCcc
Confidence 578999999999999999999999999999999999999999876553222111 1111 133444
Q ss_pred HHHHHHHHHHhcccCCCCCC
Q 020720 237 EVMRFIKVGLFCTQAGAHYR 256 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~R 256 (322)
....+.+|+..+|+.|-.+|
T Consensus 264 fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHHhhhhHhh
Confidence 44557788888999998888
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=325.67 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCC-eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDN-NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~ 71 (322)
.||+|+||.||+|.+ .+++.||+|+++... ......+.+|+.++..+ +||||+++++++...+ ..+++|||
T Consensus 14 ~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey 93 (338)
T cd05102 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEF 93 (338)
T ss_pred EeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEec
Confidence 489999999999964 135679999987543 23346789999999999 8999999999887644 57899999
Q ss_pred CCCCCHHHHHhcCCCC----------------------------------------------------------CcCCCH
Q 020720 72 LENNSLANALLGSKSK----------------------------------------------------------YVSLDW 93 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~----------------------------------------------------------~~~~~~ 93 (322)
+++|+|.+++...... ..++++
T Consensus 94 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 173 (338)
T cd05102 94 CKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTM 173 (338)
T ss_pred CCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCH
Confidence 9999999999753211 124778
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-ecccccCCCCCchHHHhh
Q 020720 94 PTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV-STRVAGTMGYLAPEYALL 172 (322)
Q Consensus 94 ~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~ 172 (322)
..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.......... .....++..|+|||++.+
T Consensus 174 ~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 250 (338)
T cd05102 174 EDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence 889999999999999999998 9999999999999999999999999997543222111 122335678999999999
Q ss_pred CCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccC
Q 020720 173 GQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQA 251 (322)
Q Consensus 173 ~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 251 (322)
..++.++|||||||++|||++ |..||......... ......+. ....+......+.+++.+||+.
T Consensus 251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGT--------RMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCC--------CCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999997 99999765332211 01111111 1111223344688999999999
Q ss_pred CCCCCCCHHHHHHHHhcccc
Q 020720 252 GAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 252 dp~~Rps~~evl~~L~~~~~ 271 (322)
||.+||++.||++.|+....
T Consensus 317 dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 317 DPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=316.13 Aligned_cols=244 Identities=20% Similarity=0.292 Sum_probs=197.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhc---HHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQG---TKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 73 (322)
+||+|+++.||+|... |+.||+|.++...... .+.+.+|+.++++++||||+++++++.+ ....+++|||++
T Consensus 27 ~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 27 LIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred EEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 3799999999999885 8899999997653332 4677899999999999999999999877 346789999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
+|+|.+++.... .+++...+.++.|++.||.|||+. + ++||||||.||++++++.+||+|||++.......
T Consensus 106 ~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 106 RGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999996543 688999999999999999999984 6 8899999999999999999999999988643321
Q ss_pred eeecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 HVSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
....++..|+|||++.+ ..++.++|||||||++|||++|..||......+. .. .....+. .+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~---~i~~~~~-----~~-- 241 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD---LIINKNN-----SL-- 241 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhcCC-----CC--
Confidence 23457889999999976 6889999999999999999999999986532211 11 1111110 01
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
..+......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 122233456889999999999999999999999997654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=336.55 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=205.0
Q ss_pred CcccCcceEEEEEEECC-CCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceE-EEe---C---CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGC-CVE---D---NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~---~---~~~~lv~e~ 71 (322)
+|.+|||+.||.|.... |..||+|++-..++...+.+.+|+++|++|+ |+|||.+++. ... . -..+|+|||
T Consensus 44 vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEy 123 (738)
T KOG1989|consen 44 VLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEY 123 (738)
T ss_pred EEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhh
Confidence 48899999999997765 4999999998888888899999999999996 9999999993 221 1 257899999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
|.||.|.|++..+... .|++.++++|+.++++|+++||.. .+||||||||.+||||+.+|..||||||.+.-.....
T Consensus 124 C~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 124 CKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred ccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 9999999999866443 599999999999999999999997 5889999999999999999999999999887322111
Q ss_pred ceee--------cccccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC
Q 020720 152 THVS--------TRVAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG 220 (322)
Q Consensus 152 ~~~~--------~~~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (322)
.... -...-|+.|+|||++. +.+.++|+|||+|||+||-|+....||+.....
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------------- 264 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------------- 264 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------------
Confidence 0000 0123689999999886 678899999999999999999999999865222
Q ss_pred ccccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 221 RLLEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 221 ~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.+++... ..-.+.+...|..||..||+.||.+||++.+|+..+.++....
T Consensus 265 ---aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1222222 1222577888999999999999999999999999887776544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.05 Aligned_cols=241 Identities=27% Similarity=0.309 Sum_probs=196.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||+.+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999765 68999999997542 2334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 82 LFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 999986543 6899999999999999999999999 9999999999999999999999999987532211 1123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|||++|..||....... ... ... .+. ..++..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~---~~~-~~~---------~~~p~~ 217 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LIL-MEE---------IRFPRT 217 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHH---HHH-cCC---------CCCCCC
Confidence 4568999999999999999999999999999999999999997542211 111 011 110 112223
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
....+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 344588899999999999999 78988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=323.53 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=211.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe-eEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN-RILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~ 76 (322)
++|+|+||.++.++++ ++..||+|.+.... ....+...+|+.+++++.|||||.+.+.|.+++. .+++|+||+||+
T Consensus 11 ~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~ 90 (426)
T KOG0589|consen 11 QVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGD 90 (426)
T ss_pred hcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCC
Confidence 5899999999999776 58899999998663 3334578999999999999999999999999988 999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+.+..++ ...+++..++.|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+++...... ....
T Consensus 91 l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~ 164 (426)
T KOG0589|consen 91 LAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLAS 164 (426)
T ss_pred HHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch-hhhh
Confidence 999998765 347999999999999999999999988 9999999999999999999999999999887654 2335
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|++||++.+.+|..|+|||||||++|||++-+.+|.......... .+........+..
T Consensus 165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~---------------ki~~~~~~Plp~~ 229 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL---------------KINRGLYSPLPSM 229 (426)
T ss_pred eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH---------------HHhhccCCCCCcc
Confidence 5789999999999999999999999999999999999999998764332211 1111224567778
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+..++..++..|++.+|..||++.++|..
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 88889999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=325.10 Aligned_cols=239 Identities=27% Similarity=0.392 Sum_probs=203.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
+||+|.||.||+|+-+ +.+.||+|.+.+. .+.+.+.+.+|+++++.++||||+.+++.|+...+.|+|+||+.| +|
T Consensus 9 ~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L 87 (808)
T KOG0597|consen 9 MIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DL 87 (808)
T ss_pred HhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hH
Confidence 4899999999999655 6899999999654 334457799999999999999999999999999999999999977 99
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..++...+ .+++..+..++.+++.||.|||+++ |+|||+||.||+++.++.+|++|||+++.+..+. ...+.
T Consensus 88 ~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vlts 159 (808)
T KOG0597|consen 88 FTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVLTS 159 (808)
T ss_pred HHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc-eeeee
Confidence 99997665 7999999999999999999999999 9999999999999999999999999999876543 33455
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..|||-|||||+..+.+|+..+|+|||||++||++.|++||...... .++ ..+. ..-..-+...
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv---~~I~----------~d~v~~p~~~ 223 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLV---KSIL----------KDPVKPPSTA 223 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHH---HHHh----------cCCCCCcccc
Confidence 77999999999999999999999999999999999999999854211 111 1111 1111223366
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...|..++...|.+||..|.+-.+++.
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 677999999999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=318.08 Aligned_cols=240 Identities=25% Similarity=0.293 Sum_probs=192.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|... +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999776 6889999998643 233446778899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99996543 6899999999999999999999999 9999999999999999999999999987532221 12234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||....... . ..... .. ...++...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~---~~~~~-~~---------~~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---M---YRKIL-QE---------PLRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---H---HHHHH-cC---------CCCCCCcC
Confidence 568999999999999999999999999999999999999997542211 1 11111 11 01122223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.||.+||++..+.+.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 3457888999999999999864433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=312.13 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~ 86 (285)
T cd05631 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGD 86 (285)
T ss_pred EEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCc
Confidence 4899999999999764 79999999986542 2233567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 87 L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05631 87 LKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VR 159 (285)
T ss_pred HHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--ec
Confidence 9988854322 26889999999999999999999999 99999999999999999999999999876533221 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|+..|+|||++.+..++.++|||||||++|+|++|..||............. .... ......+..
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~---------~~~~~~~~~ 227 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVK---------EDQEEYSEK 227 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhh---------cccccCCcc
Confidence 3468999999999999999999999999999999999999998654332211111 0000 111112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
....+.+++.+||+.||.+||+ ++++++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 3445888999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=317.90 Aligned_cols=238 Identities=27% Similarity=0.358 Sum_probs=194.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..+++|||+.+++
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 104 (329)
T PTZ00263 25 TLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGE 104 (329)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCCh
Confidence 3899999999999876 68999999986532 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 105 L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~ 173 (329)
T PTZ00263 105 LFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----F 173 (329)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----c
Confidence 999997553 6888999999999999999999999 9999999999999999999999999988654322 2
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...... ... ... ..+.. ..+..
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~---~~i-~~~~~---------~~p~~ 237 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIY---EKI-LAGRL---------KFPNW 237 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHH---HHH-hcCCc---------CCCCC
Confidence 346899999999999999999999999999999999999999753211 111 111 11111 11111
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~~ 265 (322)
...++.+++.+||+.||.+||+ +++++..
T Consensus 238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2345788999999999999997 6777654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.32 Aligned_cols=239 Identities=25% Similarity=0.330 Sum_probs=202.6
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+-|.|-.|++. +|+.+|||++.... ......+.+|+.+|+-+.|||++++|+++++..++|+|.||+++|.|
T Consensus 20 LG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGEL 99 (786)
T KOG0588|consen 20 LGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGEL 99 (786)
T ss_pred ccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchh
Confidence 899999999999765 79999999997552 22235688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++...+ ++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.....+ ....+
T Consensus 100 Fdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klLeT 170 (786)
T KOG0588|consen 100 FDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLLET 170 (786)
T ss_pred HHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--ccccc
Confidence 99997766 8999999999999999999999999 999999999999999999999999999865433 33466
Q ss_pred cccCCCCCchHHHhhCCCC-cccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQLT-KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~-~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.||.+.|.|||++.+.+|. .++||||.|||||.||+|+.||...... .+.. + .. ....++|..
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLl---K-V~---------~G~f~MPs~ 234 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLL---K-VQ---------RGVFEMPSN 234 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHH---H-HH---------cCcccCCCc
Confidence 7899999999999999984 8999999999999999999999833211 1111 1 11 122234444
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+..+|+.+|+..||++|.|++||++.
T Consensus 235 Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 235 ISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 55567888889999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=308.85 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=197.3
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+.+++||||+++++++...+..++||||++++
T Consensus 12 ~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
T cd05064 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91 (266)
T ss_pred eecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCC
Confidence 4899999999999653 35689999987653 333467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||.+...........
T Consensus 92 ~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 165 (266)
T cd05064 92 ALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165 (266)
T ss_pred cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchhcc
Confidence 9999996543 26889999999999999999999998 99999999999999999999999998764322211111
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....++..|+|||++.+..++.++|||||||++||+++ |..||......+. .. .. ..+. ....+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~---~~-~~~~--------~~~~~ 230 (266)
T cd05064 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK---AV-EDGF--------RLPAP 230 (266)
T ss_pred cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH---HH-HCCC--------CCCCC
Confidence 12234578999999999999999999999999999875 9999975432211 11 11 1111 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
......+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 33445588899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=317.91 Aligned_cols=241 Identities=27% Similarity=0.318 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999765 6899999999754 23344678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+.+.... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 82 LFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 998886543 6899999999999999999999999 9999999999999999999999999987532221 1123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. ... .. .. .++..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~---~~~-~~------~~---~~p~~ 217 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE---LIL-ME------DI---KFPRT 217 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HH---Hhc-cC------Cc---cCCCC
Confidence 35689999999999988999999999999999999999999975422111 10 000 00 01 12222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
...++.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 344578899999999999997 88998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=290.22 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=206.9
Q ss_pred CcccCcceEEEEEEE-CCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSL-RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~ 74 (322)
.||+|||+-||.++. .++..||+|++.....++.+..++|++..++++|||+++++++...+. ..|++++|...
T Consensus 28 ~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~ 107 (302)
T KOG2345|consen 28 LLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKR 107 (302)
T ss_pred eecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcc
Confidence 489999999999964 468899999999888888899999999999999999999998875443 48999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|+|.+.++....+...+++..++.|+.+|++||.+||... ++++||||||.||++++.+.+++.|||.+....-.....
T Consensus 108 Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~ 186 (302)
T KOG2345|consen 108 GSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGS 186 (302)
T ss_pred ccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeech
Confidence 9999999988777778999999999999999999999874 679999999999999999999999999887543221111
Q ss_pred --------ecccccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 155 --------STRVAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 155 --------~~~~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
......|..|+|||++. +...++++|||||||+||.|+.|..||+..... .+-+.
T Consensus 187 ~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------------GgSla 252 (302)
T KOG2345|consen 187 RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------------GGSLA 252 (302)
T ss_pred HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------------CCeEE
Confidence 11134789999999987 446789999999999999999999999754221 11111
Q ss_pred -cccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 224 -EIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 224 -~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+..+ ........+.+.+++.+||+.||.+||++.+++..+..+.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111122 1112226677999999999999999999999999887653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=318.45 Aligned_cols=241 Identities=26% Similarity=0.303 Sum_probs=195.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +|..||+|+++.. .......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5899999999999765 6899999999754 22334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 82 LFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 998886543 6899999999999999999999999 9999999999999999999999999887532221 1123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .... .. . ..+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~~~~-~~------~---~~p~~ 217 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LILM-EE------I---RFPRT 217 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHhc-CC------C---CCCCC
Confidence 3568999999999998899999999999999999999999997543221110 0110 00 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
....+.+++.+||+.||.+|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 334578889999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=313.87 Aligned_cols=238 Identities=24% Similarity=0.294 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 87 (291)
T cd05612 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE 87 (291)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCC
Confidence 4899999999999776 68999999986432 2334668899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 88 L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----~ 156 (291)
T cd05612 88 LFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----W 156 (291)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc----c
Confidence 999996553 6889999999999999999999999 9999999999999999999999999987653321 2
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|++.|+|||++.+..++.++|||||||++|+|++|..||........ . .... .+. . .++..
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~---~~i~-~~~------~---~~~~~ 220 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---Y---EKIL-AGK------L---EFPRH 220 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHH-hCC------c---CCCcc
Confidence 34689999999999988899999999999999999999999976432111 1 1111 111 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~~ 265 (322)
....+.+++.+||+.||.+||+ ++++++.
T Consensus 221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 2345788999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=309.76 Aligned_cols=239 Identities=23% Similarity=0.391 Sum_probs=202.9
Q ss_pred cccCcceEEEEEEE-CCCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSL-RDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|.||+|-+|.. ..|+.||||.++.+ +.++.-.+.+|+++|+.|+||||+.+|.+|+..+...+||||..+|.|
T Consensus 61 LGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeL 140 (668)
T KOG0611|consen 61 LGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGEL 140 (668)
T ss_pred hcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccH
Confidence 89999999999954 68999999999876 445556788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++++..++ .+++.++..++.||+.|+.|+|+++ ++|||||.+|||+|.|+++||+|||++..+... ...+.
T Consensus 141 YDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfLqT 211 (668)
T KOG0611|consen 141 YDYISERG----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFLQT 211 (668)
T ss_pred HHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc--cHHHH
Confidence 99997665 7999999999999999999999999 999999999999999999999999999887543 34567
Q ss_pred cccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
++|++-|.+||++.+.+| .+..|-||||++||-|+.|..||.+.+..... .++. .+.. .. ...+
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv------rQIs-~GaY---rE---P~~P-- 276 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV------RQIS-RGAY---RE---PETP-- 276 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH------HHhh-cccc---cC---CCCC--
Confidence 899999999999999888 48999999999999999999999876432211 1111 1111 11 1222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.+..-+|+|||-.||++|.|+.+|....
T Consensus 277 --SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 277 --SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 3366789999999999999999998753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=342.04 Aligned_cols=253 Identities=33% Similarity=0.509 Sum_probs=208.3
Q ss_pred CcccCcceEEEEEEEC--CCC----EEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR--DGT----QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||.|... .|. .||+|.++.. +.+...+|++|..+|+.++|||||+++|++.+....++++|||+
T Consensus 699 ~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~ 778 (1025)
T KOG1095|consen 699 VLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYME 778 (1025)
T ss_pred eeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcc
Confidence 4899999999999654 343 4899998755 56667899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 74 NNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 74 ~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
+|+|..+|+..+. ....+.....+.++.+||.|+.||++++ +|||||...|+|++....|||+|||+|+.....
T Consensus 779 gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~ 855 (1025)
T KOG1095|consen 779 GGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDK 855 (1025)
T ss_pred cCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhc
Confidence 9999999976521 1236888899999999999999999999 999999999999999999999999999943322
Q ss_pred cceeec-ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 151 VTHVST-RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 151 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
...... ...-...|||||.+..+.|+.|+|||||||++||++| |..||....+.+.+.. ....+++
T Consensus 856 ~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~~ggRL------ 923 (1025)
T KOG1095|consen 856 DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VLEGGRL------ 923 (1025)
T ss_pred hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HHhCCcc------
Confidence 222222 2234568999999999999999999999999999999 8888876655433321 1233322
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
+.|..++..++++|.+||+.+|++||++..|++.+.....
T Consensus 924 ---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 924 ---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 3356667779999999999999999999999998776654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.51 Aligned_cols=252 Identities=31% Similarity=0.461 Sum_probs=203.2
Q ss_pred CcccCcceEEEEEEEC--CC--CE-EEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR--DG--TQ-IAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~--~~-vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++ .. ||+|..+.+ ......++++|+++|++++|||||+++|++.....+++|||+|
T Consensus 164 kLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~ 243 (474)
T KOG0194|consen 164 KLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELC 243 (474)
T ss_pred eeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEec
Confidence 4899999999999665 22 23 899998853 3556689999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.||+|.+++...+. .++..+...++.+.|.||+|||+++ ++||||.+.|+|++.++.+||+|||+++.... ..
T Consensus 244 ~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-~~ 316 (474)
T KOG0194|consen 244 NGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-YV 316 (474)
T ss_pred CCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc-ee
Confidence 99999999977653 5999999999999999999999999 99999999999999999999999999875431 11
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
.......-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+.. ..+...+ ...
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------~kI~~~~--------~r~ 382 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------AKIVKNG--------YRM 382 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------HHHHhcC--------ccC
Confidence 11111124679999999999999999999999999999999 88898866433211 1111111 111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
..+...+..+..++.+||..||++||+|.++.+.|+......
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 223344555777788899999999999999999998776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=310.55 Aligned_cols=256 Identities=24% Similarity=0.433 Sum_probs=195.7
Q ss_pred CcccCcceEEEEEEECC-----------------CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC
Q 020720 1 MIGGGAFGVVYRGSLRD-----------------GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 62 (322)
.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.++.+++||||+++++++.+.
T Consensus 12 ~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 91 (304)
T cd05096 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE 91 (304)
T ss_pred EecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecC
Confidence 38999999999997532 3469999987653 33456789999999999999999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhcCCC---------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccc
Q 020720 63 NNRILVYEYLENNSLANALLGSKS---------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASN 127 (322)
Q Consensus 63 ~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~N 127 (322)
+..+++|||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~N 168 (304)
T cd05096 92 DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRN 168 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhh
Confidence 999999999999999999864321 1124678889999999999999999998 9999999999
Q ss_pred eEeCCCCeEEEeeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh--CCCCCCcccCC
Q 020720 128 VLLDGNFHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS--GRSSSKAAFGD 204 (322)
Q Consensus 128 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~--g~~p~~~~~~~ 204 (322)
|+++.++.+||+|||++......... ......++..|+|||++....++.++||||||+++|+|++ +..||......
T Consensus 169 ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 248 (304)
T cd05096 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248 (304)
T ss_pred eEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH
Confidence 99999999999999998754332211 1222345778999999998899999999999999999987 55677654322
Q ss_pred CchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 205 DMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
+. ............. ......++..+..+.+++.+||+.||.+|||+.+|.+.|+
T Consensus 249 ~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 249 QV---IENAGEFFRDQGR-----QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HH---HHHHHHHhhhccc-----cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 21 1111111111100 0001112223456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=330.97 Aligned_cols=246 Identities=21% Similarity=0.306 Sum_probs=199.5
Q ss_pred CcccCcceEEEEEEEC-C-CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-D-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+++|+|.
T Consensus 74 ~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~ 153 (478)
T PTZ00267 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153 (478)
T ss_pred EEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHH
Confidence 4899999999999654 4 6788999876666665677888999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-eeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 157 (322)
+++........++++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 154 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 230 (478)
T PTZ00267 154 KQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230 (478)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccc
Confidence 988654333447889999999999999999999998 99999999999999999999999999986543322 12234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. .... .+ .....+...
T Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~---~~~~-~~--------~~~~~~~~~ 295 (478)
T PTZ00267 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IM---QQVL-YG--------KYDPFPCPV 295 (478)
T ss_pred cCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-hC--------CCCCCCccC
Confidence 568999999999999999999999999999999999999997542211 11 1111 11 111122233
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.+++.+||+.||++||++.+++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 345888999999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=310.38 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=195.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||++++++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 87 (287)
T cd07848 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87 (287)
T ss_pred EecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHH
Confidence 3899999999999876 68899999987542 23346788999999999999999999999999999999999998777
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..+.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.............
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 88 ELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 6554322 26889999999999999999999998 9999999999999999999999999998654332222234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH--------HHH-hcCccccccCc
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW--------KLR-EEGRLLEIVDP 228 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~ 228 (322)
..+++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.... ... ..........+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 568999999999998889999999999999999999999997654322221111100 000 00000000001
Q ss_pred cCC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELT-------QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~-------~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... .........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 001112345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=303.71 Aligned_cols=244 Identities=27% Similarity=0.468 Sum_probs=196.6
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||++.++++..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++
T Consensus 12 lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 90 (256)
T cd05114 12 LGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90 (256)
T ss_pred ecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence 8999999999998887788999988643 333467889999999999999999999999999999999999999999998
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
..... .+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+...............++
T Consensus 91 ~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05114 91 RQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164 (256)
T ss_pred HhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCc
Confidence 65432 5889999999999999999999998 99999999999999999999999998876543322222223355
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
..|+|||++.+..++.++||||||+++|+|++ |+.||......+. . ........ . ..+......
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~---~~i~~~~~------~---~~~~~~~~~ 229 (256)
T cd05114 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---V---EMISRGFR------L---YRPKLASMT 229 (256)
T ss_pred hhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---H---HHHHCCCC------C---CCCCCCCHH
Confidence 68999999988889999999999999999999 8899865432111 1 11111111 0 111112345
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
+.+++.+||+.||++||++.++++.|.
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=311.17 Aligned_cols=240 Identities=26% Similarity=0.357 Sum_probs=190.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhc-CCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWN-IRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++... ....+.+..|..++.. .+||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999776 58899999997542 2233455667777664 48999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 82 DLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 9999986543 6899999999999999999999998 9999999999999999999999999987543222 222
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.. .....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~----------~~~~~~~ 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSILN----------DRPHFPR 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHc----------CCCCCCC
Confidence 3456899999999999889999999999999999999999999764321111 11111 0111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK-QVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~-evl~ 264 (322)
....++.+++.+||+.||.+||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 2334577888899999999999876 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=319.86 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+.+..++||||+
T Consensus 42 ~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 121 (375)
T cd05104 42 TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYC 121 (375)
T ss_pred eecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhc
Confidence 489999999999963 236689999987542 33446788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC------------------------------------------------------------------
Q 020720 73 ENNSLANALLGSKS------------------------------------------------------------------ 86 (322)
Q Consensus 73 ~~~~L~~~l~~~~~------------------------------------------------------------------ 86 (322)
++|+|.+++.....
T Consensus 122 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (375)
T cd05104 122 CYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTS 201 (375)
T ss_pred cCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHH
Confidence 99999999864321
Q ss_pred -----CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-eccccc
Q 020720 87 -----KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV-STRVAG 160 (322)
Q Consensus 87 -----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~ 160 (322)
....+++..++.++.||+.||.|||+.+ ++||||||.||+++.++.++|+|||++.......... .....+
T Consensus 202 ~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 278 (375)
T cd05104 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278 (375)
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCC
Confidence 0124788899999999999999999998 9999999999999999999999999988654332211 112234
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++.+..++.++|||||||++|+|++ |..||......... . +....+. .+.. +.....
T Consensus 279 ~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~--~----~~~~~~~-----~~~~---~~~~~~ 344 (375)
T cd05104 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--Y----KMIKEGY-----RMLS---PECAPS 344 (375)
T ss_pred CcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH--H----HHHHhCc-----cCCC---CCCCCH
Confidence 567999999999999999999999999999998 88888654322211 1 1111110 0111 111234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
++.+++.+||+.||++||++.||++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=315.41 Aligned_cols=246 Identities=20% Similarity=0.250 Sum_probs=198.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|+++... ......+.+|+.++..++||||+++++++.+.+..++||||+++++
T Consensus 8 ~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 87 (333)
T cd05600 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGD 87 (333)
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCC
Confidence 3899999999999876 58999999997542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..... ...
T Consensus 88 L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 88 FRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 999996543 6889999999999999999999999 99999999999999999999999999875433 223
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+ ...... ...+........
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~~~--~~~~~~~~~~~~ 228 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL------KYWKET--LQRPVYDDPRFN 228 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH------Hhcccc--ccCCCCCccccc
Confidence 456899999999999999999999999999999999999999764332211111 000000 000111111112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...++.+++.+||+.+|.+||++.++++.
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 34557889999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=306.07 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=195.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||+||++... +++.||+|.+..... ...+.+..|+.+++.++|+||+++.+++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999765 689999999865422 2235677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+.+.........+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9888544333447899999999999999999999998 99999999999999999999999999876543221 1223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..|++.|+|||++.+..++.++|||||||++|+|++|..||............ ... .... ....+...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~---------~~~~-~~~~~~~~ 224 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQR---------ILND-SVTYPDKF 224 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHh---------hccc-CCCCcccC
Confidence 46889999999999999999999999999999999999999754332111100 000 0001 11222334
Q ss_pred HHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
...+.+++.+||+.||++|| +++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 45688899999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=315.78 Aligned_cols=241 Identities=26% Similarity=0.314 Sum_probs=194.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +|+.||+|++... .......+..|+.++..++||||+++++++.+.+..++||||+++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999765 6899999999754 22334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
|.+++.... .+++..++.++.||+.||.|||+ .+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 82 LFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 999886543 68999999999999999999997 67 99999999999999999999999999875322211 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||......... . ... .. .. .++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~---~---~i~-~~------~~---~~p~ 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E---LIL-ME------EI---RFPR 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH---H---HHh-cC------CC---CCCC
Confidence 3346899999999999999999999999999999999999999754321111 0 000 00 01 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
....++.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2334578889999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=312.73 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=197.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|+.+ +|..+|+|++++. .....+.+..|-.+|...++|+||+++-.|.+.+.+||||||++||+
T Consensus 148 ~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD 227 (550)
T KOG0605|consen 148 VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD 227 (550)
T ss_pred eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence 5899999999999766 6999999999865 34455788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC-------
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD------- 149 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------- 149 (322)
+..+|...+ .+++..+..++.+++.|+..||+.| ++||||||+|+|||..|++||+|||++.-...
T Consensus 228 ~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 228 MMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred HHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 999997665 8999999999999999999999999 99999999999999999999999999852210
Q ss_pred ----------------Ccce----e-------------------ecccccCCCCCchHHHhhCCCCcccceehhhHHHHH
Q 020720 150 ----------------NVTH----V-------------------STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLE 190 (322)
Q Consensus 150 ----------------~~~~----~-------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~e 190 (322)
.... . ....+|||.|+|||++.+..|+..+|.||||||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 0000 0 001359999999999999999999999999999999
Q ss_pred HHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 020720 191 IISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT---MKQVVE 264 (322)
Q Consensus 191 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~evl~ 264 (322)
||.|.+||......+....+.. |+..- ..|.-.. ...+..++|.+||. ||.+|.- ++||-+
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~n-wr~~l-------~fP~~~~----~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVN-WRETL-------KFPEEVD----LSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHH-Hhhhc-------cCCCcCc----ccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999998766554433321 11100 0011111 12557788888998 9999975 566544
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=307.99 Aligned_cols=246 Identities=33% Similarity=0.562 Sum_probs=191.1
Q ss_pred CcccCcceEEEEEEEC-----CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-----DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||+++++++...+..++|+||+++
T Consensus 6 ~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~ 85 (259)
T PF07714_consen 6 QIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPG 85 (259)
T ss_dssp EEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TT
T ss_pred EEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccc
Confidence 3899999999999766 3568999999654 334468899999999999999999999999988889999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-e
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-H 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 153 (322)
|+|.+++.... ...+++..++.|+.||+.||.|||+.+ ++|+||++.||+++.++.+||+|||++........ .
T Consensus 86 g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 86 GSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp EBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999998762 226899999999999999999999998 99999999999999999999999999986632222 2
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
..........|+|||.+....++.++||||||+++|||++ |..||...... .. ...+ ..+.. ..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~---~~~~-~~~~~--------~~ 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EI---IEKL-KQGQR--------LP 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HH---HHHH-HTTEE--------TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---cccc-ccccc--------ce
Confidence 2223446778999999999999999999999999999999 67887654211 11 1111 11111 12
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.+......+.+++..||+.||.+||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2223345588899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=312.40 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=193.2
Q ss_pred CcccCcceEEEEEEE----CCCCEEEEEEecccC----hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAES----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..+++|||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 489999999999965 257899999987431 223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++|.+.+.... .+.+..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 83 SGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999996543 6788899999999999999999999 99999999999999999999999999874322211
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......|++.|+|||++.+..++.++|||||||++|+|++|..||....... .. .... .+. ..
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~---~~~~-~~~---------~~ 218 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TI---DKIL-KGK---------LN 218 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HH---HHHH-cCC---------CC
Confidence 1233468999999999998889999999999999999999999997543211 11 1111 111 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
.+......+.+++.+||+.||++|| ++.+++..
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1222234578899999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=312.78 Aligned_cols=237 Identities=24% Similarity=0.300 Sum_probs=191.0
Q ss_pred CcccCcceEEEEEEE----CCCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+.+
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 489999999999864 258899999997542 22345677899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .
T Consensus 83 ~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 83 GDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 99999985443 6899999999999999999999999 99999999999999999999999999875433211 1
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||........ . ..+. ... ...+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~---~~i~-~~~---------~~~p 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---M---TMIL-KAK---------LGMP 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---H---HHHH-cCC---------CCCC
Confidence 2335689999999999988899999999999999999999999975432111 1 1111 110 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQ 261 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~e 261 (322)
......+.+++.+||+.||.+||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 223345788899999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.82 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=194.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999776 68999999997542 23345678899999888 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 82 DLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 9998886543 6999999999999999999999999 9999999999999999999999999987432111 122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCC--chhHHHHHHHHHhcCccccccCccCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD--MLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......+..+...... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---------IRI 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------CCC
Confidence 34568999999999999999999999999999999999999997432221 1111111111111111 112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPT------MKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps------~~evl~ 264 (322)
+......+.+++.+||+.||.+||+ +.++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 2223345788999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=311.60 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=193.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++.. .......+..|..++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5899999999999776 5889999998754 223345677888888866 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+.+.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 82 DLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 9999886543 6889999999999999999999999 9999999999999999999999999987532221 122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....|++.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.. +. . ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~~-~~------~---~~p~ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESILH-DD------V---LYPV 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHHc-CC------C---CCCC
Confidence 3456899999999999989999999999999999999999999754322111 11111 10 0 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRP-------TMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rp-------s~~evl~~ 265 (322)
....++.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2234578889999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=291.47 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=203.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcH--HHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~ 76 (322)
|++|+||.||+|+.+ +++-||+|+++.+....- -..++|+.+|.+++|||||.+..+.... +..|+|||||+. +
T Consensus 84 I~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-D 162 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-D 162 (419)
T ss_pred cccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-h
Confidence 789999999999776 789999999987643222 4568999999999999999999998654 468999999976 8
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|..+++..+. ++...++..+..|++.|++|||.+. |+||||||+|+|++..|.+|++|||+|+.+++... ..+
T Consensus 163 Lksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k-~~T 235 (419)
T KOG0663|consen 163 LKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK-PYT 235 (419)
T ss_pred HHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc-cCc
Confidence 9999987763 7889999999999999999999998 99999999999999999999999999998876633 345
Q ss_pred ccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC-
Q 020720 157 RVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP- 234 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (322)
..+-|.+|+|||++.+. .|+++.|+||+|||+.||+++.+.|.+...-+.+..+.... +...+.+.|.+..++
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll-----GtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL-----GTPSEAIWPGYSELPA 310 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh-----CCCccccCCCccccch
Confidence 56779999999998865 68999999999999999999999998877666555543222 222222222221111
Q ss_pred -------------------HH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 -------------------EK-EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 -------------------~~-~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. ....-.+++..+|..||.+|.|+.|.|+.
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11 12445678888999999999999998763
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=312.23 Aligned_cols=235 Identities=26% Similarity=0.367 Sum_probs=189.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|..+ +++.||+|+++.. .......+..|..++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5899999999999776 6889999998753 223345677888888876 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 82 DLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred hHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 9999886553 6899999999999999999999999 9999999999999999999999999987532221 112
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+. .+. ...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~-~~~---------~~~~~ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAIL-NDE---------VVYPT 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHh-cCC---------CCCCC
Confidence 3356899999999999889999999999999999999999999754322111 1111 111 01122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
....++.+++.+||+.||.+||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 233457889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=312.49 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=191.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++.. .......+.+|+.++.++ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5899999999999776 6889999999754 233345677888888777 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|..++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 82 DLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 9998886543 6899999999999999999999999 9999999999999999999999999987532211 112
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCc--hhHHHHHHHHHhcCccccccCccCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM--LILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
....||..|+|||++.+..++.++|||||||++|+|++|..||........ .....+..+..... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------~~~~ 224 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------QIRI 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---------CCCC
Confidence 335689999999999999999999999999999999999999964322111 11111111111111 1122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
+......+.+++.+||+.||.+||++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 33334557889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=301.37 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=199.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... ++..|++|.+..+ ......+.+|+..++.++|+||+++++++..++..+++|||+++++|.+
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (263)
T cd05052 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 91 (263)
T ss_pred ecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHH
Confidence 3899999999999765 5889999998744 3345678999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...............
T Consensus 92 ~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 166 (263)
T cd05052 92 YLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166 (263)
T ss_pred HHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCC
Confidence 9965432 25889999999999999999999998 999999999999999999999999998865433222112223
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.+..|+|||.+.+..++.++|||||||++|+|++ |..||........ +.....+ ..+ ..+....
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~-----~~~---~~~~~~~ 231 (263)
T cd05052 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKG-----YRM---ERPEGCP 231 (263)
T ss_pred CccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC-----CCC---CCCCCCC
Confidence 4568999999998999999999999999999998 8888865422111 1111111 111 1122234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
..+.+++.+||+.||++||++.++++.|+.+
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 5588899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=311.47 Aligned_cols=236 Identities=26% Similarity=0.334 Sum_probs=187.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHH-HHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEID-MIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999776 68999999986542 222344555554 567889999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 82 ELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 9999986543 6889999999999999999999999 9999999999999999999999999987432221 122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ . .... ... . ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~---~~i~-~~~------~---~~~~ 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---Y---DNIL-NKP------L---RLKP 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---H---HHHH-cCC------C---CCCC
Confidence 345689999999999999999999999999999999999999975422111 1 1111 110 1 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK 260 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~ 260 (322)
.....+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2244588899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=309.68 Aligned_cols=236 Identities=25% Similarity=0.347 Sum_probs=187.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHH-HHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEID-MIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999876 68899999986432 222344555554 578899999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|...+.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 82 ELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 9998886443 6888999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....|++.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+. .. ....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~-~~---------~~~~~~ 217 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD---NIL-HK---------PLQLPG 217 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH---HHh-cC---------CCCCCC
Confidence 34568999999999998899999999999999999999999997542111 111 111 01 112222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK 260 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~ 260 (322)
.....+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3345688899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=301.74 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=203.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||.|+||.||+|...++..+++|.+..........+..|+.+++.++|+||+++++++.+....+++|||+++++|.++
T Consensus 13 ~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (261)
T cd05148 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92 (261)
T ss_pred hhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHH
Confidence 48999999999998887899999999877665677899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .....+
T Consensus 93 ~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~ 166 (261)
T cd05148 93 LRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDKKI 166 (261)
T ss_pred HhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccCCCC
Confidence 976432 36889999999999999999999998 999999999999999999999999998765432211 122335
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+....++.++||||||+++|+|++ |..||......+... ....... ...+.....
T Consensus 167 ~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~------~~~~~~~---------~~~~~~~~~ 231 (261)
T cd05148 167 PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD------QITAGYR---------MPCPAKCPQ 231 (261)
T ss_pred ceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH------HHHhCCc---------CCCCCCCCH
Confidence 678999999988899999999999999999998 899987543221111 1111110 112223345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 58899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=304.31 Aligned_cols=250 Identities=29% Similarity=0.491 Sum_probs=200.0
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... ++..||+|.++..... ..+.+.+|+++++.++|+||+++++++......+++|||++
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 91 (280)
T cd05049 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME 91 (280)
T ss_pred hccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCC
Confidence 4899999999999763 2478999998765443 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 74 NNSLANALLGSKS----------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 74 ~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+++|.+++..... ....+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~ 168 (280)
T cd05049 92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGM 168 (280)
T ss_pred CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCccc
Confidence 9999999975421 2335788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCc
Q 020720 144 AKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGR 221 (322)
Q Consensus 144 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (322)
+........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .. ... .+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~---~~~-~~- 240 (280)
T cd05049 169 SRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE---CIT-QG- 240 (280)
T ss_pred ceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---HHH-cC-
Confidence 875432211 11222345678999999999999999999999999999998 9999875433221 11 111 11
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 222 LLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.....+......+.+++.+||+.||++||++.||++.|++
T Consensus 241 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 241 -------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111122334568899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.09 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++++|.
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (331)
T cd06649 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91 (331)
T ss_pred eecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHH
Confidence 3899999999999776 68899999987653 334567999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 92 ~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~ 161 (331)
T cd06649 92 QVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 161 (331)
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccccc---ccc
Confidence 9996543 688999999999999999999974 5 9999999999999999999999999987553321 223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH---hcCcc------------
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR---EEGRL------------ 222 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~------------ 222 (322)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||......+.... ..... ..+..
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCccccCcccccccc
Confidence 4689999999999988999999999999999999999999965432111000 00000 00000
Q ss_pred -------------------ccccCccCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 223 -------------------LEIVDPELTQF-PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 223 -------------------~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+........ ......++.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000011 11234568899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=312.52 Aligned_cols=238 Identities=25% Similarity=0.307 Sum_probs=193.2
Q ss_pred CcccCcceEEEEEEEC-C-CCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-D-GTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~-~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... + +..||+|++... .......+.+|+.++..++||||+++++++.+.+..++||||+.+|
T Consensus 37 ~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g 116 (340)
T PTZ00426 37 TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116 (340)
T ss_pred EEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCC
Confidence 3899999999999754 3 368999998643 2233467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...... .
T Consensus 117 ~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~ 185 (340)
T PTZ00426 117 EFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185 (340)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC----c
Confidence 9999997554 6899999999999999999999999 999999999999999999999999998765332 1
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .+. .+. . ..+.
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~---~i~-~~~------~---~~p~ 249 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQ---KIL-EGI------I---YFPK 249 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHH---HHh-cCC------C---CCCC
Confidence 2356899999999999888999999999999999999999999754221 1111 111 110 0 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
.....+.+++.+||+.||.+|+ +++++++.
T Consensus 250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2223467888999999999995 88888764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=300.60 Aligned_cols=247 Identities=27% Similarity=0.479 Sum_probs=198.9
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||+.+++|.++
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (261)
T cd05072 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91 (261)
T ss_pred ecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence 389999999999988778889999986443 3357889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...............+
T Consensus 92 l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 166 (261)
T cd05072 92 LKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 166 (261)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCcc
Confidence 965432 26788899999999999999999998 9999999999999999999999999998654432222222345
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+....++.++|||||||++|+|++ |..||........ .. ... .... .+... ....
T Consensus 167 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~---~~~-~~~~----~~~~~----~~~~ 231 (261)
T cd05072 167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MS---ALQ-RGYR----MPRME----NCPD 231 (261)
T ss_pred ceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HH---HHH-cCCC----CCCCC----CCCH
Confidence 678999999988889999999999999999998 9999865422111 11 111 1100 01111 2334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|++||+++++.+.|+.
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 58889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=316.64 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.+. ++..||+|+++... ......+.+|+.+++.+ +|+||+++++++.+....+++|||+
T Consensus 45 ~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~ 124 (374)
T cd05106 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYC 124 (374)
T ss_pred eecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhc
Confidence 4899999999998642 24579999997543 33346788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC------------------------------------------------------------------
Q 020720 73 ENNSLANALLGSKS------------------------------------------------------------------ 86 (322)
Q Consensus 73 ~~~~L~~~l~~~~~------------------------------------------------------------------ 86 (322)
++|+|.+++.....
T Consensus 125 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (374)
T cd05106 125 CYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTE 204 (374)
T ss_pred cCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccC
Confidence 99999999854211
Q ss_pred CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-eecccccCCCCC
Q 020720 87 KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYL 165 (322)
Q Consensus 87 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~ 165 (322)
...++++..++.++.||+.||.|||+.+ ++||||||+||++++++.++|+|||++......... ......++..|+
T Consensus 205 ~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~ 281 (374)
T cd05106 205 DSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWM 281 (374)
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcccee
Confidence 1124788889999999999999999998 999999999999999999999999998765432221 111223456799
Q ss_pred chHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHH
Q 020720 166 APEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKV 244 (322)
Q Consensus 166 aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (322)
|||++....++.++|||||||++|+|++ |..||.......... .....+ ..+..... ...++.++
T Consensus 282 aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~------~~~~~~-----~~~~~~~~---~~~~l~~l 347 (374)
T cd05106 282 APESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY------KMVKRG-----YQMSRPDF---APPEIYSI 347 (374)
T ss_pred CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH------HHHHcc-----cCccCCCC---CCHHHHHH
Confidence 9999998899999999999999999997 999997653322111 111111 01111111 23458889
Q ss_pred HHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 245 GLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 245 ~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+.+||+.||.+||++.+|++.|+++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.06 Aligned_cols=250 Identities=30% Similarity=0.521 Sum_probs=199.6
Q ss_pred CcccCcceEEEEEEECC-C-----CEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLRD-G-----TQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.... + ..|++|.++... ......+.+|+..++.++||||+++++++......+++|||++
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 91 (283)
T cd05048 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91 (283)
T ss_pred cccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCC
Confidence 38999999999997542 2 579999987543 3334678899999999999999999999998889999999999
Q ss_pred CCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeee
Q 020720 74 NNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDF 141 (322)
Q Consensus 74 ~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Df 141 (322)
+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~df 168 (283)
T cd05048 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDF 168 (283)
T ss_pred CCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCC
Confidence 9999999965421 1135788999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhc
Q 020720 142 GLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREE 219 (322)
Q Consensus 142 g~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (322)
|++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+... .+. .
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~------~i~-~ 241 (283)
T cd05048 169 GLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE------MIR-S 241 (283)
T ss_pred cceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------HHH-c
Confidence 99875432221 12223446788999999988899999999999999999998 999987643321111 111 1
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 220 GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
......+...+..+.+++.+||+.||.+||++.||++.|+.
T Consensus 242 --------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 242 --------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11122233445668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=300.08 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=196.5
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||.|...++..+|+|.+.... .....+.+|+.++.+++||||+++++++.+.+..+++|||+.+++|.+++
T Consensus 12 lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i 90 (256)
T cd05113 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90 (256)
T ss_pred ecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHH
Confidence 89999999999988777779999987443 33467899999999999999999999999888999999999999999999
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
..... .+++..++.++.||+.||+|||+.+ ++|+||+|.||+++.++.+||+|||.+...............++
T Consensus 91 ~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05113 91 REHGK---RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164 (256)
T ss_pred HhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccC
Confidence 65432 6899999999999999999999998 99999999999999999999999999876543322222223356
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
..|+|||.+.+..++.++|||||||++|+|++ |..||........ . .... .+.. + ..+......
T Consensus 165 ~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~---~~~~-~~~~-----~---~~~~~~~~~ 229 (256)
T cd05113 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---V---EKVS-QGLR-----L---YRPHLASEK 229 (256)
T ss_pred hhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H---HHHh-cCCC-----C---CCCCCCCHH
Confidence 78999999988889999999999999999998 9999865432111 1 1111 1110 1 111122456
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
+.+++.+||+.||.+||++.+++..|+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.29 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=189.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.
T Consensus 81 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 160 (353)
T PLN00034 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160 (353)
T ss_pred hccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccc
Confidence 4899999999999766 68999999986543 333467899999999999999999999999999999999999999986
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+.. ...+..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++........ .....
T Consensus 161 ~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 161 GTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred ccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 432 4567788899999999999999999 99999999999999999999999999886543221 12234
Q ss_pred ccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 159 AGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.|+..|+|||++.. ...+.++|||||||++|||++|..||......+...... .... ......
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~---------~~~~~~ 296 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICM---------SQPPEA 296 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhc---------cCCCCC
Confidence 68999999998743 234568999999999999999999998433222111111 0000 001112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+.....++.+++.+||+.||++||++.|+++.
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22334568899999999999999999999874
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=309.45 Aligned_cols=246 Identities=24% Similarity=0.287 Sum_probs=193.8
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEeccc----ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAE----SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|+||.||++... +++.||+|++... .....+.+..|+.++..+ +|+||+++++++...+..+++|||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (332)
T cd05614 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDY 86 (332)
T ss_pred EEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeC
Confidence 3899999999998652 5889999998643 223345678899999999 589999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++++|.+++.... .+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 87 VSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99999999986543 6899999999999999999999999 9999999999999999999999999988654333
Q ss_pred ceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 152 THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||............. .... ..++.+
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~-------~~~~~~ 230 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRIL-------KCDPPF 230 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHh-------cCCCCC
Confidence 2223345689999999998865 47889999999999999999999997543332221111 1110 011222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
+......+.+++.+||+.||++|| +++++++.
T Consensus 231 ---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 ---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 222334577888999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=305.79 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=193.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... ++..||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||+++ +|.
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~ 90 (288)
T cd07871 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLK 90 (288)
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHH
Confidence 3899999999999766 689999999875432 2345678999999999999999999999999999999999975 899
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 91 ~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~ 163 (288)
T cd07871 91 QYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNE 163 (288)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCc
Confidence 88865432 5788999999999999999999999 99999999999999999999999999875432211 12234
Q ss_pred ccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC---------ccccccCc
Q 020720 159 AGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG---------RLLEIVDP 228 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 228 (322)
.+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+............... .......+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 57899999998875 568999999999999999999999997654332222111100000000 00000111
Q ss_pred cCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELTQ-----FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.... .......++.+++.+||+.||.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1100 00112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.70 Aligned_cols=239 Identities=26% Similarity=0.358 Sum_probs=190.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|..||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5899999999999776 68999999997542 23345667788887754 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05620 82 DLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRA 153 (316)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCce
Confidence 9999986543 6889999999999999999999999 999999999999999999999999998743211 1122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .... . .+.+ +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~---~~~~-~------~~~~---~~ 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFE---SIRV-D------TPHY---PR 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-C------CCCC---CC
Confidence 34568999999999999999999999999999999999999997543211 111 1111 0 1111 22
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK-QVV 263 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~-evl 263 (322)
....++.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2334577889999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=309.65 Aligned_cols=241 Identities=27% Similarity=0.370 Sum_probs=193.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... ++..||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999776 58899999997542 23345677888888887 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+.+.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 82 ~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 82 DLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 9999886553 6899999999999999999999998 99999999999999999999999999864322111 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....|++.|+|||++.+..++.++|||||||++|+|++|..||....... .. .... ... . ..+.
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~---~~i~-~~~------~---~~~~ 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LF---QSIL-EDE------V---RYPR 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HH---HHHH-cCC------C---CCCC
Confidence 23468999999999999999999999999999999999999997543211 11 1111 110 1 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM-----KQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~-----~evl~~ 265 (322)
.....+.+++.+||+.||.+||++ .+++..
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 233457889999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=302.27 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=194.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||++..+ +|+.||+|.+.... ......+..|++++++++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999766 69999999986432 22234566799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence 988864432 25888999999999999999999998 99999999999999999999999999876543221 223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|+|||++.+..++.++|||||||++|+|++|..||......... ....... +...........
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRT---------LEDEVKFEHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHh---------hccccccccccC
Confidence 45889999999999888999999999999999999999999754322111 1111110 111111111123
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
..++.+++..||+.||.+||++.|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 445788999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=308.76 Aligned_cols=239 Identities=26% Similarity=0.321 Sum_probs=188.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHH-HHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEID-MIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+.++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5899999999999765 68999999986542 223345555554 467789999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+.+.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 82 ELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 9998886543 6899999999999999999999999 9999999999999999999999999987432211 122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....|++.|+|||++.+..++.++|||||||++|+|++|..||........ . .... .. .+ ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~---~~~~-~~--------~~-~~~~ 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---Y---DNIL-HK--------PL-VLRP 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---H---HHHH-cC--------Cc-cCCC
Confidence 345689999999999999999999999999999999999999975432111 1 1111 11 00 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVV 263 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl 263 (322)
.....+.+++.+||+.||.+||++.+.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2334577889999999999999886443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.07 Aligned_cols=253 Identities=28% Similarity=0.481 Sum_probs=201.6
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+++|||+++
T Consensus 12 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (288)
T cd05093 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 91 (288)
T ss_pred ccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 4899999999999642 3456899998766655667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC---------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 75 NSLANALLGSK---------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 75 ~~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 168 (288)
T cd05093 92 GDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSR 168 (288)
T ss_pred CCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccc
Confidence 99999996543 12235899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 146 LFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 146 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||........ .. .. ..+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~---~i-~~~~~- 240 (288)
T cd05093 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE---CI-TQGRV- 240 (288)
T ss_pred cccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HH-HcCCc-
Confidence 5533221 11122335678999999998899999999999999999998 8888865432211 11 11 11111
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+......+.+++.+||+.||.+||++.+++..|+.+..
T Consensus 241 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 241 -------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111223458999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=307.60 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=192.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+.+++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999765 68899999997542 23345678899999888 6999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|..++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 82 DLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 9998886543 6999999999999999999999999 9999999999999999999999999987432211 112
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||................+...... ...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~p~ 224 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IRIPR 224 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CCCCC
Confidence 345689999999999999999999999999999999999999975443322222222222211111 11222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
.....+.+++.+||+.||.+|+++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 233457888999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.75 Aligned_cols=240 Identities=28% Similarity=0.399 Sum_probs=190.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 4899999999999776 58899999997542 22345566777887764 9999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 82 ~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 82 DLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 9999996543 6889999999999999999999998 99999999999999999999999999875322111 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ...... .+.. +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~i~~~-------~~~~---~~ 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LF---QSIRMD-------NPCY---PR 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhC-------CCCC---Cc
Confidence 23468999999999998899999999999999999999999997543211 11 111110 0111 12
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK-QVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~-evl~ 264 (322)
.....+.+++.+||+.||.+||++. ++++
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2234577889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=295.81 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=197.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|...++..+|+|.++.... .....+.+|+.+++.++||||+++++++......+++|||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5899999999999887889999999876543 334578899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++...............
T Consensus 82 ~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 82 FLRKKKD---ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9865432 5789999999999999999999998 999999999999999999999999998754332221111223
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
++..|+|||++....++.++||||||+++|++++ |..||........ . .... .+. .. ..+....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~---~~~~-~~~-----~~---~~~~~~~ 220 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R---EQVE-KGY-----RM---SCPQKCP 220 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H---HHHH-cCC-----CC---CCCCCCC
Confidence 4567999999998889999999999999999998 8899865422111 1 1111 110 01 1122234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 56889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=313.26 Aligned_cols=250 Identities=22% Similarity=0.235 Sum_probs=189.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||++... +++.||+|... ...+.+|+.++++++||||+++++++......++++|++. ++|.+
T Consensus 99 ~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~ 171 (391)
T PHA03212 99 TFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC 171 (391)
T ss_pred EEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence 3799999999999765 68999999753 2356789999999999999999999999999999999995 68888
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...............
T Consensus 172 ~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 244 (391)
T PHA03212 172 YLAAKR----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244 (391)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence 885543 6889999999999999999999998 999999999999999999999999998754322222233457
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCC----chhHHHHHHHHH---h-cC------cccc-
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD----MLILVEWTWKLR---E-EG------RLLE- 224 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~----~~~~~~~~~~~~---~-~~------~~~~- 224 (322)
||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+....... + +. .+..
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~ 324 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI 324 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence 9999999999999899999999999999999999998875432211 000010000000 0 00 0000
Q ss_pred --------ccCccCCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 --------IVDPELTQF---PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 --------~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+..... ......++.+++.+||+.||.+|||+.|+++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0123456889999999999999999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=298.97 Aligned_cols=247 Identities=30% Similarity=0.497 Sum_probs=199.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|++|.||+|...+++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..+++|||+.+++|.++
T Consensus 13 ~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (261)
T cd05068 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91 (261)
T ss_pred EecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHH
Confidence 389999999999987777889999987543 3456788999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+.... ...+++..++.++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++................
T Consensus 92 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 166 (261)
T cd05068 92 LQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF 166 (261)
T ss_pred HhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcC
Confidence 96543 236889999999999999999999998 9999999999999999999999999998665332221122223
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++.+..++.++||||||+++|+|++ |+.||.......... ....... ...+.....
T Consensus 167 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~~~~~~~---------~~~~~~~~~ 231 (261)
T cd05068 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ------QVDQGYR---------MPCPPGCPK 231 (261)
T ss_pred ceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH------HHHcCCC---------CCCCCcCCH
Confidence 457999999988899999999999999999999 999986542211110 1111100 011222345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|.+||++.++++.|+.
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 68899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=308.19 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=188.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHH---hcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMI---WNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|... +|+.||||+++... ....+.+.+|..++ +.++||||+++++++.+.+..++||||++
T Consensus 6 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 85 (324)
T cd05589 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA 85 (324)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC
Confidence 4899999999999766 68999999997542 22335566666554 56689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|...+... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 86 GGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999888532 6899999999999999999999999 9999999999999999999999999887432211 1
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
......|++.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.... . ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~~~-------~---~~ 220 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVNDE-------V---RY 220 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC-------C---CC
Confidence 123456899999999999989999999999999999999999999754322111 1111110 1 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
+......+.+++.+||+.||++|| ++.++++
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 222334578899999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=318.09 Aligned_cols=234 Identities=27% Similarity=0.392 Sum_probs=195.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|.||+|+++..+ +++.||||+++++ ...+.+..+.|.+++... +||+++.++.+|...+++|+||||+.||
T Consensus 375 vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Gg 454 (694)
T KOG0694|consen 375 VLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGG 454 (694)
T ss_pred EeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCC
Confidence 5999999999999776 6889999999876 345567888898888887 5999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
++....+.. .+++..+.-++..|+.||.|||.++ |||||||.+|||+|.+|.+||+|||+++..-... ...
T Consensus 455 dm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~~T 525 (694)
T KOG0694|consen 455 DLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-DRT 525 (694)
T ss_pred cEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC-Ccc
Confidence 943333222 6999999999999999999999999 9999999999999999999999999998543222 234
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
.+++||+.|+|||++.+..|+.+.|-|||||+|||||.|+.||.+.+.++...-+ +.. -..+|.
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI---------------~~d-~~~yP~ 589 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI---------------VND-EVRYPR 589 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------hcC-CCCCCC
Confidence 6789999999999999999999999999999999999999999976544332211 111 112344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
-...+.+.++.++|..+|.+|.-+
T Consensus 590 ~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cccHHHHHHHHHHhccCcccccCC
Confidence 455568889999999999999876
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=297.62 Aligned_cols=246 Identities=28% Similarity=0.411 Sum_probs=195.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+.+++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 4899999999999765 68999999876443 344567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee-cc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS-TR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 157 (322)
+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........... ..
T Consensus 82 ~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 82 TFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9986443 25889999999999999999999998 99999999999999999999999999875432211110 11
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...... ... ..+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~~-----~~~---~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQG-----VRL---PCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHcC-----CCC---CCccc
Confidence 123456999999998889999999999999999998 88888643221111 011110 001 11223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
....+.+++.+||+.+|++||++.+++++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=298.19 Aligned_cols=248 Identities=31% Similarity=0.488 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.+.. ...||+|.++... ......+.+|+..+++++||||+++++++.+.+..+++|||++++
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 90 (266)
T cd05033 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENG 90 (266)
T ss_pred EecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCC
Confidence 48999999999997752 4579999987543 334467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-ee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HV 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 154 (322)
+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|.||++++++.++|+|||++........ ..
T Consensus 91 ~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd05033 91 SLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164 (266)
T ss_pred CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccccccee
Confidence 99999965432 6889999999999999999999998 99999999999999999999999999987642211 11
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ . .... .. .....
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~---~~~~-~~--------~~~~~ 229 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---I---KAVE-DG--------YRLPP 229 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---H---HHHH-cC--------CCCCC
Confidence 122334678999999998899999999999999999998 9999865422111 1 1111 11 00111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 230 ~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=323.81 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=197.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC--------eeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--------NRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~ 69 (322)
+||+|+||.||+|... +|+.||||++... .......+.+|+..+..++|+||++++..+.... ..++||
T Consensus 39 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~ 118 (496)
T PTZ00283 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVL 118 (496)
T ss_pred EEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEE
Confidence 4899999999999765 6999999998654 3344567889999999999999999887765432 367999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+++|+|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 119 Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 119 DYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred eCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence 999999999999765444457899999999999999999999998 99999999999999999999999999876543
Q ss_pred Cc-ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 150 NV-THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 150 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ... .. .
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~---~~~-~~--------~ 260 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM---HKT-LA--------G 260 (496)
T ss_pred cccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHH-hc--------C
Confidence 22 122234568999999999999999999999999999999999999997532111 11 111 11 1
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+......+.+++.+||+.||.+||++.+++..
T Consensus 261 ~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1112233334568889999999999999999999863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=313.19 Aligned_cols=245 Identities=24% Similarity=0.286 Sum_probs=196.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|+++... ......+.+|+.++..++|+||+++++++.+++..++||||+++++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (350)
T cd05573 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGD 87 (350)
T ss_pred EEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCC
Confidence 4899999999999776 68999999997542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-----
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV----- 151 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 151 (322)
|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 88 L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 88 LMNLLIRKD----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999997653 6899999999999999999999998 9999999999999999999999999987654332
Q ss_pred -----------------------ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchh
Q 020720 152 -----------------------THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI 208 (322)
Q Consensus 152 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~ 208 (322)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~- 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY- 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH-
Confidence 11123346899999999999999999999999999999999999999865422111
Q ss_pred HHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 020720 209 LVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT-MKQVVEM 265 (322)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-~~evl~~ 265 (322)
..+..... ...-+.... ....+.+++.+||. ||.+||+ +.++++.
T Consensus 240 -----~~i~~~~~--~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 240 -----NKIINWKE--SLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHhccCC--cccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111000 000011111 34457888888997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=307.98 Aligned_cols=242 Identities=25% Similarity=0.315 Sum_probs=189.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHH-HHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEI-DMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999776 57889999986432 12223444444 4567889999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+.+..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 82 ELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 9999996543 5788889999999999999999999 9999999999999999999999999987532221 122
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .... . .. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~-~--------~~-~~~~ 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD---NILN-K--------PL-QLKP 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH---HHHh-C--------Cc-CCCC
Confidence 345689999999999999999999999999999999999999975432211 11 1111 0 00 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.....+.+++.+||+.||.+||++.+.+..+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 2334578888999999999999987554433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=307.56 Aligned_cols=246 Identities=25% Similarity=0.290 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +|+.||+|+++... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (330)
T cd05601 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD 87 (330)
T ss_pred EEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCC
Confidence 4899999999999766 68999999997542 2334668889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++............
T Consensus 88 L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 161 (330)
T cd05601 88 LLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161 (330)
T ss_pred HHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence 9999976532 6899999999999999999999999 999999999999999999999999999866543333333
Q ss_pred ccccCCCCCchHHHh------hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 157 RVAGTMGYLAPEYAL------LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~------~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
...||+.|+|||++. ...++.++|||||||++|+|++|..||......... ..+...... + ..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~---~--~~ 230 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRF---L--KF 230 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCc---c--CC
Confidence 446899999999987 456789999999999999999999999754322111 111111100 0 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. .......+.+++..||+ +|.+||++.+++..
T Consensus 231 ~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11 11223447788888997 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=297.35 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=195.7
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.++++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.++
T Consensus 11 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd05059 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89 (256)
T ss_pred hhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence 489999999999988777789999986432 2345788899999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...............+
T Consensus 90 l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05059 90 LRERKG---KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163 (256)
T ss_pred HHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCC
Confidence 975432 6899999999999999999999999 9999999999999999999999999987654322211112223
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. .... .. .... .+.....
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~-~~-----~~~~---~~~~~~~ 228 (256)
T cd05059 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV------ESVS-AG-----YRLY---RPKLAPT 228 (256)
T ss_pred CccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH------HHHH-cC-----CcCC---CCCCCCH
Confidence 457999999998899999999999999999999 78888754322111 1111 11 1111 1122344
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.+.+++.+||+.+|++||++.|+++.|
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=310.16 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=190.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 72 (322)
.||+|+||.||+|... +|..||+|+++.. .......+.+|+.+++.++||||+++++++.... ..+++|||+
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~ 86 (338)
T cd07859 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 86 (338)
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC
Confidence 4899999999999765 6899999998743 2233457889999999999999999999886432 479999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
. ++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 87 E-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred C-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 5 68998886543 6899999999999999999999999 99999999999999999999999999875432211
Q ss_pred --eeecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH---------HHHHhc
Q 020720 153 --HVSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT---------WKLREE 219 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~---------~~~~~~ 219 (322)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ......
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 11233568999999999875 67899999999999999999999999754322111111000 000000
Q ss_pred --CccccccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 220 --GRLLEIVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 220 --~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.... ....+.....+.+++.+||+.||++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00001123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=302.34 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=202.8
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... ++..+++|.+........+.+.+|+..++.++|+||+++++++......++||||+++
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (291)
T cd05094 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 91 (291)
T ss_pred eecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCC
Confidence 4899999999999642 3456899998766666667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeec
Q 020720 75 NSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFG 142 (322)
Q Consensus 75 ~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg 142 (322)
++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||.||+++.++.++|+|||
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg 168 (291)
T cd05094 92 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFG 168 (291)
T ss_pred CcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCC
Confidence 999999965421 1224889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcC
Q 020720 143 LAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEG 220 (322)
Q Consensus 143 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (322)
++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .. ....+
T Consensus 169 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~----~~~~~ 241 (291)
T cd05094 169 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE----CITQG 241 (291)
T ss_pred cccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhCC
Confidence 9875533221 11223346788999999998899999999999999999998 9999865432211 11 11111
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
. ....+...+..+.+++.+||+.||++||++.+|++.|+....
T Consensus 242 ~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 242 R--------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred C--------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 111122234568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=293.08 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=201.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCc-ccccceEEEeCC------eeEEEEEc
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPN-LVQLIGCCVEDN------NRILVYEY 71 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~ 71 (322)
||+|+||+||+|+.+ +|+-||+|+++.+... --....+|+.+++.++|+| |+.+++++...+ ..++|+||
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~ 98 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF 98 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence 799999999999766 7999999999876442 3367789999999999999 999999998877 78999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
++. +|..++.........++...+..++.||+.||+|||+++ |+||||||+||+|+++|.+||+|||+++...-..
T Consensus 99 ~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~ 174 (323)
T KOG0594|consen 99 LDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM 174 (323)
T ss_pred ecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence 965 899999876533235777889999999999999999999 9999999999999999999999999999655332
Q ss_pred ceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc---C
Q 020720 152 THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV---D 227 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 227 (322)
. ..+..+.|.+|+|||++.+. .|+...||||+||+++||++++..|.+....+.+..+........+....... +
T Consensus 175 ~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~ 253 (323)
T KOG0594|consen 175 R-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPD 253 (323)
T ss_pred c-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccc
Confidence 2 23445689999999999977 78999999999999999999999998776644443332222111111111100 0
Q ss_pred --ccC------CCCCHHHH---HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 --PEL------TQFPEKEV---MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 --~~~------~~~~~~~~---~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
... ........ .+..+++.+||+.+|.+|.|++..+.+
T Consensus 254 ~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 254 YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 001 11111111 357889999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=300.37 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..+++|||+.+++
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05605 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCc
Confidence 4899999999999765 68999999986542 2223557789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+.+..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 87 L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05605 87 LKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IR 159 (285)
T ss_pred HHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--cc
Confidence 9988864322 26899999999999999999999999 99999999999999999999999999876543221 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|+..|+|||++.+..++.++|||||||++|+|++|..||............ ... +.......+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~---------~~~~~~~~~~~ 227 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERR---------VKEDQEEYSEK 227 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHH---------hhhcccccCcc
Confidence 346889999999999888999999999999999999999999864322111111 000 00111122333
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
....+.+++..||+.||++|| ++.++++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 445588899999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=312.23 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=190.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||||+++|+
T Consensus 8 ~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~ 87 (381)
T cd05626 8 TLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (381)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 4899999999999765 68999999997542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-----
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV----- 151 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 151 (322)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 88 L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 88 MMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999996543 6889999999999999999999999 9999999999999999999999999875321000
Q ss_pred -----------------------------------------ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHH
Q 020720 152 -----------------------------------------THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLE 190 (322)
Q Consensus 152 -----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~e 190 (322)
.......+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000123468999999999998899999999999999999
Q ss_pred HHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHh--cccCCCCCCCCHHHHHHH
Q 020720 191 IISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLF--CTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 191 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~Rps~~evl~~ 265 (322)
|++|..||.......... ........ ..-+...... .++.+++.+ |+..++..||++.+++..
T Consensus 241 lltG~~Pf~~~~~~~~~~------~i~~~~~~--~~~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQL------KVINWENT--LHIPPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHH------HHHccccc--cCCCCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999997653321111 11100000 0001111222 335566655 556677779999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=311.61 Aligned_cols=245 Identities=22% Similarity=0.238 Sum_probs=193.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... ++..||+|++... .......+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 50 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05596 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCc
Confidence 3899999999999776 6899999998643 22334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++... .+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 130 L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 130 LVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred HHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 99998543 4788889999999999999999999 999999999999999999999999998765433222223
Q ss_pred ccccCCCCCchHHHhhC----CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYALLG----QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~----~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||........+ ..+..... . .....
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~--~---~~~~~ 270 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN--S---LTFPD 270 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC--c---CCCCC
Confidence 45689999999998753 4789999999999999999999999764321111 11111000 0 00111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~ 265 (322)
.......+.+++.+||+.+|.+ ||++.+++..
T Consensus 271 -~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 -DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1122345788899999999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.52 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=202.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|.++.. .......+.+|+.+++.++||||+++++++.+.+..++++||+++++
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08228 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGD 88 (267)
T ss_pred eeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCc
Confidence 4899999999999765 6899999987642 23344678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.........+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 164 (267)
T cd08228 89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAH 164 (267)
T ss_pred HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH-HHh
Confidence 99988654333346888999999999999999999998 99999999999999999999999999886543321 112
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC-CH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF-PE 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (322)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ... ....... ..... ..
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~---~~~~~~~---------~~~~~~~~ 231 (267)
T cd08228 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSL---CQKIEQC---------DYPPLPTE 231 (267)
T ss_pred cCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHH---HHHHhcC---------CCCCCChh
Confidence 3457889999999998889999999999999999999999986542211 111 1111110 11111 22
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.....+.+++.+||+.+|++||++.+|++.++++
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 3445688999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=309.77 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=191.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||||+.+|+
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (364)
T cd05599 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGD 87 (364)
T ss_pred EEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcH
Confidence 4899999999999776 68999999997532 2334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce---
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH--- 153 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 153 (322)
|.+++.... .+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++.........
T Consensus 88 L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 88 MMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999996543 6899999999999999999999999 999999999999999999999999998653211100
Q ss_pred ----------------------------------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCC
Q 020720 154 ----------------------------------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSK 199 (322)
Q Consensus 154 ----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~ 199 (322)
.....+||+.|+|||++....++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112358999999999999999999999999999999999999997
Q ss_pred cccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 020720 200 AAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT---MKQVVEM 265 (322)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~evl~~ 265 (322)
....... . ..... ... ....+.... ....+.+++.+|+. +|.+|++ +.|++..
T Consensus 241 ~~~~~~~---~---~~i~~-~~~-~~~~~~~~~----~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQET---Y---RKIIN-WKE-TLQFPDEVP----LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHHHH---H---HHHHc-CCC-ccCCCCCCC----CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 5432111 1 11110 000 000011111 23346777888886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=315.69 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=208.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|.||+||.|++. +...+|||.+...+....+.+.+|+..-+.++|.|||+++|.+.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5899999999999776 577899999988888888899999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCCCcceeec
Q 020720 80 ALLGSKSKYVSL--DWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 80 ~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
+++.... ++ ++.+.-.+..||++||.|||.+. |+|||||-+|+||+ -.|.+||+|||.++.... ......
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 9987665 56 78888899999999999999999 99999999999996 568999999999886543 233456
Q ss_pred ccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 157 RVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.+.||..|||||++..+ .|+.++|||||||++.||.||++||......+...+. -| +-..-+..|
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--------VG-----myKvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--------VG-----MYKVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--------hc-----ceecCCCCc
Confidence 68899999999999865 5889999999999999999999999876544322111 00 001124567
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+...+...+|.+|+.+||.+||++.++|.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 777888999999999999999999999986
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=312.60 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=197.9
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|.+. .+..||+|+++... ....+.+.+|+.+++++. ||||+++++++.+.+..++||||+
T Consensus 44 ~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~ 123 (400)
T cd05105 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYC 123 (400)
T ss_pred eecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEec
Confidence 4899999999999753 13469999997543 333467899999999996 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC------------------------------------------------------------------
Q 020720 73 ENNSLANALLGSKS------------------------------------------------------------------ 86 (322)
Q Consensus 73 ~~~~L~~~l~~~~~------------------------------------------------------------------ 86 (322)
++|+|.+++..+..
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (400)
T cd05105 124 FYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDI 203 (400)
T ss_pred CCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhc
Confidence 99999998864321
Q ss_pred --------------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEee
Q 020720 87 --------------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGD 140 (322)
Q Consensus 87 --------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~D 140 (322)
....+++..++.++.|++.||.|||+.+ ++|+||||.||+++.++.+||+|
T Consensus 204 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~D 280 (400)
T cd05105 204 QRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICD 280 (400)
T ss_pred ccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEe
Confidence 0124778888999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHh
Q 020720 141 FGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLRE 218 (322)
Q Consensus 141 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (322)
||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......... ....
T Consensus 281 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~------~~~~ 354 (400)
T cd05105 281 FGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY------NKIK 354 (400)
T ss_pred CCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH------HHHh
Confidence 9998765332211 1122346778999999998899999999999999999997 889987543221110 1111
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 219 EGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.+. .. ..+......+.+++.+||+.||++||++.+|.+.|++..
T Consensus 355 ~~~-----~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 355 SGY-----RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred cCC-----CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 110 01 112233456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=299.49 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=196.6
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||.||+|... .+..||+|+++.... .....+.+|+.++..++||||+++++++.+.+..++++||+.+
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~ 92 (283)
T cd05091 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH 92 (283)
T ss_pred hCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCC
Confidence 799999999999653 257899999975533 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeec
Q 020720 75 NSLANALLGSK------------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFG 142 (322)
Q Consensus 75 ~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg 142 (322)
++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||.||++++++.+||+|||
T Consensus 93 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg 169 (283)
T cd05091 93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLG 169 (283)
T ss_pred CcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccc
Confidence 99999985321 11235788889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcC
Q 020720 143 LAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEG 220 (322)
Q Consensus 143 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (322)
++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+. . .... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~---~~i~-~- 241 (283)
T cd05091 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---I---EMIR-N- 241 (283)
T ss_pred cccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---HHHH-c-
Confidence 9876533221 11223345778999999988889999999999999999998 8888865422111 1 1111 1
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
......+......+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 242 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 -------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11112233344558899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=294.97 Aligned_cols=246 Identities=28% Similarity=0.435 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.++ ++..+|+|+++... ....+.+.+|+.+++.++||||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 3899999999999653 57889999986543 334567899999999999999999999875 45678999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV- 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 154 (322)
+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||.||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996543 6889999999999999999999998 9999999999999999999999999998654332211
Q ss_pred -ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 -STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....++..|+|||.+....++.++|||||||++|||++ |..||........ . ..+. .+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~---~~i~-~~~~--------~~ 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---T---QMIE-SGER--------ME 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HHHH-CCCC--------CC
Confidence 112224578999999988889999999999999999998 9999875432211 1 1111 1110 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.+.....++.+++.+||+.||++||++.+|...|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2223345588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=301.58 Aligned_cols=244 Identities=26% Similarity=0.333 Sum_probs=191.8
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh--------------hcHHHHHHHHHHHhcCCCCcccccceEEEeC--Ce
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--------------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NN 64 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 64 (322)
||+|.||.|-+|... +++.||||++..... ...+...+|+.+|+++.|||||+++.+..+. +.
T Consensus 105 iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~ 184 (576)
T KOG0585|consen 105 IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDK 184 (576)
T ss_pred hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCc
Confidence 799999999999765 699999999964311 1225788999999999999999999998764 57
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 65 RILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 65 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
+|+|+|||..|.+...-... ..+.+.+++.++..++.||+|||.++ |+||||||.|+||+++|+|||+|||.+
T Consensus 185 ~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs 257 (576)
T KOG0585|consen 185 LYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVS 257 (576)
T ss_pred eEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecccee
Confidence 89999999998775443222 23899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCc----ceeecccccCCCCCchHHHhhCC----CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH
Q 020720 145 KLFPDNV----THVSTRVAGTMGYLAPEYALLGQ----LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 145 ~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~----~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
....... ........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.....-+...
T Consensus 258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~-------- 329 (576)
T KOG0585|consen 258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD-------- 329 (576)
T ss_pred eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH--------
Confidence 8763221 11223367999999999988632 3578999999999999999999998653222111
Q ss_pred HhcCccccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 217 REEGRLLEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 217 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+++..+ ....++...++.+||.+||.+||..|.++.+|....-
T Consensus 330 -------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 330 -------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1122222 1122244566889999999999999999999977653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=324.48 Aligned_cols=252 Identities=29% Similarity=0.471 Sum_probs=213.9
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||.|.||+|++|+.+. ...||||.++... +....+|+.|+.||-+++||||+++-|+.......++|+|||++|
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENG 715 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENG 715 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCC
Confidence 58999999999997762 3469999998764 455689999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|..+|+.+.. .+++.+...++.+|+.|+.||-+.+ ++||||.+.||||+.+...|++|||+++...++.....
T Consensus 716 sLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 716 SLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred cHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 99999987765 4778888999999999999999999 99999999999999999999999999997755543222
Q ss_pred cc--cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 156 TR--VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 156 ~~--~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
+. .....+|.|||.+...+++.+||||||||++||.++ |..||....+.+.+..+ ....++ .
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI------e~gyRL---------P 854 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI------EQGYRL---------P 854 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH------HhccCC---------C
Confidence 22 234679999999999999999999999999999887 99999877655443222 122222 3
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
-|.+++.-|.+||..||++|-.+||.+.+|+..|.+++..+
T Consensus 855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 35567777999999999999999999999999999998644
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=306.23 Aligned_cols=235 Identities=26% Similarity=0.350 Sum_probs=187.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCC-cccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHP-NLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +++.||+|++... .....+.+..|..++..++|+ +|+.+++++.+.+..++||||++++
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (324)
T cd05587 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (324)
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCC
Confidence 3899999999999766 5789999998754 223446778899999999765 5888999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++........ ..
T Consensus 87 ~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 158 (324)
T cd05587 87 DLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TT 158 (324)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-ce
Confidence 9999986543 6889999999999999999999998 99999999999999999999999999874322111 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+. .. ....+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~---~i~-~~---------~~~~~~ 222 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQ---SIM-EH---------NVSYPK 222 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHH-cC---------CCCCCC
Confidence 335689999999999999999999999999999999999999975432211 11 111 11 011122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
.....+.+++.+||+.||.+|++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 233457888999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=301.26 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=188.8
Q ss_pred CcccCcceEEEEEEEC--CCCEEEEEEecccC--hhcHHHHHHHHHHHhcC---CCCcccccceEEEe-----CCeeEEE
Q 020720 1 MIGGGAFGVVYRGSLR--DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNI---RHPNLVQLIGCCVE-----DNNRILV 68 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv 68 (322)
.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ....+++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv 87 (290)
T cd07862 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 87 (290)
T ss_pred EeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEE
Confidence 3899999999999763 46889999987542 22234566677776665 69999999999853 3468999
Q ss_pred EEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 69 YEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
|||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 88 FEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred EccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 99996 589988865432 25889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc-----
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL----- 223 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (322)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|..||......+.+..+.............
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 162 FQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred CC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 32 12234468999999999998899999999999999999999999998654332222111000000000000
Q ss_pred --cccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 --EIVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 --~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+.+.. ....+.....+.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 0111122345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=310.84 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=194.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 72 (322)
.||+|+||.||++... +|+.||+|.+... .....+.+.+|+.+++.++|+||+++++++.... ..++|+||+
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 86 (372)
T cd07853 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM 86 (372)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecc
Confidence 4899999999999765 6899999998643 2334567889999999999999999999998776 789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
. ++|.+.+.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 87 Q-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred c-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 6 57888875443 6899999999999999999999999 99999999999999999999999999886543322
Q ss_pred eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH----------------HH
Q 020720 153 HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT----------------WK 215 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~----------------~~ 215 (322)
.......++..|+|||++.+. .++.++|||||||++|+|++|+.||......+....+... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 223334578899999998874 4789999999999999999999999765432222111100 00
Q ss_pred HHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..............+.........++.+++.+||+.||.+|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000011112224568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.67 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=194.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||++.+. ++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+++..++||||+.+++|.
T Consensus 12 ~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (333)
T cd06650 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91 (333)
T ss_pred cccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Confidence 4899999999999776 68899999887653 334467899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~ 161 (333)
T cd06650 92 QVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 161 (333)
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---ccc
Confidence 9996543 688899999999999999999974 6 9999999999999999999999999987543221 123
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcc---------------
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRL--------------- 222 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 222 (322)
..++..|+|||++.+..++.++|||||||++|+|++|..||............. ....+..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG----CPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc----CcccCCccccccCcccCCccch
Confidence 458899999999998889999999999999999999999997543221110000 0000000
Q ss_pred ------------------ccccCccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 223 ------------------LEIVDPELTQFPE-KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 223 ------------------~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...........+. ....++.+++.+||+.||++||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000001100 12345889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.70 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=190.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+....++||||+. ++|.
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~ 90 (303)
T cd07869 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLC 90 (303)
T ss_pred eEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHH
Confidence 3899999999999876 689999999875432 233567889999999999999999999999999999999996 5787
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 91 ~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 163 (303)
T cd07869 91 QYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNE 163 (303)
T ss_pred HHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCC
Confidence 7776443 25888999999999999999999999 9999999999999999999999999987543221 112334
Q ss_pred ccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc---Cccc-----cccCc-
Q 020720 159 AGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE---GRLL-----EIVDP- 228 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~- 228 (322)
.+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ............. .... ..+.+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 57899999999875 45788999999999999999999999864321 1111111110000 0000 00000
Q ss_pred cCCCC-C---H------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELTQF-P---E------KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~~~-~---~------~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..... + . .....+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0 0 01235778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=315.05 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=212.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||.|-||.||.|.|+ ..-.||||.++.+ .-...+|+.|+.+|+.++|||+|+++++|..+..+|+|+|||..|+|.++
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdY 353 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDY 353 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHH
Confidence 799999999999887 4678999999854 44578999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
++..... .++....+.++.||+.|+.||.+++ +|||||.+.|+||.++..||++|||+++.+..+.........-
T Consensus 354 LRecnr~--ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKF 428 (1157)
T KOG4278|consen 354 LRECNRS--EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKF 428 (1157)
T ss_pred HHHhchh--hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccC
Confidence 9876543 6777788899999999999999999 9999999999999999999999999999886654443333344
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
.+-|.|||.+..+.|+.|+|||+|||+|||+.| |..||.+.+..+.+.+++.... -+.+..++.
T Consensus 429 PIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---------------M~~PeGCPp 493 (1157)
T KOG4278|consen 429 PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---------------MDGPEGCPP 493 (1157)
T ss_pred cccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc---------------ccCCCCCCH
Confidence 678999999999999999999999999999998 8888887655554444321111 133556667
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+++||+.||+.+|++||++.|+-+.++.+..
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 79999999999999999999999999887654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.53 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=196.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||+++++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (260)
T cd05070 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (260)
T ss_pred eeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHH
Confidence 3899999999999888788899999875432 3467899999999999999999999875 4567899999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||++++++.++|+|||.+...............+
T Consensus 91 ~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05070 91 LKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF 165 (260)
T ss_pred HHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCC
Confidence 965432 25889999999999999999999998 9999999999999999999999999998654332222222335
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+....++.++||||||+++|+|++ |..||......+ .. ..+..... ...+.....
T Consensus 166 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~---~~~~~~~~---------~~~~~~~~~ 230 (260)
T cd05070 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VL---EQVERGYR---------MPCPQDCPI 230 (260)
T ss_pred CccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HH---HHHHcCCC---------CCCCCcCCH
Confidence 568999999988889999999999999999999 888886532211 11 11111100 111223345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.||++|||+.++.+.|+.
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 68899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=303.96 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=195.7
Q ss_pred CcccCcceEEEEEEEC-CCC----EEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT----QIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|.+. ++. .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+++++|+++
T Consensus 14 ~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~ 92 (316)
T cd05108 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPF 92 (316)
T ss_pred eeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCC
Confidence 4899999999999764 333 48999987543 34457888999999999999999999998764 56799999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 93 g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 166 (316)
T cd05108 93 GCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166 (316)
T ss_pred CCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcce
Confidence 999999976532 5888999999999999999999998 9999999999999999999999999998664332221
Q ss_pred -ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 -STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......+..|+|||.+.+..++.++|||||||++|||++ |..||......+ . ......+.. ..
T Consensus 167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~--------~~ 231 (316)
T cd05108 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER--------LP 231 (316)
T ss_pred eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCCC--------CC
Confidence 112234668999999999999999999999999999997 999987542211 1 111111100 01
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||+.||++||++.+++..|.....
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 112223457889999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=278.71 Aligned_cols=241 Identities=27% Similarity=0.363 Sum_probs=202.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|-||.||.|+.+ ++.-||+|++... ......++.+|+++.+.|+||||+++|++|.+....|+++||...|+
T Consensus 29 ~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~ge 108 (281)
T KOG0580|consen 29 PLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGE 108 (281)
T ss_pred cccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCch
Confidence 4899999999999776 6788999998654 23334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|...+..+... .+++...+.++.|+|.||.|+|..+ ++||||||+|+|++..+.+|++|||.+...+. ....
T Consensus 109 l~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---~kR~ 180 (281)
T KOG0580|consen 109 LYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS---NKRK 180 (281)
T ss_pred HHHHHHhcccc--cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC---CCce
Confidence 99999755433 7899999999999999999999998 99999999999999999999999999876542 2335
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||..|.+||...+...+...|+|++|++.||++.|..||+.....+.+..+. + .+- .++..
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---k----------~~~---~~p~~ 244 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---K----------VDL---KFPST 244 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---H----------ccc---cCCcc
Confidence 5789999999999999999999999999999999999999998765443332221 1 111 12233
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......++|.+|+..+|.+|.+..|++..
T Consensus 245 is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 34457778888999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=293.22 Aligned_cols=246 Identities=26% Similarity=0.443 Sum_probs=194.1
Q ss_pred cccCcceEEEEEEEC---CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR---DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999664 35579999987553 333467899999999999999999999875 4578999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee--
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS-- 155 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 155 (322)
.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999865432 6899999999999999999999998 99999999999999999999999999875433222111
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....++..|+|||.+....++.++|||||||++|+|++ |..||......+.. .....+. ....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~--------~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGK--------RLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCC--------CCCCC
Confidence 11223568999999988889999999999999999996 99998755322111 1111111 01222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
......+.+++.+||+.||++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 33345688899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=293.37 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=195.9
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||+|...+...||+|.++.... ..+.+.+|+++++.++|+||+++++++. ....+++|||+++++|.+++
T Consensus 14 lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 91 (262)
T cd05071 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL 91 (262)
T ss_pred cCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHH
Confidence 899999999999877667799999875332 3467889999999999999999999874 45678999999999999999
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
..... ..+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+...............++
T Consensus 92 ~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~ 166 (262)
T cd05071 92 KGEMG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166 (262)
T ss_pred hhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCccc
Confidence 65322 25788999999999999999999998 99999999999999999999999999876543322222223456
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
..|+|||+..+..++.++|||||||++|+|++ |..||......... ..... + ............
T Consensus 167 ~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~------~~~~~-~--------~~~~~~~~~~~~ 231 (262)
T cd05071 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER-G--------YRMPCPPECPES 231 (262)
T ss_pred ceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH------HHHhc-C--------CCCCCccccCHH
Confidence 78999999988889999999999999999999 78888654322111 11110 0 001112334456
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+.+++.+||+.||++||++.++++.|+...
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=295.90 Aligned_cols=266 Identities=26% Similarity=0.362 Sum_probs=207.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEec--ccChhcHHHHHHHHHHHhcCCCCcccccceEEEe-----CCeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLS--AESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-----DNNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~ 73 (322)
||+|+||.|+.+... +|..||||.+. -+.....+...+|+..|+.++|+||+.+++++.- -+..|+|+|+|+
T Consensus 30 iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe 109 (359)
T KOG0660|consen 30 IGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME 109 (359)
T ss_pred ccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh
Confidence 899999999999766 79999999987 3466677899999999999999999999999855 346899999994
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC-cc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 152 (322)
.+|..++..+. .++...+..++.||+.||.|+|+.+ ++||||||.|++++.+..+|++|||+|+..... ..
T Consensus 110 -tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 110 -TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred -hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 58999997664 5999999999999999999999999 999999999999999999999999999977532 23
Q ss_pred eeecccccCCCCCchHHHh-hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH---------HHHhcCc-
Q 020720 153 HVSTRVAGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW---------KLREEGR- 221 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~-~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~- 221 (322)
..++..+.|-+|.|||++. ...|+.+.||||.|||+.||++|+..|.+.+..+.+..+.... .+..+..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 3446677899999999876 4579999999999999999999999998876665554442211 1110000
Q ss_pred -cccccCccCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhccccCcccc
Q 020720 222 -LLEIVDPELT-----QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM--LSKDVHLNEKA 276 (322)
Q Consensus 222 -~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~--L~~~~~~~~~~ 276 (322)
....+ +..+ ..-+......++++.+||..||.+|+|++|.++. |+...+..+++
T Consensus 262 ~yi~sl-p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 262 PYIKSL-PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHhC-CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 00000 1111 1112333457889999999999999999999874 55554444333
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.42 Aligned_cols=246 Identities=29% Similarity=0.500 Sum_probs=196.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|...+++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++|||+.+++|.++
T Consensus 13 ~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05067 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDF 90 (260)
T ss_pred eeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHH
Confidence 389999999999988888999999987543 33567899999999999999999999864 5578999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...............+
T Consensus 91 ~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05067 91 LKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF 165 (260)
T ss_pred HHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcc
Confidence 865432 36888999999999999999999998 9999999999999999999999999987654322222222335
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++....++.++||||||+++|+|++ |..||.......... ... .. .... .+.....
T Consensus 166 ~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~-~~-----~~~~---~~~~~~~ 230 (260)
T cd05067 166 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ------NLE-RG-----YRMP---RPDNCPE 230 (260)
T ss_pred cccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH------HHH-cC-----CCCC---CCCCCCH
Confidence 678999999988889999999999999999999 999997543221111 111 11 0011 1122334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|++||++++++..|+.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 68899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=292.10 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=199.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... ++..|++|.+... .......+.+|+.+++.++||||+++++++.+.+..+++|||+++++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd08529 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDL 86 (256)
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcH
Confidence 3899999999999776 6899999998643 344557888999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 87 ~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~ 160 (256)
T cd08529 87 HKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANT 160 (256)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-hhhc
Confidence 999976422 36889999999999999999999998 99999999999999999999999999886543322 1223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+++.|+|||++.+..++.++||||||+++|+|++|..||...... ... .... . ......+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~-~--------~~~~~~~~~~ 225 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI---LKII-R--------GVFPPVSQMY 225 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-c--------CCCCCCcccc
Confidence 45788999999999888999999999999999999999999754311 111 1111 1 1112222234
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 4568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=297.54 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+....+++|||++
T Consensus 13 ~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 92 (277)
T cd05062 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 92 (277)
T ss_pred eeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCC
Confidence 3899999999998653 2567999998643 23344678899999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCCCC------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 74 NNSLANALLGSKSK------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
+++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||.||++++++.++|+|||++...
T Consensus 93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 169 (277)
T cd05062 93 RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169 (277)
T ss_pred CCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCcccc
Confidence 99999998653221 124677889999999999999999998 999999999999999999999999998754
Q ss_pred CCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||........ . ......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~----~~~~~~----- 237 (277)
T cd05062 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---L----RFVMEG----- 237 (277)
T ss_pred CCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHcC-----
Confidence 3322211 112335678999999998899999999999999999999 6788865422111 1 111111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.....+......+.+++.+||+.||++||++.|+++.|++
T Consensus 238 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 ---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111222234468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=292.65 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=195.2
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|++|.||+|....+..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++|||+.+++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05069 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDF 90 (260)
T ss_pred eecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHH
Confidence 389999999999988766789999886433 33467889999999999999999999875 4567899999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+...............+
T Consensus 91 ~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05069 91 LKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF 165 (260)
T ss_pred HhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCcc
Confidence 965432 25789999999999999999999998 9999999999999999999999999997654332222222345
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||...+..++.++||||||+++|+|++ |..||........ .. ...... .. ..+.....
T Consensus 166 ~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~~~~~~------~~---~~~~~~~~ 230 (260)
T cd05069 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LE---QVERGY------RM---PCPQGCPE 230 (260)
T ss_pred chhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHcCC------CC---CCCcccCH
Confidence 678999999988889999999999999999999 8889875432111 11 111110 01 11223345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.||.+||++++|++.|+.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 68889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=304.62 Aligned_cols=235 Identities=26% Similarity=0.358 Sum_probs=188.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... ++..||+|+++... ......+..|..++..+ .|++|+++++++.+.+..++||||+++|
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (323)
T cd05616 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (323)
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCC
Confidence 4899999999999776 57899999987542 22334567788888777 5899999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+.+.... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~ 158 (323)
T cd05616 87 DLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTT 158 (323)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Ccc
Confidence 9999986543 6889999999999999999999998 9999999999999999999999999987533221 112
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+.. .. ...+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~---~i~~-~~---------~~~p~ 222 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ---SIME-HN---------VAYPK 222 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HH---HHHh-CC---------CCCCC
Confidence 345689999999999999999999999999999999999999975432211 11 1111 10 11222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
....++.+++.+||+.||++|++.
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcCCC
Confidence 334557889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.33 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=190.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.++...++||||+++|+
T Consensus 50 ~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05621 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCc
Confidence 3899999999999876 6889999998642 22334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 130 L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 130 LVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred HHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 99999543 4788899999999999999999999 999999999999999999999999999865433322233
Q ss_pred ccccCCCCCchHHHhhCC----CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYALLGQ----LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~----~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...||+.|+|||++.... ++.++|||||||++|+|++|..||......... ..+...... ..+..
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~-----~~~p~ 270 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNS-----LNFPE 270 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcc-----cCCCC
Confidence 456999999999997643 788999999999999999999999754321111 111111100 00111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~ 265 (322)
.......+.+++..|+..++.+ |+++.|+++.
T Consensus 271 -~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 -DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1112334667778888755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.39 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=189.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++|+||+++++.+.+++..++||||+++|+
T Consensus 8 ~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (376)
T cd05598 8 TIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (376)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCc
Confidence 3899999999999765 68999999986432 2234668899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC------
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN------ 150 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------ 150 (322)
|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..+...
T Consensus 88 L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 88 MMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999996543 6888999999999999999999999 999999999999999999999999987422100
Q ss_pred ------------------------------------cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhC
Q 020720 151 ------------------------------------VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG 194 (322)
Q Consensus 151 ------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g 194 (322)
.........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00001124689999999999999999999999999999999999
Q ss_pred CCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 020720 195 RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRP---TMKQVVEM 265 (322)
Q Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp---s~~evl~~ 265 (322)
..||......+... .... ... ....+..... ...+.+++.+|+ .+|.+|+ ++.+++..
T Consensus 241 ~~Pf~~~~~~~~~~------~i~~-~~~-~~~~~~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAETQL------KVIN-WET-TLHIPSQAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHHH------HHhc-cCc-cccCCCCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99997653221111 0100 000 0000111122 233566666665 5999999 88998864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=292.11 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=203.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|.++.. .......+.+|++++++++|+|++++++++.+.+..+++|||+++++
T Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (267)
T cd08224 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD 88 (267)
T ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCC
Confidence 4899999999999776 7999999988643 23335678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~ 164 (267)
T cd08224 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AH 164 (267)
T ss_pred HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc-cc
Confidence 99998754444446899999999999999999999998 999999999999999999999999998755432211 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH-
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE- 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (322)
...++..|+|||.+.+..++.++||||||+++|+|++|..||...... ......... .+ .....+.
T Consensus 165 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~--------~~~~~~~~ 231 (267)
T cd08224 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-KC--------DYPPLPAD 231 (267)
T ss_pred eecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh-cC--------CCCCCChh
Confidence 345788999999999888999999999999999999999998654311 111111111 01 1112222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.....+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 232 HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 34456889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.02 Aligned_cols=244 Identities=22% Similarity=0.278 Sum_probs=187.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++.+.+.+..++||||+++|+
T Consensus 8 ~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (382)
T cd05625 8 TLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 87 (382)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCc
Confidence 4899999999999765 68899999987542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-----
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV----- 151 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 151 (322)
|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 88 MMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999996543 6888999999999999999999999 9999999999999999999999999875321000
Q ss_pred -----------------------------------------ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHH
Q 020720 152 -----------------------------------------THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLE 190 (322)
Q Consensus 152 -----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~e 190 (322)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 020720 191 IISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT---MKQVVE 264 (322)
Q Consensus 191 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~evl~ 264 (322)
|++|..||.......... ....... ....+...... ..+.+++.+|+ .+|.+|++ +.++++
T Consensus 241 lltG~~Pf~~~~~~~~~~------~i~~~~~--~~~~p~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQM------KVINWQT--SLHIPPQAKLS----PEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHH------HHHccCC--CcCCCCcccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999997643221111 1110000 00001111222 33555665554 59999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=292.22 Aligned_cols=249 Identities=34% Similarity=0.529 Sum_probs=201.9
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.... +..|++|.++..... ..+.+.+|+..++.++|+||+++++++.+....+++|||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 58999999999997653 788999999765433 3678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCC-----CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 76 SLANALLGSKSK-----YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 76 ~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
+|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999765211 247999999999999999999999998 999999999999999999999999999866543
Q ss_pred cc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 151 VT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 151 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.. .......++..|+|||.+....++.++||||||+++|+|++ |..||......... ..... +
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~-~-------- 223 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL------EYLRK-G-------- 223 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH------HHHHc-C--------
Confidence 21 11223457889999999988889999999999999999999 58888765221111 11111 1
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.....+......+.+++.+||+.||++||++.|++..|+
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111222233456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=292.88 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=201.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.+++|.+... .......+.+|+.+++.++|+||+++++++.+++..+++|||+++++
T Consensus 9 ~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08229 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 88 (267)
T ss_pred hhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCC
Confidence 4899999999999764 7899999988643 22334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.........+++..++.++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||++......... ..
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 164 (267)
T cd08229 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AH 164 (267)
T ss_pred HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc-cc
Confidence 99998654333346899999999999999999999998 999999999999999999999999998765433221 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...++..|+|||.+.+..++.++||||||+++|+|++|..||....... .... .... ....+.. ....
T Consensus 165 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~------~~~~~~~--~~~~ 232 (267)
T cd08229 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC---KKIE------QCDYPPL--PSDH 232 (267)
T ss_pred cccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHh---hhhh------cCCCCCC--Cccc
Confidence 3457889999999988889999999999999999999999986532211 1110 0100 0001111 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
....+.+++.+||+.||++|||+.+|++.+++.
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 445688999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.28 Aligned_cols=254 Identities=30% Similarity=0.430 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeC-CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVED-NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~ 71 (322)
+||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... ...++++||
T Consensus 14 ~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey 93 (337)
T cd05054 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEY 93 (337)
T ss_pred ccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEec
Confidence 4899999999999532 35789999987543 23346788899999999 899999999988654 567899999
Q ss_pred CCCCCHHHHHhcCCCC---------------------------------------------------------CcCCCHH
Q 020720 72 LENNSLANALLGSKSK---------------------------------------------------------YVSLDWP 94 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~---------------------------------------------------------~~~~~~~ 94 (322)
+++++|.+++...... ..++++.
T Consensus 94 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 173 (337)
T cd05054 94 CKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLE 173 (337)
T ss_pred CCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHH
Confidence 9999999998643211 1267899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-eecccccCCCCCchHHHhhC
Q 020720 95 TRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLG 173 (322)
Q Consensus 95 ~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 173 (322)
.+..++.||+.||+|||+.+ ++||||||.||+++.++.++|+|||++......... ......++..|+|||++.+.
T Consensus 174 ~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 250 (337)
T cd05054 174 DLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250 (337)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCC
Confidence 99999999999999999998 999999999999999999999999999865322211 11223456789999999999
Q ss_pred CCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCC
Q 020720 174 QLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAG 252 (322)
Q Consensus 174 ~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 252 (322)
.++.++|||||||++|+|++ |..||......+... .....+.. ...+.....++.+++.+||+.+
T Consensus 251 ~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~------~~~~~~~~--------~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC------RRLKEGTR--------MRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH------HHHhccCC--------CCCCccCCHHHHHHHHHHccCC
Confidence 99999999999999999998 999987643322111 11111110 1112233456889999999999
Q ss_pred CCCCCCHHHHHHHHhcccc
Q 020720 253 AHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 253 p~~Rps~~evl~~L~~~~~ 271 (322)
|++||++.||++.|+..+.
T Consensus 317 p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 317 PEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=298.25 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=195.6
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
+||+|+||.||.+.. .++..||+|.++... ......+.+|++.++.++||||+++++++... ...+++|||+
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (283)
T cd05080 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90 (283)
T ss_pred ecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCC
Confidence 489999999988642 357889999987553 23456788999999999999999999987654 3578999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 91 ~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 91 PLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred CCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999643 5899999999999999999999998 99999999999999999999999999886543221
Q ss_pred e--eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 H--VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 ~--~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..................++...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCC
Confidence 1 11122356679999999888899999999999999999999999865432110 00000000000000001111111
Q ss_pred -CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 231 -TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 231 -~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
...+......+.+++.+||+.||++||+++++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111223345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=298.11 Aligned_cols=252 Identities=29% Similarity=0.446 Sum_probs=198.7
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||++... ....+|+|.+... .......+.+|+.++.++ +|+||+++++++..++..+++|||+
T Consensus 19 ~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~ 98 (293)
T cd05053 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA 98 (293)
T ss_pred EecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeC
Confidence 3899999999999754 2367899998754 233446788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCC------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEee
Q 020720 73 ENNSLANALLGSK------------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGD 140 (322)
Q Consensus 73 ~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~D 140 (322)
++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||||.||+++.++.++|+|
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~D 175 (293)
T cd05053 99 AHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIAD 175 (293)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCc
Confidence 9999999996432 22346889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHh
Q 020720 141 FGLAKLFPDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLRE 218 (322)
Q Consensus 141 fg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (322)
||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+.. ....
T Consensus 176 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~ 248 (293)
T cd05053 176 FGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-------KLLK 248 (293)
T ss_pred cccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-------HHHH
Confidence 99988654322111 122234568999999988899999999999999999997 88888654322111 1111
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 219 EGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.+. ....+......+.+++.+||+.||++|||+.|+++.|+..+
T Consensus 249 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 249 EGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred cCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 11122233456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=296.74 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=198.2
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.+....+++|||+++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (280)
T cd05092 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRH 91 (280)
T ss_pred ccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCC
Confidence 4899999999999642 3567899998766666678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 75 NSLANALLGSKS-----------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 75 ~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
++|.+++..... ....+++..++.++.|++.|++|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~ 168 (280)
T cd05092 92 GDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGM 168 (280)
T ss_pred CCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCc
Confidence 999999975431 1125788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCc
Q 020720 144 AKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGR 221 (322)
Q Consensus 144 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (322)
+......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+... .. ..+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~-~~~~ 241 (280)
T cd05092 169 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE------CI-TQGR 241 (280)
T ss_pred eeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH------HH-HcCc
Confidence 8754332211 1122335678999999998999999999999999999998 888886543221111 01 1110
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 222 LLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
. ...+......+.+++.+||+.||.+||++.+|++.|++
T Consensus 242 ~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 242 E--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred c--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 11112233457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.71 Aligned_cols=245 Identities=22% Similarity=0.265 Sum_probs=189.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.||||++.... ....+.+.+|+.++..++||||+++++++.+....++||||+++|+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (377)
T cd05629 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGD 87 (377)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCc
Confidence 3899999999999765 68999999986432 2334678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce---
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH--- 153 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 153 (322)
|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 88 L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 88 LMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999996543 6889999999999999999999999 999999999999999999999999998632110000
Q ss_pred -------------------------------------------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHH
Q 020720 154 -------------------------------------------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLE 190 (322)
Q Consensus 154 -------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~e 190 (322)
.....+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012358999999999999999999999999999999
Q ss_pred HHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 020720 191 IISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYR---PTMKQVVEM 265 (322)
Q Consensus 191 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---ps~~evl~~ 265 (322)
|++|..||......+... .+..... . ..+.. ......++.+++.+||. +|.+| +++.|++..
T Consensus 241 lltG~~Pf~~~~~~~~~~------~i~~~~~---~--~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSHETYR------KIINWRE---T--LYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHHHHHH------HHHccCC---c--cCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999997543221111 1110000 0 00111 01123447788888997 66665 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=296.34 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=196.5
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|.. ..+..+++|.+... .......+.+|+.+++.++||||+++++++......+++|||+++
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 91 (283)
T cd05090 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQ 91 (283)
T ss_pred eccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCC
Confidence 389999999999974 24678999998743 333446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeee
Q 020720 75 NSLANALLGSKS-------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDF 141 (322)
Q Consensus 75 ~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Df 141 (322)
++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (283)
T cd05090 92 GDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDL 168 (283)
T ss_pred CcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccc
Confidence 999999853321 1235788889999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhc
Q 020720 142 GLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREE 219 (322)
Q Consensus 142 g~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (322)
|++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .. +....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~ 241 (283)
T cd05090 169 GLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VI----EMVRK 241 (283)
T ss_pred cccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHc
Confidence 99976533221 11222335678999999988889999999999999999998 888886542211 11 11111
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 220 GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.. ....+......+.+++.+||+.||.+||++.+|++.|..+
T Consensus 242 ~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 242 RQ--------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred CC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 11 1111222334588899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=294.14 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~ 74 (322)
++|.|+||.||+|... ++..||||.+-.+.+. -.+|+++|+.++|||||++.-+|.... ...+||||++.
T Consensus 31 liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 31 LIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred EEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 5899999999999776 5799999998655332 235999999999999999988885432 34689999975
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcce
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+|.+++.........++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+........
T Consensus 107 -tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 107 -TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred -HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 899999754334457888889999999999999999998 9999999999999976 99999999999977655444
Q ss_pred eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc-------cccc
Q 020720 154 VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR-------LLEI 225 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 225 (322)
.. ...|--|+|||++.+. .|+.+.||||.||++.||+-|++.|.+....+.+..+........... ..+.
T Consensus 183 iS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 183 IS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred ee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 22 3467789999999865 799999999999999999999999998776666555543322111100 0111
Q ss_pred cCccCCC------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 VDPELTQ------FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ~~~~~~~------~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.+.. +......+.++++.++|+.+|.+|.++.|++..
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1122211 223344568899999999999999999999863
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=293.82 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-C---CCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe------eEEE
Q 020720 1 MIGGGAFGVVYRGSLR-D---GTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN------RILV 68 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~---~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv 68 (322)
+||+|+||.||+|... + +..||+|.++.+. ......+.+|+..++.++||||+++++++..... .+++
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 85 (273)
T cd05035 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVI 85 (273)
T ss_pred ccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEE
Confidence 4899999999999754 2 4679999987542 3344678999999999999999999999866554 7899
Q ss_pred EEcCCCCCHHHHHhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 69 YEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+||+++++|..++.... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 86 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 162 (273)
T cd05035 86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKK 162 (273)
T ss_pred EeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceee
Confidence 99999999999985432 12236889999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 147 FPDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 147 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
........ ......+..|+|||.+....++.++|||||||++|||++ |..||....... ..+.. ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~~--- 232 (273)
T cd05035 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RHGN--- 232 (273)
T ss_pred ccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC---
Confidence 54322111 111234678999999988889999999999999999999 888886543221 11111 1111
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
....+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 233 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 -----RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112223445689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=305.61 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=168.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|... +++.||+|+++... ......+.+|+.++..++|+||+++++.+.+....++||||+++|+
T Consensus 8 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (363)
T cd05628 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGD 87 (363)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCc
Confidence 4899999999999765 68999999997532 2233567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc----
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---- 152 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 152 (322)
|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 88 L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 88 MMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999996543 6899999999999999999999999 99999999999999999999999999874321100
Q ss_pred ------------------------------eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcc
Q 020720 153 ------------------------------HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAA 201 (322)
Q Consensus 153 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~ 201 (322)
......+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=292.45 Aligned_cols=247 Identities=30% Similarity=0.506 Sum_probs=198.7
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|..+++..+++|.+.... .....+.+|+.++++++|+||+++++++......+++|||+++++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 91 (261)
T cd05034 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91 (261)
T ss_pred eeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHH
Confidence 389999999999988877889999987443 3456789999999999999999999999988899999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+................
T Consensus 92 i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 166 (261)
T cd05034 92 LKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF 166 (261)
T ss_pred Hhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCC
Confidence 976432 26899999999999999999999998 9999999999999999999999999987654322221222334
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ... ..... ... ..+.....
T Consensus 167 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---~~~~~------~~~---~~~~~~~~ 231 (261)
T cd05034 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE---QVERG------YRM---PRPPNCPE 231 (261)
T ss_pred CccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHcC------CCC---CCCCCCCH
Confidence 568999999998889999999999999999998 999986542211 111 11110 001 11112244
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|++||+++++++.|+.
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 68899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=293.78 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=194.0
Q ss_pred CcccCcceEEEEEEECC-CC--EEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLRD-GT--QIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~ 69 (322)
+||+|+||.||+|.... +. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ...++++
T Consensus 6 ~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~ 85 (272)
T cd05075 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85 (272)
T ss_pred ccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEE
Confidence 48999999999997763 33 5899988654 344457888999999999999999999987532 2468999
Q ss_pred EcCCCCCHHHHHhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 70 EYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
||+.+++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 86 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 86 PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred EeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCccccc
Confidence 9999999998874321 12235889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
....... .....+++.|++||...+..++.++|||||||++|+|++ |..||....... .. .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~--- 232 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQGNR--- 232 (272)
T ss_pred CcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCC---
Confidence 4332211 122335678999999998899999999999999999999 788886532211 11 11111111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
...+......+.+++.+||+.||++||++.++++.|+..
T Consensus 233 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 -----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111222334588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=294.18 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=195.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..+++|||+++++|.+
T Consensus 16 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~ 95 (267)
T cd06646 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD 95 (267)
T ss_pred eeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHH
Confidence 3899999999999764 688999999976655555678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........ ......
T Consensus 96 ~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 167 (267)
T cd06646 96 IYHVTG----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFI 167 (267)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccc
Confidence 986543 6889999999999999999999998 99999999999999999999999999886532221 112345
Q ss_pred cCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 160 GTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 160 ~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
++..|+|||.+. ...++.++|||||||++|+|++|..||............ .... ...+... ....
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~~~~-~~~~ 236 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPPKLK-DKTK 236 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCCCCc-cccc
Confidence 788999999875 345788999999999999999999998644322111000 0000 0001111 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
....+.+++.+||+.||++||+++++++.|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 345688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=292.95 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=195.2
Q ss_pred CcccCcceEEEEEEEC-CCC--EEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT--QIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999775 444 4688888743 344456888999999999 8999999999999999999999999999
Q ss_pred CHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 76 SLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 76 ~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 99999965431 1235788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
+........ ......+..|+|||++....++.++|||||||++|+|++ |..||......+.. ........
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~- 229 (270)
T cd05047 159 SRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQGYR- 229 (270)
T ss_pred ccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH------HHHhCCCC-
Confidence 863221111 111223567999999988889999999999999999997 99998653221111 11111100
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+......+.+++.+||+.||.+||++.+++..|+++.
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 --------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111223345889999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=305.69 Aligned_cols=246 Identities=22% Similarity=0.243 Sum_probs=190.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus 50 ~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (371)
T cd05622 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 129 (371)
T ss_pred EEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCc
Confidence 3899999999999776 6889999998642 22334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++............
T Consensus 130 L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~ 201 (371)
T cd05622 130 LVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201 (371)
T ss_pred HHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccccc
Confidence 99998543 4788889999999999999999999 999999999999999999999999999865433222233
Q ss_pred ccccCCCCCchHHHhhCC----CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYALLGQ----LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~----~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...||+.|+|||++.... ++.++|||||||++|+|++|..||........ . ..+...... ..+..
T Consensus 202 ~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~---~~i~~~~~~-----~~~~~ 270 (371)
T cd05622 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y---SKIMNHKNS-----LTFPD 270 (371)
T ss_pred CcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---H---HHHHcCCCc-----ccCCC
Confidence 456999999999987543 78999999999999999999999975432111 1 111111000 00111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEML 266 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~L 266 (322)
.......+.+++.+||..++.+ |+++.++++..
T Consensus 271 -~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 271 -DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1123445778888899844433 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=292.36 Aligned_cols=239 Identities=23% Similarity=0.361 Sum_probs=188.1
Q ss_pred CcccCcceEEEEEEECC-------------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEE
Q 020720 1 MIGGGAFGVVYRGSLRD-------------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRIL 67 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 67 (322)
.||+|+||.||+|.... ...+++|.+..........+.+|+.++..++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 48999999999997532 23589998876555555688899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe-------EEEee
Q 020720 68 VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH-------PKIGD 140 (322)
Q Consensus 68 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~-------~kl~D 140 (322)
+|||+++++|..++.... ..+++..++.++.||+.||+|||+.+ ++|+||||.||+++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998886443 26899999999999999999999998 999999999999987664 89999
Q ss_pred eccccccCCCcceeecccccCCCCCchHHHh-hCCCCcccceehhhHHHHHHH-hCCCCCCcccCCCchhHHHHHHHHHh
Q 020720 141 FGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEII-SGRSSSKAAFGDDMLILVEWTWKLRE 218 (322)
Q Consensus 141 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDv~slG~il~ell-~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (322)
||++...... ....++..|+|||.+. ...++.++|||||||++|+|+ +|..||......+.. ...
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-
Confidence 9988654322 1234678899999887 467889999999999999998 577877643221110 000
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 219 EGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
... . .........+.+++.+||+.||.+||++.+|++.++
T Consensus 223 ~~~--------~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ--------C-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC--------c-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0 011112345788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=290.78 Aligned_cols=247 Identities=29% Similarity=0.490 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEECC--C--CEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD--G--TQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+..+++++||||+++++++.+ ...++++||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999997642 3 3689999987655 556789999999999999999999999988 8899999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce--
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999976542 36899999999999999999999998 999999999999999999999999998866432211
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. ... ..... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~---~~~~~--------~~~~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKK---IDKEG--------ERLE 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---HHhcC--------CcCC
Confidence 1112346778999999998899999999999999999998 9999865432221 111 11111 0011
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12223456888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=307.27 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=212.6
Q ss_pred CcccCcceEEEEEEEC---C--CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR---D--GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~--~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||.|-||.||+|... . .-.||||..+.+ ...+.+.|++|..+|++++||||++++|+|.+. ..|+|||.++.
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~ 474 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPL 474 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccc
Confidence 4899999999999643 2 346899999875 456678999999999999999999999999764 68999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|.|..+++.++. .++......++.||+.||+|||+.. .+||||...||||....-|||+|||+++...+.....
T Consensus 475 GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 475 GELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred hhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 999999987765 6899999999999999999999998 9999999999999999999999999999887776665
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....-+.-|||||.+....|+.++|||.|||.+||++. |..||.+..+.+....++ +.+-...
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE---------------nGeRlP~ 613 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE---------------NGERLPC 613 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec---------------CCCCCCC
Confidence 555556778999999999999999999999999999987 999999887776553321 1222345
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
|+.++..++.++.+||..||.+||.+.++...|+...
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 6666777999999999999999999999988775443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=299.24 Aligned_cols=248 Identities=22% Similarity=0.215 Sum_probs=191.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+++.. +++.||+|++... .......+.+|..++..++|+||+++++++.+.+..++||||+.+|+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~ 87 (331)
T cd05624 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGD 87 (331)
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence 3899999999999776 6889999998642 22233557889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++............
T Consensus 88 L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 161 (331)
T cd05624 88 LLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161 (331)
T ss_pred HHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence 9999975322 6889999999999999999999999 999999999999999999999999998765443332223
Q ss_pred ccccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 RVAGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
...|++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+...... ..+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~-----~~~p 230 (331)
T cd05624 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEER-----FQFP 230 (331)
T ss_pred cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCc-----ccCC
Confidence 3568999999999875 4678899999999999999999999975432111 1111111100 0111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~ 265 (322)
.........+.+++.+|+..++.+ |++++++++.
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111222345777888888865544 4678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=296.72 Aligned_cols=248 Identities=24% Similarity=0.229 Sum_probs=189.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||||+++++
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (331)
T cd05597 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGD 87 (331)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCc
Confidence 3899999999999776 6899999998642 22334568889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++............
T Consensus 88 L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 88 LLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred HHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 999996532 26889999999999999999999999 999999999999999999999999998755433222222
Q ss_pred ccccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 RVAGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
...||+.|+|||++.. ..++.++|||||||++|+|++|..||......+.. ..+...... ..+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~-----~~~~ 230 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEH-----FQFP 230 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCc-----ccCC
Confidence 3458999999999873 45788999999999999999999999754221111 111111100 0111
Q ss_pred CCCHHHHHHHHHHHHhcccCC--CCCCCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAG--AHYRPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~d--p~~Rps~~evl~~ 265 (322)
.........+.+++.+|+..+ +..||++.+++..
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111112334666777766543 3347899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=295.55 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=187.4
Q ss_pred CcccCcceEEEEEEECC-------------------------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCccccc
Q 020720 1 MIGGGAFGVVYRGSLRD-------------------------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 55 (322)
.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 48999999999986421 23588998876555555678899999999999999999
Q ss_pred ceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-
Q 020720 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF- 134 (322)
Q Consensus 56 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~- 134 (322)
++++.+....++||||+++++|..++..... .+++..+..++.||+.||+|||+.+ ++|+||||.||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998864322 6889999999999999999999998 99999999999997643
Q ss_pred ------eEEEeeeccccccCCCcceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHH-hCCCCCCcccCCCc
Q 020720 135 ------HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEII-SGRSSSKAAFGDDM 206 (322)
Q Consensus 135 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell-~g~~p~~~~~~~~~ 206 (322)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643221 12346788999998875 56899999999999999995 68888875433221
Q ss_pred hhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 207 LILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.... ... ..+ +......+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~~~------~~~--------~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFY------EKK--------HRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH------Hhc--------cCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1110 000 011 1111235888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=290.00 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=197.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|.
T Consensus 7 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 86 (255)
T cd08219 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLM 86 (255)
T ss_pred EeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHH
Confidence 4899999999999776 6899999998653 3344577889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||++++++.++|+|||.+........ .....
T Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 160 (255)
T cd08219 87 QKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTY 160 (255)
T ss_pred HHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccccc
Confidence 98864332 25788999999999999999999998 99999999999999999999999999876543221 12234
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.+++.|+|||++.+..++.++||||||+++|+|++|..||........ ..... .+ .....+....
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-~~--------~~~~~~~~~~ 225 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVC-QG--------SYKPLPSHYS 225 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHh-cC--------CCCCCCcccC
Confidence 588899999999988899999999999999999999999975321111 11111 11 1112222334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.+++.+||+.||++||++.+++..
T Consensus 226 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 458889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=294.79 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=197.0
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++..++|+||+++++++......+++|||++
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 92 (277)
T cd05032 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92 (277)
T ss_pred EecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCC
Confidence 3899999999999654 24689999986543 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCC------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 74 NNSLANALLGSKSK------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
+++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~ 169 (277)
T cd05032 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169 (277)
T ss_pred CCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhh
Confidence 99999999654321 124788899999999999999999998 999999999999999999999999998755
Q ss_pred CCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
..... .......++..|+|||.+....++.++|||||||++|+|++ |..||........ .. ....+.
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~----~~~~~~---- 238 (277)
T cd05032 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK----FVIDGG---- 238 (277)
T ss_pred ccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH----HHhcCC----
Confidence 33221 11123346788999999988889999999999999999998 8888865432211 11 111111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
....+......+.+++.+||+.+|++|||+.+++..|+
T Consensus 239 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 ----HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11122223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=291.69 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=195.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-----hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|++|.||.|... +++.|++|.+.... ....+.+.+|+.++++++||||+++++++.+....++++||+++
T Consensus 9 ~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 88 (263)
T cd06625 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88 (263)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCC
Confidence 4899999999999765 68999999986442 12235688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++..........
T Consensus 89 ~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 89 GSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred CcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999986543 6888999999999999999999999 9999999999999999999999999987543221111
Q ss_pred e--cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 S--TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 ~--~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
. ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .. ...... .....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~---~~~~~~--------~~~~~ 227 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AI---FKIATQ--------PTNPQ 227 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HH---HHHhcc--------CCCCC
Confidence 1 22447789999999998889999999999999999999999987542211 11 111110 11122
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+......+.+++.+||..+|.+||++.++++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 233344557889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=293.02 Aligned_cols=244 Identities=21% Similarity=0.366 Sum_probs=193.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|+||.||+|... +++.||+|.+..+ .......+.+|+.++++++||||+++++++...+..+++|||+++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (279)
T cd06619 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87 (279)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChH
Confidence 4899999999999764 6899999998655 3334467889999999999999999999999999999999999999986
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 88 ~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (279)
T cd06619 88 VYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTY 153 (279)
T ss_pred Hhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCC
Confidence 553 5788899999999999999999999 9999999999999999999999999987553321 2234
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.++..|+|||++.+..++.++||||||+++|+|++|..||....................... .+.+. .....
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~ 226 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP--VGQFS 226 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC--CCcCC
Confidence 688999999999988999999999999999999999999976443222111100011000000 01111 11123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.++.+++.+||+.||.+||++.|+++.
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 457889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=302.64 Aligned_cols=240 Identities=26% Similarity=0.297 Sum_probs=185.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC---CCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI---RHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||.||+|... +++.||+|++.... ......+..|..++... +||||+++++++.+....++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999776 68999999986432 12223455666666655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999886543 6899999999999999999999999 9999999999999999999999999987532221 11
Q ss_pred ecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..+. .+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~i~-~~~------~~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RNIA-FGK------VRFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HHHH-cCC------CCCCC-
Confidence 2345689999999998754 4789999999999999999999999754321111 1111 110 11110
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC----CHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRP----TMKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rp----s~~evl~ 264 (322)
......+.+++.+||+.||.+|| ++.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234477888999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=288.20 Aligned_cols=246 Identities=28% Similarity=0.444 Sum_probs=197.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||++...+++.|++|.+...... ....+.+|+.++++++|+||+++++++.+....++++||+.+++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 58999999999998766899999998765443 45788999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee-ccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS-TRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 158 (322)
++..... .+++..++.++.+++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+........... ...
T Consensus 82 ~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 82 FLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9865432 5788999999999999999999998 99999999999999999999999999875432211111 112
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ...... .. ..+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~------~~~~~~------~~---~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE------RIESGY------RM---PAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH------HHhcCC------CC---CCCccC
Confidence 23567999999988889999999999999999999 788886543221111 111000 00 112233
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
...+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=289.87 Aligned_cols=246 Identities=29% Similarity=0.469 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEEC-C---CCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-D---GTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... . +..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++. ....+++|||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 4899999999999653 2 36899999875543 34567899999999999999999999876 45679999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.|++.||+|||..+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 81 PLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred cHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999997554 6899999999999999999999998 99999999999999999999999999886543322211
Q ss_pred c--ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 156 T--RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 156 ~--~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .... + ..... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~---~-~~~~~--------~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM---L-ESGER--------LP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH---H-HcCCc--------CC
Confidence 1 1123467999999998899999999999999999998 999987543211 1111 1 11100 01
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.+......+.+++.+||+.+|++||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1222334688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=300.57 Aligned_cols=235 Identities=25% Similarity=0.359 Sum_probs=187.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|+.||+|+++... ....+.+..|..++..+. |++|+++++++.+.+..++||||++++
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g 86 (323)
T cd05615 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG 86 (323)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCC
Confidence 4899999999999766 68999999987542 233456778888888885 577888999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 87 ~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~~ 158 (323)
T cd05615 87 DLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TT 158 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc-cc
Confidence 9999986543 6899999999999999999999998 99999999999999999999999999875322211 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+.. .. . ..+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~~-~~------~---~~p~ 222 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---SIME-HN------V---SYPK 222 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CC------C---CCCc
Confidence 23458999999999998899999999999999999999999997543211 111 1111 10 0 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
....++.+++.+||+.||.+|++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHhhCCCC
Confidence 233457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=295.54 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++++||+.
T Consensus 7 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (290)
T cd05045 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86 (290)
T ss_pred cccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecC
Confidence 4899999999999653 23568988886543 3334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC--------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC
Q 020720 74 NNSLANALLGSKS--------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 74 ~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~ 133 (322)
+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~ 163 (290)
T cd05045 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEG 163 (290)
T ss_pred CCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCC
Confidence 9999999864321 1235788999999999999999999998 9999999999999999
Q ss_pred CeEEEeeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~ 211 (322)
+.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 164 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------ 237 (290)
T cd05045 164 RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER------ 237 (290)
T ss_pred CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 99999999998754322211 1122335678999999988889999999999999999998 988886542211
Q ss_pred HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 212 WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+...... ... ..+......+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 238 -~~~~~~~~-----~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -LFNLLKTG-----YRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHhCC-----CCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111111 001 1122233568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=296.04 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=195.9
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
.||+|+||.||.+.. .++..||+|.++... ......+.+|+.+++.++||||+++++++... ...+++|||+
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (284)
T cd05079 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90 (284)
T ss_pred ecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEcc
Confidence 389999999999963 257889999987553 33446789999999999999999999998775 5688999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 91 ~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 91 PSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred CCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 99999999865432 5899999999999999999999999 99999999999999999999999999886543221
Q ss_pred e--eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCC--------chhHHHHHHHHHhcCcc
Q 020720 153 H--VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD--------MLILVEWTWKLREEGRL 222 (322)
Q Consensus 153 ~--~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~ 222 (322)
. ......++..|+|||++.+..++.++|||||||++|+|+++..|........ ..............+.
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK- 243 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc-
Confidence 1 1123446778999999988889999999999999999999876643221100 0000000011111110
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
....+......+.+++.+||+.||++||++.++++.|+.+
T Consensus 244 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 244 -------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111222345689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=289.06 Aligned_cols=246 Identities=26% Similarity=0.469 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|....+..+++|.+... ......+.+|+.+++.++|+||+++++++.+ ...+++|||+++++|.++
T Consensus 13 ~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05073 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90 (260)
T ss_pred EecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHH
Confidence 38999999999998777788999988743 3335678899999999999999999999877 778999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...............+
T Consensus 91 ~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05073 91 LKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 165 (260)
T ss_pred HHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcc
Confidence 965432 25788899999999999999999998 9999999999999999999999999987654322222222335
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++....++.++|||||||++|++++ |..||......... . ....+.. .........
T Consensus 166 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~----~~~~~~~--------~~~~~~~~~ 230 (260)
T cd05073 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R----ALERGYR--------MPRPENCPE 230 (260)
T ss_pred cccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---H----HHhCCCC--------CCCcccCCH
Confidence 677999999998889999999999999999998 88998754221111 1 0011100 011122344
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|++||++.++++.|+.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 58899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=304.54 Aligned_cols=238 Identities=30% Similarity=0.440 Sum_probs=197.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||.|+||.||-|.+. +...||||......+ ..+++++.|+..|.+++|||++.+.++|..+...|+|||||- |+-
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSA 112 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA 112 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccH
Confidence 899999999999765 678899999876533 445789999999999999999999999999999999999995 588
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.|++...+. ++.+.++..|+++.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.+..... ...
T Consensus 113 sDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans 181 (948)
T KOG0577|consen 113 SDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS 181 (948)
T ss_pred HHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence 888876553 8999999999999999999999999 99999999999999999999999999876532 234
Q ss_pred cccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
++|||.|||||++. .+.|+-++|||||||+..||...++|+.....-.. ... +...-.|.+. .
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LYH------IAQNesPtLq--s 247 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH------IAQNESPTLQ--S 247 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HHH------HHhcCCCCCC--C
Confidence 78999999999986 56899999999999999999999998764321111 111 1111223333 3
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+....|..++..||++-|.+|||.++++..
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 4556678889999999999999999988753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=303.20 Aligned_cols=254 Identities=25% Similarity=0.305 Sum_probs=198.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-C-----CcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-H-----PNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.|.+|... +++.||||+++.. +.-..+...|+.+|..++ | -|+|+++++|...++.|+|+|.+.
T Consensus 193 ~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~ 271 (586)
T KOG0667|consen 193 VLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS 271 (586)
T ss_pred EecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh
Confidence 5999999999999654 7999999999844 444567788999999996 3 589999999999999999999885
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC--eEEEeeeccccccCCCc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF--HPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~ 151 (322)
.+|.+++..+. +..++...++.++.||+.||.+||..+ |||+||||+||||.+.+ .+||+|||.++......
T Consensus 272 -~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 272 -TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred -hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 58999997664 447999999999999999999999999 99999999999997543 59999999999754432
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH---------------H
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK---------------L 216 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---------------~ 216 (322)
. ..+.+-.|+|||++.+.+|+.+.||||||||+.||++|.+.|.+....+.+..+.-... .
T Consensus 346 y----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 346 Y----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred e----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 2 44567789999999999999999999999999999999888877655554433321110 0
Q ss_pred -Hh-cCccc-------------------------cccCc-cCCC---C-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 217 -RE-EGRLL-------------------------EIVDP-ELTQ---F-PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 217 -~~-~~~~~-------------------------~~~~~-~~~~---~-~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. .+.+. ....| .... . ....-..|++++.+||..||.+|+|..+.++
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000 00001 0000 1 1123456899999999999999999999987
Q ss_pred H
Q 020720 265 M 265 (322)
Q Consensus 265 ~ 265 (322)
.
T Consensus 502 H 502 (586)
T KOG0667|consen 502 H 502 (586)
T ss_pred C
Confidence 4
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=293.29 Aligned_cols=246 Identities=27% Similarity=0.333 Sum_probs=194.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|++|+.+++.+.+.+..+++|||+.+++
T Consensus 7 ~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 86 (285)
T cd05630 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCc
Confidence 4899999999999766 68999999986542 2223567789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 87 L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05630 87 LKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IK 159 (285)
T ss_pred HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--cc
Confidence 9998864432 25889999999999999999999998 99999999999999999999999999875432221 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|+..|+|||++.+..++.++|||||||++|+|++|..||............. ..... ... ..+..
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~------~~~---~~~~~ 227 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE------VQE---EYSEK 227 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh------hhh---hcCcc
Confidence 3468999999999998899999999999999999999999998643321111110 00000 001 11122
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~~ 265 (322)
....+.+++.+||+.||.+||+ ++|+++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 2345788899999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=287.43 Aligned_cols=245 Identities=24% Similarity=0.277 Sum_probs=202.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|.-|+||+++.. ++..+|+|++.... .....++..|-+||+.++||.+..+|+.++.+...|++||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 3899999999999887 46899999997653 3334567789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC-------
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD------- 149 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------- 149 (322)
|..+.+.+..+ .+++..++.++.+++.||+|||..| ||+|||||+||||.++|++-|+||.++.....
T Consensus 164 L~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 164 LHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred HHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 99999877654 8999999999999999999999999 99999999999999999999999998753210
Q ss_pred --------------------------Ccc----------------------eeecccccCCCCCchHHHhhCCCCcccce
Q 020720 150 --------------------------NVT----------------------HVSTRVAGTMGYLAPEYALLGQLTKKADV 181 (322)
Q Consensus 150 --------------------------~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv 181 (322)
... .....++||-.|+|||++.+..-+.+.|-
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 000 00012468999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---
Q 020720 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT--- 258 (322)
Q Consensus 182 ~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps--- 258 (322)
|+|||++||||.|..||.+....+.+..+- . -+..+...+ .....+.+||+++|.+||++|..
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv------~-------~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~r 384 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIV------G-------QPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKR 384 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchhhHHHHh------c-------CCCcCCCCC-cchhHHHHHHHHHhccChhhhhcccc
Confidence 999999999999999999887766543321 0 012222222 44566889999999999999998
Q ss_pred -HHHHHH
Q 020720 259 -MKQVVE 264 (322)
Q Consensus 259 -~~evl~ 264 (322)
+.||-+
T Consensus 385 GA~eIK~ 391 (459)
T KOG0610|consen 385 GAAEIKR 391 (459)
T ss_pred chHHhhc
Confidence 888765
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.42 Aligned_cols=243 Identities=24% Similarity=0.339 Sum_probs=202.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh---cHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ---GTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|.||.||++..+ +|+.+|+|.+...... ....+.+|+.+|+++. |||||.+++++++....++|||++.||
T Consensus 42 ~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GG 121 (382)
T KOG0032|consen 42 ELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGG 121 (382)
T ss_pred hhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCc
Confidence 4899999999999877 5999999999765332 3468999999999998 999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC----CeEEEeeeccccccCCCc
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN----FHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~ 151 (322)
.|.+.+... .+++..+..++.|++.++.|||+.+ ++||||||+|+|+... +.++++|||++.....
T Consensus 122 eLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-- 191 (382)
T KOG0032|consen 122 ELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-- 191 (382)
T ss_pred hHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--
Confidence 999999655 2999999999999999999999999 9999999999999633 5799999999998765
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
.......+||+.|+|||++....++..+||||+|+++|.|++|..||...........+ ..+.. ..-.+...
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~~~-~f~~~~w~ 263 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRGDF-DFTSEPWD 263 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcCCC-CCCCCCcc
Confidence 34456688999999999999999999999999999999999999999876544332211 11111 11112222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.+++..|+..||.+|+++.++++.
T Consensus 264 ----~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 264 ----DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 234457788888999999999999999984
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=294.69 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=196.4
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.++...++++||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (288)
T cd05050 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMA 91 (288)
T ss_pred cccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCC
Confidence 3899999999999753 46789999987553 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe
Q 020720 74 NNSLANALLGSKS------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH 135 (322)
Q Consensus 74 ~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~ 135 (322)
+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~ 168 (288)
T cd05050 92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 168 (288)
T ss_pred CCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCc
Confidence 9999999964321 1224788899999999999999999998 999999999999999999
Q ss_pred EEEeeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHH
Q 020720 136 PKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 136 ~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~ 213 (322)
++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .
T Consensus 169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~---~--- 242 (288)
T cd05050 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV---I--- 242 (288)
T ss_pred eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---
Confidence 99999999875432211 11112234667999999998899999999999999999997 8788864322111 1
Q ss_pred HHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 214 WKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
... ..+. ....+.....++.+++.+||+.||++||++.|+++.|++
T Consensus 243 ~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 243 YYV-RDGN--------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHH-hcCC--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 1111 111122334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=289.63 Aligned_cols=245 Identities=27% Similarity=0.510 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......++++||+.+++|.++
T Consensus 11 ~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (256)
T cd05112 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY 89 (256)
T ss_pred eecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHH
Confidence 389999999999987778899999986432 2346788999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.|++.++++||+.+ ++|+||+|.||+++.++.++|+|||++...............+
T Consensus 90 ~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05112 90 LRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163 (256)
T ss_pred HHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCcc
Confidence 865432 5789999999999999999999998 9999999999999999999999999987554332211122234
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+.+..++.++||||||+++|+|++ |..||........ ......... ...+ .....
T Consensus 164 ~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~---~~~~------~~~~~ 228 (256)
T cd05112 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV------VETINAGFR---LYKP------RLASQ 228 (256)
T ss_pred chhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHHHhCCCC---CCCC------CCCCH
Confidence 578999999998889999999999999999998 8899865332111 111111100 0111 11235
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+.+++.+||+.+|++||++.++++.|.
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 6889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=292.52 Aligned_cols=249 Identities=31% Similarity=0.427 Sum_probs=194.5
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|++|.||+|.+. .+..|++|.+.... ......+.+|+.+++.++|+||+++++++.+....+++|||++
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 92 (277)
T cd05036 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMA 92 (277)
T ss_pred ECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCC
Confidence 4899999999999764 35678999886543 3344678999999999999999999999999889999999999
Q ss_pred CCCHHHHHhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC---eEEEeeecccccc
Q 020720 74 NNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF---HPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~---~~kl~Dfg~~~~~ 147 (322)
+++|.+++..... ....+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++ .++|+|||++...
T Consensus 93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~ 169 (277)
T cd05036 93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169 (277)
T ss_pred CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccccc
Confidence 9999999965431 1235889999999999999999999998 99999999999998765 5999999998865
Q ss_pred CCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
....... ......+..|+|||++.+..++.++|||||||++|+|++ |..||........ .. .......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~---~~~~~~~---- 239 (277)
T cd05036 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME---FVTGGGR---- 239 (277)
T ss_pred CCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---HHHcCCc----
Confidence 3221111 112223568999999998999999999999999999997 9999875432211 11 0111110
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 240 -----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 -----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0112223356888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=290.58 Aligned_cols=248 Identities=27% Similarity=0.462 Sum_probs=196.7
Q ss_pred CcccCcceEEEEEEEC-CCC---EEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT---QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~---~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... ++. .+++|.+... .....+.+.+|+.++..++|+||+++.+++.+.+..+++|||++++
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (268)
T cd05063 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENG 91 (268)
T ss_pred EecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCC
Confidence 4899999999999765 333 6899998755 3344577899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... ..+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 92 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 165 (268)
T cd05063 92 ALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165 (268)
T ss_pred CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence 9999996543 26889999999999999999999998 99999999999999999999999999876543222111
Q ss_pred c--ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 156 T--RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 156 ~--~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
. ....+..|+|||++....++.++|||||||++|+|++ |..||....... ....+.... ..+.
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~~-----~~~~--- 231 (268)
T cd05063 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGF-----RLPA--- 231 (268)
T ss_pred eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcCC-----CCCC---
Confidence 1 1123457999999998889999999999999999997 999986543211 111111110 0011
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 232 -~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 -PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112334588999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=305.47 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=197.4
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.+. .+..||+|+++.... ...+.+.+|+.++.++. ||||+++++++...+..++|+||+
T Consensus 44 ~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~ 123 (401)
T cd05107 44 TLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYC 123 (401)
T ss_pred hccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEecc
Confidence 4899999999999753 346899999976533 22357889999999997 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC------------------------------------------------------------------
Q 020720 73 ENNSLANALLGSKS------------------------------------------------------------------ 86 (322)
Q Consensus 73 ~~~~L~~~l~~~~~------------------------------------------------------------------ 86 (322)
++|+|.++++....
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (401)
T cd05107 124 RYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYAD 203 (401)
T ss_pred CCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhh
Confidence 99999999965421
Q ss_pred ----------------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 87 ----------------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 87 ----------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
....+++..++.++.||+.||+|||+.+ ++|+||||.||++++++.++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL 280 (401)
T cd05107 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKI 280 (401)
T ss_pred hhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEE
Confidence 1124667778899999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++........ .......++..|+|||.+....++.++|||||||++|||++ |..||......+.. ...
T Consensus 281 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~------~~~ 354 (401)
T cd05107 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF------YNA 354 (401)
T ss_pred EecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH------HHH
Confidence 99999876432211 11122346788999999998889999999999999999998 88888654322211 111
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+. .+ ..+......+.+++.+||+.+|.+||+++||+..|++.+
T Consensus 355 ~~~~~-----~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 355 IKRGY-----RM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCC-----CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11110 01 112223456888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=298.09 Aligned_cols=240 Identities=21% Similarity=0.331 Sum_probs=207.6
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||+|.|+.|-+|++- +|..||||++.+. +.-....+++|++-|+-++|||||++|.+......+|+|+|.-++|+|.
T Consensus 26 lG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~ 105 (864)
T KOG4717|consen 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLF 105 (864)
T ss_pred hcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHH
Confidence 899999999999664 7999999999755 3334468999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++|-.+.. .+++..+.+++.||+.|+.|+|+.. ++||||||+|+.+- +-|-|||.|||++..+... ...+.
T Consensus 106 DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL~T 177 (864)
T KOG4717|consen 106 DYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKLTT 177 (864)
T ss_pred HHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--chhhc
Confidence 99976644 7999999999999999999999999 99999999998775 5688999999999877543 23456
Q ss_pred cccCCCCCchHHHhhCCCC-cccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQLT-KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~-~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.+|+..|.|||++.+..|+ ++.||||||||||-|++|+.||+...+.+.+..+. ..-...|..
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm----------------DCKYtvPsh 241 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM----------------DCKYTVPSH 241 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh----------------cccccCchh
Confidence 7899999999999999887 68899999999999999999999887766554331 222355677
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...++.++|..||..||.+|.+.+||+..
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 77889999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=292.21 Aligned_cols=247 Identities=29% Similarity=0.462 Sum_probs=195.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHH--HHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTK--EFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||+||++... +++.||+|++......... ...+|+.++++++||||+++++++.+....+++|||+.+++|
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L 85 (260)
T PF00069_consen 6 KLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSL 85 (260)
T ss_dssp EEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBH
T ss_pred EEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccc
Confidence 3899999999999877 5678999999876544332 345699999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+...... ......
T Consensus 86 ~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 157 (260)
T PF00069_consen 86 QDYLQKNK----PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NENFNP 157 (260)
T ss_dssp HHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSEBSS
T ss_pred cccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence 99997332 6899999999999999999999999 999999999999999999999999998754221 222334
Q ss_pred cccCCCCCchHHHh-hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~-~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..++..|+|||++. +..++.++||||||+++|+|++|..||......+.............. ... .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~ 228 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP--------SSS-QQSRE 228 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH--------HHT-TSHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc--------ccc-cccch
Confidence 56889999999998 788999999999999999999999999865222222211111110000 000 00000
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1166889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.89 Aligned_cols=242 Identities=27% Similarity=0.430 Sum_probs=196.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+++++|.++
T Consensus 28 lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 107 (296)
T cd06654 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107 (296)
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHH
Confidence 899999999999765 6899999999876655567889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 108 ~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 178 (296)
T cd06654 108 VTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 178 (296)
T ss_pred HHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccC
Confidence 8543 5788999999999999999999998 99999999999999999999999998875432211 1123457
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
++.|+|||.+.+..++.++|||||||++|+|++|..||.......... ....... +.+ ..+......
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~~~------~~~-~~~~~~~~~ 245 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------PEL-QNPEKLSAI 245 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcCCC------CCC-CCccccCHH
Confidence 889999999998889999999999999999999999997543221110 0000000 111 112233455
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+.+++.+||..||++||++.++++.
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhC
Confidence 8889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.19 Aligned_cols=248 Identities=29% Similarity=0.481 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEEC-C---CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-D---GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.+. + +..+|+|.++... ......+.+|+.++.+++||||+++++++.+++..+++|||++++
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (267)
T cd05066 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENG 90 (267)
T ss_pred eecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCC
Confidence 4899999999999764 2 3379999987543 334568899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 91 ~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd05066 91 SLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164 (267)
T ss_pred CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceee
Confidence 99999965432 5889999999999999999999999 99999999999999999999999999886543322111
Q ss_pred c--ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 156 T--RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 156 ~--~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
. ...++..|+|||.+.+..++.++||||||+++|++++ |..||......+... .+..... ..
T Consensus 165 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~------~~~~~~~---------~~ 229 (267)
T cd05066 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK------AIEEGYR---------LP 229 (267)
T ss_pred ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH------HHhCCCc---------CC
Confidence 1 1223567999999998899999999999999999886 999987553322111 1111100 01
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.+...+..+.+++.+||+.+|.+||++.++++.|++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1122334578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=295.21 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=194.8
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 73 (322)
+||+|+||.||++.. .++..||+|.+........+.+.+|+++++.++||||+++++++... ...++++||++
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 90 (284)
T cd05081 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90 (284)
T ss_pred eccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecC
Confidence 489999999999964 25789999999876666677899999999999999999999987543 46789999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 91 ~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (284)
T cd05081 91 YGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164 (284)
T ss_pred CCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence 9999999965432 5889999999999999999999998 999999999999999999999999999865432221
Q ss_pred e--ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCch---------hHHHHHHHHHhcCcc
Q 020720 154 V--STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML---------ILVEWTWKLREEGRL 222 (322)
Q Consensus 154 ~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 222 (322)
. .....++..|+|||.+.+..++.++|||||||++|||++|..|+......... ............
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (284)
T cd05081 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--- 241 (284)
T ss_pred eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc---
Confidence 1 11122344699999998888999999999999999999987765432111000 000000000000
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
......+......+.+++.+||+.+|++|||+.||+..|+.+
T Consensus 242 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 -----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111222344688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.16 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=198.4
Q ss_pred CcccCcceEEEEEEEC--------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR--------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|... .+..||+|.++... ......+.+|+.+++++ +||||+++++++...+..++++|
T Consensus 19 ~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 98 (334)
T cd05100 19 PLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVE 98 (334)
T ss_pred eeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEe
Confidence 3899999999999642 12368999887543 33457889999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++++|.+++..... ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|
T Consensus 99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL 175 (334)
T cd05100 99 YASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKI 175 (334)
T ss_pred cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEE
Confidence 9999999999965321 2235788899999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.. ...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------~~~ 249 (334)
T cd05100 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF------KLL 249 (334)
T ss_pred CCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH------HHH
Confidence 999998765432211 1112234567999999999899999999999999999998 78888654221111 111
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
. .. .....+......+.+++.+||+.+|.+||++.|++..|.+.....
T Consensus 250 ~-~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 250 K-EG--------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H-cC--------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 11 111122233446889999999999999999999999998887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.30 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=195.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+++++|.+
T Consensus 16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06645 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95 (267)
T ss_pred HhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHH
Confidence 3899999999999765 689999999876655555678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... .+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........ ......
T Consensus 96 ~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 167 (267)
T cd06645 96 IYHVTG----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRKSFI 167 (267)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cccccc
Confidence 986543 6899999999999999999999998 99999999999999999999999999875533221 122346
Q ss_pred cCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 160 GTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 160 ~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
|+..|+|||++. ...++.++|||||||++|+|++|..||.......... ...... . ..+.... ...
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~~~~-~---~~~~~~~-~~~ 236 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKSN-F---QPPKLKD-KMK 236 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhhccC-C---CCCcccc-cCC
Confidence 889999999875 4568899999999999999999999986543221111 001100 0 0011111 111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 2345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=282.39 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
+||+|.|+.|+++.+. +|+.+|+|+++.. ...+.+.+.+|+++.+.++||||+++.+.+.+....++|+|++.|++|
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl 97 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 97 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHH
Confidence 4899999999999655 7999999998654 344668899999999999999999999999999999999999999998
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC---CCCeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD---GNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
-.-+-.+ .-+++..+-..++||++||.|+|.++ |+|||+||+|+++. ...-+||+|||++...+ ....
T Consensus 98 ~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~ 168 (355)
T KOG0033|consen 98 FEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEA 168 (355)
T ss_pred HHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--Cccc
Confidence 7666433 26788889999999999999999999 99999999999995 33459999999999876 3344
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....|||.|||||++...+++..+|||+.|++||-||.|..||.+......+..+. .+.. ..-.+....
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-------~g~y-d~~~~~w~~-- 238 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-------AGAY-DYPSPEWDT-- 238 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-------cccc-CCCCcccCc--
Confidence 556789999999999999999999999999999999999999998743332221111 1100 000112222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+++++||..||++|.|+.|.|.
T Consensus 239 --is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 239 --VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2334778888999999999999999865
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=296.17 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=194.4
Q ss_pred CcccCcceEEEEEEEC-CCC--EEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT--QIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.+. ++. .+++|.++.. .......+.+|+.++.++ +|+||+++++++.+.+..++++||++++
T Consensus 14 ~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 93 (303)
T cd05088 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 93 (303)
T ss_pred eecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCC
Confidence 4899999999999765 454 4577776543 233446788999999999 8999999999999999999999999999
Q ss_pred CHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 76 SLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 76 ~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+|.+++..... ....+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 94 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~ 170 (303)
T cd05088 94 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 170 (303)
T ss_pred cHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcccc
Confidence 99999965421 1235789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
+........ ......+..|+|||.+....++.++|||||||++|+|++ |..||......+. . ... ..+
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~---~~~-~~~-- 239 (303)
T cd05088 171 SRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y---EKL-PQG-- 239 (303)
T ss_pred Ccccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H---HHH-hcC--
Confidence 863221111 111223567999999988889999999999999999998 9999865432211 1 111 111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
... ..+......+.+++.+||+.+|++||++.+++..|+....
T Consensus 240 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 240 ---YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 1111223457889999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.30 Aligned_cols=245 Identities=24% Similarity=0.278 Sum_probs=193.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||+||+|... +++.||+|.+.... ......+.+|+++++.++|+||+.+.+++..++..+++|||+.+++
T Consensus 7 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05632 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCcc
Confidence 4899999999999765 68999999986542 2233567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+.+..... ..+++..+..++.|++.||.|||+.+ ++|+||||.||+++.++.++|+|||++........ ..
T Consensus 87 L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05632 87 LKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IR 159 (285)
T ss_pred HHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--cc
Confidence 9988864332 26899999999999999999999998 99999999999999999999999999875432211 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||............ ....... ....+..
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~ 227 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLET---------EEVYSAK 227 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhcc---------ccccCcc
Confidence 346899999999999889999999999999999999999999754322111111 1100100 0111222
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
....+.+++..||+.||.+||+ +.+++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2344778888999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.35 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=195.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+
T Consensus 15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (268)
T cd06624 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA 94 (268)
T ss_pred EEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHH
Confidence 4899999999999765 688899999887766667889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCCCcceeec
Q 020720 80 ALLGSKSKYVSL--DWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 80 ~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
++..... .+ ++..+..++.||+.||+|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 95 ~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 167 (268)
T cd06624 95 LLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTE 167 (268)
T ss_pred HHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccc
Confidence 9975422 34 78888999999999999999998 999999999999976 67899999999875432211 122
Q ss_pred ccccCCCCCchHHHhhCC--CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 157 RVAGTMGYLAPEYALLGQ--LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~--~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
...++..|+|||++.... ++.++||||||+++|+|++|..||.......... +... ........+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~~--------~~~~~~~~~ 234 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKVG--------MFKIHPEIP 234 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhhh--------hhccCCCCC
Confidence 234788999999987643 7899999999999999999999987543211110 0000 001111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....++.+++.+||+.+|++||++.|++..
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 3344568889999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.18 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=197.9
Q ss_pred CcccCcceEEEEEEECC-----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLRD-----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|.+.. +..|++|.+... .......+.+|+.+++.++|+||+++++++.. ....+++++|+.
T Consensus 13 ~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~ 92 (280)
T cd05043 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMN 92 (280)
T ss_pred eecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCC
Confidence 48999999999997764 678999988754 33445778899999999999999999998776 467899999999
Q ss_pred CCCHHHHHhcCCCC----CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSK----YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|.||++++++.+||+|||+++.+..
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~ 169 (280)
T cd05043 93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFP 169 (280)
T ss_pred CCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccC
Confidence 99999998654321 146899999999999999999999998 99999999999999999999999999975532
Q ss_pred Ccce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 150 NVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 150 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
.... ......++..|+|||++.+..++.++|||||||++|++++ |..||..... .... ........
T Consensus 170 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~---~~~~~~~~------ 237 (280)
T cd05043 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMA---AYLKDGYR------ 237 (280)
T ss_pred CceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHH---HHHHcCCC------
Confidence 2211 1122335678999999998889999999999999999999 9999865422 1111 11111110
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
. .........+.+++.+||+.||++||++.++++.|+...
T Consensus 238 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 238 L---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 111122345889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=294.46 Aligned_cols=250 Identities=29% Similarity=0.443 Sum_probs=197.7
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+..+++|||+
T Consensus 42 ~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 121 (302)
T cd05055 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC 121 (302)
T ss_pred eeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcC
Confidence 4899999999999642 34579999987543 33346789999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 122 ~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 196 (302)
T cd05055 122 CYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196 (302)
T ss_pred CCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCc
Confidence 99999999965432 24899999999999999999999998 99999999999999999999999999886543322
Q ss_pred e-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 H-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 ~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. ......+. ..
T Consensus 197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~~-----~~-- 263 (302)
T cd05055 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEGY-----RM-- 263 (302)
T ss_pred eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcCC-----cC--
Confidence 1 1122335678999999998899999999999999999998 99998754332111 01111110 01
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
..+.....++.+++.+||+.+|++||++.|+++.|++.
T Consensus 264 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 -AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11112234688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=295.99 Aligned_cols=248 Identities=23% Similarity=0.235 Sum_probs=189.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++..+ +++.+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++||||+++|+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~ 87 (332)
T cd05623 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGD 87 (332)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCc
Confidence 4899999999999876 5788999998642 22233457889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++............
T Consensus 88 L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~ 161 (332)
T cd05623 88 LLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161 (332)
T ss_pred HHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence 9999975322 6889999999999999999999999 999999999999999999999999998754333222223
Q ss_pred ccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 RVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
...||+.|+|||++. ...++.++|||||||++|||++|..||........ ...+...... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~-----~~~p 230 (332)
T cd05623 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKER-----FQFP 230 (332)
T ss_pred ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcc-----ccCC
Confidence 356899999999986 34678999999999999999999999975432111 1111111100 0111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~ 265 (322)
.........+.+++.+|+..++++ |+++.|+++.
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111222344677777777654444 7899998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.12 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=209.2
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcH-HHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|-||.|..+....+..||+|.++.+...+. ++|.+|+++|.+++||||++++++|..++.+++|+||+++|+|..+
T Consensus 546 iGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqF 625 (807)
T KOG1094|consen 546 IGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQF 625 (807)
T ss_pred hcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHH
Confidence 899999999999888789999999998765555 8999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC-cceeecccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VTHVSTRVA 159 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~ 159 (322)
+..+... .+.-.....|+.||+.|++||.+.+ ++||||.+.|+|++.++++||+|||+++..-.. ......+.+
T Consensus 626 l~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~v 700 (807)
T KOG1094|consen 626 LSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAV 700 (807)
T ss_pred HHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeeccee
Confidence 9876433 2344456679999999999999999 999999999999999999999999999954333 333334456
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHH--hCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEII--SGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
-+.+|||+|.+..++++.++|||+||+++||++ +...||....+++. ++....+...... ......|..+
T Consensus 701 lpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~-----~~~l~~P~~c 772 (807)
T KOG1094|consen 701 LPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGR-----QVVLSRPPAC 772 (807)
T ss_pred eeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCc-----ceeccCCCcC
Confidence 678999999999999999999999999999985 57889887654432 2212222111111 1123445566
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+..+++++..||..|..+||+++++...|+...
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 677899999999999999999999999887653
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=289.91 Aligned_cols=242 Identities=27% Similarity=0.453 Sum_probs=194.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh---------cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ---------GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
+||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+....++++|
T Consensus 7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (267)
T cd06628 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE 86 (267)
T ss_pred eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence 4899999999999765 5889999988654221 12567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 87 YVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred ecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 999999999996543 6888999999999999999999998 999999999999999999999999998765422
Q ss_pred cce-----eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 151 VTH-----VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 151 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||........ . ..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~------~ 227 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I---FKIGE------N 227 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H---HHHhc------c
Confidence 111 11123478899999999988899999999999999999999999975422111 1 11100 1
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+ ..+......+.+++.+||+.||.+||++.++++
T Consensus 228 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111 222334456888899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.91 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=193.0
Q ss_pred CcccCcceEEEEEEEC-CCC----EEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT----QIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|.+. ++. .+++|.+..... .....+..|+..+..++||||+++++++.. ...++++||+++
T Consensus 14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~ 92 (279)
T cd05111 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPL 92 (279)
T ss_pred ccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCC
Confidence 4899999999999764 444 477888754322 233567788889999999999999998754 457789999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-e
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-H 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 153 (322)
|+|.+++..... .+++..++.|+.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 93 gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 93 GSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 999999975432 6899999999999999999999998 99999999999999999999999999986533221 1
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......++..|+|||.+.+..++.++|||||||++|||++ |..||........ . .....+.. +....
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~----~~~~~~~~-----~~~~~ 234 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---P----DLLEKGER-----LAQPQ 234 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHCCCc-----CCCCC
Confidence 1223446778999999998899999999999999999998 9999875432111 1 11111111 01111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.....+..++.+||..||++||++.|+++.|.....
T Consensus 235 ---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 ---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 123456778889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=295.45 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=196.5
Q ss_pred CcccCcceEEEEEEEC-CCC--EEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT--QIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++++||++++
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (297)
T cd05089 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG 88 (297)
T ss_pred eecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCC
Confidence 5899999999999765 343 4788887643 334456789999999999 7999999999999999999999999999
Q ss_pred CHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 76 SLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 76 ~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 165 (297)
T cd05089 89 NLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGL 165 (297)
T ss_pred cHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCC
Confidence 99999965321 1125888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
+........ ......+..|+|||++....++.++|||||||++|+|++ |..||......+.. ... ..+
T Consensus 166 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------~~~-~~~-- 234 (297)
T cd05089 166 SRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------EKL-PQG-- 234 (297)
T ss_pred Cccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHH-hcC--
Confidence 864321111 111123457999999988889999999999999999997 99998754322111 111 111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
... ..+......+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 235 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 ---YRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 112223345888999999999999999999999998777544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=292.20 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=195.6
Q ss_pred CcccCcceEEEEEEEC-----------------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC
Q 020720 1 MIGGGAFGVVYRGSLR-----------------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 62 (322)
.||+|+||.||++.+. ++..+|+|.++.. .......+.+|+.+++.++|+||+++++++...
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~ 91 (296)
T cd05095 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS 91 (296)
T ss_pred eccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3899999999998532 2346899998754 333457889999999999999999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhcCCCC-------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe
Q 020720 63 NNRILVYEYLENNSLANALLGSKSK-------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH 135 (322)
Q Consensus 63 ~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~ 135 (322)
+..+++|||+.+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~ 168 (296)
T cd05095 92 DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYT 168 (296)
T ss_pred CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCC
Confidence 9999999999999999999754321 124778899999999999999999998 999999999999999999
Q ss_pred EEEeeeccccccCCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh--CCCCCCcccCCCchhHHHH
Q 020720 136 PKIGDFGLAKLFPDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS--GRSSSKAAFGDDMLILVEW 212 (322)
Q Consensus 136 ~kl~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~--g~~p~~~~~~~~~~~~~~~ 212 (322)
++|+|||++.......... .....++..|++||....+.++.++|||||||++|||++ |..||......... ..
T Consensus 169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~---~~ 245 (296)
T cd05095 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI---EN 245 (296)
T ss_pred EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH---HH
Confidence 9999999987553322111 122234678999999888899999999999999999998 67888654332211 11
Q ss_pred HHHH-HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 213 TWKL-REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 213 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.... ...... .. ...+......+.+++.+||+.||.+||++.+|++.|++
T Consensus 246 ~~~~~~~~~~~--~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 246 TGEFFRDQGRQ--VY----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHhhcccc--cc----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111 111000 00 01112233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=293.46 Aligned_cols=239 Identities=25% Similarity=0.400 Sum_probs=188.8
Q ss_pred CcccCcceEEEEEEECC--------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRD--------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 48999999999996542 2348888876555555678899999999999999999999999989999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe--------EEEeeeccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH--------PKIGDFGLA 144 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~--------~kl~Dfg~~ 144 (322)
++|+|.+++..+.. .+++..++.++.||+.||+|||+.+ ++|+||||.||+++.++. ++++|||.+
T Consensus 82 ~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 82 KFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999976542 5888999999999999999999999 999999999999987765 699999987
Q ss_pred cccCCCcceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCC-CCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 145 KLFPDNVTHVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGR-SSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 145 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
...... ....++..|+|||++.+. .++.++||||||+++|+|++|. .|+......... ......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~~~-- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYEDR-- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHHcc--
Confidence 654321 223577899999999864 5789999999999999999985 555432211100 000000
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
. ..+.....++.+++.+||+.||++||+++++++.|+
T Consensus 222 -----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----H---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----c---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 112222345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.21 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=197.1
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...+++|||++++
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 91 (270)
T cd05056 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLG 91 (270)
T ss_pred eeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCC
Confidence 48999999999997542 3468999887654 4455789999999999999999999998875 4578999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 92 ~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 165 (270)
T cd05056 92 ELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA 165 (270)
T ss_pred cHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccceec
Confidence 99999965432 5899999999999999999999998 99999999999999999999999999876543322222
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....++..|+|||.+....++.++||||||+++|+|++ |..||......+... ....... . ..+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~~~~~~------~---~~~ 230 (270)
T cd05056 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG------RIENGER------L---PMP 230 (270)
T ss_pred CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHcCCc------C---CCC
Confidence 22234568999999988889999999999999999986 999997554322111 1111110 0 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
......+.+++.+||..+|++||++.+++..|+....
T Consensus 231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2334568889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=288.33 Aligned_cols=242 Identities=35% Similarity=0.521 Sum_probs=197.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....+++|||+++++|.++
T Consensus 13 ~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 90 (256)
T cd05039 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90 (256)
T ss_pred eeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHH
Confidence 4899999999999876 78999999976544 567899999999999999999999999988999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+........ ....
T Consensus 91 ~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~ 161 (256)
T cd05039 91 LRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKL 161 (256)
T ss_pred HHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc----cCCC
Confidence 965432 26899999999999999999999999 99999999999999999999999999886532211 2234
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+....++.++||||||+++|+|++ |..||......+. . .....+. .. ..+.....
T Consensus 162 ~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~-----~~---~~~~~~~~ 226 (256)
T cd05039 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PHVEKGY-----RM---EAPEGCPP 226 (256)
T ss_pred cccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHhcCC-----CC---CCccCCCH
Confidence 567999999988889999999999999999997 9999865422111 1 1111110 01 11122335
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|++||++.+++..|+.
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 58889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.45 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=192.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..+++|||+++ +|.
T Consensus 13 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 91 (309)
T cd07872 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLK 91 (309)
T ss_pred EecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHH
Confidence 3899999999999776 688899999875432 2335678899999999999999999999999999999999975 788
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .....
T Consensus 92 ~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 164 (309)
T cd07872 92 QYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNE 164 (309)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccccc
Confidence 88765432 5788999999999999999999998 99999999999999999999999999875432221 11234
Q ss_pred ccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC---------ccccccCc
Q 020720 159 AGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG---------RLLEIVDP 228 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 228 (322)
.+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+............... .....-.+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence 57889999998875 468899999999999999999999997654433222221110000000 00000000
Q ss_pred cC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 EL-----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ..........+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 0011122345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.84 Aligned_cols=248 Identities=28% Similarity=0.504 Sum_probs=195.3
Q ss_pred CcccCcceEEEEEEEC-CC---CEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DG---TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... ++ ..||+|.+... .......+..|+.+++.++||||+++++++.++...+++|||++++
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T cd05065 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENG 90 (269)
T ss_pred EecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCC
Confidence 4899999999999765 33 36999998755 3444578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV- 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 154 (322)
+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 91 ~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (269)
T cd05065 91 ALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164 (269)
T ss_pred cHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccc
Confidence 99999965432 5889999999999999999999998 9999999999999999999999999987553322111
Q ss_pred -ecccc--cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 155 -STRVA--GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 155 -~~~~~--~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
..... .+..|+|||.+.+..++.++|||||||++||+++ |..||....... ...+ ......
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~---i~~~~~--------- 229 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINA---IEQDYR--------- 229 (269)
T ss_pred cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHH---HHcCCc---------
Confidence 11111 2347999999998899999999999999999886 999987543221 1111 111000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
...+...+..+.+++.+||+.+|++||++.+|+..|++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122334578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=296.23 Aligned_cols=196 Identities=26% Similarity=0.435 Sum_probs=159.7
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||+. +
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 3899999999999754 46789999986442 23567889999999999999999999854 346789999986 4
Q ss_pred CHHHHHhcCC-----CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe----CCCCeEEEeeeccccc
Q 020720 76 SLANALLGSK-----SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKL 146 (322)
Q Consensus 76 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill----~~~~~~kl~Dfg~~~~ 146 (322)
+|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7888775321 12235889999999999999999999999 9999999999999 4567899999999986
Q ss_pred cCCCcce--eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCccc
Q 020720 147 FPDNVTH--VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAF 202 (322)
Q Consensus 147 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~ 202 (322)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 5433221 12345689999999998764 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=287.97 Aligned_cols=242 Identities=25% Similarity=0.394 Sum_probs=206.1
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|.++ +|..+|||.+..+ .+.+++..|+.++++++.|++|++|+.+.....+|+|||||..|+..++
T Consensus 41 LGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI 118 (502)
T KOG0574|consen 41 LGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDI 118 (502)
T ss_pred hcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHH
Confidence 799999999999776 6999999988654 4568999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
++.+.. ++.+.++..+++..+.||+|||... -+|||||+.|||+..+|..||+|||.+....+.... ...++|
T Consensus 119 ~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNTVIG 191 (502)
T KOG0574|consen 119 MRARRK---PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNTVIG 191 (502)
T ss_pred HHHhcC---CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCcccc
Confidence 976643 8999999999999999999999988 899999999999999999999999998765443222 235779
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
|+.|||||++..-.|+.++||||||++..||..|++||....+-...+.+ +. -.|....-+.....+
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT------~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PT------KPPPTFKKPEEWSSE 258 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cC------CCCCCCCChHhhhhH
Confidence 99999999999999999999999999999999999999866443222211 00 001112335566778
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
|-+++++||-+.|++|.|+.++++.
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 9999999999999999999998764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.85 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=198.9
Q ss_pred CcccCcceEEEEEEEC--------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR--------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++......+++||
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 101 (304)
T cd05101 22 PLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 101 (304)
T ss_pred eeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEe
Confidence 3899999999999641 24579999986542 34457789999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl 178 (304)
T cd05101 102 YASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKI 178 (304)
T ss_pred cCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEE
Confidence 9999999999975421 1235788889999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||.+.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+ .....
T Consensus 179 ~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~ 252 (304)
T cd05101 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLL 252 (304)
T ss_pred CCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHH
Confidence 9999988654322211 122335678999999988889999999999999999998 777775432111 11111
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
. .+.. ...+......+.+++.+||+.+|++||++.|+++.|.++...
T Consensus 253 ~-~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 253 K-EGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-cCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 1110 111223345688899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=287.15 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=190.9
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... ++..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 4899999999999764 34679999987653 2334578899999999999999999999999889999999999999
Q ss_pred HHHHHhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-e
Q 020720 77 LANALLGSKS-KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-V 154 (322)
Q Consensus 77 L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 154 (322)
|.+++..... .....++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||.+......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999965432 1224567778889999999999999998 999999999999999999999999998754332211 1
Q ss_pred ecccccCCCCCchHHHhhC-------CCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 155 STRVAGTMGYLAPEYALLG-------QLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~-------~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
.....++..|+|||++... .++.++||||||+++|+|++ |..||......+.... ..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-------TVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-------HhhcccCCCC
Confidence 1234567889999998642 35789999999999999996 9999975433221110 0111111112
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+.+... ....+.+++..|| .+|++||+++||+..|+
T Consensus 232 ~~~~~~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 2234667778898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=296.80 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=191.0
Q ss_pred CcccC--cceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGG--AFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+| +|++||++..+ +|+.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 84 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCC
Confidence 58999 78899999765 79999999997552 233466788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce--
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+++.||+...........
T Consensus 85 ~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 85 SAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred cHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999965422 25889999999999999999999999 999999999999999999999999865432211110
Q ss_pred ----eecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc-
Q 020720 154 ----VSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV- 226 (322)
Q Consensus 154 ----~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 226 (322)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .... .+.....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHh-----cCCcccccc
Confidence 0112346678999999876 46889999999999999999999999754322111 0000 00000000
Q ss_pred ------------------Cc------------------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 227 ------------------DP------------------ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 227 ------------------~~------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+. ............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000111223446889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=290.16 Aligned_cols=244 Identities=27% Similarity=0.442 Sum_probs=194.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++++||+++++|.++
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~ 92 (282)
T cd06643 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 92 (282)
T ss_pred cccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHH
Confidence 899999999999776 5788899998766666667889999999999999999999999999999999999999999988
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+.... .++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 93 ~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 165 (282)
T cd06643 93 MLELE---RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIG 165 (282)
T ss_pred HHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-ccccccc
Confidence 76432 26899999999999999999999998 99999999999999999999999999875432221 1223458
Q ss_pred CCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 161 TMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 161 t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
+..|+|||++. +..++.++|||||||++|+|++|..||......... ..... .. .+.. ..+.
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~-~~-----~~~~-~~~~ 232 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIAK-SE-----PPTL-AQPS 232 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHHhh-cC-----CCCC-CCcc
Confidence 89999999884 345788999999999999999999998754321111 01100 00 0111 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.+++.+||+.||.+||++.++++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234568899999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.09 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=190.3
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEE-eCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV-EDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. .+..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++++||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999653 2457999988543 3444578889999999999999999999875 45567899999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
++|.+++..... ...+..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 82 GDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999965432 4677788899999999999999998 99999999999999999999999999875432211
Q ss_pred -eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCC-CCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 -HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR-SSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 -~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......++..|+|||.+....++.++|||||||++|||++|. .||..... ..... . ...+. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~---~-~~~~~--------~ 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITV---Y-LLQGR--------R 220 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---H-HhcCC--------C
Confidence 1111233567899999998889999999999999999999964 45543211 11111 1 11110 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+...+..+.+++.+||+.+|++||++.+|+..|++..
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111112345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=310.93 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=186.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~ 71 (322)
+||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ..+++||||
T Consensus 73 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~ 148 (440)
T PTZ00036 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148 (440)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEec
Confidence 4899999999999775 68999999885432 2345799999999999999999886432 246789999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCC
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDN 150 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 150 (322)
+++ +|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++......
T Consensus 149 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 149 IPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred CCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 975 777777543333347899999999999999999999999 99999999999999665 6999999999865432
Q ss_pred cceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH------HHh-cCcc
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK------LRE-EGRL 222 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~~-~~~~ 222 (322)
.. .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..+..... ... ....
T Consensus 225 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 302 (440)
T PTZ00036 225 QR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY 302 (440)
T ss_pred CC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence 21 1234678999999998764 689999999999999999999999976543222211110000 000 0000
Q ss_pred ccccCcc-----C-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 223 LEIVDPE-----L-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 223 ~~~~~~~-----~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....-+. + ..++.....++.+++.+||+.||.+|||+.|++..
T Consensus 303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000 0 01122234568899999999999999999999853
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=290.20 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCC----EEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT----QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|.+. +|. .||+|.++.. .......+.+|+.++..++|+||+++++++... ..+++++|+++
T Consensus 14 ~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~ 92 (279)
T cd05109 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPY 92 (279)
T ss_pred ecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCC
Confidence 4899999999999754 444 4899998754 334456788999999999999999999998754 56789999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 93 g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~ 166 (279)
T cd05109 93 GCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166 (279)
T ss_pred CCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccccccee
Confidence 999999965432 6899999999999999999999998 9999999999999999999999999998664322211
Q ss_pred -ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 -STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....++..|+|||...+..++.++|||||||++|||++ |..||....... ... ....+.. ..
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~--------~~ 231 (279)
T cd05109 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD----LLEKGER--------LP 231 (279)
T ss_pred ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCc--------CC
Confidence 112234678999999988899999999999999999998 888886432211 111 1111100 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||+.||++||++.++++.|+....
T Consensus 232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 122234468889999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.05 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=193.9
Q ss_pred CcccCcceEEEEEEECC---------------CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe
Q 020720 1 MIGGGAFGVVYRGSLRD---------------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN 64 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 64 (322)
.||+|+||.||++.... ...||+|.++.. .......+.+|++++++++|+|++++++++...+.
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 91 (295)
T cd05097 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP 91 (295)
T ss_pred ccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence 48999999999986532 235899998755 23344678999999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhcCCC--------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeE
Q 020720 65 RILVYEYLENNSLANALLGSKS--------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP 136 (322)
Q Consensus 65 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~ 136 (322)
.+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~ 168 (295)
T cd05097 92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTI 168 (295)
T ss_pred cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcE
Confidence 9999999999999999854321 1124688899999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh--CCCCCCcccCCCchhHHHHH
Q 020720 137 KIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS--GRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 137 kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~--g~~p~~~~~~~~~~~~~~~~ 213 (322)
||+|||++......... ......++..|+|||++....++.++|||||||++|+|++ |..||......... ...
T Consensus 169 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~---~~~ 245 (295)
T cd05097 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI---ENT 245 (295)
T ss_pred EecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH---HHH
Confidence 99999998754322211 1122335678999999998889999999999999999998 55677654322211 111
Q ss_pred HHH-HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 214 WKL-REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 214 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+. ...... .....+...+..+.+++.+||+.||++||++++|++.|+
T Consensus 246 ~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 246 GEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 111100 001111122346899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=292.06 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=197.4
Q ss_pred CcccCcceEEEEEEECC-----------------CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC
Q 020720 1 MIGGGAFGVVYRGSLRD-----------------GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 62 (322)
.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||+++++++..+
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (296)
T cd05051 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD 91 (296)
T ss_pred cccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 48999999999986542 2458999987553 34457888999999999999999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhcCCC-------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe
Q 020720 63 NNRILVYEYLENNSLANALLGSKS-------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH 135 (322)
Q Consensus 63 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~ 135 (322)
+..++++||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~ 168 (296)
T cd05051 92 PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYT 168 (296)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCc
Confidence 999999999999999999965431 1125889999999999999999999998 999999999999999999
Q ss_pred EEEeeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh--CCCCCCcccCCCchhHHHH
Q 020720 136 PKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS--GRSSSKAAFGDDMLILVEW 212 (322)
Q Consensus 136 ~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~--g~~p~~~~~~~~~~~~~~~ 212 (322)
++|+|||++........ .......++..|+|||.+....++.++|||||||++|+|++ +..||....... ....
T Consensus 169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~ 245 (296)
T cd05051 169 IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VIEN 245 (296)
T ss_pred eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HHHH
Confidence 99999999875433221 11223345778999999988889999999999999999998 667776443211 1111
Q ss_pred HHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 213 TWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.......... ......+...+.++.+++.+||+.||.+||++.||++.|++
T Consensus 246 ~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 246 AGHFFRDDGR-----QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHhccccccc-----cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111000000 00011122233568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=285.99 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=199.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||+.+++|.+
T Consensus 10 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~ 89 (262)
T cd06613 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD 89 (262)
T ss_pred EecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 3799999999999775 578899999987766667889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 90 ~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 162 (262)
T cd06613 90 IYQVTR---GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFI 162 (262)
T ss_pred HHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccccc
Confidence 986542 26899999999999999999999998 99999999999999999999999999876543221 122345
Q ss_pred cCCCCCchHHHhhC---CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 160 GTMGYLAPEYALLG---QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 160 ~t~~y~aPE~~~~~---~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
++..|+|||.+... .++.++||||||+++|+|++|..||.......... ...... +.+........
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~~~~~-----~~~~~~~~~~~ 231 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSN-----FPPPKLKDKEK 231 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcc-----CCCccccchhh
Confidence 78899999998876 78999999999999999999999997543221111 011110 01111122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.+|.+||++.+|+.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 4567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.58 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=197.1
Q ss_pred cccCcceEEEEEEEC--------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEc
Q 020720 2 IGGGAFGVVYRGSLR--------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 2 lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...+..+++|||
T Consensus 26 lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (307)
T cd05098 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 105 (307)
T ss_pred eccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEec
Confidence 899999999999653 23469999987543 33456788899999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe
Q 020720 72 LENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG 139 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~ 139 (322)
+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 106 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~ 182 (307)
T cd05098 106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIA 182 (307)
T ss_pred CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEEC
Confidence 999999999975432 1125888999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHH
Q 020720 140 DFGLAKLFPDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLR 217 (322)
Q Consensus 140 Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 217 (322)
|||.+.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+ .. ...
T Consensus 183 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---~~---~~~- 255 (307)
T cd05098 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LF---KLL- 255 (307)
T ss_pred CCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH---HHH-
Confidence 999987553221111 111224568999999998889999999999999999998 888886432111 11 111
Q ss_pred hcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 218 EEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.... ....+......+.+++.+||+.+|++||++.+|++.|..+..
T Consensus 256 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 256 KEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HcCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111 112222334568889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.34 Aligned_cols=250 Identities=31% Similarity=0.513 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEECC-------CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRD-------GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999997642 2578999886543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-----eEEEeeeccc
Q 020720 73 ENNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-----HPKIGDFGLA 144 (322)
Q Consensus 73 ~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-----~~kl~Dfg~~ 144 (322)
++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999965321 1235788999999999999999999998 99999999999999887 8999999998
Q ss_pred cccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 145 KLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 145 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+ .. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~---~~~~~~~-- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VL---QHVTAGG-- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HH---HHHhcCC--
Confidence 75432211 11112235678999999999999999999999999999998 999986432211 11 1111111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
....+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111222334568899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=284.96 Aligned_cols=242 Identities=26% Similarity=0.431 Sum_probs=197.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... ++..+++|.+..... .+.+.+|++++++++|+||+++++++.+....++++||+.+++|.+
T Consensus 10 ~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 87 (256)
T cd06612 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD 87 (256)
T ss_pred hhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHH
Confidence 3899999999999876 488999999875433 6789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........ ......
T Consensus 88 ~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 160 (256)
T cd06612 88 IMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVI 160 (256)
T ss_pred HHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccccc
Confidence 996543 26899999999999999999999998 99999999999999999999999999886543321 122344
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||++.+..++.++||||||+++|+|++|..||........... . .. ........+.....
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~-~~------~~~~~~~~~~~~~~ 227 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------I-PN------KPPPTLSDPEKWSP 227 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------h-cc------CCCCCCCchhhcCH
Confidence 78899999999988999999999999999999999999875432211100 0 00 00111112223345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+++.+||+.||++||++.|++.
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhc
Confidence 6888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=292.96 Aligned_cols=243 Identities=21% Similarity=0.377 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++++||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 3899999999999765 689999999876555556778899999999999999999999999999999999999999998
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++......... .....
T Consensus 108 ~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 178 (297)
T cd06659 108 IVSQT-----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLV 178 (297)
T ss_pred HHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-cccee
Confidence 87432 5889999999999999999999998 999999999999999999999999998754332211 12345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||++.+..++.++|||||||++|+|++|..||......... ..... .. ............
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-~~------~~~~~~~~~~~~ 245 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRD-SP------PPKLKNAHKISP 245 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-cC------CCCccccCCCCH
Confidence 889999999999888999999999999999999999999754322111 11111 00 000111112234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.+++.+||+.+|.+||++.++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 57888999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=291.98 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+..++.++||||+++++++.+....+++|||++
T Consensus 13 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 92 (288)
T cd05061 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMA 92 (288)
T ss_pred eecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCC
Confidence 4899999999999543 24579999886543 2334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 74 NNSLANALLGSKS------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
+|+|.+++..... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~ 169 (288)
T cd05061 93 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDI 169 (288)
T ss_pred CCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccc
Confidence 9999999965321 1224566788899999999999999998 999999999999999999999999998754
Q ss_pred CCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. .. ... .
T Consensus 170 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~-~------ 236 (288)
T cd05061 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LK---FVM-D------ 236 (288)
T ss_pred cccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHH-c------
Confidence 32211 11122235678999999998899999999999999999998 7888865432211 11 111 1
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
......+......+.+++.+||+.||++||++.++++.|.+...
T Consensus 237 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 237 --GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11111122223568999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=294.40 Aligned_cols=253 Identities=27% Similarity=0.434 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC--------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR--------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|... ....+|+|.++... ......+.+|+.+++++ +||||+++++++.+.+..+++||
T Consensus 19 ~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 98 (314)
T cd05099 19 PLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVE 98 (314)
T ss_pred eecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEe
Confidence 4899999999999642 24578999987542 33456788999999999 69999999999999899999999
Q ss_pred cCCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 99 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL 175 (314)
T cd05099 99 YAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKI 175 (314)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEE
Confidence 9999999999965421 1235888999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccee-ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVTHV-STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-------~~ 248 (314)
T cd05099 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF-------KL 248 (314)
T ss_pred ccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-------HH
Confidence 9999998654321111 111224467999999998899999999999999999999 88888654221111 11
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+. ....+......+.+++.+||+.||++||++.++++.|.+...
T Consensus 249 ~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 LREGH--------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHcCC--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111 111222334468889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=287.36 Aligned_cols=237 Identities=24% Similarity=0.425 Sum_probs=188.7
Q ss_pred CcccCcceEEEEEEECC-C----------CEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLRD-G----------TQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 69 (322)
.||+|+||.||+|.... + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 48999999999997763 3 25788887654433 6788999999999999999999999988 7789999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-------eEEEeeec
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-------HPKIGDFG 142 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-------~~kl~Dfg 142 (322)
||+++++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||.||+++.++ .++|+|||
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999975542 6888999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCcceeecccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhc
Q 020720 143 LAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREE 219 (322)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (322)
++..... .....++..|+|||++... .++.++||||||+++|+|++ |..||............ . .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~------~-~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY------Q-D 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH------h-c
Confidence 9886433 1223466789999998876 78899999999999999999 56777654322111100 0 0
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 220 GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
. .... .+ ....+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~-------~~~~-~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 Q-------HRLP-MP--DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CCCC-CC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0010 01 1156889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=293.19 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=194.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||++.+. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..+++|||+++++|.
T Consensus 8 ~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~ 87 (308)
T cd06615 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 87 (308)
T ss_pred eccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHH
Confidence 3899999999999766 68889999987553 333467889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .+++..+..++.|++.||.|||+ .+ ++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 88 ~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 88 QVLKKAG----RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 9996543 68899999999999999999997 47 9999999999999999999999999887543221 123
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH-HHhcCc---------------
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-LREEGR--------------- 221 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~--------------- 221 (322)
..++..|+|||.+.+..++.++||||||+++|+|++|..||................. ......
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 4678999999999888899999999999999999999999864432111100000000 000000
Q ss_pred -----cccccCccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 -----LLEIVDPELTQFPE-KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 -----~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
............+. .....+.+++.+||+.||++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000110 123458899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=288.05 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=195.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccC------hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAES------KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..++++||+++
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (265)
T cd06631 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86 (265)
T ss_pred eEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence 489999999999987788999999986442 12235688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC----
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN---- 150 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 150 (322)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 87 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 87 GSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999996543 5889999999999999999999998 999999999999999999999999988754211
Q ss_pred -cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 151 -VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 151 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.........++..|+|||++.+..++.++||||||+++|+|++|..||.......... ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~~~-------~~ 226 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------YIGAHR-------GL 226 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH------Hhhhcc-------CC
Confidence 1111123457889999999998889999999999999999999999997542211110 000000 00
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+......+.+++.+||+.+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222334455788999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=292.18 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=187.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcC---CCCcccccceEEEeC-----CeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNI---RHPNLVQLIGCCVED-----NNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-----~~~~lv~ 69 (322)
.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++... ...++++
T Consensus 7 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 86 (288)
T cd07863 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVF 86 (288)
T ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEE
Confidence 3899999999999776 689999999875422 1223455677666655 799999999988642 3578999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 87 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 87 EHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred ccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 99975 88888865432 25899999999999999999999999 99999999999999999999999999886543
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc------
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL------ 223 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 223 (322)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||......+....+.............
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 161 QMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred ccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 221 123457889999999998899999999999999999999999987543322221111000000000000
Q ss_pred -cccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 -EIVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 -~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+.+.. ....+.....+.+++.+||+.||.+||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000100 1111223445789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=285.95 Aligned_cols=241 Identities=32% Similarity=0.467 Sum_probs=192.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEE-eCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV-EDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||++... |..+++|.++... ..+.+.+|+.++++++|+|++++++++. +++..++++||+++++|.+
T Consensus 13 ~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (256)
T cd05082 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89 (256)
T ss_pred eecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHH
Confidence 4899999999999776 7889999986443 3467889999999999999999999764 4567899999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++....... ....
T Consensus 90 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~ 160 (256)
T cd05082 90 YLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGK 160 (256)
T ss_pred HHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----CCCc
Confidence 9975432 25889999999999999999999998 9999999999999999999999999987543221 1223
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
++..|+|||++.+..++.++|||||||++|+|++ |..||....... .. .... .+ ..+ ..+....
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~---~~~~-~~-----~~~---~~~~~~~ 225 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PRVE-KG-----YKM---DAPDGCP 225 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHh-cC-----CCC---CCCCCCC
Confidence 4568999999988889999999999999999997 888886432111 11 1111 11 011 1122234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
..+.+++.+||+.+|++||++.++++.|+.
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 458889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.56 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=196.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++
T Consensus 9 ~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGS 88 (932)
T PRK13184 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88 (932)
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCC
Confidence 4899999999999776 68999999997542 2334678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCC-------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 77 LANALLGSKS-------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 77 L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
|.+++..... .....++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 89 L~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~ 165 (932)
T PRK13184 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165 (932)
T ss_pred HHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence 9999864211 1124566778899999999999999998 99999999999999999999999999976521
Q ss_pred Cc-----------------ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH
Q 020720 150 NV-----------------THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW 212 (322)
Q Consensus 150 ~~-----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 212 (322)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~---- 241 (932)
T PRK13184 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY---- 241 (932)
T ss_pred ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh----
Confidence 10 001112468999999999999999999999999999999999999997633221100
Q ss_pred HHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcccc
Q 020720 213 TWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRP-TMKQVVEMLSKDVH 271 (322)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~evl~~L~~~~~ 271 (322)
... ..++.-.......+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 242 ------~~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 242 ------RDV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ------hhh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 000100000112234578899999999999995 56677777776544
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=288.61 Aligned_cols=240 Identities=27% Similarity=0.411 Sum_probs=195.3
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|+||+++++|.+
T Consensus 12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (277)
T cd06642 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD 91 (277)
T ss_pred hcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHH
Confidence 799999999999765 58899999987543 3445678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........ ......
T Consensus 92 ~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06642 92 LLKPG-----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred HhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hhhccc
Confidence 88532 5889999999999999999999998 99999999999999999999999999876543221 112235
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||.+.+..++.++|||||||++|+|++|..||.......... ... . ............
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~-~--------~~~~~~~~~~~~ 227 (277)
T cd06642 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LIP-K--------NSPPTLEGQYSK 227 (277)
T ss_pred CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hhh-c--------CCCCCCCcccCH
Confidence 7889999999998889999999999999999999999987543221110 000 0 011122223445
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.+++.+||+.+|++||++.+++..
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.32 Aligned_cols=195 Identities=26% Similarity=0.386 Sum_probs=168.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.||+|+++... ......+.+|+.++..++|+||+++++.+.+.+..++||||+++++
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (360)
T cd05627 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGD 87 (360)
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCcc
Confidence 4899999999999776 68999999997432 2334677889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc----
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---- 152 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 152 (322)
|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 88 L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 88 MMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999996543 6899999999999999999999999 99999999999999999999999999864321100
Q ss_pred ------------------------------eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCccc
Q 020720 153 ------------------------------HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAF 202 (322)
Q Consensus 153 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~ 202 (322)
......+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00113468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=292.03 Aligned_cols=243 Identities=22% Similarity=0.402 Sum_probs=196.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||++... ++..||||.+........+.+.+|+..++.++|+||+++++.+...+..+++|||+++++|.+
T Consensus 29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (292)
T cd06658 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108 (292)
T ss_pred cccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence 3899999999999765 688999999876555556778999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..++.++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||++......... .....
T Consensus 109 ~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 179 (292)
T cd06658 109 IVTHT-----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV 179 (292)
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence 88432 5788999999999999999999998 999999999999999999999999998754332221 12345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||.+.+..++.++||||||+++|||++|..||....... ... .... .+.+.+.. ......
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~---~~~~------~~~~~~~~-~~~~~~ 246 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR---RIRD------NLPPRVKD-SHKVSS 246 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh------cCCCcccc-ccccCH
Confidence 7889999999988889999999999999999999999987532211 111 1110 11111111 112234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+..++.+||..||++|||+.++++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 57788888999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.82 Aligned_cols=247 Identities=22% Similarity=0.372 Sum_probs=190.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... ++..+|+|++... .......+..|+.++++++||||++++++|.+. ..+++||||++++
T Consensus 20 kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gG 99 (1021)
T PTZ00266 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG 99 (1021)
T ss_pred EEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCC
Confidence 3899999999999776 5788999998654 333456789999999999999999999988653 5689999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeeccCcccceEeCC-----------------CC
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD----PPIVHRDIKASNVLLDG-----------------NF 134 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~----~~i~h~dlkp~Nill~~-----------------~~ 134 (322)
+|.+++.........+++..++.|+.||+.||.|||+.+. .+|+|+||||+||||+. .+
T Consensus 100 SL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~ 179 (1021)
T PTZ00266 100 DLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179 (1021)
T ss_pred cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCC
Confidence 9999997543333479999999999999999999998431 23999999999999964 23
Q ss_pred eEEEeeeccccccCCCcceeecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH
Q 020720 135 HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW 212 (322)
Q Consensus 135 ~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 212 (322)
.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||....... ...
T Consensus 180 iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~--qli-- 253 (1021)
T PTZ00266 180 IAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS--QLI-- 253 (1021)
T ss_pred ceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH--HHH--
Confidence 48999999998653322 1233468999999999864 458899999999999999999999997542211 111
Q ss_pred HHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 213 TWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+. .. +.+. .......+.++|..||+.+|.+||++.|++.
T Consensus 254 -~~lk-~~-------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 254 -SELK-RG-------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -HHHh-cC-------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1111 00 1111 0112345888999999999999999999984
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=284.76 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=198.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
+||.|+||.||.++.. ++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||+++++|
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L 86 (256)
T cd08221 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL 86 (256)
T ss_pred EecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcH
Confidence 4899999999999765 6889999998654 344456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||.+........ ....
T Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~ 160 (256)
T cd08221 87 YDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAET 160 (256)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccc
Confidence 99997553 236889999999999999999999998 99999999999999999999999999876543321 2233
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..... .+ .....+...
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~--------~~~~~~~~~ 225 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QG--------NYTPVVSVY 225 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cC--------CCCCCcccc
Confidence 4588999999999888889999999999999999999999865322111 11111 11 111122333
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..++.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 4568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=288.60 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=196.6
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|..+ +...+++|.+...... ....+.+|++++++++|+||+++++++.+....+++|||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (275)
T cd05046 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91 (275)
T ss_pred eecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecC
Confidence 3899999999999754 2467999988654333 45778999999999999999999999999889999999999
Q ss_pred CCCHHHHHhcCCCC-----CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 74 NNSLANALLGSKSK-----YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 74 ~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++....
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~ 168 (275)
T cd05046 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168 (275)
T ss_pred CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccC
Confidence 99999999755422 125899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ . . ....+...
T Consensus 169 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~---~-~~~~~~~~---- 237 (275)
T cd05046 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---L---N-RLQAGKLE---- 237 (275)
T ss_pred cccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---H---H-HHHcCCcC----
Confidence 222222223346778999999988888999999999999999998 7788865432211 1 1 11111110
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
. ..+......+.+++.+||+.||.+||++.|++..|.+
T Consensus 238 ~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 L---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 0111223458889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=300.49 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=188.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~ 71 (322)
.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++.... ..+++|||
T Consensus 28 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 107 (359)
T cd07876 28 PIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107 (359)
T ss_pred EeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeC
Confidence 3899999999999765 6899999998643 2334567889999999999999999999986543 46899999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 108 ~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 108 MDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred CCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 976 56665531 4788899999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHH------------H----HHH
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVE------------W----TWK 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~------------~----~~~ 215 (322)
......+|..|+|||++.+..++.++|||||||++|+|++|..||......+...... . ...
T Consensus 178 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 178 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred --cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 1233467899999999999999999999999999999999999998653221110000 0 000
Q ss_pred HHhcC-cc-----ccccC----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEG-RL-----LEIVD----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~-~~-----~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..... .. .+.+. +............+.+++.+||+.||++|||+.|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00 00000 00001111123457889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.68 Aligned_cols=241 Identities=26% Similarity=0.411 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||.|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+++++|.
T Consensus 11 ~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06640 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred hcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHH
Confidence 3899999999999775 58899999987543 344577889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++... ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 91 ~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06640 91 DLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccc
Confidence 998543 5788899999999999999999998 99999999999999999999999999876543221 12224
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.++..|+|||++.+..++.++|+|||||++|+|++|..||........... . .. ...........
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~-~~--------~~~~~~~~~~~ 226 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL------I-PK--------NNPPTLTGEFS 226 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh------h-hc--------CCCCCCchhhh
Confidence 578889999999988899999999999999999999999875432211100 0 00 11123344556
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.+++.+||+.+|++||++.+++..
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=287.11 Aligned_cols=241 Identities=27% Similarity=0.418 Sum_probs=196.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||.|++|.||+|... ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++++||+++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (274)
T cd06609 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL 87 (274)
T ss_pred hhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence 3899999999999776 68999999987553 344467889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++... ++++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 88 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (274)
T cd06609 88 DLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTF 158 (274)
T ss_pred HHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccc
Confidence 999643 6899999999999999999999998 99999999999999999999999999886643321 22334
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..... . ..+.+... ...
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~~~~-~-----~~~~~~~~--~~~ 224 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FLIPK-N-----NPPSLEGN--KFS 224 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HHhhh-c-----CCCCCccc--ccC
Confidence 5788999999999888999999999999999999999999754321111 11111 0 11111111 034
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+.+++.+||..||++||+++++++
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 45888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.42 Aligned_cols=244 Identities=27% Similarity=0.444 Sum_probs=196.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||.|+||.||+|... ++..+|+|.+........+.+.+|+.++++++|+||+++++++..+...+++|||+++++|.++
T Consensus 13 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (280)
T cd06611 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSI 92 (280)
T ss_pred hcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHH
Confidence 799999999999775 6899999999877666677899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 93 ~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 165 (280)
T cd06611 93 MLELER---GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIG 165 (280)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceeec
Confidence 865432 6899999999999999999999999 99999999999999999999999998775432211 1223457
Q ss_pred CCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 161 TMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 161 t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
++.|+|||++. ...++.++||||||+++|+|++|..||......... .... .... +.+ ..+.
T Consensus 166 ~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~-----~~~-~~~~ 232 (280)
T cd06611 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------LKIL-KSEP-----PTL-DQPS 232 (280)
T ss_pred chhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------HHHh-cCCC-----CCc-CCcc
Confidence 88999999985 345678999999999999999999999754322111 1111 1100 111 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.+++..||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 233457888999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=289.98 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=195.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||.|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|..
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence 4899999999999776 589999999987776667889999999999999999999999999999999999999999988
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 99 ~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 171 (292)
T cd06644 99 IMLELDR---GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFI 171 (292)
T ss_pred HHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-cccceec
Confidence 8754332 5899999999999999999999998 9999999999999999999999999887543221 1122345
Q ss_pred cCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 160 GTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 160 ~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
++..|+|||++. ...++.++|||||||++|+|++|..||........ ..+... . ..+.. ..+
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~-----~~~~~-~~~ 238 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-S-----EPPTL-SQP 238 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhc-C-----CCccC-CCC
Confidence 788999999874 34568899999999999999999999865432110 111110 0 00111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....++.+++.+||+.||++||++.++++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 2334458889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=284.11 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=195.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 76 (322)
.||+|++|.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.. +...+++|||+++++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (257)
T cd08223 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD 86 (257)
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCc
Confidence 4899999999999765 57899999986542 3345678899999999999999999988764 446789999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... ..+++..++.++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 87 l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 160 (257)
T cd08223 87 LYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MAS 160 (257)
T ss_pred HHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC-ccc
Confidence 9999975322 26899999999999999999999999 99999999999999999999999999876543221 223
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++.+..++.++||||||+++|+|++|+.||....... . ..... .+ .+...+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~---~~~~~-~~--------~~~~~~~~ 225 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---L---VYRII-EG--------KLPPMPKD 225 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHH-hc--------CCCCCccc
Confidence 3457889999999999899999999999999999999999987432111 1 11111 11 11222334
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||.+||++.+++..
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 44568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=291.09 Aligned_cols=241 Identities=27% Similarity=0.453 Sum_probs=196.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||.|++|.||+|... +++.|++|.+........+.+.+|+..++.++||||+++++++......++++||+++++|.++
T Consensus 27 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 106 (296)
T cd06655 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV 106 (296)
T ss_pred EecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHH
Confidence 799999999999764 6899999999766555567889999999999999999999999999999999999999999998
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++......... .....+
T Consensus 107 ~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 177 (296)
T cd06655 107 VTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (296)
T ss_pred HHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcCC
Confidence 8543 5889999999999999999999999 999999999999999999999999988754332211 123457
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
+..|+|||.+.+..++.++|||||||++|+|++|..||........... ...... +.+ ..+......
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~------~~~~~~------~~~-~~~~~~~~~ 244 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PEL-QNPEKLSPI 244 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcCC------ccc-CCcccCCHH
Confidence 8899999999988899999999999999999999999976533211110 111000 001 112223345
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+++.+||..||.+||++.+++.
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhh
Confidence 778899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=284.63 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=187.4
Q ss_pred CcccCcceEEEEEEECC---CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD---GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++|+||+++++.+.+....+++|||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 38999999999996542 3568888876443 3334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-ee
Q 020720 77 LANALLGSKSK-YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HV 154 (322)
Q Consensus 77 L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 154 (322)
|.+++...... ....++.....++.||+.||+|||+.+ ++|+||||.||+++.++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765321 223567788899999999999999998 99999999999999999999999999865332211 11
Q ss_pred ecccccCCCCCchHHHhh-------CCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 155 STRVAGTMGYLAPEYALL-------GQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~-------~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||......+. . ....... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~---~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---L---KQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---H---HHHhhcc-CccCC
Confidence 122335678999999753 356789999999999999999 7778764422111 1 1111111 11111
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+.+ +......+.+++..|| .||++||++++|++.|.
T Consensus 232 ~~~~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222 2223344566777788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=284.24 Aligned_cols=246 Identities=33% Similarity=0.575 Sum_probs=196.7
Q ss_pred CcccCcceEEEEEEECC-C----CEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRD-G----TQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||.|+||.||++.... + ..||+|.++..... ..+.+.+|+..+..++|+||+++++++.+.+..+++|||+++
T Consensus 6 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~ 85 (258)
T smart00219 6 KLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEG 85 (258)
T ss_pred eeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCC
Confidence 38999999999997763 3 88999999765433 567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++...... .+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 86 ~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 86 GDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred CCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 9999999754321 2899999999999999999999998 9999999999999999999999999988654432221
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....++..|+|||.+....++.++||||||+++|+|++ |..||........ .. ... ... ....
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~---~~~-~~~--------~~~~ 225 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LE---YLK-KGY--------RLPK 225 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHh-cCC--------CCCC
Confidence 112236789999999988889999999999999999998 7788765322111 11 111 111 1111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
+......+.+++.+||+.||.+|||+.|+++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 222445688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=289.33 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=196.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+++++|.+
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 105 (297)
T cd06656 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 105 (297)
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHH
Confidence 3899999999999764 799999999976655556778899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 176 (297)
T cd06656 106 VVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (297)
T ss_pred HHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCccc
Confidence 98543 5788899999999999999999998 999999999999999999999999998754332211 12345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+++.|+|||.+.+..++.++|||||||++|+|++|..||............ ...+ .+. ...+.....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~~------~~~-~~~~~~~~~ 243 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG------TPE-LQNPERLSA 243 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccCC------CCC-CCCccccCH
Confidence 788999999999888999999999999999999999999754322111000 0000 011 111223334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 5778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=296.01 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=194.0
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeC-CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVED-NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~ 71 (322)
+||+|+||.||+|.+ .+++.||||.++... ......+.+|+.++.++ +||||+++++++... ...+++|||
T Consensus 14 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey 93 (343)
T cd05103 14 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 93 (343)
T ss_pred cccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEec
Confidence 489999999999963 247889999997643 23346788999999999 689999999988654 457899999
Q ss_pred CCCCCHHHHHhcCCCC---------------------------------------------------------------C
Q 020720 72 LENNSLANALLGSKSK---------------------------------------------------------------Y 88 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~---------------------------------------------------------------~ 88 (322)
+++|+|.+++...... .
T Consensus 94 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (343)
T cd05103 94 CKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYK 173 (343)
T ss_pred cCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhh
Confidence 9999999998653210 1
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-eecccccCCCCCch
Q 020720 89 VSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAP 167 (322)
Q Consensus 89 ~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aP 167 (322)
..+++..+..++.||+.||+|||+.+ ++|+||||.||+++.++.++|+|||++......... ......++..|+||
T Consensus 174 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 250 (343)
T cd05103 174 KVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250 (343)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence 23677888999999999999999998 999999999999999999999999998764322111 11122356679999
Q ss_pred HHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHH
Q 020720 168 EYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGL 246 (322)
Q Consensus 168 E~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 246 (322)
|.+.+..++.++||||||+++|+|++ |..||......... . .....+.. ..... .....+.+++.
T Consensus 251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~----~~~~~~~~-----~~~~~---~~~~~~~~~~~ 316 (343)
T cd05103 251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGTR-----MRAPD---YTTPEMYQTML 316 (343)
T ss_pred HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--H----HHHhccCC-----CCCCC---CCCHHHHHHHH
Confidence 99988899999999999999999997 88888654322111 1 11111110 11111 12235888999
Q ss_pred hcccCCCCCCCCHHHHHHHHhcccc
Q 020720 247 FCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 247 ~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
+||+.||++||++.||++.|+....
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=292.52 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=191.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..+++|||+. ++|.
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~ 91 (301)
T cd07873 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLK 91 (301)
T ss_pred EeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHH
Confidence 3899999999999776 68899999987543 2233567889999999999999999999999999999999997 5888
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 92 ~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 164 (301)
T cd07873 92 QYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSNE 164 (301)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-cccc
Confidence 88865432 5889999999999999999999998 999999999999999999999999998754322211 1223
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC---------c
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD---------P 228 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 228 (322)
.+++.|+|||++.+. .++.++|||||||++|+|++|..||......+....................++ +
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 468899999988754 578899999999999999999999976533221111100000000000000000 0
Q ss_pred cC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 EL-----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ..........+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0011122345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.55 Aligned_cols=245 Identities=27% Similarity=0.425 Sum_probs=195.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||++... ++..||+|.++.. .......+.+|+.++++++|+||+++++.+...+..+++|||+++++|.
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (286)
T cd06622 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD 87 (286)
T ss_pred hhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHH
Confidence 4899999999999876 7899999998754 3334467889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.++.... ....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 88 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 160 (286)
T cd06622 88 KLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKT 160 (286)
T ss_pred HHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---ccc
Confidence 9886532 12368999999999999999999996 47 9999999999999999999999999987543222 123
Q ss_pred cccCCCCCchHHHhhCC------CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 158 VAGTMGYLAPEYALLGQ------LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~------~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
..++..|+|||.+.+.. ++.++|||||||++|+|++|..||............ .. .......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~---------~~~~~~~ 228 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SA---------IVDGDPP 228 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HH---------HhhcCCC
Confidence 45788999999986543 478999999999999999999999754322111110 00 1111122
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 333445566889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=285.24 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=190.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeC------CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVED------NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~ 72 (322)
.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++... ...+++|||+
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 91 (272)
T cd06637 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91 (272)
T ss_pred heeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcC
Confidence 3899999999999765 68899999986543 3446788999999998 799999999998753 4578999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++|.+++..... ..+++..++.++.|++.|++|||+.+ ++|+||+|.||++++++.++|+|||++.......
T Consensus 92 ~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~- 165 (272)
T cd06637 92 GAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV- 165 (272)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc-
Confidence 99999999875432 36889999999999999999999998 9999999999999999999999999987543322
Q ss_pred eeecccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 153 HVSTRVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
.......|+..|+|||++. ...++.++|||||||++|+|++|..||.......... ...... .
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~~~~------~ 233 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPRNP------A 233 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhcCC------C
Confidence 1223356889999999986 3357889999999999999999999996432211110 000000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... ........+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 11122345888999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=283.03 Aligned_cols=241 Identities=30% Similarity=0.456 Sum_probs=195.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-----hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|++|.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+....++++||+++
T Consensus 7 ~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (258)
T cd06632 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86 (258)
T ss_pred eeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCC
Confidence 4899999999999776 78999999986543 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... .
T Consensus 87 ~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 87 GSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 99999996543 5889999999999999999999998 9999999999999999999999999987653322 1
Q ss_pred ecccccCCCCCchHHHhhCC-CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~-~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....++..|++||.+.... ++.++|+||||+++|+|++|..||........ ........ .....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~--------~~~~~ 223 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSK--------ELPPI 223 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcc--------cCCCc
Confidence 23345788999999988766 89999999999999999999999876431111 11111101 11122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+......+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 2233455788899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=298.45 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=189.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++... ...++||||
T Consensus 31 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~ 110 (364)
T cd07875 31 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110 (364)
T ss_pred EeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeC
Confidence 4899999999999765 6889999998753 233456788999999999999999999987543 357999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++ +|.+.+.. .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 111 ~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 111 MDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred CCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 975 67776632 4788899999999999999999998 9999999999999999999999999997653321
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH---------HHH-------
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW---------TWK------- 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------~~~------- 215 (322)
......+|..|+|||++.+..++.++|||||||++|+|++|..||......+....+.. ...
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 181 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred --cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 12334689999999999999999999999999999999999999975432211111000 000
Q ss_pred HHhcCc-cc-----cccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEGR-LL-----EIVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~~-~~-----~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...... .. ..+.... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00 0000000 01111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=282.96 Aligned_cols=246 Identities=26% Similarity=0.438 Sum_probs=197.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC------hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES------KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|++|.||+|... ++..||+|++.... ....+.+.+|+..++.++|+||+++++++.+.+..++++||+.
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 86 (268)
T cd06630 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA 86 (268)
T ss_pred eecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence 4899999999999764 68999999986432 1234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 152 (322)
+++|.+++.... ++++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++ .++|+|||.+........
T Consensus 87 ~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 87 GGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred CCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999996543 6889999999999999999999998 99999999999998775 699999999876543321
Q ss_pred e---eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 153 H---VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 153 ~---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||............ ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~--------~~ 228 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA--------TT 228 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhcc--------CC
Confidence 1 112345788999999998888999999999999999999999999754332222111 111000 11
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.....++.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 12334445566888999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=285.24 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (284)
T cd06620 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD 91 (284)
T ss_pred HcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHH
Confidence 3899999999999765 68899999886543 334578899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++...+ .+++..+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~ 161 (284)
T cd06620 92 RIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADT 161 (284)
T ss_pred HHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCc
Confidence 9986543 68999999999999999999997 46 9999999999999999999999999876442221 123
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCc-----hhHHHHHHHHHhcCccccccCccCCC
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM-----LILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
..++..|+|||++.+..++.++|||||||++|+|++|..||........ ........... ......
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 232 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV---------QEPPPR 232 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh---------hccCCC
Confidence 4588999999999888899999999999999999999999985543211 11111111111 111111
Q ss_pred CCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 233 FPE-KEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 233 ~~~-~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.+. .....+.+++.+||+.||++||++.|+++..
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 1345688899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=288.37 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=191.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... ++..||+|.++... ......+.+|+.+++.++||||+++++++.++...++||||+. ++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l 85 (285)
T cd07861 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDL 85 (285)
T ss_pred EecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCH
Confidence 3899999999999775 68999999986542 2234678899999999999999999999999999999999997 588
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 86 ~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (285)
T cd07861 86 KKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTH 160 (285)
T ss_pred HHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cccC
Confidence 888865332 236899999999999999999999998 99999999999999999999999999875432211 1122
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH--------HH----HHhcC-ccc
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT--------WK----LREEG-RLL 223 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~----~~~~~-~~~ 223 (322)
..+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+........ |. ..... ...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence 3467899999988754 5789999999999999999999999754322111110000 00 00000 000
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+.........++.+++.+||+.||++|||+.+|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000111112345788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.55 Aligned_cols=249 Identities=31% Similarity=0.475 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEEC-CCC----EEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT----QIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|.+. +|. .+|+|.+.... ......+.+|+..++.++||||+++++++.. ...++++||+.+
T Consensus 14 ~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 92 (279)
T cd05057 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPL 92 (279)
T ss_pred eecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCC
Confidence 4899999999999764 333 58999887553 3345778899999999999999999999987 788999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 93 g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 166 (279)
T cd05057 93 GCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166 (279)
T ss_pred CcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence 999999976433 5899999999999999999999988 9999999999999999999999999998654322211
Q ss_pred e-cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 S-TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 ~-~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
. ....++..|+|||.+....++.++||||||+++|+|++ |..||......+.. .... .+. ...
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~-~~~--------~~~ 231 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP------DLLE-KGE--------RLP 231 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHh-CCC--------CCC
Confidence 1 11223567999999988899999999999999999998 99998764322111 1111 110 011
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||..||++||++.++++.|+....
T Consensus 232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 112233457888999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=289.76 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=198.5
Q ss_pred CcccCcceEEEEEEEC-----CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-----DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++..+|+|.++..... ....+.+|+..++.++|+||+++++++.. ....+++|||+
T Consensus 11 ~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (284)
T cd05038 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90 (284)
T ss_pred eeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecC
Confidence 3899999999999753 3688999999765443 45789999999999999999999999877 55789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 91 ~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 91 PSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred CCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 99999999975542 5899999999999999999999998 99999999999999999999999999986652221
Q ss_pred e--eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCch--------hHHHHHHHHHhcCcc
Q 020720 153 H--VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML--------ILVEWTWKLREEGRL 222 (322)
Q Consensus 153 ~--~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~ 222 (322)
. ......++..|++||.+....++.++||||||+++|+|++|..|+......... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE- 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC-
Confidence 1 111223456799999998889999999999999999999999998654322110 00000111111110
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
....+......+.+++.+||+.+|++||++.||+++|++.
T Consensus 244 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 -------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0111222335688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=292.17 Aligned_cols=196 Identities=25% Similarity=0.435 Sum_probs=158.7
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||+.+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 3899999999999764 35789999886432 23567889999999999999999999854 4578899999865
Q ss_pred CHHHHHhcCC-----CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe----CCCCeEEEeeeccccc
Q 020720 76 SLANALLGSK-----SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKL 146 (322)
Q Consensus 76 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill----~~~~~~kl~Dfg~~~~ 146 (322)
+|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+||++ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777774321 12235888999999999999999999998 9999999999999 5667899999999986
Q ss_pred cCCCcce--eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCccc
Q 020720 147 FPDNVTH--VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAF 202 (322)
Q Consensus 147 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~ 202 (322)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 5433221 12234678999999998764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.17 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=187.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|+||+++++++...+..+++||++. ++|.+
T Consensus 176 ~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~ 248 (461)
T PHA03211 176 ALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYT 248 (461)
T ss_pred EEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHH
Confidence 3899999999999776 588999996432 345689999999999999999999999999999999995 68888
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-eeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 158 (322)
++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........ ......
T Consensus 249 ~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 249 YLGARLR---PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 8864432 6899999999999999999999999 99999999999999999999999999976533221 112235
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCC-----chhHHHHHHHHHhc-Ccccc--------
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD-----MLILVEWTWKLREE-GRLLE-------- 224 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~-------- 224 (322)
.||..|+|||++.+..++.++|||||||++|||++|..|+....... .............. .....
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 68999999999999999999999999999999999886654322111 00111111110000 00000
Q ss_pred --------ccCccCCC-CCH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 --------IVDPELTQ-FPE---KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 --------~~~~~~~~-~~~---~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.... ... .....+.+++.+||+.||.+|||+.|+|+.
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 000 112357789999999999999999999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.95 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=188.2
Q ss_pred CcccCcceEEEEEEECCC---CEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDG---TQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....+++|||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 489999999999965432 356777766443 3345789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC-cceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 155 (322)
|.+++..........++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++...... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999765433335677788899999999999999998 999999999999999999999999987642211 11112
Q ss_pred cccccCCCCCchHHHhh-------CCCCcccceehhhHHHHHHHhC-CCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 156 TRVAGTMGYLAPEYALL-------GQLTKKADVYSFGVLLLEIISG-RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-------~~~~~~sDv~slG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
....++..|+|||++.. ..++.++|||||||++|||+++ ..||....... ... .... +......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLN---HVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHh-hcccccCC
Confidence 23457889999998753 2457899999999999999974 66775432211 111 1111 11122233
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
+.+... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333222 2344677788899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=282.20 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=196.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.+|.+... +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++++||+.+++|
T Consensus 7 ~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd08218 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL 86 (256)
T ss_pred EeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcH
Confidence 3899999999999765 6899999998654 233446889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+.+..... ..+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 87 ~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 160 (256)
T cd08218 87 YKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LART 160 (256)
T ss_pred HHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhhh
Confidence 999865332 25788999999999999999999998 99999999999999999999999999876543221 1123
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+++.|+|||++.+..++.++|||||||++|+|++|..||......+ . ..... .......+...
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~---~~~~~---------~~~~~~~~~~~ 225 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---L---VLKII---------RGSYPPVSSHY 225 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---H---HHHHh---------cCCCCCCcccC
Confidence 457889999999988889999999999999999999999986432111 1 11111 11111223334
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.+|++||++.+|++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 4568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=282.45 Aligned_cols=242 Identities=26% Similarity=0.401 Sum_probs=187.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-----hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
+||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++||||+++++++.+. ...++++||+
T Consensus 9 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~ 88 (266)
T cd06651 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYM 88 (266)
T ss_pred eecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCC
Confidence 4899999999999765 68999999886432 22345688899999999999999999988753 5678999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV- 151 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 151 (322)
++++|.+++.... .+++...+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 89 PGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999996543 5888999999999999999999998 9999999999999999999999999987543211
Q ss_pred -ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 152 -THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 152 -~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
........++..|+|||.+.+..++.++|||||||++|+|++|..||........ ........ ..+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-----~~~~- 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-----TNPQ- 229 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----CCCC-
Confidence 1111224478899999999988899999999999999999999999975422111 01111000 1122
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+......+..++ +||..+|++||++.||++
T Consensus 230 --~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 --LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 2222233344555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.73 Aligned_cols=252 Identities=19% Similarity=0.229 Sum_probs=191.5
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||++... .+..|++|.+... ....+|+.+++.++||||+++++++......+++||++. ++|
T Consensus 99 ~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 172 (392)
T PHA03207 99 SLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDL 172 (392)
T ss_pred eecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCH
Confidence 3899999999999653 3678999987643 234679999999999999999999999999999999995 588
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-eeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 156 (322)
.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++........ ....
T Consensus 173 ~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 173 FTYVDRSG----PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence 88884332 6899999999999999999999998 99999999999999999999999999876543322 1223
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc---------------
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR--------------- 221 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 221 (322)
...||+.|+|||++....++.++|||||||++|+|++|+.||...........+....+......
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 45689999999999999999999999999999999999999977654332222211111100000
Q ss_pred --cccccCccC--CCCC--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 --LLEIVDPEL--TQFP--EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 --~~~~~~~~~--~~~~--~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.. .... .....++.+++.+||..||++||++.|++..
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000 0123457788999999999999999999875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=297.89 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=188.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||++... .++.||+|.+... .......+.+|+.+++.++||||+++++++... ...+++|||
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 103 (355)
T cd07874 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103 (355)
T ss_pred EeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhh
Confidence 3899999999999765 6889999998754 233446788999999999999999999988643 346899999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++ +|.+.+.. .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 104 MDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred hcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 976 56666632 4788899999999999999999999 9999999999999999999999999998653321
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH----------------HHH
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW----------------TWK 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~----------------~~~ 215 (322)
......+|..|+|||++.+..++.++|||||||++|+|++|..||......+....... ...
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred --ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 12334689999999999998999999999999999999999999975432211110000 000
Q ss_pred HHhc-Ccccc-----ccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREE-GRLLE-----IVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~-~~~~~-----~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.... ..... .+...+ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00000 000000 01111223467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=276.11 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC----h----hcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES----K----QGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~----~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
+||.|..+.|-++.++ +|.++|+|++.... . ...+.-.+|+.+|+++ .||+|+.+.++++.+...++|+|
T Consensus 24 ilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFd 103 (411)
T KOG0599|consen 24 ILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFD 103 (411)
T ss_pred HhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhh
Confidence 4799999999888655 78999999985431 1 1124456799999999 69999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
.|+.|.|.|++... +.+++.+...|+.|+.+|+.|||..+ |+||||||+|||++++.+++|+|||+++.....
T Consensus 104 l~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 104 LMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999544 48999999999999999999999999 999999999999999999999999999976543
Q ss_pred cceeecccccCCCCCchHHHhh------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 151 VTHVSTRVAGTMGYLAPEYALL------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
. .....+|||+|+|||.+.. ..|+...|+|++|+++|.||.|..||.....--++ .+.-+|.. +
T Consensus 177 e--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML-------R~ImeGky-q 246 (411)
T KOG0599|consen 177 E--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML-------RMIMEGKY-Q 246 (411)
T ss_pred h--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-------HHHHhccc-c
Confidence 3 3356789999999998863 36788999999999999999999999864221111 11122221 1
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+-+|+.. +...+..++|.+||+.||.+|.|++|+|..
T Consensus 247 F~speWa----dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 247 FRSPEWA----DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cCCcchh----hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1122222 334457889999999999999999999863
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=296.48 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=187.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++++++
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 101 (343)
T cd07878 22 PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL 101 (343)
T ss_pred ecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeec
Confidence 4899999999999765 68899999987542 22345678999999999999999999987543 346889998
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+ +++|.+++... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 102 ~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 102 M-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred C-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 8 77898887532 5899999999999999999999999 999999999999999999999999998865432
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc--ccc----
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR--LLE---- 224 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 224 (322)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+.... ......... ...
T Consensus 172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR---IMEVVGTPSPEVLKKISS 245 (343)
T ss_pred ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHhCCCCHHHHHhcch
Confidence 223468999999999876 5688999999999999999999999975432211111 000000000 000
Q ss_pred ----ccCccCCCCCH--------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 ----IVDPELTQFPE--------KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ----~~~~~~~~~~~--------~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+...+. .....+.+++.+||+.||.+|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000011111 112346789999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.00 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEECC--CCEEEEEEecccC----------hhcHHHHHHHHHHHhc-CCCCcccccceEEEeCCeeEE
Q 020720 1 MIGGGAFGVVYRGSLRD--GTQIAIKCLSAES----------KQGTKEFLTEIDMIWN-IRHPNLVQLIGCCVEDNNRIL 67 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~--~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~l 67 (322)
.||+|+||.||+|.... +..+|+|.+.... ......+.+|+.++.+ ++||||+++++++.+++..++
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 48999999999997764 7889999886431 2233557788888865 799999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 68 VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 68 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+|||+++++|.+++.........+++..++.++.|++.+|.|||. .+ ++|+||+|.||+++.++.++|+|||.+..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceee
Confidence 999999999999886533333468999999999999999999996 56 99999999999999999999999999886
Q ss_pred cCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 147 FPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .. .... ....
T Consensus 164 ~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~---~~~~-~~~~---- 230 (269)
T cd08528 164 KQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA---TKIV-EAVY---- 230 (269)
T ss_pred ccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH---HHHh-hccC----
Confidence 54432 2234457889999999998889999999999999999999999986432111 11 1111 1110
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.+... ......+.+++.+||+.||++||++.|+..+++
T Consensus 231 ~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01011 122345888999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.48 Aligned_cols=242 Identities=24% Similarity=0.405 Sum_probs=196.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+.+++|.+
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~ 105 (285)
T cd06648 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105 (285)
T ss_pred EeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHH
Confidence 4899999999999765 688999999876555556778999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+......... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 176 (285)
T cd06648 106 IVTHT-----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLV 176 (285)
T ss_pred HHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-ccccc
Confidence 98652 5889999999999999999999999 999999999999999999999999987754433221 12345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||.+.+..++.++||||||+++|+|++|..||...... ... ...... . .+... .+.....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~---~~~~~~-~-----~~~~~-~~~~~~~ 243 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAM---KRIRDN-L-----PPKLK-NLHKVSP 243 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHH---HHHHhc-C-----CCCCc-ccccCCH
Confidence 788999999998888999999999999999999999998653221 111 111111 0 01111 1112334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+++.+||+.+|++||++.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 6889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.48 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=195.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++|||++++++.+...+..++|+||+++++|
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd08220 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86 (256)
T ss_pred EecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCH
Confidence 4899999999999765 6889999998754 233456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+++..... ..+++..++.++.|++.++.|||+++ ++|+||+|.||+++.+ +.++|+|||.+........ ..
T Consensus 87 ~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~ 159 (256)
T cd08220 87 AEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AY 159 (256)
T ss_pred HHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--cc
Confidence 999975432 25889999999999999999999998 9999999999999855 4689999999886543321 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...++..|+|||.+.+..++.++||||||+++|+|++|..||........ . ..... ......+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~---~~~~~---------~~~~~~~~~ 224 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---V---LKIMS---------GTFAPISDR 224 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---H---HHHHh---------cCCCCCCCC
Confidence 34578899999999888889999999999999999999999875432211 1 11110 111122223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 34458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=280.71 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=197.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|++|.||++... +++.+++|.+.... ......+.+|++++++++||||+++++++......++++||+.+++|.
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence 3899999999999776 68999999987653 344577899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... ..+++..++.++.|++.|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 88 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~ 158 (265)
T cd06605 88 KILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KT 158 (265)
T ss_pred HHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hc
Confidence 9997653 378999999999999999999999 88 99999999999999999999999998875432211 11
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH-
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK- 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (322)
..++..|+|||.+.+..++.++||||||+++|+|++|..||......... .......... ......+..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~ 228 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVN---------EPPPRLPSGK 228 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhc---------CCCCCCChhh
Confidence 55788999999999889999999999999999999999998754321111 1111111111 111112222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||..||.+||++.+++..
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 44558889999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=282.25 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=198.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 75 (322)
.||.|+||.||++... ++..+|+|.+... .....+.+..|+++++.++|+||+++++++.. ....+++|||++++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~ 86 (265)
T cd08217 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGG 86 (265)
T ss_pred eeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCC
Confidence 3899999999999765 6889999998654 33445678899999999999999999998754 44678999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH-----EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-----~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
+|.+++.........+++..++.++.||+.||.||| +.+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 87 DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999765444457899999999999999999999 777 999999999999999999999999998876543
Q ss_pred cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
... .....+++.|+|||.+....++.++||||||+++|+|++|..||...... ... .... . ...
T Consensus 164 ~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~-~--------~~~ 227 (265)
T cd08217 164 SSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA---SKIK-E--------GKF 227 (265)
T ss_pred ccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH---HHHh-c--------CCC
Confidence 321 22345889999999999888999999999999999999999999764311 111 1111 1 112
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+......+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 23333445668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=286.24 Aligned_cols=237 Identities=30% Similarity=0.385 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.+|+|++.... ......+.+|++++++++||||+++++++.+....+++|||+++++
T Consensus 8 ~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (290)
T cd05580 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE 87 (290)
T ss_pred EeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCC
Confidence 4899999999999776 68999999986432 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++...... ..
T Consensus 88 L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 88 LFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 999996553 6899999999999999999999998 999999999999999999999999998865443 22
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||.+.+...+.++||||||+++|+|++|..||....... ... ... .+. . ..+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~-~~~------~---~~~~~ 220 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYE---KIL-EGK------V---RFPSF 220 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHh-cCC------c---cCCcc
Confidence 3457899999999988888999999999999999999999987543111 110 111 111 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
....+.+++.+||+.||.+|+ +++|++.
T Consensus 221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 245688899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.19 Aligned_cols=244 Identities=24% Similarity=0.280 Sum_probs=192.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||+||++... +|+.|++|.+.... ......+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999765 68999999986532 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence 999965432 36899999999999999999999999 99999999999999999999999998876543211 123
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|+|||++.+..++.++||||||+++|+|++|..||............. . . ........+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~-~-----~~~~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK------R-R-----TLEMAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH------h-c-----cccccccCCccC
Confidence 357789999999988889999999999999999999999997654322111110 0 0 001111122223
Q ss_pred HHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
...+.+++.+||+.||.+|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44588899999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.05 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=194.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++......+++|||+++++|
T Consensus 8 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 87 (286)
T cd07847 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVL 87 (286)
T ss_pred eecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHH
Confidence 4899999999999876 68999999986442 22335678999999999999999999999999999999999999888
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..++.... .+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 88 NELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred HHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 87774432 5899999999999999999999998 99999999999999999999999999886543321 1223
Q ss_pred cccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH--------HHhcCcc-ccccC
Q 020720 158 VAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK--------LREEGRL-LEIVD 227 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~ 227 (322)
..++..|+|||++.+ ..++.++||||||+++|+|++|..||......+.......... ....... .....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 457789999999876 4578999999999999999999999976543322211110000 0000000 00000
Q ss_pred ccCCCC------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQF------PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~~------~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+..... .......+.+++.+||+.||++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 110000 0122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.42 Aligned_cols=240 Identities=28% Similarity=0.449 Sum_probs=191.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
+||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++|||++++++++... ..+++|||+.+++|.++
T Consensus 13 ~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~ 88 (254)
T cd05083 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNF 88 (254)
T ss_pred eeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHH
Confidence 489999999999975 47889999986543 236788999999999999999999998654 47899999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 89 l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~ 159 (254)
T cd05083 89 LRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSKL 159 (254)
T ss_pred HHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----CCCCC
Confidence 975432 25889999999999999999999998 9999999999999999999999999987543211 12234
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||.+.+..++.++||||||+++|+|++ |..||........ . .....+. .. ..+.....
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~-----~~---~~~~~~~~ 224 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---K----ECVEKGY-----RM---EPPEGCPA 224 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---H----HHHhCCC-----CC---CCCCcCCH
Confidence 567999999988899999999999999999998 8898865432111 1 1111110 01 11222345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.+|++||++.+++..|++
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 57899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=285.85 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=190.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEE-----eCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCV-----EDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++.+ +||||+++++++. .++..+++|||++
T Consensus 25 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (286)
T cd06638 25 TIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN 103 (286)
T ss_pred eeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecC
Confidence 3899999999999765 688999998864322 235678899999999 6999999999874 3456899999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 179 (286)
T cd06638 104 GGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL- 179 (286)
T ss_pred CCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC-
Confidence 99999988643333346889999999999999999999998 99999999999999999999999999876533211
Q ss_pred eecccccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 154 VSTRVAGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
......|++.|+|||++.. ..++.++|||||||++|+|++|..||.......... ... ... .+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~------~~~-~~~-----~~ 247 (286)
T cd06638 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF------KIP-RNP-----PP 247 (286)
T ss_pred ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh------hcc-ccC-----CC
Confidence 1223458899999998753 457889999999999999999999987543211110 000 000 01
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.+ ..+......+.+++.+||+.||++||++.|+++.+
T Consensus 248 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 TL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 11112234588899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.84 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=201.6
Q ss_pred cccCcceEEEEEEECC-CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||.|+||.||+|..+. +-..|.|++........++++-|+++|..++||+||++++.|..++.+|++.|||.||-...+
T Consensus 40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai 119 (1187)
T KOG0579|consen 40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI 119 (1187)
T ss_pred hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence 7999999999997773 555688998877888889999999999999999999999999999999999999999998888
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..-+. .+++..+..++.|++.||.|||+++ |||||||+.|||++.+|.++|+|||.+...... ......++|
T Consensus 120 mlEL~r---~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDsFIG 192 (1187)
T KOG0579|consen 120 MLELGR---VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDSFIG 192 (1187)
T ss_pred HHHhcc---ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-HhhhccccC
Confidence 865443 7999999999999999999999999 999999999999999999999999988753322 222345789
Q ss_pred CCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 161 TMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 161 t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
||.|||||+.. ..+|+.++||||||++|.||..+.+|-..... +....++.... |..--.|.
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSe-------PPTLlqPS 259 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-------PPTLLQPS 259 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcC-------CCcccCcc
Confidence 99999999876 45789999999999999999999988654322 22222222111 22223355
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....|.+++..||.+||..||++.++++.
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 666778899999999999999999999864
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=279.53 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=201.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|++|.||+|... +++.|++|++..... .....+.+|+..+.+++|+||+++++++...+..++++||+++++|.
T Consensus 8 ~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (264)
T cd06623 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA 87 (264)
T ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHH
Confidence 4899999999999776 599999999876644 44578999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .+++..++.++.|++.|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 88 ~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~ 159 (264)
T cd06623 88 DLLKKVG----KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNT 159 (264)
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccc
Confidence 9996542 78999999999999999999999 88 999999999999999999999999998865433222 123
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH-
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK- 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (322)
..++..|+|||.+....++.++||||||+++|+|++|..||............... . .......+..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~ 227 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---C---------DGPPPSLPAEE 227 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---h---------cCCCCCCCccc
Confidence 45788999999999888999999999999999999999999766432222111111 1 1111122222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.+|++||++.++++.
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 44568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=280.53 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=191.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-----hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
+||+|+||.||.|... ++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+++|||+
T Consensus 9 ~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (265)
T cd06652 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM 88 (265)
T ss_pred EEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEec
Confidence 4899999999999765 68999999886432 22346788899999999999999999988663 4678999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 89 PGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 9999999986543 5788889999999999999999999 99999999999999999999999998875432111
Q ss_pred --eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 --HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......++..|+|||++.+..++.++|||||||++|+|++|..||........ . .... ..+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~---~~~~--------~~~~~ 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---I---FKIA--------TQPTN 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---H---HHHh--------cCCCC
Confidence 112234578899999999888899999999999999999999999875321110 0 0111 01111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+......+.+++.+||. +|++||+++||++.
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 23344445567788888884 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=279.87 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=192.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh----------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK----------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 69 (322)
.||+|+||.||+|... +|+.+|+|.++.... ...+.+.+|+.+++.++|+|++++++++...+..++|+
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (272)
T cd06629 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFL 87 (272)
T ss_pred eecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEE
Confidence 4899999999999765 689999998864311 11246788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 88 EYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 9999999999996553 6889999999999999999999998 99999999999999999999999999875433
Q ss_pred Ccce-eecccccCCCCCchHHHhhCC--CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 150 NVTH-VSTRVAGTMGYLAPEYALLGQ--LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 150 ~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
.... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||........ ........ ....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~~~~ 233 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNKR-SAPPI 233 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhccc-cCCcC
Confidence 2111 122345788999999988654 78999999999999999999999863321110 11111111 00111
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+ .........+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Cc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 1112234568888999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=279.70 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=196.1
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||.|++|.||+|... +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999776 58999999986542 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..+..++.||+.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99996543 5889999999999999999999998 9999999999999999999999999988654332 1223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|++||.+....++.++|+||||+++|+|++|..||.....+. .... ..... + ......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~~-~-------~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---NDILK-G-------NGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HHHhc-c-------CCCCCCCccc
Confidence 457889999999988889999999999999999999999998654321 1111 11110 0 1111122222
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
...+.+++.+||+.||++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 456899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.59 Aligned_cols=184 Identities=24% Similarity=0.318 Sum_probs=156.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... ++..||+|+.... ....|+.++++++|+||+++++++.+....++|+|++. ++|.+
T Consensus 73 ~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~ 145 (357)
T PHA03209 73 TLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYT 145 (357)
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHH
Confidence 3899999999999776 5788999975432 23568999999999999999999999999999999995 58888
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ..+++..++.|+.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++...... .......
T Consensus 146 ~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~ 217 (357)
T PHA03209 146 YLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLA 217 (357)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--ccccccc
Confidence 875433 26899999999999999999999998 999999999999999999999999998743221 1122346
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCC
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSK 199 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~ 199 (322)
||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 8999999999999899999999999999999998665543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=279.93 Aligned_cols=245 Identities=29% Similarity=0.457 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++++||+++++|
T Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06626 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL 86 (264)
T ss_pred EeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcH
Confidence 4899999999999765 689999999876644 3567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec-
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST- 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~- 156 (322)
.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+............
T Consensus 87 ~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 87 EELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred HHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99996543 5788999999999999999999999 999999999999999999999999998865433222111
Q ss_pred --ccccCCCCCchHHHhhCC---CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 --RVAGTMGYLAPEYALLGQ---LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 --~~~~t~~y~aPE~~~~~~---~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
...++..|+|||++.+.. .+.++||||||+++|+|++|..||........ .. ..... + ..+.+.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~---~~~~~-~-----~~~~~~ 228 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM---FHVGA-G-----HKPPIP 228 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH---HHHhc-C-----CCCCCC
Confidence 345788999999998766 88999999999999999999999975432111 10 11110 0 111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ......+.+++.+||+.+|.+||++.+++.
T Consensus 229 ~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 112445778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=287.78 Aligned_cols=245 Identities=22% Similarity=0.267 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|++|.||+|... ++..||+|.+..... .....+.+|++.++.++|+||+++++.+.+....+++|||+.+++
T Consensus 8 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (316)
T cd05574 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGE 87 (316)
T ss_pred eecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCC
Confidence 4899999999999776 589999999875532 244678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce---
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH--- 153 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 153 (322)
|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 88 L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 88 LFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred HHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 999986442 236899999999999999999999998 999999999999999999999999988754221110
Q ss_pred -------------------------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchh
Q 020720 154 -------------------------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI 208 (322)
Q Consensus 154 -------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~ 208 (322)
......|+..|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 242 (316)
T cd05574 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242 (316)
T ss_pred ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHH
Confidence 0112357889999999998889999999999999999999999997554322111
Q ss_pred HHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 020720 209 LVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT----MKQVVE 264 (322)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps----~~evl~ 264 (322)
...... ..... .......+.+++.+||+.||++||+ +.|++.
T Consensus 243 ------~~~~~~-------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 243 ------NILKKE-------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------HHhcCC-------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 011000 01111 1114456889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=282.45 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=187.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHH---hcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMI---WNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 5899999999999775 689999999865421 1123344444333 34479999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999986543 6899999999999999999999999 9999999999999999999999999987543221
Q ss_pred eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....++..|+|||.+.. ..++.++|||||||++|+|++|..||........... ..... .... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~------~~~~---~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TVNV---E 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhh------cCCc---C
Confidence 123458999999998864 5688999999999999999999999976543322111 11100 0111 2
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
.+.....++.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233445688889999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.12 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=195.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... +|+.|++|++.... ......+.+|+.++++++||||+++++++.+....++|+||+ +++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L 85 (286)
T cd07832 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDL 85 (286)
T ss_pred ecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCH
Confidence 4899999999999775 68999999987654 333467899999999999999999999999999999999999 9999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 86 ~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 86 SEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 99986543 26899999999999999999999998 9999999999999999999999999988664433222233
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh--------cC----cccc
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE--------EG----RLLE 224 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~----~~~~ 224 (322)
..++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ......... +. ....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchhhc
Confidence 4578899999988654 468999999999999999999777754332111 111111000 00 0000
Q ss_pred ccCcc-----CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPE-----LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+. +.....+....+.+++.+||+.||.+||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 001111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=299.68 Aligned_cols=243 Identities=27% Similarity=0.443 Sum_probs=202.8
Q ss_pred CcccCcceEEEEEEEC--CCC--EEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR--DGT--QIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.|++|.|. +|+ .||||+++.+... ...+|++|+.+|.+|+|+|++++||+..+ ....+|||.++.|
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLG 195 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccc
Confidence 4899999999999776 354 5799999877544 55899999999999999999999999987 6788999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-e
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-V 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 154 (322)
+|.+.++. .+...+.....+.++.|||.|+.||.+++ +|||||...|+++.....|||+|||+.+..+.+... .
T Consensus 196 SLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 196 SLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred hHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999987 33447888999999999999999999999 999999999999999999999999999977644332 2
Q ss_pred e-cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 S-TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 ~-~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
+ ....-...|+|||.+....|+.++|||+|||+||||++ |..||-+....+.+..++ + .+.-.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~--------~erLp 335 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------A--------GERLP 335 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------c--------cccCC
Confidence 2 22334668999999999999999999999999999998 789998765543332221 1 12223
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
-+..+.++++++++.||..+|++||++..|.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 46667788999999999999999999999973
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=280.15 Aligned_cols=241 Identities=25% Similarity=0.309 Sum_probs=196.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++.+++++||||+++++++.+....++++||+.+++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (258)
T cd05578 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD 86 (258)
T ss_pred EeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCC
Confidence 4899999999999776 68999999997542 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... ++++..+..++.|++.||.|||+++ ++|+||+|.||++++++.++|+|||.+....... ...
T Consensus 87 L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 157 (258)
T cd05578 87 LRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTT 157 (258)
T ss_pred HHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--ccc
Confidence 999996542 6889999999999999999999998 9999999999999999999999999988654332 122
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...++..|+|||.+....++.++|+||||+++|+|++|..||............ .... ......+..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~---------~~~~~~~~~ 224 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQE---------TADVLYPAT 224 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhc---------cccccCccc
Confidence 345788999999999888999999999999999999999999866443111111 1110 011122223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTM--KQVV 263 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~--~evl 263 (322)
....+.+++.+||+.||.+||++ +|++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 34668899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.15 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=193.5
Q ss_pred CcccCcceEEEEEEEC-CCC----EEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT----QIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. +|. .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..++++||+++
T Consensus 14 ~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~ 92 (303)
T cd05110 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPH 92 (303)
T ss_pred ccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCC
Confidence 4899999999999764 444 57889886543 23335788999999999999999999998754 46789999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 93 g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 93 GCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccccc
Confidence 999999865432 5888999999999999999999998 999999999999999999999999999865432221
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ . .....+.. . .
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~-------~-~ 231 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---P----DLLEKGER-------L-P 231 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHCCCC-------C-C
Confidence 1122335678999999998899999999999999999997 8899865421111 1 11111110 0 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+..++..||..+|++||++.++++.|..+..
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111223457888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.81 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=195.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +++.|++|.++.. .....+.+.+|+++++.++|+||+++++++...+..++++||++++.+
T Consensus 8 ~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 87 (288)
T cd07833 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87 (288)
T ss_pred EecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHH
Confidence 3899999999999776 5889999998654 233347789999999999999999999999999999999999998766
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..+..... .+++..++.++.||+.||.|||..+ ++|+||+|.||++++++.++|+|||++.............
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 88 ELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 66554322 5889999999999999999999998 9999999999999999999999999988655433222233
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH---------HHhcCccc--cc
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK---------LREEGRLL--EI 225 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~--~~ 225 (322)
..++..|+|||++... .++.++||||||+++|+|++|..||......+.......... ........ ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 5578899999999887 789999999999999999999999875433222211111000 00000000 00
Q ss_pred cCccC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 VDPEL-----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 ~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+... ...+.....++.+++.+||+.+|++||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0111122566899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=289.65 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=193.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+||.++||++...+.+-||+|.+... +.....-+.+|+..|.+| .|.+||++++|-..++.+|+||||= ..+|
T Consensus 368 ~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL 446 (677)
T KOG0596|consen 368 QIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDL 446 (677)
T ss_pred hhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccH
Confidence 48999999999998877777888876543 556668899999999999 5899999999999999999999965 5599
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-eec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 156 (322)
..+|..... ..+.-.+..+..|++.|+.++|..+ |||.||||.|+|+- .|.+||+|||+|.....+... ...
T Consensus 447 ~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 447 NKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred HHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeec
Confidence 999976653 2332378889999999999999999 99999999999987 468999999999977655443 334
Q ss_pred ccccCCCCCchHHHhhC-----------CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 157 RVAGTMGYLAPEYALLG-----------QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~-----------~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
..+||+.||+||.+... +.++++||||||||||+|+.|+.||....+. +. ++..+
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~a---------Kl~aI 585 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----IA---------KLHAI 585 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----HH---------HHHhh
Confidence 57899999999998743 2568999999999999999999999754211 11 12233
Q ss_pred cCc----cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 VDP----ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ~~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+| ++.+.+.... ++++++.||+.||.+||++.|+|+.
T Consensus 586 ~~P~~~Iefp~~~~~~~--li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDE--LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchH--HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 334 2233333322 8899999999999999999999874
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=284.79 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=190.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|..||+|.++.... .....+.+|+.++++++||||+++++++.+....++++||+++ +|
T Consensus 7 ~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l 85 (284)
T cd07839 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DL 85 (284)
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CH
Confidence 3899999999999776 689999999875422 2235678899999999999999999999999999999999974 78
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 86 ~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 158 (284)
T cd07839 86 KKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSA 158 (284)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-cCC
Confidence 87775432 26899999999999999999999999 999999999999999999999999998755332211 122
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc---C------cccc-cc
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE---G------RLLE-IV 226 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~------~~~~-~~ 226 (322)
..++..|+|||++.+. .++.++|||||||++|+|++|..|+........ ........... . .... ..
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 3568899999998765 468999999999999999999998654322111 11111000000 0 0000 00
Q ss_pred CccC------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 227 DPEL------TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 227 ~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
-+.. ....+....++.+++.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0111123456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.87 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=195.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L 77 (322)
||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+. ...+++|||+++++|
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L 88 (287)
T cd06621 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL 88 (287)
T ss_pred eccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCH
Confidence 799999999999875 688999999875433 3456789999999999999999999998654 368999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.........+++..++.++.||+.||+|||+.+ ++|+||+|.||+++.++.++|+|||++........ ..
T Consensus 89 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 162 (287)
T cd06621 89 DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GT 162 (287)
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc---cc
Confidence 9987643333346889999999999999999999998 99999999999999999999999999875432211 23
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+...... ...... +... .......
T Consensus 163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~-~~~~-~~~~~~~ 238 (287)
T cd06621 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIV-NMPNPE-LKDE-PGNGIKW 238 (287)
T ss_pred ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHh-cCCchh-hccC-CCCCCch
Confidence 34678999999999889999999999999999999999999865321 111111111111 101100 0000 0100123
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.+|++|||+.|+++.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 4568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.79 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=181.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCC------CcccccceEEEeC-CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH------PNLVQLIGCCVED-NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~~~~lv~e~~ 72 (322)
+||+|+||+||+|... +++.||||+++... .....+..|+.+++.++| .+++.+++++... ...++||+++
T Consensus 136 ~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~ 214 (467)
T PTZ00284 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY 214 (467)
T ss_pred EEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc
Confidence 3899999999999765 58899999986432 223445667777766654 4588888888664 4688899988
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCC----------------e
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNF----------------H 135 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~----------------~ 135 (322)
+++|.+++.... .+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++ .
T Consensus 215 -g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 215 -GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred -CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 678888886543 68999999999999999999997 48 99999999999998765 4
Q ss_pred EEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH
Q 020720 136 PKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK 215 (322)
Q Consensus 136 ~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 215 (322)
+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.....
T Consensus 287 vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 287 VRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred EEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 99999998764321 12345689999999999999999999999999999999999999976543322222111100
Q ss_pred -----------------HH-hcCccccccCcc-C----CCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 216 -----------------LR-EEGRLLEIVDPE-L----TQFP---EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 216 -----------------~~-~~~~~~~~~~~~-~----~~~~---~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ..+.+....++. + .... ......+.+++.+||+.||.+|||++|+++
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00 000000000000 0 0000 001245779999999999999999999997
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=284.89 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=193.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh-----cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ-----GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|++|.||+|... +|+.|++|.++..... ....+..|+.+++.++|+||+++++++.+.+..++||||+ +
T Consensus 7 ~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 85 (298)
T cd07841 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-E 85 (298)
T ss_pred eeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-C
Confidence 4899999999999765 6899999999755322 2356778999999999999999999999999999999999 8
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 86 TDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred CCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 89999996543 26899999999999999999999999 999999999999999999999999999865433211
Q ss_pred ecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH------HHhcCccccccC
Q 020720 155 STRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK------LREEGRLLEIVD 227 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 227 (322)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+.......... ............
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 122345778999998865 4678999999999999999999777765432211111100000 000000000000
Q ss_pred ------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 ------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 ------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.............+.+++.+||+.||++||++.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00011112234568899999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=280.09 Aligned_cols=245 Identities=28% Similarity=0.372 Sum_probs=195.6
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||++... +|+.+++|.+..... .....+.+|+.++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 699999999999877 599999999875433 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-----
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT----- 152 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 152 (322)
.+++.... .+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 6899999999999999999999998 99999999999999999999999999875432211
Q ss_pred --eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 --HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......++..|++||.......+.++||||||+++|+|++|..||......... ..... +.. ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~-~~~------~~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNILN-GKI------EW 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-CCc------CC
Confidence 1122345788999999998888999999999999999999999998754322111 11111 100 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.... .....+.+++.+||+.+|++||++.++.+.|+
T Consensus 221 ~~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred Cccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0110 02455889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=286.64 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++... +++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..+++|||+++++
T Consensus 8 ~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (305)
T cd05609 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGD 87 (305)
T ss_pred EeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 3899999999999776 58899999987553 2234578899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc----
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---- 152 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 152 (322)
|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 88 L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 88 CATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999996543 6899999999999999999999998 99999999999999999999999998863211000
Q ss_pred ----------eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 153 ----------HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 153 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
.......++..|+|||.+....++.++|||||||++|+|++|..||....... . ........ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~---~~~~~~~~-~ 233 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L---FGQVISDD-I 233 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhcc-c
Confidence 01112346788999999988889999999999999999999999997542211 1 11111110 0
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
..+.. .......+.+++.+||+.||++||++.++.+.|+..
T Consensus 234 ---~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 234 ---EWPEG---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ---CCCCc---cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 00111 112334578999999999999999987777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=280.61 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=193.1
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEE
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILV 68 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv 68 (322)
+||+|+||.||+|... ++..||+|++..+ .....+.+.+|+.+++.++||||+++++++.... ..+++
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 85 (273)
T cd05074 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85 (273)
T ss_pred cccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEE
Confidence 4899999999999653 3688999998754 3344567889999999999999999999886532 24788
Q ss_pred EEcCCCCCHHHHHhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 69 YEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
++|+.+++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+..
T Consensus 86 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~ 162 (273)
T cd05074 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKK 162 (273)
T ss_pred EecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccccccc
Confidence 99999999998875322 22235788899999999999999999998 99999999999999999999999999886
Q ss_pred cCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 147 FPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 147 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
....... ......+++.|++||.+....++.++|||||||++|+|++ |..||...... ...... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~----~~~~--- 232 (273)
T cd05074 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL----IKGN--- 232 (273)
T ss_pred ccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH----HcCC---
Confidence 5332211 1122335578999999998889999999999999999999 88888644221 111110 0110
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
....+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 233 -----~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 -----RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=278.70 Aligned_cols=244 Identities=22% Similarity=0.372 Sum_probs=195.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+.+..++++||+++++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (257)
T cd08225 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDL 86 (257)
T ss_pred EecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcH
Confidence 3899999999999776 58899999986542 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|.||++++++ .++|+|||.+........ ...
T Consensus 87 ~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (257)
T cd08225 87 MKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAY 160 (257)
T ss_pred HHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc-ccc
Confidence 999865432 25789999999999999999999998 99999999999999885 469999999876543322 122
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++....++.++||||||+++|+|++|..||....... ...... . .........
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~--------~~~~~~~~~ 225 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-Q--------GYFAPISPN 225 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-c--------ccCCCCCCC
Confidence 2357889999999988889999999999999999999999986542211 111111 1 111222223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.+|++||++.+++..
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 34468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=282.51 Aligned_cols=242 Identities=28% Similarity=0.445 Sum_probs=196.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||++... ++..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|.++
T Consensus 27 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 106 (293)
T cd06647 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 106 (293)
T ss_pred ecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHH
Confidence 899999999999764 6889999998765555567889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 107 ~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 177 (293)
T cd06647 107 VTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 177 (293)
T ss_pred Hhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccC
Confidence 8543 4788899999999999999999999 99999999999999999999999998875543222 1223457
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
++.|++||.+....++.++||||||+++|+|++|..||............ ...+ .+.. ..+......
T Consensus 178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~------~~~~-~~~~~~~~~ 244 (293)
T cd06647 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG------TPEL-QNPEKLSAI 244 (293)
T ss_pred ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC------CCCC-CCccccCHH
Confidence 88899999998888999999999999999999999999754332211100 0000 0111 112223345
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+.+++.+||+.+|++||++.+++..
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 7789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.55 Aligned_cols=241 Identities=26% Similarity=0.408 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... ++..||+|.+.... ......+.+|+..+.+++||||+++++++.++...++||||+++++|.
T Consensus 11 ~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~ 90 (277)
T cd06641 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 90 (277)
T ss_pred eEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHH
Confidence 3899999999999765 68899999986442 334467889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++... .+++..+..++.|++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ .....
T Consensus 91 ~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06641 91 DLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccc
Confidence 998543 5889999999999999999999998 99999999999999999999999999875533211 11224
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||....... . ..... .. ..........
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~-~~--------~~~~~~~~~~ 226 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---V---LFLIP-KN--------NPPTLEGNYS 226 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---H---HHHHh-cC--------CCCCCCcccC
Confidence 57889999999988889999999999999999999999986532211 1 11111 11 1112222334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.+++.+||+.+|.+||++.+++..
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 557888999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=279.58 Aligned_cols=246 Identities=28% Similarity=0.441 Sum_probs=192.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCC------eeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDN------NRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~ 72 (322)
.||+|++|.||+|... +++.+++|++..... ....+.+|+.+++++ +|+||+++++++.+.. ..+++|||+
T Consensus 13 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~ 91 (275)
T cd06608 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELC 91 (275)
T ss_pred eecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcC
Confidence 4899999999999875 588999999875543 346788999999999 7999999999997654 489999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 168 (275)
T cd06608 92 GGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168 (275)
T ss_pred CCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchh
Confidence 999999998754323347899999999999999999999998 99999999999999999999999999875433221
Q ss_pred eeecccccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 153 HVSTRVAGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......++..|+|||++.. ..++.++|||||||++|+|++|..||......... .+... .. .
T Consensus 169 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~-----~ 235 (275)
T cd06608 169 -RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL------FKIPR-NP-----P 235 (275)
T ss_pred -hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH------HHhhc-cC-----C
Confidence 1223457889999998864 34678999999999999999999999743221111 11110 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+ ..+......+.+++.+||..||++|||+.++++
T Consensus 236 ~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 112224456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.63 Aligned_cols=248 Identities=29% Similarity=0.396 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||.|+||.||+|... ++..+++|++.... ....+.+.+|+..++.++|+||+++++.+...+..++++|++++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~ 87 (267)
T cd06610 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87 (267)
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHH
Confidence 3799999999999765 68899999986543 335578899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce---ee
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH---VS 155 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~ 155 (322)
+++..... ...+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++......... ..
T Consensus 88 ~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 163 (267)
T cd06610 88 DIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163 (267)
T ss_pred HHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccc
Confidence 99975422 125889999999999999999999998 999999999999999999999999998765433221 12
Q ss_pred cccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....++..|+|||++... .++.++|+||||+++|+|++|..||......... .+.... ..+.+....
T Consensus 164 ~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~------~~~~~~~~~ 231 (267)
T cd06610 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQN------DPPSLETGA 231 (267)
T ss_pred ccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcC------CCCCcCCcc
Confidence 234578899999998877 7899999999999999999999999755332111 111100 011111111
Q ss_pred --HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 --EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 --~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 233456889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=324.12 Aligned_cols=253 Identities=29% Similarity=0.565 Sum_probs=199.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|... ++..||+|.+...... ...|++.+++++||||+++++++.+....++||||+++|+|.+
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 772 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHH
Confidence 4899999999999874 7899999998643322 1246888999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++. .++|..+..++.|++.|++|||....++++||||||+||+++.++..++. |+........ ....
T Consensus 773 ~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~ 839 (968)
T PLN00113 773 VLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCF 839 (968)
T ss_pred HHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcc
Confidence 994 37899999999999999999995433449999999999999998888775 5554432111 1235
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC---CCCHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT---QFPEK 236 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 236 (322)
+++.|+|||++.+..++.++|||||||++|||++|+.||...... ......|.............+++.+. .....
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 789999999999999999999999999999999999998643322 22233333332222333334455442 23456
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
+..++.+++.+||+.||++||++.||++.|++...
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 67788999999999999999999999999988764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=279.84 Aligned_cols=241 Identities=23% Similarity=0.409 Sum_probs=193.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.+. +++.|++|.++.. .......+.+|+.+++.++ |||++++++++......+++|||++++
T Consensus 8 ~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06917 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG 87 (277)
T ss_pred heeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCC
Confidence 4899999999999764 6899999998754 3344567888999999986 999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 88 ~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06917 88 SVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KR 158 (277)
T ss_pred cHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cc
Confidence 999998543 6889999999999999999999999 99999999999999999999999999886654332 12
Q ss_pred cccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....++..|+|||.+..+ .++.++||||||+++|+|++|..||.......... . ......+.+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~------~~~~~~~~~~~~- 225 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------L------IPKSKPPRLEDN- 225 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------c------cccCCCCCCCcc-
Confidence 334588899999988754 56899999999999999999999997542211100 0 000011111110
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+.+++.+||+.||++||++.+++.
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 -GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 13446888999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=282.11 Aligned_cols=242 Identities=22% Similarity=0.384 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||++... ++..||+|.+..........+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+
T Consensus 27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (292)
T cd06657 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 106 (292)
T ss_pred HcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHH
Confidence 3899999999999775 689999999876555556778999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..++.++.|++.|++|||+.+ ++|+||+|.||+++.++.++|+|||++........ ......
T Consensus 107 ~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 107 IVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 87433 5788999999999999999999998 99999999999999999999999998875543221 122345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||.+....++.++|+||||+++|+|++|..||......... .. ... .+.+.+.. ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~---~~~------~~~~~~~~-~~~~~~ 244 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KM---IRD------NLPPKLKN-LHKVSP 244 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH---HHh------hCCcccCC-cccCCH
Confidence 788999999998888899999999999999999999998753221111 10 000 01111111 112233
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+++.+||+.||.+||++.+++.
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 4778889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=281.31 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=189.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEe------CCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVE------DNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +|+||+++++++.. ....+++|||+
T Consensus 23 ~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 101 (282)
T cd06636 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC 101 (282)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeC
Confidence 4799999999999775 68899999986543 3345688899999998 79999999999853 45789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++|.+++..... ..+++..++.++.||+.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 102 GAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred CCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 99999999965432 25788889999999999999999998 99999999999999999999999999875432211
Q ss_pred eeecccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 153 HVSTRVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......++..|+|||.+. ...++.++|||||||++|+|++|..||.......... .....
T Consensus 177 -~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~~~~~-------- 241 (282)
T cd06636 177 -RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------LIPRN-------- 241 (282)
T ss_pred -CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------hHhhC--------
Confidence 122345788999999875 3467889999999999999999999996543211111 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.............+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0001111223456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=280.31 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=188.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHH-HhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDM-IWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|+++... ......+..|+.. ++.++||||+++++++..++..+++|||++ ++|
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (283)
T cd06617 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSL 86 (283)
T ss_pred EecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccH
Confidence 3899999999999776 69999999987553 2334456666665 566799999999999999999999999996 588
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+++.........+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 161 (283)
T cd06617 87 DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKT 161 (283)
T ss_pred HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc--ccc
Confidence 888765433335789999999999999999999986 7 9999999999999999999999999987653321 112
Q ss_pred ccccCCCCCchHHHhh----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYALL----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .... ..... + ..+.+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~---~~~~~-~-----~~~~~~- 229 (283)
T cd06617 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQL---KQVVE-E-----PSPQLP- 229 (283)
T ss_pred cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHH---HHHHh-c-----CCCCCC-
Confidence 2457889999998864 45688999999999999999999998643221 1111 11111 0 001111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.......+.+++.+||..+|++||++.+++.
T Consensus 230 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 -AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.15 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=190.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeC-----CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVED-----NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~ 73 (322)
.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++... +..++|+||++
T Consensus 29 ~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~ 107 (291)
T cd06639 29 TIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN 107 (291)
T ss_pred EeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence 3799999999999765 68899999986432 2235677899999998 899999999998754 35899999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 108 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 183 (291)
T cd06639 108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL- 183 (291)
T ss_pred CCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc-
Confidence 99999988643323336899999999999999999999998 99999999999999999999999999875432211
Q ss_pred eecccccCCCCCchHHHhhC-----CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 154 VSTRVAGTMGYLAPEYALLG-----QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~-----~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
......++..|+|||++... .++.++|||||||++|+|++|..||......... ..... ... +
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~------~~~~~-~~~-----~ 251 (291)
T cd06639 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL------FKIPR-NPP-----P 251 (291)
T ss_pred cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH------HHHhc-CCC-----C
Confidence 11224578899999988643 3689999999999999999999998754321111 11111 100 1
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+ ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 252 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 1122334468899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=273.28 Aligned_cols=244 Identities=30% Similarity=0.485 Sum_probs=199.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|++|.||++... ++..+++|++..........+.+|+..++.++|+|++++++++......++++||+++++|.+
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 86 (253)
T cd05122 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86 (253)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHH
Confidence 3899999999999876 689999999987655566889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ..+++..++.++.|++.||.+||..+ ++|+||+|.||+++.++.++|+|||.+........ .....
T Consensus 87 ~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 87 LLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred HHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 996653 36899999999999999999999988 99999999999999999999999999876544321 23345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|+|||.+....++.++||||||+++|+|++|..||........... ... ... +.+. .......
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-~~~-----~~~~-~~~~~~~ 225 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------IAT-NGP-----PGLR-NPEKWSD 225 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HHh-cCC-----CCcC-cccccCH
Confidence 78899999999888899999999999999999999999875432211111 000 000 1111 1111245
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68889999999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=284.10 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++++||+++++|
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 87 (286)
T cd07846 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL 87 (286)
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHH
Confidence 4899999999999876 589999998864422 2346788999999999999999999999999999999999999888
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .....
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 88 DDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred HHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 88775432 5899999999999999999999998 9999999999999999999999999987653322 11223
Q ss_pred cccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh-----------cCcc-cc
Q 020720 158 VAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE-----------EGRL-LE 224 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~-~~ 224 (322)
..++..|+|||++.+ ..++.++||||||+++|+|++|..||......+. ......... .... ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ---LYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH---HHHHHHHhCCCchhhHHHhccchHhhc
Confidence 457889999999875 3467899999999999999999988864432111 111110000 0000 00
Q ss_pred ccCccCC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 IVDPELT------QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 ~~~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0001110 011123456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.37 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=201.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||.|+||.||++... ++..|++|++..... .....+.+|++.++.++|+|++++.+.+...+..++++||+++++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 86 (258)
T cd08215 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDL 86 (258)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcH
Confidence 4899999999999776 689999999876533 5567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.........+++..++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 162 (258)
T cd08215 87 SQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKT 162 (258)
T ss_pred HHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-ceecc
Confidence 9999765433347999999999999999999999998 9999999999999999999999999988664433 12233
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+++.|+|||.+....++.++||||+|+++|+|++|..||....... . ..... . ......+...
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~---~~~~~-~--------~~~~~~~~~~ 227 (258)
T cd08215 163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L---ALKIL-K--------GQYPPIPSQY 227 (258)
T ss_pred eeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H---HHHHh-c--------CCCCCCCCCC
Confidence 467889999999988889999999999999999999999986543111 1 11111 1 1112222233
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.+|++||++.++++.
T Consensus 228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 228 SSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 4568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.12 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=200.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||++... ++..+++|.+... .......+.+|+.+++.++|+||+++++++.+....++++||+++++|
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd08530 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDL 86 (256)
T ss_pred eecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCH
Confidence 3799999999999665 6889999998754 233456778999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~---~~~ 160 (256)
T cd08530 87 SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM---AKT 160 (256)
T ss_pred HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC---ccc
Confidence 9998764333447899999999999999999999998 9999999999999999999999999998665431 223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|++||.+.+..++.++|+||||+++|+|++|..||....... .. ... . .......+...
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~---~~~-~--------~~~~~~~~~~~ 225 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR---YKV-Q--------RGKYPPIPPIY 225 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHH-h--------cCCCCCCchhh
Confidence 457889999999998889999999999999999999999997543211 00 000 1 11222333455
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..++.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 226 SQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 5678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=312.70 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=185.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC----------------
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED---------------- 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------------- 62 (322)
+||+||||.||+++++ +|+.||||++.... ......+.+|+..+++++|||||+++..+.+.
T Consensus 486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~ 565 (1351)
T KOG1035|consen 486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSES 565 (1351)
T ss_pred HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhh
Confidence 5899999999999988 89999999998664 33346789999999999999999987664110
Q ss_pred --------------------------------------------------------------------------------
Q 020720 63 -------------------------------------------------------------------------------- 62 (322)
Q Consensus 63 -------------------------------------------------------------------------------- 62 (322)
T Consensus 566 ~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~ 645 (1351)
T KOG1035|consen 566 RSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDT 645 (1351)
T ss_pred hcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcc
Confidence
Q ss_pred -----------------------CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 020720 63 -----------------------NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119 (322)
Q Consensus 63 -----------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~ 119 (322)
..+|+-||||+..++.++++.+.-. -.....|+++.+|++||+|+|+++ +|
T Consensus 646 ~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH~~g---iI 719 (1351)
T KOG1035|consen 646 SESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIHDQG---II 719 (1351)
T ss_pred hhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHHhCc---ee
Confidence 0146789999988888888665311 146789999999999999999999 99
Q ss_pred eccCcccceEeCCCCeEEEeeeccccccC------C-----------CcceeecccccCCCCCchHHHhhC---CCCccc
Q 020720 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFP------D-----------NVTHVSTRVAGTMGYLAPEYALLG---QLTKKA 179 (322)
Q Consensus 120 h~dlkp~Nill~~~~~~kl~Dfg~~~~~~------~-----------~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~s 179 (322)
||||||.|||+++++.|||+|||++.... . ......+..+||.-|+|||++.+. .|+.|+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999998610 0 001123457899999999999865 499999
Q ss_pred ceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 020720 180 DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 180 Dv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
|+|||||+++||+. ||...... ......++ .+.+ |.-..+..+....-.++|.||++.||++|||+
T Consensus 800 DmYSLGIVlFEM~y---PF~TsMER-----a~iL~~LR-~g~i-----P~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY---PFGTSMER-----ASILTNLR-KGSI-----PEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred hhHHHHHHHHHHhc---cCCchHHH-----HHHHHhcc-cCCC-----CCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 99999999999983 45433211 11111111 1111 11133344445556789999999999999999
Q ss_pred HHHHH
Q 020720 260 KQVVE 264 (322)
Q Consensus 260 ~evl~ 264 (322)
.|+|.
T Consensus 866 ~eLL~ 870 (1351)
T KOG1035|consen 866 TELLN 870 (1351)
T ss_pred HHHhh
Confidence 99975
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=282.51 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=189.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|++|.||+|... +++.||+|.+...... ....+.+|+.++++++|+||+++++++.+....++||||+.+ +|.
T Consensus 12 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~ 90 (291)
T cd07844 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLK 90 (291)
T ss_pred EEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHH
Confidence 3899999999999776 6899999998754322 234577899999999999999999999999999999999975 899
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 91 ~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 163 (291)
T cd07844 91 QYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNE 163 (291)
T ss_pred HHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccccc
Confidence 98865432 6889999999999999999999998 99999999999999999999999999875422111 11223
Q ss_pred ccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh---cCcc------ccc---
Q 020720 159 AGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE---EGRL------LEI--- 225 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~--- 225 (322)
.++..|+|||++.+ ..++.++||||||+++|+|++|..||....... ......+.... .... ...
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 46788999998875 457899999999999999999999996543211 11111110000 0000 000
Q ss_pred ----c-CccCCCCCHH--HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 ----V-DPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 ----~-~~~~~~~~~~--~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. ...+...... ....+.+++.+||+.+|.+||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000000 1245788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=278.73 Aligned_cols=243 Identities=28% Similarity=0.476 Sum_probs=196.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|++|.||+|..+ ++..+++|++..... ....+.+|++.++.++|+|++++++++......++++||+++++|.+
T Consensus 26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (286)
T cd06614 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104 (286)
T ss_pred hccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence 3799999999999876 689999999976544 55778899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........ ......
T Consensus 105 ~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 177 (286)
T cd06614 105 IITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV 177 (286)
T ss_pred HHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence 997654 26899999999999999999999998 99999999999999999999999998875433221 112234
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++..|++||.+.+..++.++||||||+++|+|++|..||......... ....... . +.. ........
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~~~~-~-----~~~-~~~~~~~~ 244 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLITTKG-I-----PPL-KNPEKWSP 244 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC-C-----CCC-cchhhCCH
Confidence 678999999998888999999999999999999999998643221111 0111110 0 011 11111345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+++.+||+.+|.+||++.+++.
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhh
Confidence 6888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=295.18 Aligned_cols=258 Identities=27% Similarity=0.365 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~ 72 (322)
.||+|+||.||+|+++ +|+.||||.++.. .....+...+|++++++++|+|||+++++=++.. ...++||||
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC 99 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC 99 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeec
Confidence 4899999999999866 7999999999764 4555678899999999999999999999854433 468999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC--C--CCeEEEeeeccccccC
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD--G--NFHPKIGDFGLAKLFP 148 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--~--~~~~kl~Dfg~~~~~~ 148 (322)
.+|+|...++... ....+++.+.+.++..++.||.|||.++ |+||||||.||++- . ....||+|||.|+...
T Consensus 100 ~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 100 SGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred CCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 9999999997654 4457999999999999999999999999 99999999999994 2 2348999999999887
Q ss_pred CCcceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
++. ......||..|++||+... +.|+..+|.|||||++|+++||..||...........+.|...............
T Consensus 176 d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 176 DNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred CCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 665 4566789999999999984 7899999999999999999999999987655533222222211111111110000
Q ss_pred -------------ccCCCCCHHHHHHHHHHHHhcccCCCCCCC--CHHHHHH
Q 020720 228 -------------PELTQFPEKEVMRFIKVGLFCTQAGAHYRP--TMKQVVE 264 (322)
Q Consensus 228 -------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp--s~~evl~ 264 (322)
|......+....++-+.+..+|..+|.+|- .+.+...
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa 305 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFA 305 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHH
Confidence 111233344555666777778888888887 4444433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=281.25 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=190.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||.|++|.||+|... +|..||||.++.+. ......+.+|++++++++||||+++++++.+....+++|||+. ++|.
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~ 86 (284)
T cd07860 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 86 (284)
T ss_pred ecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHH
Confidence 799999999999775 68999999987543 2233678899999999999999999999999999999999996 5888
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++......... ....
T Consensus 87 ~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 160 (284)
T cd07860 87 KFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHE 160 (284)
T ss_pred HHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-cccc
Confidence 88865432 26889999999999999999999998 999999999999999999999999998755332211 1223
Q ss_pred ccCCCCCchHHHhhCC-CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc---------------Ccc
Q 020720 159 AGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE---------------GRL 222 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~-~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~ 222 (322)
.++..|+|||++.+.. ++.++||||||+++|+|++|..||............ ....... ...
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhCCCChhhhhhhhHHHHHHhhc
Confidence 4678899999876544 588999999999999999999999754322111110 0000000 000
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.......+..........+.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000111112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.21 Aligned_cols=256 Identities=26% Similarity=0.343 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +++.+++|.++..... ....+.+|+.++.+++||||+++++++... ...++++||+.+
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~- 90 (293)
T cd07843 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH- 90 (293)
T ss_pred hhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-
Confidence 3899999999999876 6889999999755322 224577899999999999999999998877 889999999974
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 91 ~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~ 163 (293)
T cd07843 91 DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-Y 163 (293)
T ss_pred CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc-c
Confidence 89998865432 6899999999999999999999998 999999999999999999999999998866543211 1
Q ss_pred cccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH--------HHHHhc------C
Q 020720 156 TRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT--------WKLREE------G 220 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~------~ 220 (322)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||......+....+... |..... .
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 233467889999988764 4689999999999999999999999765432221111100 000000 0
Q ss_pred ccccccCccC-CCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 221 RLLEIVDPEL-TQFPEK-EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 221 ~~~~~~~~~~-~~~~~~-~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.........+ ..++.. ....+.+++.+||+.||++||++.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000011 111111 2455788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.52 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=192.5
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...++||||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 86 (316)
T cd07842 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86 (316)
T ss_pred EeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence 3899999999999764 47899999997632 33346778899999999999999999999988 7899999999
Q ss_pred CCCCHHHHHhcCCCCC-cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC----CCeEEEeeecccccc
Q 020720 73 ENNSLANALLGSKSKY-VSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG----NFHPKIGDFGLAKLF 147 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~----~~~~kl~Dfg~~~~~ 147 (322)
++ +|.+++....... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++...
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 87 EH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred Cc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 75 6777665433222 36889999999999999999999998 999999999999999 999999999998865
Q ss_pred CCCcc--eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCch------hHHHHHHHHH-
Q 020720 148 PDNVT--HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML------ILVEWTWKLR- 217 (322)
Q Consensus 148 ~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~- 217 (322)
..... .......++..|+|||++.+. .++.++|||||||++|+|++|..||......... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence 43322 112234578899999988764 5789999999999999999999999865443200 0000000000
Q ss_pred -----------hcCcccccc-CccCCCCC----H-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 218 -----------EEGRLLEIV-DPELTQFP----E-------KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 218 -----------~~~~~~~~~-~~~~~~~~----~-------~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......... .......+ . ....++.+++.+||+.||++|||+.|++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000 00000111 0 223458899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=280.94 Aligned_cols=239 Identities=29% Similarity=0.450 Sum_probs=189.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+||+. ++
T Consensus 22 ~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~ 100 (307)
T cd06607 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GS 100 (307)
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CC
Confidence 4899999999999765 68999999986432 2334678899999999999999999999999999999999997 57
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
+.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++...... .
T Consensus 101 l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~ 169 (307)
T cd06607 101 ASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----N 169 (307)
T ss_pred HHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-----C
Confidence 7777754322 6899999999999999999999998 999999999999999999999999988754322 2
Q ss_pred ccccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 157 RVAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
...++..|+|||++. ...++.++||||||+++|+|++|..||........ . ....... .+.+ .
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~---~~~~~~~------~~~~--~ 235 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YHIAQND------SPTL--S 235 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---H---HHHhcCC------CCCC--C
Confidence 245788999999874 45688999999999999999999999865421111 0 0111000 0111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.......+.+++.+||+.||++||++.+|+..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 12244568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=284.07 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=197.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||-+..+ +|+.||+|.+... ........++|-.+|++++.++||.+--.|+..+.+++|+..|+||+
T Consensus 192 vlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGD 271 (591)
T KOG0986|consen 192 VLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGD 271 (591)
T ss_pred EEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCc
Confidence 5899999999999665 7999999988544 34445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|...|...+. ..+++..+..++.+|+.||++||+.+ |++|||||+|||+|+.|+++|+|+|+|..+...... .
T Consensus 272 LkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~ 344 (591)
T KOG0986|consen 272 LKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--R 344 (591)
T ss_pred eeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc--c
Confidence 9988866543 37999999999999999999999999 999999999999999999999999999987655433 3
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||.+|||||++++..|+...|-|||||+||||+.|+.||...........++. . +-..-..++..
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r---------~~~~~~ey~~k 412 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---R---------TLEDPEEYSDK 412 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---H---------Hhcchhhcccc
Confidence 34799999999999999999999999999999999999999986644322211110 0 00111223344
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMK 260 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~ 260 (322)
...+...+....|++||.+|....
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCC
Confidence 445566777779999999997643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=281.17 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=192.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||.|++|.||+|... +|..||+|++.... ......+.+|+..++.++|||++++++++.+.+..++++||++ ++|
T Consensus 6 ~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l 84 (283)
T cd07835 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDL 84 (283)
T ss_pred EecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCH
Confidence 3899999999999765 69999999987553 2233578889999999999999999999999999999999995 689
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++......... ...
T Consensus 85 ~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~ 158 (283)
T cd07835 85 KKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTH 158 (283)
T ss_pred HHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cCc
Confidence 998865432 26899999999999999999999998 999999999999999999999999998754322111 122
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH-hcC----------c----
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR-EEG----------R---- 221 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~----------~---- 221 (322)
..++..|+|||++.+. .++.++||||||+++|+|++|..||............ ..... ... .
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI--FRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChHHhhhhhhchhhhhh
Confidence 3467899999987654 5689999999999999999999999754322111110 00000 000 0
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 222 LLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...................+.+++.+||+.||.+||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000111111222346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.45 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=193.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~ 76 (322)
||+|++|.||+|... ++..+|+|.+.... ......+.+|+.+++.++|+|++++++++.+. +..++++||+++ +
T Consensus 7 l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (287)
T cd07840 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-D 85 (287)
T ss_pred eccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-c
Confidence 899999999999876 58899999998653 33446788999999999999999999999888 789999999975 8
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||+|.||++++++.++|+|||++............
T Consensus 86 l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 86 LTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred HHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 888886542 26899999999999999999999998 999999999999999999999999998866443322223
Q ss_pred ccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc--------cc-
Q 020720 157 RVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE--------IV- 226 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~- 226 (322)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......................... ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3456788999997765 4578999999999999999999999976543221111110000000000000 00
Q ss_pred -----CccCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 227 -----DPELTQFPEK-EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 227 -----~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+...... ....+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000011 2456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=275.36 Aligned_cols=241 Identities=25% Similarity=0.339 Sum_probs=187.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHH---HHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEI---DMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|... +++.||+|.+..... .....+..|. ..++...||+|+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 5899999999999765 689999999865421 1112233343 34455689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++.... .+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999886443 6999999999999999999999998 99999999999999999999999999875432211
Q ss_pred eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
....|+..|+|||++.++ .++.++||||+|+++|+|++|..||............ .... .....+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~~~~-- 218 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMAVEL-- 218 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccCCCC--
Confidence 234688999999998754 6889999999999999999999999765332221111 0000 011112
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
+......+.+++.+||..+|.+|| ++.++++
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 222345688889999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=274.80 Aligned_cols=243 Identities=26% Similarity=0.286 Sum_probs=187.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHH-HhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDM-IWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +|+.||+|+++.... .....+..|..+ ....+|+|++++++++...+..++++||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 3899999999999765 689999999865422 122334445444 44558999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++..... .
T Consensus 83 ~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 83 DCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 9999996543 6889999999999999999999998 99999999999999999999999998875432 1
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....++..|+|||.+.+..++.++||||||+++|+|++|..||......... . .. ...... ..+ ....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~---~~-~~~~~~--~~~---~~~~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF---D---NI-LSRRIN--WPE---EVKE 218 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH---H---HH-HhcccC--CCC---cccc
Confidence 2335788999999998888899999999999999999999999754322111 0 01 111100 001 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
.....+.+++.+||+.||++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 23455889999999999999998776655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=278.85 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=195.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... ++..+++|.+..... .....+.+|+.++++++|+||+++++++.++...++++||+++ +|
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l 84 (283)
T cd05118 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DL 84 (283)
T ss_pred eeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CH
Confidence 3899999999999775 689999999875432 2446788999999999999999999999999999999999975 88
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 85 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 85 YKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred HHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 88876543 26899999999999999999999999 9999999999999999999999999987664432 11223
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc-----------
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI----------- 225 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 225 (322)
..++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....................
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4577889999998876 7899999999999999999999998755432211111000000000000000
Q ss_pred ---cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 ---VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 ---~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..............++.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000011122234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.75 Aligned_cols=257 Identities=21% Similarity=0.250 Sum_probs=189.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCC-CCcccccceEEEeCCe-----eEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNN-----RILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~~lv~e~ 71 (322)
+||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+. |+||+++++++...+. .+++|||
T Consensus 8 ~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 87 (295)
T cd07837 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEY 87 (295)
T ss_pred EecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeec
Confidence 4899999999999776 689999999865432 23367888999999995 6999999999887665 8999999
Q ss_pred CCCCCHHHHHhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCC
Q 020720 72 LENNSLANALLGSKSK-YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 149 (322)
+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++. ++.++|+|||++.....
T Consensus 88 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 88 LDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred cCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 986 788888654322 346899999999999999999999998 999999999999998 89999999999875432
Q ss_pred CcceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH-hcCccc----
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR-EEGRLL---- 223 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~---- 223 (322)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+. .... ......
T Consensus 164 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (295)
T cd07837 164 PVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF--KLLGTPTEQVWPGVS 240 (295)
T ss_pred Ccc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HHhCCCChhhCcchh
Confidence 211 1122346788999998865 457899999999999999999999987543221111100 0000 000000
Q ss_pred ---------cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 ---------EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 ---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+....+.....+.+++.+||+.||.+||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000111123455888999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=279.36 Aligned_cols=243 Identities=28% Similarity=0.396 Sum_probs=191.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++|||++++++++.++...+++|||+.+ +
T Consensus 32 ~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~ 110 (317)
T cd06635 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-S 110 (317)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-C
Confidence 3899999999999765 68899999986442 23345788999999999999999999999999999999999975 7
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .++++..+..++.|++.|+.|||+.+ ++|+||+|.||+++.++.++|+|||++...... .
T Consensus 111 l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~ 179 (317)
T cd06635 111 ASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----N 179 (317)
T ss_pred HHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-----c
Confidence 777775432 26899999999999999999999998 999999999999999999999999987654321 2
Q ss_pred ccccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 157 RVAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
...++..|+|||.+. ...++.++|||||||++|+|++|..||.......... ....... ....
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~~--------~~~~ 245 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNES--------PTLQ 245 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHHhccC--------CCCC
Confidence 345788999999874 4568899999999999999999999987542111111 1111110 0111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.......+.+++.+||+.+|.+||++.++++.+-..
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 122334588899999999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=281.17 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=190.6
Q ss_pred cccC--cceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGG--AFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++++||+.+++
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~ 85 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence 5666 99999999775 79999999987542 3334778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee--
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV-- 154 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 154 (322)
|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+++.||+............
T Consensus 86 l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 86 ANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred HHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999875432 25889999999999999999999998 9999999999999999999999997654322111100
Q ss_pred ----ecccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH--------------HH
Q 020720 155 ----STRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW--------------TW 214 (322)
Q Consensus 155 ----~~~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~--------------~~ 214 (322)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||.............. ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112245679999998763 478999999999999999999999976432211100000 00
Q ss_pred HHH------hc-----Ccc-----ccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 215 KLR------EE-----GRL-----LEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 215 ~~~------~~-----~~~-----~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
... .. ... .......+ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00 000 00000111 11122345678999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.76 Aligned_cols=259 Identities=25% Similarity=0.321 Sum_probs=190.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|..||+|.+... .......+.+|+.++++++|+||+++++++.... ..++++||+.
T Consensus 12 ~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 91 (336)
T cd07849 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME 91 (336)
T ss_pred EEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc
Confidence 3899999999999765 6899999998643 2233466888999999999999999999876543 5789999996
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+ +|.+++... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 92 ~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 92 T-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred c-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 4 888877543 5899999999999999999999999 999999999999999999999999998765332211
Q ss_pred --eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc---CccccccC
Q 020720 154 --VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE---GRLLEIVD 227 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 227 (322)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .......... .....+.+
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhc
Confidence 1123457889999998764 4688999999999999999999999965322111 1000000000 00000000
Q ss_pred ----------ccCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcccc
Q 020720 228 ----------PELTQ-----FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM--LSKDVH 271 (322)
Q Consensus 228 ----------~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~--L~~~~~ 271 (322)
+.... ..+....++.+++.+||+.||.+||++.|+++. ++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 111234568899999999999999999999985 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.48 Aligned_cols=260 Identities=19% Similarity=0.253 Sum_probs=180.9
Q ss_pred CcccCcceEEEEEEEC--CCCEEEEE------------------EecccChhcHHHHHHHHHHHhcCCCCcccccceEEE
Q 020720 1 MIGGGAFGVVYRGSLR--DGTQIAIK------------------CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~~vaiK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 60 (322)
.||+|+||+||++..+ .+...+.| .+. ........+.+|+.++++++||||+++++++.
T Consensus 155 ~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 233 (501)
T PHA03210 155 DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKIEEILR 233 (501)
T ss_pred EecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcEeEEEE
Confidence 3899999999998654 22222222 111 11223456789999999999999999999999
Q ss_pred eCCeeEEEEEcCCCCCHHHHHhcCCCC-CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe
Q 020720 61 EDNNRILVYEYLENNSLANALLGSKSK-YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG 139 (322)
Q Consensus 61 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~ 139 (322)
+.+..+++++++. ++|.+++...... ........++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 234 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~ 309 (501)
T PHA03210 234 SEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLG 309 (501)
T ss_pred ECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999985 4677776433211 112345667889999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccC-CCchhHHHHHHHHH-
Q 020720 140 DFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFG-DDMLILVEWTWKLR- 217 (322)
Q Consensus 140 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~- 217 (322)
|||++...............||..|+|||++.+..++.++|||||||++|||++|..++..... ..............
T Consensus 310 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~ 389 (501)
T PHA03210 310 DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389 (501)
T ss_pred eCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhccc
Confidence 9999986654333333345789999999999999999999999999999999998765443222 21111111111000
Q ss_pred -hcC------ccccccCc-cC---CCCCHH------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 218 -EEG------RLLEIVDP-EL---TQFPEK------EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 218 -~~~------~~~~~~~~-~~---~~~~~~------~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+. .+...++. .+ ...... ...++.+++.+||+.||.+||++.|++..
T Consensus 390 ~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 390 CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000000 00 000000 12346778899999999999999999863
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=270.44 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=200.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 75 (322)
.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+.+. ...++++||++++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 86 (260)
T cd06606 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86 (260)
T ss_pred EeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCC
Confidence 4899999999999876 689999999876542 4457889999999999999999999999988 8899999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-e
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-V 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 154 (322)
+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 87 ~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 87 SLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999997554 7899999999999999999999998 999999999999999999999999998866543321 1
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....++..|+|||.+.....+.++||||||+++|+|++|..||..... ... ....... .......+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~---~~~~~~~--------~~~~~~~~ 226 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMA---ALYKIGS--------SGEPPEIP 226 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHH---HHHhccc--------cCCCcCCC
Confidence 2234578899999999888899999999999999999999999986541 111 1111110 01112333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+.+++.+|++.||++||++.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 333566889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.48 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=189.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+.. ++
T Consensus 11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l 89 (288)
T cd06616 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SL 89 (288)
T ss_pred HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CH
Confidence 3899999999999776 68999999987543 334567889999999996 99999999999999899999999864 66
Q ss_pred HHHHhcC-CCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 78 ANALLGS-KSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 78 ~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++.........
T Consensus 90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 164 (288)
T cd06616 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-- 164 (288)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc--
Confidence 5543211 11123689999999999999999999974 7 999999999999999999999999998754332211
Q ss_pred cccccCCCCCchHHHhhC---CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC-C
Q 020720 156 TRVAGTMGYLAPEYALLG---QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-T 231 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~---~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 231 (322)
....++..|+|||++... .++.++|||||||++|+|++|..||..... .......... + ..+.+ .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~~~~~~~ 233 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----DPPILSN 233 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----CCCcCCC
Confidence 223578899999998866 688999999999999999999999975431 1111111100 0 01111 1
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.........+.+++.+||+.||++||++.+|+..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122344568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=277.16 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=193.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||.|++|.||+|... +|..||+|+++.... .....+.+|+.++++++|+||+++++++.+.+..+++|||+++ +|.
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~ 85 (284)
T cd07836 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLK 85 (284)
T ss_pred eeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHH
Confidence 3899999999999876 689999999876533 2346678899999999999999999999999999999999985 888
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 86 ~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 160 (284)
T cd07836 86 KYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNE 160 (284)
T ss_pred HHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccccc
Confidence 88865432 236899999999999999999999998 99999999999999999999999999875433221 11223
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc-----cccccCccCC-
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR-----LLEIVDPELT- 231 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~- 231 (322)
.++..|++||.+.+. .++.++||||||+++|+|++|..||......+................ ....+.....
T Consensus 161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07836 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR 240 (284)
T ss_pred cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccC
Confidence 467889999988764 568899999999999999999999976543322111110000000000 0000001111
Q ss_pred -------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 232 -------QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 232 -------~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.....+.+++.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111122455789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=276.84 Aligned_cols=255 Identities=25% Similarity=0.301 Sum_probs=189.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCC-CCcccccceEEEeC--CeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVED--NNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +++.||+|.++... ........+|+.++.++. |+|++++++++.+. +..++|+||+. +
T Consensus 6 ~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~ 84 (282)
T cd07831 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-M 84 (282)
T ss_pred eccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-c
Confidence 3899999999999765 68999999987542 222344567888998885 99999999999987 88999999997 4
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+.+.... ..+++..++.++.|++.||.|||+.+ ++|+||+|.||+++. +.++|+|||++.........
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~-- 155 (282)
T cd07831 85 NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY-- 155 (282)
T ss_pred cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc--
Confidence 7888776543 26899999999999999999999998 999999999999999 99999999998765432221
Q ss_pred cccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH--------HHHHhcCcccccc
Q 020720 156 TRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT--------WKLREEGRLLEIV 226 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 226 (322)
....++..|+|||.+.. ..++.++|||||||++|+|++|..||......+........ .+...........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 22457889999997654 45788999999999999999999999764332211111000 0000000000000
Q ss_pred Cc-----cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 227 DP-----ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 227 ~~-----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+ .+..........+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 0111122345679999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=270.37 Aligned_cols=241 Identities=30% Similarity=0.492 Sum_probs=197.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||++... +++.|++|.+..... .....+.+|++++++++|+|++++++++.+.+..++++||+++++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (254)
T cd06627 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSL 86 (254)
T ss_pred EEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcH
Confidence 4899999999999766 688999999976643 4557889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|.||+++.++.++|+|||.+......... ...
T Consensus 87 ~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~ 158 (254)
T cd06627 87 RQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DAS 158 (254)
T ss_pred HHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccc
Confidence 99996553 6899999999999999999999998 999999999999999999999999999866443221 223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|+|||...+...+.++||||||+++|+|++|..||........ .+.... ......+...
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~---------~~~~~~~~~~ 223 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQ---------DDHPPLPEGI 223 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhc---------cCCCCCCCCC
Confidence 4578899999999888889999999999999999999999875431111 111111 0111222233
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 456888999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=284.74 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=191.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++|+||+++++++... ...++++||+
T Consensus 12 ~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07858 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM 91 (337)
T ss_pred EeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC
Confidence 4899999999999765 6899999998653 233346778899999999999999999987654 3479999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 ~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 92 D-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred C-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 6 68988886543 6899999999999999999999998 9999999999999999999999999988654322
Q ss_pred eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH--------HHhcCc--
Q 020720 153 HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK--------LREEGR-- 221 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~-- 221 (322)
.......++..|+|||.+.. ..++.++|||||||++|+|++|..||................. ......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 12233457889999998875 4688999999999999999999999975432111111100000 000000
Q ss_pred -----cccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 -----LLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 -----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+......+....++.+++.+||+.||++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000011111112334568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=273.76 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=202.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC--CCCcccccceEEEeCC----eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI--RHPNLVQLIGCCVEDN----NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~ 74 (322)
.||+|.||+||+|.|+ |..||||++... ++..+.+|.++.+.. +|+||+.+++.-..+. .+|||++|.+.
T Consensus 218 ~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 218 IIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred EecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 3899999999999999 899999998744 346778888887765 9999999998865443 57999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-----EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-----~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
|||.|++..+ .++-...++++..+|.||++||. +|.+.|.|||||..||||..++..-|+|+|+|....+
T Consensus 294 GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 294 GSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred CcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 9999999764 68999999999999999999995 5677899999999999999999999999999986544
Q ss_pred Ccc---eeecccccCCCCCchHHHhhCC----C--CcccceehhhHHHHHHHhC----------CCCCCcccCCCchhHH
Q 020720 150 NVT---HVSTRVAGTMGYLAPEYALLGQ----L--TKKADVYSFGVLLLEIISG----------RSSSKAAFGDDMLILV 210 (322)
Q Consensus 150 ~~~---~~~~~~~~t~~y~aPE~~~~~~----~--~~~sDv~slG~il~ell~g----------~~p~~~~~~~~~~~~~ 210 (322)
... ......+||.+|||||++...- | -..+||||||.++||+... +.||....+.+.....
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee 448 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE 448 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH
Confidence 322 2224467999999999987531 2 2579999999999999752 4777766554433221
Q ss_pred HHHHHHHhcCccccccCccC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 211 EWTWKLREEGRLLEIVDPEL--TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
. .+. --.+.+.|.+ .....+.+..+.++|+.||..+|+.|-|+--|-+.|.++...+
T Consensus 449 M--rkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 449 M--RKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred H--hcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 1 000 0112223333 3445567888999999999999999999999999998876543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.06 Aligned_cols=241 Identities=25% Similarity=0.463 Sum_probs=192.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecc----cChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe--eEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSA----ESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN--RILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~ 73 (322)
+||+|+|-+||+|.+. +|-+||=-.++. ..+...+.|..|+.+|+.|+||||+++|+.+.+... ..+|+|.+.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 5899999999999665 577776333322 245556899999999999999999999999987654 789999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 152 (322)
.|+|..|+...+ .++...+..|+.||+.||.|||++ ++||+|||||=+||||+.+ |.|||+|+|+|........
T Consensus 127 SGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 127 SGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred CCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999997665 688899999999999999999997 7899999999999999865 8899999999997654322
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...+|||.|||||+.. ..|+...||||||++++||+|+.+||....+.... .+ +. ..|... ..+..
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YK---KV-~SGiKP----~sl~k 267 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YK---KV-TSGIKP----AALSK 267 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HH---HH-HcCCCH----HHhhc
Confidence 2368999999999765 88999999999999999999999999877554322 11 11 111111 11111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ..++.++|.+|+.. .++||++.|+|.
T Consensus 268 V~---dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VK---DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cC---CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11 22467788889999 999999999986
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=283.54 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=189.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+++.++|+||+++++++... ...++||||
T Consensus 23 ~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 102 (353)
T cd07850 23 PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL 102 (353)
T ss_pred EeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEec
Confidence 3899999999999765 6899999998643 333446778899999999999999999987543 356999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 103 ~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 103 MDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred cCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 964 78887742 2788899999999999999999998 9999999999999999999999999998654322
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHH------------HH---HH-
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVE------------WT---WK- 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~------------~~---~~- 215 (322)
. .....++..|+|||.+.+..++.++|||||||++|+|++|..||...........+. .. ..
T Consensus 173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 173 M--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred C--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 1 223457889999999999999999999999999999999999997543211110000 00 00
Q ss_pred HHhcCc------cccccCccC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEGR------LLEIVDPEL-----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~~------~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...... ....+.... ..........+.+++.+||+.||++||++.|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 000000000 00011234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=279.53 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=189.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCC----------eeEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN----------NRIL 67 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------~~~l 67 (322)
.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|+++++.++||||+++++++.+.. ..++
T Consensus 14 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~l 93 (302)
T cd07864 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL 93 (302)
T ss_pred eecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEE
Confidence 3799999999999876 589999999975432 23356778999999999999999999987654 7899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 68 VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 68 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
++||+++ ++...+.... ..+++..++.++.|++.||+|||+.+ ++|+||+|.||++++++.+||+|||.+...
T Consensus 94 v~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 94 VFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred EEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 9999976 6777775432 26899999999999999999999998 999999999999999999999999998865
Q ss_pred CCCcceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc-
Q 020720 148 PDNVTHVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI- 225 (322)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 225 (322)
............++..|+|||.+.+. .++.++|||||||++|+|++|+.||........+..+...............
T Consensus 167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T cd07864 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246 (302)
T ss_pred cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence 43322212223457789999988653 5789999999999999999999999754322211111110000000000000
Q ss_pred -------cC------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 -------VD------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 -------~~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+ .............+.+++.+||+.||++||++.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000001112345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=280.86 Aligned_cols=257 Identities=28% Similarity=0.355 Sum_probs=189.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+||+++++++.+. +..++||||+.+
T Consensus 14 ~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~- 92 (309)
T cd07845 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ- 92 (309)
T ss_pred eeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-
Confidence 4899999999999775 6899999998754322 223567899999999999999999998765 468999999965
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 93 ~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~-~ 165 (309)
T cd07845 93 DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-M 165 (309)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC-C
Confidence 8888886543 36899999999999999999999999 999999999999999999999999998865433211 1
Q ss_pred cccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc--------cccc-
Q 020720 156 TRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR--------LLEI- 225 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~- 225 (322)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+........... ....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 22335778999998875 4578999999999999999999999975433222211110000000000 0000
Q ss_pred -cCcc----CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 -VDPE----LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 -~~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+... +..........+.+++.+||+.||++||++.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000001124457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=276.02 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=195.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +|..|++|++... .......+.+|+.++++++ |+||+++++++.+.+..+++|||+.++
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd05581 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87 (280)
T ss_pred eecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence 3899999999999776 6999999998653 2233467889999999998 999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc---
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT--- 152 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 152 (322)
+|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 88 ~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 88 ELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999997553 6999999999999999999999998 99999999999999999999999999886543321
Q ss_pred ----------------eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH
Q 020720 153 ----------------HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 153 ----------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
.......++..|+|||.+....++.++||||||+++|++++|..||...... .... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~ 234 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQ---KI 234 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---HH
Confidence 1112345788999999998888999999999999999999999999865421 1111 11
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTM----KQVVE 264 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~----~evl~ 264 (322)
.. .....+......+.+++.+||+.||++||++ .+++.
T Consensus 235 ~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Hh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 10 0111222234558899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=277.03 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=187.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +|..|++|++...... ....+.+|+.+++.++|+||+++++++.++...++++||+. ++|.
T Consensus 12 ~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~ 90 (291)
T cd07870 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLA 90 (291)
T ss_pred EEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHH
Confidence 3899999999999765 6899999998754322 23467889999999999999999999999999999999996 5777
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 91 ~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~ 163 (291)
T cd07870 91 QYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YSSE 163 (291)
T ss_pred HHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CCCc
Confidence 6664432 25778889999999999999999998 999999999999999999999999998754322111 1223
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh-------------cCcccc
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE-------------EGRLLE 224 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~ 224 (322)
.+++.|+|||.+.+. .++.++||||||+++|+|++|..||....... ......+.... ......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 468899999988754 57889999999999999999999997553321 11111111000 000000
Q ss_pred ccCccCCCCC------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 IVDPELTQFP------EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 ~~~~~~~~~~------~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.......... ......+.+++.+|++.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 011345778899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.85 Aligned_cols=250 Identities=25% Similarity=0.317 Sum_probs=193.9
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEecccC----hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAES----KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|++|.||++... ++..||+|+++... ......+.+|+.++.++ +||||+++++.+..+...++||||
T Consensus 7 ~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (288)
T cd05583 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDY 86 (288)
T ss_pred EeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEec
Confidence 4899999999998642 47889999987432 22335678899999999 699999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 87 VNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred CCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 99999999986543 6889999999999999999999998 9999999999999999999999999987654332
Q ss_pred ceeecccccCCCCCchHHHhhCC--CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQ--LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~--~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
........++..|+|||.+.+.. .+.++||||||+++|+|++|..||.......... ........ ..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~-------~~~- 229 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILK-------SKP- 229 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHc-------cCC-
Confidence 22222345788999999987654 7889999999999999999999986432221111 11111110 001
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
..+......+.+++.+||+.||++|||+.++.+.|+..
T Consensus 230 --~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 --PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11222234577889999999999999999888877543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=284.57 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=191.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|..||+|++.... ......+.+|+.+++.++||||+++++++.. ....++|+||+.
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 91 (334)
T cd07855 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME 91 (334)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh
Confidence 4899999999999765 69999999987542 2334677889999999999999999998753 346799999995
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT- 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 152 (322)
++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 92 -~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 92 -SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred -hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 58988886543 5899999999999999999999998 99999999999999999999999999876533221
Q ss_pred --eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH--------hcCc
Q 020720 153 --HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR--------EEGR 221 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 221 (322)
.......++..|+|||.+.. ..++.++|||||||++|+|++|..||................... ....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 11123468889999998865 468899999999999999999999997543322111111000000 0000
Q ss_pred cccccC--ccCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 LLEIVD--PELTQ-----FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 ~~~~~~--~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+. +.... ..+.....+.+++.+||+.||.+||++.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 00011 112235668999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.03 Aligned_cols=254 Identities=22% Similarity=0.252 Sum_probs=191.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhc--------------HHHHHHHHHHHhcCCCCcccccceEEEeCCee
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQG--------------TKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNR 65 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 65 (322)
+||+|+||.||+|... +++.||+|.++...... ...+.+|+.+++.++|+||+++++++...+..
T Consensus 16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (335)
T PTZ00024 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI 95 (335)
T ss_pred cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence 4899999999999765 68999999986542221 12577899999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 66 ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 66 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
+++|||+. ++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 96 NLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 99999997 58999886543 6889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCc-------------ceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHH
Q 020720 146 LFPDNV-------------THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 146 ~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~ 211 (322)
...... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||......+.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--- 244 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG--- 244 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 654111 1111123467889999988764 46899999999999999999999997654322211
Q ss_pred HHHHHHhcCc---cc------------cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 212 WTWKLREEGR---LL------------EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 212 ~~~~~~~~~~---~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.......... .. ....+.+..........+.+++.+||+.+|++||+++|++..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111100000 00 000001111112234568899999999999999999999863
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=265.64 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=201.0
Q ss_pred CcccCcceEEEEE-EECCCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|+++.|-.+ ...+|.+||||++.+........+.+|++++.+. .|+||++++++|+++...|+|||.+.||+|.
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL 164 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL 164 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence 5899999999988 4568999999999888777788999999999998 6999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccccC--CCc--
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKLFP--DNV-- 151 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~~~--~~~-- 151 (322)
..|+.+. .+++.++..+.+.|+.||.+||.++ |.||||||+|||-.+-.. |||+||.+..-.. .+.
T Consensus 165 shI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 165 SHIQKRK----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9997665 7999999999999999999999999 999999999999975544 8999998775321 111
Q ss_pred --ceeecccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 152 --THVSTRVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 152 --~~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
.......+|+..|||||+.. ...|+.++|.||||+|||-||+|..||.+.-+.+.-+---..- -.-...+.+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C-r~CQ~~LFe 316 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC-RVCQNKLFE 316 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc-HHHHHHHHH
Confidence 11223467899999999875 2368899999999999999999999998765544221000000 000111233
Q ss_pred ccCccCCCCCHHHH----HHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 IVDPELTQFPEKEV----MRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 ~~~~~~~~~~~~~~----~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+.-.++|.++. .+..+++..++..|+.+|.++.+++.
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 33344445665433 34567777789999999999999887
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=277.58 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=188.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... +|+.||+|.+..... .....+.+|+.++++++||||+++++++.+....++||||++ ++|
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l 87 (294)
T PLN00009 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDL 87 (294)
T ss_pred EecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccH
Confidence 3799999999999776 689999999865432 233678899999999999999999999999999999999996 478
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+.+..... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++........ ...
T Consensus 88 ~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (294)
T PLN00009 88 KKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFT 161 (294)
T ss_pred HHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-ccc
Confidence 877754432 24678888999999999999999998 999999999999985 56799999999875533211 112
Q ss_pred ccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcc---------cccc
Q 020720 157 RVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRL---------LEIV 226 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 226 (322)
...+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+.............+... ....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 23467899999988764 5789999999999999999999999754322111111000000000000 0000
Q ss_pred ----CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 227 ----DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 227 ----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+..........+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000111223345888999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.51 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=188.2
Q ss_pred cceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHh
Q 020720 6 AFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALL 82 (322)
Q Consensus 6 ~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 82 (322)
+++.||.+... +++.||+|+++.. .......+.+|+..++.++|+||+++++++.+.+..+++|||+.+++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 45566666444 5899999998765 34455789999999999999999999999999999999999999999999997
Q ss_pred cCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc------eeec
Q 020720 83 GSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT------HVST 156 (322)
Q Consensus 83 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~ 156 (322)
.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 92 ~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THFP--EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 5432 25888999999999999999999998 99999999999999999999999998864432111 1112
Q ss_pred ccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH----------H-hcCccc
Q 020720 157 RVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL----------R-EEGRLL 223 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----------~-~~~~~~ 223 (322)
...++..|+|||++... .++.++|||||||++|+|++|..||........ ........ . ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcC
Confidence 23467789999998763 578999999999999999999999986432211 11100000 0 000000
Q ss_pred c----ccCccC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 224 E----IVDPEL-----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 224 ~----~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. ..++.. .........++.+++.+||+.||++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 000000 11122334568889999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=285.13 Aligned_cols=239 Identities=24% Similarity=0.331 Sum_probs=198.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||+|.|++|..|.+. ++..||||.+.+. +....+.+.+|+++|..++|||||+++.+.+....+++||||+.+|.+.
T Consensus 64 ig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~ 143 (596)
T KOG0586|consen 64 IGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELF 143 (596)
T ss_pred eccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhH
Confidence 899999999999776 7999999999765 3344466899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++.... ...+.++..++.|++.|++|||+++ |+|||||++|+|++.+..+||+|||++..+.. .......
T Consensus 144 ~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~lqt~ 214 (596)
T KOG0586|consen 144 DYLVKHG----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLMLQTF 214 (596)
T ss_pred HHHHhcc----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--ccccccc
Confidence 9997665 5666899999999999999999999 99999999999999999999999999987753 3344567
Q ss_pred ccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 159 AGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
+|++.|.|||++.+..+ ++.+|+||+|+++|-|+.|..||.+........ .. +... ...+.-.
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-----------rv----l~gk-~rIp~~m 278 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-----------RV----LRGK-YRIPFYM 278 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-----------hh----eeee-eccccee
Confidence 89999999999998876 589999999999999999999998643221100 00 0000 1122223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..++.++++++|-.+|.+|++++++.+.
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhh
Confidence 3446778888999999999999998653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=270.75 Aligned_cols=240 Identities=28% Similarity=0.316 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|.||+|..++.+ +|+.||+|+++++ .......-+.|-+.|+..+||.+..+.-.|...+.+|+||||..||.
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe 254 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE 254 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence 5899999999999776 7999999999876 34445667789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|...+...+ .+++.....+...|+.||.|||+++ |++||||.+|.|+|.+|++||.|||+++.--.. .....
T Consensus 255 Lf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~k 326 (516)
T KOG0690|consen 255 LFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTTK 326 (516)
T ss_pred Eeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-cceec
Confidence 987775433 6889999999999999999999998 999999999999999999999999999853322 22345
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.++|||.|+|||++....|+.+.|-|.+|+++|||++|+.||+..+......++ --.--.+|..
T Consensus 327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----------------l~ed~kFPr~ 390 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----------------LMEDLKFPRT 390 (516)
T ss_pred cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------------HhhhccCCcc
Confidence 689999999999999999999999999999999999999999876544322221 0111123333
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
...+...++..+|.+||.+|.. +.||.+
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 3344666677799999999953 555543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=269.57 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=190.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-----ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-----SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
+||+|+||.||+|... ++..|++|.+... .......+.+|+.++++++|+||+++++++.+. ...++++||+
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (264)
T cd06653 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88 (264)
T ss_pred eEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence 4899999999999765 6899999987532 123346788999999999999999999998764 4578999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 89 PGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999986543 5788999999999999999999999 99999999999999999999999999875432111
Q ss_pred --eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 --HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||....... . . .+... .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-~---~~~~~--------~~~~ 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--A-I---FKIAT--------QPTK 227 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--H-H---HHHHc--------CCCC
Confidence 11123457889999999988889999999999999999999999997532111 0 0 11110 0111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+......+.+++.+||+ +|..||++.+++.
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 23344445568888888999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=278.30 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=186.5
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCC--------eeEEEEE
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--------NRILVYE 70 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e 70 (322)
||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++||||+++++++.... ..+++||
T Consensus 20 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e 99 (310)
T cd07865 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFE 99 (310)
T ss_pred eecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEc
Confidence 899999999999776 689999999865422 22345678999999999999999999987654 3599999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|+.+ +|.+++.... ..+++.+++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 100 ~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 172 (310)
T cd07865 100 FCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172 (310)
T ss_pred CCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCC
Confidence 9964 7888775432 26899999999999999999999998 999999999999999999999999998765332
Q ss_pred cc---eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc---
Q 020720 151 VT---HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL--- 223 (322)
Q Consensus 151 ~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 223 (322)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.............
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (310)
T cd07865 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252 (310)
T ss_pred cccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 21 111234567889999988764 46889999999999999999999987653322221111110000000000
Q ss_pred --c-------------ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 --E-------------IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 --~-------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. .....+... .....+.+++.+||+.||.+||+++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 253 KLELFKKMELPQGQKRKVKERLKPY--VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred chhhhhhccCCCccchhhHHhcccc--cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000000 01234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=271.90 Aligned_cols=250 Identities=21% Similarity=0.247 Sum_probs=177.9
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEecccChhcH-----------HHHHHHHHHHhcCCCCcccccceEEEeCC--
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAESKQGT-----------KEFLTEIDMIWNIRHPNLVQLIGCCVEDN-- 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 63 (322)
+||+|+||.||+|.+.+ +..+|+|+......... .....+...+..++|++++++++++....
T Consensus 19 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 98 (294)
T PHA02882 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCR 98 (294)
T ss_pred EEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCC
Confidence 48999999999997653 45667776433321110 11233445566779999999999876543
Q ss_pred --eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeee
Q 020720 64 --NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDF 141 (322)
Q Consensus 64 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Df 141 (322)
..+++++++. .++.+.+.... ..++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+||
T Consensus 99 ~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 99 MYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred ceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEc
Confidence 3467778764 36766664332 4678889999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCcce------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH
Q 020720 142 GLAKLFPDNVTH------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK 215 (322)
Q Consensus 142 g~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 215 (322)
|++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||............... .
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~-~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC-D 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH-H
Confidence 999765322111 112245899999999999999999999999999999999999999876433222111100 0
Q ss_pred HHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 216 LREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.. ..+..+.. ........+.+++..||+.+|.+||++.++++.+
T Consensus 250 ~~-----~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 250 FI-----KRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HH-----HHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00 00000111 0111235577888889999999999999999876
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=313.73 Aligned_cols=244 Identities=30% Similarity=0.397 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
+||.|.||.||.|... +|.-.|+|.++..... ..+.+.+|+.++..++|||+|+++|+=.+.+..++.||||++|+|
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 4899999999999665 6888999988755332 236678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee---
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV--- 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 154 (322)
.++++..+ -.++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|.....+....
T Consensus 1322 a~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1322 ASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99996554 4666667778889999999999999 9999999999999999999999999999776554222
Q ss_pred ecccccCCCCCchHHHhhC---CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 155 STRVAGTMGYLAPEYALLG---QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~---~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
.....||+.|||||++.+. .-..++|||||||++.||+||+.||...+..=.... .. .. ...+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-----~V-~~--------gh~P 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-----HV-AA--------GHKP 1460 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-----HH-hc--------cCCC
Confidence 2346799999999999864 345789999999999999999999987654321111 00 11 1223
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
++|......-.+++.+||+.||..|.++.|+++.
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 4455556667788888999999999999988775
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=273.13 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=190.2
Q ss_pred CcccCcceEEEEEEE----CCCCEEEEEEecccC----hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAES----KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|+||.||.|.. .+|..||+|+++... ....+.+.+|+.+++++ +|+||+++++++..+...++++||
T Consensus 7 ~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (290)
T cd05613 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86 (290)
T ss_pred eeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEec
Confidence 489999999999975 368899999987532 22336678899999999 689999999999998899999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 87 INGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999996543 6888999999999999999999998 9999999999999999999999999987654332
Q ss_pred ceeecccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 152 THVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
........++..|+|||.+... .++.++||||||+++|+|++|..||........... ....... .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--~~~~~~~----------~ 227 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK----------S 227 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH--HHHHhhc----------c
Confidence 2222334588899999998753 467899999999999999999999864322211111 1111110 0
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
....+......+.+++.+||+.||++|| ++.+++.
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1112222334578899999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.95 Aligned_cols=239 Identities=30% Similarity=0.439 Sum_probs=189.1
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|+|++++++++......++|+||+. ++|
T Consensus 23 lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l 101 (308)
T cd06634 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 101 (308)
T ss_pred eeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCH
Confidence 799999999999875 5888999998643 22334678899999999999999999999999999999999996 578
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++..... .+++..++.++.|++.|+.|||+.+ ++|+||+|.||+++.++.++|+|||++...... ..
T Consensus 102 ~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~ 170 (308)
T cd06634 102 SDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NX 170 (308)
T ss_pred HHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-----cc
Confidence 777754332 5889999999999999999999998 999999999999999999999999988754322 23
Q ss_pred cccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..++..|+|||.+. ...++.++|||||||++|+|++|..||.......... .... ... +.. ..
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~-~~~-----~~~--~~ 236 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NES-----PAL--QS 236 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHhh-cCC-----CCc--Cc
Confidence 45788999999975 3467889999999999999999999986542211110 0110 000 111 12
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
......+.+++.+||+.+|.+||++.+++...
T Consensus 237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 23345578899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=269.11 Aligned_cols=234 Identities=21% Similarity=0.269 Sum_probs=182.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999765 688999999864422111 22222222 79999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++....... ..
T Consensus 99 ~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~ 166 (267)
T PHA03390 99 LLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CY 166 (267)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cC
Confidence 996553 7899999999999999999999998 99999999999999998 99999999887554321 23
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.... ...........
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~ 234 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-----------QKKLPFIKNVS 234 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-----------cccCCcccccC
Confidence 57889999999998899999999999999999999999998443322 1111111110 00111222344
Q ss_pred HHHHHHHHhcccCCCCCCCC-HHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPT-MKQVVE 264 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps-~~evl~ 264 (322)
..+.+++.+||+.||.+||+ ++++++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhc
Confidence 55888999999999999996 688874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=274.60 Aligned_cols=238 Identities=28% Similarity=0.438 Sum_probs=188.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|... ++..|++|.+.... ......+.+|+.+++.++|||++++++++.+....+++|||+. ++|
T Consensus 29 lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 107 (313)
T cd06633 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSA 107 (313)
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCH
Confidence 799999999999765 68899999986542 2333578899999999999999999999999999999999996 577
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .++++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 108 ~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 108 SDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 77775433 26899999999999999999999998 99999999999999999999999998764322 123
Q ss_pred cccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..++..|+|||++. ...++.++|||||||++|+|++|..||.......... ...... . +.. ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~-~-----~~~--~~ 242 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQND-S-----PTL--QS 242 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcC-C-----CCC--Cc
Confidence 45788999999984 4568899999999999999999999987543211111 111100 0 111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.+++.+||+.+|.+||++.+++..
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122347889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=282.91 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=195.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 72 (322)
.||.|++|.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.... ..+++|+|+
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 86 (330)
T cd07834 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM 86 (330)
T ss_pred eecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecch
Confidence 4899999999999876 58999999987543 344578899999999999999999999988775 789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
. ++|.+++.... .+++..++.++.||+.||++||+.+ ++|+||||.||+++.++.++|+|||++........
T Consensus 87 ~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 87 E-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred h-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 7 48888886543 7899999999999999999999998 99999999999999999999999999987644321
Q ss_pred --eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC--------c
Q 020720 153 --HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG--------R 221 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~ 221 (322)
.......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.......... .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 112334578899999999877 78999999999999999999999997654322111110000000000 0
Q ss_pred cccccC-------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 LLEIVD-------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 ~~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+. ..+....+.....+.+++.+||+.+|.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 00011111234558899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.10 Aligned_cols=236 Identities=28% Similarity=0.326 Sum_probs=191.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||++... +++.+++|++..... .....+..|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999776 589999999875432 2446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..++.++.|++.|+.|||+.+ ++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99996553 6899999999999999999999998 9999999999999999999999999987654321 11233
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..++..|++||.+.+...+.++|+||||+++|+|++|..||...... ... ..... . .. ..+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~~-~------~~---~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIY---EKILK-D------PL---RFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHhc-C------CC---CCCCCC
Confidence 45788999999998888899999999999999999999999654321 111 11111 0 01 122222
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQ 261 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~e 261 (322)
...+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456788999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=271.21 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=190.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcC---CCCcccccceEEEeCCe-----eEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNI---RHPNLVQLIGCCVEDNN-----RILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~ 69 (322)
.||+|+||.||+|..+ ++..||+|+++..... ....+.+|+.++.++ +|+|++++++++...+. .+++|
T Consensus 6 ~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~ 85 (287)
T cd07838 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVF 85 (287)
T ss_pred EecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEe
Confidence 4899999999999877 5899999999754322 234566777766555 69999999999988776 89999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 86 e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 86 EHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred hhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 99975 79888865432 25899999999999999999999998 99999999999999999999999999876543
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc----c---
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR----L--- 222 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~--- 222 (322)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||......+....+ ......... .
T Consensus 160 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 160 EMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI--FDVIGLPSEEEWPRNVS 235 (287)
T ss_pred Ccc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH--HHHcCCCChHhcCCCcc
Confidence 321 12234678899999999889999999999999999999999888754332211111 000000000 0
Q ss_pred --ccccC----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 223 --LEIVD----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 223 --~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+. .............+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0111112233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=258.93 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=190.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||.|+.|.||++..+ +|.-+|||..+.. +.+..++++..+.++..- ++|+||+.+|+|..+...++.||.+.. -+.
T Consensus 100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~e 178 (391)
T KOG0983|consen 100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAE 178 (391)
T ss_pred hcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHH
Confidence 899999999999877 5889999998755 455567888888877766 599999999999999999999998853 455
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
.++..... ++++..+-++...++.||.||..+.. ++|||+||+|||+|+.|.+||+|||++..+-+... .++.
T Consensus 179 kLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--htrs 251 (391)
T KOG0983|consen 179 KLLKRIKG---PIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--HTRS 251 (391)
T ss_pred HHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecccc--cccc
Confidence 55544332 78998888999999999999987543 99999999999999999999999999986644322 3455
Q ss_pred ccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 159 AGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 159 ~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
.|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+...+-. .+. ++..+. .|.+.. ..
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~lt---kvln~e------PP~L~~-~~ 319 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLT---KVLNEE------PPLLPG-HM 319 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHH---HHHhcC------CCCCCc-cc
Confidence 68899999998873 4688999999999999999999999987644321 111 111111 022211 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....|++++..||++|+.+||...++++.
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 134558889999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.80 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=189.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeC--CeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVED--NNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... +|..+|+|++... .......+.+|+.+++++ +||||+++++++... ...++||||+.
T Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 92 (337)
T cd07852 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME- 92 (337)
T ss_pred hhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-
Confidence 4899999999999776 6889999988543 233345677899999999 999999999998654 36899999997
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
++|.+++... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 93 ~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 93 TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 4898888543 5788899999999999999999998 99999999999999999999999999886543221
Q ss_pred --eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH---------HH--Hh
Q 020720 153 --HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW---------KL--RE 218 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~---------~~--~~ 218 (322)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+......... .. ..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 12233457889999998764 457899999999999999999999996543322111110000 00 00
Q ss_pred cCccccccC----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 219 EGRLLEIVD----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 219 ~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.......+. ..+..........+.+++.+||+.||++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000 00111111134568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=271.37 Aligned_cols=257 Identities=24% Similarity=0.306 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... +++.|++|.+..... .......+|+..+.+++ |+||+++++++.+++..++||||+ +++|
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l 84 (283)
T cd07830 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNL 84 (283)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCH
Confidence 3899999999999876 588999999865432 22344567999999998 999999999999999999999999 7799
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+.+.... ...+++..++.++.|++.+|.|||+++ ++|+||+|.||+++.++.++|+|||.+........ ...
T Consensus 85 ~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (283)
T cd07830 85 YQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTD 157 (283)
T ss_pred HHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCC
Confidence 88886543 236899999999999999999999998 99999999999999999999999999875543221 123
Q ss_pred cccCCCCCchHHHh-hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH----------HHHHHhcCcccccc
Q 020720 158 VAGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW----------TWKLREEGRLLEIV 226 (322)
Q Consensus 158 ~~~t~~y~aPE~~~-~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~ 226 (322)
..++..|+|||++. ...++.++|+||||+++|+|++|+.||......+....... .............+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 45788999999875 44578999999999999999999999876543222111100 00000000000000
Q ss_pred C----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 227 D----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 227 ~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. ..+..........+.+++.+||+.||++||++.|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 00111111123568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=260.05 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=192.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEe----CCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVE----DNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~ 74 (322)
+||-|-.|.|-.+.++ +|+.+|+|++... ....+|++.-... .|||||.++++|.. ...+.+|||.++|
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 5899999999999766 7999999998632 3456788876666 69999999999854 3456789999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC---CCCeEEEeeeccccccCCCc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD---GNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~ 151 (322)
|.|...++.++.. .+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.+ .|..+||+|||+++....+
T Consensus 144 GeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~- 217 (400)
T KOG0604|consen 144 GELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP- 217 (400)
T ss_pred hHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCC-
Confidence 9999999877644 7999999999999999999999999 99999999999996 4566999999999976543
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
......+-|+-|.|||++...+|+..+|+||+||++|-||+|.+||+...+....--+. ..+...-.
T Consensus 218 -~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk------------~rI~~gqy 284 (400)
T KOG0604|consen 218 -GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------RRIRTGQY 284 (400)
T ss_pred -ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH------------hHhhccCc
Confidence 22345667999999999999999999999999999999999999998765532211111 00111112
Q ss_pred CCCHH----HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 232 QFPEK----EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~----~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.++.. .++...++|+.+|..+|.+|.|+.+++..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 33333 34457788999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=270.58 Aligned_cols=260 Identities=29% Similarity=0.403 Sum_probs=194.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC--CCCcccccceEEEeCC----eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI--RHPNLVQLIGCCVEDN----NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~ 74 (322)
+||+|.||.||+|... ++.||||++.. ++.+.+..|-.+.+.. +|+||+++++.-.... .++||++|.+.
T Consensus 217 li~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 5899999999999888 59999999874 4456777777776654 8999999998855444 78999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA------DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~------~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
|+|.+++..+ .++|....+++..+++||+|||... .++|+|||||.+||||..|++..|+|||++..+.
T Consensus 293 GsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 293 GSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred CcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999766 6999999999999999999999742 4679999999999999999999999999999775
Q ss_pred CCcc-eeecccccCCCCCchHHHhhC-CCC-----cccceehhhHHHHHHHhCCCCCCc-ccCCCchhHH---------H
Q 020720 149 DNVT-HVSTRVAGTMGYLAPEYALLG-QLT-----KKADVYSFGVLLLEIISGRSSSKA-AFGDDMLILV---------E 211 (322)
Q Consensus 149 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~-----~~sDv~slG~il~ell~g~~p~~~-~~~~~~~~~~---------~ 211 (322)
.... ......+||.+|||||++.+. .+. .+.||||+|.+||||++.-.-+.. ..+.-.+.+. +
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 3322 222346799999999999764 222 478999999999999985433221 1111000000 0
Q ss_pred HHHHHHhcCccccccCccCCCCC--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 212 WTWKLREEGRLLEIVDPELTQFP--EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
..+... +.+...|.+++.- -..+.-+.+.+..||..||+.|.|+.-+-+.+..+....
T Consensus 448 ~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 448 EMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011111 1111223332211 134556889999999999999999999999888877654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=280.77 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=187.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--------------Cee
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--------------NNR 65 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------------~~~ 65 (322)
.||.|+||.||+|... +|..||+|.+........+.+.+|+++++.++||||+++++++... ...
T Consensus 12 ~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (342)
T cd07854 12 PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSV 91 (342)
T ss_pred EecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceE
Confidence 3899999999999765 6899999998776666667889999999999999999999876543 357
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccc
Q 020720 66 ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLA 144 (322)
Q Consensus 66 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~ 144 (322)
++++||+. ++|.+++... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++ .++.++|+|||.+
T Consensus 92 ~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 92 YIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred EEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccc
Confidence 89999997 5898888533 5889999999999999999999998 99999999999997 4567899999998
Q ss_pred cccCCCcce--eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH----H
Q 020720 145 KLFPDNVTH--VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL----R 217 (322)
Q Consensus 145 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----~ 217 (322)
......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.................. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 754322111 1122346889999998764 46788999999999999999999999754322111110000000 0
Q ss_pred hc---Ccccccc--CccCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 218 EE---GRLLEIV--DPELT-----QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 218 ~~---~~~~~~~--~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ....... ..... ........++.+++.+||+.||.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0000000 00000 011122345888999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=266.89 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=190.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-----ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-----SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||++... .+..+++|.++.. .......+..|+.+++.++||||+++++++.+....++++||+++
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (260)
T cd08222 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86 (260)
T ss_pred eecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCC
Confidence 3899999999999765 3445556655431 222345677899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||.+........ .
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-~ 161 (260)
T cd08222 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-L 161 (260)
T ss_pred CCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc-c
Confidence 9999988654333347899999999999999999999998 999999999999975 5699999999876533221 1
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..... .... .......+
T Consensus 162 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~---~~~~---------~~~~~~~~ 226 (260)
T cd08222 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVV---LRIV---------EGPTPSLP 226 (260)
T ss_pred ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHH---------cCCCCCCc
Confidence 223457889999999988888999999999999999999999986431 11111 1111 11122233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.+++.+||+.||++||++.++++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 4455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.23 Aligned_cols=257 Identities=26% Similarity=0.323 Sum_probs=186.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCcccccceEEEeCC--------eeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--------NRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~ 69 (322)
.||+|+||.||+|... +++.+|+|++...... ....+.+|+++++.++||||+++++++.+.. ..++++
T Consensus 15 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~ 94 (311)
T cd07866 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT 94 (311)
T ss_pred EeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEE
Confidence 3899999999999776 6899999998654322 2346778999999999999999999875433 468999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+.+ +|...+.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 95 ~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 167 (311)
T cd07866 95 PYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167 (311)
T ss_pred ecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence 99965 6777665432 26999999999999999999999999 99999999999999999999999999875432
Q ss_pred Ccce----------eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh
Q 020720 150 NVTH----------VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE 218 (322)
Q Consensus 150 ~~~~----------~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (322)
.... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T cd07866 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247 (311)
T ss_pred CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 2111 11223467889999988654 578999999999999999999999875433221111110000000
Q ss_pred c------Cccccc----cCccCCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 219 E------GRLLEI----VDPELTQF----PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 219 ~------~~~~~~----~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. ..+... ........ .......+.+++.+||+.||.+|||+.|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 248 EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 000000 00000000 0112245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=269.24 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=194.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|++|.||+|... +++.|++|.+.... ....+.+..|+.+++.++|+||+++++++.+.+..++++||+. ++|
T Consensus 6 ~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l 84 (282)
T cd07829 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDL 84 (282)
T ss_pred cccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCH
Confidence 4899999999999776 58999999997653 3334677889999999999999999999999999999999997 589
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... ..+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 85 ~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 85 KKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred HHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 99997653 26899999999999999999999998 99999999999999999999999999876543221 1122
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH--------HHHHhcCccccccCc
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT--------WKLREEGRLLEIVDP 228 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 228 (322)
..++..|+|||.+... .++.++|||||||++|+|++|..||...........+... +.....-......-+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3457789999998766 7899999999999999999999998764322211111000 000000000000000
Q ss_pred cC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 EL-----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ....+.....+.+++.+||+.||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0111122456899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=275.29 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=186.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~ 71 (322)
.||+|+||.||+|... +|..||+|++... .......+.+|+.+++.++||||+++++++.... ..++||||
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 101 (343)
T cd07880 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF 101 (343)
T ss_pred EeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEec
Confidence 3899999999999755 6899999998643 2223456889999999999999999999986553 35899999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+ +++|.+++... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 102 ~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 102 M-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred C-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 8 67898888532 6899999999999999999999999 9999999999999999999999999987543321
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH---------HHHHHhc--
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW---------TWKLREE-- 219 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------~~~~~~~-- 219 (322)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.............. .......
T Consensus 173 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 173 ----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 22356889999999876 4578999999999999999999999975432111110000 0000000
Q ss_pred ----CccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 220 ----GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+.......+..........+.+++.+|++.||++||++.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000011111122345889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.52 Aligned_cols=244 Identities=26% Similarity=0.443 Sum_probs=186.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|.+. +++.||+|.++... ......+..|+.++.+. .|+||+++++++.+....+++|||+. ++|
T Consensus 22 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l 100 (296)
T cd06618 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCL 100 (296)
T ss_pred EeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCH
Confidence 3899999999999877 48999999997543 23345667777766666 59999999999999999999999985 477
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+++..... .+++..+..++.|++.|++|||+ .+ ++|+||+|+||++++++.++|+|||++......... .
T Consensus 101 ~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--~ 172 (296)
T cd06618 101 DKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--T 172 (296)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--c
Confidence 777755332 68899999999999999999997 47 999999999999999999999999998765332211 2
Q ss_pred ccccCCCCCchHHHhhCC----CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYALLGQ----LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~----~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...++..|+|||.+.... ++.++||||||+++|+|++|..||...... .... ....... . +....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~-~-----~~~~~ 241 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE-P-----PSLPP 241 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC-C-----CCCCC
Confidence 234678899999987553 788999999999999999999998653211 1111 1111110 0 11111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.......+.+++.+||+.||.+||++.++++.
T Consensus 242 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11233458889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=279.15 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=188.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe------eEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN------RILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~ 71 (322)
.||+|++|.||+|... ++..||+|++... .......+.+|+.++++++|+||+++.+++...+. .++++||
T Consensus 22 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 101 (343)
T cd07851 22 PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL 101 (343)
T ss_pred EeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEec
Confidence 3899999999999776 6889999998643 23344667889999999999999999998766554 8999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+ +++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 102 ~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 102 M-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred C-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 8 56999988642 6899999999999999999999998 999999999999999999999999998865332
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC--c-------
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG--R------- 221 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~------- 221 (322)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........+ .......... .
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCCHHHHhhccc
Confidence 223457889999998865 36789999999999999999999999754322111 1111100000 0
Q ss_pred -----cccccC----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 -----LLEIVD----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 -----~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+. +.+..........+.+++.+||+.||.+|||+.+|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 00000011124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=275.67 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=187.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~ 71 (322)
.||+|+||.||+|... +|..||+|.+.... ......+.+|+.+++.++||||+++++++.... ..++++||
T Consensus 22 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 101 (342)
T cd07879 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY 101 (342)
T ss_pred EeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecc
Confidence 4899999999999765 68999999986432 222356889999999999999999999986543 45899999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+.. +|..+.. ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 102 ~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 102 MQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred ccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 964 7776652 15889999999999999999999998 999999999999999999999999998754322
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH-----------hc
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR-----------EE 219 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 219 (322)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ....... ..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHHHHhcc
Confidence 123456888999999876 46889999999999999999999999754321111 1111000 00
Q ss_pred Ccccc-------ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcccc
Q 020720 220 GRLLE-------IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM--LSKDVH 271 (322)
Q Consensus 220 ~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~--L~~~~~ 271 (322)
..... .....+....+.....+.+++.+||+.||.+||++.+++.. ++....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00000000011223457899999999999999999999854 555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=289.91 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=202.7
Q ss_pred CcccCcceEEEEEEEC----C----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR----D----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.|++|... . ...||||.++.. .....+.+..|+.+|+.+ +|+||+.++++|...+..++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 3899999999999643 1 346899998765 334568899999999999 69999999999999999999999
Q ss_pred cCCCCCHHHHHhcCC---C-------CC--cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSK---S-------KY--VSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+..|+|.++++..+ . .. ..+.....+.++.|||.|++||++.. ++||||...|||+.++..+|+
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kI 459 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKI 459 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEE
Confidence 999999999998765 0 00 13888899999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCcceeecccc--cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHH
Q 020720 139 GDFGLAKLFPDNVTHVSTRVA--GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWK 215 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~ 215 (322)
+|||+++.............. -...|||||.+....|+.++|||||||+||||++ |..||.+......+ .+
T Consensus 460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l------~~ 533 (609)
T KOG0200|consen 460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL------LE 533 (609)
T ss_pred ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH------HH
Confidence 999999965444333322222 2456999999999999999999999999999999 77888663211111 11
Q ss_pred HHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 216 LREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+|.. -+.|..+..++..+|+.||+.+|++||++.++.+.++..+
T Consensus 534 ~l~~G~r--------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 534 FLKEGNR--------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHhcCCC--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1122211 2334555667889999999999999999999999998853
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=275.73 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=185.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++... ...++++++
T Consensus 24 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~ 103 (345)
T cd07877 24 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 103 (345)
T ss_pred EeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehh
Confidence 3899999999999754 68999999986532 22346788899999999999999999988543 336778877
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+ +++|.+++... .+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 104 ~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 104 M-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred c-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 6 77998887532 5889999999999999999999999 999999999999999999999999998754322
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH-----H---HhcC--
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-----L---REEG-- 220 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~---~~~~-- 220 (322)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||................. . ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 174 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred ---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 123457889999998876 4678999999999999999999999965432211111000000 0 0000
Q ss_pred -cc----ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 221 -RL----LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 221 -~~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. .........+........+.+++.+||+.||.+||++.+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000000000001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=271.38 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=185.9
Q ss_pred CcccCcceEEEEEEEC-C--CCEEEEEEeccc--ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeC----CeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-D--GTQIAIKCLSAE--SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVED----NNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e 70 (322)
+||+|+||.||++... . +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ...+++++
T Consensus 7 ~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e 86 (332)
T cd07857 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE 86 (332)
T ss_pred EccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEe
Confidence 4899999999999765 4 778999998643 222346788899999999 599999999875432 35678888
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|+. ++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 87 LME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred ccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 885 68998886443 6899999999999999999999999 999999999999999999999999999765432
Q ss_pred cce---eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH---------HHHHH
Q 020720 151 VTH---VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW---------TWKLR 217 (322)
Q Consensus 151 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------~~~~~ 217 (322)
... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.............. .....
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 111 1123468899999998765 4688999999999999999999999875432111110000 00000
Q ss_pred hcCc--ccccc----CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 218 EEGR--LLEIV----DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 218 ~~~~--~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.... ..... ...+..........+.+++.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00000 00001111112345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=284.74 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=205.8
Q ss_pred CcccCcceEEEEEEE-CCC----CEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSL-RDG----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-~~~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||+||+|.+ ..| -+||||++... ..+...++++|+.+|.+++|||+++++++|.... ..||++|++.
T Consensus 703 vLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~ 781 (1177)
T KOG1025|consen 703 VLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPL 781 (1177)
T ss_pred eeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhccc
Confidence 589999999999955 333 46899998755 3444588999999999999999999999998765 7889999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|+|.++++..+. .+.....+.|+.|||.|+.|||.+. ++||||-+.||||..-..+|+.|||+++....+....
T Consensus 782 G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 782 GCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred chHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999987654 6888999999999999999999998 9999999999999999999999999999876554433
Q ss_pred ecc-cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 STR-VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 ~~~-~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
... ..-.+.|||-|.+....++.++|||||||++|||+| |..|+.+....+...+++ .+ .--.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g--------eRLs 920 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG--------ERLS 920 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc--------ccCC
Confidence 222 223567999999999999999999999999999998 999998775544332221 11 1124
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.|+....++.-++.+||..|+..||+++++...+.+...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 466677789999999999999999999999988766544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=264.93 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=197.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCC--C----cccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH--P----NLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
++|+|.||.|-.+... .+..||||+++.- ..-.+..+-|+++++++.+ | -+|++.++|...++.|+|+|.+
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell- 173 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL- 173 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-
Confidence 4899999999999665 5789999998733 3334566779999999932 2 3688888899999999999988
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC--------------------CC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD--------------------GN 133 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--------------------~~ 133 (322)
|.|+.+++..+. +.+++...+..++.|+++++++||+.+ ++|.||||+||++. ++
T Consensus 174 G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks 248 (415)
T KOG0671|consen 174 GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS 248 (415)
T ss_pred ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence 669999997653 458999999999999999999999999 99999999999983 23
Q ss_pred CeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 213 (322)
..++|+|||.+....... ...+.|-.|.|||++.+.+|+.++||||+||||+||.+|...|+...+.+.+..++.+
T Consensus 249 ~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 249 TAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred cceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 458999999998654443 3456789999999999999999999999999999999999999988776666555433
Q ss_pred HHH--------------HhcCcc-----------ccccCcc--C---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 020720 214 WKL--------------REEGRL-----------LEIVDPE--L---TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVV 263 (322)
Q Consensus 214 ~~~--------------~~~~~~-----------~~~~~~~--~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl 263 (322)
..- ...+++ ...+++. + ......+..+|++|+..||..||.+|+|+.|++
T Consensus 325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 210 000100 0000000 0 011234556799999999999999999999998
Q ss_pred HH
Q 020720 264 EM 265 (322)
Q Consensus 264 ~~ 265 (322)
+.
T Consensus 405 ~H 406 (415)
T KOG0671|consen 405 SH 406 (415)
T ss_pred cC
Confidence 63
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=268.18 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=189.7
Q ss_pred CcccCcceEEEEEEE-CCCCEEEEEEecccC-------hhcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL-RDGTQIAIKCLSAES-------KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 71 (322)
+||+|+|+.||+|.+ ...+.||+|+-.... ..-.+...+|..+-+.|+||.||++|+++.- .+.+|-|+||
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY 549 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY 549 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence 589999999999954 468899999875432 1223567899999999999999999999864 4567889999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccC
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFP 148 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~ 148 (322)
|+|.+|.-++..++ .+++.++..|+.||+.||.||... .+||+|.||||.|||+.. -|.+||.|||+++++.
T Consensus 550 ceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 550 CEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred cCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 99999999997665 799999999999999999999986 678999999999999953 4779999999999876
Q ss_pred CCcce------eecccccCCCCCchHHHhhC----CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh
Q 020720 149 DNVTH------VSTRVAGTMGYLAPEYALLG----QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE 218 (322)
Q Consensus 149 ~~~~~------~~~~~~~t~~y~aPE~~~~~----~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (322)
..... ......||.+|++||.+.-+ +.+.|.||||.|||+|+++.|+.||......... ..
T Consensus 625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI---------Lq 695 (775)
T KOG1151|consen 625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI---------LQ 695 (775)
T ss_pred CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---------Hh
Confidence 54332 22346799999999987633 5688999999999999999999999865433221 11
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 020720 219 EGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVV 263 (322)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl 263 (322)
+..+...-.-.++. -+....+...+|++||+.--.+|.+..++.
T Consensus 696 eNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111111111 112233467788889999988888766654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=259.51 Aligned_cols=219 Identities=22% Similarity=0.179 Sum_probs=175.3
Q ss_pred CcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhc
Q 020720 5 GAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLG 83 (322)
Q Consensus 5 G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 83 (322)
|.+|.||++... +++.||+|.++... ...+|...+....||||+++++++.+....+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999775 68999999997543 223455555666799999999999999999999999999999999865
Q ss_pred CCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccCCC
Q 020720 84 SKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163 (322)
Q Consensus 84 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~ 163 (322)
.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 FL----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred hc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 43 5899999999999999999999998 9999999999999999999999999876543321 22335678
Q ss_pred CCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHH
Q 020720 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIK 243 (322)
Q Consensus 164 y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (322)
|+|||.+....++.++||||+|+++|+|++|..|+........ ..... ..+......+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~---~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTL---NIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------ccccc---CCcccCCHHHHH
Confidence 9999998888889999999999999999999987653211100 00000 122223445888
Q ss_pred HHHhcccCCCCCCCCH
Q 020720 244 VGLFCTQAGAHYRPTM 259 (322)
Q Consensus 244 l~~~cl~~dp~~Rps~ 259 (322)
++.+||+.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=270.23 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=186.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 76 (322)
+||.|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++++||+ +++
T Consensus 17 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~ 95 (328)
T cd07856 17 PVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTD 95 (328)
T ss_pred eecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccC
Confidence 4899999999999765 7999999988543 22334678899999999999999999999866 45788999998 568
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++... ++++..+..++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 96 L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~----~ 163 (328)
T cd07856 96 LHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM----T 163 (328)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCc----C
Confidence 98888533 5788888999999999999999998 9999999999999999999999999987543211 2
Q ss_pred ccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH---------HHHHHhcCc--ccc
Q 020720 157 RVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW---------TWKLREEGR--LLE 224 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~--~~~ 224 (322)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. ......... ...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 2346788999998765 5689999999999999999999999965432111110000 000000000 000
Q ss_pred ccCc----cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDP----ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.. ......+.....+.+++.+||+.+|++||++.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000111223568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.40 Aligned_cols=243 Identities=25% Similarity=0.250 Sum_probs=198.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.|..++.+ +++.||+|+++.- ...+..-|..|-.+|..-+.+=|+.++-.|.++.++|+||||++||+
T Consensus 82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 5999999999999876 6889999999763 34455678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|-.++.... .+++..+..++..|+.||..||+.| +|||||||+|||+|..|++||+|||.+..+..+..-...
T Consensus 162 lltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~ 234 (1317)
T KOG0612|consen 162 LLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSS 234 (1317)
T ss_pred HHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEec
Confidence 999995443 7999999999999999999999999 999999999999999999999999999888777666667
Q ss_pred ccccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 RVAGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
..+|||.|.+||+++. +.|++.+|-||+||++|||+.|..||+...-...+..+. .... .-
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm------~hk~--------~l 300 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM------NHKE--------SL 300 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh------chhh--------hc
Confidence 7889999999999972 568899999999999999999999998754443333221 1110 11
Q ss_pred CCC--HHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 020720 232 QFP--EKEVMRFIKVGLFCTQAGAHYRPT---MKQVVEM 265 (322)
Q Consensus 232 ~~~--~~~~~~l~~l~~~cl~~dp~~Rps---~~evl~~ 265 (322)
.+| .+.+.+..++|.+.+ -+|..|.. +.++-..
T Consensus 301 ~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 112 123344556665555 56778887 8887654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=257.50 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=188.3
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||.|+||+|++-.++ +|+..|||+++.... .+.++++.|.+...+- ++||||++||.+..++.+|+.||.|+- ||.
T Consensus 72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlD 150 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLD 150 (361)
T ss_pred hcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHH
Confidence 899999999998666 799999999987644 5557788887765544 799999999999999999999999964 554
Q ss_pred HHHh-cCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALL-GSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~-~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+.. ....+...+++..+-.|....+.||.||-..-. |+|||+||+|||++..|.+||+|||++....+.... +.
T Consensus 151 klYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk--T~ 226 (361)
T KOG1006|consen 151 KLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK--TV 226 (361)
T ss_pred HHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHHHh--hh
Confidence 4331 111122368888888999999999999987543 999999999999999999999999998765443222 33
Q ss_pred cccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 158 VAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
-.|-..|||||.+.. ..++.+|||||||++|||+.||+.|+..+... .+-..+. ..+....+..+ .-..
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~V-v~gdpp~l~~~---~~~~ 297 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQV-VIGDPPILLFD---KECV 297 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHH-HcCCCCeecCc---cccc
Confidence 356778999998873 35899999999999999999999999877441 1111111 11211111110 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....|..++..|+.+|-+.||...+++.+
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 345568888888999999999999999764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=275.10 Aligned_cols=234 Identities=21% Similarity=0.263 Sum_probs=198.6
Q ss_pred cccCcceEEEEEEECCC-CEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDG-TQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~-~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||-|+||.|=++..++. ..+|+|++++. +....+.+..|-.+|..++.|+||++|..|.+....|++||-|-||.|
T Consensus 428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl 507 (732)
T KOG0614|consen 428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL 507 (732)
T ss_pred cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchh
Confidence 89999999999977643 34899988765 445567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+..++.++ .++..++..++..+++|++|||+++ |++|||||+|.+++.+|.+||.|||+++....... .-+
T Consensus 508 WTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--TwT 578 (732)
T KOG0614|consen 508 WTILRDRG----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TWT 578 (732)
T ss_pred hhhhhhcC----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc--eee
Confidence 99997765 7999999999999999999999999 99999999999999999999999999998765433 235
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.+.-..+..+-.... .-.+|...
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------------~i~~Pr~I 644 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------------KIEFPRRI 644 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------------hhhccccc
Confidence 7899999999999999999999999999999999999999998765444433311111 11345555
Q ss_pred HHHHHHHHHhcccCCCCCCCC
Q 020720 238 VMRFIKVGLFCTQAGAHYRPT 258 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps 258 (322)
.....++|+++...+|.+|..
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhc
Confidence 566778888899999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=234.67 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=197.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||+|.||+||+|+.. +++-||+|+++.++. .--...++|+-+++.++|.|||+++++...+..+.+|+|||+ .+|.
T Consensus 10 igegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlk 88 (292)
T KOG0662|consen 10 IGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLK 88 (292)
T ss_pred hcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHH
Confidence 899999999999766 588899999987633 333678999999999999999999999999999999999995 5888
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
.+...... .++...+..++.|++.||.++|+++ +.|||+||+|.++..+|.+||+|||+++.++-...... ..
T Consensus 89 kyfdslng---~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcys-ae 161 (292)
T KOG0662|consen 89 KYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS-AE 161 (292)
T ss_pred HHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-ce
Confidence 88875543 6888899999999999999999999 99999999999999999999999999998765544333 33
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccccc---CccC-CC
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV---DPEL-TQ 232 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~ 232 (322)
+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+-++.+..+.+......+.....+- |-.. +.
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 468999999998865 57899999999999999987 555566665555555554433322222221110 1000 11
Q ss_pred CC---------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 233 FP---------EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 233 ~~---------~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
++ +....+=.+++...+.-+|..|.++++.++.
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11 1122233566777888899999999887653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.30 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
+||+|-||+||-|+++ +|+.||||++.+. .......+.+|+.+|+++.||.||.+--.|+..+..++|||.+. |++
T Consensus 571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDM 649 (888)
T KOG4236|consen 571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDM 649 (888)
T ss_pred hccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chH
Confidence 5899999999999876 7999999999654 34445788999999999999999999999999999999999995 577
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---CeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN---FHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+++...... ++++..-..++.||+.||.|||.++ |+|+||||+|||+... ..+||+|||++++.++.. .
T Consensus 650 LEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 650 LEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred HHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 7777655332 7899888899999999999999999 9999999999999654 469999999999887643 2
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....+||+.|+|||++..+.|...-|+||.|+|+|.-|+|..||....+.... ++ .. .-+. +..+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQ------NA---aFMy----Pp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQ------NA---AFMY----PPNP 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hh------cc---cccc----CCCc
Confidence 34578999999999999999999999999999999999999999865332111 11 00 0011 1111
Q ss_pred -HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 -EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 -~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.....+++|..+|+..-.+|-+.+..+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 223344778888899999999998877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=273.38 Aligned_cols=231 Identities=24% Similarity=0.312 Sum_probs=185.1
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+|.|+|+.|-.+... +++.+++|++.... .+-.+|+.++... +||||+++.+.+.+....++|||.+.|+-+.+
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ 405 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLR 405 (612)
T ss_pred cCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHH
Confidence 689999999888655 68899999997552 2233466555555 89999999999999999999999999998888
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe-CCCCeEEEeeeccccccCCCcceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL-DGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
.+.... ....++..|+.+|+.|+.|||.++ ++||||||+|||+ +..++++|+|||.++..... ....
T Consensus 406 ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp 473 (612)
T KOG0603|consen 406 RIRSKP-----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTP 473 (612)
T ss_pred HHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----hccc
Confidence 876553 233677789999999999999999 9999999999999 58899999999999876544 2233
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
+-|..|.|||++....+++++|+||||++||+||+|+.||........+ . ..+ -.+ .+....+
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei--~---~~i---------~~~---~~s~~vS 536 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI--H---TRI---------QMP---KFSECVS 536 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH--H---Hhh---------cCC---ccccccC
Confidence 4678999999999999999999999999999999999999877655111 1 000 001 1123344
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+|+.+||+.||.+||++.++...
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccC
Confidence 557788889999999999999999753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=285.30 Aligned_cols=138 Identities=31% Similarity=0.418 Sum_probs=124.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||||+++... ......+..|+.++..++||||+++++++......++||||+.+++
T Consensus 11 ~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~ 90 (669)
T cd05610 11 PISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGD 90 (669)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCC
Confidence 3899999999999776 68999999987542 3334678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 91 L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 91 VKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999996543 5888999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=250.77 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=194.3
Q ss_pred cccCcceEEEEEEEC---C--CCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLR---D--GTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~---~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 73 (322)
||+|.||.||+|.-. + ...+|||.++.+.. .-.....+|+..++.++|||++.+..++.. +...++++||.+
T Consensus 32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE 111 (438)
T KOG0666|consen 32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE 111 (438)
T ss_pred ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh
Confidence 899999999999433 2 23789999976532 223678899999999999999999999877 778899999998
Q ss_pred CCCHHHHHhcCC-CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC----CeEEEeeeccccccC
Q 020720 74 NNSLANALLGSK-SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN----FHPKIGDFGLAKLFP 148 (322)
Q Consensus 74 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~----~~~kl~Dfg~~~~~~ 148 (322)
. +|+.+++-.. .+...++...+..|+.||+.|+.|||++= ++||||||.||||..+ |.|||+|||+++.+.
T Consensus 112 h-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~ 187 (438)
T KOG0666|consen 112 H-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFN 187 (438)
T ss_pred h-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhh
Confidence 7 7888886432 22247888999999999999999999987 9999999999999877 999999999999887
Q ss_pred CCccee--ecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCc------hhHHHHHHHHHhc
Q 020720 149 DNVTHV--STRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM------LILVEWTWKLREE 219 (322)
Q Consensus 149 ~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~ 219 (322)
+..... ...++-|.+|+|||++.+. .|+++.|||+.|||+.||++-.+.|.+...... ...+..+.++ -
T Consensus 188 ~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~v--L 265 (438)
T KOG0666|consen 188 NPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEV--L 265 (438)
T ss_pred ccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHH--c
Confidence 665443 2346679999999999865 689999999999999999999888875432211 1111112111 1
Q ss_pred CccccccCccCCCCCHH-------------------H-------HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 220 GRLLEIVDPELTQFPEK-------------------E-------VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 220 ~~~~~~~~~~~~~~~~~-------------------~-------~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+...+...|.+...|.- . ...-++++..+|+.||-+|.|+++.++.
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11111122222222110 0 0125778889999999999999998874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=250.40 Aligned_cols=238 Identities=27% Similarity=0.366 Sum_probs=192.8
Q ss_pred cceEEEEEEEC-CCCEEEEEEecccChhc-HHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhc
Q 020720 6 AFGVVYRGSLR-DGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLG 83 (322)
Q Consensus 6 ~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 83 (322)
+||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999877 58999999997665544 68899999999999999999999999999999999999999999999965
Q ss_pred CCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccCCC
Q 020720 84 SKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163 (322)
Q Consensus 84 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~ 163 (322)
.. .+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 43 3888999999999999999999998 9999999999999999999999999988664432 2233457889
Q ss_pred CCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHH
Q 020720 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIK 243 (322)
Q Consensus 164 y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (322)
|++||.+....++.++||||||+++|+|++|..||........ ... ....... ...........++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~----~~~~~~~------~~~~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFK----KIGKPKP------PFPPPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH----HHhccCC------CCccccccCCHHHHH
Confidence 9999999888899999999999999999999999875322111 111 1111100 000000003356889
Q ss_pred HHHhcccCCCCCCCCHHHHHH
Q 020720 244 VGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 244 l~~~cl~~dp~~Rps~~evl~ 264 (322)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=248.02 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEe--------CCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--------DNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~ 69 (322)
.||+|.||+||+|+.+ +|+.||+|++-.+.+ .--....+|+.+|..++|+|++.++.+|.. ...+++||
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf 103 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF 103 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence 3899999999999776 588899987754432 223577899999999999999999998843 23579999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
.+|+. +|.-++... ...++..++.++++++..||.|+|++. |+|||+||.|+||+.+|.++|+|||+++.+..
T Consensus 104 ~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 104 DFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred HHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 99976 777777443 247999999999999999999999998 99999999999999999999999999975532
Q ss_pred C---cceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH--------HHH
Q 020720 150 N---VTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW--------KLR 217 (322)
Q Consensus 150 ~---~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~ 217 (322)
. .....+..+-|.+|++||.+.+ ..++++.|||..||++.||+++.+.+++......+..+.-.. ...
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 2 2223344566999999999886 478999999999999999999999998776655554443211 101
Q ss_pred hcCccccccCcc-CC----CCCHHHH------HHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 218 EEGRLLEIVDPE-LT----QFPEKEV------MRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 218 ~~~~~~~~~~~~-~~----~~~~~~~------~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
.+-.+.+.+.-+ +. ....+.. .+.++++..+|..||.+|+++++++..-
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111111100 10 0011111 2467888889999999999999998653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=260.63 Aligned_cols=234 Identities=26% Similarity=0.354 Sum_probs=189.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||+|.+|.-+ +...||||+++.+. ..+.+--+.|-++|... +-|.+++++.+|..-+.+|+||||+.||
T Consensus 356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG 435 (683)
T KOG0696|consen 356 VLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG 435 (683)
T ss_pred EeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence 5899999999999655 57789999998652 22333344566666655 5689999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|-..++.-+ .+.++.+..++.+||-||-+||+++ |++||||.+|||++.+|.+||.|||+++.---. ....
T Consensus 436 DLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~~TT 507 (683)
T KOG0696|consen 436 DLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-GVTT 507 (683)
T ss_pred hhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC-Ccce
Confidence 9988887655 6888889999999999999999999 999999999999999999999999999853222 1223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++...+|+...|-||+|++||||+.|+.||.+.+.++....+ . ..-..++.
T Consensus 508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------~----------ehnvsyPK 571 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------M----------EHNVSYPK 571 (683)
T ss_pred eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------H----------HccCcCcc
Confidence 4678999999999999999999999999999999999999999976544332211 1 11123455
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPT 258 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps 258 (322)
....+...++...|.+.|.+|..
T Consensus 572 slSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 572 SLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccHHHHHHHHHHhhcCCccccC
Confidence 55566788888899999999954
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=268.84 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=199.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEe-----CCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVE-----DNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~~lv~e~~~ 73 (322)
+||.|.+|.||+++.. +++-.|+|+...... ..+++..|+.+++.+ .|||++.+++++.. ++.+|||||||.
T Consensus 26 vig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~ 104 (953)
T KOG0587|consen 26 VIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG 104 (953)
T ss_pred EEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC
Confidence 4899999999999765 688899998765433 336677899999888 69999999999854 467999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+||..|++.... ...+.|..+..|+..++.|+.+||++. ++|||||-.|||++.++.|||+|||.+....... .
T Consensus 105 gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-g 178 (953)
T KOG0587|consen 105 GGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-G 178 (953)
T ss_pred CccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc-c
Confidence 999999997665 458999999999999999999999998 9999999999999999999999999988654432 2
Q ss_pred eecccccCCCCCchHHHhhC-----CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 154 VSTRVAGTMGYLAPEYALLG-----QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~-----~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.....+||+.|||||++... .|+..+|+||||++..||--|.+|+....+.-.++.+ . -+|
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------p--------RNP 244 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------P--------RNP 244 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC------C--------CCC
Confidence 23456799999999999743 4778999999999999999999998765443332221 0 012
Q ss_pred cCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 229 ELT-QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 229 ~~~-~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+ .-+..-.++|.++|..||.+|-.+||++.++++.
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 222 2256677889999999999999999999998763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.19 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=161.1
Q ss_pred CcccCcceEEEEEEEC-C----CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceE------EEeCCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-D----GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC------CVEDNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~~~~lv~ 69 (322)
.||+|+||.||+|... + +..||+|++...... +....+ .+....+.++..+... .......++|+
T Consensus 139 ~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ 214 (566)
T PLN03225 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVW 214 (566)
T ss_pred EEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEE
Confidence 3899999999999775 4 689999987643221 111111 1122222223222221 23556789999
Q ss_pred EcCCCCCHHHHHhcCCCC----------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-
Q 020720 70 EYLENNSLANALLGSKSK----------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG- 132 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~- 132 (322)
||+.+++|.+++...... ........+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 215 ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~ 291 (566)
T PLN03225 215 RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEG 291 (566)
T ss_pred EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCC
Confidence 999999999998654210 001123346679999999999999998 999999999999985
Q ss_pred CCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhC----------------------CCCcccceehhhHHHHH
Q 020720 133 NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG----------------------QLTKKADVYSFGVLLLE 190 (322)
Q Consensus 133 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~sDv~slG~il~e 190 (322)
++.+||+|||++...............+++.|+|||.+... .++.++|||||||++||
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e 371 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 371 (566)
T ss_pred CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence 58999999999986543333333456789999999976432 23456799999999999
Q ss_pred HHhCCCCCCcccCCCchhHHHHHHHHHhcCc----cccccCcc----CC---CCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 020720 191 IISGRSSSKAAFGDDMLILVEWTWKLREEGR----LLEIVDPE----LT---QFPEKEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 191 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~---~~~~~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
|+++..++... ..... ..+...+. ....+.+. +. +..........+++.+||+.||.+|||+
T Consensus 372 l~~~~~~~~~~----~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 372 MAFPNLRSDSN----LIQFN---RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHhCcCCCchH----HHHHH---HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 99876554321 11110 00000000 00000010 00 0001112235589999999999999999
Q ss_pred HHHHHH
Q 020720 260 KQVVEM 265 (322)
Q Consensus 260 ~evl~~ 265 (322)
.++++.
T Consensus 445 ~e~L~H 450 (566)
T PLN03225 445 KAALAH 450 (566)
T ss_pred HHHhCC
Confidence 999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=245.66 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEECC------CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRD------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 72 (322)
++-+|.||.||.|.|.+ .+.|.+|.++.. ..-....++.|...+-.+.|||+..+.+++.++ ...++++.+.
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 35689999999996652 345677777654 333457788999999999999999999998654 5788999999
Q ss_pred CCCCHHHHHhcCCC----CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc-
Q 020720 73 ENNSLANALLGSKS----KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF- 147 (322)
Q Consensus 73 ~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~- 147 (322)
..|+|..++...+. .-..++-.....++.|++.|++|||+.+ ++|.||.+.|++||+..+|||+|=.+++..
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccC
Confidence 99999999974322 1224555667788999999999999999 999999999999999999999999888843
Q ss_pred CCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 148 PDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
+.+..........+..||+||.+.+..|+.++||||||+++|||+| |+.|+...++.++...+. ...+
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk------dGyR----- 516 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK------DGYR----- 516 (563)
T ss_pred cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh------ccce-----
Confidence 3333333333446779999999999999999999999999999998 889988765544433321 2222
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
-..|.+++.++..+|..||..+|++||+++|++.-|..
T Consensus 517 ----laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 517 ----LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 23355677789999999999999999999999988754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=254.96 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=171.0
Q ss_pred cccCcceEEEEEE-ECCCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||-|+||+|.++. .++...||+|.+++.+ .........|-.||...+.+-||++|-.|.+++.+||||+|++||++
T Consensus 637 iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDm 716 (1034)
T KOG0608|consen 637 IGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDM 716 (1034)
T ss_pred ecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccH
Confidence 8999999999994 4457789999997653 34456778899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC---------
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP--------- 148 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~--------- 148 (322)
-.+|...+ -+++..++.++.++..|+++.|+.| +|||||||+|||||.+|.+||.|||++.-+.
T Consensus 717 MSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 717 MSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred HHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99998776 6899999999999999999999999 9999999999999999999999999985321
Q ss_pred --CCcce------------------------------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCC
Q 020720 149 --DNVTH------------------------------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196 (322)
Q Consensus 149 --~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~ 196 (322)
++... .....+||+.|+|||++....++..+|-||.|||||||+.|+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 00000 0011469999999999999999999999999999999999999
Q ss_pred CCCcccCCCch
Q 020720 197 SSKAAFGDDML 207 (322)
Q Consensus 197 p~~~~~~~~~~ 207 (322)
||-........
T Consensus 870 pf~~~tp~~tq 880 (1034)
T KOG0608|consen 870 PFLADTPGETQ 880 (1034)
T ss_pred CccCCCCCcce
Confidence 99876655443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=264.16 Aligned_cols=242 Identities=25% Similarity=0.345 Sum_probs=183.7
Q ss_pred CcccCcceE-EEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGV-VYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~-v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
++|.|+.|+ ||+|... |+.||||++-.+ ...-+.+|+..|+.- +|||||++++.-.+....|+..|.|. .+|.
T Consensus 516 ilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~ 590 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQ 590 (903)
T ss_pred HcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHH
Confidence 478898885 5999887 899999987533 235677899999888 79999999988888889999999995 5999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---C--CeEEEeeeccccccCCCcce
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---N--FHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++...............+.++.|++.||++||+.+ |+||||||+||||+. + .+++|+|||+++........
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999774211111222456788999999999999999 999999999999976 2 56899999999977544322
Q ss_pred --eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhC-CCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 154 --VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG-RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
......||.+|+|||++....-+.++|||||||++|+.++| .+||......+.-.+ ..+..+ ..+
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L-----~~L 735 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTL-----VHL 735 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccce-----eee
Confidence 23346699999999999988888899999999999999996 899975532211100 000111 011
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...... +..++|.+|++.||..||++.+|+..
T Consensus 736 ~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EPLPDC---EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ccCchH---HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111111 67788889999999999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=251.97 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=171.1
Q ss_pred CcccCcceEEEEEEE-----------------CCCCEEEEEEecccChhcHHHH--------------HHHHHHHhcCCC
Q 020720 1 MIGGGAFGVVYRGSL-----------------RDGTQIAIKCLSAESKQGTKEF--------------LTEIDMIWNIRH 49 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~~--------------~~e~~~l~~l~h 49 (322)
.||+|+||.||+|.. ..++.||||++........++| ..|+.++.+++|
T Consensus 152 ~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~ 231 (507)
T PLN03224 152 KLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKR 231 (507)
T ss_pred EeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhc
Confidence 489999999999953 2356899999875543322333 346667777766
Q ss_pred Ccc-----cccceEEEe--------CCeeEEEEEcCCCCCHHHHHhcCCCC--------------------CcCCCHHHH
Q 020720 50 PNL-----VQLIGCCVE--------DNNRILVYEYLENNSLANALLGSKSK--------------------YVSLDWPTR 96 (322)
Q Consensus 50 ~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~ 96 (322)
.++ ++++++|.. .+..++|+||+.+++|.++++..... ...+++..+
T Consensus 232 ~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~ 311 (507)
T PLN03224 232 NPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVI 311 (507)
T ss_pred ccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHH
Confidence 544 666777643 35689999999999999998643211 113466788
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCC-
Q 020720 97 ANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175 (322)
Q Consensus 97 ~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~- 175 (322)
+.++.|++.+|.|||+.+ ++||||||.||+++.++.+||+|||++...............+++.|+|||.+.....
T Consensus 312 ~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~ 388 (507)
T PLN03224 312 KGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSC 388 (507)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCC
Confidence 899999999999999998 9999999999999999999999999987543322211122235789999998764321
Q ss_pred ---------------------CcccceehhhHHHHHHHhCCC-CCCcccCCCch-h---HHHHHHHHHhcCccccccCcc
Q 020720 176 ---------------------TKKADVYSFGVLLLEIISGRS-SSKAAFGDDML-I---LVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 176 ---------------------~~~sDv~slG~il~ell~g~~-p~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~ 229 (322)
..+.||||+||++|+|++|.. ||.....-... . .....|....... .+
T Consensus 389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~----~~-- 462 (507)
T PLN03224 389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK----YD-- 462 (507)
T ss_pred CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC----CC--
Confidence 135799999999999999875 66432111100 0 0000111110000 01
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGA---HYRPTMKQVVEM 265 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp---~~Rps~~evl~~ 265 (322)
+. ..........+++.+||..+| .+|+|++|+++.
T Consensus 463 ~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 463 FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 112223457778888998765 689999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=239.97 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=192.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+|++|..+++. +.+-||+|+++++ ..++..-.+.|-....+. +||.+|-++.+|..+..+++|.||.+||
T Consensus 257 vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg 336 (593)
T KOG0695|consen 257 VIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG 336 (593)
T ss_pred eecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc
Confidence 5899999999999776 6788999999865 344445566777777776 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|--.++.++ .+++..+..+...|..||.|||+.| |++||||.+|+|+|..|.+||.|||+++.--... ...
T Consensus 337 dlmfhmqrqr----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~g-d~t 408 (593)
T KOG0695|consen 337 DLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DTT 408 (593)
T ss_pred ceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCC-ccc
Confidence 9977776655 6999999999999999999999999 9999999999999999999999999988543322 233
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCC-CchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGD-DMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..++||+.|.|||++.+..|....|-|+||++++||+.|+.||.....+ .......+..++..+.. -..|
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---------irip 479 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---------IRIP 479 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---------cccc
Confidence 5688999999999999999999999999999999999999999754322 12222233333322211 1223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPT 258 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps 258 (322)
.....+...+++..|++||.+|..
T Consensus 480 rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcC
Confidence 333344566777789999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=222.42 Aligned_cols=197 Identities=28% Similarity=0.411 Sum_probs=162.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||+|++|.|-+-++. +|.-.|+|.++... .+..+..++|+.+..+. .+|++|.+||........|+.||.++. ||.
T Consensus 54 lGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sld 132 (282)
T KOG0984|consen 54 LGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLD 132 (282)
T ss_pred hcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHH
Confidence 799999999888665 79999999998763 34456778888876655 799999999999999999999999965 676
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
.+-..--.+...+++..+-+|+..+++||.|||++-+ ++|||+||.|||++.+|+||++|||++....+.... +-.
T Consensus 133 kfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk--t~d 208 (282)
T KOG0984|consen 133 KFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK--TMD 208 (282)
T ss_pred HHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhHH--HHh
Confidence 5554322334479999999999999999999998643 999999999999999999999999999876554332 223
Q ss_pred ccCCCCCchHHHhh----CCCCcccceehhhHHHHHHHhCCCCCCcccC
Q 020720 159 AGTMGYLAPEYALL----GQLTKKADVYSFGVLLLEIISGRSSSKAAFG 203 (322)
Q Consensus 159 ~~t~~y~aPE~~~~----~~~~~~sDv~slG~il~ell~g~~p~~~~~~ 203 (322)
.|-..|+|||.+.. ..|+.++||||||+++.||.+++.||..+..
T Consensus 209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 46678999998863 3689999999999999999999999987654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=234.62 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=195.3
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~ 73 (322)
||.|+||.||.+.+. +|+.|++|.+..- .-...+.+.+|+.+|..++|.|++..+++..-. ...|+++|.+.
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ 140 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ 140 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence 799999999999665 7999999987532 223447899999999999999999998886432 23567778774
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
.+|+.++-.. ..++...+.-++.||++||.|||+.+ |.||||||.|.+++.|..+||+|||+++....+...
T Consensus 141 -SDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 141 -SDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred -hhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 3777777433 37888899999999999999999999 999999999999999999999999999976655555
Q ss_pred eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH--------HHHhcCcccc
Q 020720 154 VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW--------KLREEGRLLE 224 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 224 (322)
.++..+-|.-|.|||++++. .|+.+.||||.||++.||+..+..|+...+.+.+.++.... +..-++....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 56666678899999999975 68999999999999999999999998776666555443211 1112222222
Q ss_pred ccC-----ccC---CC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 225 IVD-----PEL---TQ--FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 225 ~~~-----~~~---~~--~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
++. |.+ .. .+...-.+-..+...++..||++|.+..+.+..+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 222 111 11 1122334456677779999999999998887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=222.42 Aligned_cols=210 Identities=35% Similarity=0.569 Sum_probs=182.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999776 4899999999765432 35778999999999999999999999999899999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCCCcceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
++.... ..+++..++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 996542 26889999999999999999999998 999999999999999 89999999999886543321 12234
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 477899999998877 788999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.+++..|++.||++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457788888999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=243.48 Aligned_cols=255 Identities=24% Similarity=0.256 Sum_probs=200.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC------CCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR------HPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.|+|-|++|..|... .|..||||+|+. ++...+.=+.|+++|++|+ --|+++++..|...+++|+|+|.+.
T Consensus 440 ~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls- 517 (752)
T KOG0670|consen 440 TGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS- 517 (752)
T ss_pred cccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-
Confidence 599999999999766 488999999984 4445567788999999995 3589999999999999999999884
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcce
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 153 (322)
.+|.+++...+ ....+....+..+++|+..||..|-+.+ ++|.||||.||||.+. ..+||||||.|.....+..
T Consensus 518 lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei- 592 (752)
T KOG0670|consen 518 LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEI- 592 (752)
T ss_pred chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccc-
Confidence 58999997664 4457888999999999999999999999 9999999999999866 5689999999987655432
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH-----HHhcCc-------
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-----LREEGR------- 221 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~------- 221 (322)
+...-+-.|.|||++.+.+|+...|+||.||+||||.||+..|.+..+.+++-+..-... +...+.
T Consensus 593 --tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD 670 (752)
T KOG0670|consen 593 --TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD 670 (752)
T ss_pred --cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc
Confidence 222334579999999999999999999999999999999999999888777655432210 000000
Q ss_pred --------------------cccccCc------------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 --------------------LLEIVDP------------ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 --------------------~~~~~~~------------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+...+.| .+.+-.......|.+|+..|+..||++|.|..+.|..
T Consensus 671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 0111111 1122223455678999999999999999999988753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=219.66 Aligned_cols=244 Identities=19% Similarity=0.310 Sum_probs=181.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceE-EEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGC-CVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|.||.+-+++++ +.+.+++|.+.... ...++|.+|...--.| .|.||+.-|++ |...+.+++++||++.|+|
T Consensus 31 ~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL 109 (378)
T KOG1345|consen 31 QLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDL 109 (378)
T ss_pred HhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchh
Confidence 3899999999999887 68899999987543 2347889998876556 58999998776 4556788899999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC--CCCeEEEeeeccccccCCCcceee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD--GNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
.+-+... .+.+.....++.|++.|+.|+|+.+ ++|||||.+||||- +.-+|||+|||.....+.....
T Consensus 110 ~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-- 179 (378)
T KOG1345|consen 110 RSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-- 179 (378)
T ss_pred hhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceehh--
Confidence 9988654 5778888999999999999999999 99999999999993 3457999999998865543322
Q ss_pred cccccCCCCCchHHHhhC-----CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 156 TRVAGTMGYLAPEYALLG-----QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~-----~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
..-+..|.+||+.... ...+.+|||.||+++|.++||..||+.....+. ... .|.....+. .+.+
T Consensus 180 --~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~--~~~~w~~rk-----~~~~ 249 (378)
T KOG1345|consen 180 --LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYW--EWEQWLKRK-----NPAL 249 (378)
T ss_pred --hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHH--HHHHHhccc-----CccC
Confidence 2245689999987632 356889999999999999999999985433222 111 121111111 1222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+..-.....+++++.++-+..+|.+|-...++.+.
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22222233346667777899999999776666554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=250.71 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
+|.|.+|.||+++.. ++...|+|+++.....+..-+.+|+-+++..+||||+.+++.+.....+|+.||||.+|+|++.
T Consensus 23 vgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdi 102 (829)
T KOG0576|consen 23 VGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDI 102 (829)
T ss_pred ecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccce
Confidence 799999999999765 7899999999998888888899999999999999999999999999999999999999999998
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
-+... ++.+.++...+...+.+++|||+.+ -+|||||-.||++++.|.+|+.|||.+..+...... ...++|
T Consensus 103 y~~Tg----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~K-rksfiG 174 (829)
T KOG0576|consen 103 YHVTG----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-RKSFIG 174 (829)
T ss_pred eeecc----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhh-hhcccC
Confidence 87665 8999999999999999999999999 899999999999999999999999998766543322 244789
Q ss_pred CCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 161 TMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 161 t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
|+-|||||+.. .+.|...+|||++|+...||---+.|......-..+.++. . ..++|.-......-
T Consensus 175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------k-----S~~qpp~lkDk~kw 243 (829)
T KOG0576|consen 175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------K-----SGFQPPTLKDKTKW 243 (829)
T ss_pred CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------c-----cCCCCCcccCCccc
Confidence 99999999875 5578899999999999999988887755443333222221 1 11222222223344
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...|.++++.|+.++|.+||+++.++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 556788888899999999999887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=242.81 Aligned_cols=189 Identities=27% Similarity=0.372 Sum_probs=162.7
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC----hh----cHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEE
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES----KQ----GTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVY 69 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~----~~----~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 69 (322)
||+|+||.|+.|.++ +...|+||.+.++. .. ..-.+.-|+++|..++ |+||++++++|++++.++++|
T Consensus 569 lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~t 648 (772)
T KOG1152|consen 569 LGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLET 648 (772)
T ss_pred ccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEe
Confidence 799999999999877 46789999886541 11 1113456999999997 999999999999999999999
Q ss_pred EcCC-CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 70 EYLE-NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 70 e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
|... +.+|.++++... .+++.++..|+.|++.|+++||+++ |+|||||-+|+.++.+|-+||+|||.+....
T Consensus 649 e~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 649 EVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred cCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9764 569999997665 7999999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcceeecccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCc
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKA 200 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~ 200 (322)
+. ....+.||..|.|||++.+.+| ...-|||++|++||.++....||+.
T Consensus 722 sg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 SG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 32 2345679999999999998887 5778999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=216.93 Aligned_cols=194 Identities=33% Similarity=0.491 Sum_probs=168.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|++|.||++... ++..+++|.+...... ..+.+.+|++.+..++|+|++++++++......++++|++++++|.
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 85 (225)
T smart00221 6 KLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLF 85 (225)
T ss_pred EeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHH
Confidence 3799999999999876 4899999999866554 5688999999999999999999999999989999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+..............
T Consensus 86 ~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 86 DYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred HHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99976542 1788999999999999999999998 99999999999999999999999999887654321122334
Q ss_pred ccCCCCCchHHH-hhCCCCcccceehhhHHHHHHHhCCCCCCc
Q 020720 159 AGTMGYLAPEYA-LLGQLTKKADVYSFGVLLLEIISGRSSSKA 200 (322)
Q Consensus 159 ~~t~~y~aPE~~-~~~~~~~~sDv~slG~il~ell~g~~p~~~ 200 (322)
.++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 577889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=208.92 Aligned_cols=246 Identities=20% Similarity=0.291 Sum_probs=183.6
Q ss_pred cccCcceEEEEEEE-CCCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCC--eeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSL-RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDN--NRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L 77 (322)
+|+|-+++||.|.. .++..++||+++. -..+.+.+|+.+|+.+. +|||+.++++..+.. ...+++||+++.+.
T Consensus 46 ~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Df 122 (338)
T KOG0668|consen 46 VGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDF 122 (338)
T ss_pred HcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccH
Confidence 69999999999964 4688899999873 33478899999999996 999999999987654 56899999998877
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
..+.. .++...+...+.+++.||.|+|+.| |.|||+||.|+++|.. ..++|+|+|++..+.......
T Consensus 123 k~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn-- 190 (338)
T KOG0668|consen 123 KQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN-- 190 (338)
T ss_pred HHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCceee--
Confidence 76662 5777889999999999999999999 9999999999999965 459999999999875443221
Q ss_pred ccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCccc-CCCchhHHHHHHHHHh------------cCc-
Q 020720 157 RVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAF-GDDMLILVEWTWKLRE------------EGR- 221 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~------------~~~- 221 (322)
-.+.+--|--||++.. ..++..-|+|||||++..|+..+.||.... +.+.+..+.......+ ...
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 1234556788998875 457889999999999999999999986543 3333333322111000 000
Q ss_pred -----------cccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 -----------LLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 -----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...++.+.-+.+. ..+.++++...|..|-.+|+|+.|.+..
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~---~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLV---SPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhccccccHHHhCCccccccC---ChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111111111 2357788888999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=221.32 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=186.3
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC--------CCcccccceEEEe----CCeeEEE
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR--------HPNLVQLIGCCVE----DNNRILV 68 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~~----~~~~~lv 68 (322)
||=|.|++||++.+. +.+.||+|+.+ ....-.+..+.|+.+|++++ ..+||++++.|.. +.+.|+|
T Consensus 86 LGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMV 164 (590)
T KOG1290|consen 86 LGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMV 164 (590)
T ss_pred ccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEE
Confidence 788999999999654 68899999987 33444577889999999983 3479999999865 3578999
Q ss_pred EEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---------------
Q 020720 69 YEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN--------------- 133 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~--------------- 133 (322)
+|++ |-+|..+|.... +..++...+..|++||+.||.|||...+ |||.||||+|||+..+
T Consensus 165 fEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~ 239 (590)
T KOG1290|consen 165 FEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKDAREAGEAT 239 (590)
T ss_pred ehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhhhhhhcccc
Confidence 9999 567888886553 3478999999999999999999998654 9999999999997100
Q ss_pred --------------------------------------------------------------------------------
Q 020720 134 -------------------------------------------------------------------------------- 133 (322)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (322)
T Consensus 240 ~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~ 319 (590)
T KOG1290|consen 240 TSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERS 319 (590)
T ss_pred ccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhc
Confidence
Q ss_pred -----------------------------------------------------------------------CeEEEeeec
Q 020720 134 -----------------------------------------------------------------------FHPKIGDFG 142 (322)
Q Consensus 134 -----------------------------------------------------------------------~~~kl~Dfg 142 (322)
..+||+|||
T Consensus 320 ~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlG 399 (590)
T KOG1290|consen 320 TLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLG 399 (590)
T ss_pred ccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeecc
Confidence 013555555
Q ss_pred cccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCC------chhHH-HHHHH
Q 020720 143 LAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD------MLILV-EWTWK 215 (322)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~------~~~~~-~~~~~ 215 (322)
-|+++..+. +..+.|-.|+|||++.+..|++.+||||++|++|||+||-..|....+.. .+..+ +....
T Consensus 400 NACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~ 475 (590)
T KOG1290|consen 400 NACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGK 475 (590)
T ss_pred chhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhh
Confidence 555433221 22346778999999999999999999999999999999999997654432 11111 11111
Q ss_pred ----HHhcCc-----------cccc--cCc--------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 ----LREEGR-----------LLEI--VDP--------ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ----~~~~~~-----------~~~~--~~~--------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+...++ +..+ +.+ +-..++.++..+|.+++.-||+.+|.+|||+.++++.
T Consensus 476 iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 476 IPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred ccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 111111 1111 000 0023556778889999999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=221.05 Aligned_cols=251 Identities=24% Similarity=0.277 Sum_probs=185.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~ 72 (322)
+|.|.. .|..+.+. .++.||+|..... .....+...+|...+..++|+||++++.++.-. ...++|||++
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m 103 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM 103 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence 455555 44445333 5889999987544 344567889999999999999999999998533 2468999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
+. +|...+.. .++-..+..|+.|++.|+.+||+.+ |+||||||+||++..++.+||.|||++......
T Consensus 104 ~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 104 DA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred hh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--
Confidence 64 78888861 4677789999999999999999999 999999999999999999999999999865433
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH---------HHHHhcC---
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT---------WKLREEG--- 220 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~--- 220 (322)
..++..+.|--|.|||++.+..+.+.+||||+||++.||++|...|.+....+....+... .++.+.+
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 3456667788999999999988999999999999999999999998854433332222100 0000000
Q ss_pred ---c-----------cccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 221 ---R-----------LLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 221 ---~-----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+ .....-+...+.+.-......+++.+||-.||++|-+++++|+.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 00000011111122234456788899999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=251.12 Aligned_cols=195 Identities=19% Similarity=0.218 Sum_probs=135.7
Q ss_pred cCCC-CcccccceEE-------EeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 020720 46 NIRH-PNLVQLIGCC-------VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117 (322)
Q Consensus 46 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~ 117 (322)
.++| +||+.+++.| .+....++++||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3445 5777788876 2234567778877 569999996432 26999999999999999999999999
Q ss_pred eeeccCcccceEeCCCCe-------------------EEEeeeccccccCCCcc---------------eeecccccCCC
Q 020720 118 IVHRDIKASNVLLDGNFH-------------------PKIGDFGLAKLFPDNVT---------------HVSTRVAGTMG 163 (322)
Q Consensus 118 i~h~dlkp~Nill~~~~~-------------------~kl~Dfg~~~~~~~~~~---------------~~~~~~~~t~~ 163 (322)
|+||||||+||||+..+. +|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965444 45555555542110000 00011347888
Q ss_pred CCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHH
Q 020720 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIK 243 (322)
Q Consensus 164 y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (322)
|+|||++.+..++.++|||||||+||||++|..|+..... .. ...... .+.+.. .....+...
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~---~~~~~~-----~~~~~~----~~~~~~~~~ 243 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM---SSLRHR-----VLPPQI----LLNWPKEAS 243 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH---HHHHHh-----hcChhh----hhcCHHHHH
Confidence 9999999999999999999999999999998877643210 00 011100 011111 111233567
Q ss_pred HHHhcccCCCCCCCCHHHHHH
Q 020720 244 VGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 244 l~~~cl~~dp~~Rps~~evl~ 264 (322)
++.+||+.||.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 788899999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=197.50 Aligned_cols=167 Identities=22% Similarity=0.167 Sum_probs=125.3
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|+|.+++..++. .+++..++.|+.|++.||.|||+.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999975432 6999999999999999999999865 999999999999999 99887654321
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..|++.|+|||++.+..++.++|||||||++|||++|..||........ ........... ..+......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~------~~~~~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPA------DDPRDRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhcc------CCccccccH
Confidence 2578999999999999999999999999999999999999865432111 11111100000 001111112
Q ss_pred HHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 235 EKEVM--RFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 235 ~~~~~--~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
..... .+.+++.+||+.||.+||++.|+++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22222 589999999999999999999999987544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=208.18 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=187.1
Q ss_pred cccCcceEEEEEEEC----CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLR----DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
||+|.|++||++... .++.||+|.+... ..-..+..|+++|..+ -+.||+++.+++..++...+|+||++...
T Consensus 44 igeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~ 121 (418)
T KOG1167|consen 44 IGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDR 121 (418)
T ss_pred ccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccC
Confidence 899999999999543 3678999998643 3346789999999999 68999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccC-------
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFP------- 148 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~------- 148 (322)
..++.. .++...+..+++.+..||+++|++| |+||||||.|++.+.. +.-.|.|||++....
T Consensus 122 f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 122 FRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred HHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 988883 5778899999999999999999999 9999999999999854 668999999997210
Q ss_pred --C----Ccce------------------------------eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHH
Q 020720 149 --D----NVTH------------------------------VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEI 191 (322)
Q Consensus 149 --~----~~~~------------------------------~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~el 191 (322)
. +... ......||++|.|||++... ..+++.||||.|+|+..+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 0 0000 00113599999999998865 568899999999999999
Q ss_pred HhCCCCCCcccCC-CchhHHHHHH------H-HHhcCc--ccc---------------ccC-ccCC----------CCCH
Q 020720 192 ISGRSSSKAAFGD-DMLILVEWTW------K-LREEGR--LLE---------------IVD-PELT----------QFPE 235 (322)
Q Consensus 192 l~g~~p~~~~~~~-~~~~~~~~~~------~-~~~~~~--~~~---------------~~~-~~~~----------~~~~ 235 (322)
++++.||.....+ +.+..+.... + ....++ +.+ .++ ..+. ....
T Consensus 272 ls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d 351 (418)
T KOG1167|consen 272 LSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSD 351 (418)
T ss_pred hccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccc
Confidence 9999998765443 2222211110 0 111122 111 000 0010 0011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+++++.+|+..||.+|.++++.|..
T Consensus 352 ~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 352 VFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 122357889999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=198.23 Aligned_cols=243 Identities=23% Similarity=0.380 Sum_probs=184.9
Q ss_pred cccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
|.+...|+.|+|+|+ |..+++|+++.. ......+|..|.-.|+.+.||||.++++.|.....+.++..|++.|+|..
T Consensus 198 l~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 198 LAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 456778999999999 667788988654 23344789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe--eeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG--DFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .-.+-.++.+++..++.|++|||+.. +-|.---|....+++|++.+.+|+ |--++. +. ..
T Consensus 277 vlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--qe------~g 345 (448)
T KOG0195|consen 277 VLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE------VG 345 (448)
T ss_pred HHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--ec------cc
Confidence 9987643 35666788899999999999999974 223344588999999999887775 321111 11 11
Q ss_pred cccCCCCCchHHHhhCCCC---cccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYALLGQLT---KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~---~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..-.+.|++||.++..+-+ .++|+|||++++|||.|...||....+-+. ..++..++. ... .+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmkialegl-----rv~---ip 411 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKIALEGL-----RVH---IP 411 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhhhhccc-----ccc---CC
Confidence 2246899999999876543 689999999999999999999987654322 222333332 222 34
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+.....+.+++.-|++.||.+||.++.|+-.|++..
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 444444566666699999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-26 Score=198.27 Aligned_cols=255 Identities=22% Similarity=0.253 Sum_probs=189.5
Q ss_pred CcccCcceEEEEEEECC--CCEEEEEEecccChhcHHHHHHHHHHHhcCC----CCcccccceEE-EeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLRD--GTQIAIKCLSAESKQGTKEFLTEIDMIWNIR----HPNLVQLIGCC-VEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||.+.... ...+|+|............+..|..++..+. .+++..+++.+ ......++||+.+
T Consensus 25 ~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~- 103 (322)
T KOG1164|consen 25 KIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL- 103 (322)
T ss_pred eccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-
Confidence 38999999999997664 3578999887653333336777888888886 36888888888 4777889999977
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-----CeEEEeeecccc--c
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-----FHPKIGDFGLAK--L 146 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-----~~~kl~Dfg~~~--~ 146 (322)
|.+|.++..... ...++..++..++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+++ .
T Consensus 104 G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 104 GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 779999886554 337999999999999999999999999 9999999999999865 469999999998 4
Q ss_pred cCCCcc-----ee--ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc
Q 020720 147 FPDNVT-----HV--STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE 219 (322)
Q Consensus 147 ~~~~~~-----~~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (322)
+..... .. .....||..|.++....+...+.+.|+||++.++.+++.|..||............. +....
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~~~~~ 255 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---KDPRK 255 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---HHhhh
Confidence 321111 11 123459999999999999999999999999999999999999997665443322211 11111
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 220 GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
... .. .....+.+ +.++...+-..+...+|....+...|......
T Consensus 256 ~~~----~~-~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 256 LLT----DR-FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hcc----cc-ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000 00 22233333 44444445568999999999999987766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=195.30 Aligned_cols=165 Identities=19% Similarity=0.193 Sum_probs=124.3
Q ss_pred CcccCcceEEEEEEEC--CCCEEEEEEeccc-----ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR--DGTQIAIKCLSAE-----SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||+||+|.+. +++.+|||++... .......+.+|++++++++|+|+++.+.. .+..++||||++
T Consensus 25 ~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~ 101 (365)
T PRK09188 25 VLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTE 101 (365)
T ss_pred EEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccC
Confidence 4899999999999764 5777899986532 12234678999999999999999863322 245799999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccC-cccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDI-KASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
|++|.. +. ... ...++.|++.+|.|||+.+ ++|||| ||+|||++.++.++|+|||++........
T Consensus 102 G~~L~~-~~-------~~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 102 GVPLHL-AR-------PHG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred CCCHHH-hC-------ccc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 999963 21 111 1467889999999999999 999999 99999999999999999999986643321
Q ss_pred ee-------ecccccCCCCCchHHHhhCC------CCccccee
Q 020720 153 HV-------STRVAGTMGYLAPEYALLGQ------LTKKADVY 182 (322)
Q Consensus 153 ~~-------~~~~~~t~~y~aPE~~~~~~------~~~~sDv~ 182 (322)
.. .+...++..|.|||.+.... .+..+|-|
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 11 13456788899999886432 23446666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-27 Score=216.12 Aligned_cols=249 Identities=23% Similarity=0.256 Sum_probs=186.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecc-----cChhcH-HHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSA-----ESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~-----~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
++|.|++|.|+..... ....++.|.++. +..... ..+..|+.+-..++|+|++..+..+.+.......||||+
T Consensus 325 ~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~ 404 (601)
T KOG0590|consen 325 VLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCP 404 (601)
T ss_pred eeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhccc
Confidence 4789999988777543 344444454331 111111 226678888888999999988888776666656699999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT- 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 152 (322)
+ +|..++.... .+...++..++.|++.|+.|+|..| +.|||+|++|++++.+|.+|++|||.+..+.....
T Consensus 405 ~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 405 Y-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred H-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9 9999996552 5788899999999999999999999 99999999999999999999999999886543322
Q ss_pred --eeecccccCCCCCchHHHhhCCCCc-ccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 153 --HVSTRVAGTMGYLAPEYALLGQLTK-KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~~~~~-~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
......+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+..... ..+.-...+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-------~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-------NNYSDQRNIFEG 549 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------hccccccccccC
Confidence 3345677999999999999999875 689999999999999999999877665443200 000000111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..........+...++.+||+.||.+|.|+.+|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 12233344556788999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=177.56 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=191.3
Q ss_pred cccCcceEEEEEE-ECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCC-CcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH-PNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|+||.+|.|. ..+|..||||+-..... ...+..|..+...+++ ..|..+..++.+...-.+||+.. |.+|.+
T Consensus 23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEd 99 (341)
T KOG1163|consen 23 IGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLED 99 (341)
T ss_pred ecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHH
Confidence 8999999999995 45799999999764433 3567788888888865 67888888888888889999988 779999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---CeEEEeeeccccccCCCcce---
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN---FHPKIGDFGLAKLFPDNVTH--- 153 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~--- 153 (322)
++.-+.. .++..+++.++.|++.-++|+|..+ ++||||||+|+|..-+ ..+.|+|||+++.+.+....
T Consensus 100 LfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI 173 (341)
T KOG1163|consen 100 LFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI 173 (341)
T ss_pred HHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence 9976654 6888999999999999999999999 9999999999998643 56899999999976433211
Q ss_pred ---eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 154 ---VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 154 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
......||.+|.+--...+-..+.+.|+-|+|.+|.++.-|..||++..........+.+.+... +..+
T Consensus 174 pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~--------s~~i 245 (341)
T KOG1163|consen 174 PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM--------STPI 245 (341)
T ss_pred ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc--------CCCH
Confidence 22346799999998877777788999999999999999999999998876655555444333221 1122
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L 266 (322)
..++...+.+|.-.+..|-...-++-|+..-+-+.+
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 223333444566667778887778888876665544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=184.03 Aligned_cols=249 Identities=20% Similarity=0.243 Sum_probs=192.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|.||.++.|..- ++..||||.-... ..+.++..|++..+.| ..+.|..++-|..++-+-.+|+|.+ |.||.|
T Consensus 36 IGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLED 112 (449)
T KOG1165|consen 36 IGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLED 112 (449)
T ss_pred cccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHH
Confidence 899999999999543 7999999986543 3346777888888888 5799999988887777778999988 779999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-----CeEEEeeeccccccCCCccee
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-----FHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-----~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
++..++. .++..++..++.|++.-++|+|.+. +|+|||||+|+||..- ..+.++|||+++.+.+.....
T Consensus 113 LFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 113 LFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred HHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 9988875 6999999999999999999999998 9999999999999643 458999999999775433221
Q ss_pred ------ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 155 ------STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 155 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.....||.+||+=-...+..-+.+.|+-|||-++++.|-|..||++...+......+.+........
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~------- 259 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP------- 259 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC-------
Confidence 1235699999999888888999999999999999999999999999877766555544333221111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
+..++...+.+|..-+...-..+-.+-|+.+-+...+.
T Consensus 260 -i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 260 -IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred -HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 12223333444555555556667777888766655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-23 Score=181.34 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=191.5
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChh---cHHHHHHHHHHHhcCCCC-cccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ---GTKEFLTEIDMIWNIRHP-NLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||.|+|+.||.+... ..+++|.+...... ....+.+|+..+..+.|+ +|+++.+++......+++++++.++++
T Consensus 8 l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l 85 (384)
T COG0515 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSL 85 (384)
T ss_pred ecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcH
Confidence 789999999999777 77899998765333 367899999999999988 799999999777778999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcce---
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTH--- 153 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~--- 153 (322)
.+++...... ..+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .+++.|||.+.........
T Consensus 86 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (384)
T COG0515 86 EDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161 (384)
T ss_pred HHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccc
Confidence 9777544211 25888999999999999999999999 99999999999999998 7999999999855433221
Q ss_pred --eecccccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCC-CchhHHHHHHHHHhcCccccccC
Q 020720 154 --VSTRVAGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGD-DMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......++..|++||.+.+ ...+...|+||+|++++++++|..||...... ......... .... .. ...
T Consensus 162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~-~~-~~~ 236 (384)
T COG0515 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII---LELP-TP-SLA 236 (384)
T ss_pred cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH---HhcC-Cc-ccc
Confidence 2345679999999999987 57889999999999999999999996655432 011111111 1110 00 000
Q ss_pred ccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 PEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 ~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
... ..........+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 001 01112223457788888999999999998887753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=207.15 Aligned_cols=240 Identities=22% Similarity=0.295 Sum_probs=174.5
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccC-hhcHHHHHHHHHH--HhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAES-KQGTKEFLTEIDM--IWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||++.|=+|.+|+++.|. |+||++-..+ .-....+.++++- ...+++||++++..+-..+...|+|-+|... +|+
T Consensus 31 LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLy 108 (1431)
T KOG1240|consen 31 LGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLY 108 (1431)
T ss_pred cCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhh
Confidence 799999999999988777 8999985443 3344445444443 4455899999998887777788889898855 899
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc--CCCcc----
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF--PDNVT---- 152 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~--~~~~~---- 152 (322)
|.+..+. .+...+...|+.|++.||..+|+.+ |+|||||.+||||+.-+.+.|+||..-+.. +++.+
T Consensus 109 DRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 109 DRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred hhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 9995554 6788889999999999999999999 999999999999999999999999866532 22211
Q ss_pred eeecccccCCCCCchHHHhhC----------C-CCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcC
Q 020720 153 HVSTRVAGTMGYLAPEYALLG----------Q-LTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEG 220 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~----------~-~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (322)
....+...-.+|.|||.+... . .+++-||||+||+++||++ |++||+... +.. .+..+
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a----Yr~~~ 251 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA----YRSGN 251 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh----HhccC
Confidence 122233345689999988642 2 5678899999999999988 677776321 000 00000
Q ss_pred ccccccCcc--CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 020720 221 RLLEIVDPE--LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLS 267 (322)
Q Consensus 221 ~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~ 267 (322)
..+++ +...... .+..++..|++.||++|.++++.|+.-.
T Consensus 252 ----~~~~e~~Le~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 252 ----ADDPEQLLEKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ----ccCHHHHHHhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 00000 0111111 3677888899999999999999988743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=172.59 Aligned_cols=162 Identities=16% Similarity=0.146 Sum_probs=125.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHH---------HHHHHHHHhcCCCCcccccceEEEeC--------C
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKE---------FLTEIDMIWNIRHPNLVQLIGCCVED--------N 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~--------~ 63 (322)
+||.|+||.||.+.. ++..+|+|+++......... +.+|+..+.++.|++|..+.+++... +
T Consensus 38 ~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~ 116 (232)
T PRK10359 38 VFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAH 116 (232)
T ss_pred EecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccC
Confidence 489999999999765 47789999997654333222 57899999999999999999886643 3
Q ss_pred eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 64 NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 64 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
..+++|||++|.+|.++. .++. ....+++.++..+|..+ ++|+|++|.||+++.+| ++|+|||.
T Consensus 117 ~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~ 180 (232)
T PRK10359 117 TYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSG 180 (232)
T ss_pred CeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCC
Confidence 478999999999998874 2332 24558999999999999 99999999999999998 99999998
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHH
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEII 192 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell 192 (322)
.......... ..+.....+..++|+|+||+++..+.
T Consensus 181 ~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 181 KRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 7644221110 11334445668999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=169.28 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=107.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChh--c------------------------HHHHHHHHHHHhcCCCCcccc
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ--G------------------------TKEFLTEIDMIWNIRHPNLVQ 54 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~iv~ 54 (322)
.||+|+||.||+|...+|+.||+|+++..... . ......|+..+.++.++++..
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~ 83 (190)
T cd05147 4 CISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC 83 (190)
T ss_pred ccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence 48999999999998778999999999754211 0 012245999999998888755
Q ss_pred cceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeccCcccceEeCCC
Q 020720 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL-HEEADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 55 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~~~~i~h~dlkp~Nill~~~ 133 (322)
...+... ..++||||++++++....... ..++...+..++.|++.+|.++ |+.+ ++||||||+||+++ +
T Consensus 84 p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 84 PEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 4443222 238999999987776543222 2688899999999999999999 6888 99999999999998 4
Q ss_pred CeEEEeeecccccc
Q 020720 134 FHPKIGDFGLAKLF 147 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~ 147 (322)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=173.90 Aligned_cols=228 Identities=18% Similarity=0.178 Sum_probs=146.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCC----------CCcccccceEEEeC----
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIR----------HPNLVQLIGCCVED---- 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~~~---- 62 (322)
+||.|+++.||.+.+. +|+++|+|++.... ....+.+.+|.-.+..+. |-.++-.++.....
T Consensus 19 ~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~ 98 (288)
T PF14531_consen 19 IIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPP 98 (288)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-S
T ss_pred ccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCc
Confidence 4899999999999877 69999999986543 223466667765555542 22333333433211
Q ss_pred --------C-----eeEEEEEcCCCCCHHHHHhc---CCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCccc
Q 020720 63 --------N-----NRILVYEYLENNSLANALLG---SKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKAS 126 (322)
Q Consensus 63 --------~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~ 126 (322)
. ..+++|+-+ -++|.+++.. .......+.....+.+..|++..+++||+.| ++|+||+|+
T Consensus 99 ~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~ 174 (288)
T PF14531_consen 99 FFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPE 174 (288)
T ss_dssp EEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGG
T ss_pred ceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccccee
Confidence 1 136677777 4578877642 2211223445566777899999999999999 999999999
Q ss_pred ceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhC--------CCCcccceehhhHHHHHHHhCCCCC
Q 020720 127 NVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--------QLTKKADVYSFGVLLLEIISGRSSS 198 (322)
Q Consensus 127 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~sDv~slG~il~ell~g~~p~ 198 (322)
|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+||..||
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred eEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 999999999999999877654432211 2345789999977542 4688999999999999999999999
Q ss_pred CcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 020720 199 KAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYR 256 (322)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 256 (322)
.......... ..+.. +.+.++.+..+|..+|+.||.+|
T Consensus 251 ~~~~~~~~~~-------------------~~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEADPE-------------------WDFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGSTSG-------------------GGGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCcccccc-------------------ccchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 8553221110 01222 22666678899999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=162.56 Aligned_cols=139 Identities=18% Similarity=0.214 Sum_probs=109.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChh---------------------c-----HHHHHHHHHHHhcCCCCcccc
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ---------------------G-----TKEFLTEIDMIWNIRHPNLVQ 54 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~iv~ 54 (322)
.||+|++|.||+|...+|+.||||+++..... . ...+..|+..+.++.++++..
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (190)
T cd05145 4 CISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV 83 (190)
T ss_pred eeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 48999999999998778999999998764211 0 122357899999999998865
Q ss_pred cceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCC
Q 020720 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 55 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~ 133 (322)
...+.... .++||||++++++....... ..++......++.|++.++.++|+ .+ ++|+||||+||+++ +
T Consensus 84 p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 84 PEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred ceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 55544332 47999999987554332222 157788899999999999999999 88 99999999999999 8
Q ss_pred CeEEEeeeccccccCC
Q 020720 134 FHPKIGDFGLAKLFPD 149 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~ 149 (322)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=179.77 Aligned_cols=217 Identities=24% Similarity=0.361 Sum_probs=164.0
Q ss_pred HhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-eecc
Q 020720 44 IWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI-VHRD 122 (322)
Q Consensus 44 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i-~h~d 122 (322)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.|.+... ...+++.....++..|+.||.|||+.. + .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 45789999999999999999999999999999999999763 337889999999999999999999865 5 9999
Q ss_pred CcccceEeCCCCeEEEeeeccccccCCCc-ceeecccccCCCCCchHHHhhC-------CCCcccceehhhHHHHHHHhC
Q 020720 123 IKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTRVAGTMGYLAPEYALLG-------QLTKKADVYSFGVLLLEIISG 194 (322)
Q Consensus 123 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-------~~~~~sDv~slG~il~ell~g 194 (322)
++..|++++....+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987654210 1111112234579999998763 146789999999999999999
Q ss_pred CCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 195 RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
+.||......... .+.+..+.. .....+.|.+.... +....+..++..||..+|..||++++|-..++....
T Consensus 155 ~~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999875443332 111112111 11122333332221 333368999999999999999999999888766553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=155.26 Aligned_cols=182 Identities=16% Similarity=0.089 Sum_probs=137.2
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhc----HHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQG----TKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+|++|+||+||.+.. .+..++.+.+....... ...+.+|+++|+++. ++++.+++++ +..+++|+|+.|.
T Consensus 9 ~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~ 83 (218)
T PRK12274 9 PLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGA 83 (218)
T ss_pred eecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCc
Confidence 489999999997755 47888878776443211 125789999999995 5788888876 3468999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccC-cccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDI-KASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
+|...+.. ....++.|++.+|.++|+.| ++|+|| ||.||+++.++.++|+|||++.........
T Consensus 84 ~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 84 AMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 88654311 11346789999999999999 999999 799999999999999999999865443321
Q ss_pred ---e--------ecccccCCCCCchHHHhhC-CCC-cccceehhhHHHHHHHhCCCCCCcc
Q 020720 154 ---V--------STRVAGTMGYLAPEYALLG-QLT-KKADVYSFGVLLLEIISGRSSSKAA 201 (322)
Q Consensus 154 ---~--------~~~~~~t~~y~aPE~~~~~-~~~-~~sDv~slG~il~ell~g~~p~~~~ 201 (322)
. ......++.|+.|+...-. ..+ ...+-++.|+-+|.++|+..+....
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0112257889999865533 333 5678889999999999999886543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=186.00 Aligned_cols=185 Identities=21% Similarity=0.229 Sum_probs=151.7
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||+||+|...+|+.||+|+-+...... |.--.+++.+|+ -+.|+.+..++...+..++|+||.+.|+|
T Consensus 705 e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtl 781 (974)
T KOG1166|consen 705 EIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTL 781 (974)
T ss_pred eeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccH
Confidence 489999999999988889999999977654432 222233344443 35677777888888889999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-------CCCeEEEeeeccccccCCC
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-------GNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-------~~~~~kl~Dfg~~~~~~~~ 150 (322)
.+++...+ .+++..++.++.|++..++.||..+ |||+||||+|++|. ++-.++|+|||.+..+.--
T Consensus 782 ld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf 854 (974)
T KOG1166|consen 782 LDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF 854 (974)
T ss_pred HHhhccCC----CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence 99997444 7899999999999999999999999 99999999999994 3345899999998754211
Q ss_pred -cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCC
Q 020720 151 -VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR 195 (322)
Q Consensus 151 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~ 195 (322)
........++|-.+-++|+..+.+|+...|.|.|+.+++.||.|+
T Consensus 855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 122345567899999999999999999999999999999999995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-23 Score=184.73 Aligned_cols=225 Identities=26% Similarity=0.278 Sum_probs=175.8
Q ss_pred CcccCcceEEEEEEE----CCCCEEEEEEecccChh--cHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
++|+|+||.|+.++. ..|.-+|+|++++.... .......|..++...+ ||.++++.-.+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 589999999998732 34788999988754211 1124455777777776 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+|.|...+... ..+.+.........++.+++.+|+.+ ++|+|+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 99888777443 36777888888889999999999999 999999999999999999999999999865433221
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
+||..|||||++. ....++|-||||++++||++|..||.. + .+. .+. ..-...
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~---~~~---~Il----------~~~~~~ 206 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D---TMK---RIL----------KAELEM 206 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H---HHH---HHh----------hhccCC
Confidence 7899999999988 567889999999999999999999986 1 111 111 001233
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
+........+++..++..+|.+|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 44555556667777888888888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-21 Score=155.84 Aligned_cols=130 Identities=17% Similarity=0.195 Sum_probs=102.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-----CCCcccccceEEEeCC---e-eEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-----RHPNLVQLIGCCVEDN---N-RILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e 70 (322)
+||+|+||.||. ++ ++.. +||++........+.+.+|+.+++.+ +||||+++++++.++. . ..+|+|
T Consensus 9 ~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 9 PLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred eecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 589999999996 44 4444 79998765444567899999999999 6799999999998874 3 347899
Q ss_pred c--CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeeccCcccceEeCC----CCeEEEeeecc
Q 020720 71 Y--LENNSLANALLGSKSKYVSLDWPTRANICLGTASGL-SFLHEEADPPIVHRDIKASNVLLDG----NFHPKIGDFGL 143 (322)
Q Consensus 71 ~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~~~~i~h~dlkp~Nill~~----~~~~kl~Dfg~ 143 (322)
| +.+++|.+++... .+++. ..++.|++.++ +|||+++ |+||||||+||+++. ++.++|+|++.
T Consensus 86 ~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 5578999999542 34444 35577777777 9999999 999999999999974 34799999543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=158.45 Aligned_cols=196 Identities=20% Similarity=0.261 Sum_probs=140.1
Q ss_pred CCCcccccceEEEe---------------------------CCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHH
Q 020720 48 RHPNLVQLIGCCVE---------------------------DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANIC 100 (322)
Q Consensus 48 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 100 (322)
+|||||++..+|.+ ...+|+||.-.+ .+|..++-.+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999888743 124688988774 48999997663 4556677788
Q ss_pred HHHHHHHHHHhhcCCCCeeeccCcccceEeC--CC--CeEEEeeeccccccCCCccee-----ecccccCCCCCchHHHh
Q 020720 101 LGTASGLSFLHEEADPPIVHRDIKASNVLLD--GN--FHPKIGDFGLAKLFPDNVTHV-----STRVAGTMGYLAPEYAL 171 (322)
Q Consensus 101 ~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--~~--~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~t~~y~aPE~~~ 171 (322)
.|+++|+.|||+++ +.|||+|.+|||+. ++ ..+.|+|||.+-......-.. .-...|....||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999993 33 347889999876433221111 11234778899999887
Q ss_pred hCC--C----CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHH
Q 020720 172 LGQ--L----TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVG 245 (322)
Q Consensus 172 ~~~--~----~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 245 (322)
..+ . -.|+|.|+.|.+.||+++...||+.... ..+..- ..-...++.++......+.+++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r-------------~Yqe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTR-------------TYQESQLPALPSRVPPVARQLV 490 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechh-------------hhhhhhCCCCcccCChHHHHHH
Confidence 432 1 2589999999999999999999987321 111110 0011344555555566688888
Q ss_pred HhcccCCCCCCCCHHHHHHHH
Q 020720 246 LFCTQAGAHYRPTMKQVVEML 266 (322)
Q Consensus 246 ~~cl~~dp~~Rps~~evl~~L 266 (322)
...|+.||++|++..=....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 889999999999865544443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=148.42 Aligned_cols=133 Identities=23% Similarity=0.315 Sum_probs=112.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChh--------cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ--------GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|++|.||+|.. .|..+++|........ ....+.+|+.++..+.|+++.....++.+....+++|||+
T Consensus 3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 489999999999987 4778999986543211 1245778999999999999988888877788889999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999985331 1 78889999999999999999 99999999999999 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=146.89 Aligned_cols=130 Identities=24% Similarity=0.362 Sum_probs=107.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh--------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK--------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|.+. |..+++|....... .....+.+|+.++..+.++++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 6899999999999865 78899998653311 11256778999999999888776666666777789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874321 1 78899999999999999 99999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=147.33 Aligned_cols=139 Identities=17% Similarity=0.133 Sum_probs=104.2
Q ss_pred CcccCcceEEEEEE--ECCCCEEEEEEecccChh------------------------cHHHHHHHHHHHhcCCCCcccc
Q 020720 1 MIGGGAFGVVYRGS--LRDGTQIAIKCLSAESKQ------------------------GTKEFLTEIDMIWNIRHPNLVQ 54 (322)
Q Consensus 1 ~lg~G~~g~v~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~iv~ 54 (322)
.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+..+.++.+. .+.
T Consensus 35 ~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~-~i~ 113 (237)
T smart00090 35 CISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA-GVP 113 (237)
T ss_pred eeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc-CCC
Confidence 48999999999998 457999999998754210 012356899999999753 222
Q ss_pred cceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC
Q 020720 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134 (322)
Q Consensus 55 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~ 134 (322)
+..++.. ...++||||+++.+|........ .+....+..++.|++.++.+||..+. ++|+||||+||+++ ++
T Consensus 114 ~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~ 185 (237)
T smart00090 114 VPKPIAW-RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DG 185 (237)
T ss_pred CCeeeEe-cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CC
Confidence 2223222 23579999999988766542221 45566678999999999999998653 99999999999999 88
Q ss_pred eEEEeeeccccccC
Q 020720 135 HPKIGDFGLAKLFP 148 (322)
Q Consensus 135 ~~kl~Dfg~~~~~~ 148 (322)
.++|+|||.+....
T Consensus 186 ~i~LiDFg~a~~~~ 199 (237)
T smart00090 186 KVVIIDVSQSVELD 199 (237)
T ss_pred CEEEEEChhhhccC
Confidence 99999999887543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=163.71 Aligned_cols=172 Identities=22% Similarity=0.319 Sum_probs=128.0
Q ss_pred eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 64 NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 64 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
.+++.|++|...+|.+++..+. .....++.....|+.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997553 23357788899999999999999 67 99999999999999999999999999
Q ss_pred ccccCCCc-----ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHH
Q 020720 144 AKLFPDNV-----THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLR 217 (322)
Q Consensus 144 ~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 217 (322)
........ ....+...||..||+||.+.+..|+.++||||||++|+||+. -...++... .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------t 468 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------T 468 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH--------------h
Confidence 88665433 223455779999999999999999999999999999999996 222222110 0
Q ss_pred hcCccccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 020720 218 EEGRLLEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQ 261 (322)
Q Consensus 218 ~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~e 261 (322)
........+.|.. .+.+. -..++.+++...|.+||++.+
T Consensus 469 ~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 469 LTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 0000111122222 22222 346677899999999994443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=140.47 Aligned_cols=131 Identities=18% Similarity=0.159 Sum_probs=102.9
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChh----------------------cHHHHHHHHHHHhcCCCCc--ccccc
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ----------------------GTKEFLTEIDMIWNIRHPN--LVQLI 56 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~--iv~~~ 56 (322)
.||+|+||.||++...+|+.||||+++..... ....+..|+.++..+.+++ +..++
T Consensus 22 ~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~ 101 (198)
T cd05144 22 QIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPI 101 (198)
T ss_pred ccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCcee
Confidence 48999999999998888999999987643210 1123567888898887774 33333
Q ss_pred eEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeE
Q 020720 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP 136 (322)
Q Consensus 57 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~ 136 (322)
+ ....+++|||+++++|..+... .....++.+++.++.++|..+ ++|+||+|.||++++++.+
T Consensus 102 ~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 102 D----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred e----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcE
Confidence 3 2455899999999998765420 245678899999999999998 9999999999999999999
Q ss_pred EEeeeccccccC
Q 020720 137 KIGDFGLAKLFP 148 (322)
Q Consensus 137 kl~Dfg~~~~~~ 148 (322)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=159.63 Aligned_cols=129 Identities=22% Similarity=0.317 Sum_probs=105.9
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--C------hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--S------KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|.+... .+++|+.... . ....+.+.+|++++..++|++++....++.+....++||||+
T Consensus 340 ~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~ 418 (535)
T PRK09605 340 LIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYI 418 (535)
T ss_pred eeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEec
Confidence 489999999999987643 4444443211 1 112356889999999999999998887877777889999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
++++|.+++. ....++.+++.+|.+||+.+ ++||||||.||++ .++.++|+|||++..
T Consensus 419 ~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 419 GGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999883 34678999999999999999 9999999999999 678899999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-19 Score=166.63 Aligned_cols=201 Identities=25% Similarity=0.302 Sum_probs=134.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+|..|++|.||.++++ +.+.+|+|+ +++.- +.+- ++.....|.+| |+-..
T Consensus 90 lisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------gDc~t 140 (1205)
T KOG0606|consen 90 LISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------GDCAT 140 (1205)
T ss_pred eeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee---------------------chhhh
Confidence 3667999999999887 577888854 32211 1111 33333444444 33333
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-------
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT------- 152 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------- 152 (322)
.+...+ +++... +.+++|||+.+ |+|||+||+|.+|+.-|.+|+.|||+++.......
T Consensus 141 llk~~g----~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 141 LLKNIG----PLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hcccCC----CCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 332222 333322 78899999998 99999999999999999999999999874321100
Q ss_pred -------eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 153 -------HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 153 -------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
......+||+.|.|||++....|....|-|++|+|+||.+-|..||.+...++.+..+. ....
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi-----sd~i----- 275 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-----SDDI----- 275 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh-----hhhc-----
Confidence 01123579999999999999999999999999999999999999998775543322211 0110
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPT 258 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps 258 (322)
..++- ......+..+++.++|+.+|..|--
T Consensus 276 ~wpE~---dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 EWPEE---DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ccccc---CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 11111 1222233667777799999999953
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.5e-17 Score=133.54 Aligned_cols=133 Identities=17% Similarity=0.226 Sum_probs=103.3
Q ss_pred Ccc-cCcceEEEEEEECCCCEEEEEEecccC-------------hhcHHHHHHHHHHHhcCCCCcc--cccceEEEeCC-
Q 020720 1 MIG-GGAFGVVYRGSLRDGTQIAIKCLSAES-------------KQGTKEFLTEIDMIWNIRHPNL--VQLIGCCVEDN- 63 (322)
Q Consensus 1 ~lg-~G~~g~v~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~- 63 (322)
+|| .|+.|+||.+... +..++||.+.... ......+.+|+.++..+.|++| +.++++.....
T Consensus 38 ~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred eeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 366 8999999999776 7789999885321 1223567889999999998775 66666644332
Q ss_pred ---eeEEEEEcCCC-CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe
Q 020720 64 ---NRILVYEYLEN-NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG 139 (322)
Q Consensus 64 ---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~ 139 (322)
..++|+|++++ .+|.+++... .++.. .+.+++.++.+||..| |+|+||||.|||++.++.++|+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6898888532 34433 3568999999999999 9999999999999999999999
Q ss_pred eeccccc
Q 020720 140 DFGLAKL 146 (322)
Q Consensus 140 Dfg~~~~ 146 (322)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998775
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=8e-17 Score=129.66 Aligned_cols=133 Identities=21% Similarity=0.215 Sum_probs=94.2
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhc--HHH----------------------HHHHHHHHhcCCCCc--ccc
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQG--TKE----------------------FLTEIDMIWNIRHPN--LVQ 54 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~~--iv~ 54 (322)
.||+|+||.||+|...+|+.||||+++...... ... ...|...+..+.+.. +.+
T Consensus 4 ~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 83 (187)
T cd05119 4 PIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPK 83 (187)
T ss_pred ccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCc
Confidence 489999999999987789999999987542211 111 124555555554332 333
Q ss_pred cceEEEeCCeeEEEEEcCCCCCHHH-HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCC
Q 020720 55 LIGCCVEDNNRILVYEYLENNSLAN-ALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDG 132 (322)
Q Consensus 55 ~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~ 132 (322)
++++ ...+++|||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ ++|+||+|+||+++
T Consensus 84 ~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 84 PIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred eEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 3332 24589999999854321 111110 11 5678899999999999999 88 99999999999999
Q ss_pred CCeEEEeeecccccc
Q 020720 133 NFHPKIGDFGLAKLF 147 (322)
Q Consensus 133 ~~~~kl~Dfg~~~~~ 147 (322)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.8e-19 Score=162.36 Aligned_cols=246 Identities=24% Similarity=0.279 Sum_probs=180.3
Q ss_pred cccCcceEEEEEEECC--CCEEEEEEecccC--hhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLRD--GTQIAIKCLSAES--KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
||+|+|+.|-...... ...+|.|.+.... ......+..|..+-..+. |+|++.+++...+.+..+++++|..+++
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~ 107 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGS 107 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccc
Confidence 7899999988875542 4456666655432 222345556888878886 9999999999999999999999999999
Q ss_pred HHHHH-hcCCCCCcCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCC--Cc
Q 020720 77 LANAL-LGSKSKYVSLDWPTRANICLGTASGLSFLH-EEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPD--NV 151 (322)
Q Consensus 77 L~~~l-~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~--~~ 151 (322)
+.+-+ .... ...+...+-..+.|+..++.|+| ..+ +.|+|++|+|.+++..+ ..++.|||++..+.. ..
T Consensus 108 ~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~ 181 (601)
T KOG0590|consen 108 LFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA 181 (601)
T ss_pred cccccccCCc---cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence 98877 3221 14566677889999999999999 888 99999999999999999 999999999987655 33
Q ss_pred ceeeccccc-CCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 152 THVSTRVAG-TMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 152 ~~~~~~~~~-t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.......+| ++.|.|||...+. -..+..|+||.|+++..+++|..|+......+.... .|.. .....
T Consensus 182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~~---~~~~~------- 250 (601)
T KOG0590|consen 182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWKS---NKGRF------- 250 (601)
T ss_pred ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-eecc---ccccc-------
Confidence 334445668 9999999988874 456889999999999999999999987654432110 0000 00000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
-............+++..++..+|+.|.+.+++..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00111112223556666688899999999888754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=122.47 Aligned_cols=132 Identities=20% Similarity=0.248 Sum_probs=109.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCC--CcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH--PNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|.++.||++...+ ..+++|....... ...+.+|+..+..+++ .++.+++.+....+..++++||++++++.
T Consensus 5 ~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 5 LLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred ecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 37999999999998764 7899999865433 5678889999999976 58888888887778899999999887665
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
.+ +......++.+++.+++++|......++|+|++|.||++++.+.+++.||+.+..
T Consensus 82 ~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 33 4456677889999999999985333499999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.8e-16 Score=129.35 Aligned_cols=204 Identities=24% Similarity=0.317 Sum_probs=141.7
Q ss_pred HHHHhcCCCCcccccceEEEeC-----CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 020720 41 IDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115 (322)
Q Consensus 41 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~ 115 (322)
...|-++.|.|||+++.++.+. ....|++||+..|++..+|...+.....+......+|+.||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 4455666799999999998654 346899999999999999987766666788888899999999999999997 6
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc----eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHH
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT----HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEI 191 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~el 191 (322)
++++|+++.-+.|++..+|-+|+.--.- ........ .......+.++|.+||.-.....+.++|||+||+...+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 8899999999999999999888753211 11110000 011123367899999976666778899999999999999
Q ss_pred HhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 192 ISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 192 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.-+..-....... . ..+. ...+....+...+ ..++.. |++..|..||+|.+++..
T Consensus 276 ailEiq~tnseS~--~-~~ee-----~ia~~i~~len~lqr~~i~k-----------cl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESK--V-EVEE-----NIANVIIGLENGLQRGSITK-----------CLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcce--e-ehhh-----hhhhheeeccCccccCcCcc-----------cccCCCCCCcchhhhhcC
Confidence 8775432211110 0 0000 0001111111222 344444 999999999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.9e-15 Score=132.72 Aligned_cols=138 Identities=17% Similarity=0.241 Sum_probs=96.5
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcH----------------------------------------HHHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT----------------------------------------KEFLTEI 41 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~~e~ 41 (322)
||.|++|.||+|..++|+.||||+.+....... -++.+|+
T Consensus 125 lasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea 204 (437)
T TIGR01982 125 LAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREA 204 (437)
T ss_pred eeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHH
Confidence 789999999999999999999999865421110 0234455
Q ss_pred HHHhcCC----CCcccccceEE-EeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHH-HHHHHhhcCC
Q 020720 42 DMIWNIR----HPNLVQLIGCC-VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTAS-GLSFLHEEAD 115 (322)
Q Consensus 42 ~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~-~l~~lH~~~~ 115 (322)
..+.++. +.+-+.+-.++ ......+++|||++|++|.++...... .. ....++..++. .+..+|..+
T Consensus 205 ~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 205 ANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 5555552 22223322233 223457899999999999887643211 12 22345555555 478899988
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
++|+|++|.||+++.++.++++|||++....
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-14 Score=130.30 Aligned_cols=240 Identities=24% Similarity=0.240 Sum_probs=173.0
Q ss_pred ccc--CcceEEEEEEE--C-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCC
Q 020720 2 IGG--GAFGVVYRGSL--R-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 2 lg~--G~~g~v~~~~~--~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+|. |.+|.||.+.. . ++..+|+|.-+.. .+.....=++|+.....+ .|+|.++.+..+.+.+..++-+|+|.
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~ 201 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG 201 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc
Confidence 578 99999999976 3 5788999974322 233334445677666666 58999999999999999999999885
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTAS----GLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFP 148 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 148 (322)
.+|..+.+... ..++...++..+.+... ||..+|+.. ++|-|+||.||+...+ ...++.|||+...+.
T Consensus 202 -~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 202 -ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred -chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEcc
Confidence 67777775443 25788889999999999 999999998 9999999999999999 889999999988765
Q ss_pred CCcce----eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 149 DNVTH----VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 149 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
...-. ...+..+...|++||+. .+.++.++|||++|.++.+-.++..+........ |.-.... .
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~~---~ 342 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQG---Y 342 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccccccc---c
Confidence 43311 11223577889999965 4567899999999999999988876544321111 0000000 0
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.. +++..-...+..++.+|++.+|-.|++.+.+..
T Consensus 343 -ip~---e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 -IPL---EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -Cch---hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 122222233444778899999999998887754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-13 Score=124.27 Aligned_cols=166 Identities=19% Similarity=0.254 Sum_probs=128.4
Q ss_pred ECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHH
Q 020720 15 LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWP 94 (322)
Q Consensus 15 ~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 94 (322)
..++.+|.++.++...........+-+..|+.++||||+++++.++..+..|+|+|-+. .|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 34688899998876665445677888999999999999999999999999999999885 57777743 3356
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCC
Q 020720 95 TRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174 (322)
Q Consensus 95 ~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 174 (322)
.+...+.||+.||.+||..++ ++|++|....|+|+..|..||++|.+......... .......--.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 778889999999999986443 99999999999999999999999988765432221 111111223567777553322
Q ss_pred CCcccceehhhHHHHHHHhC
Q 020720 175 LTKKADVYSFGVLLLEIISG 194 (322)
Q Consensus 175 ~~~~sDv~slG~il~ell~g 194 (322)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 345999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=109.35 Aligned_cols=128 Identities=18% Similarity=0.173 Sum_probs=93.8
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccc-cceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ-LIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.++++ ++.+ .....++||||++|.++.+.
T Consensus 6 l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 6 LKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLTE 81 (170)
T ss_pred cCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccccc
Confidence 678999999999876 77899999764432 2234678999998886655543 4433 33345799999999877542
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA--DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
. . ....++.+++.+|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 82 ~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 1 11345678999999999876 12249999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.8e-14 Score=127.86 Aligned_cols=138 Identities=13% Similarity=0.208 Sum_probs=89.4
Q ss_pred cccCcceEEEEEEECC-CCEEEEEEecccChhc----------------------------------HH------HHHHH
Q 020720 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQG----------------------------------TK------EFLTE 40 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~----------------------------------~~------~~~~e 40 (322)
||+|++|.||+|..++ |+.||||+++..-... .+ ++.+|
T Consensus 127 lasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~E 206 (537)
T PRK04750 127 LASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMRE 206 (537)
T ss_pred hcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHH
Confidence 7899999999999886 9999999997441110 11 13344
Q ss_pred HHHHhcCC----CCcccccceEEEe-CCeeEEEEEcCCCCCHHHHH--hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc
Q 020720 41 IDMIWNIR----HPNLVQLIGCCVE-DNNRILVYEYLENNSLANAL--LGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113 (322)
Q Consensus 41 ~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 113 (322)
+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.++. ...+.....+....+..++.| +...
T Consensus 207 a~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~ 279 (537)
T PRK04750 207 AANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRD 279 (537)
T ss_pred HHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhC
Confidence 44444442 3333433333332 34567999999999998753 222111112223333333334 3456
Q ss_pred CCCCeeeccCcccceEeCCCC----eEEEeeeccccccCC
Q 020720 114 ADPPIVHRDIKASNVLLDGNF----HPKIGDFGLAKLFPD 149 (322)
Q Consensus 114 ~~~~i~h~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 149 (322)
| ++|+|++|.||+++.++ .++++|||+......
T Consensus 280 G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 280 G---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred C---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 7 99999999999999988 999999999886643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-12 Score=113.44 Aligned_cols=168 Identities=18% Similarity=0.330 Sum_probs=129.5
Q ss_pred eEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEE----eCCeeEEEEEcCCC-CCHHHHH
Q 020720 8 GVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV----EDNNRILVYEYLEN-NSLANAL 81 (322)
Q Consensus 8 g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l 81 (322)
.+.|++... +|..|++|++..+..........-+++++++.|+|+|++.+++. .+..+++|++|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 467898655 89999999995444333344455788999999999999998875 35578999999985 4787777
Q ss_pred hcCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 82 LGSKS-----------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 82 ~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
..... .....++..+|.++.|++.||.++|+.| +.-+-|.+.+|+++.+.+++++.+|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 54332 2235778999999999999999999999 999999999999999999999998887765443
Q ss_pred cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCC
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS 196 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~ 196 (322)
.. +| +.. -.+-|.=.||.+++.|.||..
T Consensus 447 ~~-------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT-------------EP--LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-------------cc--hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 11 111 134577889999999999953
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-12 Score=98.83 Aligned_cols=140 Identities=22% Similarity=0.298 Sum_probs=104.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--------ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--------SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+|-+|+-+.|+++.+. |+..+||.-... ..-......+|++.+.++.--.|.-..-++.+...-.++|||+
T Consensus 14 likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 14 LIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 3678999999999887 788788854222 1112356778999999987666666666677777788999999
Q ss_pred CC-CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccc
Q 020720 73 EN-NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKL 146 (322)
Q Consensus 73 ~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~ 146 (322)
+| .++.+++...-.. .........++..|-..+.-||.++ ++|+||..+||++..++. +.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 87 4788888654321 2222333778889999999999998 999999999999965543 58999999874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.7e-12 Score=101.55 Aligned_cols=135 Identities=18% Similarity=0.161 Sum_probs=95.7
Q ss_pred CcccCcceEEEEEEECC-------CCEEEEEEecccC------------h----------hcHHHH----HHHHHHHhcC
Q 020720 1 MIGGGAFGVVYRGSLRD-------GTQIAIKCLSAES------------K----------QGTKEF----LTEIDMIWNI 47 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-------~~~vaiK~~~~~~------------~----------~~~~~~----~~e~~~l~~l 47 (322)
.||.|--+.||.|...+ +..+|||+.+... . .....+ .+|+..|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 47899999999996542 4799999886420 0 011222 3799999988
Q ss_pred CC--CcccccceEEEeCCeeEEEEEcCCCCCHHH-HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeccC
Q 020720 48 RH--PNLVQLIGCCVEDNNRILVYEYLENNSLAN-ALLGSKSKYVSLDWPTRANICLGTASGLSFL-HEEADPPIVHRDI 123 (322)
Q Consensus 48 ~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~~~~i~h~dl 123 (322)
.. -++..++++ ..-++||||+.+..+.. .+.. ..++......+..+++.++..| |+.+ ++|+||
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 54 345555544 45678999997643321 1211 1344456677889999999998 8888 999999
Q ss_pred cccceEeCCCCeEEEeeeccccccC
Q 020720 124 KASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 124 kp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
++.||+++ ++.++|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-11 Score=95.71 Aligned_cols=131 Identities=25% Similarity=0.358 Sum_probs=100.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc---Chh-----cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE---SKQ-----GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~---~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
++++|+-+.+|.+.+. |..+++|.-..+ .+. ....-.+|+.++.++.--.|.-..=+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999776 555777753322 111 1234567999999987666666566666777888999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
+|-.|.+++... ...++..+-.-+.-||..+ |+|+||.++||++...+ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888543 2456667778888999999 99999999999998765 999999998743
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-10 Score=100.46 Aligned_cols=255 Identities=16% Similarity=0.119 Sum_probs=155.4
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccc----cceEEE--eC-CeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQ----LIGCCV--ED-NNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~----~~~~~~--~~-~~~~lv~e~~~ 73 (322)
||+|+-+.+|..-.- +. .+.|++.........+. +..|... .||-+.. ...... +. ....++|+.+.
T Consensus 19 LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~ 93 (637)
T COG4248 19 LGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVS 93 (637)
T ss_pred ccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCC
Confidence 799999999975222 12 35588876554433332 2233333 4554322 111111 12 23668888887
Q ss_pred CC-CHHHHHh--cCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 74 NN-SLANALL--GSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 74 ~~-~L~~~l~--~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
+. .+..+.. .+..++...+|....+.+..++.+.+.||..| .+-+|+.++|+||++++.|.|.|-+......+.
T Consensus 94 g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 94 GKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred CccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCC
Confidence 65 2333332 23345557889999999999999999999999 999999999999999999999986544433222
Q ss_pred cceeecccccCCCCCchHHHhhC-----CCCcccceehhhHHHHHHHhC-CCCCCcccCCCc-hhHHH-HHHHHHhcCcc
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLG-----QLTKKADVYSFGVLLLEIISG-RSSSKAAFGDDM-LILVE-WTWKLREEGRL 222 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~sDv~slG~il~ell~g-~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~ 222 (322)
......+|...|.+||...-. .-+...|.|.||+++|+||.| ++||.+...... -...+ .+ ..++.
T Consensus 171 --~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I----a~g~f 244 (637)
T COG4248 171 --TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI----AHGRF 244 (637)
T ss_pred --ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh----hccee
Confidence 223345789999999976522 346789999999999999886 899986532111 00000 00 01111
Q ss_pred ccccC------ccCCCCCH-HHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHhccc
Q 020720 223 LEIVD------PELTQFPE-KEVMRFIKVGLFCTQA--GAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 223 ~~~~~------~~~~~~~~-~~~~~l~~l~~~cl~~--dp~~Rps~~evl~~L~~~~ 270 (322)
...-+ +.....+- .....+..+..+|+.. ++.-||+++-++..|..+.
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 11111 11111111 1112355566667753 3668999999988775443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-11 Score=101.67 Aligned_cols=140 Identities=20% Similarity=0.313 Sum_probs=105.2
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCC--cccccceEEEeC---CeeEEEEEcCCCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHP--NLVQLIGCCVED---NNRILVYEYLENN 75 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~~~ 75 (322)
|+.|..+.||++...+|..+++|....... .....+..|+.+++.+.+. ++.+++.+.... +..+++|||++|.
T Consensus 6 l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~ 85 (223)
T cd05154 6 LSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGR 85 (223)
T ss_pred cCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCE
Confidence 788999999999877678899999765432 2346788999999999763 456667666553 2568999999998
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA----------------------------------------- 114 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----------------------------------------- 114 (322)
++.+.+.. ..++......++.+++.+|..||+..
T Consensus 86 ~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 86 VLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred ecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 88765521 14666677777888888888887521
Q ss_pred ------------CCCeeeccCcccceEeCC--CCeEEEeeeccccc
Q 020720 115 ------------DPPIVHRDIKASNVLLDG--NFHPKIGDFGLAKL 146 (322)
Q Consensus 115 ------------~~~i~h~dlkp~Nill~~--~~~~kl~Dfg~~~~ 146 (322)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 67789999987763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.6e-12 Score=115.03 Aligned_cols=238 Identities=20% Similarity=0.165 Sum_probs=164.6
Q ss_pred cccCcceEEEEEEEC--CCCEEEEEEecccChhcHHH--HHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLR--DGTQIAIKCLSAESKQGTKE--FLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~--~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
||.|.|+.|+....+ ++..|++|.+.........+ -+.|+.+...+ .|.+++.++..+......++--|||.+++
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s 352 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGS 352 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcc
Confidence 788999999988544 57788999876553333322 34566665555 68899998888888888889999999998
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+...+... ..+.+...+.+..|++.++.++|+.. .+|+|++|.||++..+ +.-++.|||....+....
T Consensus 353 ~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---- 421 (524)
T KOG0601|consen 353 SSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---- 421 (524)
T ss_pred hhhhhHHH----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec----
Confidence 77666322 25777889999999999999999998 9999999999999886 778999998875321110
Q ss_pred cccccCCCCC--chHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 156 TRVAGTMGYL--APEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 156 ~~~~~t~~y~--aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.......++. ++.......+..+.|+||||..+.+.+++........... .+.......
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-------------------~i~~~~~p~ 482 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-------------------TIRSGDTPN 482 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-------------------eeecccccC
Confidence 0111233444 4444456678899999999999999998864433221110 011111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
.+.....+..+...++..++..||.+.++.......
T Consensus 483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred CCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 222224455555669999999999998887655433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.8e-10 Score=90.45 Aligned_cols=126 Identities=21% Similarity=0.215 Sum_probs=83.4
Q ss_pred EEEEEEECCCCEEEEEEecccCh-------------h-------------cHHHHHHHHHHHhcCCCCc--ccccceEEE
Q 020720 9 VVYRGSLRDGTQIAIKCLSAESK-------------Q-------------GTKEFLTEIDMIWNIRHPN--LVQLIGCCV 60 (322)
Q Consensus 9 ~v~~~~~~~~~~vaiK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~~--iv~~~~~~~ 60 (322)
.||.|...+|..+|+|+.+.... . ......+|++.|.++..-+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988899999999864210 0 1134668999999997664 4555544
Q ss_pred eCCeeEEEEEcCC--CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeeccCcccceEeCCCCeEE
Q 020720 61 EDNNRILVYEYLE--NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF-LHEEADPPIVHRDIKASNVLLDGNFHPK 137 (322)
Q Consensus 61 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~-lH~~~~~~i~h~dlkp~Nill~~~~~~k 137 (322)
. .-.+||||++ |..+..+.... ++......++.+++..+.. +|..+ ++|+||++.||+++++ .+.
T Consensus 79 ~--~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 N--RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp E--TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred e--CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 2 3469999998 65665544322 1134456677778885554 67888 9999999999999988 999
Q ss_pred EeeeccccccC
Q 020720 138 IGDFGLAKLFP 148 (322)
Q Consensus 138 l~Dfg~~~~~~ 148 (322)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.1e-10 Score=93.85 Aligned_cols=131 Identities=16% Similarity=0.092 Sum_probs=94.9
Q ss_pred EEEEEEECCCCEEEEEEecccChh-----------cHHHHHHHHHHHhcCCCCcc--cccceEEEe-----CCeeEEEEE
Q 020720 9 VVYRGSLRDGTQIAIKCLSAESKQ-----------GTKEFLTEIDMIWNIRHPNL--VQLIGCCVE-----DNNRILVYE 70 (322)
Q Consensus 9 ~v~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e 70 (322)
.|.+.... |+.|.||........ ....+.+|...+.++...+| ..++++... ....++|+|
T Consensus 37 rvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 45565554 778999977433211 11247789999888854444 334455543 234789999
Q ss_pred cCCCC-CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-------CCeEEEeeec
Q 020720 71 YLENN-SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-------NFHPKIGDFG 142 (322)
Q Consensus 71 ~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-------~~~~kl~Dfg 142 (322)
++++. +|.+++..... .+.+......++.+++..+.-||..| ++|+|+++.|||++. +..+.|+||+
T Consensus 116 ~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 116 DLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 99876 89998853211 14556777899999999999999999 999999999999975 4679999999
Q ss_pred ccc
Q 020720 143 LAK 145 (322)
Q Consensus 143 ~~~ 145 (322)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.3e-10 Score=90.81 Aligned_cols=130 Identities=21% Similarity=0.182 Sum_probs=96.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh----------------------hcHHHHHHHHHHHhcCCCC--cccccc
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK----------------------QGTKEFLTEIDMIWNIRHP--NLVQLI 56 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--~iv~~~ 56 (322)
.||-|--+.||.|..+.|.++|||.-+.... -......+|.++|.++... .+.+.+
T Consensus 98 ~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~ 177 (304)
T COG0478 98 KIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI 177 (304)
T ss_pred ccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcc
Confidence 3899999999999999999999997653211 0123467899999999655 666666
Q ss_pred eEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeE
Q 020720 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP 136 (322)
Q Consensus 57 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~ 136 (322)
++ +.-.+|||+++|..|...-. +....-.++..|+.-+.-+-..| ++|+|+++-||+++++|.+
T Consensus 178 ~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 178 AW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred cc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCE
Confidence 54 45568999999976654331 22333445555556666555778 9999999999999999999
Q ss_pred EEeeeccccc
Q 020720 137 KIGDFGLAKL 146 (322)
Q Consensus 137 kl~Dfg~~~~ 146 (322)
.++||-.+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999977654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.4e-11 Score=115.00 Aligned_cols=237 Identities=22% Similarity=0.206 Sum_probs=152.7
Q ss_pred cCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 4 GGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 4 ~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+|+++.++.+.-. .|...++|+..... ....+.+..+-.++-...+|.++....-+.-.....++++|..+++|..
T Consensus 814 S~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~S 893 (1205)
T KOG0606|consen 814 SGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPS 893 (1205)
T ss_pred CCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchh
Confidence 5667777666433 24334444433221 1111222222222222234555544444445567889999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC------C---
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD------N--- 150 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------~--- 150 (322)
.++... +.+.......+..+..++++||... +.|+|++|.|.+...++..++.||+.....+. .
T Consensus 894 kl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 894 KLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred hhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 987654 4555556666677889999999887 89999999999999999999999974332110 0
Q ss_pred ------------c-----c----eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhH
Q 020720 151 ------------V-----T----HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLIL 209 (322)
Q Consensus 151 ------------~-----~----~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~ 209 (322)
. . .......+|+.|.+||...+..-...+|.|++|++++|.++|..||...........
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence 0 0 011224589999999999999999999999999999999999999987644332110
Q ss_pred HHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 020720 210 VEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMK 260 (322)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ 260 (322)
+ .. .+......+.....+..+++...+..+|.+|-.+.
T Consensus 1047 i-------~~------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1047 I-------LN------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred c-------cc------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 0 00 01111222333344456666668899999997766
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.3e-11 Score=107.18 Aligned_cols=150 Identities=23% Similarity=0.296 Sum_probs=101.3
Q ss_pred HHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee--------cccccCCCCCchHHHhh
Q 020720 101 LGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS--------TRVAGTMGYLAPEYALL 172 (322)
Q Consensus 101 ~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~ 172 (322)
.+++.|+.|+|+.. .++|++|.|++|.++.++..||+.|+.+........... .-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34669999999854 499999999999999999999999998875443211111 11224568999999999
Q ss_pred CCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccC
Q 020720 173 GQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQA 251 (322)
Q Consensus 173 ~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 251 (322)
...+.++|+||+|+++|.+.. |+..+........+.... ...+-.........+.++.+=+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------------cccccccccccccCcHHHHHHHHHHhcC
Confidence 888999999999999999984 444444332222221111 0011111112233334466666678999
Q ss_pred CCCCCCCHHHHHH
Q 020720 252 GAHYRPTMKQVVE 264 (322)
Q Consensus 252 dp~~Rps~~evl~ 264 (322)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=7e-09 Score=83.06 Aligned_cols=137 Identities=12% Similarity=0.087 Sum_probs=101.7
Q ss_pred ccCcceEEEEEEECCCCEEEEEEeccc------ChhcHHHHHHHHHHHhcCCCCc--ccccceEEEeC----CeeEEEEE
Q 020720 3 GGGAFGVVYRGSLRDGTQIAIKCLSAE------SKQGTKEFLTEIDMIWNIRHPN--LVQLIGCCVED----NNRILVYE 70 (322)
Q Consensus 3 g~G~~g~v~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e 70 (322)
|+||.+-|+..... |..+-+|.-... .+.....|.+|+..|.++...+ +.++..+.... ...+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 56899999998766 446888876421 1446689999999999995432 44444221111 23689999
Q ss_pred cCCC-CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe--EEEeeecccc
Q 020720 71 YLEN-NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH--PKIGDFGLAK 145 (322)
Q Consensus 71 ~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~--~kl~Dfg~~~ 145 (322)
-+.+ .+|.+++...... +.+......++.+++.+++-||..+ +.|+|+.+.||+++.++. +.++||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 7753 4888887554222 5677778899999999999999999 999999999999986667 9999997665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.5e-09 Score=83.76 Aligned_cols=106 Identities=20% Similarity=0.209 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhcCCCC--cccccceEEEeCC----eeEEEEEcCCCC-CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHH
Q 020720 34 TKEFLTEIDMIWNIRHP--NLVQLIGCCVEDN----NRILVYEYLENN-SLANALLGSKSKYVSLDWPTRANICLGTASG 106 (322)
Q Consensus 34 ~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~ 106 (322)
.....+|...+..+... .+.+++++..... ..++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 35678888888877533 3455566655432 358999999874 7999986533 25556778899999999
Q ss_pred HHHHhhcCCCCeeeccCcccceEeCCCC---eEEEeeeccccc
Q 020720 107 LSFLHEEADPPIVHRDIKASNVLLDGNF---HPKIGDFGLAKL 146 (322)
Q Consensus 107 l~~lH~~~~~~i~h~dlkp~Nill~~~~---~~kl~Dfg~~~~ 146 (322)
++-||..| ++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999999887 899999987664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.7e-09 Score=94.02 Aligned_cols=140 Identities=16% Similarity=0.247 Sum_probs=91.0
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcH----------------------------------------HHHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT----------------------------------------KEFLTEI 41 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~~e~ 41 (322)
|+.++-|.||+|+.++|+.||||+.+..-.... -++.+|.
T Consensus 133 iAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA 212 (517)
T COG0661 133 IASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREA 212 (517)
T ss_pred hhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHH
Confidence 577899999999999999999999875421110 0133455
Q ss_pred HHHhcC-----CCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 020720 42 DMIWNI-----RHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116 (322)
Q Consensus 42 ~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ 116 (322)
..+.++ +.+++.-..=+++......++|||++|..+.+...-... ..+...+.....++. +..+-..+
T Consensus 213 ~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~f--~~q~~~dg-- 285 (517)
T COG0661 213 ANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRAF--LRQLLRDG-- 285 (517)
T ss_pred HHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHHH--HHHHHhcC--
Confidence 555544 123332222223334567899999999988887532211 344333332222221 33334456
Q ss_pred CeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
+.|.|.+|.||+++.+|.+.+.|||+......
T Consensus 286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.5e-08 Score=80.82 Aligned_cols=137 Identities=15% Similarity=0.168 Sum_probs=84.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCc--ccccceEEEeCCeeEEEEEcCCCCC-H
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN--LVQLIGCCVEDNNRILVYEYLENNS-L 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~-L 77 (322)
.||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+++++....+...++||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 3799999999984 25567889876433 3356788999999886433 4667788777777889999999863 2
Q ss_pred HHHH---------------------hcCCCCCcCCCHHHHHH-HHHH----------HHH-HHHHHhhc-CCCCeeeccC
Q 020720 78 ANAL---------------------LGSKSKYVSLDWPTRAN-ICLG----------TAS-GLSFLHEE-ADPPIVHRDI 123 (322)
Q Consensus 78 ~~~l---------------------~~~~~~~~~~~~~~~~~-i~~q----------i~~-~l~~lH~~-~~~~i~h~dl 123 (322)
...+ +.-... ..+...... +..+ +.. ...+|... ....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 110000 111111000 0000 001 11222211 1234799999
Q ss_pred cccceEeCCCCeEEEeeecccc
Q 020720 124 KASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 124 kp~Nill~~~~~~kl~Dfg~~~ 145 (322)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.6e-07 Score=76.51 Aligned_cols=135 Identities=21% Similarity=0.262 Sum_probs=91.4
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChh-------------------cHH-----HHHHHHHHHhcCCC--Cccccc
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ-------------------GTK-----EFLTEIDMIWNIRH--PNLVQL 55 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~-------------------~~~-----~~~~e~~~l~~l~h--~~iv~~ 55 (322)
|.+|--+.||+|...++..+|+|+++..... +.. -..+|+..|+++.. -.+.+.
T Consensus 56 istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~P 135 (268)
T COG1718 56 ISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEP 135 (268)
T ss_pred ecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence 6788889999998888999999999753211 000 12357777776632 233344
Q ss_pred ceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCC
Q 020720 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNF 134 (322)
Q Consensus 56 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~ 134 (322)
+.+. .-.+||||+.... .....-+..++...+...+..+++..+.-|-. .+ ++|+||+.-|||+. ++
T Consensus 136 i~~~----~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 136 IAFR----NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DG 203 (268)
T ss_pred eeec----CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CC
Confidence 4432 2358999996431 11111122234444677788888888888877 66 99999999999999 88
Q ss_pred eEEEeeeccccccC
Q 020720 135 HPKIGDFGLAKLFP 148 (322)
Q Consensus 135 ~~kl~Dfg~~~~~~ 148 (322)
.+.++||+.+....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.1e-07 Score=74.01 Aligned_cols=113 Identities=19% Similarity=0.238 Sum_probs=73.9
Q ss_pred CCCEEEEEEecccChhcHHHH---------HHHHHHHhcC---CCCcccccceEEEe-----CCeeEEEEEcCCCCCHHH
Q 020720 17 DGTQIAIKCLSAESKQGTKEF---------LTEIDMIWNI---RHPNLVQLIGCCVE-----DNNRILVYEYLENNSLAN 79 (322)
Q Consensus 17 ~~~~vaiK~~~~~~~~~~~~~---------~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~ 79 (322)
+|..+++|..+.......+.| .+++..+..+ ....+..++.+... ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 478889998876544333322 2333333333 23333333333222 234568999999988866
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
+. .+++ .+...++.++..||..| +.|+|.+|.|+++++++ ++++||+...
T Consensus 133 ~~--------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 133 IE--------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred ch--------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 54 2332 24456778899999999 99999999999999665 8999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.7e-07 Score=70.38 Aligned_cols=125 Identities=20% Similarity=0.257 Sum_probs=90.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccc-cceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ-LIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+|++|.+|.||++.+. |..+|+|+-+.+++ ...+..|+++|..+.--++.+ ++.+.. -++.|||++|..|.+
T Consensus 29 ~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~ 101 (201)
T COG2112 29 ELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhh
Confidence 4899999999999998 66899998766544 478889999999997766654 333322 235599999988877
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCc-ccceEeCCCCeEEEeeeccccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIK-ASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlk-p~Nill~~~~~~kl~Dfg~~~~ 146 (322)
..... +... +..+++.-.-|-..| |-|+.|+ |...++..++.+.|+||..+..
T Consensus 102 ~~~~~-------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG-------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc-------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 66321 1222 233556655666677 9999998 5656666666999999998773
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-06 Score=73.52 Aligned_cols=139 Identities=17% Similarity=0.130 Sum_probs=82.6
Q ss_pred ccCcc-eEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 3 GGGAF-GVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 3 g~G~~-g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
..|.. +.||+.... +..+++|...... ...+.+|++++..+. +-.+.+++++....+..++||++++|.++...
T Consensus 7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 34444 788998655 4678889875432 345677888888773 34455677777666678899999998877644
Q ss_pred Hh-------------------cCCCCCcCCCHH--HHHHHHH--------------------HHHHHHHHHhh----cCC
Q 020720 81 LL-------------------GSKSKYVSLDWP--TRANICL--------------------GTASGLSFLHE----EAD 115 (322)
Q Consensus 81 l~-------------------~~~~~~~~~~~~--~~~~i~~--------------------qi~~~l~~lH~----~~~ 115 (322)
.. .......++... ....... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 110000011100 0000000 01111222211 112
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 448999999999999998888999998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-06 Score=72.63 Aligned_cols=141 Identities=18% Similarity=0.239 Sum_probs=81.0
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCC--cccccceEEEe---CCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHP--NLVQLIGCCVE---DNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~~~~ 76 (322)
|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|+++++..
T Consensus 5 l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 5 LSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred CCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 6789999999998886 68999997644 4456777888888887433 34556654322 335689999999987
Q ss_pred HHH----------------HHh---cCCCCCcCCCHHH---------HHHH------------HHHHHH-HHHHHhh---
Q 020720 77 LAN----------------ALL---GSKSKYVSLDWPT---------RANI------------CLGTAS-GLSFLHE--- 112 (322)
Q Consensus 77 L~~----------------~l~---~~~~~~~~~~~~~---------~~~i------------~~qi~~-~l~~lH~--- 112 (322)
+.. .+. .......+..... .... ...+.. .+..++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 777 110 1100000111100 0000 111222 2333332
Q ss_pred -cCCCCeeeccCcccceEeC-CCCeEEEeeecccc
Q 020720 113 -EADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAK 145 (322)
Q Consensus 113 -~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~ 145 (322)
.....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1233499999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.1e-08 Score=91.07 Aligned_cols=180 Identities=18% Similarity=0.147 Sum_probs=126.7
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCc-ccccceEEEeCCeeEEEEEcCCCC-CHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN-LVQLIGCCVEDNNRILVYEYLENN-SLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~ 79 (322)
+++|+++++++.+....+....+.+... ....-++++|.+++||| .+..++-+..+...++.++++.++ +-..
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 3577888888775443333444554332 44556899999999999 666676677777889999999877 2221
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
... .....+.......++..-+.+++++|+.. -+|+| ||+..+ +..++.||+....+.... ......
T Consensus 325 ~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 325 EMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred cCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 111 11112334445556666778899999865 58888 776655 678999999877554332 234456
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCC
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSK 199 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~ 199 (322)
+++.++|||+...+.+..+.|+|++|.-..++--|..|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 8999999999999999999999999998888877776644
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.3e-06 Score=67.16 Aligned_cols=126 Identities=17% Similarity=0.220 Sum_probs=88.9
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccC----------------hhcHHHHHHHHHHHhcCC------CCcccccceE
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAES----------------KQGTKEFLTEIDMIWNIR------HPNLVQLIGC 58 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 58 (322)
+||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++|+
T Consensus 8 ~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 489999998885 4455667889987655 112345566666665555 8899999999
Q ss_pred EEeCCeeEEEEEcCCC------CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC
Q 020720 59 CVEDNNRILVYEYLEN------NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG 132 (322)
Q Consensus 59 ~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~ 132 (322)
..++-...+|+|.+.. -+|.+++... .++. ..... +-.-..||-.++ |+.+|++|.||++..
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 9999999999997643 2788888443 3444 33333 334456777777 999999999999963
Q ss_pred CC----eEEEee
Q 020720 133 NF----HPKIGD 140 (322)
Q Consensus 133 ~~----~~kl~D 140 (322)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-06 Score=80.22 Aligned_cols=139 Identities=17% Similarity=0.224 Sum_probs=86.8
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhc-------------------------------HH------HHHHHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQG-------------------------------TK------EFLTEIDMI 44 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~------~~~~e~~~l 44 (322)
||.-+.|.|++|+.++|+.||||+-+..-... .+ +|.+|++..
T Consensus 169 iaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Na 248 (538)
T KOG1235|consen 169 IAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNA 248 (538)
T ss_pred hhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhH
Confidence 57778999999999999999999976532111 00 133454444
Q ss_pred hcC----CCCc------ccccceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC
Q 020720 45 WNI----RHPN------LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114 (322)
Q Consensus 45 ~~l----~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 114 (322)
.++ .|-+ |.+++.- ......|+|||++|..+.|+-.-... .++...+..-+.++. +..+-..|
T Consensus 249 e~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 249 ERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHhcC
Confidence 433 2333 2333322 23467899999999866554322211 344444333332222 23333456
Q ss_pred CCCeeeccCcccceEeCC----CCeEEEeeeccccccCCC
Q 020720 115 DPPIVHRDIKASNVLLDG----NFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 115 ~~~i~h~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~~ 150 (322)
++|+|=+|.||+++. ++.+.+.|||+.......
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999999984 677999999998865443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.2e-06 Score=68.48 Aligned_cols=104 Identities=21% Similarity=0.236 Sum_probs=81.4
Q ss_pred HHHHHHHhcCCC-CcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 020720 38 LTEIDMIWNIRH-PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116 (322)
Q Consensus 38 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ 116 (322)
..|.-+++.+.+ +++.+++|+| ..+++.||...+++...... -......+|..+.+|+.++++.+.+|+..-..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888865 6999999998 34678999987765422100 01112578999999999999999999986555
Q ss_pred CeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
.+.-.|++++|+-+++++++|++|.+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 589999999999999999999999986653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-05 Score=69.25 Aligned_cols=73 Identities=11% Similarity=0.063 Sum_probs=53.7
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCC---CcccccceEEEeC---CeeEEEEEcCCCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH---PNLVQLIGCCVED---NNRILVYEYLENN 75 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~---~~~~lv~e~~~~~ 75 (322)
||.|..+.||.....+++ +++|..+. ......+..|+..++.+.- -.+.++++++... +..++|||++++.
T Consensus 22 i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~ 98 (297)
T PRK10593 22 ISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGV 98 (297)
T ss_pred cCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCE
Confidence 789999999999766554 67787542 1123578889999988843 3677788777543 5689999999987
Q ss_pred CH
Q 020720 76 SL 77 (322)
Q Consensus 76 ~L 77 (322)
++
T Consensus 99 ~~ 100 (297)
T PRK10593 99 SV 100 (297)
T ss_pred ec
Confidence 54
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-05 Score=78.93 Aligned_cols=75 Identities=15% Similarity=0.309 Sum_probs=53.6
Q ss_pred cccCcceEEEEEEECCC---CEEEEEEecccC-hhcHHHHHHHHHHHhcCC-CCcc--cccceEEEeC---CeeEEEEEc
Q 020720 2 IGGGAFGVVYRGSLRDG---TQIAIKCLSAES-KQGTKEFLTEIDMIWNIR-HPNL--VQLIGCCVED---NNRILVYEY 71 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~ 71 (322)
++.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..|+||||
T Consensus 46 l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~ 125 (822)
T PLN02876 46 FGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEY 125 (822)
T ss_pred eCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEe
Confidence 57788999999876643 467888764332 123457889999999985 6654 6677776654 457899999
Q ss_pred CCCCC
Q 020720 72 LENNS 76 (322)
Q Consensus 72 ~~~~~ 76 (322)
++|..
T Consensus 126 v~G~~ 130 (822)
T PLN02876 126 LEGRI 130 (822)
T ss_pred cCCcc
Confidence 98864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.9e-06 Score=81.57 Aligned_cols=198 Identities=21% Similarity=0.190 Sum_probs=139.0
Q ss_pred HHHHHHHHHHhcCCCCcccccceEEEeCCee----EEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHH
Q 020720 35 KEFLTEIDMIWNIRHPNLVQLIGCCVEDNNR----ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110 (322)
Q Consensus 35 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 110 (322)
.....|...+.++.|+|++.++.+..+.... .+..++|...++...+..-. .++....+.+..++..||+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHH
Confidence 3445577888888999999999997665432 24567888888888775544 788899999999999999999
Q ss_pred hhcCCCCeeeccCccc---ceEeCCCCeEEEe--eeccccccCCCcceeecccccCCCCCchHHHhhCCCCc--ccceeh
Q 020720 111 HEEADPPIVHRDIKAS---NVLLDGNFHPKIG--DFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK--KADVYS 183 (322)
Q Consensus 111 H~~~~~~i~h~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~sDv~s 183 (322)
|+.. ..|.-|... +...+..+.+... ||+............. ...+..+.++|......+.. ..|+|.
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHH
Confidence 9986 777666665 5666777777777 8888776654433222 23455678888777665544 479999
Q ss_pred hhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 020720 184 FGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVV 263 (322)
Q Consensus 184 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl 263 (322)
+|..+..+..|..+-....... .-+...... .+......|+..++++|+++.+++
T Consensus 378 lgll~~~~~~~~~i~~~~~~~~----------------------~~l~~~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAVPV----------------------SLLDVLSTS---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHHhhhhhcCcccccccchh----------------------hhhccccch---hhhhhhhhhcchhhhhccchhhhh
Confidence 9999999998865533211000 001111111 355566679999999999999998
Q ss_pred HHH
Q 020720 264 EML 266 (322)
Q Consensus 264 ~~L 266 (322)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.9e-06 Score=67.81 Aligned_cols=71 Identities=15% Similarity=0.197 Sum_probs=43.6
Q ss_pred cccCcce-EEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCC---cccccceEEEeC---CeeEEEEEcCCC
Q 020720 2 IGGGAFG-VVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHP---NLVQLIGCCVED---NNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g-~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~~~ 74 (322)
|+.|+.. .||+. +..+++|..+.. .....+.+|++.+..+... .+..+++..... ...+++|++++|
T Consensus 5 ~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 5 VDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred ccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 4556665 58876 345788876532 2345788899999887532 233334333222 234789999998
Q ss_pred CCHH
Q 020720 75 NSLA 78 (322)
Q Consensus 75 ~~L~ 78 (322)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.8e-06 Score=69.47 Aligned_cols=139 Identities=17% Similarity=0.121 Sum_probs=77.2
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCccc-ccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLV-QLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
+..|-.+.+|+.... +..+++|........-.....+|..+++.+....++ +++... . .++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 456788899988744 677889986543222112356788888888644343 333332 2 3689999998655321
Q ss_pred -----------------HhcCCCCCcCCCHHH-HHHHHHHH---------HHHHHHHhhc-----CCCCeeeccCcccce
Q 020720 81 -----------------LLGSKSKYVSLDWPT-RANICLGT---------ASGLSFLHEE-----ADPPIVHRDIKASNV 128 (322)
Q Consensus 81 -----------------l~~~~~~~~~~~~~~-~~~i~~qi---------~~~l~~lH~~-----~~~~i~h~dlkp~Ni 128 (322)
++.......+++... ...+..++ ...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111111111222111 11111111 1112222111 122489999999999
Q ss_pred EeCCCCeEEEeeeccccc
Q 020720 129 LLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 129 ll~~~~~~kl~Dfg~~~~ 146 (322)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999987763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.6e-05 Score=64.99 Aligned_cols=71 Identities=15% Similarity=0.270 Sum_probs=45.5
Q ss_pred cccCcceEEEEEEECC--CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRD--GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
|..|-...+|+....+ +..|++|+....... .....+|+.++..+....+ .+++..+ .+ .++|||++|.++
T Consensus 6 l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~--~~l~e~i~G~~l 79 (235)
T cd05157 6 FTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF--QN--GLIYEFIPGRTL 79 (235)
T ss_pred cCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe--CC--cEEEEeeCCCcC
Confidence 5667788999997664 678999987543221 1233468888888854344 3343332 22 379999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00011 Score=65.44 Aligned_cols=73 Identities=16% Similarity=0.191 Sum_probs=50.9
Q ss_pred cccCcceEEEEEEECCC-CEEEEEEeccc-----C--hhcHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEEE
Q 020720 2 IGGGAFGVVYRGSLRDG-TQIAIKCLSAE-----S--KQGTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~-~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 70 (322)
||.|.++.||++...+| +.++||.-... . +-..+....|.+.|..+. -.++.+++.+ +.+..++|||
T Consensus 34 lggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME 111 (401)
T PRK09550 34 IGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVME 111 (401)
T ss_pred cCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEe
Confidence 68899999999988766 48999984311 1 223456677888887762 2345666655 4456789999
Q ss_pred cCCCCC
Q 020720 71 YLENNS 76 (322)
Q Consensus 71 ~~~~~~ 76 (322)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00023 Score=62.26 Aligned_cols=29 Identities=31% Similarity=0.447 Sum_probs=25.5
Q ss_pred CeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
.+||+|+.|.||+++.+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999977667899998776
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=62.54 Aligned_cols=140 Identities=16% Similarity=0.135 Sum_probs=79.9
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCc--ccccceE------EEeCCeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN--LVQLIGC------CVEDNNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e~~~ 73 (322)
|..|....+|+....+ ..+++|+... .....+..|+.++..+.... +.+++.. ....+..+++++|++
T Consensus 22 i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 22 ISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred ccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 4567778899987654 4688898764 23355667777777774322 3343331 123456689999998
Q ss_pred CCCHHH----HH----------hc----CCCC---CcCCCHHHHH----------HHHHHHHHHHHHHhhc----CCCCe
Q 020720 74 NNSLAN----AL----------LG----SKSK---YVSLDWPTRA----------NICLGTASGLSFLHEE----ADPPI 118 (322)
Q Consensus 74 ~~~L~~----~l----------~~----~~~~---~~~~~~~~~~----------~i~~qi~~~l~~lH~~----~~~~i 118 (322)
|..+.. .. +. .... .....|.... .....+..++.++.+. ....+
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 865421 00 00 0000 0001111100 0111223344444431 12249
Q ss_pred eeccCcccceEeCCCCeEEEeeecccc
Q 020720 119 VHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 119 ~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
+|+|+.|.||++++++.+.|+||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCceEEEeehhhhc
Confidence 999999999999998878999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00015 Score=62.82 Aligned_cols=72 Identities=21% Similarity=0.296 Sum_probs=46.0
Q ss_pred cccCcceEEEEEEECC-------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCccc-ccceEEEeCCeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLRD-------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLV-QLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~ 73 (322)
|..|-...+|+....+ ++.+++|+..... .......+|+.++..+....+. +++.++. + ..|++|++
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~ 80 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP 80 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence 3456677899987654 5789999976443 2234567788888887543333 4444442 2 35899988
Q ss_pred CCCHH
Q 020720 74 NNSLA 78 (322)
Q Consensus 74 ~~~L~ 78 (322)
|.++.
T Consensus 81 G~~l~ 85 (302)
T cd05156 81 SRTLT 85 (302)
T ss_pred CCcCC
Confidence 87654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00083 Score=58.38 Aligned_cols=141 Identities=16% Similarity=0.215 Sum_probs=77.1
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCc--ccccceE------EEeCCeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN--LVQLIGC------CVEDNNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e~~~ 73 (322)
++.|....+|+....+| .+++|+..... ....+..|++++..+.... +.+++.. ....+..+++++|++
T Consensus 30 ~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~ 106 (307)
T TIGR00938 30 IAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ 106 (307)
T ss_pred cCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence 45666688999876645 57889875422 1234555666666663222 3333332 122456789999998
Q ss_pred CCCHH-----------HHH---hcCCCCC-----c---CCCHHHHH------------HHHHHHHHHHHHHhh----cCC
Q 020720 74 NNSLA-----------NAL---LGSKSKY-----V---SLDWPTRA------------NICLGTASGLSFLHE----EAD 115 (322)
Q Consensus 74 ~~~L~-----------~~l---~~~~~~~-----~---~~~~~~~~------------~i~~qi~~~l~~lH~----~~~ 115 (322)
|..+. ..+ +...... . .-.|.... .....+...++++.. ...
T Consensus 107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~ 186 (307)
T TIGR00938 107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP 186 (307)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 85431 111 1100100 0 00011000 001122334444532 112
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 349999999999999998877899998765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00025 Score=61.41 Aligned_cols=137 Identities=20% Similarity=0.216 Sum_probs=92.1
Q ss_pred cccCcceEEEEEEECCCCEEEEEEeccc-----Ch-----------------hcH----HHHHHHHHHHhcCCCCccccc
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE-----SK-----------------QGT----KEFLTEIDMIWNIRHPNLVQL 55 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~-----~~-----------------~~~----~~~~~e~~~l~~l~h~~iv~~ 55 (322)
|..|--+.||.|...+|..+|||+++.. +. ... .-...|++.|.+++...|.-.
T Consensus 152 iSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~P 231 (520)
T KOG2270|consen 152 ISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCP 231 (520)
T ss_pred cccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 5567788999998888999999998642 00 001 124468888888765554322
Q ss_pred ceEEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe
Q 020720 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH 135 (322)
Q Consensus 56 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~ 135 (322)
--+... .-.|||+|+.+..... ...+...+....+..+-+|++.-+.-|.+.+. +||.||+--|+|+. +|.
T Consensus 232 ePIlLk--~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 232 EPILLK--NHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-DGK 302 (520)
T ss_pred Cceeee--cceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-CCE
Confidence 222221 2358999995322111 11223356667788888889888888877554 99999999999986 468
Q ss_pred EEEeeecccccc
Q 020720 136 PKIGDFGLAKLF 147 (322)
Q Consensus 136 ~kl~Dfg~~~~~ 147 (322)
+.++|.+.+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999998877643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00028 Score=60.26 Aligned_cols=70 Identities=24% Similarity=0.370 Sum_probs=45.1
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC---CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI---RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
|+.|....+|+.. .+++.+.+|+-. ......|..|+.-|+.| ..-.+.+++++....+..+|++||++.+
T Consensus 25 v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 25 VSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp E--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred cCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 5678888999887 557889999865 23335677788888777 3456778888888777889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=7.1e-05 Score=63.67 Aligned_cols=130 Identities=16% Similarity=0.161 Sum_probs=89.8
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChh----------------------cHHHHHHHHHHHhcCCC-C-cccccce
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQ----------------------GTKEFLTEIDMIWNIRH-P-NLVQLIG 57 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h-~-~iv~~~~ 57 (322)
||-|--+.+|.+....|++.++|.-+..... +.-...+|+..|+.+.. . .+.+.++
T Consensus 100 IGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD 179 (465)
T KOG2268|consen 100 IGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPID 179 (465)
T ss_pred cccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 7888899999999888999999976432110 11234578888887743 2 2333343
Q ss_pred EEEeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEE
Q 020720 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPK 137 (322)
Q Consensus 58 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~k 137 (322)
+ +.-++|||++.+..|...-+ -.+.+. +...+..-+--|.++| +||+|+.--||++++++.++
T Consensus 180 ~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 180 H----NRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred c----cceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEE
Confidence 3 45678999999887754432 122233 3344445566777788 99999999999999999999
Q ss_pred EeeeccccccC
Q 020720 138 IGDFGLAKLFP 148 (322)
Q Consensus 138 l~Dfg~~~~~~ 148 (322)
++||-......
T Consensus 243 vIDFPQmvS~s 253 (465)
T KOG2268|consen 243 VIDFPQMVSTS 253 (465)
T ss_pred EeechHhhccC
Confidence 99997665443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00057 Score=54.69 Aligned_cols=118 Identities=23% Similarity=0.332 Sum_probs=79.2
Q ss_pred CcccCcc-eEEEEEEECCCCEEEEEEecc---cCh------------------hcHHHHHHHHHHHhcC---CCCcc--c
Q 020720 1 MIGGGAF-GVVYRGSLRDGTQIAIKCLSA---ESK------------------QGTKEFLTEIDMIWNI---RHPNL--V 53 (322)
Q Consensus 1 ~lg~G~~-g~v~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~e~~~l~~l---~h~~i--v 53 (322)
+||.|.- |.||+++.. |+.||+|+++. ... .....|..|-+...++ .+.++ |
T Consensus 44 fLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Av 122 (207)
T PF13095_consen 44 FLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAV 122 (207)
T ss_pred ecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEE
Confidence 4899999 999999988 78999999321 100 1113466777766666 34556 8
Q ss_pred ccceEEEeC------------------CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 020720 54 QLIGCCVED------------------NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115 (322)
Q Consensus 54 ~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~ 115 (322)
+++|+..-. ....+|.||.+... .....-+.+|.+-+..+|+.+
T Consensus 123 kc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~~~~k~g- 184 (207)
T PF13095_consen 123 KCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLKILHKLG- 184 (207)
T ss_pred EeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHHHHHHCC-
Confidence 888886322 01245666655432 112233456777788899999
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
|+-+|+++.|.. .=+|+|||.+
T Consensus 185 --I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 185 --IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred --eeeccCcccccc-----CCEEEecccC
Confidence 999999999987 3478999854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0009 Score=57.70 Aligned_cols=128 Identities=20% Similarity=0.266 Sum_probs=78.3
Q ss_pred EEEEEEECCCCEEEEEEec-ccChhcHHHHHHHHHHHhcCCC--CcccccceEEEeCC--eeEEEEEcCCCCCHHHHHhc
Q 020720 9 VVYRGSLRDGTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRH--PNLVQLIGCCVEDN--NRILVYEYLENNSLANALLG 83 (322)
Q Consensus 9 ~v~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~ 83 (322)
.+|..... ++.++++... ...........+|+..++.+.- -.+...+++|.++. ..++||+|++|..+.+....
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 34444433 7788888321 1233445667788888888743 33444566666555 67999999988533222211
Q ss_pred CCCCCcCCCHHHHHHHH-HHHHHHHHHHhh--------------------------------------------------
Q 020720 84 SKSKYVSLDWPTRANIC-LGTASGLSFLHE-------------------------------------------------- 112 (322)
Q Consensus 84 ~~~~~~~~~~~~~~~i~-~qi~~~l~~lH~-------------------------------------------------- 112 (322)
. ... ...+ ..++..|+.||+
T Consensus 119 ~-------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 119 E-------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred c-------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 0 000 0111 244444444443
Q ss_pred cC-----CCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 113 EA-----DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 113 ~~-----~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+. ...++|+|+++.|++++.++-+=|.||+++..
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 11 14589999999999999998899999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0015 Score=55.78 Aligned_cols=31 Identities=26% Similarity=0.462 Sum_probs=25.4
Q ss_pred CCeeeccCcccceEeCCCCe-EEEeeeccccc
Q 020720 116 PPIVHRDIKASNVLLDGNFH-PKIGDFGLAKL 146 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~-~kl~Dfg~~~~ 146 (322)
..++|+|++|.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997554 56999997764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=1.1e-05 Score=80.52 Aligned_cols=161 Identities=14% Similarity=0.044 Sum_probs=119.7
Q ss_pred HHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC
Q 020720 37 FLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114 (322)
Q Consensus 37 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 114 (322)
...|...++...|+++.....-... ....+..++|+.+|.+.+.+.....+..++....+...-++.+....-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555556688888776555432 23457889999999999999877666666766666655555566677766543
Q ss_pred --CCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHH
Q 020720 115 --DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEII 192 (322)
Q Consensus 115 --~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell 192 (322)
+...+|+++|+-|.++..+-.+++.++|+.+..... ........+++-|+.|+....-.++.++|+|..|+.+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 234789999999999999999999999999843322 22223345778899999888889999999999999999998
Q ss_pred hCCCCC
Q 020720 193 SGRSSS 198 (322)
Q Consensus 193 ~g~~p~ 198 (322)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887665
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0013 Score=58.08 Aligned_cols=137 Identities=16% Similarity=0.207 Sum_probs=77.1
Q ss_pred cCcceEEEEEEECC-----CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCccc-ccceEEEeCCeeEEEEEcCCCCCH
Q 020720 4 GGAFGVVYRGSLRD-----GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLV-QLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 4 ~G~~g~v~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.|-...+|++...+ ++.|++|+....... .-...+|..+++.+...++. ++++++.. + .|.+|+++.+|
T Consensus 46 gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~~l 120 (344)
T PLN02236 46 GAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHARTL 120 (344)
T ss_pred CcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCCCC
Confidence 46677889986532 367899987654322 22336788888888554443 44555422 2 57899877665
Q ss_pred HHH-----------------HhcCCCC--CcCCCHHHHHHHHHHH-----------------HHHHHHH----hh-cCCC
Q 020720 78 ANA-----------------LLGSKSK--YVSLDWPTRANICLGT-----------------ASGLSFL----HE-EADP 116 (322)
Q Consensus 78 ~~~-----------------l~~~~~~--~~~~~~~~~~~i~~qi-----------------~~~l~~l----H~-~~~~ 116 (322)
... ++..... .....+..+..+..++ ...+..| .. ....
T Consensus 121 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~ 200 (344)
T PLN02236 121 SAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEI 200 (344)
T ss_pred CHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCc
Confidence 321 1111100 0111233333333222 1112222 11 1123
Q ss_pred CeeeccCcccceEeCC-CCeEEEeeecccc
Q 020720 117 PIVHRDIKASNVLLDG-NFHPKIGDFGLAK 145 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~ 145 (322)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999986 4689999998775
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.003 Score=56.38 Aligned_cols=77 Identities=16% Similarity=0.131 Sum_probs=49.6
Q ss_pred cccCcceEEEEEEECCCCEEEEEEeccc-----C--hhcHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEEEc
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE-----S--KQGTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
||.|....||+.... +..++||.-... . +........|+..|+.+. ..++.+++.++. +..+++||+
T Consensus 40 iggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~ 116 (418)
T PLN02756 40 VGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRY 116 (418)
T ss_pred cCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEee
Confidence 678888999998765 556899975411 1 113344455667666653 246777887766 446788999
Q ss_pred CCC--CCHHHHH
Q 020720 72 LEN--NSLANAL 81 (322)
Q Consensus 72 ~~~--~~L~~~l 81 (322)
+++ ..+.+.+
T Consensus 117 L~~~~~ilr~~L 128 (418)
T PLN02756 117 LEPPHIILRKGL 128 (418)
T ss_pred cCCcceehhhhh
Confidence 977 3444444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0047 Score=53.73 Aligned_cols=30 Identities=23% Similarity=0.252 Sum_probs=27.2
Q ss_pred CeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
.++|+|+.+.|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0062 Score=49.58 Aligned_cols=70 Identities=20% Similarity=0.286 Sum_probs=48.0
Q ss_pred CcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC---CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 5 GAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI---RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 5 G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
|..-..|..... ..++.+|+- .......|..|+.-|..+ +.-.+.+++.+.....+.++|+||++.+.+.
T Consensus 27 G~inea~~v~dg-~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDG-TDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecC-CcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 333444544433 567888873 344456777888777776 3456777888888889999999999876543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0061 Score=53.47 Aligned_cols=78 Identities=14% Similarity=0.185 Sum_probs=49.1
Q ss_pred cccCcceEEEEEEECCC-CEEEEEEecc-------cChhcHHHHHHHHHHHhcCC--CCc-ccccceEEEeCCeeEEEEE
Q 020720 2 IGGGAFGVVYRGSLRDG-TQIAIKCLSA-------ESKQGTKEFLTEIDMIWNIR--HPN-LVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~-~~vaiK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~e 70 (322)
||.|....||++..++| +.++||.-.. +-+-...+..-|...|+... .|. +.+++.+ +.+...++||
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vME 80 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVME 80 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHh
Confidence 68899999999987654 6899996421 11333455566777776653 343 4444433 4556678999
Q ss_pred cCCCC-CHHHHH
Q 020720 71 YLENN-SLANAL 81 (322)
Q Consensus 71 ~~~~~-~L~~~l 81 (322)
+++.. .|.+.+
T Consensus 81 dL~~~~ilR~~L 92 (370)
T TIGR01767 81 DLSHHKIARKGL 92 (370)
T ss_pred hCccchHHHHHH
Confidence 98643 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0013 Score=53.74 Aligned_cols=29 Identities=28% Similarity=0.445 Sum_probs=20.9
Q ss_pred CeeeccCcccceEe-CCCCeEEEeeecccc
Q 020720 117 PIVHRDIKASNVLL-DGNFHPKIGDFGLAK 145 (322)
Q Consensus 117 ~i~h~dlkp~Nill-~~~~~~kl~Dfg~~~ 145 (322)
.++|+|+.|.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0094 Score=51.83 Aligned_cols=28 Identities=25% Similarity=0.335 Sum_probs=24.4
Q ss_pred CeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999987 568899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0063 Score=53.41 Aligned_cols=138 Identities=12% Similarity=0.200 Sum_probs=74.9
Q ss_pred cCcceEEEEEEECC----CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCccc-ccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 4 GGAFGVVYRGSLRD----GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLV-QLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 4 ~G~~g~v~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.|--..+|+....+ +..|++|+...... ..-...+|..+++.+..-++. ++++++ . +. +|.+|+++.+|.
T Consensus 24 gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G--~i~~fi~g~~l~ 98 (330)
T PLN02421 24 GGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-G-NG--MIQSFINARTLT 98 (330)
T ss_pred CcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-C-Cc--EeehhhcCCCCC
Confidence 35566788876442 24789998764322 222345688888888655553 445444 2 22 588998776542
Q ss_pred HH-------H----------hcCCCC--CcCCCHHHHHHHHHHH-------------------------HHHHHHHh-hc
Q 020720 79 NA-------L----------LGSKSK--YVSLDWPTRANICLGT-------------------------ASGLSFLH-EE 113 (322)
Q Consensus 79 ~~-------l----------~~~~~~--~~~~~~~~~~~i~~qi-------------------------~~~l~~lH-~~ 113 (322)
.. + +..... ..+-.+..+..+..++ +..+..+. ..
T Consensus 99 ~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~ 178 (330)
T PLN02421 99 PSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSL 178 (330)
T ss_pred hHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccC
Confidence 10 1 111100 0011122222222221 11111111 11
Q ss_pred C-CCCeeeccCcccceEeCC-CCeEEEeeeccccc
Q 020720 114 A-DPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKL 146 (322)
Q Consensus 114 ~-~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~ 146 (322)
+ ...++|+|+.+.||++++ ++.++++||..+..
T Consensus 179 ~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 179 KAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred CCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 224899999999999975 57899999988763
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.019 Score=50.18 Aligned_cols=137 Identities=20% Similarity=0.275 Sum_probs=77.9
Q ss_pred cceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc------cccceEE--EeCC--eeEEEEEcCCCC
Q 020720 6 AFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL------VQLIGCC--VEDN--NRILVYEYLENN 75 (322)
Q Consensus 6 ~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i------v~~~~~~--~~~~--~~~lv~e~~~~~ 75 (322)
.-..+|+....+|+. ++|+.+.. .....+..|...+..+.-..| ...-|-. .-.. ..+.+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345688888777776 88998765 445667777777777732211 1111111 1123 677899999987
Q ss_pred CHHH------------HH---h----cCC----CCCcCCCHH-------------HHHHHHHHHHHHHHHHhhcC-----
Q 020720 76 SLAN------------AL---L----GSK----SKYVSLDWP-------------TRANICLGTASGLSFLHEEA----- 114 (322)
Q Consensus 76 ~L~~------------~l---~----~~~----~~~~~~~~~-------------~~~~i~~qi~~~l~~lH~~~----- 114 (322)
.+.. ++ + ... .......|. .-.....++...+..+...-
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 00 0 000 000011221 00012233444444444321
Q ss_pred CCC--eeeccCcccceEeCCCCe-EEEeeecccc
Q 020720 115 DPP--IVHRDIKASNVLLDGNFH-PKIGDFGLAK 145 (322)
Q Consensus 115 ~~~--i~h~dlkp~Nill~~~~~-~kl~Dfg~~~ 145 (322)
..+ +||+|+.|.||+++.+.. +-++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 112 899999999999998884 8999999765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.01 Score=52.75 Aligned_cols=78 Identities=23% Similarity=0.241 Sum_probs=49.3
Q ss_pred cccCcceEEEEEEECC-CCEEEEEEecc------cChhcHHHHHHHHHHHhcCC--CCc-ccccceEEEeCCeeEEEEEc
Q 020720 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSA------ESKQGTKEFLTEIDMIWNIR--HPN-LVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~-~~~vaiK~~~~------~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~e~ 71 (322)
||.|-...||++...+ ++.|+||.-.. +-+-..++..-|.+.|+... .|. +.+++.+ +.....+|||+
T Consensus 37 igdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vMEd 114 (409)
T PRK12396 37 IGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVMED 114 (409)
T ss_pred cCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHHh
Confidence 6889999999998753 56799996421 12334466677777777663 353 4445433 45566789998
Q ss_pred CCCC-CHHHHH
Q 020720 72 LENN-SLANAL 81 (322)
Q Consensus 72 ~~~~-~L~~~l 81 (322)
++.. .|.+.+
T Consensus 115 L~~~~ilR~~L 125 (409)
T PRK12396 115 LSDHTILRTAL 125 (409)
T ss_pred CcccHHHHHHH
Confidence 8543 344443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.07 Score=46.79 Aligned_cols=71 Identities=15% Similarity=0.202 Sum_probs=44.1
Q ss_pred CcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCC--cccccc---e--EEEeCCeeEEEEEcCCCCC
Q 020720 5 GAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHP--NLVQLI---G--CCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 5 G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~~~~ 76 (322)
+.-..||+....+|..+++|+.+.. ......+..|++.+..+... .++... + +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3456789988777888999987633 23456667777777666321 122211 1 1233456788999988763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0099 Score=48.18 Aligned_cols=115 Identities=14% Similarity=0.113 Sum_probs=68.7
Q ss_pred ceEEEEEEECCCCEEEEEEecccChh-cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcCC
Q 020720 7 FGVVYRGSLRDGTQIAIKCLSAESKQ-GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSK 85 (322)
Q Consensus 7 ~g~v~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 85 (322)
.++.-.++.+-|. ..+|+++..... ...-+..+++++.++. .|+++.. .....+.++.|+|.....
T Consensus 75 NsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-------- 141 (308)
T PF07387_consen 75 NSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-------- 141 (308)
T ss_pred ceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc--------
Confidence 3344444333233 355655533333 3355677888887764 3555541 133356788998864311
Q ss_pred CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 86 SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 86 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
. ..-.|..+ +.+|.-.|+. +...+|+|..|+|||-|..|-+||.|-+..
T Consensus 142 -----~---~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -----N---FSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -----c---hhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 0 11111111 3667788854 234999999999999999999999997643
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0077 Score=52.44 Aligned_cols=102 Identities=16% Similarity=0.165 Sum_probs=69.5
Q ss_pred eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 64 NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 64 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+.|++|++. |+++.. + ....+.++..++.+.+..++-+..+- +.-|||+.-.||+|+ +|.|.|+||-+
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 456666655 444432 2 14567889999999999888888743 489999999999999 99999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehh
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSF 184 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~sl 184 (322)
++....+.. +-....-.|-.+.+.. +..-+||-+
T Consensus 368 sRl~~~q~~------isy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 368 SRLSYSQGI------ISYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred eecccCCce------eeccccCchhhhcCcc-ceeeeHHHH
Confidence 984332221 1223445566565332 555666654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.025 Score=50.55 Aligned_cols=70 Identities=21% Similarity=0.284 Sum_probs=40.7
Q ss_pred cCcceEEEEEEECCC--CE-----EEEEEecccChhcHHHHHHHHHHHhcCCCCcccc-cceEEEeCCeeEEEEEcCCCC
Q 020720 4 GGAFGVVYRGSLRDG--TQ-----IAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ-LIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 4 ~G~~g~v~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.|-...+|++...++ .. |.++... ......-+-.+|+.+++.+...++.+ +++.+. -+++.||++|.
T Consensus 60 gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efIeGr 134 (383)
T PTZ00384 60 NGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWVEGN 134 (383)
T ss_pred CcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEeccc
Confidence 477778898865432 22 3444322 22121223456889999887666655 444432 24899999887
Q ss_pred CHH
Q 020720 76 SLA 78 (322)
Q Consensus 76 ~L~ 78 (322)
+|.
T Consensus 135 ~l~ 137 (383)
T PTZ00384 135 TMG 137 (383)
T ss_pred cCC
Confidence 653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0028 Score=57.40 Aligned_cols=71 Identities=18% Similarity=0.234 Sum_probs=48.0
Q ss_pred EEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-CeeEEEEEcCCCCCHHHHHhcC
Q 020720 10 VYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-NNRILVYEYLENNSLANALLGS 84 (322)
Q Consensus 10 v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 84 (322)
++.|....|..+ ..-+. .......++...++++.+.|+|...++++-... ....+|+|++ +-+|.+++..+
T Consensus 5 ~~~a~~~~~~~c-~nglp--lt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLP--LTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCc--CCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 455655545433 22222 223346778889999999999999998886543 3467889988 55899988544
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.18 Score=51.21 Aligned_cols=29 Identities=31% Similarity=0.462 Sum_probs=24.8
Q ss_pred eeeccCcccceEeCCCC--eEE-Eeeeccccc
Q 020720 118 IVHRDIKASNVLLDGNF--HPK-IGDFGLAKL 146 (322)
Q Consensus 118 i~h~dlkp~Nill~~~~--~~k-l~Dfg~~~~ 146 (322)
+||+|+.+.||+++.++ .+. |+|||.+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999999875 454 999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.12 Score=47.23 Aligned_cols=29 Identities=17% Similarity=0.340 Sum_probs=24.2
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
..++|.|+.+.||+.++++ ++|+||..+.
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeecccc
Confidence 3589999999999887554 9999998765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 322 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-59 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-56 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-26 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-166
Identities = 121/273 (44%), Positives = 175/273 (64%), Gaps = 4/273 (1%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIGCC 59
++G G FG VY+G L DGT +A+K L E QG + +F TE++MI H NL++L G C
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ R+LVY Y+ N S+A+ L LDWP R I LG+A GL++LH+ DP I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+KA+N+LLD F +GDFGLAKL THV+T V GT+G++APEY G+ ++K
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 216
Query: 180 DVYSFGVLLLEIISGRSSSKAAF--GDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEK 236
DV+ +GV+LLE+I+G+ + A DD ++L++W L +E +L +VD +L + ++
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269
EV + I+V L CTQ+ RP M +VV ML D
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 416 bits (1073), Expect = e-147
Identities = 120/279 (43%), Positives = 173/279 (62%), Gaps = 5/279 (1%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+IG G FG VY+G LRDG ++A+K + ES QG +EF TEI+ + RHP+LV LIG C
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
E N IL+Y+Y+EN +L L GS +S+ W R IC+G A GL +LH I+H
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIH 162
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPD-NVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
RD+K+ N+LLD NF PKI DFG++K + + TH+ST V GT+GY+ PEY + G+LT+K+
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS 222
Query: 180 DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT-QFPEKEV 238
DVYSFGV+L E++ RS+ + +M+ L EW + G+L +IVDP L + + +
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESL 282
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKAL 277
+F + C + RP+M V+ L + L E +
Sbjct: 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 411 bits (1059), Expect = e-145
Identities = 94/276 (34%), Positives = 151/276 (54%), Gaps = 14/276 (5%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSA----ESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FGVVY+G + + T +A+K L+A +++ ++F EI ++ +H NLV+L+
Sbjct: 38 KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G + ++ LVY Y+ N SL + L L W R I G A+G++FLHE
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRCKIAQGAANGINFLHEN--- 152
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP-DNVTHVSTRVAGTMGYLAPEYALLGQL 175
+HRDIK++N+LLD F KI DFGLA+ T +++R+ GT Y+APE L G++
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEI 211
Query: 176 TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-LREEGRLLEIVDPELTQFP 234
T K+D+YSFGV+LLEII+G + + L++ + EE + + +D ++
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDAD 269
Query: 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270
V V C + RP +K+V ++L +
Sbjct: 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-86
Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 31/292 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+ G FG V++ L +A+K + KQ + E+ + ++H N++Q IG
Sbjct: 31 VKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 61 EDNN----RILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD- 115
+ L+ + E SL++ L K + W +I A GL++LHE+
Sbjct: 89 RGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 116 ------PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV-STRVAGTMGYLAPE 168
P I HRDIK+ NVLL N I DFGLA F + + GT Y+APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 169 YA-----LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223
+ D+Y+ G++L E+ S +++ + ML E + +
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263
Query: 224 EIV-----DPELTQ-FPEKEVMR-FIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
E+V P L + + M + C A R + V E +++
Sbjct: 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-68
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 48/313 (15%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTE--IDMIWNIRHPNLVQLIGC 58
+IG G +G VY+GSL +A+K S ++Q F+ E I + + H N+ + I
Sbjct: 20 LIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVG 75
Query: 59 CVEDN-----NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
+LV EY N SL L + DW + + GL++LH E
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 114 AD------PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-------PDNVTHVSTRVAG 160
P I HRD+ + NVL+ + I DFGL+ P + + G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 161 TMGYLAPEYA-------LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213
T+ Y+APE K+ D+Y+ G++ EI R + + +
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPEYQMAFQ 249
Query: 214 WKLREEGRLLEIVD-----------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQV 262
++ ++ PE + V + C A R T +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
Query: 263 VEMLSKDVHLNEK 275
E +++ + + E+
Sbjct: 310 EERMAELMMIWER 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 7e-65
Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 40/277 (14%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G+FG V+R G+ +A+K L + + EFL E+ ++ +RHPN+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ N +V EYL SL L S ++ LD R ++ A G+++LH +PPIV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL-TKK 178
HR++K+ N+L+D + K+ DFGL++L S AGT ++APE L + +K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPE-VLRDEPSNEK 219
Query: 179 ADVYSFGVLLLEIISGR------SSSKAAFGDDMLILVEWTWKLREEGRLLEI---VDPE 229
+DVYSFGV+L E+ + + + ++ + + + LEI ++P+
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAA------------VGFKCKRLEIPRNLNPQ 267
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
+ ++ C RP+ ++++L
Sbjct: 268 V-----AAIIE------GCWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-63
Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 32/272 (11%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G GAFGVV + R +AIK + +ES++ K F+ E+ + + HPN+V+L G C+
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
N LV EY E SL N L G++ + CL + G+++LH ++HR
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPL-PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 122 DIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL-TKKA 179
D+K N+LL KI DFG A ++ T G+ ++APE G ++K
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE-VFEGSNYSEKC 184
Query: 180 DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI---VDPELTQFPEK 236
DV+S+G++L E+I+ + F + W + R + + + +
Sbjct: 185 DVFSWGIILWEVITR----RKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPI-----E 234
Query: 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+M C RP+M+++V++++
Sbjct: 235 SLMTR------CWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-62
Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 45/285 (15%)
Query: 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGT-------KEFLTEIDMIWNIRHPNL 52
IG G FG+V++G L D + +AIK L +G +EF E+ ++ N+ HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
V+L G +V E++ L + LL + W + + L A G+ ++
Sbjct: 86 VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYMQN 140
Query: 113 EADPPIVHRDIKASNVLLD-----GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAP 167
+ +PPIVHRD+++ N+ L K+ DFGL++ H + + G ++AP
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAP 195
Query: 168 EYALLGQL---TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
E + + T+KAD YSF ++L I++G + F + +++ +REEG
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTG----EGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 225 I---VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
I P L + V+ C RP +V+ L
Sbjct: 251 IPEDCPPRL-----RNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-62
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 39/278 (14%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+ G +++G + G I +K L S + +++F E + HPN++ ++G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 60 VE--DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+ L+ ++ SL N L + +D L A G++FLH +P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ--- 174
I + + +V++D + +I + F S ++APE AL +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPE-ALQKKPED 186
Query: 175 -LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI---VDPEL 230
+ AD++SF VLL E+++ + F D L +E K+ EG I + P +
Sbjct: 187 TNRRSADMWSFAVLLWELVTR----EVPFAD--LSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
++M+ C RP +V +L K
Sbjct: 241 -----SKLMK------ICMNEDPAKRPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-62
Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCL----SAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG G FG VYR G ++A+K + Q + E + ++HPN++ L
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G C+++ N LV E+ L L G + + N + A G+++LH+EA
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 117 PIVHRDIKASNVLLDGNFHP--------KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE 168
PI+HRD+K+SN+L+ KI DFGLA+ + AG ++APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 169 YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228
+K +DV+S+GVLL E+++G + F + + + + L I P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTG----EVPFRG--IDGLAVAYGVAMNKLALPI--P 236
Query: 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P ++M C H RP+ +++ L+
Sbjct: 237 STCPEPFAKLME------DCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-58
Identities = 66/291 (22%), Positives = 115/291 (39%), Gaps = 53/291 (18%)
Query: 2 IGGGAFGVVYRGSLRDGTQ-IAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G FG + + R+ + + +K L ++ + FL E+ ++ + HPN+++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+D + EY++ +L + KS W R + ASG+++LH I+H
Sbjct: 78 KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-------------VSTRVAGTMGYLAP 167
RD+ + N L+ N + + DFGLA+L D T V G ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 168 EYALLGQL-TKKADVYSFGVLLLEIISGR------SSSKAAFGDDMLILVEWTWKLREEG 220
E + G+ +K DV+SFG++L EII FG ++
Sbjct: 192 E-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-----------RGF 239
Query: 221 RLLEI---VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P + + C RP+ ++ L
Sbjct: 240 LDRYCPPNCPPSFFP-----IT------VRCCDLDPEKRPSFVKLEHWLET 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-57
Identities = 66/277 (23%), Positives = 128/277 (46%), Gaps = 37/277 (13%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G+FG VY+G +A+K L+ + Q + F E+ ++ RH N++ +G
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
I V ++ E +SL + L S++K + +I TA G+ +LH I+
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPD-NVTHVSTRVAGTMGYLAPE---YALLGQL 175
HRD+K++N+ L + KIGDFGLA + +H +++G++ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 176 TKKADVYSFGVLLLEIISGR------SSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229
+ ++DVY+FG++L E+++G+ ++ +V + ++
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE-----MVGRGSLSPDLSKVRSNCPKR 257
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
+ K +M C + RP+ +++ +
Sbjct: 258 M-----KRLMA------ECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-56
Identities = 73/299 (24%), Positives = 114/299 (38%), Gaps = 45/299 (15%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFL--TEIDMIWNIRHPNLVQLIGC 58
IG G +G V+ G R G ++A+K + + TEI +RH N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAA 99
Query: 59 CVEDNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
++ L+ +Y EN SL + L K +LD + + + SGL LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 115 D-----PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAGTMGYLA 166
P I HRD+K+ N+L+ N I D GLA F + V GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 167 PEYALLGQL-------TKKADVYSFGVLLLEIISGRSSSKAA----------FGDDMLIL 209
PE L L AD+YSFG++L E+ S D
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 210 VEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
++ R + + +++ + + C R T +V + L+K
Sbjct: 274 DMREIVCIKKLR-PSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-55
Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 53/303 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDM--IWNIRHPNLVQLIGC 58
+G G +G V+RGS + G +A+K S+ ++ + E ++ +RH N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIAS 70
Query: 59 CVEDNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+ + L+ Y E SL + L + +LD + I L ASGL+ LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 115 D-----PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV---STRVAGTMGYLA 166
P I HRD+K+ N+L+ N I D GLA + + + + GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 167 PE------YALLGQLTKKADVYSFGVLLLEIISGRSSS------KAAFGD---------D 205
PE K+ D+++FG++L E+ S+ K F D D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 206 MLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265
M +V + + I + + + + +K C R T ++ +
Sbjct: 246 MRKVVC------VDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKKT 296
Query: 266 LSK 268
L+K
Sbjct: 297 LTK 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-55
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 54/291 (18%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+IG G FG VY G ++AI+ + E ++ K F E+ RH N+V +G
Sbjct: 40 LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
C+ + ++ + +L + + +K LD I G+ +LH I
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKL----FPDNVTHVSTRVAGTMGYLAPE------ 168
+H+D+K+ NV D N I DFGL + G + +LAPE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 169 ---YALLGQLTKKADVYSFGVLLLEIISGRS-----SSKAAFGDDMLILVEWTWKLREEG 220
+K +DV++ G + E+ + ++A W++
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-----------WQMGTGM 259
Query: 221 RLLEI---VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+ + E+ +++ FC RPT ++++ML K
Sbjct: 260 KPNLSQIGMGKEI-----SDILL------FCWAFEQEERPTFTKLMDMLEK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-53
Identities = 77/299 (25%), Positives = 124/299 (41%), Gaps = 45/299 (15%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTE--IDMIWNIRHPNLVQLIGC 58
IG G FG V+RG R G ++A+K S+ ++ + E I +RH N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA 104
Query: 59 CVEDNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+DN LV +Y E+ SL + L ++ + L TASGL+ LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 115 D-----PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF---PDNVTHVSTRVAGTMGYLA 166
P I HRD+K+ N+L+ N I D GLA D + GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 167 PEYALLGQL-------TKKADVYSFGVLLLEIISGRSSS------KAAFGD----DMLIL 209
PE L + K+AD+Y+ G++ EI S + + D D +
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 210 VEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
++ R I + + + + + ++ C A R T ++ + LS+
Sbjct: 279 EMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRE---CWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-44
Identities = 66/285 (23%), Positives = 122/285 (42%), Gaps = 32/285 (11%)
Query: 2 IGGGAFGVVYRGSLR-----DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V G +A+K L +++ ++F EI+++ +++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 57 GCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
G C R L+ EYL SL + L K + +D G+ +L +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKR 134
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYALL 172
+HRD+ N+L++ KIGDFGL K+ P + + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 173 GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD----- 227
+ + +DV+SFGV+L E+ + SK+ + M ++ L+E++
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251
Query: 228 --PELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P+ P++ +M C + RP+ + + + +
Sbjct: 252 PRPDGC--PDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-44
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G FG V+ G LR D T +A+K +FL E ++ HPN+V+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ +V E ++ L +++ L T + A+G+ +L + +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY----LAPEYALLGQL 175
HRD+ A N L+ KI DFG+++ D V G APE G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRY 292
Query: 176 TKKADVYSFGVLLLEIIS 193
+ ++DV+SFG+LL E S
Sbjct: 293 SSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-44
Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 2 IGGGAFGVVYRGSL-----RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V G +A+K L +++ ++F EI+++ +++H N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 57 GCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
G C R L+ EYL SL + L K + +D G+ +L +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKR 165
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYALL 172
+HRD+ N+L++ KIGDFGL K+ P + + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 173 GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW---------KLREEGRLL 223
+ + +DV+SFGV+L E+ + SK+ + M ++ +L + L
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 224 EIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P+ P++ +M C + RP+ + + + +
Sbjct: 283 PR--PDGC--PDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 50/294 (17%)
Query: 2 IGGGAFGVVYRGSL-----RDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G FG V G Q+A+K L E + EI+++ N+ H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 56 IGCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
G C ED L+ E+L + SL L +K+K ++ + + G+ +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYAL 171
VHRD+ A NVL++ KIGDFGL K + + + + + APE +
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 172 LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231
+ +DV+SFGV L E+++ + D L+++ P
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT--------YCDS---------DSSPMALFLKMIGPTHG 245
Query: 232 QFPEKEVMRFIKVG-----------------LFCTQAGAHYRPTMKQVVEMLSK 268
Q ++ +K G C + R + + ++E
Sbjct: 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 23/268 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ G+ T++AIK L + + FL E ++ +RH LVQL E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ I V EY+ SL + L G KY+ L P ++ ASG++++ VHR
Sbjct: 251 EPIYI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D++A+N+L+ N K+ DFGLA+L DN + + APE AL G+ T K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 182 YSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240
+SFG+LL E+ + GR ++L V E G + P ++M
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRMPC--PPECPESLHDLM- 414
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
C + RPT + + L
Sbjct: 415 -----CQCWRKEPEERPTFEYLQAFLED 437
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-43
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G+F VY+G ++A +K + F E +M+ ++HPN+V+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 59 CV---EDNNRILVY-EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+ I++ E + + +L L ++ + + C GL FLH
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR- 148
Query: 115 DPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
PPI+HRD+K N+ + G KIGD GLA L + V GT ++APE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YEE 204
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
+ + DVY+FG+ +LE+ +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSE 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-43
Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 23/268 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ G+ T++AIK L + + FL E ++ +RH LVQL E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ I V EY+ SL + L G KY+ L P ++ ASG++++ VHR
Sbjct: 334 EPIYI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D++A+N+L+ N K+ DFGLA+L DN + + APE AL G+ T K+DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 182 YSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240
+SFG+LL E+ + GR ++L V E G + P ++M
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRMPC--PPECPESLHDLM- 497
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
C + RPT + + L
Sbjct: 498 -----CQCWRKEPEERPTFEYLQAFLED 520
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-43
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 19/198 (9%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
IG G FG+V+ G + ++AIK + ++G ++F+ E +++ + HP LVQL G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
C+E LV E++E+ L++ L + T +CL G+++L E +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLAPEYALLGQL 175
+HRD+ A N L+ N K+ DFG+ + D+ T GT + +PE +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRY 182
Query: 176 TKKADVYSFGVLLLEIIS 193
+ K+DV+SFGVL+ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FGVV G + +A+K + K+G+ EF E + + HP LV+ G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
C ++ +V EY+ N L N L +S L+ +C G++FL
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---F 125
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLAPEYALLGQL 175
+HRD+ A N L+D + K+ DFG+ + D+ GT + APE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKY 182
Query: 176 TKKADVYSFGVLLLEIIS 193
+ K+DV++FG+L+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 29/272 (10%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIG 57
+GGG +G VY G + +A+K L K+ T +EFL E ++ I+HPNLVQL+G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + ++ E++ +L + L + VS + +S + +L ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEKKN--- 338
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
+HR++ A N L+ N K+ DFGL++L + + + APE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 178 KADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236
K+DV++FGVLL EI + G S + L+ E+ +E PE
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMER--PEGCPEKVY 449
Query: 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
E+M C Q RP+ ++ +
Sbjct: 450 ELM------RACWQWNPSDRPSFAEIHQAFET 475
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 38/287 (13%)
Query: 2 IGGGAFGVVYRGSLRD-----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G FG V G +A+K L A+ Q + EID++ + H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 56 IGCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
GCC + LV EY+ SL + L + G+++LH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ 153
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYAL 171
+HRD+ A NVLLD + KIGDFGLAK P+ + R G + APE
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 172 LGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEW-------TWKLREEGRLL 223
+ +DV+SFGV L E+++ SS LI + +L E G L
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270
Query: 224 EIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P+ P + +M C + A +RPT + ++ +L
Sbjct: 271 PR--PDKC--PAEVYHLM------KNCWETEASFRPTFENLIPILKT 307
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FGVV G R +AIK + K+G+ EF+ E ++ N+ H LVQL G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
C + ++ EY+ N L N L + + +C + +L +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQ---F 141
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLAPEYALLGQL 175
+HRD+ A N L++ K+ DFGL++ D+ T G+ + PE + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKF 198
Query: 176 TKKADVYSFGVLLLEIIS 193
+ K+D+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 35/286 (12%)
Query: 2 IGGGAFGVVYRGSLR-----DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V G +A+K L ++F EI ++ + +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 57 GCCVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
G + LV EYL + L + L +++ LD G+ +L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 147
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYALL 172
VHRD+ A N+L++ H KI DFGLAKL P + + R G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 173 GQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTW-------KLREEGRLLE 224
++++DV+SFGV+L E+ + S + ++ E +L EEG+ L
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP 264
Query: 225 IVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P P + E+M C RP+ + L
Sbjct: 265 A--PPAC--PAEVHELM------KLCWAPSPQDRPSFSALGPQLDM 300
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-42
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 25/201 (12%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIGC 58
+G G FG V+ G T++A+K L KQG+ FL E +++ ++H LV+L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
++ I + EY+EN SL + L +++ ++ A G++F+ E
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFIEERN---Y 130
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT------MGYLAPEYALL 172
+HRD++A+N+L+ KI DFGLA+L DN T G APE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWT---APEAINY 184
Query: 173 GQLTKKADVYSFGVLLLEIIS 193
G T K+DV+SFG+LL EI++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-42
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 2 IGGGAFGVVYRGSLRDG-----TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQL 55
+G GAFG VY+G +AIK L + E L E ++ ++ +P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+G C+ ++ + + + L + + K + N C+ A G+++L +
Sbjct: 83 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLAPEYALL 172
+VHRD+ A NVL+ H KI DFGLAKL G ++A E L
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILH 193
Query: 173 GQLTKKADVYSFGVLLLEIIS 193
T ++DV+S+GV + E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-41
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 2 IGGGAFGVVYRGSLRDG---TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIG 57
+G G FG V +G R +AIK L +++ E + E ++ + +P +V+LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + + V E L L+G + + + A + + G+ +L E+
Sbjct: 78 VCQAEALML-VMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYALLGQL 175
VHRD+ A NVLL + KI DFGL+K + ++ + R AG + APE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 176 TKKADVYSFGVLLLEIIS 193
+ ++DV+S+GV + E +S
Sbjct: 191 SSRSDVWSYGVTMWEALS 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-40
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ + T++A+K + S + FL E +++ ++H LV+L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ I + E++ SL + L + L P + A G++F+ + +HR
Sbjct: 255 EPIYI-ITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 308
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG---YLAPEYALLGQLTKK 178
D++A+N+L+ + KI DFGLA++ DN T G + APE G T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 179 ADVYSFGVLLLEIIS 193
+DV+SFG+LL+EI++
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 69/328 (21%), Positives = 136/328 (41%), Gaps = 34/328 (10%)
Query: 2 IGGGAFGVVYRGSLRDG-----TQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G FG V++G + IK + +S +Q + + I ++ H ++V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+G C + ++ V +YL SL + + + L N + A G+ +L E
Sbjct: 81 LGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-MGYLAPEYALLGQ 174
+VHR++ A NVLL ++ DFG+A L P + + A T + ++A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 175 LTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
T ++DV+S+GV + E+++ G ++ L+ E+G L P++
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGERLA--QPQIC-- 242
Query: 234 PEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYRGNTSYSL 291
VM + C + RPT K++ ++ + L +
Sbjct: 243 TIDVYMVM------VKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGP 296
Query: 292 GASSSETSSSQKHKGKRSVDHEVPTSAQ 319
++ + + +D ++ A+
Sbjct: 297 EPHGLTNKKLEEVELEPELDLDLDLEAE 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-40
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 2 IGGGAFGVVYRGSLR----DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FGVV RG +A+KCL + + +F+ E++ + ++ H NL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L G + ++ V E SL + L + T + + A G+ +L +
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESKR 141
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY--LAPEYALL 172
+HRD+ A N+LL KIGDFGL + P N H + + + APE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 173 GQLTKKADVYSFGVLLLEIIS 193
+ +D + FGV L E+ +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-40
Identities = 71/297 (23%), Positives = 126/297 (42%), Gaps = 57/297 (19%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FG+VY G + T++AIK ++ S + EFL E ++ ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRA------NICLGTASGLS 108
L+G + +++ E + L + L + + + A G++
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL--- 165
+L VHRD+ A N ++ +F KIGDFG+ + ++ G G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205
Query: 166 --APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWKL 216
+PE G T +DV+SFGV+L EI + G S+ + +L V
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFV------ 253
Query: 217 REEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
EG LL+ P+ P+ E+MR C Q RP+ +++ + +++
Sbjct: 254 -MEGGLLDK--PDNC--PDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEME 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V G R G ++A+KC+ ++ + FL E ++ +RH NLVQL+G VE
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 62 DNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ + +V EY+ SL + L + L + +L VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RD+ A NVL+ + K+ DFGL K + T + ++ + + APE + + K+D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 368
Query: 181 VYSFGVLLLEIIS-GRS 196
V+SFG+LL EI S GR
Sbjct: 369 VWSFGILLWEIYSFGRV 385
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-40
Identities = 74/314 (23%), Positives = 119/314 (37%), Gaps = 68/314 (21%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G GAFG V+ + +A+K L S+ ++F E +++ ++H ++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN-----------ICLGTA 104
G C E ++V+EY+ + L L L + A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY 164
+G+ +L A VHRD+ N L+ KIGDFG+++ RV G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-GGRTM 221
Query: 165 L-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEW 212
L PE L + T ++DV+SFGV+L EI + S + + +
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS------NTEAIDCI-- 273
Query: 213 TWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270
+GR LE P P + +MR C Q R ++K V L
Sbjct: 274 -----TQGRELER--PRAC--PPEVYAIMR------GCWQREPQQRHSIKDVHARL---- 314
Query: 271 HLNEKALTEPGVYR 284
+ P VY
Sbjct: 315 ---QALAQAPPVYL 325
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 2 IGGGAFGVVYRGSLRDG---TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLIG 57
+G G FG V +G R +AIK L +++ E + E ++ + +P +V+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + + V E L L+G + + + A + + G+ +L E+
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY--LAPEYALLGQL 175
VHR++ A NVLL + KI DFGL+K + ++ + R AG APE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 176 TKKADVYSFGVLLLEIIS 193
+ ++DV+S+GV + E +S
Sbjct: 517 SSRSDVWSYGVTMWEALS 534
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-40
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 2 IGGGAFGVVYRGSLRDGT-----QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
IG G FG VY+G L+ + +AIK L A +++ +FL E ++ H N+++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G + +++ EY+EN +L L + + G A+G+ +L
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG------TMGYLAPEY 169
VHRD+ A N+L++ N K+ DFGL+++ D+ T G T APE
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEA 221
Query: 170 ALLGQLTKKADVYSFGVLLLEIIS 193
+ T +DV+SFG+++ E+++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 2 IGGGAFGVVYRGSLRDG---TQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V +G + +A+K L E E L E +++ + +P +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G C ++ + V E E L L ++ + + + G+ +L EE++
Sbjct: 85 GICEAESWML-VMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL-EESN- 137
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM--GYLAPEYALLGQ 174
VHRD+ A NVLL + KI DFGL+K + + + G + APE +
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 175 LTKKADVYSFGVLLLEIIS 193
+ K+DV+SFGVL+ E S
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 1 MIGGGAFGVVYRGSLRDG-----TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY+G +AIK L + E L E ++ ++ +P++ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+G C+ ++ + + + L + + K + N C+ A G+++L +
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT-MGYLAPEYALLG 173
+VHRD+ A NVL+ H KI DFGLAKL + ++A E L
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 174 QLTKKADVYSFGVLLLEIIS 193
T ++DV+S+GV + E+++
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG G G V G LR +AIK L A +++ ++FL+E ++ HPN+++L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G ++V EY+EN SL L + + G +G+ +L +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG------TMGYLAPEYA 170
VHRD+ A NVL+D N K+ DFGL+++ D+ T G T APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAI 226
Query: 171 LLGQLTKKADVYSFGVLLLEIIS 193
+ +DV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 2 IGGGAFGVVYRGSL----RDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V G L + +AIK L +++ ++FL E ++ HPN+++L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G + ++V EY+EN SL + L ++ + G ASG+ +L +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL--APEYALLGQ 174
VHRD+ A N+L++ N K+ DFGL ++ D+ T G + +PE +
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 175 LTKKADVYSFGVLLLEIIS 193
T +DV+S+G++L E++S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-39
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 62/297 (20%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G GAFG V+ + +A+K L + K+F E +++ N++H ++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 56 IGCCVEDNNRILVYEYLENNSL------------ANALLGSKSKYVSLDWPTRANICLGT 103
G C + + I+V+EY+++ L + L +I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
ASG+ +L A VHRD+ N L+ N KIGDFG+++ +V G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHT 195
Query: 164 YL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVE 211
L PE + + T ++DV+SFGV+L EI + S +++ +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS------NTEVIECI- 248
Query: 212 WTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
+GR+LE P + P++ +VM C Q R +K++ ++L
Sbjct: 249 ------TQGRVLER--PRVC--PKEVYDVML------GCWQREPQQRLNIKEIYKIL 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-39
Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 25/214 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G F V L DG A+K + +Q +E E DM HPN+++L+ C+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 61 EDNNR----ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ L+ + + +L N + K K L + LG GL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA--------GTMGYLAPE 168
HRD+K +N+LL P + D G +V + T+ Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 169 ------YALLGQLTKKADVYSFGVLLLEIISGRS 196
+ ++ + + DV+S G +L ++ G
Sbjct: 214 LFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEG 244
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-39
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 2 IGGGAFGVVYRGSLRDG-TQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIG 57
+GGG +G VY G + +A+K L K+ T +EFL E ++ I+HPNLVQL+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + ++ E++ +L + L + VS + +S + +L ++
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEKKN--- 131
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL-----APEYALL 172
+HRD+ A N L+ N K+ DFGL++L + T A APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAY 186
Query: 173 GQLTKKADVYSFGVLLLEIIS 193
+ + K+DV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 81/321 (25%), Positives = 123/321 (38%), Gaps = 60/321 (18%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQ 54
+G GAFG VY G + Q+A+K L + + +FL E +I H N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSK---SKYVSLDWPTRANICLGTASGLSFLH 111
IG ++ R ++ E + L + L ++ S+ SL ++ A G +L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 112 EEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL--- 165
+ +HRDI A N LL KIGDFG+A+ ++ S G L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 166 --APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWKL 216
PE + G T K D +SFGVLL EI S +S+ ++L V
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFV------ 258
Query: 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKA 276
G ++ P+ P +M C Q RP ++E + E
Sbjct: 259 -TSGGRMDP--PKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERI-------EYC 302
Query: 277 LTEPGVYRGNTSYSLGASSSE 297
+P V G E
Sbjct: 303 TQDPDVINTALPIEYGPLVEE 323
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 79/321 (24%), Positives = 119/321 (37%), Gaps = 60/321 (18%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G GAFG VY G + Q+A+K L S+Q +FL E +I H N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRA---NICLGTASGLSFLH 111
IG ++ R ++ E + L + L ++ + ++ A G +L
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 112 EEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL--- 165
+ +HRDI A N LL KIGDFG+A+ ++ G L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 251
Query: 166 --APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWKL 216
PE + G T K D +SFGVLL EI S +S ++L V
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLEFV------ 299
Query: 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKA 276
G ++ P+ P +M C Q RP ++E + E
Sbjct: 300 -TSGGRMDP--PKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERI-------EYC 343
Query: 277 LTEPGVYRGNTSYSLGASSSE 297
+P V G E
Sbjct: 344 TQDPDVINTALPIEYGPLVEE 364
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 81/292 (27%), Positives = 121/292 (41%), Gaps = 53/292 (18%)
Query: 1 MIGGGAFGVVYRGSLRDG----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG VY G+L D A+K L+ +FLTE ++ + HPN++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 56 IGCCVEDNNRIL-VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+G C+ L V Y+++ L N + + L A G+ +L A
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYL---A 145
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL------APE 168
VHRD+ A N +LD F K+ DFGLA+ D V G A E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 169 YALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWKLREEGR 221
+ T K+DV+SFGVLL E+++ ++ D+ + + +GR
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYL-------LQGR 249
Query: 222 LLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
L PE P+ EVM L C A RP+ ++V +S
Sbjct: 250 RLLQ--PEYC--PDPLYEVM------LKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-38
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLI 56
+G G FG VY G + +A+K + K +F++E ++ N+ HP++V+LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G E+ I + E L + L +K+ L T L +++L
Sbjct: 80 GIIEEEPTWI-IMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLAPEYALLG 173
VHRDI N+L+ K+GDFGL++ D + + T +++PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINFR 189
Query: 174 QLTKKADVYSFGVLLLEIIS 193
+ T +DV+ F V + EI+S
Sbjct: 190 RFTTASDVWMFAVCMWEILS 209
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 66/204 (32%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G FG V G R G ++A+KC+ K + FL E ++ +RH NLVQL+G
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 60 VEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
VE+ + +V EY+ SL + L + L + +L
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLEGNN---F 138
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL-----APEYALLG 173
VHRD+ A NVL+ + K+ DFGL K G L APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREK 189
Query: 174 QLTKKADVYSFGVLLLEIIS-GRS 196
+ + K+DV+SFG+LL EI S GR
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 58/295 (19%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G FG V L+ ++A+K L + +EFL E + HP++ +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 56 IGCCVEDNNRI------LVYEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGL 107
+G + + ++ ++++ L LL S+ +L T + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL-- 165
+L + +HRD+ A N +L + + DFGL++ + G L
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPV 203
Query: 166 ---APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWK 215
A E T +DV++FGV + EI++ G ++ ++ +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------EIYNYL----- 252
Query: 216 LREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
G L+ P E+ ++M C A RP+ + L
Sbjct: 253 --IGGNRLKQ--PPEC--MEEVYDLMY------QCWSADPKQRPSFTCLRMELEN 295
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 79/283 (27%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 1 MIGGGAFGVVYRGSLRDG----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FGVVY G D Q AIK LS Q + FL E ++ + HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 56 IGCCVEDNNRIL-VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
IG + + Y+ + L + + + + L A G+ +L A
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL---A 141
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM---GYLAPEYAL 171
+ VHRD+ A N +LD +F K+ DFGLA+ D + + + A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 172 LGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230
+ T K+DV+SFGVLL E+++ G + D+ + +GR L PE
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQGRRLPQ--PEY 252
Query: 231 TQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
P+ +VM C +A RPT + +V + + V
Sbjct: 253 C--PDSLYQVM------QQCWEADPAVRPTFRVLVGEVEQIVS 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-38
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
++G G +G+VY G L + +IAIK + + ++ EI + +++H N+VQ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
E+ + E + SL+ LL SK + + T GL +LH+ IV
Sbjct: 89 SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 120 HRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL--T 176
HRDIK NVL++ + KI DFG +K T GT+ Y+APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 177 KKADVYSFGVLLLEIISGR 195
K AD++S G ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-38
Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 57/294 (19%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+G G FG V G+L+ ++A+K + + S++ +EFL+E + + HPN+++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 56 IGCCVEDNNRI-----LVYEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLS 108
+G C+E +++ ++ +++ L LL S+ + + T + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL--- 165
+L ++ +HRD+ A N +L + + DFGL+K + G + +
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMPVK 214
Query: 166 --APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWKL 216
A E T K+DV++FGV + EI + G + +M +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------EMYDYL------ 262
Query: 217 REEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
G L+ PE ++ E+M C + RPT + L K
Sbjct: 263 -LHGHRLKQ--PEDC--LDELYEIMY------SCWRTDPLDRPTFSVLRLQLEK 305
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-38
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQLI 56
IG G FG V++G +AIK + + +FL E + HP++V+LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G E+ I + E L + L K LD + ++ L++L +
Sbjct: 83 GVITENPVWI-IMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR-- 136
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL-----APEYAL 171
VHRDI A NVL+ N K+GDFGL++ D+ + +++ G L APE
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-----GKLPIKWMAPESIN 190
Query: 172 LGQLTKKADVYSFGVLLLEIIS 193
+ T +DV+ FGV + EI+
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLV 53
+G G F +++G R+ T++ +K L + ++ F M+ + H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
G CV + ILV E+++ SL L +K+ ++ + + A+ + FL EE
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL-EE 131
Query: 114 ADPPIVHRDIKASNVLLDGNFHP--------KIGDFGLAK-LFPDNVTHVSTRVAGTMGY 164
++H ++ A N+LL K+ D G++ + P ++ +
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------W 183
Query: 165 LAPEYALL--GQLTKKADVYSFGVLLLEIIS 193
+ PE + L D +SFG L EI S
Sbjct: 184 VPPE-CIENPKNLNLATDKWSFGTTLWEICS 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 75/339 (22%), Positives = 135/339 (39%), Gaps = 56/339 (16%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG S DG Q IK +S S + +E E+ ++ N++HPN+VQ
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVS----LDWPTRANICLGTASGLSFLHEE 113
E+ + +V +Y E L + K LDW ICL L +H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA----LKHVHDR 144
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE----- 168
I+HRDIK+ N+ L + ++GDFG+A++ V + GT YL+PE
Sbjct: 145 K---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 169 -YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAF-GDDMLILVEWTWKLREEGRLLEIV 226
Y K+D+++ G +L E+ + + AF M LV L+I+
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKH----AFEAGSMKNLV------------LKII 238
Query: 227 DPELTQFPE---KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM----LSKDVHLNEKALTE 279
++ + + RP++ ++E + L+ + + E
Sbjct: 239 SGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAE 295
Query: 280 PGVYRGNTSYSLGASSSETSSSQKHKGKRSVDHEVPTSA 318
+ + + ++ +S ++ ++ A
Sbjct: 296 EFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPA 334
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 71/278 (25%), Positives = 116/278 (41%), Gaps = 32/278 (11%)
Query: 2 IGGGAFGVVYRGSLRDG----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG G FG V++G +AIK S ++FL E + HP++V+LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G E+ I + E L + L K LD + ++ L++L +
Sbjct: 458 GVITENPVWI-IMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR-- 511
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
VHRDI A NVL+ N K+GDFGL++ D+ + +++ + ++APE + T
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 177 KKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235
+DV+ FGV + EI+ G + +D++ + E G L + P P
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGERLPM--PPNC--PP 619
Query: 236 K--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
+M C RP ++ LS +
Sbjct: 620 TLYSLM------TKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE---FLTEIDMIWNIRHPNLVQLI 56
IG G F VYR L DG +A+K + K + EID++ + HPN+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+EDN +V E + L+ + K + + T + S L +H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
++HRDIK +NV + K+GD GL + F T + V GT Y++PE
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 177 KKADVYSFGVLLLEIISGR 195
K+D++S G LL E+ + +
Sbjct: 215 FKSDIWSLGCLLYEMAALQ 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 82/291 (28%), Positives = 121/291 (41%), Gaps = 51/291 (17%)
Query: 1 MIGGGAFGVVYRGSLRDG----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG VY G+L D A+K L+ +FLTE ++ + HPN++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 56 IGCCVEDNNRIL-VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+G C+ L V Y+++ L N + + L A G+ FL A
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFL---A 209
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL-----APEY 169
VHRD+ A N +LD F K+ DFGLA+ D T L A E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALES 267
Query: 170 ALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILVEWTWKLREEGRL 222
+ T K+DV+SFGVLL E+++ ++ D+ + + +GR
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYL-------LQGRR 314
Query: 223 LEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
L PE P+ EVM L C A RP+ ++V +S
Sbjct: 315 LLQ--PEYC--PDPLYEVM------LKCWHPKAEMRPSFSELVSRISAIFS 355
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 63/298 (21%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G FG VY+G L +AIK L + +EF E + ++HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 55 LIGCCVEDNNRILVYEYLENNSL------------ANALLGSKSKYVSLDWPTRANICLG 102
L+G +D +++ Y + L + ++ +L+ P ++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 103 TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM 162
A+G+ +L + +VH+D+ NVL+ + KI D GL + V
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLGN 189
Query: 163 GYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLILV 210
L APE + G+ + +D++S+GV+L E+ S G S D++ ++
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDVVEMI 243
Query: 211 EWTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
++L P+ P +M + C RP K + L
Sbjct: 244 -------RNRQVLPC--PDDC--PAWVYALM------IECWNEFPSRRPRFKDIHSRL 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-37
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 15/220 (6%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG G++G + DG + K + ++ + ++E++++ ++HPN+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 58 CCVEDNNRIL--VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
++ N L V EY E LA+ + + LD + L H +D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 116 PP--IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
++HRD+K +NV LDG + K+GDFGLA++ + + T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE-QMNR 190
Query: 174 QL-TKKADVYSFGVLLLEIISGRSSSKAAF-GDDMLILVE 211
+K+D++S G LL E+ + F L
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP----PFTAFSQKELAG 226
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 76/323 (23%), Positives = 129/323 (39%), Gaps = 53/323 (16%)
Query: 2 IGGGAFGVVYRGSLRDG---TQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLI 56
IG G FG V + ++ AIK + SK ++F E++++ + HPN++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN------------ICLGTA 104
G C L EY + +L + L S+ + + A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY 164
G+ +L + +HRD+ A N+L+ N+ KI DFGL++ V TMG
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 202
Query: 165 L-----APEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLRE 218
L A E T +DV+S+GVLL EI+S G + ++ +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------P 255
Query: 219 EGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKA 276
+G LE P ++ ++MR C + + RP+ Q++ L + K
Sbjct: 256 QGYRLE--KPLNC--DDEVYDLMR------QCWREKPYERPSFAQILVSL-NRMLEERKT 304
Query: 277 LTEPGVYRGNTSYSLGASSSETS 299
+Y T + S+ E +
Sbjct: 305 YVNTTLYEKFTYAGIDCSAEEAA 327
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 70/308 (22%), Positives = 118/308 (38%), Gaps = 71/308 (23%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG GAFG V++ T +A+K L E S +F E ++ +PN+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN---------------- 98
L+G C L++EY+ L L V + +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 99 ----ICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154
I A+G+++L ++ VHRD+ N L+ N KI DFGL++ N+
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSA 227
Query: 155 STRVAGTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAF 202
A + PE + T ++DV+++GV+L EI S G +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------ 281
Query: 203 GDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMK 260
++++ V +G +L PE P + +MR C RP+
Sbjct: 282 HEEVIYYV-------RDGNILAC--PENC--PLELYNLMR------LCWSKLPADRPSFC 324
Query: 261 QVVEMLSK 268
+ +L +
Sbjct: 325 SIHRILQR 332
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
++G GAFG V + + D AIK + ++ L+E+ ++ ++ H +V+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 60 VEDNNRI-------------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASG 106
+E N + + EY EN +L + + S+ ++ +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEA 128
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS----------- 155
LS++H + I+HRD+K N+ +D + + KIGDFGLAK ++ +
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 156 --TRVAGTMGYLAPE-YALLGQLTKKADVYSFGVLLLEIISG 194
T GT Y+A E G +K D+YS G++ E+I
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 61/282 (21%), Positives = 107/282 (37%), Gaps = 46/282 (16%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNL--VQLI 56
IG G V++ AIK L Q + EI + ++ + ++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ D +V E N L + L K S+D R + + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR-VAGTMGYLAPE------- 168
IVH D+K +N L+ K+ DFG+A + T V GT+ Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 169 ----YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
+++ K+DV+S G +L + G K F + + +L
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYG----KTPFQQIINQIS----------KLHA 251
Query: 225 IVDPELT-QFPE---KEVMRFIKVGLFCTQAGAHYRPTMKQV 262
I+DP +FP+ K++ +K C + R ++ ++
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPEL 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 52/200 (26%), Positives = 78/200 (39%), Gaps = 14/200 (7%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLI 56
+G G++G V++ S DG A+K + L E+ + +HP V+L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
E L E SL ++ SL T L+ LH +
Sbjct: 124 QAWEEGGILYLQTELCGP-SLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
+VH D+K +N+ L K+GDFGL + G Y+APE L G
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYG 233
Query: 177 KKADVYSFGVLLLEIISGRS 196
ADV+S G+ +LE+
Sbjct: 234 TAADVFSLGLTILEVACNME 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 76/304 (25%), Positives = 127/304 (41%), Gaps = 54/304 (17%)
Query: 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPN 51
+G GAFG V +A+K L + +++ + ++E++M+ I +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN------------I 99
++ L+G C +D ++ EY +L L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G+ +L A +HRD+ A NVL+ N KI DFGLA+ ++ ++
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKK 215
Query: 160 GTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWT 213
T G L APE T ++DV+SFGVL+ EI + G S +++ L+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 272
Query: 214 WKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
+EG ++ P + +MR C A RPT KQ+VE L + +
Sbjct: 273 ----KEGHRMDK--PANC--TNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 272 LNEK 275
L
Sbjct: 319 LTTN 322
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 54/304 (17%)
Query: 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPN 51
+G G FG V +A+K L + +++ + ++E++M+ I +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN------------I 99
++ L+G C +D ++ EY +L L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G+ +L A +HRD+ A NVL+ N KI DFGLA+ ++ ++
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKK 261
Query: 160 GTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWT 213
T G L APE T ++DV+SFGVL+ EI + G S +++ L+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 318
Query: 214 WKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
+EG ++ P + +MR C A RPT KQ+VE L + +
Sbjct: 319 ----KEGHRMDK--PANC--TNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 272 LNEK 275
L
Sbjct: 365 LTTN 368
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 61/282 (21%), Positives = 108/282 (38%), Gaps = 46/282 (16%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNL--VQLI 56
IG G V++ AIK L Q + EI + ++ + ++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ D +V E N L + L K S+D R + + +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 128
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR-VAGTMGYLAPE------- 168
IVH D+K +N L+ + K+ DFG+A + T V GT+ Y+ PE
Sbjct: 129 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 169 ----YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
+++ K+DV+S G +L + G K F + + +L
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYG----KTPFQQIINQIS----------KLHA 232
Query: 225 IVDPELT-QFPE---KEVMRFIKVGLFCTQAGAHYRPTMKQV 262
I+DP +FP+ K++ +K C + R ++ ++
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPEL 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 18/201 (8%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G+FG V+R + G Q A+K + E + + E+ + P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
E + E LE SL + + L GL +LH I+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 120 HRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTR----VAGTMGYLAPEYALLGQ 174
H D+KA NVLL + + DFG A + S + GT ++APE +
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 175 LTKKADVYSFGVLLLEIISGR 195
K D++S ++L +++G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 72/309 (23%), Positives = 118/309 (38%), Gaps = 64/309 (20%)
Query: 2 IGGGAFGVVYRGSLRD------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLV 53
+G GAFG V +A+K L + + ++E+ ++ +I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 54 QLIGCCVEDNNRILV-YEYLENNSLANALLGSKSKYVSLDWPTRAN------------IC 100
L+G C + ++V E+ + +L+ L ++++V
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 101 LGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160
A G+ FL A +HRD+ A N+LL KI DFGLA+ ++ V
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRK 207
Query: 161 TMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDMLI 208
L APE T ++DV+SFGVLL EI S G ++
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCR 262
Query: 209 LVEWTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
+ +EG + P+ T + + M C RPT ++VE L
Sbjct: 263 RL-------KEGTRMRA--PDYT--TPEMYQTML------DCWHGEPSQRPTFSELVEHL 305
Query: 267 SKDVHLNEK 275
+ N +
Sbjct: 306 GNLLQANAQ 314
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 71/308 (23%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G FG V + + T +A+K L S ++ L+E +++ + HP++++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 55 LIGCCVEDNNRILVYEYLENNSLANAL------------LGSKSKYVSLDWPTRANICLG 102
L G C +D +L+ EY + SL L G SLD P + +G
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 103 T--------ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154
+ G+ +L A+ +VHRD+ A N+L+ KI DFGL++ +V
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEE 203
Query: 155 STRVAGTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAF 202
+ V + G + A E T ++DV+SFGVLL EI++ G
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP------ 257
Query: 203 GDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMK 260
+ + L+ + G +E P+ E+ +M C + RP
Sbjct: 258 PERLFNLL-------KTGHRMER--PDNC--SEEMYRLML------QCWKQEPDKRPVFA 300
Query: 261 QVVEMLSK 268
+ + L K
Sbjct: 301 DISKDLEK 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-35
Identities = 73/304 (24%), Positives = 121/304 (39%), Gaps = 57/304 (18%)
Query: 2 IGGGAFGVVYRGSLRD------GTQIAIKCLSAESKQGT-----KEFLTEIDMIWNI-RH 49
+G GAFG V + ++A+K L K + ++E+ ++ ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMSELKIMSHLGQH 109
Query: 50 PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN----------I 99
N+V L+G C +++ EY L N L + AN
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G++FL A +HRD+ A NVLL KIGDFGLA+ ++ + S +
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIV 222
Query: 160 GTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWT 213
L APE T ++DV+S+G+LL EI S G + +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY----- 277
Query: 214 WKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
KL ++G + P P+ +M+ C +RPT +Q+ L +
Sbjct: 278 -KLVKDGYQMAQ--PAFA--PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQEQAQ 326
Query: 272 LNEK 275
+ +
Sbjct: 327 EDRR 330
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 60/282 (21%), Positives = 107/282 (37%), Gaps = 46/282 (16%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNL--VQLI 56
IG G V++ AIK L Q + EI + ++ + ++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ D +V E N L + L K S+D R + + +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR-VAGTMGYLAPE------- 168
IVH D+K +N L+ + K+ DFG+A + T V G + Y+ PE
Sbjct: 176 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 169 ----YALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224
+++ K+DV+S G +L + G K F + + +L
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYG----KTPFQQIINQIS----------KLHA 279
Query: 225 IVDPELT-QFPE---KEVMRFIKVGLFCTQAGAHYRPTMKQV 262
I+DP +FP+ K++ +K C + R ++ ++
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPEL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 82/327 (25%), Positives = 139/327 (42%), Gaps = 56/327 (17%)
Query: 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPN 51
+G GAFG V T++A+K L ++ +++ + ++E++M+ I +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN------------I 99
++ L+G C +D ++ EY +L L + + + N
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G+ +L A +HRD+ A NVL+ + KI DFGLA+ ++ H+
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 249
Query: 160 GTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWT 213
T G L APE T ++DV+SFGVLL EI + G S +++ L+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 306
Query: 214 WKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
+EG ++ P + +MR C A RPT KQ+VE L +
Sbjct: 307 ----KEGHRMDK--PSNC--TNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRI-- 350
Query: 272 LNEKALTEPGVYRGNTSYSLGASSSET 298
+ + E G Y + + ++E
Sbjct: 351 VALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 61/289 (21%), Positives = 103/289 (35%), Gaps = 54/289 (18%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIG 57
IG G FG V++ DG AIK + L E+ + +H ++V+
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
ED++ ++ EY SLA+A+ + ++ L GL ++H +
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--- 135
Query: 118 IVHRDIKASNVLLDGNFHP-------------------KIGDFGLAKLFPDNVTHVSTRV 158
+VH DIK SN+ + P KIGD G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---- 191
Query: 159 AGTMGYLAPEYALLGQL---TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK 215
G +LA E +L + KAD+++ + ++ + GD +
Sbjct: 192 -GDSRFLANE--VLQENYTHLPKADIFALALTVVCAAGAEPLPRN--GDQWHEIR----- 241
Query: 216 LREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
+GRL P + Q +E +KV RP+ +V+
Sbjct: 242 ---QGRL-----PRIPQVLSQEFTELLKV---MIHPDPERRPSAMALVK 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 45/219 (20%), Positives = 86/219 (39%), Gaps = 33/219 (15%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLT-----------------EIDMI 44
+ G F + +D A+K + ++F E+ +I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 45 WNIRHPNLVQLIGCCVEDNNRI-LVYEYLEN----NSLANALLGSKSKYVSLDWPTRANI 99
+I++ + G + + + + ++YEY+EN + K+ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
+ S++H E + I HRD+K SN+L+D N K+ DFG ++ D S
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 160 GTMGYLAPEYALLGQLT---KKADVYSFGVLLLEIISGR 195
GT ++ PE + + K D++S G+ L +
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 70/306 (22%), Positives = 118/306 (38%), Gaps = 65/306 (21%)
Query: 2 IGGGAFGVVYRGSLRD------GTQIAIKCLSAESKQGTK-EFLTEIDMIWNI-RHPNLV 53
+G GAFG V + +A+K L + + ++E+ ++ + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN--------------I 99
L+G C +++ EY L N L + ++
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159
A G++FL A +HRD+ A N+LL KI DFGLA+ ++ + S V
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVV 203
Query: 160 GTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAFGDDML 207
L APE T ++DV+S+G+ L E+ S G
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-----DSKFY 258
Query: 208 ILVEWTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265
++ +EG + PE P + ++M+ C A RPT KQ+V++
Sbjct: 259 KMI-------KEGFRMLS--PEHA--PAEMYDIMK------TCWDADPLKRPTFKQIVQL 301
Query: 266 LSKDVH 271
+ K +
Sbjct: 302 IEKQIS 307
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG GA G VY + G ++AI+ ++ + + + + EI ++ ++PN+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V EYL SL + + +D A +C L FLH ++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ N+LL + K+ DFG + ST V GT ++APE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 181 VYSFGVLLLEIISG 194
++S G++ +E+I G
Sbjct: 199 IWSLGIMAIEMIEG 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGC 58
++G GA V+RG + G AIK + S + E +++ + H N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 59 CVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
E R +L+ E+ SL L S L + G++ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 117 PIVHRDIKASNVLL----DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE---- 168
IVHR+IK N++ DG K+ DFG A+ D+ + GT YL P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYER 189
Query: 169 ----YALLGQLTKKADVYSFGVLLLEIISGR 195
+ D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFG VY+ + G A K + +S++ ++++ EI+++ HP +V+L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
D ++ E+ ++ +L L P +C L+FLH + I+H
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKR---IIH 140
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK--- 177
RD+KA NVL+ ++ DFG++ + + + GT ++APE + +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199
Query: 178 --KADVYSFGVLLLEIISG 194
KAD++S G+ L+E+
Sbjct: 200 DYKADIWSLGITLIEMAQI 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 49/227 (21%), Positives = 90/227 (39%), Gaps = 35/227 (15%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+IG G FG V++ DG IK K ++ E+ + + H N+V GC
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIK----RVKYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 60 VEDNNRI----------------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT 103
+ + E+ + +L + + + + +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--LALELFEQI 131
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
G+ ++H + +++RD+K SN+ L KIGDFGL ++ TR GT+
Sbjct: 132 TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLR 186
Query: 164 YLAPEYALLGQL--TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI 208
Y++PE + K+ D+Y+ G++L E++ AF
Sbjct: 187 YMSPE--QISSQDYGKEVDLYALGLILAELLHV---CDTAFETSKFF 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 75/315 (23%), Positives = 115/315 (36%), Gaps = 70/315 (22%)
Query: 2 IGGGAFGVVYRGSLRDG------TQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLV 53
+G GAFG V + Q+A+K L + + ++E+ M+ + H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT---------- 103
L+G C L++EY L N L + K+ + L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 104 ---------ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154
A G+ FL VHRD+ A NVL+ KI DFGLA+ ++
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSD 225
Query: 155 STRVAGTMGYL-----APEYALLGQLTKKADVYSFGVLLLEIIS-------GRSSSKAAF 202
S V L APE G T K+DV+S+G+LL EI S G +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 203 GDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMK 260
KL + G ++ P E+ +M+ C + RP+
Sbjct: 286 ------------KLIQNGFKMDQ--PFYA--TEEIYIIMQ------SCWAFDSRKRPSFP 323
Query: 261 QVVEMLSKDVHLNEK 275
+ L + E+
Sbjct: 324 NLTSFLGCQLADAEE 338
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 47/194 (24%), Positives = 95/194 (48%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G+ G+V G Q+A+K + +Q + E+ ++ + +H N+V++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++ E+L+ +L + + V L+ A +C L++LH + ++H
Sbjct: 113 VGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ ++LL + K+ DFG +V + V GT ++APE + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVD 223
Query: 181 VYSFGVLLLEIISG 194
++S G++++E++ G
Sbjct: 224 IWSLGIMVIEMVDG 237
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGCC 59
IG G+FG V++G R +AIK + E + E + EI ++ P + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
++D ++ EYL S + L + LD A I GL +LH E +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSEK---KI 141
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRDIKA+NVLL + K+ DFG+A D +T V GT ++APE KA
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 200
Query: 180 DVYSFGVLLLEIISG 194
D++S G+ +E+ G
Sbjct: 201 DIWSLGITAIELARG 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 21/204 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEID-MIWNIRHPNLVQLIGCCV 60
+G GA G + + D +A+K + + E+ + + HPN+++
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ + + E +L + ++ L+ + T SGL+ LH IVH
Sbjct: 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN---IVH 141
Query: 121 RDIKASNVLL-----DGNFHPKIGDFGLAKLFPDNVTHVSTR--VAGTMGYLAPEY---A 170
RD+K N+L+ G I DFGL K S R V GT G++APE
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 171 LLGQLTKKADVYSFGVLLLEIISG 194
T D++S G + +IS
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGC 58
++G GA V+RG + G AIK + S + E +++ + H N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 59 CVEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
E R +L+ E+ SL L S L + G++ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 117 PIVHRDIKASNVLL----DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE---- 168
IVHR+IK N++ DG K+ DFG A+ D+ + GT YL P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYER 189
Query: 169 ----YALLGQLTKKADVYSFGVLLLEIISGR 195
+ D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 63/208 (30%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGC 58
+G G FG V R +D G Q+AIK E +E EI ++ + HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 79
Query: 59 CVEDNNRI-------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
+ ++ L EY E L L L + +S L +LH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 112 EEADPPIVHRDIKASNVLLDGNFHP---KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE 168
E I+HRD+K N++L KI D G AK + V GT+ YLAPE
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPE 193
Query: 169 YALLGQL-TKKADVYSFGVLLLEIISGR 195
L + T D +SFG L E I+G
Sbjct: 194 -LLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 65/310 (20%), Positives = 117/310 (37%), Gaps = 57/310 (18%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIGC 58
+G G FGVV+ + D AIK + +++ +E + E+ + + HP +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 59 CVEDNN---------RILVY---EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASG 106
+E N ++ +Y + +L + + G + + +I L A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHIFLQIAEA 130
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-----------PDNVTHVS 155
+ FLH + ++HRD+K SN+ + K+GDFGL P
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 156 TRVAGTMGYLAPEYALLGQLTK-----KADVYSFGVLLLEIISGRSSSKAAFGDDMLILV 210
T GT Y++PE Q+ K D++S G++L E++ F M +
Sbjct: 188 TGQVGTKLYMSPE-----QIHGNSYSHKVDIFSLGLILFELLY-------PFSTQMERVR 235
Query: 211 EWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM-LSKD 269
T +R P TQ E ++ RP ++E + +D
Sbjct: 236 TLT-DVRN-----LKFPPLFTQKYPCEY-VMVQD---MLSPSPMERPEAINIIENAVFED 285
Query: 270 VHLNEKALTE 279
+ K +
Sbjct: 286 LDFPGKTVLR 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G++G VY+ G +AIK + ES +E + EI ++ P++V+ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++ + +V EY S+++ + + + +L A I T GL +LH +H
Sbjct: 95 KNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIH 148
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIKA N+LL+ H K+ DFG+A D + +T + GT ++APE AD
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVAD 207
Query: 181 VYSFGVLLLEIISG 194
++S G+ +E+ G
Sbjct: 208 IWSLGITAIEMAEG 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE--SKQGTKE-FLTEIDMIWNIRHPNLVQLIG 57
+G G FG VY + +A+K L K G + E+++ ++RHPN+++L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 58 CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
D R+ L+ EY ++ L K D A A+ LS+ H +
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
++HRDIK N+LL KI DFG + P + + GT+ YL PE
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMHD 185
Query: 177 KKADVYSFGVLLLEIISGR 195
+K D++S GVL E + G+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE--SKQGTKEFL-TEIDMIWNIRHPNLVQLIG 57
+G G FG VY ++ +A+K L K+G + L EI++ ++RHPN++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 58 CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
D RI L+ E+ L L K+ D A A L + HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
++HRDIK N+L+ KI DFG + P GT+ YL PE + G+
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPE-MIEGKTH 189
Query: 176 TKKADVYSFGVLLLEIISGR 195
+K D++ GVL E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-31
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFL-TEIDMIWNIRHPNLVQLIGCC 59
IG GA VV ++AIK ++ E Q + + L EI + HPN+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVS----LDWPTRANICLGTASGLSFLHEEAD 115
V + LV + L S+ + + +K LD T A I GL +LH+
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTM-G---YLAPEYAL 171
+HRD+KA N+LL + +I DFG++ +V T G ++APE +
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE--V 197
Query: 172 LGQLT---KKADVYSFGVLLLEIISGR 195
+ Q+ KAD++SFG+ +E+ +G
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 41/209 (19%), Positives = 75/209 (35%), Gaps = 22/209 (10%)
Query: 2 IGGGA--FGVVYRG-SLRDGTQIAIKC--LSAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG G V G + ++ L A S + E+ + HPN+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ DN +V ++ S + + ++ A I G L ++H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHMG-- 148
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR------VAGTMGYLAPEYA 170
VHR +KAS++L+ + + + + +L+PE
Sbjct: 149 -YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-- 205
Query: 171 LLGQLTK----KADVYSFGVLLLEIISGR 195
+L Q + K+D+YS G+ E+ +G
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 49/220 (22%), Positives = 80/220 (36%), Gaps = 34/220 (15%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEID-MIWNIRHPNLVQLIGCCV 60
+G G+ G V G +A+K + L EI + + HPN+++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 61 EDNNRILVYEYLENNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPP 117
D + E +L + + ++ ASG++ LH
Sbjct: 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 118 IVHRDIKASNVLLD-------------GNFHPKIGDFGLAKLFPDNVTHVSTR---VAGT 161
I+HRD+K N+L+ N I DFGL K + T +GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 162 MGYLAPE-------YALLGQLTKKADVYSFGVLLLEIISG 194
G+ APE +LT+ D++S G + I+S
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCC 59
+G G +G VY+G ++ G AIK + +E EI+M+ H N+ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 60 VEDNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
++ N LV E+ S+ + + +K + +W A IC GLS LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQH 148
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
++HRDIK NVLL N K+ DFG++ V +T GT ++APE
Sbjct: 149 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 204
Query: 174 QLTK-----KADVYSFGVLLLEIISG 194
+ K+D++S G+ +E+ G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G GVV++ S + G +A K + E K + + E+ ++ P +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
D + E+++ SL L + + + + GL++L E+ I+
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK--IM 154
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K SN+L++ K+ DFG++ D++ + + V GT Y++PE + ++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYSVQS 211
Query: 180 DVYSFGVLLLEIISGR 195
D++S G+ L+E+ GR
Sbjct: 212 DIWSMGLSLVEMAVGR 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-30
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAES--KQGTKE-FLTEIDMIWNIRHPNLVQLIG 57
+G G+F VYR S+ G ++AIK + ++ K G + E+ + ++HP++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 58 CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
ED+N + LV E N + L K++ + +G+ +LH
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
I+HRD+ SN+LL N + KI DFGLA T + GT Y++PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATRSAH 189
Query: 176 TKKADVYSFGVLLLEIISGR 195
++DV+S G + ++ GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+GGG VY ++AIK + E ++ K F E+ + H N+V +I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
ED+ LV EY+E +L+ + + L T N G+ H+
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VTHVSTRVAGTMGYLAPEYALLGQLT 176
IVHRDIK N+L+D N KI DFG+AK + +T + V GT+ Y +PE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATD 190
Query: 177 KKADVYSFGVLLLEIISGR 195
+ D+YS G++L E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 20/203 (9%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAES--KQGTKE-FLTEIDMIWNIRHPNLVQLI 56
+G G F + A K + K +E EI + ++ H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G EDN+ + +V E SL K+ L P G +LH
Sbjct: 108 GF-FEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRNR- 161
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF--PDNVTHVSTRVAGTMGYLAPEYALLG 173
++HRD+K N+ L+ + KIGDFGLA V GT Y+APE L
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPE-VLSK 215
Query: 174 QL-TKKADVYSFGVLLLEIISGR 195
+ + + DV+S G ++ ++ G+
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 48/219 (21%), Positives = 81/219 (36%), Gaps = 25/219 (11%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGC 58
++ G F VY + G + A+K L + ++ + + E+ + + HPN+VQ
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 59 CVEDNNR-------ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
L+ L L L +S+ L T I T + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMH 153
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA-----------G 160
PPI+HRD+K N+LL K+ DFG A + +
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 161 TMGYLAPEYALLGQ---LTKKADVYSFGVLLLEIISGRS 196
T Y PE L + +K D+++ G +L + +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAES--KQGTKE-FLTEIDMIWNIRHPNLVQLI 56
+G G F + A K + K +E EI + ++ H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G EDN+ + +V E SL K+ L P G +LH
Sbjct: 82 GF-FEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRNR- 135
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
++HRD+K N+ L+ + KIGDFGLA + + GT Y+APE L +
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSKKG 191
Query: 176 -TKKADVYSFGVLLLEIISGR 195
+ + DV+S G ++ ++ G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 12/201 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWN-IRHPNLVQLIGC 58
+G GA+GVV + G +A+K + A Q K L ++D+ + P V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ + + E + + SL K ++ I + L LH + +
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE----YALLGQ 174
+HRD+K SNVL++ K+ DFG++ D+V AG Y+APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPERINPELNQKG 189
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+ K+D++S G+ ++E+ R
Sbjct: 190 YSVKSDIWSLGITMIELAILR 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 38/217 (17%), Positives = 72/217 (33%), Gaps = 28/217 (12%)
Query: 1 MIGGGAFGVVYRGSLRD------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAF VY + D + +K + ++ + ++
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 55 LIGCCVEDNNRILVYEYLENNSLANAL-LGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
+ N +LV E +L NA+ L + + + + + +H+
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 114 ADPPIVHRDIKASNVLL-----------DGNFHPKIGDFGLA---KLFPDNVTHVSTRVA 159
I+H DIK N +L D + + D G + KLFP T
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI--FTAKC 246
Query: 160 GTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGR 195
T G+ E L + + D + + ++ G
Sbjct: 247 ETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 55/192 (28%), Positives = 100/192 (52%), Gaps = 11/192 (5%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+G GAFG V+ R G + IK ++ S+ ++ EI+++ ++ HPN++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ +N +V E E L ++ ++++ +L A + + L++ H + +V
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 120 HRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
H+D+K N+L + KI DFGLA+LF + ST AGT Y+APE +T
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE-VFKRDVT 203
Query: 177 KKADVYSFGVLL 188
K D++S GV++
Sbjct: 204 FKCDIWSAGVVM 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY +R+ +AIK +S +S + ++ + E+ + +RHPN +Q G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + ++ LV EY S ++ L K L A + G GL++LH
Sbjct: 122 CYLREHTAWLVMEYCLG-SASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR--VAGTMGYLAPEYALLGQL 175
++HRD+KA N+LL K+GDFG A + ++ GT ++APE L
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWMAPEVILAMDE 227
Query: 176 T---KKADVYSFGVLLLEIISG 194
K DV+S G+ +E+
Sbjct: 228 GQYDGKVDVWSLGITCIELAER 249
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G+FG V + G + A+K +S + K + L E+ ++ + HPN+++L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+ LV E L + ++ S+ ++ +D A I SG++++H+
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVD---AARIIRQVLSGITYMHKNK--- 146
Query: 118 IVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
IVHRD+K N+LL + + +I DFGL+ F + GT Y+APE L G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLHGT 203
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+K DV+S GV+L ++SG
Sbjct: 204 YDEKCDVWSTGVILYILLSGC 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V + + AIK + ++ S + L E+ ++ + HPN+++L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ N LV E + L + ++ + K+ +D A I SG+++LH+ I
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEII-HRMKFNEVD---AAVIIKQVLSGVTYLHKHN---I 157
Query: 119 VHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHRD+K N+LL + + KI DFGL+ +F + GT Y+APE L +
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKY 214
Query: 176 TKKADVYSFGVLLLEIISGR 195
+K DV+S GV+L +++G
Sbjct: 215 DEKCDVWSIGVILFILLAGY 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESK-QGTKEFLTEIDMIW-NIRHPNLVQLIGC 58
IG GA+G V + G +A+K + + + K+ L ++D++ + P +VQ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVS-LDWPTRANICLGTASGLSFLHEEADPP 117
+ + + E + + S S + I L T L+ L E
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE----YALLG 173
I+HRDIK SN+LLD + + K+ DFG++ D++ TR AG Y+APE A
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQ 204
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
++DV+S G+ L E+ +GR
Sbjct: 205 GYDVRSDVWSLGITLYELATGR 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 19/203 (9%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAE--SKQGTKE-FLTEIDMIWNIRHPNLVQL- 55
++G G G VY +A+K +S S + E ++ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 56 -IGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
G E + ++ + + LA L + L P I S L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VTHVSTRVAGTMGYLAPEYALL 172
HRD+K N+L+ + + DFG+A D +T + GT+ Y+APE
Sbjct: 154 G---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSE 209
Query: 173 GQLTKKADVYSFGVLLLEIISGR 195
T +AD+Y+ +L E ++G
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G++G V + + A K + + F EI+++ ++ HPN+++L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++ + LV E L ++ K + D A I S +++ H+ + H
Sbjct: 77 DNTDIYLVMELCTGGELFERVV-HKRVFRESD---AARIMKDVLSAVAYCHKLN---VAH 129
Query: 121 RDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
RD+K N L + K+ DFGLA F + GT Y++P+ L G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-VLEGLYGP 186
Query: 178 KADVYSFGVLL 188
+ D +S GV++
Sbjct: 187 ECDEWSAGVMM 197
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 45/204 (22%), Positives = 73/204 (35%), Gaps = 26/204 (12%)
Query: 1 MIGGGAFGVVYRGS-LR-DGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIG 57
I G G +Y +G + +K L + + E + + HP++VQ+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 58 CCVEDNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
VE +R +V EY+ SL + L L LS+LH
Sbjct: 147 F-VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH 199
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
+V+ D+K N++L K+ D G + + GT G+ APE
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEIV- 249
Query: 172 LGQLTKKADVYSFGVLLLEIISGR 195
T D+Y+ G L +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESK-QGTKEFLTEIDMIWN-IRHPNLVQLIGC 58
+G G G V++ + G IA+K + + K L ++D++ P +VQ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ + + + E + + + + + L +L E+ +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGP----IPERILGKMTVAIVKALYYLKEKHG--V 146
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE-----YALLG 173
+HRD+K SN+LLD K+ DFG++ D+ R AG Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKP 204
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
+ADV+S G+ L+E+ +G+
Sbjct: 205 DYDIRADVWSLGISLVELATGQ 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 14/191 (7%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAF V+ R G A+KC+ EI ++ I+H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ LV + + L + +L + Y D + + S + +LHE IVH
Sbjct: 77 STTHYYLVMQLVSGGELFDRIL-ERGVYTEKD---ASLVIQQVLSAVKYLHENG---IVH 129
Query: 121 RDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
RD+K N+L + N I DFGL+K+ + + + GT GY+APE +K
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQKPYSK 186
Query: 178 KADVYSFGVLL 188
D +S GV+
Sbjct: 187 AVDCWSIGVIT 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-28
Identities = 30/234 (12%), Positives = 67/234 (28%), Gaps = 41/234 (17%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE----------------------- 36
++G G + + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 37 -----FLTEIDMIWNIRHPNLVQLIGCCVEDN--NRILVYEYLENN--SLANALLGSKSK 87
F+ D++ + + ++++ + +R +Y +++N + LL S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 88 YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147
+ SL R + L L+ LH +VH ++ +++LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 148 PDNVTHVSTRVAGTMGYLAPEYALLGQ-----LTKKADVYSFGVLLLEIISGRS 196
+ R A GQ +T D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLS-------------AESKQGTKEFLTEIDMIWNI 47
+G GA+G V + ++ AIK + ++ +E EI ++ ++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 48 RHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGL 107
HPN+++L + LV E+ E L ++ ++ K+ D ANI SG+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDECD---AANIMKQILSGI 159
Query: 108 SFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY 164
+LH+ IVHRDIK N+LL + + KI DFGL+ F + + GT Y
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYY 214
Query: 165 LAPEYALLGQLTKKADVYSFGVLLLEIISGR 195
+APE L + +K DV+S GV++ ++ G
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G G+FG V + R + A+K + ++ + T L E++++ + HPN+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ ++ +V E L + ++ + ++ D A I SG++++H+ I
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEII-KRKRFSEHD---AARIIKQVFSGITYMHKHN---I 142
Query: 119 VHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHRD+K N+LL + + KI DFGL+ F N GT Y+APE L G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE-VLRGTY 199
Query: 176 TKKADVYSFGVLLLEIISGR 195
+K DV+S GV+L ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSGT 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKC-----LSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
IG G F VV R R+ G Q A+K ++ T++ E + ++HP++V+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+ D +V+E+++ L ++ ++ L + H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 116 PPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
I+HRD+K VLL + + K+G FG+A ++ RV GT ++APE
Sbjct: 151 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207
Query: 173 GQLTKKADVYSFGVLL 188
K DV+ GV+L
Sbjct: 208 EPYGKPVDVWGCGVIL 223
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 32/239 (13%), Positives = 72/239 (30%), Gaps = 52/239 (21%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE----------------------- 36
++G G + + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 37 -----FLTEIDMIWNIRHPNLVQLIGCCVEDN--NRILVYEYLENN--SLANALLGSKSK 87
F+ D++ + + ++++ + +R +Y +++N + LL S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 88 YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147
+ SL R + L L+ LH +VH ++ +++LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 148 PDNVTHVSTRVAGTMGYLAPEYALL-----------GQLTKKADVYSFGVLLLEIISGR 195
D VS+ + G+ PE +T D ++ G+++ I
Sbjct: 255 RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 16/193 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G G+FG V + R + A+K + ++ + T L E++++ + HPN+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ ++ +V E L + ++ + ++ D A I SG++++H+ I
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEII-KRKRFSEHD---AARIIKQVFSGITYMHKHN---I 142
Query: 119 VHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHRD+K N+LL + + KI DFGL+ F N GT Y+APE L G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE-VLRGTY 199
Query: 176 TKKADVYSFGVLL 188
+K DV+S GV+L
Sbjct: 200 DEKCDVWSAGVIL 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 20/229 (8%), Positives = 50/229 (21%), Gaps = 41/229 (17%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCL---SAESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+ G VV+ + A+K + S+ + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 57 GCC--------------------------VEDNNRILVYEYLENN--SLANALLGSKSKY 88
N +L+ + L + L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 89 VSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148
+ + L + +VH N+ + + +GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 149 DNVTHVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
+ + Y E+ T + + G+ + +
Sbjct: 246 TR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQL- 55
++G G V+ LRD +A+K L A F E + HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 56 -IGCCVEDNNRI--LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
G + +V EY++ +L + + + + L+F H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV--STRVAGTMGYLAPEYA 170
I+HRD+K +N+++ K+ DFG+A+ D+ V + V GT YL+PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 171 LLGQLTKKADVYSFGVLLLEIISGR 195
+ ++DVYS G +L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 25/202 (12%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLS--------AESKQGTKEFLTEIDMIWNIRHPNL 52
+G GA G V R ++AI+ +S A TEI+++ + HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
+++ + + +V E +E L + ++ + + +LHE
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVV-GNKRLKEAT---CKLYFYQMLLAVQYLHE 257
Query: 113 EADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE- 168
I+HRD+K NVLL + + KI DFG +K+ + + + GT YLAPE
Sbjct: 258 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEV 312
Query: 169 --YALLGQLTKKADVYSFGVLL 188
+ D +S GV+L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 11/198 (5%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFGVV+R + R G A K + + + EI + +RHP LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+DN +++YE++ L + +K + GL +HE VH
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDE---AVEYMRQVCKGLCHMHENN---YVH 278
Query: 121 RDIKASNVLLDGNFHP--KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
D+K N++ K+ DFGL GT + APE A +
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 179 ADVYSFGVLLLEIISGRS 196
D++S GVL ++SG S
Sbjct: 337 TDMWSVGVLSYILLSGLS 354
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GAF VV R + G + A K + S + ++ E + ++HPN+V+L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E++ LV++ + L ++ ++ Y D ++ +++ H I
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIV-AREFYSEAD---ASHCIQQILESIAYCHSNG---I 126
Query: 119 VHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHR++K N+LL K+ DFGLA D+ AGT GYL+PE L
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLKKDP 183
Query: 176 -TKKADVYSFGVLL 188
+K D+++ GV+L
Sbjct: 184 YSKPVDIWACGVIL 197
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V+ ++ ++ A K L+ + ++G + + E ++ + +V L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWP-TR---ANICLGTASGLSFLH 111
E + LV + + + P A I G L LH
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLH 306
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
+ I++RD+K NVLLD + + +I D GLA T GT G++APE L
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE-LL 361
Query: 172 LGQL-TKKADVYSFGVLLLEIISGRS 196
LG+ D ++ GV L E+I+ R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 11/190 (5%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+GGG FG V++ G ++A K + + +E EI ++ + H NL+QL
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
N+ +LV EY++ L + ++ LD G+ +H+ I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQMY---ILH 210
Query: 121 RDIKASNVLL--DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
D+K N+L KI DFGLA+ + + GT +LAPE ++
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVVNYDFVSFP 268
Query: 179 ADVYSFGVLL 188
D++S GV+
Sbjct: 269 TDMWSVGVIA 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 48/190 (25%), Positives = 75/190 (39%), Gaps = 11/190 (5%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFGVV+R + G K ++ EI ++ + HP L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +L+ E+L L + + K + N GL +HE + IVH
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEHS---IVH 172
Query: 121 RDIKASNVLL--DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
DIK N++ KI DFGLA + + T + APE +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 179 ADVYSFGVLL 188
D+++ GVL
Sbjct: 231 TDMWAIGVLG 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLS---------AESKQGTKEFLTEIDMIWNI-RHP 50
+G G VV R + + A+K + E ++ + L E+D++ + HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
N++QL + LV++ ++ L + L K + I + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKE---TRKIMRALLEVICAL 140
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE-- 168
H+ IVHRD+K N+LLD + + K+ DFG + V GT YLAPE
Sbjct: 141 HKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEII 195
Query: 169 ----YALLGQLTKKADVYSFGVLL 188
K+ D++S GV++
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLS--------AESKQGTKEFLTEIDMIWNIRHPNL 52
+G GA G V R ++AIK +S A TEI+++ + HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
+++ + + +V E +E L + ++ + + +LHE
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVV-GNKRLKEAT---CKLYFYQMLLAVQYLHE 132
Query: 113 EADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
I+HRD+K NVLL + + KI DFG +K+ + + + GT YLAPE
Sbjct: 133 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPE- 186
Query: 170 ALLGQL----TKKADVYSFGVLL 188
L+ + D +S GV+L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQG---TKEFLTEIDMIWNIRHPNLVQLIG 57
+G G + VY+G + G +A+K + +S++G T + EI ++ ++H N+V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELKHENIVRLYD 70
Query: 58 CCVEDNNRILVYEYLENNSLANAL--LGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+N LV+E+++N+ L + + L+ GL+F HE
Sbjct: 71 VIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-- 173
I+HRD+K N+L++ K+GDFGLA+ F V S+ V T+ Y AP+ L+G
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD-VLMGSR 184
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
+ D++S G +L E+I+G+
Sbjct: 185 TYSTSIDIWSCGCILAEMITGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK--CLSAESKQGTKEF-LTEIDMIWNIRHPNLVQLIG 57
+G G++G+V + + G +AIK S + + K+ + EI ++ +RH NLV L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + LV+E++++ + + L + LD+ +G+ F H
Sbjct: 92 VCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QL 175
I+HRDIK N+L+ + K+ DFG A+ VA T Y APE L+G +
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE-LLVGDVKY 202
Query: 176 TKKADVYSFGVLLLEIISGR 195
K DV++ G L+ E+ G
Sbjct: 203 GKAVDVWAIGCLVTEMFMGE 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 20/198 (10%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLS------AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G F +V + + G + A K + + +E E+ ++ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L + +L+ E + L + L K + + G+++LH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEE---ATSFIKQILDGVNYLHTKK 135
Query: 115 DPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
I H D+K N++L H K+ DFGLA D + GT ++APE
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIV 190
Query: 171 LLGQLTKKADVYSFGVLL 188
L +AD++S GV+
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIW-NIRHPNLVQLIGCC 59
IG G++ V R + + A+K + +SK+ E EI+++ +HPN++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHPNIITLKDVY 85
Query: 60 VEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+D + +V E ++ L + +L + + + + + + +LH + +
Sbjct: 86 -DDGKYVYVVTELMKGGELLDKIL-RQKFFSERE---ASAVLFTITKTVEYLHAQG---V 137
Query: 119 VHRDIKASNVLL---DGNFHP-KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
VHRD+K SN+L GN +I DFG AK + T T ++APE L Q
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE-VLERQ 195
Query: 175 L-TKKADVYSFGVLL 188
D++S GVLL
Sbjct: 196 GYDAACDIWSLGVLL 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 56/244 (22%), Positives = 83/244 (34%), Gaps = 54/244 (22%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKC-----LSAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
IG G++GVV AIK + + + + TE+ ++ + HPN+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 56 IGCCVEDNNRILVYEYLENNSL--------------------------ANALLGSKSKYV 89
++ LV E L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 90 SLDWPTR----------ANICLGTASGLSFLHEEADPPIVHRDIKASNVLL--DGNFHPK 137
+ +NI S L +LH + I HRDIK N L + +F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 138 IGDFGLAKLFPDNVTHVSTR---VAGTMGYLAPEYALLGQL---TKKADVYSFGVLLLEI 191
+ DFGL+K F AGT ++APE L K D +S GVLL +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 192 ISGR 195
+ G
Sbjct: 270 LMGA 273
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V +R ++ A K L + ++G L E ++ + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHE 112
E + + LV + L + A IC G L LH
Sbjct: 251 -YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAAEICCG----LEDLHR 304
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
E IV+RD+K N+LLD + H +I D GLA P+ T + RV GT+GY+APE +
Sbjct: 305 ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE-VVK 358
Query: 173 GQL-TKKADVYSFGVLLLEIISGRS 196
+ T D ++ G LL E+I+G+S
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GAF VV R + G + A K + S + ++ E + ++HPN+V+L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E++ LV++ + L ++ ++ Y D ++ +++ H I
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIV-AREFYSEAD---ASHCIQQILESIAYCHSNG---I 149
Query: 119 VHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHR++K N+LL K+ DFGLA D+ AGT GYL+PE L
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLKKDP 206
Query: 176 -TKKADVYSFGVLL 188
+K D+++ GV+L
Sbjct: 207 YSKPVDIWACGVIL 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKE--------FLTEIDMIWNIR-HPN 51
IG G VV R R G + A+K + +++ + E E ++ + HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
++ LI + LV++ + L + L K + +I +SFLH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLT-EKVALSEKE---TRSIMRSLLEAVSFLH 217
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE--- 168
IVHRD+K N+LLD N ++ DFG + + GT GYLAPE
Sbjct: 218 ANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILK 272
Query: 169 ---YALLGQLTKKADVYSFGVLL 188
K+ D+++ GV+L
Sbjct: 273 CSMDETHPGYGKEVDLWACGVIL 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIK-CLSAESKQGTKEF-LTEIDMIWNIRHPNLVQLIGC 58
IG G++GVV++ + G +AIK L +E K+ L EI M+ ++HPNLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
LV+EY ++ + + L + +I T ++F H+
Sbjct: 71 FRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QLT 176
+HRD+K N+L+ + K+ DFG A+L + VA T Y +PE L+G Q
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE-LLVGDTQYG 181
Query: 177 KKADVYSFGVLLLEIISGR 195
DV++ G + E++SG
Sbjct: 182 PPVDVWAIGCVFAELLSGV 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCC 59
+G G+F + + + A+K +S + T++ EI + HPN+V+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ + LV E L L + K + + + I S +S +H+ +V
Sbjct: 76 HDQLHTFLVMELLNGGELFERIK-KKKHFSETE---ASYIMRKLVSAVSHMHDVG---VV 128
Query: 120 HRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
HRD+K N+L + N KI DFG A+L P + + T T+ Y APE L
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE-LLNQNGY 186
Query: 176 TKKADVYSFGVLL 188
+ D++S GV+L
Sbjct: 187 DESCDLWSLGVIL 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 20/198 (10%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL------SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G F +V + + G + A K + S+ +E E++++ IRHPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L + +L+ E + L + L K + G+ +LH +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLA-EKESLTEDE---ATQFLKQILDGVHYLHSKR 128
Query: 115 DPPIVHRDIKASNVLLDGNFHP----KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
I H D+K N++L P K+ DFG+A + GT ++APE
Sbjct: 129 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIV 183
Query: 171 LLGQLTKKADVYSFGVLL 188
L +AD++S GV+
Sbjct: 184 NYEPLGLEADMWSIGVIT 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAES-KQG---TKEFLTEIDMIWNIRHPNLVQLIG 57
+G G +GVVY+ G +A+K + ++ +G T + EI ++ + HPN+V LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHPNIVSLID 86
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+ LV+E++E + L L L G++ H+
Sbjct: 87 VIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQHR--- 139
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QL 175
I+HRD+K N+L++ + K+ DFGLA+ F V + V T+ Y AP+ L+G +
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD-VLMGSKKY 197
Query: 176 TKKADVYSFGVLLLEIISGR 195
+ D++S G + E+I+G+
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 75/356 (21%), Positives = 121/356 (33%), Gaps = 108/356 (30%)
Query: 2 IGGGAFGVVYRGSL------RDGTQIAIKCLSAESKQG-TKEFLTEIDMIWNI-RHPNLV 53
+G GAFG V +A+K L + + ++E+ ++ +I H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 54 QLIGCCVEDNNRILV----------YEYL------------------ENNSLANALLGSK 85
L+G C + ++V YL + A+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 86 SKYVSLDWPTRANICLGT-----------------------------------ASGLSFL 110
+ + ++++ G A G+ FL
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYL----- 165
A +HRD+ A N+LL KI DFGLA+ ++ V L
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWM 262
Query: 166 APEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGD----DMLILVEWTWKLREEGR 221
APE T ++DV+SFGVLL EI S G + I E+ +L+E R
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTR 314
Query: 222 LLEIVDPELTQFPEK--EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEK 275
+ P+ T + + M C RPT ++VE L + N +
Sbjct: 315 MRA---PDYT--TPEMYQTML------DCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 20/198 (10%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLS------AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G F +V + + G + A K + + +E E+ ++ + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L + +L+ E + L + L K + + G+++LH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEE---ATSFIKQILDGVNYLHTKK 135
Query: 115 DPPIVHRDIKASNVLLDGNFHP----KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
I H D+K N++L P K+ DFGLA D V + GT ++APE
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIV 190
Query: 171 LLGQLTKKADVYSFGVLL 188
L +AD++S GV+
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 16/194 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GAF VV R G + A + S + ++ E + ++HPN+V+L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E+ + L+++ + L ++ ++ Y D ++ + H+ +
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIV-AREYYSEAD---ASHCIQQILEAVLHCHQMG---V 131
Query: 119 VHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHR++K N+LL K+ DFGLA AGT GYL+PE L
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE-VLRKDP 189
Query: 176 -TKKADVYSFGVLL 188
K D+++ GV+L
Sbjct: 190 YGKPVDLWACGVIL 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDM---IWNIRHPNLV 53
+IG G FG VY D ++ A+KCL + KQG L E M + P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 54 QLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSF 109
+ +++ + + + L L S+ S R A I LG L
Sbjct: 256 CMS-YAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAD-MRFYAAEIILG----LEH 307
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
+H +V+RD+K +N+LLD + H +I D GLA F H V GT GY+APE
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 170 ALLGQL-TKKADVYSFGVLLLEIISGRS 196
G AD +S G +L +++ G S
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-----FLTEIDMIWNIRHPNLVQL 55
+G G F VY+ +AIK + + K+ L EI ++ + HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+ +N LV++++E + L + K + L L T GL +LH+
Sbjct: 78 LDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-- 173
I+HRD+K +N+LLD N K+ DFGLAK F + +V T Y APE L G
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPE-LLFGAR 188
Query: 174 QLTKKADVYSFGVLLLEIISGR 195
D+++ G +L E++
Sbjct: 189 MYGVGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G + VY+G S +A+K + E ++G + E+ ++ +++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+ + LV+EYL+ + L L ++ GL++ H + ++
Sbjct: 70 HTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QLTK 177
HRD+K N+L++ K+ DFGLA+ V T+ Y P+ LLG +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD-ILLGSTDYST 180
Query: 178 KADVYSFGVLLLEIISGR 195
+ D++ G + E+ +GR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 15/191 (7%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GA +VYR + A+K L K TEI ++ + HPN+++L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
LV E + L + ++ K Y D A+ +++LHE IVH
Sbjct: 119 TPTEISLVLELVTGGELFDRIV-EKGYYSERD---AADAVKQILEAVAYLHENG---IVH 171
Query: 121 RDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
RD+K N+L + KI DFGL+K+ V V GT GY APE
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGP 229
Query: 178 KADVYSFGVLL 188
+ D++S G++
Sbjct: 230 EVDMWSVGIIT 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 25/205 (12%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGC 58
++G GA V + A+K + + E++M++ + H N+++LI
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
E++ LV+E + S+ + + + + L+ + + AS L FLH + I
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELE---ASVVVQDVASALDFLHNKG---I 132
Query: 119 VHRDIKASNVLLDGNFHP---KIGDFGLAKLFPDNVTHVSTR------VAGTMGYLAPEY 169
HRD+K N+L + KI DF L N G+ Y+APE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE- 191
Query: 170 ALLGQLT------KKADVYSFGVLL 188
+ K+ D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAES-KQG---TKEFLTEIDMIWNIRHPNLVQLIG 57
IG G +GVVY+ G A+K + E +G T + EI ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+LV+E+L+ + L L L+ T + L +G+++ H+
Sbjct: 68 VIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--QL 175
++HRD+K N+L++ KI DFGLA+ F V + + T+ Y AP+ L+G +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD-VLMGSKKY 178
Query: 176 TKKADVYSFGVLLLEIISGR 195
+ D++S G + E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL------SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G F VV + + G Q A K + S+ ++ E+ ++ I+HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L + IL+ E + L + L K + +G+ +LH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEE---ATEFLKQILNGVYYLHSLQ 134
Query: 115 DPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
I H D+K N++L KI DFGLA + GT ++APE
Sbjct: 135 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIV 189
Query: 171 LLGQLTKKADVYSFGVLL 188
L +AD++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVIT 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 2 IGGGAFGVVYRGSLRD---GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G G +G VY+ +D A+K + + EI ++ ++HPN++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 59 CVEDNNRI--LVYEYLENNSLANAL-----LGSKSKYVSLDWPTRANICLGTASGLSFLH 111
+ +R L+++Y E++ L + + + K V L ++ G+ +LH
Sbjct: 87 FLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 112 EEADPPIVHRDIKASNVLLDGNFHP----KIGDFGLAKLF--PDNV-THVSTRVAGTMGY 164
++HRD+K +N+L+ G KI D G A+LF P + V T Y
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 165 LAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
APE LLG TK D+++ G + E+++
Sbjct: 202 RAPEL-LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 38/191 (19%), Positives = 71/191 (37%), Gaps = 14/191 (7%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G FG+V+R K + EI ++ RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++++E++ + + S + + + L FLH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNERE---IVSYVHQVCEALQFLHSHN---IGH 125
Query: 121 RDIKASNVLL--DGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
DI+ N++ + KI +FG A+ P + + + Y APE ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVST 182
Query: 178 KADVYSFGVLL 188
D++S G L+
Sbjct: 183 ATDMWSLGTLV 193
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAES-KQG---TKEFLTEIDMIWNIRHPNLVQLI 56
IG G +G V++ + +A+K + + +G + L EI ++ ++H N+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLH 67
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
D LV+E+ + + L S LD + GL F H
Sbjct: 68 DVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG--Q 174
++HRD+K N+L++ N K+ +FGLA+ F V S V T+ Y P+ L G
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD-VLFGAKL 178
Query: 175 LTKKADVYSFGVLLLEIISGR 195
+ D++S G + E+ +
Sbjct: 179 YSTSIDMWSAGCIFAELANAG 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G+FGVV++ L + ++AIK + Q + E+ ++ ++HPN+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 62 DNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT---ASGLSFLHE 112
+ ++ LV EY+ + A + I L L+++H
Sbjct: 104 NGDKKDEVFLNLVLEYVPET-VYRAS---RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 113 EADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLF---PDNVTHVSTRVAGTMGYLAPE 168
I HRDIK N+LLD K+ DFG AK+ NV+++ +R Y APE
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE 211
Query: 169 YALLG--QLTKKADVYSFGVLLLEIISGR 195
+ G T D++S G ++ E++ G+
Sbjct: 212 -LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-24
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 22/204 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQI-AIKCLSAES----KQGTKEFLTEIDMIWNIRHPNLVQLI 56
+G G+F V ++ AIK L + E D++ + HP V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKLY 96
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
+D Y +N L + K TR A I L +LH +
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET-CTRFYTAEIVSA----LEYLHGK 149
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR-VAGTMGYLAPEYALL 172
I+HRD+K N+LL+ + H +I DFG AK+ GT Y++PE L
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLT 205
Query: 173 GQL-TKKADVYSFGVLLLEIISGR 195
+ K +D+++ G ++ ++++G
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 61/236 (25%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS----------------AESKQGTKEFLTEIDMI 44
IG G++GVV + D T A+K LS ++ + I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 45 WNI----------RHPNLVQLIGCCVEDNNR---ILVYEYLENNSLANALLGSKSKYVSL 91
+ HPN+V+L+ ++D N +V+E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV-------------M 126
Query: 92 DWPTRANICLGTA--------SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143
+ PT + A G+ +LH + I+HRDIK SN+L+ + H KI DFG+
Sbjct: 127 EVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT----KKADVYSFGVLLLEIISGR 195
+ F + +S GT ++APE +L K DV++ GV L + G+
Sbjct: 184 SNEFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAES-KQGTKEF----LTEID---MIWNIRHPNL 52
IG GA+G VY+ G +A+K + + G + E+ + HPN+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 53 VQLIGCCVEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGL 107
V+L+ C LV+E+++ + L L K+ L T ++ GL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIKDLMRQFLRGL 133
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF--PDNVTHVSTRVAGTMGYL 165
FLH IVHRD+K N+L+ K+ DFGLA+++ +T V T+ Y
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLWYR 186
Query: 166 APEYALLG-QLTKKADVYSFGVLLLEIISGR 195
APE LL D++S G + E+ +
Sbjct: 187 APE-VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRH-PNLVQLIG 57
+G G F VV + + G + A K L + E L EI ++ + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVS-LDWPTRANICLGTASGLSFLHEEADP 116
+ IL+ EY + + L ++ VS D + G+ +LH+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---VIRLIKQILEGVYYLHQNN-- 151
Query: 117 PIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
IVH D+K N+LL KI DFG+++ + + GT YLAPE
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLAPEILNYD 208
Query: 174 QLTKKADVYSFGVLL 188
+T D+++ G++
Sbjct: 209 PITTATDMWNIGIIA 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
IG G+FG V D ++ A+K ++ + + + E+ ++ + HP LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
++ + +V + L L L ++ + + + + + L +L +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEET-VKLFICELVMA----LDYLQNQ 134
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
I+HRD+K N+LLD + H I DF +A + P + +AGT Y+APE
Sbjct: 135 R---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPE-MFSS 188
Query: 174 QL----TKKADVYSFGVLLLEIISGRS 196
+ + D +S GV E++ GR
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G+FGVVY+ L D G +AIK + Q + E+ ++ + H N+V+L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 61 EDNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT---ASGLSFLH 111
+ LV +Y+ + + + + L L+++H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPET-VYRVA---RHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 112 EEADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLF---PDNVTHVSTRVAGTMGYLAP 167
I HRDIK N+LLD + K+ DFG AK NV+++ +R Y AP
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 168 EYALLG--QLTKKADVYSFGVLLLEIISGR 195
E + G T DV+S G +L E++ G+
Sbjct: 226 E-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-23
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAES-KQG---TKEFLTEIDMIWNIRHPNLVQLI 56
+G G +G VY+ +AIK + E ++G T + E+ ++ ++H N+++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHRNIIELK 99
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
++ L++EY EN+ L + K + + +G++F H
Sbjct: 100 SVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSRR-- 152
Query: 117 PIVHRDIKASNVLLDGNFHP-----KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
+HRD+K N+LL + KIGDFGLA+ F + + + T+ Y PE L
Sbjct: 153 -CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE-IL 209
Query: 172 LG--QLTKKADVYSFGVLLLEIISGR 195
LG + D++S + E++
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAF V ++ Q+ A+K ++ + F E D++ N + QL
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHE 112
+D N + LV EY L LL + + + R A I + + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLT-LLSKFGERIPAEM-ARFYLAEIVMA----IDSVHR 180
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE---- 168
VHRDIK N+LLD H ++ DFG + T S GT YL+PE
Sbjct: 181 LG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 169 ---YALLGQLTKKADVYSFGVLLLEIISGRS 196
G + D ++ GV E+ G++
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAFG V L++ ++ A+K L+ + T F E D++ N + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHE 112
+D+N + LV +Y L LL + + R A + + + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEEM-ARFYLAEMVIA----IDSVHQ 193
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE---- 168
VHRDIK N+L+D N H ++ DFG ++ T S+ GT Y++PE
Sbjct: 194 LH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 169 -YALLGQLTKKADVYSFGVLLLEIISGRS 196
G+ + D +S GV + E++ G +
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 32/202 (15%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIW-NIRHPNLVQLIGC 58
++G G G V R G + A+K L + E+D W P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY---DS--PKARQEVDHHWQASGGPHIVCILDV 90
Query: 59 CVEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLH 111
E+ + ++ E +E L + + + + R A I + + FLH
Sbjct: 91 Y-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT----EREAAEIMRDIGTAIQFLH 145
Query: 112 EEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPE 168
I HRD+K N+L + + K+ DFG AK N + T T Y+APE
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 169 YALLGQL--TKKADVYSFGVLL 188
+LG K D++S GV++
Sbjct: 200 --VLGPEKYDKSCDMWSLGVIM 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 26/210 (12%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLS-------AESKQGTKEFLTEIDMIWNIR---- 48
++G G FG V+ G L D Q+AIK + + L E+ ++W +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 49 HPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
HP +++L+ +LV E + K L + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAP 167
H +VHRDIK N+L+D K+ DFG L D GT Y P
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPP 207
Query: 168 EYALLGQL--TKKADVYSFGVLLLEIISGR 195
E+ + A V+S G+LL +++ G
Sbjct: 208 EW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-22
Identities = 37/177 (20%), Positives = 65/177 (36%), Gaps = 15/177 (8%)
Query: 27 SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKS 86
S +I + N V + + + +L + + S
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 87 KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK- 145
+ +I + A + FLH + ++HRD+K SN+ + K+GDFGL
Sbjct: 158 LE-DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 146 ----------LFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEII 192
L P T GT Y++PE + K D++S G++L E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 2/89 (2%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIGC 58
+G G FGVV+ + D AIK + +++ +E + E+ + + HP +V+
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSK 87
+E E E + S
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSS 101
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-22
Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 30/210 (14%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLT------EIDMIWNIRH--PNL 52
+G G FG VY G + D +AIK + + E E+ ++ + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS----LDWPTRANICLGTASGLS 108
++L+ ++ +L+ E E +++ L + +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPV-------QDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 109 FLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAP 167
H ++HRDIK N+L+D N K+ DFG L D V GT Y P
Sbjct: 164 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPP 217
Query: 168 EYALLGQL--TKKADVYSFGVLLLEIISGR 195
E+ + + A V+S G+LL +++ G
Sbjct: 218 EW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEF---LTEIDMIWNIRHPNLVQLI 56
++G G FG V + + A+K L E E LTE ++ N RHP L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG-TASGLSFLHEEA 114
+ ++R+ V EY L L S+ + S D RA S L +LH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED---RARFYGAEIVSALDYLHSEK 268
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAPEYALL 172
+ +V+RD+K N++LD + H KI DFGL K + GT YLAPE L
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPE-VLE 322
Query: 173 GQL-TKKADVYSFGVLLLEIISGRS 196
+ D + GV++ E++ GR
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAES-KQGTKEFLT---EIDMIWNIRHPNLVQLI 56
IG G FG V++ + G ++A+K + E+ K+G +T EI ++ ++H N+V LI
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLKHENVVNLI 82
Query: 57 GCCVEDNNRI--------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
C + LV+++ E++ LA LL + V + +GL
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHD-LA-GLLSNVL--VKFTLSEIKRVMQMLLNGLY 138
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-------THVSTRVAGT 161
++H I+HRD+KA+NVL+ + K+ DFGLA+ F T+ RV T
Sbjct: 139 YIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN---RVV-T 191
Query: 162 MGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
+ Y PE LLG D++ G ++ E+ +
Sbjct: 192 LWYRPPEL-LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCL--------SAESKQGTKEFLTEIDMIWNIRHPNL 52
+G GAFG V+ ++ +K + + EI ++ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 53 VQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
++++ E+ LV E + A + + LD P + I S + +L
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLR 147
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYA 170
+ I+HRDIK N+++ +F K+ DFG A + + GT+ Y APE
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYCAPE-V 200
Query: 171 LLGQL--TKKADVYSFGVLLLEIISGR 195
L+G + +++S GV L ++
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
+IG GAFG V + ++ A+K LS + + F E D++ P +VQL
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
+D +V EY+ L N + + V W R A + L L +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKW-ARFYTAEVVLA----LDAIHSM 187
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
+HRD+K N+LLD + H K+ DFG GT Y++PE L
Sbjct: 188 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE-VLKS 243
Query: 174 QL-----TKKADVYSFGVLLLEIISGRS 196
Q ++ D +S GV L E++ G +
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 1 MIGGGAFGVVY---RGSLRDGTQI-AIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQ 54
++G G+FG V+ + S D Q+ A+K L + + E D++ + HP +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 55 LIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFL 110
L + ++ L+ ++L L L SK + + + A + L L L
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEED-VKFYLAELALA----LDHL 142
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
H I++RD+K N+LLD H K+ DFGL+K D+ + GT+ Y+APE
Sbjct: 143 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE-V 197
Query: 171 LLGQL-TKKADVYSFGVLLLEIISGRS 196
+ + T+ AD +SFGVL+ E+++G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-21
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGCC 59
+G GA+G V + +A+K + + E + EI + + H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA--------SGLSFLH 111
E N + L EY L + + + A +G+ +LH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEP----------DAQRFFHQLMAGVVYLH 122
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT--HVSTRVAGTMGYLAPEY 169
I HRDIK N+LLD + KI DFGLA +F N ++ GT+ Y+APE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177
Query: 170 ALLGQL--TKKADVYSFGVLLLEIISGR 195
L + + DV+S G++L +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC-- 58
G G FG V G + G +AIK + + + +E L + + + HPN+VQL
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFY 89
Query: 59 --CVEDNNRI---LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT---ASGLSFL 110
D I +V EY+ + L ++ Y P I + + L
Sbjct: 90 TLGERDRRDIYLNVVMEYVPDT-LHRCC---RNYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHP-KIGDFGLAKLF---PDNVTHVSTRVAGTMGYLA 166
H + + HRDIK NVL++ K+ DFG AK NV ++ +R Y A
Sbjct: 146 HLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRA 199
Query: 167 PEYALLG--QLTKKADVYSFGVLLLEIISGR 195
PE + G T D++S G + E++ G
Sbjct: 200 PEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEF---LTEIDMIWNIRHPNLVQLI 56
++G G FG V + + A+K L E E +TE ++ N RHP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHE 112
+ ++R+ V EY L L S+ + + + R A I L +LH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEER-ARFYGAEIVSA----LEYLHS 123
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAPEYA 170
+V+RDIK N++LD + H KI DFGL K + T GT YLAPE
Sbjct: 124 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPEYLAPE-V 176
Query: 171 LLGQL-TKKADVYSFGVLLLEIISGRS 196
L + D + GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-21
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGCC 59
+G GA+G V + +A+K + + E + EI + + H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA--------SGLSFLH 111
E N + L EY L + + + A +G+ +LH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEP----------DAQRFFHQLMAGVVYLH 122
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT--HVSTRVAGTMGYLAPEY 169
I HRDIK N+LLD + KI DFGLA +F N ++ GT+ Y+APE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177
Query: 170 ALLGQL--TKKADVYSFGVLLLEIISGR 195
L + + DV+S G++L +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G F V + G ++AIK + + ++ E+ ++ + HPN+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ L+ EY + + L + + + + S + + H++ I
Sbjct: 83 IETEKTLYLIMEYASGGEVFD-YLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL--T 176
VHRD+KA N+LLD + + KI DFG + F + G Y APE G+
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-LFQGKKYDG 192
Query: 177 KKADVYSFGVLLLEIISGR 195
+ DV+S GV+L ++SG
Sbjct: 193 PEVDVWSLGVILYTLVSGS 211
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-20
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEF---LTEIDMIWNIRHPNLVQLI 56
+G G+FG V+ R + A+K L E K+ E M+ + HP ++++
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
G + ++ +Y+E L + L KS+ + A +CL L +LH +
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNP-VAKFYAAEVCLA----LEYLHSK 125
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
I++RD+K N+LLD N H KI DFG AK PD VT+ T + GT Y+APE +
Sbjct: 126 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY--T-LCGTPDYIAPE-VVST 177
Query: 174 QL-TKKADVYSFGVLLLEIISGRS 196
+ K D +SFG+L+ E+++G +
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEF---LTEIDMIWNIRHPNLVQLI 56
+G G+FG V ++ A+K L + K+ L E ++ + P LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLHEE 113
+++N +V EY+ + + L + S R A I L +LH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPH-ARFYAAQIVLT----FEYLHSL 160
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
+++RD+K N+L+D + ++ DFG AK T + GT LAPE L
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWT---LCGTPEALAPEIILSK 213
Query: 174 QLTKKADVYSFGVLLLEIISGRS 196
K D ++ GVL+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYP 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 31/201 (15%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCC 59
+G G G V + + + A+K L + E+++ W + P++V+++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ---DC--PKARREVELHWRASQCPHIVRIVDVY 124
Query: 60 VEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLHE 112
E+ +V E L+ L + + + + R + I + +LH
Sbjct: 125 -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT----EREASEIMKSIGEAIQYLHS 179
Query: 113 EADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
I HRD+K N+L N K+ DFG AK + + ++T T Y+APE
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPE- 233
Query: 170 ALLGQL--TKKADVYSFGVLL 188
+LG K D++S GV++
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIM 253
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-20
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 2 IGGGAFGVVYRG-SLRDGTQI-AIKCLSAES-KQG---TKEFLTEID---MIWNIRHPNL 52
IG GA+G V++ L++G + A+K + ++ ++G + + E+ + HPN+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNV 76
Query: 53 VQLIGCCVEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGL 107
V+L C LV+E+++ + L L K + T ++ GL
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL--DKVPEPGVPTETIKDMMFQLLRGL 133
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF--PDNVTHVSTRVAGTMGYL 165
FLH +VHRD+K N+L+ + K+ DFGLA+++ +T V T+ Y
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TLWYR 186
Query: 166 APEYALLG-QLTKKADVYSFGVLLLEIISGR 195
APE LL D++S G + E+ +
Sbjct: 187 APE-VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-20
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 1 MIGGGAFGVVY---RGSLRDGTQI-AIKCLSAES-KQGTKEF---LTEIDMIWNIRHPNL 52
++G G +G V+ + + + +I A+K L + K+ E +++ ++HP +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 53 VQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLS 108
V LI + ++ L+ EYL L L + D A I + L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDT-ACFYLAEISMA----LG 135
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLA 166
LH++ I++RD+K N++L+ H K+ DFGL K + VTH T GT+ Y+A
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--T-FCGTIEYMA 189
Query: 167 PEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
PE L+ + D +S G L+ ++++G
Sbjct: 190 PE-ILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 46/221 (20%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLS--AESKQGTKEF---------LTEIDMIWNIRHP 50
I G++G V G +G +AIK + + L EI ++ + HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 51 NLVQLIGC----CVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANIC----- 100
N++ L +++ LV E + + LA + + + + + +I
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI---HDQRIVI---SPQHIQYFMYH 142
Query: 101 -LGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVST 156
L GL LHE A +VHRD+ N+LL N I DF LA+ + +V+
Sbjct: 143 IL---LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 157 RVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
R Y APE ++ TK D++S G ++ E+ + +
Sbjct: 197 RW-----YRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 34/208 (16%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLT-EIDMIWNIRHPNLVQLIGCC 59
IG G FGV +A+K + E E + EI ++RHPN+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA--------SGLSFLH 111
+ + ++ EY L + A SG+S+ H
Sbjct: 86 LTPTHLAIIMEYASGGELYE--------RIC----NAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 112 EEADPPIVHRDIKASNVLLDGNFHP--KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
I HRD+K N LLDG+ P KI DFG +K + + + V GT Y+APE
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPE- 187
Query: 170 ALLGQL--TKKADVYSFGVLLLEIISGR 195
LL Q K ADV+S GV L ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI-- 56
+G GA+G V R G ++AIK LS +S+ K E+ ++ +++H N++ L+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 57 ---GCCVEDNNRI-LVYEYLE---NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
+ + LV +++ + K +Y + GL +
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY----------LVYQMLKGLKY 141
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAPE 168
+H A +VHRD+K N+ ++ + KI DFGLA+ +T V TR Y APE
Sbjct: 142 IHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193
Query: 169 YAL-LGQLTKKADVYSFGVLLLEIISGR 195
L + D++S G ++ E+++G+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEF---LTEID-MIWNIRHPNLVQL 55
+IG G+FG V + A+K L ++ KE ++E + ++ N++HP LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 56 IGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGLSFLH 111
+ +++ V +Y+ L L + + R A I L +LH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPR-ARFYAAEIASA----LGYLH 156
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGYLAPEY 169
IV+RD+K N+LLD H + DFGL K + ++ T ST GT YLAPE
Sbjct: 157 SLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPE- 209
Query: 170 ALLGQL-TKKADVYSFGVLLLEIISGRS 196
L Q + D + G +L E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
+IG G++ V L+ +I A+K + + Q K + HP
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHP 70
Query: 51 NLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASG 106
LV L C + +R+ V EY+ L + + + + + R A I L
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEH-ARFYSAEISLA---- 122
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGY 164
L++LHE I++RD+K NVLLD H K+ D+G+ K L P + T T GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNY 176
Query: 165 LAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
+APE L G+ D ++ GVL+ E+++GRS
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
++G G+FG V + ++ A+K L E K L + P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPP 402
Query: 51 NLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASG 106
L QL C + +R+ V EY+ L + + A I +G
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPH-AVFYAAEIAIG---- 454
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGY 164
L FL + I++RD+K NV+LD H KI DFG+ K ++ T T GT Y
Sbjct: 455 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPDY 508
Query: 165 LAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
+APE + Q K D ++FGVLL E+++G++
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
+IG G++ V L+ +I A++ + + Q K + HP
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHP 113
Query: 51 NLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASG 106
LV L C + +R+ V EY+ L + + + + + R A I L
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEH-ARFYSAEISLA---- 165
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGY 164
L++LHE I++RD+K NVLLD H K+ D+G+ K L P + T T GT Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNY 219
Query: 165 LAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
+APE L G+ D ++ GVL+ E+++GRS
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
++G G+FG V + ++ A+K L E K L + P
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPP 81
Query: 51 NLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASG 106
L QL C + +R+ V EY+ L + + A I +G
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPH-AVFYAAEIAIG---- 133
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGY 164
L FL + I++RD+K NV+LD H KI DFG+ K ++ T T GT Y
Sbjct: 134 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDY 187
Query: 165 LAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
+APE + Q K D ++FGVLL E+++G++
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 70/215 (32%), Positives = 94/215 (43%), Gaps = 41/215 (19%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLSAESKQGTKEFLTEIDMI-----------WNIR 48
M+G G+FG V+ + Q AIK L K+ + D +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 49 HPNLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTA 104
HP L + C + + V EYL L + L A I LG
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSR-ATFYAAEIILG-- 130
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTM 162
L FLH + IV+RD+K N+LLD + H KI DFG+ K + D T +T GT
Sbjct: 131 --LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTP 182
Query: 163 GYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
Y+APE LLGQ D +SFGVLL E++ G+S
Sbjct: 183 DYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-19
Identities = 22/200 (11%), Positives = 48/200 (24%), Gaps = 45/200 (22%)
Query: 2 IGGGAFGVVYRGSLRD---GTQIAIKCL---SAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
GG ++ D Q+A+ + +E L+ + I P + ++
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+ ++V E++ SL S A+ H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
+ S V + + + +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179
Query: 176 TKKADVYSFGVLLLEIISGR 195
+ D+ G L ++ R
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-19
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 37/213 (17%)
Query: 1 MIGGGAFGVVYRGSLRDGTQI-AIKCLS---------AESKQGTKEFLTEIDMIWNIRHP 50
++G G+FG V +++ + A+K L E K L+ HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHP 84
Query: 51 NLVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASG 106
L QL CC + +R+ V E++ L + KS+ R A I
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEAR-ARFYAAEIISA---- 136
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK--LFPDNVTHVSTRVAGTMGY 164
L FLH++ I++RD+K NVLLD H K+ DFG+ K + T +T GT Y
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDY 190
Query: 165 LAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
+APE L L D ++ GVLL E++ G +
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 1 MIGGGAFGVVY---RGSLRDGTQI-AIKCLS----AESKQGTKEFLTEIDMIWNIRH-PN 51
++G GA+G V+ + S D ++ A+K L + + T+ TE ++ +IR P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 52 LVQLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTR---ANICLGTASGL 107
LV L + ++ L+ +Y+ L L S+ + + + I L L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHL--SQRERFTEHE-VQIYVGEIVLA----L 172
Query: 108 SFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAP 167
LH+ I++RDIK N+LLD N H + DFGL+K F + T + GT+ Y+AP
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 168 EYALLGQL---TKKADVYSFGVLLLEIISGRS 196
+ + G K D +S GVL+ E+++G S
Sbjct: 230 D-IVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V R G ++AIK L +S+ K E+ ++ ++RH N++ L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 59 CVEDNNRI------LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
D LV ++ + LG K+ L + GL ++H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTD------LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYAL 171
A I+HRD+K N+ ++ + KI DFGLA+ +T +V TR Y APE +
Sbjct: 147 -AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPE-VI 197
Query: 172 LG--QLTKKADVYSFGVLLLEIISGR 195
L + T+ D++S G ++ E+I+G+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAES--KQGTKEFLT-EIDMIWNIRHPNLVQLIG 57
+G G FG V G G ++A+K L+ + + EI + RHP++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 58 CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ +V EY+ L + + + ++ + S + + H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYIC-KHGR---VEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
+VHRD+K NVLLD + + KI DFGL+ + D + T G+ Y APE + G+L
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-SCGSPNYAAPE-VISGRLY 187
Query: 176 -TKKADVYSFGVLLLEIISGR 195
+ D++S GV+L ++ G
Sbjct: 188 AGPEVDIWSCGVILYALLCGT 208
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 35/207 (16%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCC 59
+G G + V+ + + ++ +K L K K+ EI ++ N+R PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 60 VEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANIC------LGTASGLSFLH 111
+ +R LV+E++ N K Y +L T +I L L + H
Sbjct: 101 KDPVSRTPALVFEHVNNTDF-------KQLYQTL---TDYDIRFYMYEIL---KALDYCH 147
Query: 112 EEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
I+HRD+K NV++D + ++ D+GLA+ F + RVA + + PE
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVA-SRYFKGPE-L 201
Query: 171 LLG--QLTKKADVYSFGVLLLEIISGR 195
L+ D++S G +L +I +
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI-- 56
IG GA G+V +AIK LS +++ K E+ ++ + H N++ L+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 57 ---GCCVEDNNRI-LVYEYLE---NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
+E+ + LV E ++ + L + Y + G+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY----------LLYQMLCGIKH 179
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVSTRVAGTMGYLA 166
LH I+HRD+K SN+++ + KI DFGLA+ + +V TR Y A
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRA 231
Query: 167 PEYALLGQLTKKADVYSFGVLLLEIISGR 195
PE L + D++S G ++ E++ +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 40/216 (18%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLT----EIDMIWNIRHPNLVQLI 56
+G G++G V + A+K L + + EI ++ +RH N++QL+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 57 G-CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA--------SG 106
E+ ++ +V EY G + LD + A G
Sbjct: 73 DVLYNEEKQKMYMVMEYCVC--------GMQEM---LDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF----PDNVTHVSTRVAGTM 162
L +LH + IVH+DIK N+LL KI G+A+ D+ S G+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSP 175
Query: 163 GYLAPEYALLGQLT---KKADVYSFGVLLLEIISGR 195
+ PE G T K D++S GV L I +G
Sbjct: 176 AFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI-- 56
IG GA G+V +AIK LS +++ K E+ ++ + H N++ L+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 57 ---GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
+E+ + +V E ++ N ++ + LD + + G+ LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDAN--LCQVIQME-----LDHERMSYLLYQMLCGIKHLHS 145
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVSTRVAGTMGYLAPEY 169
A I+HRD+K SN+++ + KI DFGLA+ + +V TR Y APE
Sbjct: 146 -AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 197
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGR 195
L + D++S G ++ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 37/213 (17%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC- 58
IG GA+G+V + ++AIK +S E + + L EI ++ RH N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 59 ---CVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG---TASGLSFLH 111
+E + +V + +E + L L K++++S D +IC GL ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETD-LYKLL---KTQHLSND-----HICYFLYQILRGLKYIH 145
Query: 112 EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-------VSTRVAGTMGY 164
A+ ++HRD+K SN+LL+ KI DFGLA++ + H V+TR Y
Sbjct: 146 S-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR-----WY 197
Query: 165 LAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
APE +L TK D++S G +L E++S R
Sbjct: 198 RAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 27/206 (13%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLI-- 56
+G GA+G V + G ++A+K LS +S K E+ ++ +++H N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 57 ---GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
+E+ N + LV + + L N + K + ++ D + GL ++H
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGAD-LNNIV---KCQKLTDD--HVQFLIYQILRGLKYIHS 150
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYAL 171
AD I+HRD+K SN+ ++ + KI DFGLA+ D +T +V+TR Y APE +
Sbjct: 151 -AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPE-IM 201
Query: 172 LG--QLTKKADVYSFGVLLLEIISGR 195
L + D++S G ++ E+++GR
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 46/238 (19%), Positives = 87/238 (36%), Gaps = 57/238 (23%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G+FG+V + G + A+K + + + K E+D++ + H N+++L+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YK--NRELDIMKVLDHVNIIKLVDYFY 70
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRAN-------------------ICL 101
+ ++ + + +
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 102 GTAS------------------GLSFLHEEADPPIVHRDIKASNVLLDGNFHP-KIGDFG 142
S + F+H I HRDIK N+L++ + K+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 143 LAKLF---PDNVTHVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
AK +V ++ +R Y APE +LG + T D++S G + E+I G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPEL-MLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA-ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC- 58
+G GA+GVV + G +AIK + + L EI ++ + +H N++ +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 59 ---CVEDNNRI-LVYEYLENNSL-----ANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
E+ N + ++ E ++ + L L +Y T +
Sbjct: 79 RPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHIQY----------FIYQTLRAVKV 127
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR----------VA 159
LH ++ ++HRD+K SN+L++ N K+ DFGLA++ ++ S VA
Sbjct: 128 LHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 160 GTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
T Y APE +L + ++ DV+S G +L E+ R
Sbjct: 185 -TRWYRAPE-VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 50/224 (22%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G G+V+ ++AIK + Q K L EI +I + H N+V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 61 EDNNRI--------------LVYEYLENNSL-----ANALLGSKSKYVSLDWPTRANICL 101
+++ +V EY+E + L LL ++
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARL----------FMY 127
Query: 102 GTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTH------- 153
GL ++H A+ ++HRD+K +N+ ++ + KIGDFGLA++ + +H
Sbjct: 128 QLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 154 VSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGR 195
+ T+ Y +P LL TK D+++ G + E+++G+
Sbjct: 185 LVTK-----WYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLT----EIDMIWNIRHPNLVQLI 56
+G G FG V G G ++A+K L+ K + + + EI + RHP++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 57 GCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
+ + I +V EY+ L + + + LD + SG+ + H
Sbjct: 83 QV-ISTPSDIFMVMEYVSGGELFDYIC-KNGR---LDEKESRRLFQQILSGVDYCHRHM- 136
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
+VHRD+K NVLLD + + KI DFGL+ + D + T G+ Y APE + G+L
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPE-VISGRL 191
Query: 176 TK--KADVYSFGVLLLEIISGR 195
+ D++S GV+L ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSAE--SKQGTKEFLT-EIDMIWNIRHPNLVQLIG 57
+G G+FG V + + ++A+K +S + K + EI + +RHP++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 58 CCVEDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ I +V EY L + ++ K + + + + H
Sbjct: 77 V-ITTPTDIVMVIEYA-GGELFDYIV-EKKR---MTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
IVHRD+K N+LLD N + KI DFGL+ + D + T G+ Y APE + G+L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT-SCGSPNYAAPE-VINGKLY 184
Query: 177 K--KADVYSFGVLLLEIISGR 195
+ DV+S G++L ++ GR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 56/248 (22%), Positives = 93/248 (37%), Gaps = 68/248 (27%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G++G VY +AIK ++ E K L EI ++ ++ +++L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 59 CVEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA--------- 104
+ D+ +V E +++ L + I L
Sbjct: 94 IIPDDLLKFDELYIVLEIADSD-LKKLF--------------KTPIFLTEEHIKTILYNL 138
Query: 105 -SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT----------- 152
G +F+HE + I+HRD+K +N LL+ + K+ DFGLA+
Sbjct: 139 LLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 153 ---------------HVSTRVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRS 196
HV TR Y APE LL + TK D++S G + E+++
Sbjct: 196 EPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 197 SSKAAFGD 204
S +
Sbjct: 251 SHINDPTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 55/302 (18%), Positives = 101/302 (33%), Gaps = 79/302 (26%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLS--AESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G++G V + +AIK + E K L EI ++ + H ++V+++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 59 CV----EDNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA--------- 104
+ E + + +V E +++ R + L
Sbjct: 121 VIPKDVEKFDELYVVLEIADSD-FKKLF--------------RTPVYLTELHIKTLLYNL 165
Query: 105 -SGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
G+ ++H A I+HRD+K +N L++ + K+ DFGLA+ S
Sbjct: 166 LVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 164 --------------------------YLAPEYALLGQL--TKKADVYSFGVLLLEIISGR 195
Y APE +L Q T+ DV+S G + E+++
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE-LILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 196 SSSKAAF--------GDDMLILVEWTWKLREEGRLLEIVDPELTQF------PEKEVMRF 241
+ A G L + +L P +E +
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 242 IK 243
++
Sbjct: 342 LE 343
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 2 IGGGAFGVVYRGS-LRDGTQIAIKCLSA--ESKQGTKEFLTEIDMIWNIR-HPNLVQLIG 57
+G GA+G+V++ R G +A+K + ++ + EI ++ + H N+V L+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 58 CCVEDNNR--ILVYEYLENNSL-----ANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
DN+R LV++Y+E + L AN L +Y + + +L
Sbjct: 77 VLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQY----------VVYQLIKVIKYL 125
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG------- 163
H ++HRD+K SN+LL+ H K+ DFGL++ F + +
Sbjct: 126 HS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 164 -------------YLAPEYALLGQL--TKKADVYSFGVLLLEIISGR 195
Y APE LLG TK D++S G +L EI+ G+
Sbjct: 183 DQPILTDYVATRWYRAPE-ILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 40/199 (20%), Positives = 73/199 (36%), Gaps = 48/199 (24%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCC 59
+G G G V + + + A+K L + E+++ W + P++V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 60 VEDNNRI-----LVYEYLENNSLANALLGSKSKYVSLDWPTR--ANICLGTASGLSFLHE 112
E+ +V E L+ L + + + + R + I + +LH
Sbjct: 81 -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT----EREASEIMKSIGEAIQYLHS 135
Query: 113 EADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
I HRD+K N+L N K+ DFG AK + Y
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGE-----KY----- 175
Query: 170 ALLGQLTKKADVYSFGVLL 188
K D++S GV++
Sbjct: 176 ------DKSCDMWSLGVIM 188
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-13
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH-PNLVQLIGCC 59
IG G+FG +Y G + G ++AIK ++K E + ++ + + C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
E + ++V E L SL + L S+ SL T + S + ++H + +
Sbjct: 75 AEGDYNVMVMELL-GPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---FI 127
Query: 120 HRDIKASNVLLDGNFHPK---IGDFGLAKLFPDNVT--HVSTR----VAGTMGYLAPEYA 170
HRD+K N L+ I DFGLAK + D T H+ R + GT Y A
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINT 186
Query: 171 LLG-QLTKKADVYSFGVLLLEIISGR 195
LG + +++ D+ S G +L+ G
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 33/175 (18%), Positives = 56/175 (32%), Gaps = 28/175 (16%)
Query: 2 IGGGAFGVVYRG---------SLRDGTQIAIKC------LSAESKQGTKEFLTEIDMIW- 45
G++Y S + ++K L E + W
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 46 ---NIRHPNLVQLIGC-CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL 101
+ + +G +D R LV L SL +AL S +S + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE--RSVLQVAC 166
Query: 102 GTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI--GDFGLAKLFPDNVTHV 154
L FLHE VH ++ A N+ +D ++ +G A + + HV
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCC 59
IG G+FG +Y G +++ ++AIK + ++K + E + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
VE + +LV + L SL + L S+ +SL T + + + F+H ++ +
Sbjct: 73 VEGDYNVLVMDLL-GPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---FL 125
Query: 120 HRDIKASNVLLDGNFHPK---IGDFGLAKLFPDNVT--HVSTR----VAGTMGYLAPEYA 170
HRDIK N L+ I DFGLAK + D T H+ R + GT Y A
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNT 184
Query: 171 LLG-QLTKKADVYSFGVLLLEIISGR 195
LG + +++ D+ S G +L+ + G
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH-PNLVQLIGCC 59
IG G+FGV++ G +L + Q+AIK S E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
E + +LV + L SL + LL + S+ T A + + +HE++ +V
Sbjct: 76 QEGLHNVLVIDLL-GPSLED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKS---LV 128
Query: 120 HRDIKASNVLLDGNFHPK-----IGDFGLAKLFPDNVT--HVSTR----VAGTMGYLAPE 168
+RDIK N L+ + DFG+ K + D VT H+ R ++GT Y
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MSI 187
Query: 169 YALLG-QLTKKADVYSFGVLLLEIISGR 195
LG + +++ D+ + G + + + G
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 22/207 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G FG + G +L +AIK +S+ + Q+
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFGP 75
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+V E L SL + L + SL T I + S + ++H + +++
Sbjct: 76 CGKYNAMVLELL-GPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 121 RDIKASNVLL--DGNFHPKIG---DFGLAKLF--PDNVTHVSTR----VAGTMGYLAPEY 169
RD+K N L+ GN ++ DF LAK + P+ H+ R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY-MSIN 187
Query: 170 ALLG-QLTKKADVYSFGVLLLEIISGR 195
LG + +++ D+ + G + + + G
Sbjct: 188 THLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 5e-12
Identities = 32/193 (16%), Positives = 53/193 (27%), Gaps = 55/193 (28%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCL--------SAESKQGTKEFLTEIDM---------I 44
IG G FG V++ D T +AIK + + ++ +E L EI +
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 45 WNIRHPNLVQLIGCCV------------------------------EDNNRILVYEYLEN 74
R + L +D+ +V E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134
+ + T +I + L+ HRD+ NVLL
Sbjct: 147 GIDLE-----QMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTS 199
Query: 135 HPKIGDFGLAKLF 147
K+ K
Sbjct: 200 LKKLHYTLNGKSS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 32/177 (18%)
Query: 2 IGGGAFGVVYRGSLRDGTQI------AIKCLSAESKQ-----------GTKEFLTEIDMI 44
IG G FG +Y + + +K +++ E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 45 WNIRHPNLVQLIGCCVEDNN----RILVYEYLENNSLANALLGSKSKYVSLDWPTRANIC 100
+++ + + G + D N R ++ + + L + + +K S T +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSR--KTVLQLS 158
Query: 101 LGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPK---IGDFGLAKLFPDNVTHV 154
L L ++HE VH DIKASN+LL +P + D+GLA + H
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLL-NYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR----------- 48
+G G F V+ + + T +A+K + + K T+ EI ++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 49 HPNLVQLIGCCVEDNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTA 104
++++L+ +V+E L N LA L K ++ + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHRGIPLIYVKQISKQLL 141
Query: 105 SGLSFLHEEADPPIVHRDIKASNVLLD------GNFHPKIGDFGLAKLFPDNVT-HVSTR 157
GL ++H I+H DIK NVL++ KI D G A + ++ T + TR
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISG------RSSSKAAFGDDML 207
Y +PE LLG AD++S L+ E+I+G DD +
Sbjct: 200 E-----YRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 35/175 (20%), Positives = 62/175 (35%), Gaps = 31/175 (17%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQ--------------GTKEFLTEIDMIWN 46
IG G FG++Y + A + E ++ K+ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 47 IRHPNLVQLIGC----CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLG 102
+ + + G + R +V E L L ++ T + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS--GQNGTFKKS--TVLQLGIR 159
Query: 103 TASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPK---IGDFGLAKLFPDNVTHV 154
L ++HE VH DIKA+N+LL G +P + D+GL+ + N H
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLL-GYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRH------P 50
+IG G+FG V + + +A+K + E + Q EI ++ ++R
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
N++ ++ N+ + +E L N L + +K + SL R L L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN-LYELIKKNKFQGFSLPL-VRK-FAHSILQCLDAL 216
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHP--KIGDFGLAKLFPDNV-THVSTRVAGTMGYLAP 167
H+ I+H D+K N+LL K+ DFG + V T++ +R Y AP
Sbjct: 217 HKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAP 268
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISGR 195
E L + D++S G +L E+++G
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 50/280 (17%), Positives = 77/280 (27%), Gaps = 92/280 (32%)
Query: 67 LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKAS 126
+V+E L ++ L KS Y L P I GL +LH + I+H DIK
Sbjct: 122 MVFEVLGHHLLK---WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPE 176
Query: 127 NVLL-------------------------------------------------DGNFHPK 137
N+LL K
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 138 IGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRS 196
I D G A + T T Y + E L+G AD++S + E+ +G
Sbjct: 237 IADLGNACWVHKHFTEDIQ----TRQYRSLE-VLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 197 ----SSKAAFGDDMLILVEWT-------------WKLR-----EEGRLLEIVD------- 227
S + D + K ++G L I
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 228 ---PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
E ++ ++E F L + R T + +
Sbjct: 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 26/208 (12%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHP------ 50
+IG G+FG V + + +AIK + + Q E+ ++ +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116
Query: 51 NLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
+V L + N+ LV+E L N L + L + + + + L FL
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYN-LYDLL--RNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHP--KIGDFGLAKLFPDNV-THVSTRVAGTMGYLAP 167
+ I+H D+K N+LL KI DFG + + ++ +R Y +P
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 227
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISGR 195
E L D++S G +L+E+ +G
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 48/234 (20%), Positives = 78/234 (33%), Gaps = 64/234 (27%)
Query: 1 MIGGGAFGVVYRG--SLRDGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHP----- 50
+G G FG V R +Q+A+K + K EI+++ I+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 51 -NLVQLIG--------CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL 101
V + C + +E+L+ N + P ++
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN-----------NFQPYPLPHVRHMAY 130
Query: 102 GTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP-------------------KIGDFG 142
L FLHE + H D+K N+L + ++ DFG
Sbjct: 131 QLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 143 LAKLFPDNV-THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISG 194
A ++ T V+TR Y PE +L + DV+S G +L E G
Sbjct: 188 SATFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 64/234 (27%)
Query: 1 MIGGGAFGVVYRG--SLRDGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRHP----- 50
+G GAFG V G +A+K + + +EI ++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 51 -NLVQLIG--------CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL 101
VQ++ C V + + Y++++ N ++ +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKEN-----------GFLPFRLDHIRKMAY 125
Query: 102 GTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP-------------------KIGDFG 142
++FLH + H D+K N+L + + K+ DFG
Sbjct: 126 QICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 143 LAKLFPDNV-THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISG 194
A ++ T VSTR Y APE +L ++ DV+S G +L+E G
Sbjct: 183 SATYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 49/238 (20%), Positives = 84/238 (35%), Gaps = 68/238 (28%)
Query: 1 MIGGGAFGVVYRGS-LRDGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRH-----PN 51
+G G FG V + + A+K + K E D++ I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 52 LVQLIG--------CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGT 103
+V+ G C + + +YE + N Y C+
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRN-----------NYNGFHIEDIKLYCIEI 146
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHP-------------------------KI 138
L++L + + + H D+K N+LLD + K+
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 139 GDFGLAKLFPDNV-THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISG 194
DFG A D + ++TR Y APE +L +D++SFG +L E+ +G
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCVLAELYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 322 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.81 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.77 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.01 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.55 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.0 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.9 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-61 Score=410.76 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=207.2
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
||+|+||+||+|.+. ++..||||+++.......+.|.+|+.+|++++|||||+++++|.+++..++|||||++|
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G 100 (299)
T 4asz_A 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 100 (299)
T ss_dssp EEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCC
Confidence 899999999999764 46789999998777777789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC---------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 76 SLANALLGSK---------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 76 ~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+|.+++.... .....+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~ 177 (299)
T 4asz_A 101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRD 177 (299)
T ss_dssp BHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred cHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCccccee
Confidence 9999997542 23347999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 147 FPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 147 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ .. ..+.. +.
T Consensus 178 ~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~---~~i~~-~~--- 247 (299)
T 4asz_A 178 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI---ECITQ-GR--- 247 (299)
T ss_dssp HTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HHHHH-TC---
T ss_pred cCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HHHHc-CC---
Confidence 5433222 2233568999999999999999999999999999999998 899998653221 11 11111 11
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
....+...+.++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 248 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 248 -----VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223334456889999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=411.94 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=202.4
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
||+|+||+||+|.+. +++.||||+++.......+.|.+|+.+|++++|||||+++++|.+.+..++|||||++|
T Consensus 49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G 128 (329)
T 4aoj_A 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 128 (329)
T ss_dssp EEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred EccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 899999999999864 47889999998777777789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 76 SLANALLGSKS-----------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 76 ~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
+|.+++..... ...++++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 129 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla 205 (329)
T 4aoj_A 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 205 (329)
T ss_dssp BHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred cHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccc
Confidence 99999976432 1236999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc-ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 145 KLFPDNV-THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 145 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
+...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||......+. . ..+....+
T Consensus 206 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~---~~i~~g~~- 278 (329)
T 4aoj_A 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I---DCITQGRE- 278 (329)
T ss_dssp --------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H---HHHHHTCC-
T ss_pred eeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H---HHHHcCCC-
Confidence 8654332 222334568999999999999999999999999999999999 8999976532211 1 11111111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
+ ..+...+.++.+++.+||+.||++|||+.||++.|+.+..
T Consensus 279 -----~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 279 -----L---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -----C---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----C---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1 1223334568899999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=408.64 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=205.9
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||+||+|.+. +++.||||+++... ....+.|.+|+.++++++|||||+++++|.+++..++|||||++
T Consensus 34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~ 113 (308)
T 4gt4_A 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH 113 (308)
T ss_dssp EEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSS
T ss_pred eccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCC
Confidence 899999999999763 46789999997543 34457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeec
Q 020720 75 NSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFG 142 (322)
Q Consensus 75 ~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg 142 (322)
|+|.+++..... ....+++..++.|+.||+.||+|||+++ ++||||||+||||++++.+||+|||
T Consensus 114 G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFG 190 (308)
T 4gt4_A 114 GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLG 190 (308)
T ss_dssp CBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSC
T ss_pred CcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcc
Confidence 999999965421 1236899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCc-ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcC
Q 020720 143 LAKLFPDNV-THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEG 220 (322)
Q Consensus 143 ~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (322)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||......+ .. ..+. .+
T Consensus 191 lar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~---~~i~-~~ 263 (308)
T 4gt4_A 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VV---EMIR-NR 263 (308)
T ss_dssp CBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HH---HHHH-TT
T ss_pred cceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHH-cC
Confidence 998653322 222344578999999999999999999999999999999998 899997653221 11 1111 11
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
. ....+...+..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 264 ~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 264 Q--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred C--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1 112333445568899999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=402.78 Aligned_cols=250 Identities=26% Similarity=0.472 Sum_probs=199.7
Q ss_pred cccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
||+|+||+||+|.++. .||||+++.. .....+.|.+|+.++++++|||||++++++.+ +..++|||||++|+|.+
T Consensus 44 iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~ 120 (307)
T 3omv_A 44 IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYK 120 (307)
T ss_dssp CCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHH
T ss_pred EeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHH
Confidence 8999999999998763 5999998754 34455789999999999999999999998864 56899999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 158 (322)
++..... .+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .......
T Consensus 121 ~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 194 (307)
T 3omv_A 121 HLHVQET---KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP 194 (307)
T ss_dssp HHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------C
T ss_pred HHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccc
Confidence 9975543 6999999999999999999999998 9999999999999999999999999998654322 2233456
Q ss_pred ccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 159 AGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 159 ~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
+||+.|||||++.+ ..++.++|||||||++|||+||+.||.......... .....+ ...|.+...+.
T Consensus 195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~----~~~p~~~~~~~ 264 (307)
T 3omv_A 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRG----YASPDLSKLYK 264 (307)
T ss_dssp CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTT----CCCCCSTTSCT
T ss_pred ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcC----CCCCCcccccc
Confidence 79999999999974 358999999999999999999999997653322111 111111 12233344444
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
..+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 55566889999999999999999999999987664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=413.80 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=196.1
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
||+|+||+||+|.+. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|+|||||+||+|.
T Consensus 32 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~ 111 (350)
T 4b9d_A 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLF 111 (350)
T ss_dssp C------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 899999999999876 6999999999754 3445578999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++...+. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...... ......
T Consensus 112 ~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~ 185 (350)
T 4b9d_A 112 KRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARAC 185 (350)
T ss_dssp HHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHHH
T ss_pred HHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-cccccc
Confidence 99975432 26789999999999999999999999 9999999999999999999999999998654321 223446
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..+... .....+....
T Consensus 186 ~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~~i~~~---------~~~~~~~~~s 250 (350)
T 4b9d_A 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LV---LKIISG---------SFPPVSLHYS 250 (350)
T ss_dssp HSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHHT---------CCCCCCTTSC
T ss_pred CCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH---HHHHcC---------CCCCCCccCC
Confidence 79999999999999999999999999999999999999997643211 11 111111 1112222334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 45888999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=405.26 Aligned_cols=244 Identities=23% Similarity=0.276 Sum_probs=201.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|.+. +|+.||||+++.+.. ..+|+.+++.++|||||++++++.+++..++|||||+||+|.++
T Consensus 66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~ 140 (336)
T 4g3f_A 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHH
T ss_pred eccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHH
Confidence 899999999999876 699999999975432 24699999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcce----ee
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTH----VS 155 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~----~~ 155 (322)
+...+ .+++..++.++.||+.||+|||+++ |+||||||+||||+.+| .+||+|||+++........ ..
T Consensus 141 l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~ 213 (336)
T 4g3f_A 141 IKQMG----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213 (336)
T ss_dssp HHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred HHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence 97654 7999999999999999999999999 99999999999999988 5999999999876433211 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|||||++.+..++.++|||||||++|||++|..||...........+ .... +.+...++
T Consensus 214 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-------~~~~~~~~ 280 (336)
T 4g3f_A 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEP-------PPIREIPP 280 (336)
T ss_dssp CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSC-------CGGGGSCT
T ss_pred CccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCC-------CCchhcCc
Confidence 2357999999999999999999999999999999999999999876554433222 1111 11112233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.....+.+++.+||+.||.+|||+.|+++.|....
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 33455888999999999999999999998876554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=405.81 Aligned_cols=241 Identities=22% Similarity=0.388 Sum_probs=202.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+|||||++|+|.++
T Consensus 82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~ 161 (346)
T 4fih_A 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 161 (346)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHH
T ss_pred eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence 899999999999876 7999999999766555567789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++........ .....+|
T Consensus 162 l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~G 232 (346)
T 4fih_A 162 VTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 232 (346)
T ss_dssp HHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCS
T ss_pred HHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccccc
Confidence 9653 5999999999999999999999999 99999999999999999999999999987654322 2345689
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
|+.|+|||++.+..|+.++|||||||++|||++|..||......+ ... .+... ..+.+ ........+
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---~i~~~------~~~~~-~~~~~~s~~ 299 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK---MIRDN------LPPRL-KNLHKVSPS 299 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHS------SCCCC-SCGGGSCHH
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH---HHHcC------CCCCC-CccccCCHH
Confidence 999999999999999999999999999999999999997542211 111 11111 11111 112233445
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+++.+||+.||++|||+.|+++
T Consensus 300 ~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 300 LKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 888999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=399.27 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=201.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||+||+|.+. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|||||+||+
T Consensus 39 ~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~ 118 (311)
T 4aw0_A 39 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118 (311)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 4899999999999876 7999999999753 23345789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 155 (322)
|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 119 L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 119 LLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp HHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 999997654 7999999999999999999999999 9999999999999999999999999998765332 2334
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... .+.. +. .. ++.
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~---~i~~-~~------~~---~p~ 255 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFA---KIIK-LE------YD---FPE 255 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHH-TC------CC---CCT
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHc-CC------CC---CCc
Confidence 457899999999999999999999999999999999999999975422 11111 1111 11 11 122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVV 263 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl 263 (322)
....++.+++.+||+.||++|||++|++
T Consensus 256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2334578899999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=407.09 Aligned_cols=241 Identities=22% Similarity=0.374 Sum_probs=202.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+|+|||||+||+|.++
T Consensus 159 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~ 238 (423)
T 4fie_A 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 238 (423)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred eccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHH
Confidence 899999999999876 6999999999876666667889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||++........ .....+|
T Consensus 239 i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~G 309 (423)
T 4fie_A 239 VTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 309 (423)
T ss_dssp HHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCEE
T ss_pred Hhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccccccc
Confidence 9643 5999999999999999999999999 99999999999999999999999999987644322 2345689
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
|+.|||||++.+..|+.++|||||||++|||++|..||...... .... .+.... .+.+. .......+
T Consensus 310 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~i~~~~------~~~~~-~~~~~s~~ 376 (423)
T 4fie_A 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK---MIRDNL------PPRLK-NLHKVSPS 376 (423)
T ss_dssp CTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHSC------CCCCS-CTTSSCHH
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HHHcCC------CCCCc-ccccCCHH
Confidence 99999999999999999999999999999999999999754221 1111 111111 11111 11222345
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+++.+||+.||++|||+.|+++
T Consensus 377 ~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 377 LKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 888999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=388.19 Aligned_cols=241 Identities=26% Similarity=0.423 Sum_probs=193.6
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~ 74 (322)
||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.++++++|||||++++++.+ +...++|||||++
T Consensus 34 iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~g 113 (290)
T 3fpq_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS 113 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCC
Confidence 899999999999876 6899999998644 34455789999999999999999999999865 3457999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCCCcce
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
|+|.+++.... .+++..+..|+.||+.||+|||+++ ++|+||||||+|||++ .++.+||+|||++......
T Consensus 114 g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--- 185 (290)
T 3fpq_A 114 GTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 185 (290)
T ss_dssp CBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence 99999997654 7999999999999999999999863 3599999999999998 4799999999999864432
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....+||+.|||||++.+ .++.++|||||||++|||+||+.||........ .. ..+ ..+... +.+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~---~~i-~~~~~~----~~~--- 251 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-TSGVKP----ASF--- 251 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-TTTCCC----GGG---
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH---HHH-HcCCCC----CCC---
Confidence 2235679999999998865 699999999999999999999999975432211 11 111 111111 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.....++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112234788999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=384.55 Aligned_cols=238 Identities=23% Similarity=0.347 Sum_probs=185.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|... +|+.||||+++... ......+.+|+.++++++|||||++++++.+++..++||||+ +|+
T Consensus 20 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~ 98 (275)
T 3hyh_A 20 TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 98 (275)
T ss_dssp EEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCC
Confidence 3899999999999876 69999999997542 334567999999999999999999999999999999999999 679
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..+. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 99 L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~ 169 (275)
T 3hyh_A 99 LFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLK 169 (275)
T ss_dssp HHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccC
Confidence 999997654 7999999999999999999999999 9999999999999999999999999998654322 234
Q ss_pred ccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 157 RVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .... ..+. .+. . .++.
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~---~~i~-~~~------~---~~p~ 233 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLF---KNIS-NGV------Y---TLPK 233 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHH-HTC------C---CCCT
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHH-cCC------C---CCCC
Confidence 4679999999999998876 5799999999999999999999975321 1111 1111 111 1 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....++.+++.+||+.||++|||++|+++
T Consensus 234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 23345788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=388.78 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=189.8
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||+||+|+.. +++.||||+++... ......+.+|+.++++++|||||++++++.+++..++|||||+|
T Consensus 31 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 110 (304)
T 3ubd_A 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG 110 (304)
T ss_dssp EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTT
T ss_pred EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCC
Confidence 3899999999999762 47889999997542 22335688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 111 g~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 182 (304)
T 3ubd_A 111 GDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 182 (304)
T ss_dssp CEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC------CC
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC-cc
Confidence 99999997654 7999999999999999999999999 9999999999999999999999999998653322 22
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....+||+.|+|||++.+..++.++|||||||++|||++|..||......+ ... .+.. +. . .++
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~-~~------~---~~p 246 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT---MILK-AK------L---GMP 246 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC------C---CCC
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH---HHHc-CC------C---CCC
Confidence 344679999999999999999999999999999999999999997543221 111 1111 11 1 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTM-----KQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~-----~evl~ 264 (322)
.....++.+++.+||+.||++|||+ +|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 2233458889999999999999985 56654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=391.38 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=204.9
Q ss_pred CcccCcceEEEEEEECC------CCEEEEEEecccC-hhcHHHHHHHHHHHhcCCC-CcccccceEEEeC-CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLRD------GTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRH-PNLVQLIGCCVED-NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~~~lv~e~ 71 (322)
.||+|+||+||+|.+.. ++.||||.++... ....+.+.+|+.+|.+++| ||||+++++|.+. +.+++||||
T Consensus 71 ~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey 150 (353)
T 4ase_A 71 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 150 (353)
T ss_dssp EEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEEC
T ss_pred EEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEc
Confidence 38999999999997642 3579999997653 3445789999999999966 8999999999765 568999999
Q ss_pred CCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe
Q 020720 72 LENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG 139 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~ 139 (322)
|++|+|.+++..... ....+++..+..++.|||.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~ 227 (353)
T 4ase_A 151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 227 (353)
T ss_dssp CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEEC
Confidence 999999999975432 1235899999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHH
Q 020720 140 DFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLR 217 (322)
Q Consensus 140 Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 217 (322)
|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |..||.......... ...
T Consensus 228 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~------~~i 301 (353)
T 4ase_A 228 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRL 301 (353)
T ss_dssp CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH------HHH
T ss_pred cchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH------HHH
Confidence 9999986644332 23345678999999999999999999999999999999998 899998654332211 111
Q ss_pred hcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 218 EEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+.. +. .+.....++.+++.+||+.||++|||+.||++.|+.++.
T Consensus 302 ~~g~~-----~~---~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 302 KEGTR-----MR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHTCC-----CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC-----CC---CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 11111 11 222334458889999999999999999999999988764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=381.63 Aligned_cols=258 Identities=30% Similarity=0.364 Sum_probs=194.3
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC----eeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN----NRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L 77 (322)
||+|+||+||+|.+. |+.||||+++..... ...+..|+..+.+++|||||++++++.+++ .+++||||+++|+|
T Consensus 11 iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL 88 (303)
T 3hmm_A 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp EEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred EeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcH
Confidence 899999999999885 899999999754321 223345666677889999999999998764 57999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA-----DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++... .+++..++.++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 163 (303)
T 3hmm_A 89 FDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp HHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred HHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence 9999754 5899999999999999999999861 12399999999999999999999999999986543322
Q ss_pred e---eecccccCCCCCchHHHhhC------CCCcccceehhhHHHHHHHhCCCCCCcccCCCchh--------HHHHHHH
Q 020720 153 H---VSTRVAGTMGYLAPEYALLG------QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI--------LVEWTWK 215 (322)
Q Consensus 153 ~---~~~~~~~t~~y~aPE~~~~~------~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~--------~~~~~~~ 215 (322)
. .....+||+.|+|||++.+. .++.++|||||||++|||+||..||.......... .......
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 243 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHH
Confidence 2 12345799999999999764 36789999999999999999987765432211100 0011111
Q ss_pred HHhcCccccccCccCCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 216 LREEGRLLEIVDPELTQF--PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.... ..++|.+... ..+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 244 ~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 244 VVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111 1223333221 2356677899999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=378.25 Aligned_cols=243 Identities=22% Similarity=0.352 Sum_probs=184.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------------eeE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------------NRI 66 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~ 66 (322)
.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+ ..+
T Consensus 12 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ 91 (299)
T 4g31_A 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91 (299)
T ss_dssp EEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEE
Confidence 4899999999999876 79999999997654 334578999999999999999999999987654 368
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 67 LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 67 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+|||||++|+|.+++.... .....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~ 167 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167 (299)
T ss_dssp EEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--
T ss_pred EEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCcccee
Confidence 9999999999999997653 2224566778999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcce-----------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH
Q 020720 147 FPDNVTH-----------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK 215 (322)
Q Consensus 147 ~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 215 (322)
....... .....+||+.|||||++.+..++.++|||||||++|||++ ||.... ........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~~~~ 239 (299)
T 4g31_A 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVRTLTD 239 (299)
T ss_dssp ------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHH
T ss_pred cCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHHHHH
Confidence 5432211 1234579999999999999999999999999999999996 765321 11111111
Q ss_pred HHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 216 LREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. . .............+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~-~--------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 240 VR-N--------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-T--------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Hh-c--------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1 1111112233345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=371.99 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=195.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe------CCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE------DNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~ 71 (322)
.||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.. .+..|+||||
T Consensus 61 ~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~ 140 (398)
T 4b99_A 61 TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL 140 (398)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEEC
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeC
Confidence 3899999999999876 7999999999754 33445778999999999999999999998754 3578999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
|+ |+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 141 ~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 141 ME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp CS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 96 57999996543 7999999999999999999999999 9999999999999999999999999998654321
Q ss_pred ---ceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 152 ---THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 152 ---~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
.......+||+.|+|||++.+. .++.++||||+||++|||++|..||.+....+.+..+ .... +.......
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~--g~p~~~~~ 287 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVL--GTPSPAVI 287 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHH--CCCCGGGT
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhc--CCCChHHh
Confidence 2223456899999999998875 5689999999999999999999999865433322222 1110 00000000
Q ss_pred ---------------ccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 ---------------PELTQFP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 ---------------~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+.....+ +....++.+++.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111 1123457889999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=358.31 Aligned_cols=271 Identities=45% Similarity=0.779 Sum_probs=233.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
+||+|+||.||+|..++|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.++
T Consensus 46 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 125 (321)
T 2qkw_B 46 LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125 (321)
T ss_dssp CSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGG
T ss_pred eeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHH
Confidence 48999999999999888999999998876666678899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceeecccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTRVA 159 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~ 159 (322)
+.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ........
T Consensus 126 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 202 (321)
T 2qkw_B 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202 (321)
T ss_dssp SSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCE
T ss_pred HhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccC
Confidence 9766544457999999999999999999999999 9999999999999999999999999998643222 12223345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC-CCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (322)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+.......+.+...+++.+ ........
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (321)
T 2qkw_B 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESL 282 (321)
T ss_dssp EETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHH
T ss_pred CCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHH
Confidence 89999999999999999999999999999999999999987766665555555555555555666666665 45667888
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCcc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNE 274 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~~ 274 (322)
..+.+++.+||+.||++||++.|+++.|+......+
T Consensus 283 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 899999999999999999999999999998876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=380.29 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=195.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHH---HHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFL---TEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||+||+|... +|+.||||++.... ......+. .++.+++.++|||||++++++.+.+.+|+||||++
T Consensus 196 ~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~ 275 (689)
T 3v5w_A 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 275 (689)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCC
Confidence 4899999999999876 69999999996431 12223333 44677778899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.......
T Consensus 276 GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-- 346 (689)
T 3v5w_A 276 GGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346 (689)
T ss_dssp SCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC--
Confidence 999999997654 6999999999999999999999999 9999999999999999999999999998764432
Q ss_pred eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
....+||+.|+|||++.. ..++.++|||||||++|||++|..||......+......... ... . .
T Consensus 347 -~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~~------~---~ 412 (689)
T 3v5w_A 347 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMA------V---E 412 (689)
T ss_dssp -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HCC------C---C
T ss_pred -CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CCC------C---C
Confidence 234689999999999974 579999999999999999999999998765544332221111 110 1 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
++.....++.+++.+||+.||.+|++ ++||++
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 22223345888999999999999998 678765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=379.37 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=203.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+.+++|||||+||+|.+
T Consensus 164 ~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~ 243 (573)
T 3uto_A 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243 (573)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHH
Confidence 3899999999999876 799999999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC--CeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN--FHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........ ...
T Consensus 244 ~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--~~~ 315 (573)
T 3uto_A 244 KVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKV 315 (573)
T ss_dssp HHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--EEE
T ss_pred HHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--eee
Confidence 996443 26899999999999999999999999 9999999999999854 8899999999997654322 344
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.+. .+.. ... ..-.+.....
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~------~i~~-~~~-~~~~~~~~~~---- 383 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR------NVKS-CDW-NMDDSAFSGI---- 383 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHT-TCC-CCCSGGGTTS----
T ss_pred eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHh-CCC-CCCcccccCC----
Confidence 579999999999999999999999999999999999999997643322111 1111 100 0001111222
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.||.+||++.|+++.
T Consensus 384 s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 384 SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3347889999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=355.03 Aligned_cols=190 Identities=29% Similarity=0.399 Sum_probs=162.8
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||+||+|..+ +++.||+|.+.... ....+.+|+++++.+ +||||+++++++.+.+..++||||++++
T Consensus 28 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~ 105 (361)
T 4f9c_A 28 KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE 105 (361)
T ss_dssp EEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCC
T ss_pred EEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcc
Confidence 3899999999999653 46789999986443 346788999999998 6999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcc--
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~-- 152 (322)
+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 106 ~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 106 SFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp CHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred cHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 9999982 5899999999999999999999999 9999999999999877 8999999999975432211
Q ss_pred -------------------------eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCccc
Q 020720 153 -------------------------HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAF 202 (322)
Q Consensus 153 -------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~ 202 (322)
......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 112235699999999999875 58999999999999999999999997543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=352.65 Aligned_cols=267 Identities=44% Similarity=0.776 Sum_probs=221.7
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|...+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 37 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 116 (326)
T 3uim_A 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116 (326)
T ss_dssp EEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHH
T ss_pred eEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHH
Confidence 3899999999999887899999999975532 223468899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc---CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE---ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
++.........+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||+|||++............
T Consensus 117 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 193 (326)
T 3uim_A 117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193 (326)
T ss_dssp HHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEEC
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCcccccccc
Confidence 9987766656799999999999999999999999 7 999999999999999999999999999876554444445
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCccc--CCCchhHHHHHHHHHhcCccccccCccC-CCC
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAF--GDDMLILVEWTWKLREEGRLLEIVDPEL-TQF 233 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... .........+..............+..+ ...
T Consensus 194 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 3uim_A 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY 273 (326)
T ss_dssp CCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC
T ss_pred cccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcccc
Confidence 5669999999999999999999999999999999999999996321 1222233333333333344444444444 456
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.......+.+++.+||+.||.+|||+.||++.|++..
T Consensus 274 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 7788889999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=341.33 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=205.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|.+. +++.||+|.+........+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+
T Consensus 17 ~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 96 (310)
T 3s95_A 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96 (310)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred eecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHH
Confidence 4899999999999876 689999999877777777899999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-----
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV----- 154 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~----- 154 (322)
++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 97 ~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (310)
T 3s95_A 97 IIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170 (310)
T ss_dssp HHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred HHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence 9976432 6899999999999999999999999 9999999999999999999999999998654332211
Q ss_pred --------ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 155 --------STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 155 --------~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||................. .
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----------~ 240 (310)
T 3s95_A 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----------L 240 (310)
T ss_dssp ---------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----------H
T ss_pred ccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----------c
Confidence 1135689999999999999999999999999999999999999875433221111000000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.... +......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 241 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 241 DRYC---PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHTC---CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111 11222348889999999999999999999999987754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=337.28 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=201.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+
T Consensus 27 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (297)
T 3fxz_A 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106 (297)
T ss_dssp EEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHH
Confidence 3899999999999865 699999999977666667889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ......
T Consensus 107 ~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 177 (297)
T 3fxz_A 107 VVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (297)
T ss_dssp HHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred HHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCcc
Confidence 99654 5899999999999999999999999 99999999999999999999999999886543322 223456
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........ +. ...+.....
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~------~~-~~~~~~~~~ 244 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT------PE-LQNPEKLSA 244 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCS------CC-CSCGGGSCH
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCC------CC-CCCccccCH
Confidence 899999999999999999999999999999999999999754321111 11111111 00 111233345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.+++.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 58899999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=337.66 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... |+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 44 ~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 122 (309)
T 3p86_A 44 KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122 (309)
T ss_dssp EEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHH
T ss_pred EeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHH
Confidence 3899999999999875 8899999987553 344568899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... ...+++..++.++.||+.||+|||+.+ ++++||||||+||+++.++.+||+|||++....... ......
T Consensus 123 ~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 199 (309)
T 3p86_A 123 RLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSA 199 (309)
T ss_dssp HHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----------------
T ss_pred HHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cccccC
Confidence 99976431 124899999999999999999999864 359999999999999999999999999997543322 122345
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....... .....+....
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~------~~~~~~~--------~~~~~~~~~~ 265 (309)
T 3p86_A 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV------AAVGFKC--------KRLEIPRNLN 265 (309)
T ss_dssp --CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHHSC--------CCCCCCTTSC
T ss_pred CCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC--------CCCCCCccCC
Confidence 6899999999999999999999999999999999999999754322111 1111111 1112223334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 45889999999999999999999999999887543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=340.22 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=199.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 22 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L 101 (328)
T 3fe3_A 22 TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 101 (328)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcH
Confidence 3899999999999874 7999999999654 344557789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 102 ~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~ 172 (328)
T 3fe3_A 102 FDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDA 172 (328)
T ss_dssp HHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGT
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cccc
Confidence 99997654 6999999999999999999999999 9999999999999999999999999998654332 2344
Q ss_pred cccCCCCCchHHHhhCCCC-cccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQLT-KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~-~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||........ . ..... +. ...+..
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~---~~i~~-~~---------~~~p~~ 236 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---R---ERVLR-GK---------YRIPFY 236 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHH-CC---------CCCCTT
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHHh-CC---------CCCCCC
Confidence 6799999999999988775 799999999999999999999975432111 1 11111 11 111222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||.+|||++|+++.
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 33457889999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=331.71 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=205.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++.+++||||+++++++.+....++||||+++++|.++
T Consensus 15 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (268)
T 3sxs_A 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93 (268)
T ss_dssp EEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred eeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHH
Confidence 389999999999998888899999997543 3456789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 94 l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 167 (268)
T 3sxs_A 94 LRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF 167 (268)
T ss_dssp HHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCC
T ss_pred HHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCc
Confidence 97543 25899999999999999999999999 9999999999999999999999999998765544333334456
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ....... ....+.....
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~---------~~~~~~~~~~ 232 (268)
T 3sxs_A 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGH---------RLYRPHLASD 232 (268)
T ss_dssp CGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTC---------CCCCCTTSCH
T ss_pred CcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCC---------CCCCCCcChH
Confidence 778999999999999999999999999999999 99998754322111 1111111 0111112234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 588899999999999999999999999888654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=332.18 Aligned_cols=248 Identities=26% Similarity=0.482 Sum_probs=204.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.++
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 95 (269)
T 4hcu_A 17 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95 (269)
T ss_dssp EEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred eecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHH
Confidence 389999999999998888899999997543 3456789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 96 l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 169 (269)
T 4hcu_A 96 LRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 169 (269)
T ss_dssp HHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTC
T ss_pred HHhcCc---ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCccc
Confidence 975432 6899999999999999999999999 9999999999999999999999999998664433222333456
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++.|+|||++.+..++.++||||||+++|+|++ |..||........ ....... ... ..+.....
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~~~~~~------~~~---~~~~~~~~ 234 (269)
T 4hcu_A 170 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG------FRL---YKPRLAST 234 (269)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTT------CCC---CCCTTSCH
T ss_pred ccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHhcC------ccC---CCCCcCCH
Confidence 778999999999999999999999999999999 9999875432211 1111111 011 11222234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 5888999999999999999999999998765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=330.99 Aligned_cols=255 Identities=28% Similarity=0.386 Sum_probs=201.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~ 97 (294)
T 4eqm_A 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97 (294)
T ss_dssp EEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCC
Confidence 3899999999999876 6899999998643 33444778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... ++++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++............
T Consensus 98 L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (294)
T 4eqm_A 98 LSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170 (294)
T ss_dssp HHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence 999997654 6999999999999999999999999 999999999999999999999999999866544333334
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...... ...... . ......
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~-~~~~~~-~---~~~~~~ 239 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQ-DSVPNV-T---TDVRKD 239 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHS-SCCCCH-H---HHSCTT
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhh-ccCCCc-c---hhcccC
Confidence 45689999999999999999999999999999999999999975432111 011111 111000 0 111122
Q ss_pred HHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccccCc
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-TMKQVVEMLSKDVHLN 273 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-s~~evl~~L~~~~~~~ 273 (322)
.+..+.+++.+||+.||.+|| +++++.+.|+......
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 334588899999999999998 8999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=339.97 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=202.9
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.+. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 56 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 135 (325)
T 3kul_A 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135 (325)
T ss_dssp EEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTC
T ss_pred EEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCC
Confidence 4899999999999875 2446999999765 4445578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce--
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 136 ~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (325)
T 3kul_A 136 SLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209 (325)
T ss_dssp BHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCE
T ss_pred cHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCcccee
Confidence 99999965432 6899999999999999999999999 999999999999999999999999999876443221
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.. ....... ...
T Consensus 210 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------~~~~~~~---------~~~ 274 (325)
T 3kul_A 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------SSVEEGY---------RLP 274 (325)
T ss_dssp ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHHTTC---------CCC
T ss_pred eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHHcCC---------CCC
Confidence 2223346778999999999999999999999999999999 99999754322111 1111111 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.+......+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 22233455889999999999999999999999999887543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=343.93 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=204.9
Q ss_pred CcccCcceEEEEEEEC--------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR--------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|.+. ++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 88 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e 167 (370)
T 2psq_A 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 167 (370)
T ss_dssp EESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEE
Confidence 3899999999999752 34579999997653 34457899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl 244 (370)
T 2psq_A 168 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKI 244 (370)
T ss_dssp CCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred cCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEE
Confidence 9999999999976532 1235889999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......... ..
T Consensus 245 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~------~~ 318 (370)
T 2psq_A 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK------LL 318 (370)
T ss_dssp CCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HH
T ss_pred ccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------HH
Confidence 99999986543322 11223456788999999999999999999999999999999 999997653322111 11
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+. ....+......+.+++.+||+.||.+||++.|+++.|+++..
T Consensus 319 -~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 319 -KEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -HTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 112233344568899999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=337.65 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=201.8
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC----eeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN----NRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... ++.||||++.... ........|+.++++++||||+++++++.+.. ..++||||+++++
T Consensus 31 ~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~ 108 (322)
T 3soc_A 31 VKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS 108 (322)
T ss_dssp EEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred eecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCC
Confidence 4899999999999877 7899999997543 33345667999999999999999999998754 3699999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE----------ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
|.+++... .+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++..
T Consensus 109 L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 109 LSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp HHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred HHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 99999654 589999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCCCcc-eeecccccCCCCCchHHHhhC-----CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH--------
Q 020720 147 FPDNVT-HVSTRVAGTMGYLAPEYALLG-----QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW-------- 212 (322)
Q Consensus 147 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~-----~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~-------- 212 (322)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..............
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 543322 222335689999999999863 456789999999999999999999987654433222111
Q ss_pred -HHHHHhcCccccccCccCCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 213 -TWKLREEGRLLEIVDPELTQ--FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 213 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
....... ....+.+.. ........+.+++.+||+.||++|||+.||++.|+++..
T Consensus 261 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQEVVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000 111122211 122455679999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=330.91 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=201.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.+.++..||+|+++... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|.++
T Consensus 31 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 109 (283)
T 3gen_A 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109 (283)
T ss_dssp ECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHH
T ss_pred hcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHH
Confidence 389999999999999888899999997543 3357789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 110 l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 183 (283)
T 3gen_A 110 LREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 183 (283)
T ss_dssp HHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTS
T ss_pred HHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCcc
Confidence 97532 26999999999999999999999999 9999999999999999999999999998664433222233446
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..... + ..... +.....
T Consensus 184 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~-~-----~~~~~---~~~~~~ 248 (283)
T 3gen_A 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQ-G-----LRLYR---PHLASE 248 (283)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHT-T-----CCCCC---CTTCCH
T ss_pred CcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HHHhc-c-----cCCCC---CCcCCH
Confidence 778999999999999999999999999999998 99999764322111 11111 1 11111 122234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+.+++.+||+.||.+|||+.++++.|+....
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 58889999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=336.08 Aligned_cols=241 Identities=27% Similarity=0.300 Sum_probs=198.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||+|+++.. .......+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~ 91 (337)
T 1o6l_A 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCc
Confidence 4899999999999876 6999999999754 23345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 92 L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~ 163 (337)
T 1o6l_A 92 LFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 163 (337)
T ss_dssp HHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBC
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cccc
Confidence 999996543 6899999999999999999999999 9999999999999999999999999998543222 1223
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|+|||++.+..++.++|||||||++|||++|..||....... .. ..+.. .. . .++..
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~-~~------~---~~p~~ 227 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELILM-EE------I---RFPRT 227 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-CC------C---CCCTT
T ss_pred ccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HH---HHHHc-CC------C---CCCCC
Confidence 4579999999999999999999999999999999999999997542211 11 11111 11 1 12222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
....+.+++.+||+.||.+|| ++.|+++.
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 334588899999999999999 89999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=331.80 Aligned_cols=242 Identities=21% Similarity=0.381 Sum_probs=201.1
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.++
T Consensus 53 lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 132 (321)
T 2c30_A 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132 (321)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHH
Confidence 899999999999876 7999999999876666678899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... .....|
T Consensus 133 l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~g 203 (321)
T 2c30_A 133 VSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVG 203 (321)
T ss_dssp HTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCCCCS
T ss_pred HHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-cccccC
Confidence 8543 5899999999999999999999999 999999999999999999999999998866443222 234568
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
|+.|+|||++.+..++.++||||||+++|+|++|..||...... ... ....... .+.+ .........
T Consensus 204 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~---~~~~~~~------~~~~-~~~~~~~~~ 270 (321)
T 2c30_A 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM---KRLRDSP------PPKL-KNSHKVSPV 270 (321)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHSS------CCCC-TTGGGSCHH
T ss_pred CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHhcCC------CCCc-CccccCCHH
Confidence 99999999999999999999999999999999999999754221 111 1111111 1111 111223345
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+.+++.+||+.||++||++.|+++.
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8889999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=334.20 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=197.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh------cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ------GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 19 ~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 98 (361)
T 2yab_A 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98 (361)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCC
Confidence 3899999999999876 6999999999764321 35788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC----eEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF----HPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 149 (322)
+++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||++.....
T Consensus 99 gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 99 GGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp SCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 999999996543 6999999999999999999999999 99999999999998877 799999999987654
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ..+. .... .+.+.
T Consensus 172 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~---~~i~-~~~~--~~~~~ 240 (361)
T 2yab_A 172 GV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L---ANIT-AVSY--DFDEE 240 (361)
T ss_dssp TC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HHHH-TTCC--CCCHH
T ss_pred CC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHH-hcCC--CCCch
Confidence 32 22345699999999999999999999999999999999999999976422111 1 1111 1100 00000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. .......+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~---~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 241 F---FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp H---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h---ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0112345788999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=331.61 Aligned_cols=253 Identities=17% Similarity=0.204 Sum_probs=204.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +|+.||||++..... .+.+.+|+.+++++ +||||+++++++.+....++||||+ +++|.
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (330)
T 2izr_A 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLE 92 (330)
T ss_dssp ECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHH
Confidence 3899999999999864 789999999875432 24678899999999 9999999999999999999999999 89999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe-----EEEeeeccccccCCCcce
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH-----PKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~ 153 (322)
+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++. +||+|||++.........
T Consensus 93 ~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 93 DLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred HHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 99976422 6999999999999999999999999 999999999999999887 999999999865432221
Q ss_pred ------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 154 ------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 154 ------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........................
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----- 241 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI----- 241 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-----
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-----
Confidence 123456999999999999999999999999999999999999999877555443333322221111100
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+.... + .+.+++..||+.||.+||++++|++.|+....
T Consensus 242 ~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 242 EVLCENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0011111 2 68899999999999999999999999876643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=333.45 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 14 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (323)
T 3tki_A 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93 (323)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGG
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHH
Confidence 3899999999999876 799999999875432 23467889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 157 (322)
+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 94 ~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (323)
T 3tki_A 94 DRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (323)
T ss_dssp GGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred HHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence 9986543 6999999999999999999999999 9999999999999999999999999998653222 122234
Q ss_pred cccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..||+.|+|||++.+..+ +.++|||||||++|+|++|..||........... . ...... .......
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~----~~~~~~--------~~~~~~~ 233 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-D----WKEKKT--------YLNPWKK 233 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH-H----HHTTCT--------TSTTGGG
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-H----Hhcccc--------cCCcccc
Confidence 568999999999988775 7899999999999999999999986544322111 0 111100 0011122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 33457889999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=352.05 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=203.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+|.++
T Consensus 195 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~ 272 (454)
T 1qcf_A 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDF 272 (454)
T ss_dssp EEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHH
T ss_pred EcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHH
Confidence 389999999999999888899999997543 45688999999999999999999999986 5678999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...............+
T Consensus 273 l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 347 (454)
T 1qcf_A 273 LKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347 (454)
T ss_dssp HHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSS
T ss_pred HHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcc
Confidence 965321 25788999999999999999999999 9999999999999999999999999998654322221222345
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++....++.++|||||||++|||++ |..||......+. . ..+....+. ..+.....
T Consensus 348 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~---~~i~~~~~~---------~~~~~~~~ 412 (454)
T 1qcf_A 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I---RALERGYRM---------PRPENCPE 412 (454)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H---HHHHHTCCC---------CCCTTSCH
T ss_pred cccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHcCCCC---------CCCCCCCH
Confidence 778999999999999999999999999999999 9999975432211 1 111111111 11223345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.+.+++.+||+.||++|||+.+|++.|+.....
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 688999999999999999999999999988653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=326.56 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=208.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC--eeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--NRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++||||+++++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 95 (319)
T 4euu_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95 (319)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCB
T ss_pred EecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCC
Confidence 4899999999999876 58999999997543 344577889999999999999999999998765 7799999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe----CCCCeEEEeeeccccccCCCcc
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++ +.++.+||+|||++........
T Consensus 96 L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~ 171 (319)
T 4euu_A 96 LYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171 (319)
T ss_dssp HHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC
T ss_pred HHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc
Confidence 9999976532 224899999999999999999999999 9999999999999 8888999999999987654322
Q ss_pred eeecccccCCCCCchHHHh--------hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCch-hHHHHHHHHHhcCccc
Q 020720 153 HVSTRVAGTMGYLAPEYAL--------LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML-ILVEWTWKLREEGRLL 223 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~--------~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 223 (322)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||......... ..........+.....
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~ 249 (319)
T 4euu_A 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249 (319)
T ss_dssp --BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCE
T ss_pred --eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccch
Confidence 23346899999999987 467899999999999999999999999765443222 2221111111111110
Q ss_pred cc---------cC---ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 224 EI---------VD---PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 224 ~~---------~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.. .. +............+.+++.+||+.||++|||++|+++..+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred hhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 00 00 11124556777789999999999999999999999998876553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=342.43 Aligned_cols=250 Identities=28% Similarity=0.491 Sum_probs=192.5
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 52 ~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 131 (373)
T 2qol_A 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131 (373)
T ss_dssp EEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCC
Confidence 4899999999999764 4778999999765 3445578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV- 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 154 (322)
+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 132 sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 205 (373)
T 2qol_A 132 SLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205 (373)
T ss_dssp BHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred cHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccce
Confidence 99999975532 6899999999999999999999999 9999999999999999999999999998664332211
Q ss_pred -ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 -STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||....... .. ... ..+.. ..
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~---~~i-~~~~~--------~~ 270 (373)
T 2qol_A 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VI---KAV-DEGYR--------LP 270 (373)
T ss_dssp --------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HH---HHH-HTTEE--------CC
T ss_pred eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHH-HcCCC--------CC
Confidence 112235678999999999999999999999999999998 999997543211 11 111 11100 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 122334558899999999999999999999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=325.04 Aligned_cols=261 Identities=35% Similarity=0.594 Sum_probs=214.6
Q ss_pred cccCcceEEEEEEECCCCEEEEEEeccc----ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAE----SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|
T Consensus 39 lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 117 (307)
T 2nru_A 39 MGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117 (307)
T ss_dssp EEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred cccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcH
Confidence 899999999999874 889999998643 233457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-eeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 156 (322)
.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ....
T Consensus 118 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 193 (307)
T 2nru_A 118 LDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193 (307)
T ss_dssp HHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred HHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence 99996432 1236899999999999999999999999 99999999999999999999999999986543322 2223
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH-hcCccccccCccCCCCCH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR-EEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (322)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||............. .... ....+...+++.+...+.
T Consensus 194 ~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 270 (307)
T 2nru_A 194 RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK--EEIEDEEKTIEDYIDKKMNDADS 270 (307)
T ss_dssp SCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH--HHHHTTSCCHHHHSCSSCSCCCH
T ss_pred ccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH--HHhhhhhhhhhhhccccccccch
Confidence 4568999999998765 57899999999999999999999998765544332221 1111 122233445566667778
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.....+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 88889999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=345.01 Aligned_cols=249 Identities=28% Similarity=0.405 Sum_probs=201.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 121 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 200 (377)
T 3cbl_A 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200 (377)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHH
Confidence 3899999999999886 78999999987543 333467889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee-cc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS-TR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 157 (322)
+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........... ..
T Consensus 201 ~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~ 274 (377)
T 3cbl_A 201 TFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274 (377)
T ss_dssp HHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSC
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCC
Confidence 9997543 25899999999999999999999999 99999999999999999999999999986543221111 11
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+++.|+|||++....++.++|||||||++|||++ |..||......... .....+.. . ..+..
T Consensus 275 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~-----~---~~~~~ 339 (377)
T 3cbl_A 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKGGR-----L---PCPEL 339 (377)
T ss_dssp CEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTTCC-----C---CCCTT
T ss_pred CCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC-----C---CCCCC
Confidence 234678999999999999999999999999999998 99998764322111 11111110 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 3345888999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=352.30 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=206.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++.+....++||||+++|+|.+
T Consensus 227 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~ 305 (495)
T 1opk_A 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305 (495)
T ss_dssp ESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHH
Confidence 3899999999999887 48899999997543 346789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...............
T Consensus 306 ~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 380 (495)
T 1opk_A 306 YLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380 (495)
T ss_dssp HHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCC
T ss_pred HHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCc
Confidence 9976432 26899999999999999999999999 999999999999999999999999999876543333333344
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
++..|+|||++....++.++|||||||++|||++ |..||........... + ..+. . ...+....
T Consensus 381 ~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~------~-~~~~-----~---~~~~~~~~ 445 (495)
T 1opk_A 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------L-EKDY-----R---MERPEGCP 445 (495)
T ss_dssp CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------H-HTTC-----C---CCCCTTCC
T ss_pred CCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------H-HcCC-----C---CCCCCCCC
Confidence 6778999999999999999999999999999999 9999976543221111 1 1110 0 11222334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+.+++.+||+.||.+||++.+|++.|+....
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 558889999999999999999999999988763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=328.72 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=199.9
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++... ...++||||++
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 96 (295)
T 3ugc_A 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 96 (295)
T ss_dssp EEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCT
T ss_pred eeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCC
Confidence 389999999999974 25889999999877777778899999999999999999999998653 46899999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT- 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 152 (322)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 97 ~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (295)
T 3ugc_A 97 YGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170 (295)
T ss_dssp TCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--------
T ss_pred CCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcce
Confidence 9999999976532 5899999999999999999999999 99999999999999999999999999986643322
Q ss_pred -eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCC---------CchhHHHHHHHHHhcCcc
Q 020720 153 -HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGD---------DMLILVEWTWKLREEGRL 222 (322)
Q Consensus 153 -~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~ 222 (322)
.......++..|+|||++.+..++.++||||||+++|+|++|..|+...... ...............
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 247 (295)
T 3ugc_A 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN--- 247 (295)
T ss_dssp -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT---
T ss_pred eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc---
Confidence 1122234667799999999999999999999999999999999998643211 000000011111111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
......+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 248 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 248 -----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111223334456889999999999999999999999998765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.12 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=198.3
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||+|.+..+..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++
T Consensus 192 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l 269 (452)
T 1fmk_A 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269 (452)
T ss_dssp EEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred ecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHH
Confidence 89999999999999877889999997543 345789999999999999999999999866 6789999999999999999
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
..... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...............++
T Consensus 270 ~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 344 (452)
T 1fmk_A 270 KGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344 (452)
T ss_dssp SHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CC
T ss_pred HhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCccc
Confidence 64321 25899999999999999999999999 99999999999999999999999999986543322222334467
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
..|+|||++....++.++|||||||++|||++ |..||......+. ........+ ...+......
T Consensus 345 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~~i~~~~~---------~~~~~~~~~~ 409 (452)
T 1fmk_A 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYR---------MPCPPECPES 409 (452)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTCC---------CCCCTTSCHH
T ss_pred ccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCC---------CCCCCCCCHH
Confidence 88999999999999999999999999999999 9999975432211 111111111 1122233456
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
+.+++.+||+.||++|||+.+|++.|+......
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 889999999999999999999999999887544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=324.37 Aligned_cols=255 Identities=21% Similarity=0.243 Sum_probs=205.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++||||+ +++|.
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 93 (298)
T 1csn_A 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 93 (298)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHH
Confidence 3899999999999864 78999999986443 234678899999999 8999999999999999999999999 89999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe-----EEEeeeccccccCCCcce
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH-----PKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~ 153 (322)
+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++. +||+|||++.........
T Consensus 94 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 94 DLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred HHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 99976532 5899999999999999999999998 999999999999987776 999999999865433221
Q ss_pred ------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 154 ------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 154 ------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..........................
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 244 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE--- 244 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH---
T ss_pred ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH---
Confidence 12345689999999999999999999999999999999999999987655444333322222111111100
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.... ....+.+++.+||+.||++||++.+|++.|+.....
T Consensus 245 -~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 245 -LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp -HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0112 234588999999999999999999999999887653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=325.40 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|...+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++ +|.
T Consensus 28 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 106 (311)
T 3niz_A 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK 106 (311)
T ss_dssp EEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHH
T ss_pred hccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHH
Confidence 3899999999999988899999999975432 2346788999999999999999999999999999999999985 788
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 107 ~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 179 (311)
T 3niz_A 107 KVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHE 179 (311)
T ss_dssp HHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----CC
T ss_pred HHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccCC
Confidence 88865432 6899999999999999999999999 99999999999999999999999999986643322 22334
Q ss_pred ccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc------cC---c
Q 020720 159 AGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI------VD---P 228 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~ 228 (322)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+............... .. .
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 68999999999876 56899999999999999999999999876655543332111100000000000 00 0
Q ss_pred cCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELTQ-----FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.... ..+....++.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 01112345889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=338.07 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=194.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|+.||+|+++.. .......+.+|..+++.+ +||||+++++++.+.+..++||||+++|
T Consensus 30 ~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg 109 (353)
T 3txo_A 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG 109 (353)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCC
Confidence 4899999999999876 6899999999754 233456788999999988 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 110 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~ 181 (353)
T 3txo_A 110 DLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTT 181 (353)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC-ccc
Confidence 9999997654 6999999999999999999999999 9999999999999999999999999998543222 223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|||++|..||......+.. ..+.. +. ..++.
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~-~~---------~~~p~ 245 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAILN-DE---------VVYPT 245 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CC---------CCCCT
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH------HHHHc-CC---------CCCCC
Confidence 3467999999999999999999999999999999999999999764322111 11111 11 11122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM------KQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~------~evl~ 264 (322)
.....+.+++.+||+.||.+||++ .|+++
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 233457889999999999999998 77765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=335.83 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=203.8
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 54 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 133 (343)
T 1luf_A 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133 (343)
T ss_dssp EEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCC
Confidence 3899999999999764 34789999997653 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCC--------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC
Q 020720 74 NNSLANALLGSKSK--------------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 74 ~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~ 133 (322)
+++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 134 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~ 210 (343)
T 1luf_A 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 210 (343)
T ss_dssp TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCC
Confidence 99999999764321 146899999999999999999999999 9999999999999999
Q ss_pred CeEEEeeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~ 211 (322)
+.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~- 286 (343)
T 1luf_A 211 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---VI- 286 (343)
T ss_dssp GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH-
T ss_pred CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH---HH-
Confidence 9999999999976532221 11223457889999999999999999999999999999999 999997543211 11
Q ss_pred HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 212 WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
... ..+ .....+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 287 --~~~-~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 287 --YYV-RDG--------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp --HHH-HTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --HHH-hCC--------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 111 111 1112223334568899999999999999999999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=326.88 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=197.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 97 (326)
T 2y0a_A 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97 (326)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCC
Confidence 3899999999999876 689999999975432 245789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC----eEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF----HPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 149 (322)
+++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++.....
T Consensus 98 ~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 98 GGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp SCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred CCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 999999996543 6999999999999999999999999 99999999999999887 799999999986643
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....... . ......
T Consensus 171 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~-~-~~~~~~ 240 (326)
T 2y0a_A 171 GNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSAVN-Y-EFEDEY 240 (326)
T ss_dssp TSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHHTC-C-CCCHHH
T ss_pred CCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHhcC-C-CcCccc
Confidence 221 23456899999999999999999999999999999999999999754221111 1111100 0 000000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 241 FSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011 23457889999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=325.43 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=190.6
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++||||++++
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~ 100 (281)
T 1mp8_A 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG 100 (281)
T ss_dssp EEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTE
T ss_pred EeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCC
Confidence 38999999999997642 456999998754 3344578899999999999999999999974 56789999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 101 ~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (281)
T 1mp8_A 101 ELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174 (281)
T ss_dssp EHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccccc
Confidence 99999975532 6899999999999999999999999 99999999999999999999999999986654333223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +.. + .....+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~------i~~-~--------~~~~~~ 239 (281)
T 1mp8_A 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR------IEN-G--------ERLPMP 239 (281)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------HHT-T--------CCCCCC
T ss_pred ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH------HHc-C--------CCCCCC
Confidence 33456788999999999999999999999999999996 9999976543322111 111 1 111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
......+.+++.+||+.||++||++.|+++.|+....
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3334558889999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=328.99 Aligned_cols=238 Identities=26% Similarity=0.353 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||+|+++... ....+.+.+|..+++.++||||+++++++.+....++||||+++++
T Consensus 13 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~ 92 (318)
T 1fot_A 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 92 (318)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCC
Confidence 4899999999999876 69999999997542 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 93 L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~ 161 (318)
T 1fot_A 93 LFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TY 161 (318)
T ss_dssp HHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BC
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc----cc
Confidence 999997654 6899999999999999999999999 999999999999999999999999999865432 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+.... . .++..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~---~~i~~~~-------~---~~p~~ 225 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY---EKILNAE-------L---RFPPF 225 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHCC-------C---CCCTT
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCC-------C---CCCCC
Confidence 4568999999999999999999999999999999999999997542211 11 1111111 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
...++.+++.+||+.||++|| +++|+++.
T Consensus 226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 334588899999999999999 88888753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=328.25 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=198.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 12 ~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~ 90 (321)
T 1tki_A 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHH
Confidence 3899999999999876 6889999998754 3445678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC--CCeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG--NFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||++........ ...
T Consensus 91 ~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 162 (321)
T 1tki_A 91 RINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRL 162 (321)
T ss_dssp HHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--EEE
T ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--ccc
Confidence 996543 26899999999999999999999999 999999999999987 78999999999987654322 234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+|+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ....... .. ...+.....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~-~~-~~~~~~~~~---- 230 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMNAE-YT-FDEEAFKEI---- 230 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTC-CC-CCHHHHTTS----
T ss_pred ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH---HHHHcCC-CC-CChhhhccC----
Confidence 568999999999998889999999999999999999999997643221 11 1111111 00 000001122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 231 s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 231 SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3458899999999999999999999973
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=334.66 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=197.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-----hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 31 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 110 (351)
T 3c0i_A 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG 110 (351)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSS
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 3899999999999876 69999999986431 22457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccccCCCc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKLFPDNV 151 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 151 (322)
++|.+.+.........+++..++.++.||+.||.|||+++ ++||||||+||+++.++. +||+|||++.......
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 187 (351)
T 3c0i_A 111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187 (351)
T ss_dssp CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS
T ss_pred CCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC
Confidence 9998888654333336899999999999999999999999 999999999999986654 9999999998765432
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc-cC
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP-EL 230 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 230 (322)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ... ..... +... ..+ ..
T Consensus 188 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~~-~~~~--~~~~~~ 256 (351)
T 3c0i_A 188 L-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGIIK-GKYK--MNPRQW 256 (351)
T ss_dssp C-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHHH-TCCC--CCHHHH
T ss_pred e-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHHc-CCCC--CCcccc
Confidence 2 22345689999999999999999999999999999999999999976321 111 11111 1100 000 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... ...+.+++.+||+.||++||++.|+++
T Consensus 257 ~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 257 SHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112 345888999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=325.91 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=207.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|.+. ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 98 (288)
T 3kfa_A 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98 (288)
T ss_dssp ESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred ecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 3899999999999877 5889999999754 3446788999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...............
T Consensus 99 ~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 173 (288)
T 3kfa_A 99 YLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173 (288)
T ss_dssp HHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEE
T ss_pred HHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCc
Confidence 9976432 26899999999999999999999999 999999999999999999999999999876655444444556
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
+++.|+|||++.+..++.++||||||+++|+|++ |..||............ . .. .. ...+....
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~------~-~~-----~~---~~~~~~~~ 238 (288)
T 3kfa_A 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------E-KD-----YR---MERPEGCP 238 (288)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH------H-TT-----CC---CCCCTTCC
T ss_pred cccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------h-cc-----CC---CCCCCCCC
Confidence 7889999999999999999999999999999999 89998765332221111 1 11 00 11122233
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+.+++.+||+.||.+||++.++++.|+....
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 458899999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=339.08 Aligned_cols=255 Identities=30% Similarity=0.438 Sum_probs=205.3
Q ss_pred CcccCcceEEEEEEEC--------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR--------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|... .+..||+|+++.. .......+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 76 ~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e 155 (382)
T 3tt0_A 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 155 (382)
T ss_dssp EEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEE
Confidence 3899999999999752 2357999999765 344457889999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++++|.+++..... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 156 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL 232 (382)
T 3tt0_A 156 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKI 232 (382)
T ss_dssp CCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred ecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEE
Confidence 9999999999976542 1235899999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... . ...
T Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---~----~~~ 305 (382)
T 3tt0_A 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L----FKL 305 (382)
T ss_dssp CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H----HHH
T ss_pred cccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHH
Confidence 99999986543221 22233456788999999999999999999999999999999 999987543211 1 111
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
...+. ....+......+.+++.+||+.||++||++.||++.|+++....
T Consensus 306 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 306 LKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHTTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHcCC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111 11112223345888999999999999999999999999887543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=335.92 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=202.7
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCe-eEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNN-RILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~lv~e~ 71 (322)
.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+. .++||||
T Consensus 29 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~ 108 (359)
T 3vhe_A 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 108 (359)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEEC
T ss_pred eecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEe
Confidence 389999999999973 246789999997653 34457799999999999 78999999999987654 8999999
Q ss_pred CCCCCHHHHHhcCCCC--------------------------------------------------------------Cc
Q 020720 72 LENNSLANALLGSKSK--------------------------------------------------------------YV 89 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~--------------------------------------------------------------~~ 89 (322)
+++|+|.+++...... ..
T Consensus 109 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3vhe_A 109 CKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188 (359)
T ss_dssp CTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTT
T ss_pred cCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhcc
Confidence 9999999999765421 11
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-eeecccccCCCCCchH
Q 020720 90 SLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPE 168 (322)
Q Consensus 90 ~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE 168 (322)
.+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .......+|+.|+|||
T Consensus 189 ~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 189 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265 (359)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChh
Confidence 2889999999999999999999999 99999999999999999999999999986543322 2233456888999999
Q ss_pred HHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHh
Q 020720 169 YALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLF 247 (322)
Q Consensus 169 ~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 247 (322)
++.+..++.++|||||||++|+|++ |..||........... ....+. ....+......+.+++.+
T Consensus 266 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------~~~~~~--------~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR------RLKEGT--------RMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH------HHHHTC--------CCCCCTTCCHHHHHHHHH
T ss_pred hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH------HHHcCC--------CCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999998 9999976544322111 111111 111122233458889999
Q ss_pred cccCCCCCCCCHHHHHHHHhcccc
Q 020720 248 CTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 248 cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
||+.||.+||++.|+++.|+....
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999999987753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=329.29 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=204.6
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.. .++..||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (314)
T 2ivs_A 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109 (314)
T ss_dssp EEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecC
Confidence 389999999999975 23578999999754 34445788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC--------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC
Q 020720 74 NNSLANALLGSKS--------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 74 ~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~ 133 (322)
+++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~ 186 (314)
T 2ivs_A 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEG 186 (314)
T ss_dssp TCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred CCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCC
Confidence 9999999976542 1234889999999999999999999999 9999999999999999
Q ss_pred CeEEEeeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~ 211 (322)
+.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 187 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-- 264 (314)
T 2ivs_A 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-- 264 (314)
T ss_dssp TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--
T ss_pred CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence 99999999999866433222 2223456788999999999999999999999999999999 9999976543221111
Q ss_pred HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 212 WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+. ....+......+.+++.+||+.||.+||++.++++.|+++..
T Consensus 265 -----~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 265 -----LKTGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp -----HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hhcCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 111222334558899999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=331.55 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=195.4
Q ss_pred CcccCcceEEEEEEEC-CCCE----EEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQ----IAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. +++. ||+|.++.. .....+.+.+|+.++++++||||+++++++.+.. .+++++|+.+
T Consensus 22 ~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~ 100 (327)
T 3poz_A 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPF 100 (327)
T ss_dssp EEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTT
T ss_pred EEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCC
Confidence 4899999999999765 4443 588887543 3345578999999999999999999999998754 7889999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
|+|.+++..... .+++..++.|+.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 101 g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 174 (327)
T 3poz_A 101 GCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp CBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccc
Confidence 999999976543 6899999999999999999999999 999999999999999999999999999876433222
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........... ...+. ...
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~--------~~~ 239 (327)
T 3poz_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE--------RLP 239 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTC--------CCC
T ss_pred cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcCC--------CCC
Confidence 2223446789999999999999999999999999999999 9999976543322111 11111 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.+......+.+++.+||+.||.+||++.++++.|+.....
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 2233345688999999999999999999999999887653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.41 Aligned_cols=243 Identities=32% Similarity=0.463 Sum_probs=200.2
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-eeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-NRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.++++++||||+++++++.+.. ..++||||+++|+|.+
T Consensus 200 ~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~ 276 (450)
T 1k9a_A 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276 (450)
T ss_dssp EEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHH
T ss_pred eecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHH
Confidence 3899999999999887 7899999997543 4578999999999999999999999987765 7899999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++....... ....
T Consensus 277 ~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~ 347 (450)
T 1k9a_A 277 YLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGK 347 (450)
T ss_dssp HHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----------C
T ss_pred HHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cCCC
Confidence 9976532 24789999999999999999999999 9999999999999999999999999998543221 1234
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+ ..+. . ...+....
T Consensus 348 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~~-----~---~~~p~~~~ 412 (450)
T 1k9a_A 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY-----K---MDAPDGCP 412 (450)
T ss_dssp CCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-------HTTC-----C---CCCCTTCC
T ss_pred CCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC-----C---CCCCCcCC
Confidence 6889999999999999999999999999999998 99999876544322111 1111 0 11223334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
..+.++|.+||+.||++|||+.++++.|+.+.
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 56888999999999999999999999998765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.31 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=195.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|... +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 96 ~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~ 175 (373)
T 2x4f_A 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175 (373)
T ss_dssp ECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHH
T ss_pred EEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 3899999999999775 699999999987766677889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe--CCCCeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL--DGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||++........ ...
T Consensus 176 ~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 176 RIIDES---YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp HHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 886543 26899999999999999999999999 9999999999999 6778999999999987644322 223
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+.... . ..........
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~-~-~~~~~~~~~~---- 315 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACR-W-DLEDEEFQDI---- 315 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC-C-CSCSGGGTTS----
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcc-C-CCChhhhccC----
Confidence 46899999999999889999999999999999999999999764322111 1111110 0 0011111223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.+++.+||+.||.+||++.|+++
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 345889999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=323.01 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=203.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.++
T Consensus 15 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (267)
T 3t9t_A 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93 (267)
T ss_dssp EEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHH
T ss_pred EecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHH
Confidence 389999999999998888899999997543 3347889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 94 ~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 167 (267)
T 3t9t_A 94 LRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 167 (267)
T ss_dssp HHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTC
T ss_pred HhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccccccc
Confidence 976532 6899999999999999999999999 9999999999999999999999999998654332222233446
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
++.|+|||++.+..++.++||||||+++|+|++ |..||....... . ........ .. ..+.....
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~i~~~~------~~---~~~~~~~~ 232 (267)
T 3t9t_A 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V---VEDISTGF------RL---YKPRLAST 232 (267)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTTC------CC---CCCTTSCH
T ss_pred cccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---H---HHHHhcCC------cC---CCCccCcH
Confidence 778999999999999999999999999999999 899987542211 1 11111110 01 11222334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5888999999999999999999999998765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=333.35 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L 115 (362)
T 2bdw_A 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115 (362)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCH
Confidence 3899999999999876 6899999999754 334457789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---CeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN---FHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+.+.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++....... .
T Consensus 116 ~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~ 186 (362)
T 2bdw_A 116 FEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--A 186 (362)
T ss_dssp HHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--S
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--c
Confidence 99996543 6899999999999999999999999 9999999999999865 459999999998665332 2
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..+.. +.. ....+..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~---~~i~~-~~~-~~~~~~~---- 254 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY---AQIKA-GAY-DYPSPEW---- 254 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHH-TCC-CCCTTGG----
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHh-CCC-CCCcccc----
Confidence 23456999999999999989999999999999999999999999754221 111 11111 110 0000111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.+++.+||+.||.+||++.|+++.
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1223458889999999999999999999763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=336.71 Aligned_cols=242 Identities=23% Similarity=0.343 Sum_probs=199.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+.+|+
T Consensus 22 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~ 101 (384)
T 4fr4_A 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGD 101 (384)
T ss_dssp EEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCc
Confidence 4899999999999876 68999999986532 3345788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 102 L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~ 172 (384)
T 4fr4_A 102 LRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QIT 172 (384)
T ss_dssp HHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBC
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC--cee
Confidence 999997654 6999999999999999999999999 9999999999999999999999999998664332 224
Q ss_pred ccccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 157 RVAGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
...||+.|+|||++.. ..++.++|||||||++|+|++|..||.............. .. ......
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~----------~~~~~~ 239 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FE----------TTVVTY 239 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HH----------HCCCCC
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hh----------hcccCC
Confidence 4679999999999874 4589999999999999999999999986544433222211 11 111122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPT-MKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps-~~evl~ 264 (322)
+......+.+++.+||+.||.+||+ +++++.
T Consensus 240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 3333456889999999999999998 677654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=333.53 Aligned_cols=239 Identities=23% Similarity=0.350 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+ +|+
T Consensus 16 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~ 94 (336)
T 3h4j_B 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGE 94 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCc
Confidence 3899999999999875 78999999986432 222357889999999999999999999999999999999999 678
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 95 l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~ 165 (336)
T 3h4j_B 95 LFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLK 165 (336)
T ss_dssp HHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TTC
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--ccc
Confidence 988886553 6999999999999999999999999 9999999999999999999999999998654332 223
Q ss_pred ccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 157 RVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ..+.......+.
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~~~~~p~ 229 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSCVYVMPD 229 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSSCCCCCT
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcCCCCCcc
Confidence 4569999999999987776 68999999999999999999999764332211 111111222233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 334558889999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.20 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=200.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 58 ~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~ 137 (387)
T 1kob_A 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 137 (387)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHH
Confidence 3899999999999876 689999999987766667789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC--CCeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG--NFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|||++........ ...
T Consensus 138 ~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~ 209 (387)
T 1kob_A 138 RIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKV 209 (387)
T ss_dssp HTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEE
T ss_pred HHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc--eee
Confidence 996543 26899999999999999999999999 999999999999974 47799999999987654322 233
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .+.... . .+.+. .....
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~i~~~~-~--~~~~~---~~~~~ 277 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVKRCD-W--EFDED---AFSSV 277 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHHCC-C--CCCSS---TTTTS
T ss_pred eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCC-C--CCCcc---ccccC
Confidence 46899999999999999999999999999999999999999764221 1111 111110 0 01111 11122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 3458899999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=321.96 Aligned_cols=245 Identities=30% Similarity=0.509 Sum_probs=189.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh----hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK----QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|.+. ++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 14 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (271)
T 3dtc_A 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP 92 (271)
T ss_dssp EEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEE
T ss_pred eeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCC
Confidence 4899999999999876 88999999875432 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC--------CCeEEEeeeccccccC
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG--------NFHPKIGDFGLAKLFP 148 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~--------~~~~kl~Dfg~~~~~~ 148 (322)
|.+++... .+++..++.++.|++.||.|||+.+..+++|+||||+||+++. ++.++|+|||++....
T Consensus 93 L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 167 (271)
T 3dtc_A 93 LNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167 (271)
T ss_dssp HHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccc
Confidence 99999533 6899999999999999999999987445889999999999986 7789999999998654
Q ss_pred CCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.... ....|++.|+|||++.+..++.++||||||+++|+|++|..||........ ........
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-------- 230 (271)
T 3dtc_A 168 RTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMNK-------- 230 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTSC--------
T ss_pred cccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcCC--------
Confidence 3322 234689999999999999999999999999999999999999975432111 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.....+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0112223334568899999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=339.58 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 59 ~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 138 (396)
T 4dc2_A 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 138 (396)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCC
Confidence 4899999999999876 68899999997542 22335678899999887 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 139 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~ 210 (396)
T 4dc2_A 139 DLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 210 (396)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCB
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC-Ccc
Confidence 9999997654 6999999999999999999999999 9999999999999999999999999998532221 223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCch--hHHHHHHHHHhcCccccccCccCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML--ILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
...+||+.|+|||++.+..++.++|||||||++|||++|..||......+.. .......+...... ..+
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~~~ 281 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------IRI 281 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---------CCC
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---------cCC
Confidence 4467999999999999999999999999999999999999999754322111 00111111111111 122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
+......+.+++.+||+.||.+||++
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 22334458889999999999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=339.40 Aligned_cols=254 Identities=28% Similarity=0.388 Sum_probs=201.8
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 78 ~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 157 (367)
T 3l9p_A 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 157 (367)
T ss_dssp ECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCC
Confidence 3899999999999743 4678999999654 34455678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC---eEEEeeecccccc
Q 020720 74 NNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF---HPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~---~~kl~Dfg~~~~~ 147 (322)
+++|.+++..... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||+|||++...
T Consensus 158 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~ 234 (367)
T 3l9p_A 158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234 (367)
T ss_dssp TEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred CCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence 9999999975431 2235899999999999999999999999 99999999999999555 5999999999743
Q ss_pred CCC-cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDN-VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||........ . .......
T Consensus 235 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~---~~i~~~~----- 303 (367)
T 3l9p_A 235 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---L---EFVTSGG----- 303 (367)
T ss_dssp HHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H---HHHHTTC-----
T ss_pred ccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHcCC-----
Confidence 211 1111233457889999999999999999999999999999998 9999975432211 1 1111111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
....+......+.+++.+||+.||.+||++.+|++.|+.....
T Consensus 304 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 ----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222334588899999999999999999999999877643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=339.56 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=197.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+|+|
T Consensus 18 ~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (444)
T 3soa_A 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97 (444)
T ss_dssp EEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBH
T ss_pred EeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCH
Confidence 3899999999999775 68999999997553 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC---CCCeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD---GNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+.+.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++.+||+|||++........ .
T Consensus 98 ~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~ 169 (444)
T 3soa_A 98 FEDIVARE----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-A 169 (444)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-B
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-e
Confidence 99997654 6999999999999999999999999 99999999999998 568899999999986644322 2
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+. .+.. ....+.....
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~-~~~~-~~~~~~~~~~- 240 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LY---QQIK-AGAY-DFPSPEWDTV- 240 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHH-HTCC-CCCTTTTTTS-
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HH---HHHH-hCCC-CCCccccccC-
Confidence 234569999999999999999999999999999999999999997543211 11 1111 1111 0111111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ---s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 241 ---TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3448889999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=331.23 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEEC-CCCE----EEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQ----IAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. +++. |++|.+... .....+.+.+|+.++++++||||+++++++.... .+++++|+.+
T Consensus 22 ~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~ 100 (327)
T 3lzb_A 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPF 100 (327)
T ss_dssp EEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSS
T ss_pred EeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCC
Confidence 4899999999999765 4554 577776543 3445678999999999999999999999998754 7889999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
++|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 101 g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~ 174 (327)
T 3lzb_A 101 GCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp CBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence 999999976543 6899999999999999999999999 999999999999999999999999999865433221
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+ ..+. ...
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~~~--------~~~ 239 (327)
T 3lzb_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE--------RLP 239 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC--------CCC
T ss_pred cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC--------CCC
Confidence 1223446778999999999999999999999999999999 99999765433221111 1111 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCcc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNE 274 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~~ 274 (322)
.+......+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus 240 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 240 QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 222334458889999999999999999999999998875443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=329.76 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=191.2
Q ss_pred CcccCcceEEEEEEECC-C---CEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCee------EEE
Q 020720 1 MIGGGAFGVVYRGSLRD-G---TQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNR------ILV 68 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~---~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv 68 (322)
.||+|+||.||+|.... + ..||+|+++.. .....+.+.+|+.++++++||||+++++++...... +++
T Consensus 30 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 109 (323)
T 3qup_A 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVI 109 (323)
T ss_dssp EEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEE
T ss_pred eecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEE
Confidence 38999999999997653 3 27999999765 344567899999999999999999999999877654 899
Q ss_pred EEcCCCCCHHHHHhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 69 YEYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
|||+++++|.+++.... .....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~ 186 (323)
T 3qup_A 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRK 186 (323)
T ss_dssp EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecccccc
Confidence 99999999999996432 22235899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 147 FPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 147 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........... ... +
T Consensus 187 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------~~~-~---- 255 (323)
T 3qup_A 187 IYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY------LIG-G---- 255 (323)
T ss_dssp --------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------HHT-T----
T ss_pred ccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH------Hhc-C----
Confidence 543221 11223446778999999999999999999999999999999 8999976543322111 111 1
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.....+......+.+++.+||+.||.+|||+.++++.|++....
T Consensus 256 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 256 ----NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11122223345688999999999999999999999999988753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=332.56 Aligned_cols=238 Identities=23% Similarity=0.300 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus 48 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~ 127 (350)
T 1rdq_E 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127 (350)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCc
Confidence 4899999999999876 69999999986542 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 128 L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~ 196 (350)
T 1rdq_E 128 MFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp HHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----cc
Confidence 999997653 6899999999999999999999999 999999999999999999999999999865432 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+.. +. . .++..
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~-~~------~---~~p~~ 260 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY---EKIVS-GK------V---RFPSH 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-CC------C---CCCTT
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HH---HHHHc-CC------C---CCCCC
Confidence 4568999999999999999999999999999999999999997542211 11 11111 11 1 12222
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~~ 265 (322)
....+.+++.+||+.||.+||+ ++||++.
T Consensus 261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 3445889999999999999998 8888753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=335.03 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=204.6
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEE--eCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV--EDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.++++++||||+++++++. +....++||||++
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 3lxl_A 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109 (327)
T ss_dssp EEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCT
T ss_pred hccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecC
Confidence 389999999999984 358899999998777777788999999999999999999999987 4556899999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 110 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 183 (327)
T 3lxl_A 110 SGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183 (327)
T ss_dssp TCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSE
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCcc
Confidence 9999999975432 6899999999999999999999999 999999999999999999999999999876543322
Q ss_pred --eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCc--------hhHHHHHHHHHhcCccc
Q 020720 154 --VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM--------LILVEWTWKLREEGRLL 223 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 223 (322)
......+|+.|+|||++.+..++.++|||||||++|+|++|..||........ .............+
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 260 (327)
T 3lxl_A 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG--- 260 (327)
T ss_dssp EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT---
T ss_pred ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc---
Confidence 22234577889999999999999999999999999999999999865322100 00000011111111
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.....+......+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 261 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 261 -----QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred -----cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11122333445688999999999999999999999999888653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=334.38 Aligned_cols=240 Identities=27% Similarity=0.388 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|..+ +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 24 ~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg 103 (345)
T 1xjd_A 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 103 (345)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCC
Confidence 4899999999999876 68999999997542 23456778899999876 9999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 104 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~ 175 (345)
T 1xjd_A 104 DLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKT 175 (345)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCB
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-Ccc
Confidence 9999997543 6899999999999999999999999 9999999999999999999999999998543221 123
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+.... +. ++.
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~~~-------~~---~p~ 239 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LF---HSIRMDN-------PF---YPR 239 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCC-------CC---CCT
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HH---HHHHhCC-------CC---CCc
Confidence 44679999999999999999999999999999999999999997543211 11 1111111 11 122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK-QVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~-evl~ 264 (322)
.....+.+++.+||+.||++||++. ++++
T Consensus 240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 2334588899999999999999997 6653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=329.70 Aligned_cols=247 Identities=22% Similarity=0.256 Sum_probs=177.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|.
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 4899999999999876 6899999998643 3467788999999997 999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC---eEEEeeeccccccCCCcceee
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF---HPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||++........ ..
T Consensus 95 ~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 95 ERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 9997654 6999999999999999999999999 99999999999998766 899999999986543322 22
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC-CCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT-QFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 234 (322)
....+|+.|+|||++.+..++.++|||||||++|+|++|..||.....................+.. ... ...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccc
Confidence 3456899999999999999999999999999999999999999865432111111111111111110 000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 122445889999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=330.68 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++||||++++
T Consensus 16 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg 95 (345)
T 3a8x_A 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 95 (345)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCC
Confidence 4899999999999876 6899999999754 334456788999999988 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 96 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~ 167 (345)
T 3a8x_A 96 DLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 167 (345)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCB
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-Ccc
Confidence 9999997543 6999999999999999999999999 9999999999999999999999999998543221 123
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCch--hHHHHHHHHHhcCccccccCccCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML--ILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
...+||+.|+|||++.+..++.++|||||||++|||++|..||......... .............. ..+
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~~~ 238 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------IRI 238 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---------CCC
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---------CCC
Confidence 3457999999999999999999999999999999999999999754322111 00111111111111 112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
+......+.+++.+||+.||.+||++
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 22334458889999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=321.09 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=195.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||+++ ++
T Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 87 (292)
T 3o0g_A 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87 (292)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EH
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CH
Confidence 3899999999999876 68999999997543 33347788999999999999999999999999999999999986 55
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+.+..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 88 ~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 160 (292)
T 3o0g_A 88 KKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSA 160 (292)
T ss_dssp HHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCS
T ss_pred HHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cccC
Confidence 555544322 6999999999999999999999999 99999999999999999999999999986643322 2234
Q ss_pred cccCCCCCchHHHhhCC-CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc---Cccccc--------
Q 020720 158 VAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE---GRLLEI-------- 225 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~-~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------- 225 (322)
..+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ............. ......
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 56899999999998765 799999999999999999998886543222 1111111111100 000000
Q ss_pred -----cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 -----VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 -----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+..........+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0001112222344568899999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=330.93 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=199.9
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...++||||+
T Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 107 (302)
T 4e5w_A 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107 (302)
T ss_dssp EEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECC
T ss_pred ccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeC
Confidence 389999999999983 368899999997543 34457889999999999999999999999876 6689999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 108 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 108 PSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp TTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC
T ss_pred CCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCc
Confidence 99999999965432 6899999999999999999999999 99999999999999999999999999987654332
Q ss_pred --eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccC--------CCchhHHHHHHHHHhcCcc
Q 020720 153 --HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFG--------DDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~ 222 (322)
.......+|..|+|||++.+..++.++||||||+++|+|++|..|+..... ................+
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 259 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG-- 259 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT--
T ss_pred ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc--
Confidence 222334578889999999999999999999999999999999988653210 00000011111111111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.....+......+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 260 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 ------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111223334456889999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=323.55 Aligned_cols=251 Identities=26% Similarity=0.489 Sum_probs=191.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... ..||+|+++.. .....+.+.+|+.++++++||||+++++++ .....++||||+++++|.
T Consensus 31 ~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~ 107 (289)
T 3og7_A 31 RIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY 107 (289)
T ss_dssp EEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHH
T ss_pred EecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHH
Confidence 3899999999999765 35999998755 344557899999999999999999999965 556789999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 157 (322)
+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ......
T Consensus 108 ~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (289)
T 3og7_A 108 HHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181 (289)
T ss_dssp HHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------
T ss_pred HHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccc
Confidence 9996543 26899999999999999999999999 9999999999999999999999999987553221 122234
Q ss_pred cccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..||+.|+|||++. ...++.++||||||+++|+|++|..||......+.. ......+. ..+.+....
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~----~~~~~~~~~ 251 (289)
T 3og7_A 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGS----LSPDLSKVR 251 (289)
T ss_dssp --CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH------HHHHHHTS----CCCCTTSSC
T ss_pred cCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH------HHHhcccc----cCcchhhcc
Confidence 56899999999986 567889999999999999999999999765432211 11111111 112223333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 344456899999999999999999999999998765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=330.23 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=202.0
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+
T Consensus 52 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 131 (344)
T 1rjb_A 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 131 (344)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecC
Confidence 389999999999975 245689999997542 33447889999999999 9999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCC-------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC
Q 020720 73 ENNSLANALLGSKSK-------------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~ 133 (322)
++++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 132 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~ 208 (344)
T 1rjb_A 132 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHG 208 (344)
T ss_dssp TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETT
T ss_pred CCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCC
Confidence 999999999765421 124789999999999999999999999 9999999999999999
Q ss_pred CeEEEeeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~ 211 (322)
+.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 209 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--- 285 (344)
T 1rjb_A 209 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--- 285 (344)
T ss_dssp TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH---
T ss_pred CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH---
Confidence 9999999999986543322 22234457889999999999999999999999999999998 999997664332211
Q ss_pred HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 212 WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.....+ ..+ ..+......+.+++.+||+.||.+||++.++++.|+.....
T Consensus 286 ---~~~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 286 ---KLIQNG-----FKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp ---HHHHTT-----CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---HHHhcC-----CCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111111 011 11222344588899999999999999999999999887653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=322.29 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=194.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhc--CCCCcccccceEEEeC----CeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWN--IRHPNLVQLIGCCVED----NNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... ++.||||++... ....+..|.+++.. ++||||+++++++.+. ...++||||+++
T Consensus 15 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~ 90 (301)
T 3q4u_A 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90 (301)
T ss_dssp EEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred eeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence 3899999999999874 899999998643 33555666666665 7999999999997553 457899999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH--------EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
++|.+++... .+++..++.++.|++.||+||| +.+ ++||||||+||+++.++.+||+|||++..
T Consensus 91 g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 91 GSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp CBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 9999999533 6899999999999999999999 888 99999999999999999999999999976
Q ss_pred cCCCccee---ecccccCCCCCchHHHhhC------CCCcccceehhhHHHHHHHhC----------CCCCCcccCCCch
Q 020720 147 FPDNVTHV---STRVAGTMGYLAPEYALLG------QLTKKADVYSFGVLLLEIISG----------RSSSKAAFGDDML 207 (322)
Q Consensus 147 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~------~~~~~sDv~slG~il~ell~g----------~~p~~~~~~~~~~ 207 (322)
........ .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 54332221 1234689999999999876 455799999999999999999 7888765443322
Q ss_pred hHHHHHHHHHhcCccccccCccCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 208 ILVEWTWKLREEGRLLEIVDPELT--QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
... ........ ...+.+. .........+.+++.+||+.||.+|||+.||++.|+++
T Consensus 243 ~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 243 FED--MRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHH--HHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhh--hhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 11111100 0111111 12335677899999999999999999999999999753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=329.94 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=197.1
Q ss_pred CcccCcceEEEEEEEC-CCCE----EEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQ----IAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. ++.. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++||||+.+
T Consensus 20 ~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 98 (325)
T 3kex_A 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPL 98 (325)
T ss_dssp EEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTT
T ss_pred eeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCC
Confidence 4899999999999765 4554 7888775432 223356778999999999999999999986 4568899999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 172 (325)
T 3kex_A 99 GSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172 (325)
T ss_dssp CBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC
T ss_pred CCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccc
Confidence 99999997543 26889999999999999999999999 999999999999999999999999999876543322
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+ ..+.. ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~--------~~ 237 (325)
T 3kex_A 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGER--------LA 237 (325)
T ss_dssp C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTCB--------CC
T ss_pred cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCCC--------CC
Confidence 2234557889999999999999999999999999999999 99999865433222111 11110 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.+......+.+++.+||+.||.+||++.++++.|+.....
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111223477888899999999999999999999887653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=320.89 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=203.8
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+.++++++||||+++++++ ..+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 3899999999999753 5778999999765 344567899999999999999999999998 5567899999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee--
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV-- 154 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 154 (322)
|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 96 L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 96 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 999996443 26899999999999999999999999 9999999999999999999999999998764433221
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+... .. ..+. ....
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~i-~~~~--------~~~~ 234 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------FI-EQGK--------RMEC 234 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH------HH-HTTC--------CCCC
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH------HH-hcCC--------cCCC
Confidence 122346788999999999999999999999999999998 999997654322111 11 1111 1122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
+......+.+++.+||+.||.+||++.++++.|+......
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2333456889999999999999999999999998886533
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=320.12 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|...+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||+++ +|.
T Consensus 9 ~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (288)
T 1ob3_A 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK 87 (288)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHH
T ss_pred hcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHH
Confidence 3899999999999888899999999975532 2236788999999999999999999999999999999999976 899
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 160 (288)
T 1ob3_A 88 KLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHE 160 (288)
T ss_dssp HHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccccc
Confidence 98875432 6899999999999999999999999 99999999999999999999999999986543221 12334
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC---ccc-----cccCcc
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG---RLL-----EIVDPE 229 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~ 229 (322)
.+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+... ......... ... ...++.
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhhcccccccc
Confidence 689999999999764 58999999999999999999999997643222111 111110000 000 001111
Q ss_pred CC--------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LT--------QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~--------~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. .........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10 111223445889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=332.59 Aligned_cols=259 Identities=18% Similarity=0.237 Sum_probs=198.0
Q ss_pred CcccC--cceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGG--AFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+| +||.||+|... +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 32 ~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 111 (389)
T 3gni_B 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 111 (389)
T ss_dssp EEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred cccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCC
Confidence 48999 99999999877 69999999997552 444577889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc----
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV---- 151 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 151 (322)
+|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+.......
T Consensus 112 ~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~ 186 (389)
T 3gni_B 112 SAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186 (389)
T ss_dssp BHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECS
T ss_pred CHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccccccc
Confidence 999999765322 6899999999999999999999999 9999999999999999999999999886432111
Q ss_pred --ceeecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH--------hc
Q 020720 152 --THVSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR--------EE 219 (322)
Q Consensus 152 --~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------~~ 219 (322)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. .... ..
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 265 (389)
T 3gni_B 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTSTIPA 265 (389)
T ss_dssp CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------
T ss_pred ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCcccccccccc
Confidence 111123468889999999987 5789999999999999999999999986544432211100 0000 00
Q ss_pred Cc-------------cccc----------cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 220 GR-------------LLEI----------VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 220 ~~-------------~~~~----------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. .... ...............+.+++.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000 0000011222334568899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=331.71 Aligned_cols=260 Identities=17% Similarity=0.228 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEECC------CCEEEEEEecccChhcH-----------HHHHHHHHHHhcCCCCcccccceEEEeC-
Q 020720 1 MIGGGAFGVVYRGSLRD------GTQIAIKCLSAESKQGT-----------KEFLTEIDMIWNIRHPNLVQLIGCCVED- 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 62 (322)
.||+|+||.||+|.+.. ++.||+|++........ ..+..|+..+..++||||+++++++...
T Consensus 42 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 121 (364)
T 3op5_A 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK 121 (364)
T ss_dssp ECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEE
T ss_pred EEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeecc
Confidence 38999999999998764 47899999876542211 2344566778888999999999998765
Q ss_pred ---CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC--CCCeEE
Q 020720 63 ---NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD--GNFHPK 137 (322)
Q Consensus 63 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--~~~~~k 137 (322)
...++||||+ +++|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||++ .++.+|
T Consensus 122 ~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 122 NGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp TTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEE
T ss_pred CCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEE
Confidence 4589999999 9999999976532 6999999999999999999999999 99999999999999 889999
Q ss_pred EeeeccccccCCCcce------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHH
Q 020720 138 IGDFGLAKLFPDNVTH------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 138 l~Dfg~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~ 211 (322)
|+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~ 274 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHH
Confidence 9999999765432111 1123459999999999999999999999999999999999999998654433221111
Q ss_pred HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 212 WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.. .....+...+++.+. ....+..+.+++..||+.||.+||++.+|++.|+.....
T Consensus 275 --~~-~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 275 --KI-RYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp --HH-HHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --HH-HhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11 111112222222221 011234588889999999999999999999999877653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=322.42 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=202.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++|.++
T Consensus 20 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 97 (279)
T 1qpc_A 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDF 97 (279)
T ss_dssp EEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHH
T ss_pred eecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHH
Confidence 389999999999998888899999987543 34578899999999999999999999976 4568999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 98 l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 172 (279)
T 1qpc_A 98 LKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172 (279)
T ss_dssp TTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCC
T ss_pred HhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCC
Confidence 95432 125899999999999999999999999 9999999999999999999999999998765443333334456
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++.+..++.++||||||+++|+|++ |..||........ . .... .+ ... ..+.....
T Consensus 173 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~~~~-~~-----~~~---~~~~~~~~ 237 (279)
T 1qpc_A 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I---QNLE-RG-----YRM---VRPDNCPE 237 (279)
T ss_dssp CTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H---HHHH-TT-----CCC---CCCTTCCH
T ss_pred ccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---H---HHHh-cc-----cCC---CCcccccH
Confidence 789999999999999999999999999999999 8999875432111 1 1111 11 001 11222334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+.+++.+||+.||++||++.++++.|+....
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 58889999999999999999999999988764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=327.32 Aligned_cols=244 Identities=21% Similarity=0.344 Sum_probs=192.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC---------------
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--------------- 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------------- 63 (322)
.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 13 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (332)
T 3qd2_B 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKD 92 (332)
T ss_dssp EEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcc
Confidence 3899999999999887 79999999997543 334578999999999999999999999986643
Q ss_pred ------------------------------------------eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHH
Q 020720 64 ------------------------------------------NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICL 101 (322)
Q Consensus 64 ------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 101 (322)
..+++|||+++++|.+++.... .....++..++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~ 171 (332)
T 3qd2_B 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFI 171 (332)
T ss_dssp ---------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHH
T ss_pred ccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHH
Confidence 2799999999999999997654 233456677899999
Q ss_pred HHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-----------eeecccccCCCCCchHHH
Q 020720 102 GTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-----------HVSTRVAGTMGYLAPEYA 170 (322)
Q Consensus 102 qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~ 170 (322)
||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .......||+.|+|||++
T Consensus 172 qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 248 (332)
T 3qd2_B 172 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248 (332)
T ss_dssp HHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHH
T ss_pred HHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHh
Confidence 9999999999999 99999999999999999999999999987654321 112334689999999999
Q ss_pred hhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhccc
Q 020720 171 LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQ 250 (322)
Q Consensus 171 ~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 250 (322)
.+..++.++|||||||++|+|++|..|+... ........ . .............+.+++.+||+
T Consensus 249 ~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~~-~--------~~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 249 HGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDVR-N--------LKFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp HCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHHH-T--------TCCCHHHHHHCHHHHHHHHHHHC
T ss_pred cCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHhh-c--------cCCCcccccCChhHHHHHHHHcc
Confidence 9999999999999999999999987664321 00001111 1 11112223344567899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 020720 251 AGAHYRPTMKQVVEM 265 (322)
Q Consensus 251 ~dp~~Rps~~evl~~ 265 (322)
.||.+||++.|+++.
T Consensus 312 ~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 312 PSPTERPEATDIIEN 326 (332)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CCCCcCCCHHHHhhc
Confidence 999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=324.99 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CC-------CEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DG-------TQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++ ..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 15 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (289)
T 4fvq_A 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFV 94 (289)
T ss_dssp EEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECC
Confidence 3899999999999765 34 479999998766677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe--------EEEeeeccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH--------PKIGDFGLA 144 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~--------~kl~Dfg~~ 144 (322)
++++|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++. +||+|||++
T Consensus 95 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~ 168 (289)
T 4fvq_A 95 KFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168 (289)
T ss_dssp TTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred CCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence 99999999976532 4899999999999999999999999 999999999999998887 999999998
Q ss_pred cccCCCcceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 145 KLFPDNVTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 145 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
...... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..|+......... . ......
T Consensus 169 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~---~~~~~~---- 234 (289)
T 4fvq_A 169 ITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--L---QFYEDR---- 234 (289)
T ss_dssp TTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--H---HHHHTT----
T ss_pred ccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--H---HHhhcc----
Confidence 754321 23457899999999987 67899999999999999999966554433221111 0 001110
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+ +......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 235 ----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 235 ----HQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ----CCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ----CCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 11112347788999999999999999999999998874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=336.64 Aligned_cols=245 Identities=22% Similarity=0.240 Sum_probs=197.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 76 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~ 155 (410)
T 3v8s_A 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155 (410)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 4899999999999876 68999999986431 1223457889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 156 L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 156 LVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp HHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99999654 5899999999999999999999999 999999999999999999999999999876554433444
Q ss_pred ccccCCCCCchHHHhhCC----CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYALLGQ----LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~----~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
..+||+.|+|||++.+.. ++.++|||||||++|||++|..||........ ........... .-+....
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~~~~-----~~p~~~~ 299 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIMNHKNSL-----TFPDDND 299 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHC-----CCCTTCC
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HHHHHhccccc-----cCCCccc
Confidence 567999999999998765 78999999999999999999999975432211 11111100000 0011122
Q ss_pred CCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~ 265 (322)
.+ ..+.+++.+||+.+|.+ ||+++||++.
T Consensus 300 ~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 300 IS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 33 34788889999999988 9999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=339.28 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 23 ~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~ 102 (476)
T 2y94_A 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102 (476)
T ss_dssp EEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 3899999999999876 79999999996542 2234678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 103 L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~ 173 (476)
T 2y94_A 103 LFDYICKNG----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLR 173 (476)
T ss_dssp HHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CBC
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc--ccc
Confidence 999996543 6999999999999999999999999 9999999999999999999999999998764432 223
Q ss_pred ccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 157 RVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .. ..+. .+. ...+.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~---~~i~-~~~---------~~~p~ 237 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LF---KKIC-DGI---------FYTPQ 237 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HH---HHHH-TTC---------CCCCT
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HH---HHHh-cCC---------cCCCc
Confidence 4569999999999988766 689999999999999999999997543221 11 1111 111 11122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 238 YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 22345888999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=330.01 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=202.1
Q ss_pred CcccCcceEEEEEEEC-----CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-----DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 72 (322)
.||+|+||.||++.+. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 38 ~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (318)
T 3lxp_A 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117 (318)
T ss_dssp EEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCC
T ss_pred eecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecc
Confidence 3899999999988542 58889999997653 34457899999999999999999999999884 5789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++... .+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 118 ~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 118 PLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp TTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred cCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 999999999654 4899999999999999999999999 99999999999999999999999999987654332
Q ss_pred e--eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCC--------chhHHHHHHHHHhcCcc
Q 020720 153 H--VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDD--------MLILVEWTWKLREEGRL 222 (322)
Q Consensus 153 ~--~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~ 222 (322)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||....... ..............+
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 267 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-- 267 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc--
Confidence 1 2233457788999999999999999999999999999999999987532110 000000011111111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.....+......+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1122233344568899999999999999999999999987754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=351.21 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=198.6
Q ss_pred cccCcceEEEEEEEC---CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR---DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|.+. ++..||||+++... ....+.+.+|+.++++++||||+++++++.. +..++||||+.+|+|
T Consensus 344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 422 (613)
T ss_dssp EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBH
T ss_pred EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcH
Confidence 799999999999764 46679999997653 3456889999999999999999999999876 568999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee--e
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV--S 155 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 155 (322)
.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......... .
T Consensus 423 ~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 423 HKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99996543 26999999999999999999999999 9999999999999999999999999998654332211 1
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....+++.|+|||++.+..++.++|||||||++|||++ |..||......+... .+ ..+. ....+
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------~i-~~~~--------~~~~p 561 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------FI-EQGK--------RMECP 561 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH------HH-HTTC--------CCCCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HH-HcCC--------CCCCC
Confidence 22335689999999999999999999999999999998 999998654332111 11 1111 11222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
......+.++|.+||+.||.+||++.+|++.|+....
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 3344568899999999999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=330.79 Aligned_cols=240 Identities=25% Similarity=0.348 Sum_probs=196.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|+.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 27 ~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg 106 (353)
T 2i0e_A 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 106 (353)
T ss_dssp EEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 4899999999999887 5889999999754 223456788999999988 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 107 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~ 178 (353)
T 2i0e_A 107 DLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTT 178 (353)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCB
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-ccc
Confidence 9999997543 6999999999999999999999999 9999999999999999999999999998543221 123
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|||++|..||....... .. ..+... . . .++.
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~~~-~------~---~~p~ 242 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSIMEH-N------V---AYPK 242 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHC-C------C---CCCT
T ss_pred ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HH---HHHHhC-C------C---CCCC
Confidence 34579999999999999999999999999999999999999997542211 11 111111 1 1 1222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
.....+.+++.+||+.||.+||+ +.++++
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 33445888999999999999995 467765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=338.88 Aligned_cols=248 Identities=24% Similarity=0.246 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||+||+|... +++.||+|+++... ......+.+|..++..++||||+++++++.+.+..++||||+++|+
T Consensus 81 ~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~ 160 (437)
T 4aw2_A 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160 (437)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCc
Confidence 4899999999999877 58899999996431 1122347889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 161 L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 234 (437)
T 4aw2_A 161 LLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234 (437)
T ss_dssp HHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECC
T ss_pred HHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccc
Confidence 9999976422 6999999999999999999999999 999999999999999999999999999876554444444
Q ss_pred ccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 RVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
..+||+.|+|||++. ...++.++|||||||++|||++|..||......+... .......... +.....
T Consensus 235 ~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~~~----~p~~~~ 307 (437)
T 4aw2_A 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHKERFQ----FPTQVT 307 (437)
T ss_dssp SCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHHHHCC----CCSSCC
T ss_pred cccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---hhhhcccccc----CCcccc
Confidence 567999999999997 4568999999999999999999999998643222111 1111010000 111112
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHY--RPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~evl~~ 265 (322)
.. ...+.+++.+||..+|++ ||+++|+++.
T Consensus 308 ~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 308 DV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 23 334788899999888888 9999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=327.39 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEECC-----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRD-----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.... +..||+|+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 51 ~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 130 (333)
T 1mqb_A 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130 (333)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCC
Confidence 48999999999997642 235999999755 334456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 131 ~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 131 GALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp EEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred CcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 999999975432 6899999999999999999999999 999999999999999999999999999865433211
Q ss_pred -eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 154 -VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 154 -~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .. ..+. .+. ..
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~---~~~~-~~~--------~~ 269 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VM---KAIN-DGF--------RL 269 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHH-TTC--------CC
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HH---HHHH-CCC--------cC
Confidence 1122345778999999999999999999999999999999 999997543211 11 1111 110 01
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
..+......+.+++.+||+.||.+||++.++++.|++....
T Consensus 270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223344588899999999999999999999999887653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=351.27 Aligned_cols=251 Identities=30% Similarity=0.469 Sum_probs=203.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||.||+|.+..+..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+.+++|.++
T Consensus 274 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~ 351 (535)
T 2h8h_A 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 351 (535)
T ss_dssp EEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHH
T ss_pred ecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHH
Confidence 389999999999999877889999997543 345789999999999999999999999866 678999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...............+
T Consensus 352 l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 426 (535)
T 2h8h_A 352 LKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426 (535)
T ss_dssp HSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTS
T ss_pred HhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcC
Confidence 964321 25889999999999999999999999 9999999999999999999999999998654322111222346
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+..|+|||++....++.++|||||||++|||++ |..||......+. ...+....+ ...+.....
T Consensus 427 ~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~~~i~~~~~---------~~~~~~~~~ 491 (535)
T 2h8h_A 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYR---------MPCPPECPE 491 (535)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------HHHHHTTCC---------CCCCTTCCH
T ss_pred cccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCC---------CCCCCCCCH
Confidence 778999999999999999999999999999999 8999975432211 111111111 111223345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.+.++|.+||+.||++||++.+|++.|+......
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 5889999999999999999999999999887543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=322.94 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=205.4
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 109 (313)
T 1t46_A 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC 109 (313)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecC
Confidence 389999999999975 246789999997553 34457899999999999 9999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCC--------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 73 ENNSLANALLGSKSK--------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
++++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 186 (313)
T 1t46_A 110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKI 186 (313)
T ss_dssp TTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEE
T ss_pred CCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEE
Confidence 999999999765321 225899999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......... ..
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~ 260 (313)
T 1t46_A 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------KM 260 (313)
T ss_dssp CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH------HH
T ss_pred ccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH------HH
Confidence 999999866543322 2223456788999999999999999999999999999999 999997654332211 11
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.... ... ..+......+.+++.+||+.||.+||++.|+++.|++...
T Consensus 261 ~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 261 IKEG-----FRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHT-----CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccC-----CCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111 001 1112233458889999999999999999999999988764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=326.97 Aligned_cols=241 Identities=23% Similarity=0.318 Sum_probs=187.8
Q ss_pred CcccCcceEEEEEEE----CCCCEEEEEEecccC----hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAES----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 24 ~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3a62_A 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL 103 (327)
T ss_dssp EEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred EEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCC
Confidence 489999999999976 468999999997542 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 175 (327)
T 3a62_A 104 SGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG- 175 (327)
T ss_dssp TTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred CCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCC-
Confidence 9999999997543 6899999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+.. .. ..
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~-~~---------~~ 239 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TI---DKILK-CK---------LN 239 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHH-TC---------CC
T ss_pred ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHh-CC---------CC
Confidence 12234568999999999999999999999999999999999999997543211 11 11111 10 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
.+......+.+++.+||+.||.+|| ++.|+++.
T Consensus 240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 2222334588899999999999999 77788763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=326.74 Aligned_cols=243 Identities=24% Similarity=0.338 Sum_probs=182.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +++.||+|+++... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 60 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 137 (349)
T 2w4o_A 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD 137 (349)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHH
Confidence 3899999999999877 58899999997543 34678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCcceeec
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||++....... ...
T Consensus 138 ~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 208 (349)
T 2w4o_A 138 RIVEKG----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMK 208 (349)
T ss_dssp HHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccc
Confidence 996543 6899999999999999999999999 999999999999975 8899999999998654321 123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. ..+. .... ....+. ...
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~---~~i~-~~~~-~~~~~~----~~~ 277 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF---RRIL-NCEY-YFISPW----WDE 277 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH---HHHH-TTCC-CCCTTT----TTT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH---HHHH-hCCC-ccCCch----hhh
Confidence 45689999999999999999999999999999999999999975433211 11 1111 1110 111111 122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||++||++.|+++.
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33458899999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=325.92 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=194.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|+||.||+|... +++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||||+++++|.
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 99 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL 99 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHH
Confidence 4899999999999765 6999999999876666678899999999985 7999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccccCCCcc---
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKLFPDNVT--- 152 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~--- 152 (322)
+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++. +||+|||++........
T Consensus 100 ~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 100 SHIHKRR----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 9997653 6899999999999999999999999 999999999999998776 99999999875432111
Q ss_pred ---eeecccccCCCCCchHHHhh-----CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhH--------HHHHHHH
Q 020720 153 ---HVSTRVAGTMGYLAPEYALL-----GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLIL--------VEWTWKL 216 (322)
Q Consensus 153 ---~~~~~~~~t~~y~aPE~~~~-----~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~--------~~~~~~~ 216 (322)
.......||+.|+|||++.. ..++.++|||||||++|+|++|..||......+.... .......
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11123458999999999875 5678999999999999999999999986544321100 0000111
Q ss_pred HhcCccccccCccCCCCCHH----HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 217 REEGRLLEIVDPELTQFPEK----EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~----~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+. ...+.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 253 i~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 253 IQEGK---------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHCC---------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhccC---------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111 111211 23458899999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=319.85 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..+++|||++++
T Consensus 19 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 97 (281)
T 3cc6_A 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYG 97 (281)
T ss_dssp EEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred EEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCC
Confidence 48999999999997542 335999998765 34456789999999999999999999999764 4578999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 98 ~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 171 (281)
T 3cc6_A 98 ELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171 (281)
T ss_dssp BHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--------
T ss_pred CHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccccc
Confidence 99999975432 5899999999999999999999999 99999999999999999999999999986654332223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||........... ...... ...+
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~------~~~~~~---------~~~~ 236 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV------LEKGDR---------LPKP 236 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH------HHHTCC---------CCCC
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH------HhcCCC---------CCCC
Confidence 33456788999999999999999999999999999998 9999975443322111 111111 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
......+.+++.+||+.||++||++.|+++.|+....
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 2223458889999999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=325.37 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=190.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++++++||||+++++++.+++..++||||++ ++|.
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~ 90 (317)
T 2pmi_A 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLK 90 (317)
T ss_dssp -------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHH
T ss_pred EECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHH
Confidence 4899999999999776 689999999975532 334678899999999999999999999999999999999998 5899
Q ss_pred HHHhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 79 NALLGSK--SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 79 ~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ...
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 166 (317)
T 2pmi_A 91 KYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFS 166 (317)
T ss_dssp HHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-CCC
T ss_pred HHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-cCC
Confidence 9886432 12235889999999999999999999999 99999999999999999999999999986543222 123
Q ss_pred ccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc--Ccccc------ccC
Q 020720 157 RVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE--GRLLE------IVD 227 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~------~~~ 227 (322)
...+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+.... ....... ..... ...
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTTCGGGGGCTTCC
T ss_pred CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhHhhhhhhhhhcc
Confidence 34689999999999864 689999999999999999999999976533222111 1111000 00000 000
Q ss_pred ccCCC-------------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQ-------------FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~-------------~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+.. ........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00112345889999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=320.75 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=192.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
+||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+++++|.++
T Consensus 15 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~ 89 (307)
T 2eva_A 15 VVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNV 89 (307)
T ss_dssp EEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHH
T ss_pred EeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHH
Confidence 4899999999999886 788999998643 34578899999999999999999999876 347899999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh---cCCCCeeeccCcccceEeCCCCe-EEEeeeccccccCCCcceeec
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHE---EADPPIVHRDIKASNVLLDGNFH-PKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~~i~h~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
+.... ....+++..++.++.|++.||+|||+ .+ ++|+||||+||+++.++. +||+|||++...... ..
T Consensus 90 l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~ 161 (307)
T 2eva_A 90 LHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MT 161 (307)
T ss_dssp HHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc----cc
Confidence 97653 22347888999999999999999999 66 999999999999988876 799999998754332 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+.... +.. + ..+..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~-~~~-----~---~~~~~ 228 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHN-GTR-----P---PLIKN 228 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHHHT-TCC-----C---CCBTT
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHHhc-CCC-----C---Ccccc
Confidence 345899999999999999999999999999999999999999754332211 1111111 110 1 11122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
....+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 234588899999999999999999999999877643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=326.14 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..+ +||||+++++++.+.+..++||||+.+++
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~ 115 (327)
T 3lm5_A 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115 (327)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCc
Confidence 3899999999999876 69999999987542 33457889999999999 56999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCcce
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
|.+++.... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|||++........
T Consensus 116 L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~- 189 (327)
T 3lm5_A 116 IFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189 (327)
T ss_dssp GGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc-
Confidence 999985432 236899999999999999999999999 999999999999998 78999999999986643321
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ...... . ......
T Consensus 190 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~~~~-~-----~~~~~~ 256 (327)
T 3lm5_A 190 -LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL------NISQVN-V-----DYSEET 256 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTC-C-----CCCTTT
T ss_pred -cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------HHHhcc-c-----ccCchh
Confidence 233568999999999999999999999999999999999999997643221111 111100 0 001111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.......+.+++.+||+.||.+|||++++++.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 12233458889999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.21 Aligned_cols=241 Identities=26% Similarity=0.299 Sum_probs=188.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||||+++.. .......+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 155 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~ 234 (446)
T 4ejn_A 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 234 (446)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCB
T ss_pred EEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCc
Confidence 4899999999999876 6999999999754 23344677889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 235 L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 306 (446)
T 4ejn_A 235 LFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 306 (446)
T ss_dssp HHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC-ccc
Confidence 999996553 68999999999999999999998 88 9999999999999999999999999997543322 223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.... . .++.
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~-------~---~~p~ 370 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEE-------I---RFPR 370 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-------C---CCCT
T ss_pred ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHHhCC-------C---CCCc
Confidence 3467999999999999999999999999999999999999999754322111 1111111 1 1222
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
.....+.+++.+||+.||.+|| ++.|+++.
T Consensus 371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 2334588899999999999999 99999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=326.59 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=203.4
Q ss_pred CcccCcceEEEEEEEC--------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR--------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 42 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 121 (334)
T 2pvf_A 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121 (334)
T ss_dssp EEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEE
T ss_pred EEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEE
Confidence 3899999999999763 4678999999755 334457889999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCC------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKSK------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL 198 (334)
T 2pvf_A 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKI 198 (334)
T ss_dssp CCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred CCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEE
Confidence 99999999999765421 124889999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .. ...
T Consensus 199 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~~~ 272 (334)
T 2pvf_A 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LF---KLL 272 (334)
T ss_dssp CCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH---HHH
T ss_pred ccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---HH---HHH
Confidence 999999866543221 1223446788999999999999999999999999999999 999987542211 11 111
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
. .+. ....+......+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 273 ~-~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 273 K-EGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H-HTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h-cCC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 111 0112223334588899999999999999999999999988753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=317.53 Aligned_cols=247 Identities=31% Similarity=0.535 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhc-------HHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQG-------TKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.. ++||||+
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~ 103 (287)
T 4f0f_A 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFV 103 (287)
T ss_dssp ECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECC
T ss_pred ccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEec
Confidence 3899999999999875 78999999986543221 167889999999999999999999986554 6999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe-----EEEeeecccccc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH-----PKIGDFGLAKLF 147 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~-----~kl~Dfg~~~~~ 147 (322)
++++|.+.+..... .+++..++.++.|++.||+|||+.+ ++++|+||||+||+++.++. +||+|||++...
T Consensus 104 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 104 PCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp TTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred CCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 99999998865432 6999999999999999999999864 45999999999999988776 999999998754
Q ss_pred CCCcceeecccccCCCCCchHHHh--hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVTHVSTRVAGTMGYLAPEYAL--LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
... .....||+.|+|||++. ...++.++|||||||++|+|++|..||........... .......
T Consensus 180 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~----- 246 (287)
T 4f0f_A 180 VHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----NMIREEG----- 246 (287)
T ss_dssp SSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----HHHHHSC-----
T ss_pred ccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----HHHhccC-----
Confidence 332 23456899999999984 45678999999999999999999999976544322111 1111111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
..+ ..+......+.+++.+||+.||.+||++.|+++.|+++
T Consensus 247 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 22223345688999999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=327.87 Aligned_cols=245 Identities=23% Similarity=0.269 Sum_probs=187.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||++... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 27 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~ 105 (361)
T 3uc3_A 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE 105 (361)
T ss_dssp EESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHH
Confidence 3899999999999877 799999999975432 23668899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe--EEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH--PKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++. +||+|||++....... ....
T Consensus 106 ~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 176 (361)
T 3uc3_A 106 RICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 176 (361)
T ss_dssp HHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCCC
Confidence 996543 6999999999999999999999999 999999999999987765 9999999987432221 1233
Q ss_pred cccCCCCCchHHHhhCCCCcc-cceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKK-ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~-sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..||+.|+|||++.+..++.+ +|||||||++|+|++|..||............ ........ . .+ +.....
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~-~--~~-~~~~~~--- 247 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVK-Y--SI-PDDIRI--- 247 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTC-C--CC-CTTSCC---
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCC-C--CC-CCcCCC---
Confidence 568999999999988887655 89999999999999999999876544332211 11111100 0 00 111112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 248 -s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 248 -SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2457889999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=314.93 Aligned_cols=238 Identities=23% Similarity=0.313 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... ++..+|+|.+........+.+.+|+.++++++||||+++++++.+....++||||+++++|.+
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (277)
T 3f3z_A 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE 95 (277)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHH
Confidence 3899999999999876 578999999987656667889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcceeec
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++....... ...
T Consensus 96 ~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~ 166 (277)
T 3f3z_A 96 RVVHKR----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMR 166 (277)
T ss_dssp HHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBC
T ss_pred HHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--chh
Confidence 986654 6899999999999999999999999 9999999999999 788999999999998654332 223
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH-
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE- 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (322)
...+|+.|+|||++.+ .++.++||||||+++|+|++|..||......... ....... ...+.
T Consensus 167 ~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~----------~~~~~~ 229 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKIREGT----------FTFPEK 229 (277)
T ss_dssp CCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC----------CCCCHH
T ss_pred ccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCC----------CCCCch
Confidence 3468999999998865 4899999999999999999999999764322111 1111111 11111
Q ss_pred ---HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 ---KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ---~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12345889999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.86 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=201.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 192 ~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~ 271 (543)
T 3c4z_A 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD 271 (543)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCC
Confidence 3899999999999876 69999999996542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||++........ ...
T Consensus 272 L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~~ 347 (543)
T 3c4z_A 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTK 347 (543)
T ss_dssp HHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-CBC
T ss_pred HHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-ccc
Confidence 99999765544457999999999999999999999999 99999999999999999999999999987643322 123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ...... . ...++..
T Consensus 348 ~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~~i~~-~---------~~~~p~~ 415 (543)
T 3c4z_A 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRVLE-Q---------AVTYPDK 415 (543)
T ss_dssp CCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HHHHHH-C---------CCCCCTT
T ss_pred cccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HHHHhh-c---------ccCCCcc
Confidence 357999999999999999999999999999999999999999875433222111 111111 1 1112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTM-----KQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~-----~evl~ 264 (322)
....+.+++.+||+.||.+||++ ++|++
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 34458889999999999999975 56654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=331.25 Aligned_cols=250 Identities=31% Similarity=0.483 Sum_probs=190.2
Q ss_pred CcccCcceEEEEEEEC--CC--CEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR--DG--TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|... ++ ..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ ++..++||||+++
T Consensus 96 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~ 175 (373)
T 3c1x_A 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 175 (373)
T ss_dssp EEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTT
T ss_pred EeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCC
Confidence 3899999999999754 22 36899998653 34456789999999999999999999998754 4578999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
++|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 176 g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 176 GDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp CBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 999999975432 5888999999999999999999999 999999999999999999999999999865332211
Q ss_pred --eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 154 --VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
......+++.|+|||++.+..++.++|||||||++|||++ |..||......+.... . ..+..
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~------~-~~~~~-------- 314 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------L-LQGRR-------- 314 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH------H-HTTCC--------
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH------H-HcCCC--------
Confidence 1123446788999999999999999999999999999999 6667765443332211 1 11110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 315 ~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122233458889999999999999999999999988764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=321.89 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=194.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|+++.. .......+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 39 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (310)
T 2wqm_A 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118 (310)
T ss_dssp EEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCB
T ss_pred eecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCC
Confidence 3899999999999875 7999999999753 34455788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 119 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 194 (310)
T 2wqm_A 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAH 194 (310)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred HHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-ccc
Confidence 99999653222336899999999999999999999999 99999999999999999999999999876543221 122
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++.+..++.++||||||+++|+|++|..||....... ... ..... .... +.. ....
T Consensus 195 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~---~~~~~-~~~~-----~~~--~~~~ 262 (310)
T 2wqm_A 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL---CKKIE-QCDY-----PPL--PSDH 262 (310)
T ss_dssp ----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHH---HHHHH-TTCS-----CCC--CTTT
T ss_pred ccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHH---HHHhh-cccC-----CCC--cccc
Confidence 3468999999999999999999999999999999999999997543221 111 11111 1111 111 0112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
....+.+++.+||+.||++||++.+|++.|+++....
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 2345888999999999999999999999998886543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=330.25 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=207.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC--eeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--NRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.. ..++||||+++++
T Consensus 16 ~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~ 95 (396)
T 4eut_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95 (396)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEE
T ss_pred EEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCC
Confidence 4899999999999876 59999999997543 334577889999999999999999999998765 6799999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe----CCCCeEEEeeeccccccCCCcc
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||++ +.++.+||+|||++........
T Consensus 96 L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~ 171 (396)
T 4eut_A 96 LYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171 (396)
T ss_dssp HHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG
T ss_pred HHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc
Confidence 9999965432 123899999999999999999999999 9999999999999 8888899999999986644322
Q ss_pred eeecccccCCCCCchHHHhh--------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCc-hhHHHHHHHHHhcCccc
Q 020720 153 HVSTRVAGTMGYLAPEYALL--------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM-LILVEWTWKLREEGRLL 223 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 223 (322)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.......+.....
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~ 249 (396)
T 4eut_A 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249 (396)
T ss_dssp --SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCE
T ss_pred --cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccch
Confidence 233568999999999875 5678899999999999999999999986544322 22221111111111000
Q ss_pred cc---------cC---ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 224 EI---------VD---PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 224 ~~---------~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.. .. +............+.+++.+||+.||++||++.|+++.+..++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 00 00 11234556777888999999999999999999999998877654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=316.70 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=201.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEE-EeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC-VEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +|+.||+|++..... ...+.+|+.+++.++|++++..+.++ .+....+++|||+ +++|.
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (296)
T 3uzp_A 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE 92 (296)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHH
Confidence 3899999999999874 799999999865433 24688999999999998877766665 5567789999999 89999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcce--
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+++..... .+++..++.++.||+.||+|||+++ ++|+||||+||++ +.++.+||+|||++.........
T Consensus 93 ~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 93 DLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence 99974432 6999999999999999999999999 9999999999999 48889999999999865433221
Q ss_pred ----eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 154 ----VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 154 ----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........................ ...
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 242 (296)
T 3uzp_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----EVL 242 (296)
T ss_dssp CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----HHH
T ss_pred cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----HHH
Confidence 123456899999999999999999999999999999999999999876544333222222211111100 000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.... ...+.+++.+||+.||++||++.+|++.|+......
T Consensus 243 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 243 CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0122 245888999999999999999999999998876544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=324.55 Aligned_cols=253 Identities=20% Similarity=0.223 Sum_probs=193.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++
T Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 2h34_A 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120 (309)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEE
T ss_pred EEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCC
Confidence 4899999999999876 68899999997543 2334778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++............
T Consensus 121 L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 193 (309)
T 2h34_A 121 LAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193 (309)
T ss_dssp HHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccccc
Confidence 999997543 6899999999999999999999999 999999999999999999999999998765443322333
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++.+..++.++||||||+++|+|++|..||...... .. ........ +.....+..
T Consensus 194 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~---~~~~~~~~------~~~~~~~~~ 260 (309)
T 2h34_A 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM---GAHINQAI------PRPSTVRPG 260 (309)
T ss_dssp ---CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH---HHHHHSCC------CCGGGTSTT
T ss_pred ccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH---HHHhccCC------CCccccCCC
Confidence 456899999999999889999999999999999999999999754221 11 11111110 001111222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccccCc
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-TMKQVVEMLSKDVHLN 273 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-s~~evl~~L~~~~~~~ 273 (322)
....+.+++.+||+.||.+|| +++++++.|+......
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 233588899999999999999 9999999998887543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=317.14 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (279)
T 3fdn_A 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 95 (279)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCc
Confidence 3899999999999776 57899999986432 2234678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 96 l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 165 (279)
T 3fdn_A 96 VYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 165 (279)
T ss_dssp HHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc---cc
Confidence 999996553 6899999999999999999999998 9999999999999999999999999886543322 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++.+..++.++||||||+++|+|++|..||......... ..... . .. ..+..
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~------~~---~~~~~ 229 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISR-V------EF---TFPDF 229 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-T------CC---CCCTT
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------HHHHh-C------CC---CCCCc
Confidence 456899999999999999999999999999999999999999754221111 11111 0 01 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||.+||++.|+++.
T Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 33457889999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=331.73 Aligned_cols=239 Identities=25% Similarity=0.307 Sum_probs=185.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHH-HhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDM-IWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|..+ +++.||+|+++... ......+..|..+ ++.++||||+++++++.+.+..++||||+++|
T Consensus 45 ~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg 124 (373)
T 2r5t_A 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124 (373)
T ss_dssp EEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCC
Confidence 4899999999999876 68899999997542 2334566777776 57789999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 125 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~~ 196 (373)
T 2r5t_A 125 ELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-STT 196 (373)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CCC
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC-Ccc
Confidence 9999997543 6899999999999999999999999 9999999999999999999999999998533221 123
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|||++|..||........ . ..+.. .. . .++.
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~---~~i~~-~~------~---~~~~ 260 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y---DNILN-KP------L---QLKP 260 (373)
T ss_dssp CSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---H---HHHHH-SC------C---CCCS
T ss_pred ccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H---HHHHh-cc------c---CCCC
Confidence 446799999999999999999999999999999999999999975432111 1 11111 11 1 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVV 263 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl 263 (322)
.....+.+++.+||+.||.+||++.+.+
T Consensus 261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 261 NITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 2334578899999999999999985433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=335.78 Aligned_cols=247 Identities=23% Similarity=0.206 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|..+ +|+.||+|+++... ....+.+.+|..++..++||||+++++++.+.+..++||||+++|+
T Consensus 68 ~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~ 147 (412)
T 2vd5_A 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147 (412)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCc
Confidence 4899999999999876 69999999996432 2223457889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 148 L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 221 (412)
T 2vd5_A 148 LLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221 (412)
T ss_dssp HHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECS
T ss_pred HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCccccc
Confidence 9999975432 6899999999999999999999999 999999999999999999999999999876544433334
Q ss_pred ccccCCCCCchHHHhh-------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 157 RVAGTMGYLAPEYALL-------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~-------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
..+||+.|+|||++.. ..++.++|||||||++|||++|..||........... ....... ..
T Consensus 222 ~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i~~~~~~--------~~ 290 (412)
T 2vd5_A 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK---IVHYKEH--------LS 290 (412)
T ss_dssp SCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHTHHHH--------CC
T ss_pred eeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH---HHhcccC--------cC
Confidence 4679999999999983 5689999999999999999999999976432211111 1110000 01
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYR---PTMKQVVEM 265 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~R---ps~~evl~~ 265 (322)
+.........++.+++.+||. +|.+| |+++|+++.
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111112233458889999999 99998 589999763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=319.50 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=191.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 108 (285)
T 3is5_A 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL 108 (285)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHH
T ss_pred eeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHH
Confidence 3899999999999876 68999999987553 345678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcceee
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+++.........+++..++.++.||+.||+|||+.+ ++|+||||+||++ +.++.+||+|||++....... ..
T Consensus 109 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 183 (285)
T 3is5_A 109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HS 183 (285)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---------
T ss_pred HHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc--cC
Confidence 998643222237999999999999999999999999 9999999999999 556789999999997654322 12
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....+|+.|+|||++. ..++.++||||||+++|+|++|..||......... ......... ........
T Consensus 184 ~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~---~~~~~~~~-- 251 (285)
T 3is5_A 184 TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKATYKEPN---YAVECRPL-- 251 (285)
T ss_dssp ---CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCC---CCC--CCC--
T ss_pred cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhhccCCcc---cccccCcC--
Confidence 3456899999999875 56889999999999999999999999754321111 111111100 00111122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.+++.+||+.||++||++.|+++
T Consensus 252 --~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 252 --TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 244788999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=317.93 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=195.6
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEE-eCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV-EDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.... +..+|+|.+... .....+.+.+|+.++++++||||+++++++. .++..+++|||+++
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~ 111 (298)
T 3f66_A 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 111 (298)
T ss_dssp EEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTT
T ss_pred eeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCC
Confidence 48999999999997642 235899998754 3344578999999999999999999999865 45578999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 112 ~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (298)
T 3f66_A 112 GDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185 (298)
T ss_dssp CBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhc
Confidence 999999975432 6889999999999999999999999 99999999999999999999999999986543221
Q ss_pred -eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhC-CCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 -HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISG-RSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 -~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......+|+.|+|||.+.+..++.++||||||+++|+|++| ..||......+.... .. .+. .
T Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~------~~-~~~--------~ 250 (298)
T 3f66_A 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LL-QGR--------R 250 (298)
T ss_dssp C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH------HH-TTC--------C
T ss_pred cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH------Hh-cCC--------C
Confidence 112234567889999999999999999999999999999995 455554433222111 11 111 1
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+......+.+++.+||+.||.+||++.|+++.|+....
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11112223458889999999999999999999999988764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=341.48 Aligned_cols=246 Identities=26% Similarity=0.309 Sum_probs=201.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 191 ~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~ 270 (576)
T 2acx_A 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270 (576)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 4899999999999876 7999999999653 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 271 L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--~~ 343 (576)
T 2acx_A 271 LKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IK 343 (576)
T ss_dssp HHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--EE
T ss_pred HHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc--cc
Confidence 9999976532 25899999999999999999999999 99999999999999999999999999987654322 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ... ... . .++..
T Consensus 344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~--~i~-~~~------~---~~p~~ 411 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVK-EVP------E---EYSER 411 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH--HHH-HCC------C---CCCTT
T ss_pred ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH--Hhh-ccc------c---cCCcc
Confidence 35799999999999998999999999999999999999999987544322221111 111 110 1 12222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
....+.+++.+||+.||.+|| ++.|+++.
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 334588899999999999999 78888763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=315.67 Aligned_cols=246 Identities=22% Similarity=0.378 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC--CeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED--NNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|.++ ++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+. ...+++|||+++++
T Consensus 17 ~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 95 (271)
T 3kmu_A 17 KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95 (271)
T ss_dssp EEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCB
T ss_pred HhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCc
Confidence 3899999999999887 889999999765 344457899999999999999999999999877 77899999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... ..+++..++.++.||+.||+|||+.+ .+++|+||||+||+++.++.++|.|||+...... .
T Consensus 96 L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~ 166 (271)
T 3kmu_A 96 LYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------P 166 (271)
T ss_dssp HHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------T
T ss_pred HHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc------c
Confidence 9999976532 25899999999999999999999853 4599999999999999999999999888764322 2
Q ss_pred ccccCCCCCchHHHhhCCCCc---ccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 157 RVAGTMGYLAPEYALLGQLTK---KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~---~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
...+|+.|+|||++.+..++. ++|||||||++|+|++|..||........ .......+ ..+ ..
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-----~~~---~~ 232 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG-----LRP---TI 232 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-----CCC---CC
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-----CCC---CC
Confidence 235789999999998765544 89999999999999999999975432111 11111111 111 22
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2233445888999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=324.89 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=199.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||++... +|+.||+|++........+.+.+|+.+++.++||||+++++++.. ....++||||+.++
T Consensus 36 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~ 115 (317)
T 2buj_A 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115 (317)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTC
T ss_pred EecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCC
Confidence 3899999999999874 799999999987777777889999999999999999999999873 34789999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce--
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+|.+++.........+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 116 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~ 192 (317)
T 2buj_A 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192 (317)
T ss_dssp BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHH
T ss_pred cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccccc
Confidence 999999764333347999999999999999999999999 999999999999999999999999988754321110
Q ss_pred ------eecccccCCCCCchHHHhhCC---CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 154 ------VSTRVAGTMGYLAPEYALLGQ---LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 154 ------~~~~~~~t~~y~aPE~~~~~~---~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
......||+.|+|||++.... ++.++||||||+++|+|++|..||............ .. ...
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~-~~~---- 263 (317)
T 2buj_A 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AV-QNQ---- 263 (317)
T ss_dssp HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HH-HCC----
T ss_pred ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----Hh-hcc----
Confidence 011234799999999887543 688999999999999999999999653221111110 00 000
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.. ..........+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 264 -~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 264 -LS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -CC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 01112223458899999999999999999999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=318.99 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=198.7
Q ss_pred CcccCcceEEEEEEE--C-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSL--R-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~--~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.. . +++.||+|+++... ....+.+.+|+.+++.++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 389999999999954 2 46889999997553 23357899999999999999999999998 567789999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV- 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 154 (322)
+|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 103 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 103 PLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence 9999997654 6899999999999999999999999 9999999999999999999999999998765433222
Q ss_pred -ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 155 -STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 155 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ . .....+. ...
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~--------~~~ 240 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T----AMLEKGE--------RMG 240 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H----HHHHTTC--------CCC
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCC--------CCC
Confidence 122345688999999999899999999999999999999 9999976432211 1 1111111 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 223334558899999999999999999999999988764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=325.02 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=189.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe----eEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN----RILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~ 72 (322)
.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++..... .++||||+
T Consensus 19 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~ 98 (311)
T 3ork_A 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98 (311)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecC
Confidence 4899999999999875 78999999997653 2334678899999999999999999999876543 49999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 99 DGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp CEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 9999999997554 6899999999999999999999999 99999999999999999999999999986543222
Q ss_pred --eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 --HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ............ ....
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~--~~~~ 243 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP--SARH 243 (311)
T ss_dssp ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCH--HHHS
T ss_pred ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCc--cccc
Confidence 122335689999999999999999999999999999999999999975432111 111111111000 0000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHhcc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE-MLSKD 269 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~-~L~~~ 269 (322)
.. ....+.+++.+||+.||.+||++.+++. .+.+.
T Consensus 244 ~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 11 2345888999999999999997776654 44443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=317.77 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=200.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEE-EeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC-VEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|++..... ...+.+|+.+++.++|++++..+..+ .+....+++|||+ +++|.
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (296)
T 4hgt_A 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE 92 (296)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred eecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHH
Confidence 3899999999999874 789999998754432 24578899999999988877776665 5667889999999 89999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcc---
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVT--- 152 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~--- 152 (322)
+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||++ +.++.+||+|||++........
T Consensus 93 ~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 166 (296)
T 4hgt_A 93 DLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp HHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence 99975432 6999999999999999999999999 9999999999999 7889999999999986543322
Q ss_pred ---eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 153 ---HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 153 ---~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........................ ...
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 242 (296)
T 4hgt_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----EVL 242 (296)
T ss_dssp CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----HHH
T ss_pred CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh----hhh
Confidence 1123456899999999999999999999999999999999999999876554433333222221111110 000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.... ...+.+++.+||+.||++||++.+|++.|+......
T Consensus 243 ~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 243 CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0122 245889999999999999999999999998876533
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=321.82 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=187.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--------------------------hcHHHHHHHHHHHhcCCCCccc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--------------------------QGTKEFLTEIDMIWNIRHPNLV 53 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~iv 53 (322)
.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+
T Consensus 20 ~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 99 (298)
T 2zv2_A 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVV 99 (298)
T ss_dssp EEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 3899999999999875 689999999865421 1135688999999999999999
Q ss_pred ccceEEEe--CCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC
Q 020720 54 QLIGCCVE--DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD 131 (322)
Q Consensus 54 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~ 131 (322)
++++++.+ ....++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 100 KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVG 171 (298)
T ss_dssp CEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred eEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEC
Confidence 99999987 5678999999999999876532 26999999999999999999999999 99999999999999
Q ss_pred CCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCC---CCcccceehhhHHHHHHHhCCCCCCcccCCCchh
Q 020720 132 GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ---LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI 208 (322)
Q Consensus 132 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~ 208 (322)
.++.+||+|||++........ ......||+.|+|||++.+.. .+.++|||||||++|+|++|..||..... ..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~ 247 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---MC 247 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred CCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---HH
Confidence 999999999999986643322 223456899999999987665 37889999999999999999999975321 11
Q ss_pred HHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 209 LVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. ........ . ..+.....+ ..+.+++.+||+.||++||++.|+++
T Consensus 248 ~---~~~~~~~~-~---~~~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 L---HSKIKSQA-L---EFPDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H---HHHHHHCC-C---CCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H---HHHHhccc-C---CCCCccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 11111111 0 001112223 44888999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=319.85 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=198.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh------cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ------GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 19 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (321)
T 2a2a_A 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98 (321)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCC
Confidence 3899999999999876 6899999999754321 35789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC----eEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF----HPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 149 (322)
+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++.....
T Consensus 99 ~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 99 GGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp SCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 999999997543 6899999999999999999999999 99999999999999888 799999999986654
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ..... ... .+.+.
T Consensus 172 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~i~~-~~~--~~~~~ 240 (321)
T 2a2a_A 172 GVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L---ANITS-VSY--DFDEE 240 (321)
T ss_dssp TCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HHHHT-TCC--CCCHH
T ss_pred ccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---H---HHHHh-ccc--ccChh
Confidence 322 2334689999999999999999999999999999999999999975422111 1 11111 000 00010
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. .......+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 F---FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp H---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred h---hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 01123458899999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=325.54 Aligned_cols=257 Identities=18% Similarity=0.228 Sum_probs=192.7
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEecccChh-----------cHHHHHHHHHHHhcCCCCcccccceEEEe----
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAESKQ-----------GTKEFLTEIDMIWNIRHPNLVQLIGCCVE---- 61 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 61 (322)
.||+|+||.||+|... ++..+|+|++...... ....+.+|+..+..++||||+++++++.+
T Consensus 44 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~ 123 (345)
T 2v62_A 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123 (345)
T ss_dssp EC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSS
T ss_pred eEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCC
Confidence 3899999999999875 5788999998755321 11346678899999999999999999988
Q ss_pred CCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC--eEEEe
Q 020720 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF--HPKIG 139 (322)
Q Consensus 62 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~--~~kl~ 139 (322)
....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 124 ~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 124 RSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp CEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEEC
T ss_pred CcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEE
Confidence 67899999999 999999996553 7999999999999999999999999 99999999999999887 99999
Q ss_pred eeccccccCCCcc------eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH
Q 020720 140 DFGLAKLFPDNVT------HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 140 Dfg~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 213 (322)
|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ-TAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH-HHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH-HHH
Confidence 9999976532211 111335689999999999999999999999999999999999999975433322111 111
Q ss_pred HHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 214 WKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...... ....+..... .......+.+++.+||+.||++||++.+|++.|+...
T Consensus 275 ~~~~~~--~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 275 TNLLDE--LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHT--TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred Hhhccc--ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111110 0010101111 0022335888999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=317.93 Aligned_cols=251 Identities=29% Similarity=0.412 Sum_probs=198.2
Q ss_pred CcccCcceEEEEEEEC-CC---CEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCee-EEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DG---TQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNR-ILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. ++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.. +++|||+.+
T Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~ 107 (298)
T 3pls_A 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH 107 (298)
T ss_dssp EEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTT
T ss_pred eeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccC
Confidence 4899999999999753 23 379999987543 34457889999999999999999999999876655 999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 108 ~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 108 GDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp CBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred CCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999976432 6889999999999999999999999 99999999999999999999999999975533221
Q ss_pred -eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 153 -HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 153 -~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..|+......... .. ....+. ..
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~~----~~~~~~--------~~ 247 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--TH----FLAQGR--------RL 247 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--HH----HHHTTC--------CC
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--HH----HhhcCC--------CC
Confidence 1122345788999999999999999999999999999999976665443222211 11 011111 01
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+......+.+++.+||+.||.+|||+.++++.|++...
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122233458899999999999999999999999988764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=322.44 Aligned_cols=240 Identities=21% Similarity=0.324 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 48 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 127 (335)
T 2owb_A 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127 (335)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCC
Confidence 4899999999999876 5889999998654 33455788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ...
T Consensus 128 L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (335)
T 2owb_A 128 LLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 199 (335)
T ss_dssp HHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred HHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc-ccc
Confidence 999986543 6899999999999999999999999 99999999999999999999999999986543222 123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|++.|+|||++.+..++.++||||||+++|+|++|..||......+.. ....... . ..+..
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~-------~---~~~~~ 263 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKNE-------Y---SIPKH 263 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC-------C---CCCTT
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhcCC-------C---CCCcc
Confidence 356899999999999999999999999999999999999999754321111 1111111 1 11122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||++||++.|+++
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345788999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=350.22 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=197.1
Q ss_pred cccCcceEEEEEEEC---CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLR---DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~ 455 (635)
T 4fl3_A 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGP 455 (635)
T ss_dssp EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCC
Confidence 899999999999553 4678999999754 33446789999999999999999999999864 56889999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--ee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT--HV 154 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 154 (322)
|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 456 L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 456 LNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp HHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred HHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999997554 6899999999999999999999999 99999999999999999999999999986643322 11
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||......... .....+. ....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~--------~~~~ 593 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE--------RMGC 593 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC--------CCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC--------CCCC
Confidence 223346788999999999999999999999999999998 99999765332111 1111111 1122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+......+.+++.+||+.||++||++.+|++.|+...
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2333456889999999999999999999999998653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=324.53 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=189.7
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCC--CcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRH--PNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++...+++.||+|++... .....+.+.+|+.++..++| +||+++++++.+....++||| +.+++
T Consensus 16 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~ 94 (343)
T 3dbq_A 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 94 (343)
T ss_dssp EESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEE
T ss_pred EEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCC
Confidence 38999999999998888999999998754 33445778999999999976 999999999999999999999 55789
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-ee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 155 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+|||++ ++.+||+|||++......... ..
T Consensus 95 L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 95 LNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp HHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccC
Confidence 999997654 6899999999999999999999999 99999999999997 678999999999866433222 22
Q ss_pred cccccCCCCCchHHHhh-----------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 156 TRVAGTMGYLAPEYALL-----------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-----------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .. .........
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~---~~~~~~~~~---- 237 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--IS---KLHAIIDPN---- 237 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HH---HHHHHHCTT----
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HH---HHHHHhcCC----
Confidence 34569999999999976 67889999999999999999999999754221 11 111111100
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
... ..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 -~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 -HEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -SCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 001 1122223457889999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=323.85 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=195.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-----CCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-----HPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... +++.||||+++. .......+..|+.+++.+. ||||+++++++...+..++||||+ +
T Consensus 42 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~ 119 (360)
T 3llt_A 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-G 119 (360)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-C
T ss_pred EEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-C
Confidence 3899999999999875 689999999873 3444567788999999986 999999999999999999999999 8
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC----------------------
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---------------------- 132 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---------------------- 132 (322)
++|.+++...... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.
T Consensus 120 ~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 194 (360)
T 3llt_A 120 PSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194 (360)
T ss_dssp CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred CCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccccc
Confidence 8999999765432 5899999999999999999999999 999999999999975
Q ss_pred ---CCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhH
Q 020720 133 ---NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLIL 209 (322)
Q Consensus 133 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~ 209 (322)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....
T Consensus 195 ~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 195 RTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp EESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 7889999999998644322 235689999999999999999999999999999999999999976533222211
Q ss_pred HHHHH--------HHHhcCccccccC--------ccCCCCCH--------------HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 210 VEWTW--------KLREEGRLLEIVD--------PELTQFPE--------------KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 210 ~~~~~--------~~~~~~~~~~~~~--------~~~~~~~~--------------~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
+.... ...........++ +....... .....+.+++.+||+.||++|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 11100 0000000000000 00000000 001457799999999999999999
Q ss_pred HHHHH
Q 020720 260 KQVVE 264 (322)
Q Consensus 260 ~evl~ 264 (322)
.|+++
T Consensus 351 ~elL~ 355 (360)
T 3llt_A 351 AELLK 355 (360)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=328.45 Aligned_cols=245 Identities=21% Similarity=0.297 Sum_probs=186.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHh-cCCCCcccccceEEEe----CCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIW-NIRHPNLVQLIGCCVE----DNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|... +|+.||||+++.. ..+.+|+.++. ..+||||+++++++.. ....++||||+++
T Consensus 69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred eeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 3899999999999876 6899999998632 45667888874 4589999999999876 5578999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 151 (322)
|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 144 g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 144 GELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp EEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 999999976532 26899999999999999999999999 999999999999997 7889999999998654322
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||............. ..+. .+.. ..-.+...
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~i~-~~~~-~~~~~~~~ 292 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--TRIR-MGQY-EFPNPEWS 292 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH--HHHH-HTCC-CCCTTTTT
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH--HHHH-cCcc-cCCCcccc
Confidence 2234568999999999999999999999999999999999999998654432111010 0011 1110 00011112
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. ....+.+++.+||+.||.+|||+.|+++.
T Consensus 293 ~----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 293 E----VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2 23458899999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=324.34 Aligned_cols=257 Identities=17% Similarity=0.192 Sum_probs=198.2
Q ss_pred CcccCcceEEEEEEECC---------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccc---------------cc
Q 020720 1 MIGGGAFGVVYRGSLRD---------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ---------------LI 56 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------------~~ 56 (322)
.||+|+||.||+|.... ++.||+|++... ..+.+|+.++++++||||++ ++
T Consensus 49 ~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~ 123 (352)
T 2jii_A 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM 123 (352)
T ss_dssp EEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred EecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchh
Confidence 38999999999997763 789999998744 45788999999999999988 56
Q ss_pred eEEEe-CCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-
Q 020720 57 GCCVE-DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF- 134 (322)
Q Consensus 57 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~- 134 (322)
+++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++
T Consensus 124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp EEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEE
T ss_pred hccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCC
Confidence 67766 67889999999 999999997652 137999999999999999999999999 99999999999999998
Q ss_pred -eEEEeeeccccccCCCcce------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCch
Q 020720 135 -HPKIGDFGLAKLFPDNVTH------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDML 207 (322)
Q Consensus 135 -~~kl~Dfg~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~ 207 (322)
.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 277 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence 8999999999765432211 112346899999999999999999999999999999999999999876433211
Q ss_pred hHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 208 ILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
........... .......... .......+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 278 -~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 278 -IMKQKQKFVDK--PGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp -HHHHHHHHHHS--CCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHHhccCC--hhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111111111 1111111110 0112245888999999999999999999999998887544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=323.31 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=198.5
Q ss_pred CcccCcceEEEEEEEC-CCCEE--EEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQI--AIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~v--aiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... ++..+ |+|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||++++
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 111 (327)
T 1fvr_A 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 111 (327)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCC
Confidence 4899999999999765 56644 99988753 333456789999999999 9999999999999999999999999999
Q ss_pred CHHHHHhcCC------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 76 SLANALLGSK------------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 76 ~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+|.+++.... .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 112 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~ 188 (327)
T 1fvr_A 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 188 (327)
T ss_dssp BHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCc
Confidence 9999997653 22346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
+...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .... ..+
T Consensus 189 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~~~-~~~-- 257 (327)
T 1fvr_A 189 SRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKL-PQG-- 257 (327)
T ss_dssp EESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHG-GGT--
T ss_pred Ccccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HHHh-hcC--
Confidence 8743211 11123346789999999999999999999999999999998 9999975432111 0111 111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.. ...+......+.+++.+||+.||.+||++.++++.|+.....
T Consensus 258 ---~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 258 ---YR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---CC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01 112223335588999999999999999999999999887653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=322.76 Aligned_cols=253 Identities=23% Similarity=0.420 Sum_probs=202.6
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 111 (322)
T 1p4o_A 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 111 (322)
T ss_dssp EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCC
Confidence 3899999999999654 36789999997543 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 74 NNSLANALLGSK------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
+++|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~ 188 (322)
T 1p4o_A 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188 (322)
T ss_dssp TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccccc
Confidence 999999996421 11235789999999999999999999999 999999999999999999999999998755
Q ss_pred CCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ . ... ..+
T Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~~~-~~~----- 256 (322)
T 1p4o_A 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---L---RFV-MEG----- 256 (322)
T ss_dssp GGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---H---HHH-HTT-----
T ss_pred ccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---H---HHH-HcC-----
Confidence 33221 11223456889999999999999999999999999999999 8888875422111 1 111 111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.....+......+.+++.+||+.||.+||++.|+++.|+....
T Consensus 257 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 257 ---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1112223334558889999999999999999999999988765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=315.08 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=177.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++
T Consensus 18 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (278)
T 3cok_A 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGE 97 (278)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCc
Confidence 3899999999999875 79999999996442 2234678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ..
T Consensus 98 L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 170 (278)
T 3cok_A 98 MNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HY 170 (278)
T ss_dssp HHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-ce
Confidence 999997543 26899999999999999999999999 999999999999999999999999999865432221 22
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++.+..++.++||||||+++|+|++|..||........... ..... ...+..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------------~~~~~-~~~~~~ 234 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK---------------VVLAD-YEMPSF 234 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC-CCCCTT
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH---------------Hhhcc-cCCccc
Confidence 34689999999999988899999999999999999999999976543321110 00000 112222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 235 LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 3345888999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=314.03 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=197.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 92 (284)
T 3kk8_A 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92 (284)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred hhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCH
Confidence 3899999999999876 6899999998654 344457788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+.+.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|||++........
T Consensus 93 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~-- 163 (284)
T 3kk8_A 93 FEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163 (284)
T ss_dssp HHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--
Confidence 98886553 6899999999999999999999999 999999999999986655 99999999976543322
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||........ . ..... +.. ....+.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~---~~~~~-~~~-~~~~~~~~~~- 234 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---Y---AQIKA-GAY-DYPSPEWDTV- 234 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHH-TCC-CCCTTTTTTS-
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---H---HHHHh-ccc-cCCchhhccc-
Confidence 2335689999999999999999999999999999999999999975422111 1 11111 110 0011111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.+++.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 235 ---TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 344888999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=320.26 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=191.2
Q ss_pred CcccCcceEEEEEEEC----CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC-----eeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR----DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN-----NRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 69 (322)
+||+|+||.||+|... ++..||+|+++.. .....+.+.+|+.++++++||||+++++++.+.. ..+++|
T Consensus 41 ~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~ 120 (313)
T 3brb_A 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120 (313)
T ss_dssp EEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEE
T ss_pred ceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEE
Confidence 3899999999999654 2457999998754 3344577899999999999999999999997755 359999
Q ss_pred EcCCCCCHHHHHhcCC--CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecccccc
Q 020720 70 EYLENNSLANALLGSK--SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~ 147 (322)
||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp ECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred ecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 9999999999985332 22346999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... .. .+
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------~~-~~----- 265 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY------LL-HG----- 265 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------HH-TT-----
T ss_pred ccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH------HH-cC-----
Confidence 43221 11223446788999999999999999999999999999999 8888876533221111 11 11
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.....+......+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 266 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 266 ---HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111222333458899999999999999999999999987753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=316.33 Aligned_cols=241 Identities=21% Similarity=0.319 Sum_probs=198.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 101 (294)
T 2rku_A 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101 (294)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCC
Confidence 4899999999999876 5889999998654 23445778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 102 L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (294)
T 2rku_A 102 LLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 173 (294)
T ss_dssp HHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccc
Confidence 999986543 6899999999999999999999999 99999999999999999999999999986543222 123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...+++.|+|||++.+..++.++||||||+++|+|++|..||......+.. ..... .. . ..+..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~-~~------~---~~~~~ 237 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKK-NE------Y---SIPKH 237 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT-TC------C---CCCTT
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhh-cc------C---CCccc
Confidence 356899999999999989999999999999999999999999754321111 11111 10 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+.+++.+||+.||++||++.|+++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 23457889999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=328.04 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=197.9
Q ss_pred CcccCcceEEEEEEE----CCCCEEEEEEecccC----hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL----RDGTQIAIKCLSAES----KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++.+ +||||+++++++......++||||
T Consensus 61 ~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 140 (355)
T 1vzo_A 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140 (355)
T ss_dssp EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECC
T ss_pred EeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeec
Confidence 389999999999977 368999999986432 22335667899999999 699999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 141 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 141 INGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred CCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 99999999997553 6899999999999999999999999 9999999999999999999999999998654433
Q ss_pred ceeecccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 152 THVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. ......
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~---------- 281 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS---------- 281 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC----------
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhcc----------
Confidence 3333456799999999999863 47899999999999999999999998654433322211 111110
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRP-----TMKQVVEML 266 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~L 266 (322)
....+......+.+++.+||+.||.+|| +++|+++..
T Consensus 282 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1122223334578899999999999999 999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=320.47 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=202.9
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCC-eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDN-NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~ 71 (322)
.||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+ ..+++|||
T Consensus 34 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~ 113 (316)
T 2xir_A 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113 (316)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEEC
T ss_pred EEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEc
Confidence 389999999999974 246889999997653 33446789999999999 7899999999987755 48999999
Q ss_pred CCCCCHHHHHhcCCCC------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe
Q 020720 72 LENNSLANALLGSKSK------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG 139 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~ 139 (322)
+++++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 190 (316)
T 2xir_A 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 190 (316)
T ss_dssp CTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEC
Confidence 9999999999765432 112789999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHH
Q 020720 140 DFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLR 217 (322)
Q Consensus 140 Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 217 (322)
|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......... ....
T Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-----~~~~ 265 (316)
T 2xir_A 191 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLK 265 (316)
T ss_dssp CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH-----HHHH
T ss_pred CCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH-----HHhc
Confidence 9999986543322 22334557889999999999999999999999999999998 999997654332211 1111
Q ss_pred hcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 218 EEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
. +.. . ..+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 266 ~-~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 266 E-GTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp H-TCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-Ccc-----C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 110 1 1122233458889999999999999999999999987764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=324.79 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=194.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 31 ~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 110 (335)
T 3dls_A 31 PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110 (335)
T ss_dssp ECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 3899999999999865 689999999975421 1234577899999999999999999999999999999999
Q ss_pred CCCC-CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 72 LENN-SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 72 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
+.+| +|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 111 ~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 111 HGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp CTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 9766 9999997654 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred cceeecccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ...
T Consensus 184 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------------~~~ 240 (335)
T 3dls_A 184 KL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------------EAA 240 (335)
T ss_dssp CC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------------TTC
T ss_pred Cc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------------hhc
Confidence 22 234568999999999998877 789999999999999999999997532110 000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+......+.+++.+||+.||.+||++.++++.
T Consensus 241 -~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 -IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111123458889999999999999999999984
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=315.87 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=194.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 10 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 89 (311)
T 4agu_A 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVL 89 (311)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchH
Confidence 3899999999999876 59999999986543 23346788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ ....
T Consensus 90 ~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 161 (311)
T 4agu_A 90 HELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDD 161 (311)
T ss_dssp HHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCC
Confidence 99886553 6899999999999999999999999 99999999999999999999999999986543322 1234
Q ss_pred cccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH--------HHHhcCcccccc-C
Q 020720 158 VAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW--------KLREEGRLLEIV-D 227 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~ 227 (322)
..+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+.... ............ .
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 468999999999986 578999999999999999999999997654333222211100 000000000000 0
Q ss_pred ccCCCCC------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 PELTQFP------EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 ~~~~~~~------~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+...... +.....+.+++.+||+.||.+|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 1223458899999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=325.11 Aligned_cols=238 Identities=29% Similarity=0.436 Sum_probs=192.5
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+. |+|
T Consensus 62 lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l 140 (348)
T 1u5q_A 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140 (348)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred EccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCH
Confidence 899999999999864 78999999997542 2334678899999999999999999999999999999999997 578
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 141 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----~~ 209 (348)
T 1u5q_A 141 SDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NS 209 (348)
T ss_dssp HHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CC
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----Cc
Confidence 88875432 26899999999999999999999999 999999999999999999999999999765322 23
Q ss_pred cccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..||+.|+|||++. ...++.++|||||||++|+|++|..||....... .......... +.. ..
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~------~~~--~~ 275 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES------PAL--QS 275 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC------CCC--CC
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCC------CCC--CC
Confidence 46899999999985 4678999999999999999999999997542211 1111111111 111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.+++.+||+.||++|||+.++++.
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1223457889999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=319.59 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=192.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-----hcHHHHHHHHHHHhcC---CCCcccccceEEEeCC-----eeE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-----QGTKEFLTEIDMIWNI---RHPNLVQLIGCCVEDN-----NRI 66 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~-----~~~ 66 (322)
.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.... ..+
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~ 95 (308)
T 3g33_A 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95 (308)
T ss_dssp EECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEE
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEE
Confidence 3899999999999875 689999999874321 1124566777776666 5999999999998765 479
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 67 LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 67 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
++|||+. ++|.+++...... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 96 lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 96 LVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169 (308)
T ss_dssp EEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred EEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence 9999997 5999999765432 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc--
Q 020720 147 FPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE-- 224 (322)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 224 (322)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..............
T Consensus 170 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 170 YSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp STTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred cCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 54332 22445789999999999999999999999999999999999999976533222211110000000000000
Q ss_pred -----ccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 -----IVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 -----~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.+.. ....+.....+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 00011223458899999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=315.99 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=195.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence 4899999999999875 688999999987666666889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCCCcceeeccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++........ .....
T Consensus 109 ~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 109 LLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 997653 2235678899999999999999999999 999999999999987 89999999999986543221 12334
Q ss_pred ccCCCCCchHHHhhCC--CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 159 AGTMGYLAPEYALLGQ--LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~--~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.|++.|+|||++.+.. ++.++||||||+++|+|++|..||......... . ....... ..+ ..+..
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~---~~~~~~~-----~~~---~~~~~ 250 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--M---FKVGMFK-----VHP---EIPES 250 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--H---HHHHHHC-----CCC---CCCTT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--H---Hhhcccc-----ccc---ccccc
Confidence 6899999999998754 789999999999999999999999754322111 0 0100000 111 22223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||++||++.++++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3445888999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=322.65 Aligned_cols=243 Identities=21% Similarity=0.319 Sum_probs=192.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +|+.||+|++..... ...+|++++.++ +||||+++++++.+....++||||+++|+|.
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~ 104 (342)
T 2qr7_A 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL 104 (342)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHH
Confidence 3899999999999876 689999999975432 234688888887 7999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC----CeEEEeeeccccccCCCccee
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN----FHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
+.+.... .+++..++.++.||+.||.|||+.+ ++||||||+||++..+ +.+||+|||++........ .
T Consensus 105 ~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 176 (342)
T 2qr7_A 105 DKILRQK----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-L 176 (342)
T ss_dssp HHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-C
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-c
Confidence 9997654 6999999999999999999999999 9999999999998543 3599999999986543322 2
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||............. .+. .+... +. ....
T Consensus 177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~-~~~~~--~~---~~~~ 247 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIG-SGKFS--LS---GGYW 247 (342)
T ss_dssp BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHH-HCCCC--CC---STTT
T ss_pred eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHc-cCCcc--cC---cccc
Confidence 234568999999999998889999999999999999999999998654333222221 111 11110 00 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+.+++.+||+.||++||++.++++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 223345888999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=317.06 Aligned_cols=253 Identities=27% Similarity=0.389 Sum_probs=194.8
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC--CCCcccccceEEEeC----CeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI--RHPNLVQLIGCCVED----NNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... ++.||+|++.... ...+..|.+++... +||||+++++++... ...++||||+++
T Consensus 44 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 119 (337)
T 3mdy_A 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119 (337)
T ss_dssp EEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTT
T ss_pred EeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCC
Confidence 3899999999999887 8999999986432 24445555555554 999999999999887 678999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE--------ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
++|.+++... .+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++..
T Consensus 120 g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 120 GSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp CBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCcee
Confidence 9999999654 589999999999999999999988 7 99999999999999999999999999976
Q ss_pred cCCCccee---ecccccCCCCCchHHHhhCCCCcc------cceehhhHHHHHHHhC----------CCCCCcccCCCch
Q 020720 147 FPDNVTHV---STRVAGTMGYLAPEYALLGQLTKK------ADVYSFGVLLLEIISG----------RSSSKAAFGDDML 207 (322)
Q Consensus 147 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~------sDv~slG~il~ell~g----------~~p~~~~~~~~~~ 207 (322)
........ .....||+.|+|||++.+...+.+ +|||||||++|||++| ..||.........
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 54332221 123468999999999987766655 9999999999999999 6676654433322
Q ss_pred hHHHHHHHHHhcCccccccCccCCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 208 ILVEWTWKLREEGRLLEIVDPELTQ--FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
... ....... ....+.+.. ........+.+++.+||+.||++||++.||++.|+.+..
T Consensus 272 ~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 272 YED--MREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HHH--HHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhh--hHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 111 0111100 111121111 123667789999999999999999999999999988764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=330.47 Aligned_cols=235 Identities=14% Similarity=0.095 Sum_probs=182.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHH---HHHhcCCCCcccccc-------eEEEeCC---
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEI---DMIWNIRHPNLVQLI-------GCCVEDN--- 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~--- 63 (322)
.||+|+||.||+|... +|+.||||++... .....+.+.+|+ ..+++++||||++++ +++.+.+
T Consensus 80 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 159 (377)
T 3byv_A 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159 (377)
T ss_dssp EEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCS
T ss_pred eeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcc
Confidence 3899999999999864 6999999999743 334557889999 555666899999998 6665543
Q ss_pred --------------eeEEEEEcCCCCCHHHHHhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCccc
Q 020720 64 --------------NRILVYEYLENNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKAS 126 (322)
Q Consensus 64 --------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~ 126 (322)
..+++|||+ +|+|.+++..... ....+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 160 ~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~ 235 (377)
T 3byv_A 160 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPV 235 (377)
T ss_dssp EEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred ccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 278999999 5799999975321 1123445888899999999999999999 999999999
Q ss_pred ceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhC-----------CCCcccceehhhHHHHHHHhCC
Q 020720 127 NVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-----------QLTKKADVYSFGVLLLEIISGR 195 (322)
Q Consensus 127 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~sDv~slG~il~ell~g~ 195 (322)
|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 236 NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 236 DIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp GEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred HEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 99999999999999999985432 2234457 999999999987 8999999999999999999999
Q ss_pred CCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 196 SSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.||........... +.......+ ..+.+++.+||+.||++||++.|+++
T Consensus 311 ~Pf~~~~~~~~~~~----------------~~~~~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 311 LPITKDAALGGSEW----------------IFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CCC------CCSGG----------------GGSSCCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCcccccccchhh----------------hhhhccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99976533222111 111112333 44888999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=317.16 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=198.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++||||++++
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 92 (279)
T 2w5a_A 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92 (279)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTE
T ss_pred hccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCC
Confidence 3899999999999876 6899999999754 34445788999999999999999999998854 56789999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA--DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+|.+++.........+++..++.++.|++.||.|||+.+ ..+++|+||||+||+++.++.+||+|||++........
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~- 171 (279)
T 2w5a_A 93 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS- 171 (279)
T ss_dssp EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-
T ss_pred CHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc-
Confidence 999999754333346999999999999999999999865 23499999999999999999999999999986543321
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ... ..+. .+. ....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~i~-~~~--------~~~~ 236 (279)
T 2w5a_A 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA---GKIR-EGK--------FRRI 236 (279)
T ss_dssp HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-HTC--------CCCC
T ss_pred cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH---HHHh-hcc--------cccC
Confidence 122346899999999999989999999999999999999999999764321 111 1111 111 1122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
+......+.+++.+||+.||.+||++.||++.+..
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 22334568899999999999999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=325.27 Aligned_cols=249 Identities=24% Similarity=0.246 Sum_probs=191.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-----ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-----SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 33 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g 112 (345)
T 3hko_A 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112 (345)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCC
Confidence 3899999999999875 6889999998643 234457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC------------------------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 020720 75 NSLANALLGSKS------------------------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPI 118 (322)
Q Consensus 75 ~~L~~~l~~~~~------------------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i 118 (322)
++|.+++..... ....+++..++.++.||+.||+|||+.+ +
T Consensus 113 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 189 (345)
T 3hko_A 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---I 189 (345)
T ss_dssp CBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 999999852110 0113457778899999999999999999 9
Q ss_pred eeccCcccceEeCCCC--eEEEeeeccccccCCC---cceeecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHH
Q 020720 119 VHRDIKASNVLLDGNF--HPKIGDFGLAKLFPDN---VTHVSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEI 191 (322)
Q Consensus 119 ~h~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~el 191 (322)
+|+||||+||+++.++ .+||+|||++...... .........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 269 (345)
T 3hko_A 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269 (345)
T ss_dssp ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHH
T ss_pred cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999998776 8999999999854321 1112234568999999999975 6789999999999999999
Q ss_pred HhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 192 ISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 192 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
++|..||......+.. ......... ...+.... ....+.+++.+||+.||.+||++.|+++
T Consensus 270 ~~g~~pf~~~~~~~~~------~~~~~~~~~--~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 270 LMGAVPFPGVNDADTI------SQVLNKKLC--FENPNYNV----LSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHSSCSSCCSSHHHHH------HHHHHCCCC--TTSGGGGG----SCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHCCCCCCCCChHHHH------HHHHhcccc--cCCccccc----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999765322111 111111100 00111111 2345888999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=319.32 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=202.1
Q ss_pred CcccCcceEEEEEEE-----CCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC--eeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL-----RDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN--NRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~ 73 (322)
.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++...+ ..++||||++
T Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 127 (326)
T 2w1i_A 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 127 (326)
T ss_dssp EEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCT
T ss_pred eeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCC
Confidence 389999999999974 368899999998776666788999999999999999999999986654 6899999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 128 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~ 201 (326)
T 2w1i_A 128 YGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201 (326)
T ss_dssp TCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccc
Confidence 9999999976532 5899999999999999999999999 999999999999999999999999999876543322
Q ss_pred e--ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccC--------C-CchhHHHHHHHHHhcCcc
Q 020720 154 V--STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFG--------D-DMLILVEWTWKLREEGRL 222 (322)
Q Consensus 154 ~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~~~~ 222 (322)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||..... . ...............+.
T Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 280 (326)
T 2w1i_A 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG- 280 (326)
T ss_dssp EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC-
T ss_pred cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC-
Confidence 1 1223467789999999999999999999999999999999998764310 0 00000001111111110
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
....+......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 281 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 281 -------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122333456889999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=334.23 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=185.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCC--eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDN--NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~ 74 (322)
.||+|+||.||+|.+. +|+.||||++... .......+.+|+.++..+. ||||+++++++...+ ..++||||++
T Consensus 16 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~- 94 (388)
T 3oz6_A 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME- 94 (388)
T ss_dssp C-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-
T ss_pred EeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-
Confidence 4899999999999775 6999999998643 4455677889999999997 999999999997654 6899999997
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC----
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN---- 150 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 150 (322)
++|.+++... .+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 95 TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 5899998653 5889999999999999999999999 999999999999999999999999999864321
Q ss_pred ----------------cceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH
Q 020720 151 ----------------VTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 151 ----------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 213 (322)
........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+.+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-- 244 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII-- 244 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 0112234579999999999986 678999999999999999999999997653322221111
Q ss_pred HHHHhcCc---cccc------------------cCccCCCCCH-------------HHHHHHHHHHHhcccCCCCCCCCH
Q 020720 214 WKLREEGR---LLEI------------------VDPELTQFPE-------------KEVMRFIKVGLFCTQAGAHYRPTM 259 (322)
Q Consensus 214 ~~~~~~~~---~~~~------------------~~~~~~~~~~-------------~~~~~l~~l~~~cl~~dp~~Rps~ 259 (322)
....... +... .......... .....+.+++.+||+.||++|||+
T Consensus 245 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 245 -GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp -HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred -HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 1000000 0000 0000000000 123458899999999999999999
Q ss_pred HHHHHH
Q 020720 260 KQVVEM 265 (322)
Q Consensus 260 ~evl~~ 265 (322)
.|+++.
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=327.47 Aligned_cols=243 Identities=22% Similarity=0.319 Sum_probs=190.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCC--CCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIR--HPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|...+++.||||++... .....+.+.+|+.++..++ ||||+++++++...+..++||| +.+++
T Consensus 63 ~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~ 141 (390)
T 2zmd_A 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 141 (390)
T ss_dssp EEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEE
T ss_pred EEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCC
Confidence 38999999999998888999999998754 3445578999999999996 5999999999999999999999 56789
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-ee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 155 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++......... ..
T Consensus 142 L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 142 LNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp HHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 999997654 6889999999999999999999998 99999999999996 588999999999866433221 22
Q ss_pred cccccCCCCCchHHHhh-----------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 156 TRVAGTMGYLAPEYALL-----------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-----------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .. .........
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~---~~~~~~~~~---- 284 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--IS---KLHAIIDPN---- 284 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HH---HHHHHHCTT----
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HH---HHHHHhCcc----
Confidence 34569999999999875 36889999999999999999999999754221 11 111111110
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......... ...+.+++.+||+.||.+||++.|+++.
T Consensus 285 -~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 -HEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -SCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011111222 3457889999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=323.89 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=201.8
Q ss_pred CcccCcceEEEEEEEC-CC-----CEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DG-----TQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.+..++||||+
T Consensus 53 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (333)
T 2i1m_A 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 132 (333)
T ss_dssp EEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecC
Confidence 3899999999999865 23 479999997653 34457789999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC----------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeec
Q 020720 73 ENNSLANALLGSKS----------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFG 142 (322)
Q Consensus 73 ~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg 142 (322)
++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 133 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 209 (333)
T 2i1m_A 133 CYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFG 209 (333)
T ss_dssp TTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred CCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccc
Confidence 99999999964311 1225789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcC
Q 020720 143 LAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEG 220 (322)
Q Consensus 143 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (322)
++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......... .....+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~------~~~~~~ 283 (333)
T 2i1m_A 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY------KLVKDG 283 (333)
T ss_dssp GGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH------HHHHHT
T ss_pred cccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH------HHHhcC
Confidence 9985533222 22233456788999999999999999999999999999998 889987654332211 111111
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 221 RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
. ... .+......+.+++.+||+.||.+||++.||++.|+....
T Consensus 284 ~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 284 Y-----QMA---QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp C-----CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----CCC---CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 0 011 111223458889999999999999999999999987653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=318.26 Aligned_cols=242 Identities=25% Similarity=0.376 Sum_probs=195.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||.||+|... +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+....+++|||+++++|.+
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (304)
T 2jam_A 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD 95 (304)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred eccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHH
Confidence 4899999999999876 799999999986655555778899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcceeec
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++...... ...
T Consensus 96 ~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~ 165 (304)
T 2jam_A 96 RILERG----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMS 165 (304)
T ss_dssp HHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTH
T ss_pred HHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccc
Confidence 986543 6899999999999999999999999 9999999999999 78899999999998754322 123
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|++.|+|||++.+..++.++||||||+++|+|++|..||....... .. ..+.. +.. . +. ......
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~i~~-~~~-~-~~---~~~~~~ 233 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LF---EKIKE-GYY-E-FE---SPFWDD 233 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHH-CCC-C-CC---TTTTTT
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHc-CCC-C-CC---cccccc
Confidence 3468999999999998899999999999999999999999997543211 11 11111 110 0 00 111122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3345889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=334.82 Aligned_cols=186 Identities=24% Similarity=0.372 Sum_probs=148.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 72 (322)
+||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 60 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 139 (458)
T 3rp9_A 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139 (458)
T ss_dssp C-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC
T ss_pred EeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc
Confidence 4899999999999776 6899999998653 344557899999999999999999999998543 4689999998
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 140 ~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 140 D-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp S-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred c-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 4 68999996553 6999999999999999999999999 99999999999999999999999999986542211
Q ss_pred --------------------------eeecccccCCCCCchHHHh-hCCCCcccceehhhHHHHHHHhC
Q 020720 153 --------------------------HVSTRVAGTMGYLAPEYAL-LGQLTKKADVYSFGVLLLEIISG 194 (322)
Q Consensus 153 --------------------------~~~~~~~~t~~y~aPE~~~-~~~~~~~sDv~slG~il~ell~g 194 (322)
......+||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 1223456899999999874 56799999999999999999993
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=323.49 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHH--HHHHhcCCCCcccccceEEEe-----CCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTE--IDMIWNIRHPNLVQLIGCCVE-----DNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e--~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... ++.||||++..... ..+..| +..+..++||||+++++.+.. ....++||||++
T Consensus 20 ~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 95 (336)
T 3g2f_A 20 LIGRGRYGAVYKGSLD-ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95 (336)
T ss_dssp EEEECSSEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred ecccCCCeEEEEEEEC-CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence 4899999999999774 89999999974432 333444 444556899999999986543 225689999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE---------ADPPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
+++|.+++... ..++..++.++.||+.||+|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 96 ~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 96 NGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp TCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccce
Confidence 99999999655 358889999999999999999998 7 999999999999999999999999999
Q ss_pred cccCCCc-------ceeecccccCCCCCchHHHhh-------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHH
Q 020720 145 KLFPDNV-------THVSTRVAGTMGYLAPEYALL-------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILV 210 (322)
Q Consensus 145 ~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~ 210 (322)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 8654321 111223468999999999986 45667999999999999999998777544332211110
Q ss_pred -H----------HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCcc
Q 020720 211 -E----------WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNE 274 (322)
Q Consensus 211 -~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~~ 274 (322)
. ..............+ +............+.+++.+||+.||++|||+.|+++.|+.++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKF-PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCC-CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hhcccCCCchHHHHHhhhcccccCCCC-CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 0 000001111000011 11111233466679999999999999999999999999999886543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=315.06 Aligned_cols=243 Identities=31% Similarity=0.466 Sum_probs=191.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-CeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-NNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... |+.||+|+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++++|.+
T Consensus 28 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (278)
T 1byg_A 28 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 104 (278)
T ss_dssp EEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHH
T ss_pred EEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHH
Confidence 3899999999999876 8899999987543 457889999999999999999999997654 47899999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 105 ~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~ 175 (278)
T 1byg_A 105 YLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGK 175 (278)
T ss_dssp HHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc----cCCC
Confidence 9965421 13888999999999999999999999 9999999999999999999999999987543321 2234
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
+++.|+|||++.+..++.++||||||+++|+|++ |..||......+... .. ..+ . ....+....
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~------~~-~~~-----~---~~~~~~~~~ 240 (278)
T 1byg_A 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------RV-EKG-----Y---KMDAPDGCP 240 (278)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH------HH-TTT-----C---CCCCCTTCC
T ss_pred ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HH-hcC-----C---CCCCcccCC
Confidence 6889999999999999999999999999999998 999997653322111 11 111 0 112222334
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
..+.+++.+||+.||.+||++.++++.|+...
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 45888999999999999999999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.96 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=201.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCC-CcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH-PNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.++| +++..+..++.+....++||||+ +++|.
T Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~ 90 (483)
T 3sv0_A 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (483)
T ss_dssp CCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHH
Confidence 4899999999999875 6999999998654332 457889999999987 55556666667788899999999 89999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcce--
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTH-- 153 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-- 153 (322)
+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++.........
T Consensus 91 ~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 91 DLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 99975432 6999999999999999999999999 9999999999999 68899999999999865433221
Q ss_pred ----eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 154 ----VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 154 ----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......................+. ..
T Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~----~l 240 (483)
T 3sv0_A 165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE----AL 240 (483)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH----HH
T ss_pred cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH----HH
Confidence 1224569999999999999999999999999999999999999998876555444433322222111110 00
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.... ..++.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 241 ~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 241 CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1122 345889999999999999999999999887664
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=313.48 Aligned_cols=238 Identities=24% Similarity=0.326 Sum_probs=196.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+++|||+++++
T Consensus 21 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 100 (284)
T 2vgo_A 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 100 (284)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCc
Confidence 3899999999999876 58889999986432 2234678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 101 L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 170 (284)
T 2vgo_A 101 LYKELQKHG----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RR 170 (284)
T ss_dssp HHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---BC
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc---cc
Confidence 999997653 6899999999999999999999998 9999999999999999999999999987554322 12
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...|++.|+|||++.+..++.++||||||+++|+|++|..||......... .... .. +. ..+..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~~------~~---~~~~~ 234 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIV-NV------DL---KFPPF 234 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TT------CC---CCCTT
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHh-cc------cc---CCCCc
Confidence 346899999999999999999999999999999999999999754321111 1111 11 11 12222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 3345888999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=320.87 Aligned_cols=237 Identities=24% Similarity=0.313 Sum_probs=185.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|... +|+.||||++.... .........|+..+.++ +||||+++++++.+.+..++||||+ +++
T Consensus 64 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~ 142 (311)
T 3p1a_A 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142 (311)
T ss_dssp EEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCC
Confidence 3899999999999887 79999999986542 33344555666666555 9999999999999999999999999 668
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 143 L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~ 214 (311)
T 3p1a_A 143 LQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GE 214 (311)
T ss_dssp HHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--------
T ss_pred HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC--Cc
Confidence 9888865532 6999999999999999999999998 99999999999999999999999999886543322 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+ .++.++|||||||++|||++|..|+..... +.....+. ..+.+ +..
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~----~~~~~---~~~ 276 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY----LPPEF---TAG 276 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC----CCHHH---HTT
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC----CCccc---ccC
Confidence 3458999999998875 789999999999999999999776654211 01111111 01111 111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||++|||+.|+++
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2345889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=334.21 Aligned_cols=253 Identities=22% Similarity=0.248 Sum_probs=189.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus 69 ~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~ 148 (464)
T 3ttj_A 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148 (464)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred EeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeC
Confidence 3899999999999776 6899999999754 444567889999999999999999999998654 356999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
++++ |.+.+.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 149 ~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 149 MDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp CSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred CCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 9764 6666632 4889999999999999999999999 9999999999999999999999999998654322
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH----------------H
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW----------------K 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~----------------~ 215 (322)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+.... .
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 219 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp --CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred --ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 2344678999999999999999999999999999999999999997654322221111000 0
Q ss_pred HHhcC------ccccccCccCCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEG------RLLEIVDPELTQF----PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~------~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..... .....+...+... .......+.+++.+||+.||++|||++|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 11124568999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=320.65 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=188.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcH-HHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|+++....... ..+.+|+.+++.++||||+++++++.+.+..++||||+++ +|.
T Consensus 9 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (324)
T 3mtl_A 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLK 87 (324)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHH
T ss_pred EEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHH
Confidence 3899999999999876 789999999975432221 2456799999999999999999999999999999999974 898
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 160 (324)
T 3mtl_A 88 QYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNE 160 (324)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-ccccc
Confidence 88876542 6899999999999999999999999 99999999999999999999999999875543221 22334
Q ss_pred ccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC---------c
Q 020720 159 AGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD---------P 228 (322)
Q Consensus 159 ~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 228 (322)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+................. +
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 67999999999886 5689999999999999999999999976543322221111000000000000000 0
Q ss_pred cCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELT-----QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~-----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... .........+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 001112345789999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=315.19 Aligned_cols=241 Identities=27% Similarity=0.427 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 108 (303)
T 3a7i_A 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 108 (303)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred hhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHH
Confidence 3899999999999765 68999999997553 344578999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 109 ~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 179 (303)
T 3a7i_A 109 DLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 179 (303)
T ss_dssp HHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCC
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-ccCcc
Confidence 999542 6899999999999999999999999 99999999999999999999999999976543321 12334
Q ss_pred ccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
.+++.|+|||++.+..++.++||||||+++|+|++|..||....... .. ..... .. .+.+ .....
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~~-~~-----~~~~---~~~~~ 244 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VL---FLIPK-NN-----PPTL---EGNYS 244 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHH-SC-----CCCC---CSSCC
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HH---HHhhc-CC-----CCCC---ccccC
Confidence 68999999999999999999999999999999999999997542211 11 11111 11 1111 22223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.+++.+||+.||.+||++.++++.
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 458889999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=309.95 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 14 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (276)
T 2yex_A 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93 (276)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGG
T ss_pred EeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHH
Confidence 3899999999999876 68999999987542 334578899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc-eeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-HVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 157 (322)
+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 94 ~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 94 DRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp GGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred HHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 9986443 6899999999999999999999999 99999999999999999999999999876532211 12234
Q ss_pred cccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......... .. ...... .......
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~----~~~~~~--------~~~~~~~ 233 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD----WKEKKT--------YLNPWKK 233 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-HH----HHTTCT--------TSTTGGG
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-HH----hhhccc--------ccCchhh
Confidence 568999999999987765 789999999999999999999998654432211 11 111100 0011122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 234 IDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 3345788999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=314.66 Aligned_cols=239 Identities=23% Similarity=0.343 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|+++.. .......+.+|+..+..+ +||||+++++++.+.+..++||||+++++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 97 (289)
T 1x8b_A 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGS 97 (289)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred hhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCc
Confidence 3899999999999876 7999999999754 234457788999999999 99999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-------------------CeEE
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-------------------FHPK 137 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-------------------~~~k 137 (322)
|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ ..++
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k 174 (289)
T 1x8b_A 98 LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174 (289)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEE
T ss_pred HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence 99999754322236899999999999999999999999 9999999999999844 4799
Q ss_pred EeeeccccccCCCcceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH
Q 020720 138 IGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 138 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
|+|||.+....... ...+|+.|+|||++.+. .++.++|||||||++|+|++|..|+.... .. ...
T Consensus 175 l~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~------~~~ 240 (289)
T 1x8b_A 175 IGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QW------HEI 240 (289)
T ss_dssp ECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HH------HHH
T ss_pred EcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HH------HHH
Confidence 99999988664332 23488999999999876 56789999999999999999987764321 00 011
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+ .....+......+.+++.+||+.||++||++.|+++.
T Consensus 241 -~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 241 -RQG--------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HTT--------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HcC--------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1112222233458889999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=320.91 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=186.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh--cHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ--GTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++++++||||+++++++.+....++||||+++ +|
T Consensus 41 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L 119 (329)
T 3gbz_A 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DL 119 (329)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EH
T ss_pred EEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CH
Confidence 3899999999999765 6899999999755332 245678999999999999999999999999999999999975 99
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe-----CCCCeEEEeeeccccccCCCcc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL-----DGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill-----~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||++ +.++.+||+|||++........
T Consensus 120 ~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 120 KKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp HHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence 99997664 6899999999999999999999999 9999999999999 4556699999999986643322
Q ss_pred eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc--c----
Q 020720 153 HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE--I---- 225 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---- 225 (322)
......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.............. .
T Consensus 193 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 193 -QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 22334679999999999875 489999999999999999999999976433222111110000000000000 0
Q ss_pred --cCccCCCCCH------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 --VDPELTQFPE------KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 --~~~~~~~~~~------~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+....... .....+.+++.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000 12345789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=319.62 Aligned_cols=253 Identities=28% Similarity=0.398 Sum_probs=197.7
Q ss_pred CcccCcceEEEEEEE------CCCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSL------RDGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.. .++..||+|++... .......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 37 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (327)
T 2yfx_A 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMA 116 (327)
T ss_dssp ECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCC
Confidence 389999999999973 25778999999754 34455788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC---CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeecccccc
Q 020720 74 NNSLANALLGSKS---KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLF 147 (322)
Q Consensus 74 ~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~ 147 (322)
+++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++. +..++|+|||++...
T Consensus 117 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193 (327)
T ss_dssp TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence 9999999976532 1235889999999999999999999999 999999999999984 446999999998754
Q ss_pred CCCc-ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 148 PDNV-THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 148 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
.... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .. .... .+.
T Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~~~~-~~~---- 262 (327)
T 2yfx_A 194 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL---EFVT-SGG---- 262 (327)
T ss_dssp HC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH---HHHH-TTC----
T ss_pred ccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HH---HHHh-cCC----
Confidence 3221 122233457889999999999999999999999999999998 889987542211 11 1111 111
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
....+......+.+++.+||+.||.+||++.++++.|+....
T Consensus 263 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 ----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111122233458889999999999999999999999987764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=307.81 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=194.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 91 (283)
T 3bhy_A 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 91 (283)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecC
Confidence 3899999999999877 699999999875421 235789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC----eEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF----HPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 149 (322)
+++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||++.....
T Consensus 92 ~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 92 GGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp SCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 999999996543 6899999999999999999999999 99999999999999877 799999999986543
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
... .....+++.|+|||++.+..++.++||||||+++|+|++|..||......... .... .... ...+.
T Consensus 165 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~--~~~~~ 233 (283)
T 3bhy_A 165 GNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------TNIS-AVNY--DFDEE 233 (283)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TTCC--CCCHH
T ss_pred CCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------HHhH-hccc--CCcch
Confidence 221 23345899999999999999999999999999999999999999754321111 1111 0000 00000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. .......+.+++.+||+.||++||++.|+++
T Consensus 234 ~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 234 Y---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp H---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h---cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0112345888999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=317.12 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=193.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
+||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 111 (331)
T 4aaa_A 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTIL 111 (331)
T ss_dssp EGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchH
Confidence 4899999999999876 58999999986543 33346688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 112 ~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 183 (331)
T 4aaa_A 112 DDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDD 183 (331)
T ss_dssp HHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred HHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCC
Confidence 88875543 6999999999999999999999999 99999999999999999999999999976543221 2233
Q ss_pred cccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH--------HHHHhcCc-cccccC
Q 020720 158 VAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT--------WKLREEGR-LLEIVD 227 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~ 227 (322)
..+++.|+|||++.+. .++.++|||||||++|+|++|..||......+....+... ........ ......
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 4689999999999875 7899999999999999999999999765432222111100 00000000 000111
Q ss_pred ccCCC-CC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQ-FP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~-~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+.. .+ +.....+.+++.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111 11 123456889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=321.54 Aligned_cols=245 Identities=16% Similarity=0.190 Sum_probs=196.0
Q ss_pred CcccCcceEEEEEE------ECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGS------LRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
+||+|+||.||+|. ..+++.||+|+++... ...+..|+.++..++ |+||+.+++++...+..++||||
T Consensus 72 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~ 148 (365)
T 3e7e_A 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148 (365)
T ss_dssp EEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred EeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence 38999999999993 3468899999997554 356677777777776 99999999999999999999999
Q ss_pred CCCCCHHHHHhcCCC-CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-----------CCeEEEe
Q 020720 72 LENNSLANALLGSKS-KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-----------NFHPKIG 139 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-----------~~~~kl~ 139 (322)
+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+
T Consensus 149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEe
Confidence 999999999964211 2236999999999999999999999998 999999999999998 8999999
Q ss_pred eeccccccCC-CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh
Q 020720 140 DFGLAKLFPD-NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE 218 (322)
Q Consensus 140 Dfg~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (322)
|||++..... ..........||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------- 294 (365)
T 3e7e_A 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----------- 294 (365)
T ss_dssp CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----------
T ss_pred eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----------
Confidence 9999975431 2223334567999999999999999999999999999999999999999755332110
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHhcccc
Q 020720 219 EGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYR-PTMKQVVEMLSKDVH 271 (322)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-ps~~evl~~L~~~~~ 271 (322)
+...+...+ ....+.+++..||+.+|.+| |++.++.+.|+....
T Consensus 295 -------~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 -------PEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -------ECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------echhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 111222222 13446677888999999998 678888888877654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=321.19 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 40 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 119 (360)
T 3eqc_A 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119 (360)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred eecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHH
Confidence 3899999999999876 6899999999765 3444578999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++...... ....
T Consensus 120 ~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 189 (360)
T 3eqc_A 120 QVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 189 (360)
T ss_dssp HHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C---
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccC
Confidence 9997654 689999999999999999999985 8 999999999999999999999999998754211 1233
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH---------H------------
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK---------L------------ 216 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---------~------------ 216 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||................. .
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 4689999999999999999999999999999999999999975432211100000000 0
Q ss_pred --HhcCccc----cccCccCCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 217 --REEGRLL----EIVDPELTQFP-EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 217 --~~~~~~~----~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....... ..........+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000 00000011111 1123458899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=324.24 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=189.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~ 71 (322)
.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++.... ..++||||
T Consensus 32 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~ 111 (367)
T 1cm8_A 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111 (367)
T ss_dssp EC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred EeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEec
Confidence 3899999999999875 6999999998643 3344577899999999999999999999997653 45999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+ +++|.+++... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 112 ~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 112 M-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp C-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred C-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 9 78999999653 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC----------
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG---------- 220 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 220 (322)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+..+ .......
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHHTCSC
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHHHHHHhhh
Confidence 234568999999999887 67999999999999999999999999865332221111 1100000
Q ss_pred --------ccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 221 --------RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 221 --------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+.......+..........+.+++.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000011112222334558899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=320.11 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=193.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhc-----HHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQG-----TKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|... +|+.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 96 (346)
T 1ua2_A 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96 (346)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC
Confidence 4899999999999876 68999999997542211 24678999999999999999999999999999999999986
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 97 -~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~ 168 (346)
T 1ua2_A 97 -DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 168 (346)
T ss_dssp -EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred -CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc-c
Confidence 8888886543 26888999999999999999999999 99999999999999999999999999986543322 2
Q ss_pred ecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc---Ccccc------
Q 020720 155 STRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE---GRLLE------ 224 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~------ 224 (322)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+. .......... .....
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhhhhccCcc
Confidence 2345689999999998764 588999999999999999999999876532221 1111111100 00000
Q ss_pred ccC-ccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVD-PELTQFP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~-~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+. ......+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0001111 2223568899999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=317.32 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=195.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--------hcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--------QGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++.++ +||||+++++++......++|||
T Consensus 101 ~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 180 (365)
T 2y7j_A 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180 (365)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEEC
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEE
Confidence 3899999999999886 799999999875431 1235678999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 181 ~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 181 LMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred eCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 999999999997543 6999999999999999999999999 999999999999999999999999998866433
Q ss_pred cceeecccccCCCCCchHHHhhC------CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLG------QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~------~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... .... .+. .+...
T Consensus 254 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~---~i~-~~~~~- 323 (365)
T 2y7j_A 254 EK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLR---MIM-EGQYQ- 323 (365)
T ss_dssp CC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-HTCCC-
T ss_pred cc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHH---HHH-hCCCC-
Confidence 22 2345689999999998743 5788999999999999999999999754211 1111 111 11100
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+..... ...+.+++.+||+.||.+||++.|+++
T Consensus 324 ~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 324 FSSPEWDDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCHHHHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111122 234888999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=309.89 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=189.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (276)
T 2h6d_A 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97 (276)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCc
Confidence 3899999999999876 79999999986542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 98 L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 168 (276)
T 2h6d_A 98 LFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLR 168 (276)
T ss_dssp HHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred HHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--cee
Confidence 999997553 6899999999999999999999999 9999999999999999999999999998654332 123
Q ss_pred ccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 157 RVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+++.|+|||++.+..+ +.++||||||+++|+|++|..||...... ... ..... +. ...+.
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~-~~---------~~~~~ 232 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF---KKIRG-GV---------FYIPE 232 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHH-CC---------CCCCT
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH---HHhhc-Cc---------ccCch
Confidence 3468999999999987765 68999999999999999999999753211 111 11111 11 11122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.+++.+||+.||++||++.|+++.
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 223458889999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=334.76 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=197.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+.+++
T Consensus 33 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 112 (484)
T 3nyv_A 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112 (484)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC
Confidence 4899999999999876 79999999986542 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe---CCCCeEEEeeeccccccCCCcce
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL---DGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
|.+.+.... .+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.+||+|||++.......
T Consensus 113 L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 183 (484)
T 3nyv_A 113 LFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-- 183 (484)
T ss_dssp HHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC--
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc--
Confidence 999997654 6999999999999999999999999 9999999999999 567899999999998664432
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+ .. ..+.. +.... -.+..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~-~~~~~-~~~~~--- 251 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---IL---KKVEK-GKYTF-ELPQW--- 251 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-CCCCC-CSGGG---
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHc-CCCCC-CCccc---
Confidence 2234568999999998876 68999999999999999999999997643221 11 11111 11100 00111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
......+.+++.+||+.||.+|||+.|+++.
T Consensus 252 -~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 252 -KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1223458899999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=326.30 Aligned_cols=244 Identities=24% Similarity=0.338 Sum_probs=184.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--------hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--------KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++. .+..++||||
T Consensus 142 ~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~ 220 (419)
T 3i6u_A 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLEL 220 (419)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEc
Confidence 3899999999999776 68999999986532 112235789999999999999999999975 4568999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC---eEEEeeeccccccC
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF---HPKIGDFGLAKLFP 148 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~---~~kl~Dfg~~~~~~ 148 (322)
+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++ .+||+|||++....
T Consensus 221 ~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 221 MEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp CTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred CCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 99999999886543 6999999999999999999999999 99999999999997544 59999999998764
Q ss_pred CCcceeecccccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ . ..+... .
T Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~-----i-~~~~~~-~ 364 (419)
T 3i6u_A 294 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ-----I-TSGKYN-F 364 (419)
T ss_dssp -------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH-----H-HTTCCC-C
T ss_pred CCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH-----H-hcCCCC-C
Confidence 322 2234578999999998853 57789999999999999999999999865443322111 0 111100 0
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.... ....+.+++.+||+.||.+||++.|+++.
T Consensus 365 ~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 365 IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000011 23458899999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=331.52 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=191.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+.+++|
T Consensus 44 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 123 (494)
T 3lij_A 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123 (494)
T ss_dssp EEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcH
Confidence 3899999999999876 68999999997542 33357789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---CeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN---FHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+.+.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.. +.+||+|||++....... .
T Consensus 124 ~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~ 194 (494)
T 3lij_A 124 FDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--K 194 (494)
T ss_dssp HHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--C
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--c
Confidence 99886553 6899999999999999999999999 9999999999999764 559999999998664332 2
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||......... ..+.. +.. ....+.....+
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~-~~~-~~~~~~~~~~s 265 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL------RKVEK-GKY-TFDSPEWKNVS 265 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-TCC-CCCSGGGTTSC
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CCC-CCCchhcccCC
Confidence 23456999999999876 56899999999999999999999999764322111 11111 111 00111122333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+.+++.+||+.||.+|||+.|+++
T Consensus 266 ----~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 266 ----EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 34888999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=326.66 Aligned_cols=190 Identities=27% Similarity=0.399 Sum_probs=160.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 72 (322)
+||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 33 ~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 112 (432)
T 3n9x_A 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112 (432)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC
Confidence 4899999999999876 6889999999753 344557899999999999999999999998766 5689999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
. ++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 113 ~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 113 D-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp S-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred C-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 6 59999997553 6999999999999999999999999 99999999999999999999999999986543221
Q ss_pred ---------------------eeecccccCCCCCchHHH-hhCCCCcccceehhhHHHHHHHhCCCCC
Q 020720 153 ---------------------HVSTRVAGTMGYLAPEYA-LLGQLTKKADVYSFGVLLLEIISGRSSS 198 (322)
Q Consensus 153 ---------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~sDv~slG~il~ell~g~~p~ 198 (322)
......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 122456789999999986 4567999999999999999999865554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.55 Aligned_cols=253 Identities=29% Similarity=0.394 Sum_probs=199.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhc--CCCCcccccceEEEeCC----eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWN--IRHPNLVQLIGCCVEDN----NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~ 74 (322)
.||+|+||.||+|... |+.||+|++... ....+.+|.+++.. ++||||+++++++.... ..++||||+++
T Consensus 49 ~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~ 124 (342)
T 1b6c_B 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124 (342)
T ss_dssp EEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTT
T ss_pred eecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCC
Confidence 3899999999999885 899999998643 34667788888887 79999999999998876 78999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH--------EEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
++|.+++... .+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 125 g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 125 GSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVR 196 (342)
T ss_dssp CBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence 9999999654 5899999999999999999999 777 99999999999999999999999999986
Q ss_pred cCCCcce---eecccccCCCCCchHHHhhCC------CCcccceehhhHHHHHHHhC----------CCCCCcccCCCch
Q 020720 147 FPDNVTH---VSTRVAGTMGYLAPEYALLGQ------LTKKADVYSFGVLLLEIISG----------RSSSKAAFGDDML 207 (322)
Q Consensus 147 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~sDv~slG~il~ell~g----------~~p~~~~~~~~~~ 207 (322)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.........
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 5433222 123456899999999987652 34789999999999999999 7788765433221
Q ss_pred hHHHHHHHHHhcCccccccCccCCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 208 ILVEWTWKLREEGRLLEIVDPELTQ--FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.. . ........ ...+.+.. ........+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 277 ~~-~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 277 VE-E-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp HH-H-HHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-H-HHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11 1 11111111 11122211 223566789999999999999999999999999987753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=320.49 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=181.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEe--------CCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVE--------DNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--------~~~~~lv~e 70 (322)
+||+|+||.||+|.+. +++.||+|++........+.+.+|+.++.++. ||||+++++++.. ....+++||
T Consensus 35 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e 114 (337)
T 3ll6_A 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE 114 (337)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEE
T ss_pred EEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEE
Confidence 4899999999999875 68999999997777777788999999999996 9999999999843 345789999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|+. |+|.+++.... ....+++..++.++.||+.||.|||+.+ ++++|+||||+||+++.++.+||+|||++......
T Consensus 115 ~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 191 (337)
T 3ll6_A 115 LCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191 (337)
T ss_dssp CCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSC
T ss_pred ecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceecccc
Confidence 996 68988886421 1126999999999999999999999863 34999999999999999999999999999865432
Q ss_pred cce-----------eecccccCCCCCchHHH---hhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHH
Q 020720 151 VTH-----------VSTRVAGTMGYLAPEYA---LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 151 ~~~-----------~~~~~~~t~~y~aPE~~---~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
... ......+|+.|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--------- 262 (337)
T 3ll6_A 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--------- 262 (337)
T ss_dssp C-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred CcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---------
Confidence 211 11134589999999998 5667899999999999999999999999754221100
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
. . ...... .......+.+++.+||+.||.+||++.|+++.|+....
T Consensus 263 -~-~----~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 263 -N-G----KYSIPP---HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------CCCCT---TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -c-C----cccCCc---ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0 000001 11112237788999999999999999999999987764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=344.91 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=197.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..++||||+++|
T Consensus 348 ~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg 427 (674)
T 3pfq_A 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427 (674)
T ss_dssp ESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSC
T ss_pred EEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCC
Confidence 4899999999999876 6889999999753 223346788899999988 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 428 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~ 499 (674)
T 3pfq_A 428 DLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTT 499 (674)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CCB
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC-ccc
Confidence 9999997654 6999999999999999999999999 9999999999999999999999999998543222 223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|||++|..||......+.. ..+.. . ...++.
T Consensus 500 ~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~-~---------~~~~p~ 563 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIME-H---------NVAYPK 563 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHS-S---------CCCCCT
T ss_pred ccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH------HHHHh-C---------CCCCCc
Confidence 4567999999999999999999999999999999999999999764322111 11111 1 112223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTM-----KQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~-----~evl~ 264 (322)
....++.+++.+||+.||++||++ +||++
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 334558889999999999999997 66664
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=308.81 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=193.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 33 ~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 112 (290)
T 1t4h_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred eccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecC
Confidence 3899999999999776 6889999998754 34456788999999999999999999999875 346899999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
+++|.+++.... .+++..++.++.||+.||.|||+.+ .+++|+||||+||+++ .++.+||+|||++........
T Consensus 113 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 187 (290)
T 1t4h_A 113 SGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187 (290)
T ss_dssp SCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred CCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc
Confidence 999999997643 6899999999999999999999864 3499999999999998 789999999999976543322
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
....||+.|+|||++. ..++.++|||||||++|+|++|..||......... .... ..+... ...
T Consensus 188 ---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~-~~~~~~----~~~-- 251 (290)
T 1t4h_A 188 ---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRV-TSGVKP----ASF-- 251 (290)
T ss_dssp ---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHH-TTTCCC----GGG--
T ss_pred ---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHH-hccCCc----ccc--
Confidence 2346899999999876 46899999999999999999999999754322111 1111 111110 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+......+.+++.+||+.||.+|||+.|+++.
T Consensus 252 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11112358889999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=313.39 Aligned_cols=241 Identities=22% Similarity=0.378 Sum_probs=196.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe----------------CC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----------------DN 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~ 63 (322)
+||+|+||.||+|... +|+.||+|+++... ..+.+|+.++++++||||+++++++.. ..
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (284)
T 2a19_B 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK 93 (284)
T ss_dssp EEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEE
T ss_pred eeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcc
Confidence 4899999999999886 79999999997554 346789999999999999999999864 34
Q ss_pred eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 64 NRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 64 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 168 (284)
T 2a19_B 94 CLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL 168 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchh
Confidence 57999999999999999965421 26899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
+........ .....+++.|+|||++.+..++.++||||||+++|+|++|..|+.... ...... ...
T Consensus 169 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~~-~~~--- 234 (284)
T 2a19_B 169 VTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTDL-RDG--- 234 (284)
T ss_dssp CEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHHH-HTT---
T ss_pred heecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHHh-hcc---
Confidence 886644322 233468999999999999999999999999999999999988864321 001111 111
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.+.. .....+.+++.+||+.||.+||++.|+++.|......
T Consensus 235 -----~~~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 235 -----IISD---IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -----CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -----cccc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111 1223477889999999999999999999999877643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=333.58 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+....++||||+.+++|
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 108 (486)
T 3mwu_A 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108 (486)
T ss_dssp EEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcH
Confidence 4899999999999876 7999999998643 233457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC---CCCeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD---GNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||++........
T Consensus 109 ~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~-- 179 (486)
T 3mwu_A 109 FDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179 (486)
T ss_dssp HHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc--
Confidence 99886553 6999999999999999999999999 99999999999995 556799999999986543322
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+ .. ..+. .+.... -.+...
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~-~~~~~~-~~~~~~--- 247 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRVE-TGKYAF-DLPQWR--- 247 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-HTCCCS-CSGGGG---
T ss_pred cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-hCCCCC-CCcccC---
Confidence 234568999999998875 58999999999999999999999997643221 11 1111 111100 001111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.+++.+||+.||.+|||+.|+++.
T Consensus 248 -~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 223458899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.75 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=193.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 36 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 113 (314)
T 3com_A 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113 (314)
T ss_dssp ECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHH
Confidence 3899999999999876 58999999997543 34678999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 114 ~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 186 (314)
T 3com_A 114 IIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVI 186 (314)
T ss_dssp HHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCC
T ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccC
Confidence 996332 26899999999999999999999999 99999999999999999999999999976543322 123346
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
+++.|+|||++.+..++.++||||||+++|+|++|..||........ ......... +. ...+.....
T Consensus 187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~------~~-~~~~~~~~~ 253 (314)
T 3com_A 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPTNPP------PT-FRKPELWSD 253 (314)
T ss_dssp SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC------CC-CSSGGGSCH
T ss_pred CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC------cc-cCCcccCCH
Confidence 88999999999998999999999999999999999999975422111 111111110 01 111222345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+.+++.+||+.||.+||++.++++
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHHh
Confidence 6889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=328.36 Aligned_cols=242 Identities=26% Similarity=0.389 Sum_probs=192.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-------------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-------------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRI 66 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 66 (322)
.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 43 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 122 (504)
T 3q5i_A 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122 (504)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3899999999999876 688999999875421 23467899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC---eEEEeeecc
Q 020720 67 LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF---HPKIGDFGL 143 (322)
Q Consensus 67 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~---~~kl~Dfg~ 143 (322)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 123 lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp EEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 9999999999999986553 6999999999999999999999999 99999999999998776 699999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
+........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||......... ..+. .+...
T Consensus 196 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~-~~~~~ 265 (504)
T 3q5i_A 196 SSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII------KKVE-KGKYY 265 (504)
T ss_dssp CEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HCCCC
T ss_pred CEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-cCCCC
Confidence 987654322 23456999999999886 56899999999999999999999999764322111 1111 11110
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. -.+..... ...+.+++.+||+.||.+|||+.|+++
T Consensus 266 ~-~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 266 F-DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp C-CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00001122 245888999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=317.25 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=192.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEe--------CCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--------DNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~ 69 (322)
.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~ 103 (351)
T 3mi9_A 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103 (351)
T ss_dssp ECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEE
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEE
Confidence 3899999999999875 799999999865432 224678899999999999999999999977 34689999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+++ +|.+.+..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 176 (351)
T 3mi9_A 104 DFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSL 176 (351)
T ss_dssp ECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCC
T ss_pred eccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccc
Confidence 99975 77777755432 6999999999999999999999999 99999999999999999999999999986542
Q ss_pred Cc---ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 150 NV---THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 150 ~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ .... +.....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~--~~~~~~ 251 (351)
T 3mi9_A 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLC--GSITPE 251 (351)
T ss_dssp CSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHH--CCCCTT
T ss_pred cccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHh--CCCChh
Confidence 21 122234568999999999876 45799999999999999999999999865332222111 1111 100000
Q ss_pred cCcc---------C------CCCCHHH------HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 VDPE---------L------TQFPEKE------VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ~~~~---------~------~~~~~~~------~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+. + ....... ...+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 0 0001111 2347899999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=315.50 Aligned_cols=243 Identities=25% Similarity=0.427 Sum_probs=191.3
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.++
T Consensus 27 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 106 (302)
T 2j7t_A 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI 106 (302)
T ss_dssp EECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHH
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHH
Confidence 899999999999886 5899999999877666678899999999999999999999999999999999999999999998
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .......|
T Consensus 107 ~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~ 179 (302)
T 2j7t_A 107 MLELDR---GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIG 179 (302)
T ss_dssp HHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----C
T ss_pred HHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccccC
Confidence 865322 6899999999999999999999999 9999999999999999999999999875321111 11123458
Q ss_pred CCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 161 TMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 161 t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
++.|+|||++. ...++.++||||||+++|+|++|..||........ ......... + ....+.
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~------~-~~~~~~ 246 (302)
T 2j7t_A 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSDP------P-TLLTPS 246 (302)
T ss_dssp CGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC------C-CCSSGG
T ss_pred ChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccCC------c-ccCCcc
Confidence 89999999984 56788999999999999999999999975432111 111111110 0 011122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+.+++.+||+.||.+|||+.++++
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 23455889999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=312.39 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=179.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcH-HHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGT-KEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||+|+++... .... +.+.++...++.++||||+++++++.+.+..++||||+++ +|
T Consensus 14 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 92 (290)
T 3fme_A 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SL 92 (290)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EH
T ss_pred hcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-ch
Confidence 3899999999999875 68999999997552 2222 3445555668888999999999999999999999999975 88
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
.+++.........+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 167 (290)
T 3fme_A 93 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KD 167 (290)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc--cc
Confidence 777754222233799999999999999999999998 8 99999999999999999999999999986543322 22
Q ss_pred ccccCCCCCchHHH----hhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 157 RVAGTMGYLAPEYA----LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 157 ~~~~t~~y~aPE~~----~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
...||+.|+|||++ ....++.++|||||||++|+|++|..||....... ... ........ +..
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~---~~~~~~~~------~~~-- 234 (290)
T 3fme_A 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQL---KQVVEEPS------PQL-- 234 (290)
T ss_dssp --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHH---HHHHHSCC------CCC--
T ss_pred ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHH---HHHhccCC------CCc--
Confidence 34689999999996 45678899999999999999999999997542211 111 11111110 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11123345889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=308.59 Aligned_cols=243 Identities=22% Similarity=0.261 Sum_probs=190.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC----hhcHHHHHHHHHHHhcCCCCcccccceEEE--eCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES----KQGTKEFLTEIDMIWNIRHPNLVQLIGCCV--EDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++. +....++||||++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (305)
T 2wtk_C 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV 91 (305)
T ss_dssp EEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCS
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhcc
Confidence 4899999999999875 68999999997542 234578999999999999999999999984 4457899999998
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC-cc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN-VT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 152 (322)
++ |.+++..... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 92 ~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 165 (305)
T 2wtk_C 92 CG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165 (305)
T ss_dssp EE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS
T ss_pred CC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccc
Confidence 76 7777765432 26899999999999999999999999 999999999999999999999999999865432 12
Q ss_pred eeecccccCCCCCchHHHhhCC--CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQ--LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~--~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ... ..+. .+.
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~i~-~~~--------- 229 (305)
T 2wtk_C 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLF---ENIG-KGS--------- 229 (305)
T ss_dssp CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHH-HCC---------
T ss_pred cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHH---HHHh-cCC---------
Confidence 2223456899999999988654 378999999999999999999999753211 111 1111 111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+......+.+++.+||+.||.+||++.|+++.
T Consensus 230 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122233458889999999999999999999963
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=314.34 Aligned_cols=255 Identities=27% Similarity=0.371 Sum_probs=179.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 101 (303)
T 2vwi_A 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101 (303)
T ss_dssp ECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHH
T ss_pred eeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchH
Confidence 4899999999999765 68999999986543 334467889999999999999999999999999999999999999999
Q ss_pred HHHhcC----CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--
Q 020720 79 NALLGS----KSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 79 ~~l~~~----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
+++... ......+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 102 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 178 (303)
T 2vwi_A 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178 (303)
T ss_dssp HHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC------
T ss_pred HHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCcc
Confidence 998631 112236899999999999999999999999 99999999999999999999999999876543211
Q ss_pred --eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc-
Q 020720 153 --HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP- 228 (322)
Q Consensus 153 --~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 228 (322)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........... .. ..........
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~-~~~~~~~~~~~ 251 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML------TL-QNDPPSLETGV 251 (303)
T ss_dssp ---------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------HH-TSSCCCTTC--
T ss_pred chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH------Hh-ccCCCcccccc
Confidence 11223468999999999876 5789999999999999999999999976543221110 01 1111000000
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
............+.+++.+||+.||.+||++.++++.
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011112223458889999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=312.36 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=190.3
Q ss_pred CcccCcceEEEEEEEC--CCC--EEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR--DGT--QIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|.+. +++ .||+|+++.. .....+.+.+|+.++++++||||+++++++.+.. .++++||++
T Consensus 25 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~ 103 (291)
T 1u46_A 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAP 103 (291)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCT
T ss_pred eecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEeccc
Confidence 3899999999999753 333 6899998754 2344578899999999999999999999987654 889999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 104 ~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 104 LGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp TCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred CCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 999999997542 26899999999999999999999999 999999999999999999999999999876543322
Q ss_pred --eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 154 --VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
......++..|+|||++.+..++.++||||||+++|+|++ |..||........ ......... .
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~--------~ 243 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGE--------R 243 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCC--------C
T ss_pred hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccCC--------C
Confidence 1223456778999999999999999999999999999999 9999975532111 111111110 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+......+.+++.+||+.||.+||++.++++.|++...
T Consensus 244 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11122334558899999999999999999999999987753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=319.85 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=195.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC--------CCcccccceEEE----eCCeeEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR--------HPNLVQLIGCCV----EDNNRIL 67 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~~~~~~l 67 (322)
.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.+++.++ |+||+++++++. .....++
T Consensus 44 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~l 122 (397)
T 1wak_A 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM 122 (397)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEE
T ss_pred EeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEE
Confidence 3899999999999765 6889999999743 444577889999999985 788999999987 4557899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCC------------
Q 020720 68 VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNF------------ 134 (322)
Q Consensus 68 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~------------ 134 (322)
||||+ +++|.+.+..... ..+++..++.++.||+.||.|||++ + ++||||||+|||++.++
T Consensus 123 v~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~ 196 (397)
T 1wak_A 123 VFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATE 196 (397)
T ss_dssp EECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-
T ss_pred EEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHH
Confidence 99999 5566666654321 2699999999999999999999998 8 99999999999999876
Q ss_pred -------------------------------------eEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCc
Q 020720 135 -------------------------------------HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177 (322)
Q Consensus 135 -------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 177 (322)
.+||+|||++...... .....||+.|+|||++.+..++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCCc
Confidence 7999999999865432 23346899999999999999999
Q ss_pred ccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH-hcCc----------c-ccccCc-----------------
Q 020720 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR-EEGR----------L-LEIVDP----------------- 228 (322)
Q Consensus 178 ~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~----------~-~~~~~~----------------- 228 (322)
++|||||||++|+|++|..||.................+. ..+. . ...+..
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999998765443221111111100 0000 0 000000
Q ss_pred ---cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ---ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ---~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+......+.+++.+||+.||++|||+.|+++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001235667778999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=320.05 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=178.7
Q ss_pred CcccCcceEEEEEEEC---CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR---DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|... +++.||+|++.... ....+.+|+.++++++||||+++++++.. ....++||||+.+
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~- 104 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-
Confidence 4899999999999865 57889999996542 23568899999999999999999999965 6688999999975
Q ss_pred CHHHHHhcCC-----CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe----CCCCeEEEeeeccccc
Q 020720 76 SLANALLGSK-----SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL----DGNFHPKIGDFGLAKL 146 (322)
Q Consensus 76 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill----~~~~~~kl~Dfg~~~~ 146 (322)
+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 7877775221 12235899999999999999999999999 9999999999999 7788999999999986
Q ss_pred cCCCcc--eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCC------chhHHHHHHHHH
Q 020720 147 FPDNVT--HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDD------MLILVEWTWKLR 217 (322)
Q Consensus 147 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~~~ 217 (322)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.......
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~ 261 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence 643221 222345789999999999874 58999999999999999999999997554321 011111111100
Q ss_pred hcCccccccCccC------------------CCCCH---------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 218 EEGRLLEIVDPEL------------------TQFPE---------KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 218 ~~~~~~~~~~~~~------------------~~~~~---------~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
+.......+.+ ..... .....+.+++.+||+.||.+|||++|+++.
T Consensus 262 --g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 262 --GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp --CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 00000 012357889999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.41 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=185.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~ 71 (322)
.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..++||||
T Consensus 32 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~ 111 (371)
T 2xrw_A 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111 (371)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEEC
T ss_pred eeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEc
Confidence 3899999999999776 6899999999754 3344577889999999999999999999987654 67999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+++ +|.+++.. .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 112 MDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp CSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred CCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 975 78888742 4889999999999999999999999 9999999999999999999999999998654321
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH----------------HHH
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW----------------TWK 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~----------------~~~ 215 (322)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.. ...
T Consensus 182 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred --ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 22345689999999999999999999999999999999999999976432211110000 000
Q ss_pred HHhcCcc------ccccCccC-CC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEGRL------LEIVDPEL-TQ---FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~~~------~~~~~~~~-~~---~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....... ...+.... .. ........+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000 00000000 00 112235678999999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=310.67 Aligned_cols=243 Identities=25% Similarity=0.349 Sum_probs=189.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++.... .++||||
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~ 95 (322)
T 2ycf_A 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLEL 95 (322)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEEC
T ss_pred EEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEec
Confidence 3899999999999876 688999999865321 12245789999999999999999999987654 8999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccccC
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKLFP 148 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~~~ 148 (322)
+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++. +||+|||++....
T Consensus 96 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 96 MEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp CTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 99999999996543 6899999999999999999999999 999999999999987664 9999999998664
Q ss_pred CCcceeecccccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||............ . ..+...
T Consensus 169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~-~~~~~~-- 238 (322)
T 2ycf_A 169 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ-----I-TSGKYN-- 238 (322)
T ss_dssp CCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH-----H-HHTCCC--
T ss_pred ccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH-----H-HhCccc--
Confidence 332 123456899999999975 457889999999999999999999999865443322111 1 111100
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+.. .......+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FIPEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCchh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0112345889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=322.65 Aligned_cols=192 Identities=23% Similarity=0.304 Sum_probs=165.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC------CCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI------RHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|... +++.||||+++.. ......+.+|+.+++.+ +|+||+++++++......++||||+.
T Consensus 104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 182 (429)
T 3kvw_A 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182 (429)
T ss_dssp EEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC
T ss_pred EcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC
Confidence 4899999999999776 6899999999743 33446677788888777 57899999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe--EEEeeeccccccCCCc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH--PKIGDFGLAKLFPDNV 151 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~ 151 (322)
++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++......
T Consensus 183 -~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~- 255 (429)
T 3kvw_A 183 -MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR- 255 (429)
T ss_dssp -CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-
T ss_pred -CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-
Confidence 589999876542 25899999999999999999999999 999999999999999987 999999999764432
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccC
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFG 203 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~ 203 (322)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 256 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 256 ---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 2235689999999999999999999999999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.37 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=194.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++.+++||||+++++++... ...++||||+.
T Consensus 34 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~ 113 (364)
T 3qyz_A 34 YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113 (364)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS
T ss_pred EeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC
Confidence 4899999999999876 6889999999754 334447889999999999999999999998665 36899999997
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+ +|.+++... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 114 ~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 114 T-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp E-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred c-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 4 899998654 5899999999999999999999999 999999999999999999999999999865432221
Q ss_pred e--ecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc-----
Q 020720 154 V--STRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI----- 225 (322)
Q Consensus 154 ~--~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (322)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...............
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 1 2345689999999987654 5899999999999999999999999766444333222110000000000000
Q ss_pred ----c-CccCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 ----V-DPELTQF-----PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ----~-~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. .+..... .......+.+++.+||+.||.+|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 11223458899999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.12 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=197.0
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.+.. +..||+|.++.. .....+.+.+|+.++++++||||+++++++. ++..++||||+++|
T Consensus 397 ~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g 475 (656)
T 2j0j_A 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG 475 (656)
T ss_dssp EEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred EEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCC
Confidence 38999999999997642 457999998754 3344578999999999999999999999985 45689999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 476 ~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 549 (656)
T 2j0j_A 476 ELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549 (656)
T ss_dssp BHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC------
T ss_pred cHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceec
Confidence 99999975532 6899999999999999999999999 99999999999999999999999999987654433333
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....+++.|+|||++.+..++.++|||||||++|||++ |..||......+. . ..+..... ...+
T Consensus 550 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~---~~i~~~~~---------~~~~ 614 (656)
T 2j0j_A 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I---GRIENGER---------LPMP 614 (656)
T ss_dssp ----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H---HHHHHTCC---------CCCC
T ss_pred cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---H---HHHHcCCC---------CCCC
Confidence 34456789999999999999999999999999999997 9999975432211 1 11111111 1122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 233456889999999999999999999999998765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=308.45 Aligned_cols=243 Identities=22% Similarity=0.301 Sum_probs=195.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---------hhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---------KQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 69 (322)
.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++.+....++||
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 103 (298)
T 1phk_A 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103 (298)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEE
Confidence 3899999999999876 68999999997543 122456889999999995 999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 104 DLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred eccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence 9999999999997543 6899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeecccccCCCCCchHHHh------hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYAL------LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
... .....+++.|+|||++. ...++.++||||||+++|+|++|..||....... .. ..... +..
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~~-~~~- 246 (298)
T 1phk_A 177 GEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML---RMIMS-GNY- 246 (298)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-TCC-
T ss_pred Ccc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HH---HHHhc-CCc-
Confidence 322 23346899999999986 3467899999999999999999999997542211 11 11111 110
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... ..........+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 QFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 1111223455889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.98 Aligned_cols=244 Identities=9% Similarity=-0.026 Sum_probs=174.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHH---HHHhcCCCCcccccc-------eEEEeCC---
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEI---DMIWNIRHPNLVQLI-------GCCVEDN--- 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~--- 63 (322)
.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+ ..++. +||||++++ +++...+
T Consensus 69 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~ 147 (371)
T 3q60_A 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPP 147 (371)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCS
T ss_pred eccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCC
Confidence 3899999999999876 789999999986542 3345677784 55555 799988754 4544332
Q ss_pred --------------eeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeeeccC
Q 020720 64 --------------NRILVYEYLENNSLANALLGSKSKYVSLDWPTR------ANICLGTASGLSFLHEEADPPIVHRDI 123 (322)
Q Consensus 64 --------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~qi~~~l~~lH~~~~~~i~h~dl 123 (322)
..++||||++ ++|.+++..... .+.+..+ +.++.||+.||+|||+++ ++||||
T Consensus 148 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDi 220 (371)
T 3q60_A 148 FAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHF 220 (371)
T ss_dssp SSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred eeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcC
Confidence 3799999998 899999975422 3455555 778899999999999999 999999
Q ss_pred cccceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCCCcc
Q 020720 124 KASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSSKAA 201 (322)
Q Consensus 124 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~~~~ 201 (322)
||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999998654321 13456799999999987 67899999999999999999999999876
Q ss_pred cCCCchhHHHHHHHHHhcCccccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 202 FGDDMLILVEWTWKLREEGRLLEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
........ ............. ..........+.+++.+||+.||++||++.++++
T Consensus 297 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 297 TPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred Ccccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 43321100 0000000000011 1111223445888999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.26 Aligned_cols=248 Identities=17% Similarity=0.228 Sum_probs=192.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEe--CCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVE--DNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +++.||+|+++... .+.+.+|+.++++++ ||||+++++++.+ ....+++|||+.+++
T Consensus 43 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 119 (330)
T 3nsz_A 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 119 (330)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCC
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchh
Confidence 3899999999999765 78999999987433 467889999999997 9999999999987 567899999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
|.+++. .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||++........ .
T Consensus 120 l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~ 187 (330)
T 3nsz_A 120 FKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 187 (330)
T ss_dssp HHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--C
T ss_pred HHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--c
Confidence 999883 4888999999999999999999999 99999999999999776 899999999986543322 2
Q ss_pred cccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH---------HHhcCcc---
Q 020720 156 TRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK---------LREEGRL--- 222 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~--- 222 (322)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ...... .......
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHhcCCchhhhHHHHhccccc
Confidence 33468899999999987 67899999999999999999999999654322111 110000 0000000
Q ss_pred -----------ccccCccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 223 -----------LEIVDPEL-TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 223 -----------~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
........ ..........+.+++.+||+.||.+|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 01111234568899999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=323.42 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=176.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...++++|+
T Consensus 36 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~ 115 (367)
T 2fst_X 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115 (367)
T ss_dssp ECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEEC
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecc
Confidence 3899999999999765 6899999998653 334557888999999999999999999998654 567999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+ +++|.+++... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 116 ~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 116 M-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp C-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred c-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 9 67998888542 6999999999999999999999999 999999999999999999999999999865432
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc---ccc---
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR---LLE--- 224 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 224 (322)
.....+|..|+|||++.+ ..++.++|||||||++|+|++|..||......+.+..+ ........ +..
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAELLKKISS 259 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHTTCCC
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHHHhhh
Confidence 234568999999999887 67899999999999999999999999765432222111 11100000 000
Q ss_pred -----ccC--ccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 -----IVD--PELTQFP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 -----~~~--~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.+. +...... ......+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000111 1123458899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=317.26 Aligned_cols=249 Identities=20% Similarity=0.249 Sum_probs=195.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhc-----------------HHHHHHHHHHHhcCCCCcccccceEEEeCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQG-----------------TKEFLTEIDMIWNIRHPNLVQLIGCCVEDN 63 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 63 (322)
.||+|+||.||+|.. +|+.||+|++....... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 38 ~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 116 (348)
T 2pml_X 38 TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD 116 (348)
T ss_dssp EEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSS
T ss_pred EEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 389999999999988 79999999987542211 178899999999999999999999999999
Q ss_pred eeEEEEEcCCCCCHHHH------HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeE
Q 020720 64 NRILVYEYLENNSLANA------LLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHP 136 (322)
Q Consensus 64 ~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~ 136 (322)
..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ .+ ++|+||+|+||+++.++.+
T Consensus 117 ~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~ 191 (348)
T 2pml_X 117 EVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRV 191 (348)
T ss_dssp EEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCE
T ss_pred eEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcE
Confidence 99999999999999998 5332 13479999999999999999999999 88 9999999999999999999
Q ss_pred EEeeeccccccCCCcceeecccccCCCCCchHHHhhC-CCCc-ccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH
Q 020720 137 KIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-QLTK-KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW 214 (322)
Q Consensus 137 kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 214 (322)
+|+|||.+...... ......+++.|+|||++.+. .++. ++|||||||++|+|++|..||......... . .
T Consensus 192 kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~---~ 263 (348)
T 2pml_X 192 KLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL--F---N 263 (348)
T ss_dssp EECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH--H---H
T ss_pred EEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--H---H
Confidence 99999999865433 22345689999999999877 6666 999999999999999999999865442111 1 1
Q ss_pred HHHhcCcccccc--CccC--------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 215 KLREEGRLLEIV--DPEL--------TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 215 ~~~~~~~~~~~~--~~~~--------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ..+...... .... ..........+.+++.+||+.||.+||++.|+++
T Consensus 264 ~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 NI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111110000 0000 0001223446889999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=319.17 Aligned_cols=255 Identities=25% Similarity=0.288 Sum_probs=188.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~ 73 (322)
+||+|+||.||+|.+. +|+.||||++..... ...+|+++++.++||||+++++++... ...++||||++
T Consensus 61 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~ 136 (420)
T 1j1b_A 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136 (420)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc
Confidence 4899999999999886 699999999865422 234699999999999999999998542 13678999997
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 152 (322)
+ +|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++........
T Consensus 137 ~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 212 (420)
T 1j1b_A 137 E-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212 (420)
T ss_dssp E-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred c-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC
Confidence 6 666666432222337999999999999999999999999 9999999999999955 6789999999986543322
Q ss_pred eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH------HHHh-cCcccc
Q 020720 153 HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW------KLRE-EGRLLE 224 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~------~~~~-~~~~~~ 224 (322)
.....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.+..+.... .+.. ......
T Consensus 213 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 213 --NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp --CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred --ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 2335689999999999765 78999999999999999999999998654322221111100 0000 000001
Q ss_pred ccCccCCC------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPELTQ------FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~~~~------~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..-+.+.. +......++.+++.+||+.||.+||++.|+++.
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11111111 112223568899999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=313.11 Aligned_cols=243 Identities=27% Similarity=0.412 Sum_probs=187.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEe------CCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVE------DNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~ 72 (322)
+||+|+||.||+|.+. +|+.||+|++.... .....+.+|+.+++++ +||||+++++++.. .+..++||||+
T Consensus 31 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (326)
T 2x7f_A 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109 (326)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECC
T ss_pred EeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcC
Confidence 4899999999999875 68999999987543 3346788999999999 89999999999987 46789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 110 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 184 (326)
T 2x7f_A 110 GAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184 (326)
T ss_dssp TTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred CCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence 9999999997643 236899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeecccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 153 HVSTRVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......+++.|+|||++. ...++.++|||||||++|+|++|..||........ ........ .
T Consensus 185 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~----- 251 (326)
T 2x7f_A 185 -RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPRNP-A----- 251 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C-----
T ss_pred -ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhcCc-c-----
Confidence 123346899999999987 55788999999999999999999999965422111 11111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.. ........+.+++.+||+.||.+||++.++++
T Consensus 252 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 11112345888999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.75 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=186.2
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh-----------hcHHHHHHHHHHHhcCCCCcccccceEEEeC-----Ce
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK-----------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NN 64 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 64 (322)
.||+|+||.||+|...+|+.||||++..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 108 (362)
T 3pg1_A 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108 (362)
T ss_dssp EEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCE
T ss_pred EeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcce
Confidence 4899999999999888899999999864321 2237889999999999999999999998543 35
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccc
Q 020720 65 RILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLA 144 (322)
Q Consensus 65 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~ 144 (322)
.++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 109 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 181 (362)
T 3pg1_A 109 LYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA 181 (362)
T ss_dssp EEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC-
T ss_pred EEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCcc
Confidence 799999997 58888886543 26899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCcceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc--
Q 020720 145 KLFPDNVTHVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR-- 221 (322)
Q Consensus 145 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (322)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ........
T Consensus 182 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~ 256 (362)
T 3pg1_A 182 REDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI---VEVVGTPKIE 256 (362)
T ss_dssp ----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHH
T ss_pred ccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCChH
Confidence 7543322 1233568899999999887 67899999999999999999999999764322211111 11000000
Q ss_pred ---------cccccCccCC--------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 222 ---------LLEIVDPELT--------QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 222 ---------~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....+..... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000010 1111223458899999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=321.42 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=188.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----------------
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED----------------- 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----------------- 62 (322)
.||+|+||.||+|... +|+.||||++..+... ..+|+.+++.++||||+++++++...
T Consensus 14 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (383)
T 3eb0_A 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKL 89 (383)
T ss_dssp EEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----------------
T ss_pred EEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccc
Confidence 4899999999999775 7999999998654322 23699999999999999999998543
Q ss_pred ---------------------CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 020720 63 ---------------------NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121 (322)
Q Consensus 63 ---------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~ 121 (322)
...++||||+++ +|.+.+.........+++..++.++.||+.||+|||+.+ ++||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~ 165 (383)
T 3eb0_A 90 GGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHR 165 (383)
T ss_dssp --------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECS
T ss_pred cccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccC
Confidence 347899999985 777777542222337999999999999999999999999 9999
Q ss_pred cCcccceEeC-CCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCC
Q 020720 122 DIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSK 199 (322)
Q Consensus 122 dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~ 199 (322)
||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 9999999997 689999999999986543322 2334679999999998875 48999999999999999999999998
Q ss_pred cccCCCchhHHHHHH------HH-HhcCccccccCccCCC------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 200 AAFGDDMLILVEWTW------KL-REEGRLLEIVDPELTQ------FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 200 ~~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+....+.... .. ..........-+.... ++......+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 654332221111000 00 0000000000011110 12223445889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=304.69 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=186.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe-------------CCeeE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-------------DNNRI 66 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------~~~~~ 66 (322)
.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (303)
T 1zy4_A 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91 (303)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEE
T ss_pred eeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceE
Confidence 4899999999999875 7999999999643 3445788999999999999999999998865 34679
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 67 LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 67 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 92 IQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp EEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred EEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 9999999999999997543 26788999999999999999999999 99999999999999999999999999886
Q ss_pred cCCCc-------------ceeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHH
Q 020720 147 FPDNV-------------THVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW 212 (322)
Q Consensus 147 ~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 212 (322)
..... ........|++.|+|||++.+. .++.++|||||||++|+|++ ||..... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-----~~~~ 237 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-----RVNI 237 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-----HHHH
Confidence 54221 1112335689999999999864 68999999999999999998 4442211 1111
Q ss_pred HHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 213 TWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...... .. ..+. ...+......+.+++.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~-~~--~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRS-VS--IEFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHS-TT--CCCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccc-cc--cccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111 00 0011 22333344557889999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=306.39 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=187.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEE--------------eCCee
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV--------------EDNNR 65 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------------~~~~~ 65 (322)
.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++. +....
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (320)
T 2i6l_A 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSV 97 (320)
T ss_dssp ECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEE
T ss_pred EeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCce
Confidence 3899999999999877 58999999998777777788999999999999999999999873 34678
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccc
Q 020720 66 ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLA 144 (322)
Q Consensus 66 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~ 144 (322)
++||||+. ++|.+++... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++ .++.+||+|||++
T Consensus 98 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 98 YIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp EEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 99999997 5999999542 6899999999999999999999999 99999999999997 5679999999999
Q ss_pred cccCCCcc--eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh---
Q 020720 145 KLFPDNVT--HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE--- 218 (322)
Q Consensus 145 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--- 218 (322)
........ .......++..|+|||++.. ..++.++|||||||++|+|++|..||...........+ .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~ 245 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LESIPVVH 245 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHSCCCC
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCc
Confidence 86543211 11233457899999998875 67899999999999999999999999865322111111 00000
Q ss_pred -------cCccccccC-----cc--CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 219 -------EGRLLEIVD-----PE--LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 219 -------~~~~~~~~~-----~~--~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.......+. +. +..........+.+++.+||+.||.+||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000 00 00011122345889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=315.66 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=191.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|+||.||+|..+. .+|+|+++... ....+.+.+|+.++++++||||+++++++.+....+++|||+++++|.
T Consensus 40 ~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 117 (319)
T 2y4i_B 40 LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117 (319)
T ss_dssp BCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHH
T ss_pred EeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHH
Confidence 48999999999998763 49999987542 223356778999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc----cee
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV----THV 154 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~ 154 (322)
+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++ ++.++|+|||++....... ...
T Consensus 118 ~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~ 190 (319)
T 2y4i_B 118 SVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190 (319)
T ss_dssp HHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCS
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccc
Confidence 9996543 26899999999999999999999999 99999999999998 6799999999987543211 111
Q ss_pred ecccccCCCCCchHHHhh---------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc
Q 020720 155 STRVAGTMGYLAPEYALL---------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI 225 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~---------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
.....|++.|+|||++.. ..++.++|||||||++|+|++|..||........ ...... +.
T Consensus 191 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~---- 259 (319)
T 2y4i_B 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQMGT-GM---- 259 (319)
T ss_dssp CBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HHHHHT-TC----
T ss_pred cccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHhcc-CC----
Confidence 223458899999999874 3578899999999999999999999975432111 111111 11
Q ss_pred cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 226 VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.+.... ......+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 260 -~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 -KPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -CCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -CCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111 012234788999999999999999999999999887544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=310.95 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=193.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-----------CCcccccceEEEeCC----e
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-----------HPNLVQLIGCCVEDN----N 64 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~~----~ 64 (322)
.||+|+||.||+|... +++.||||++.. .......+.+|+.++++++ |+||+++++++...+ .
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 104 (373)
T 1q8y_A 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 104 (373)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred eeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCce
Confidence 3899999999999875 689999999974 3344567888999998886 899999999987654 7
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeC------CCCeEE
Q 020720 65 RILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLD------GNFHPK 137 (322)
Q Consensus 65 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~------~~~~~k 137 (322)
.+++|||+ +++|.+++...... .+++..++.++.||+.||+|||++ + ++||||||+||+++ ..+.+|
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~k 178 (373)
T 1q8y_A 105 VVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK 178 (373)
T ss_dssp EEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred EEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEE
Confidence 89999999 88999999764322 589999999999999999999998 8 99999999999994 445899
Q ss_pred EeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH
Q 020720 138 IGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR 217 (322)
Q Consensus 138 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 217 (322)
|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.................+.
T Consensus 179 l~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 179 IADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp ECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred EcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 9999999865432 223468999999999999999999999999999999999999998654322111111000000
Q ss_pred -hcCccc--------------------cccC-----------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 218 -EEGRLL--------------------EIVD-----------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 218 -~~~~~~--------------------~~~~-----------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.-+... ..+. ......+......+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 000000 0000 01123456777889999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.38 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=189.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCee------EEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNR------ILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~ 71 (322)
.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+.. ++||||
T Consensus 49 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 128 (371)
T 4exu_A 49 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF 128 (371)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEEC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcc
Confidence 3899999999999776 6899999999754 333457888999999999999999999999877654 999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+. ++|.+++.. .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 129 ~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 129 MQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred cc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 97 588887721 4899999999999999999999999 999999999999999999999999999855332
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc-------
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL------- 223 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (322)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+ .... +...
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~--~~~~~~~~~~~ 269 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVT--GVPGTEFVQKL 269 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHH--CCCCHHHHTTC
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHh--CCCcHHHHHHh
Confidence 234568999999999987 68899999999999999999999999764322221111 1100 0000
Q ss_pred ---------cccC----ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 224 ---------EIVD----PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 224 ---------~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+. ..+..........+.+++.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 00000111224568899999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=309.78 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=196.4
Q ss_pred CcccCcceEEEEEEE-C-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCc------ccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSL-R-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN------LVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.. . +++.||+|+++.. ....+.+.+|+.+++.++|++ ++++++++.+.+..++||||+
T Consensus 21 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (339)
T 1z57_A 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL 99 (339)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC
Confidence 389999999999976 3 6889999998743 344577889999999887654 999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-------------------C
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-------------------N 133 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-------------------~ 133 (322)
+++|.+++..... .++++..++.++.||+.||+|||+++ ++||||||+||+++. +
T Consensus 100 -~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~ 173 (339)
T 1z57_A 100 -GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173 (339)
T ss_dssp -CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESC
T ss_pred -CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccC
Confidence 8899999976542 26889999999999999999999999 999999999999987 6
Q ss_pred CeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 213 (322)
+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...
T Consensus 174 ~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 174 PDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp CCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred CCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 679999999998644322 2346899999999999999999999999999999999999999765332222111110
Q ss_pred HH-----HHhcCcccccc---------------------C--ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 214 WK-----LREEGRLLEIV---------------------D--PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 214 ~~-----~~~~~~~~~~~---------------------~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. ..........+ . .............+.+++.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 00 00000000000 0 00112234556779999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=311.06 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=190.9
Q ss_pred CcccCcceEEEEEEEC--CCCEEEEEEecccCh--hcHHHHHHHHHHHhcC---CCCcccccceEEE-----eCCeeEEE
Q 020720 1 MIGGGAFGVVYRGSLR--DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNI---RHPNLVQLIGCCV-----EDNNRILV 68 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv 68 (322)
.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.+++.+ +||||+++++++. .....++|
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 97 (326)
T 1blx_A 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 97 (326)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEE
T ss_pred eecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEE
Confidence 3899999999999873 588999999865422 1223456677766655 8999999999987 45678999
Q ss_pred EEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 69 YEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
|||+. ++|.+++...... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 98 FEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 171 (326)
T ss_dssp EECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence 99997 5999999765422 5899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh---cCccc--
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE---EGRLL-- 223 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 223 (322)
... ......+++.|+|||++.+..++.++|||||||++|+|++|..||......+.. ........ .....
T Consensus 172 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 172 FQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp GGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCGGGSCTT
T ss_pred CCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCcccCccc
Confidence 221 223356899999999999999999999999999999999999999765332211 11111100 00000
Q ss_pred -----ccc----CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 -----EIV----DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 -----~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+ ...+..........+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00111122223445888999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=318.03 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=183.3
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||+||.+...+|+.||||++..+. .+.+.+|+.+++++ +||||+++++++.+.+..++||||+. ++|.+
T Consensus 22 ~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~ 97 (434)
T 2rio_A 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD 97 (434)
T ss_dssp EEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred eEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence 489999999987766679999999986532 35678899999876 89999999999999999999999996 59999
Q ss_pred HHhcCCCCCcC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-------------CeEEEeeecc
Q 020720 80 ALLGSKSKYVS---LDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-------------FHPKIGDFGL 143 (322)
Q Consensus 80 ~l~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-------------~~~kl~Dfg~ 143 (322)
++......... ..+..++.++.||+.||+|||+.+ ++||||||+||+++.+ +.+||+|||+
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~ 174 (434)
T 2rio_A 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174 (434)
T ss_dssp HHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence 99765422111 233456789999999999999999 9999999999999754 4899999999
Q ss_pred ccccCCCcce---eecccccCCCCCchHHHhh-------CCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHH
Q 020720 144 AKLFPDNVTH---VSTRVAGTMGYLAPEYALL-------GQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEW 212 (322)
Q Consensus 144 ~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~ 212 (322)
+......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....... .
T Consensus 175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~----- 248 (434)
T 2rio_A 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-S----- 248 (434)
T ss_dssp CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-H-----
T ss_pred ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-H-----
Confidence 9876543221 1224569999999999975 568999999999999999999 899996542211 0
Q ss_pred HHHHHhcCccccccCccCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 213 TWKLREEGRLLEIVDPELT-QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.... +.. .. +... ........++.+++.+||+.||.+||++.++++
T Consensus 249 --~i~~-~~~--~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 --NIIR-GIF--SL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHH-TCC--CC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHhc-CCC--Cc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0111 100 00 1111 223456678999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=317.78 Aligned_cols=258 Identities=22% Similarity=0.233 Sum_probs=182.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe-------eEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN-------RILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~ 72 (322)
.||+|+||.||+|... +|+.||||++... ........+++..+..++||||+++++++...+. .++||||+
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~ 108 (360)
T 3e3p_A 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108 (360)
T ss_dssp ---------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence 4899999999999876 6899999998644 2333456778888899999999999999976443 78999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCC
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH--EEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 149 (322)
++ +|.+.+.........+++..++.++.|++.||.||| +.+ ++||||||+||+++. ++.+||+|||++.....
T Consensus 109 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~ 184 (360)
T 3e3p_A 109 PD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184 (360)
T ss_dssp SC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT
T ss_pred cc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCC
Confidence 86 555444322122337899999999999999999999 888 999999999999996 89999999999986654
Q ss_pred CcceeecccccCCCCCchHHHhhCC-CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH---------HHHHhc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT---------WKLREE 219 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~---------~~~~~~ 219 (322)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+... ......
T Consensus 185 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3e3p_A 185 SEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS 262 (360)
T ss_dssp TSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred CCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence 322 23346899999999987654 899999999999999999999999865332222111100 000000
Q ss_pred CccccccC-------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 220 GRLLEIVD-------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 220 ~~~~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
........ ..+..........+.+++.+||+.||.+|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 00112222345678999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=300.30 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+....++++||+.+++|
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (287)
T 2wei_A 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108 (287)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCH
Confidence 3899999999999876 6899999998654 234567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC---CeEEEeeeccccccCCCccee
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN---FHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
.+++.... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++........
T Consensus 109 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-- 179 (287)
T 2wei_A 109 FDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179 (287)
T ss_dssp HHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--
Confidence 99886543 6899999999999999999999999 9999999999999754 4699999999886543322
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
.....+++.|+|||++.+ .++.++||||||+++|+|++|..||......+ .. .... .+.... ..+.....
T Consensus 180 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~-~~~~~~-~~~~~~~~- 249 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRVE-TGKYAF-DLPQWRTI- 249 (287)
T ss_dssp CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-HCCCCC-CSGGGTTS-
T ss_pred cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-cCCCCC-Cchhhhhc-
Confidence 123457889999998865 48999999999999999999999997643211 11 1111 111100 00111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...+.+++.+||+.||.+|||+.|+++
T Consensus 250 ---~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 250 ---SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 345888999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=320.96 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=187.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe------eEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN------RILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~ 74 (322)
+||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||+++++++..... .++||||+++
T Consensus 47 ~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~ 122 (394)
T 4e7w_A 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122 (394)
T ss_dssp EEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE
T ss_pred EEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc
Confidence 48999999999999876667999988644321 2369999999999999999999865443 7899999987
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCCCcce
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+ +.+.+.........+++..++.++.||+.||+|||+.+ ++||||||+||+++ .++.+||+|||++........
T Consensus 123 ~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~- 197 (394)
T 4e7w_A 123 T-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP- 197 (394)
T ss_dssp E-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred c-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC-
Confidence 5 44333321112237999999999999999999999999 99999999999999 799999999999986543322
Q ss_pred eecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH------HHHh-cCccccc
Q 020720 154 VSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW------KLRE-EGRLLEI 225 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~ 225 (322)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+.... .... .......
T Consensus 198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (394)
T 4e7w_A 198 -NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH 276 (394)
T ss_dssp -CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS
T ss_pred -CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 2334689999999998765 58999999999999999999999998654332222111100 0000 0000000
Q ss_pred cCccCCC------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 226 VDPELTQ------FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 226 ~~~~~~~------~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.-+.... +......++.+++.+||+.||.+|||+.|+++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0011111 111233468899999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=314.62 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=191.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++... ...+++|||+.
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 97 (353)
T 2b9h_A 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ 97 (353)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS
T ss_pred EEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC
Confidence 3899999999999876 6899999999644 334456788999999999999999999987654 67899999997
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 98 -~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 98 -TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp -EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred -ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 5899998653 5899999999999999999999999 999999999999999999999999999865432211
Q ss_pred ---------eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc--
Q 020720 154 ---------VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR-- 221 (322)
Q Consensus 154 ---------~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (322)
......||+.|+|||++.. ..++.++|||||||++|+|++|..||...........+ ........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~ 245 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGIIGTPHSD 245 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCST
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhCCCchh
Confidence 1122468999999998875 67899999999999999999999999765322111111 11000000
Q ss_pred --cc--------cc---c----CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 222 --LL--------EI---V----DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 222 --~~--------~~---~----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. .. + ...+....+.....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 00 0 00000001122345889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.65 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=190.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe------eEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN------RILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~ 71 (322)
.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++..... .+++|||
T Consensus 31 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 110 (353)
T 3coi_A 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF 110 (353)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEEC
T ss_pred eEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecc
Confidence 3899999999999876 6899999999654 33345778899999999999999999999977654 4999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+. ++|.+++.. .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 111 ~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 111 MQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred cc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 97 588777631 4899999999999999999999999 999999999999999999999999998864322
Q ss_pred ceeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhc-----------
Q 020720 152 THVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE----------- 219 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 219 (322)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+ ......
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTEFVQKLND 253 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH---HHHHCBCCHHHHTTCSC
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHHHHhh
Confidence 233468999999999886 67899999999999999999999999865322211111 110000
Q ss_pred -------CccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 220 -------GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 220 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+.....+.+..........+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000001112223333445568899999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=304.89 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=188.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCC--CCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIR--HPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++ |+||+++++++.+.+..+++|| +.+++
T Consensus 35 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~ 113 (313)
T 3cek_A 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 113 (313)
T ss_dssp EEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEE
T ss_pred EecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCc
Confidence 38999999999998888999999999754 3445578899999999997 5999999999999999999999 55789
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-ee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 155 (322)
|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||++......... ..
T Consensus 114 L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 114 LNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp HHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----------
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccc
Confidence 999997654 6899999999999999999999999 999999999999964 89999999999865433221 12
Q ss_pred cccccCCCCCchHHHhh-----------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccc
Q 020720 156 TRVAGTMGYLAPEYALL-----------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE 224 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~-----------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (322)
....|++.|+|||++.+ ..++.++||||||+++|+|++|..||....... . .........
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~---~~~~~~~~~---- 256 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--S---KLHAIIDPN---- 256 (313)
T ss_dssp ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--H---HHHHHHCTT----
T ss_pred cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--H---HHHHHHhcc----
Confidence 33468999999999875 468889999999999999999999997543211 1 111111110
Q ss_pred ccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....... .....+.+++.+||+.||.+||++.|+++.
T Consensus 257 -~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 -HEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -SCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -cccCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0111111 123458888999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=307.42 Aligned_cols=244 Identities=22% Similarity=0.273 Sum_probs=166.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|... +|+.||+|++... . ....+....++.++||||+++++++.. ....++||||++++
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg 111 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence 4899999999999877 6999999998643 2 122223334566799999999999876 44589999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCcc
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 152 (322)
+|.+++..... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||++.......
T Consensus 112 ~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 112 ELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp EHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 99999976542 36999999999999999999999999 999999999999976 4559999999998654322
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||.............. ... .. ......+...
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~-~~-~~~~~~~~~~- 258 (336)
T 3fhr_A 186 --LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--RIR-LG-QYGFPNPEWS- 258 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCTTTST-
T ss_pred --cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--hhh-cc-ccccCchhhc-
Confidence 2334679999999999888899999999999999999999999976543321110000 000 00 0000011112
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.....+.+++.+||+.||.+|||+.|+++
T Consensus 259 ---~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 259 ---EVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23345888999999999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=306.10 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=172.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHH-HHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEID-MIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||||+++... ......+..|+. +++.++||||+++++++.+.+..++||||+.+ +|
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l 107 (327)
T 3aln_A 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SF 107 (327)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EH
T ss_pred eeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-Ch
Confidence 3899999999999876 68999999997653 333455666666 67778999999999999999999999999986 78
Q ss_pred HHHHhcC-CCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 78 ANALLGS-KSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 78 ~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
.+++... ......+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++........ .
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 182 (327)
T 3aln_A 108 DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--K 182 (327)
T ss_dssp HHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------
T ss_pred HHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc--c
Confidence 7777531 01122689999999999999999999998 8 99999999999999999999999999976543321 2
Q ss_pred cccccCCCCCchHHH----hhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 156 TRVAGTMGYLAPEYA----LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~----~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
....||+.|+|||++ .+..++.++|||||||++|+|++|..||......... -........+.+.
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----------~~~~~~~~~~~~~ 251 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----------LTQVVKGDPPQLS 251 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCSCCCCCC
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----------HHHHhcCCCCCCC
Confidence 233689999999998 4567899999999999999999999999754321100 0000000011111
Q ss_pred -CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 232 -QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 232 -~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.........+.+++.+||+.||.+||++.++++
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111123345889999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.66 Aligned_cols=191 Identities=25% Similarity=0.308 Sum_probs=162.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CC-----cccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HP-----NLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+ +|+++++++...+..++||||+.
T Consensus 61 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 139 (382)
T 2vx3_A 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139 (382)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC
T ss_pred EEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC
Confidence 3899999999999876 6889999999743 334566778888888774 44 49999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh--cCCCCeeeccCcccceEeC--CCCeEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE--EADPPIVHRDIKASNVLLD--GNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~~i~h~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~ 149 (322)
++|.+++..... ..+++..++.++.|++.||.|||. .+ |+||||||+|||++ .++.+||+|||++.....
T Consensus 140 -~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 140 -YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp -CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred -CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 599999976532 258999999999999999999994 56 99999999999995 478899999999987643
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCccc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAF 202 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~ 202 (322)
. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 214 ~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 214 R----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp C----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 233568999999999999999999999999999999999999998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.63 Aligned_cols=233 Identities=25% Similarity=0.402 Sum_probs=186.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh------cHHHHHHHHHHHhcC----CCCcccccceEEEeCCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ------GTKEFLTEIDMIWNI----RHPNLVQLIGCCVEDNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~ 69 (322)
.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.++ +||||+++++++.+.+..++++
T Consensus 38 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~ 117 (312)
T 2iwi_A 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117 (312)
T ss_dssp EEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEE
T ss_pred EEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEE
Confidence 3899999999999775 6899999999754321 223456789999888 8999999999999999999999
Q ss_pred Ec-CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeecccccc
Q 020720 70 EY-LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLF 147 (322)
Q Consensus 70 e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 147 (322)
|+ +.+++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++ .++.++|+|||++...
T Consensus 118 e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 118 ERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp ECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 99 78899999997643 6899999999999999999999999 99999999999999 8899999999999866
Q ss_pred CCCcceeecccccCCCCCchHHHhhCCCC-cccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 148 PDNVTHVSTRVAGTMGYLAPEYALLGQLT-KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
.... .....++..|+|||++.+..+. .++||||||+++|+|++|..||..... ... ..
T Consensus 191 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~-~~----- 249 (312)
T 2iwi_A 191 HDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILE-AE----- 249 (312)
T ss_dssp CSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-TC-----
T ss_pred ccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhh-hc-----
Confidence 5432 2334589999999999887764 589999999999999999999964310 000 00
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+......+.+++.+||+.||++||++.|+++.
T Consensus 250 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 ----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122233458889999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.04 Aligned_cols=253 Identities=20% Similarity=0.262 Sum_probs=192.3
Q ss_pred CcccCcceEEEEEEEC-CC-CEEEEEEecccChhcHHHHHHHHHHHhcCCCCc------ccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DG-TQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN------LVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~ 72 (322)
.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++...+..++||||+
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 104 (355)
T 2eu9_A 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL 104 (355)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC
T ss_pred EeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc
Confidence 3899999999999875 44 68999999743 344577888999999997665 899999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEe-------------------CCC
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLL-------------------DGN 133 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill-------------------~~~ 133 (322)
+++|.+++..... ..+++..++.++.||+.||.|||+.+ ++||||||+||++ +.+
T Consensus 105 -~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 178 (355)
T 2eu9_A 105 -GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178 (355)
T ss_dssp -CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC
T ss_pred -CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCC
Confidence 5567676654432 26899999999999999999999998 9999999999999 567
Q ss_pred CeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 213 (322)
+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...
T Consensus 179 ~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (355)
T 2eu9_A 179 TSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254 (355)
T ss_dssp CCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 889999999998644322 3346899999999999999999999999999999999999999865432222211111
Q ss_pred HH-----HHhcCcccc-ccC----------------------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 214 WK-----LREEGRLLE-IVD----------------------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 214 ~~-----~~~~~~~~~-~~~----------------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.. ......... ... .............+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000000 000 0001122334567899999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=308.43 Aligned_cols=233 Identities=23% Similarity=0.379 Sum_probs=190.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChh------cHHHHHHHHHHHhcCC--CCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQ------GTKEFLTEIDMIWNIR--HPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
+||+|+||.||+|... +++.||||++...... ....+.+|+.++++++ |+||+++++++.+.+..++++|+
T Consensus 50 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 129 (320)
T 3a99_A 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129 (320)
T ss_dssp ECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEc
Confidence 4899999999999765 6899999999754221 2245677999999996 59999999999999999999999
Q ss_pred CCC-CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCC
Q 020720 72 LEN-NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 72 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 149 (322)
+.+ ++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++ .++.+||+|||++.....
T Consensus 130 ~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 130 PEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp CSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred CCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 976 89999997643 6899999999999999999999999 99999999999999 789999999999986653
Q ss_pred CcceeecccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ... ...
T Consensus 203 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~-~~~------ 260 (320)
T 3a99_A 203 TV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQV------ 260 (320)
T ss_dssp SC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CCC------
T ss_pred cc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhc-ccc------
Confidence 32 223458999999999988776 6889999999999999999999964310 001 100
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..+......+.+++.+||+.||++||++.|+++.
T Consensus 261 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 ---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123458889999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.60 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=181.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
+||+|+||+||.....+|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||||+. ++|.+
T Consensus 31 ~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~ 106 (432)
T 3p23_A 31 VLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE 106 (432)
T ss_dssp EEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred eeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHH
Confidence 4899999997766566799999999865432 2356799999999 89999999999999999999999996 59999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-----CCeEEEeeeccccccCCCcc--
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-----NFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
++..... ...+..++.++.||+.||.|||+.+ |+||||||+||+++. ...+||+|||++........
T Consensus 107 ~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 107 YVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp HHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred HHHhcCC---CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 9976543 3555567899999999999999999 999999999999953 23588999999986543221
Q ss_pred eeecccccCCCCCchHHHh---hCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 153 HVSTRVAGTMGYLAPEYAL---LGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~---~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.......||+.|+|||++. ...++.++|||||||++|+|++ |..||......... ..... ...
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--------~~~~~-----~~~ 247 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--------ILLGA-----CSL 247 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--------HHTTC-----CCC
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--------HHhcc-----CCc
Confidence 2223456999999999987 4567889999999999999999 88888543221100 00000 001
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
............+.+++.+||+.||.+||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111122334556788999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=300.81 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=172.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcH-HHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGT-KEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||.||+|... +|+.||||++..... ... +.+.++..+++.++||||+++++++.+.+..++||||+ ++.+
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~ 110 (318)
T 2dyl_A 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCA 110 (318)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEH
T ss_pred eeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcH
Confidence 3899999999999876 699999999975532 222 34445556788889999999999999999999999999 5566
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE-ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
..+..... ..+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 111 ~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 182 (318)
T 2dyl_A 111 EKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KD 182 (318)
T ss_dssp HHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--cc
Confidence 66654322 2689999999999999999999985 8 99999999999999999999999999876543221 23
Q ss_pred ccccCCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 157 RVAGTMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
...+++.|+|||++. ...++.++|||||||++|+|++|..||...... .... ........ +.+.
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~~~------~~~~ 251 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL---TKVLQEEP------PLLP 251 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH---HHHHHSCC------CCCC
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH---HHHhccCC------CCCC
Confidence 346899999999984 456889999999999999999999999754321 1111 11111110 1111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
........+.+++.+||+.||.+||++.++++
T Consensus 252 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 -GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01112334888999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=289.33 Aligned_cols=223 Identities=12% Similarity=0.075 Sum_probs=177.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|... +|+.||||++.... ....+.+.+|+..+.+++||||+++++++.+.+..++||||+++++
T Consensus 38 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~ 117 (286)
T 3uqc_A 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117 (286)
T ss_dssp EEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEE
T ss_pred EEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCC
Confidence 3899999999999876 58999999997653 3334788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++... .....+..++.||+.||+|||+++ ++||||||+||+++.++.+||++++
T Consensus 118 L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 118 LQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp HHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred HHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 99999432 345578889999999999999999 9999999999999999999997433
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC---CCC
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL---TQF 233 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 233 (322)
|++| ++.++|||||||++|+|++|..||............ ...+.... ...
T Consensus 175 -------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 -------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQPIEPADI 228 (286)
T ss_dssp -------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSCBCCHHHH
T ss_pred -------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccCCCChhhc
Confidence 3333 688999999999999999999999865433211000 00000000 011
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.......+.+++.+||+.||++| |+.|+++.|+......
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 11233458899999999999999 9999999998876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=319.87 Aligned_cols=255 Identities=26% Similarity=0.292 Sum_probs=193.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEe------CCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE------DNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~ 72 (322)
.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 21 ~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~ 100 (676)
T 3qa8_A 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100 (676)
T ss_dssp CCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeC
Confidence 4899999999999775 6899999998754 44456789999999999999999999998755 66789999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCe---EEEeeeccccccCC
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFH---PKIGDFGLAKLFPD 149 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~ 149 (322)
++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++. ++|+|||++.....
T Consensus 101 ~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~ 176 (676)
T 3qa8_A 101 EGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176 (676)
T ss_dssp SSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred CCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence 99999999976532 235889999999999999999999999 999999999999997664 99999999987644
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccc----
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEI---- 225 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 225 (322)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..............
T Consensus 177 ~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~-i~~~~~~~~~~~~~l~g~ 253 (676)
T 3qa8_A 177 GEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDLTGA 253 (676)
T ss_dssp CCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT-CC------CCSCCCCSSS
T ss_pred ccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh-hhcccchhhhhhhhhccc
Confidence 322 23456899999999999999999999999999999999999999653110000000 00000000000000
Q ss_pred --cC---ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 020720 226 --VD---PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQV 262 (322)
Q Consensus 226 --~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev 262 (322)
+. +............+.+++.+||+.||.+|||+.++
T Consensus 254 ~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00 11233445567789999999999999999999773
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.33 Aligned_cols=219 Identities=19% Similarity=0.272 Sum_probs=172.7
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHH-hcCCCCcccccceEEEe----CCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMI-WNIRHPNLVQLIGCCVE----DNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|... +++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....++||||+++
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred ccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 4899999999999875 6899999998632 4567788887 66699999999999877 6678999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 151 (322)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++....
T Consensus 100 ~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 100 GELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 999999976532 26899999999999999999999999 999999999999998 7889999999886432
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
+..++.++|||||||++|+|++|..||......... ......+.....
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~~~~~~~ 219 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQY 219 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTTCC
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHHHhhccc
Confidence 134578999999999999999999999754322110 000011111111
Q ss_pred CCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 232 QFPE----KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 232 ~~~~----~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..+. .....+.+++.+||+.||.+|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1221 22456889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.44 Aligned_cols=235 Identities=15% Similarity=0.094 Sum_probs=174.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---hcHHHHHHHHHHHhcCCC-Cccccc---------ceE--------
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---QGTKEFLTEIDMIWNIRH-PNLVQL---------IGC-------- 58 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~iv~~---------~~~-------- 58 (322)
+||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+.++..++| +|...+ .+.
T Consensus 85 ~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (413)
T 3dzo_A 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164 (413)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---
T ss_pred ccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCc
Confidence 4899999999999865 799999999874432 224778999999999977 322111 111
Q ss_pred ----EEe-----CCeeEEEEEcCCCCCHHHHHhcC---CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCccc
Q 020720 59 ----CVE-----DNNRILVYEYLENNSLANALLGS---KSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKAS 126 (322)
Q Consensus 59 ----~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~ 126 (322)
+.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~ 240 (413)
T 3dzo_A 165 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPV 240 (413)
T ss_dssp ------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred cccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccc
Confidence 111 12356677765 67999888421 122336788899999999999999999999 999999999
Q ss_pred ceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHH----------hhCCCCcccceehhhHHHHHHHhCCC
Q 020720 127 NVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA----------LLGQLTKKADVYSFGVLLLEIISGRS 196 (322)
Q Consensus 127 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~sDv~slG~il~ell~g~~ 196 (322)
|||++.++.+||+|||++...... .....| +.|+|||++ ....++.++|||||||++|+|++|+.
T Consensus 241 NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 241 DIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp GEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred eEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999999999998864332 334567 999999999 44457889999999999999999999
Q ss_pred CCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 197 SSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
||.......... ..+ ......+ ..+.+++.+||+.||.+||++.++++
T Consensus 316 Pf~~~~~~~~~~---------------~~~-~~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 316 PNTDDAALGGSE---------------WIF-RSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCCTTGGGSCSG---------------GGG-SSCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcchhhhHH---------------HHH-hhcccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 997643222111 111 1112333 45888999999999999999877754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=319.50 Aligned_cols=231 Identities=21% Similarity=0.294 Sum_probs=185.3
Q ss_pred CcccCcceEEEEEEEC--CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCe-----eEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR--DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNN-----RILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~ 72 (322)
.||+|+||.||+|.+. +|+.||||++... .......+.+|+.++++++||||+++++++.+.+. .++||||+
T Consensus 87 ~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~ 166 (681)
T 2pzi_A 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166 (681)
T ss_dssp EEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECC
T ss_pred EEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeC
Confidence 3899999999999875 5899999998644 34445678999999999999999999999987665 79999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+||+|||++......
T Consensus 167 ~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 167 GGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp CCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred CCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence 99999887632 5899999999999999999999999 9999999999999985 8999999999865433
Q ss_pred eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 153 HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
....||+.|+|||++.+.. +.++|||||||++|+|++|..||......... . ..
T Consensus 235 ---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------------------~--~~ 288 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------------------E--DD 288 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------------------T--TC
T ss_pred ---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc--------------------c--cc
Confidence 3346899999999987754 89999999999999999998887643221100 0 00
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHhcc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPT-MKQVVEMLSKD 269 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps-~~evl~~L~~~ 269 (322)
........+.+++.+||+.||.+||+ ++++...|...
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 01122356889999999999999995 55555655544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.02 Aligned_cols=234 Identities=18% Similarity=0.134 Sum_probs=174.9
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccC--------hhcHHHHHHHHHHHhcCC---------C--------------
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAES--------KQGTKEFLTEIDMIWNIR---------H-------------- 49 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h-------------- 49 (322)
.||+|+||.||+|.+ +|+.||||++.... ....+.+.+|+.+++.++ |
T Consensus 27 ~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~ 105 (336)
T 2vuw_A 27 KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQG 105 (336)
T ss_dssp EEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEES
T ss_pred eecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecC
Confidence 389999999999987 58999999997653 223477888999888886 4
Q ss_pred ---CcccccceEEEe-------------CCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh-h
Q 020720 50 ---PNLVQLIGCCVE-------------DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH-E 112 (322)
Q Consensus 50 ---~~iv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~ 112 (322)
|||+++++++.+ ....++||||+++|++.+.+.. ..+++..++.++.||+.||+||| +
T Consensus 106 ~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~ 180 (336)
T 2vuw_A 106 SYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180 (336)
T ss_dssp SCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 555555555443 6789999999999976666633 26899999999999999999999 8
Q ss_pred cCCCCeeeccCcccceEeCCCC--------------------eEEEeeeccccccCCCcceeecccccCCCCCchHHHhh
Q 020720 113 EADPPIVHRDIKASNVLLDGNF--------------------HPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172 (322)
Q Consensus 113 ~~~~~i~h~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 172 (322)
.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.+
T Consensus 181 ~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 181 LR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCC
T ss_pred CC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcC
Confidence 99 99999999999999887 8999999999865432 3468999999999987
Q ss_pred CCCCcccceehhhHH-HHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccC
Q 020720 173 GQLTKKADVYSFGVL-LLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQA 251 (322)
Q Consensus 173 ~~~~~~sDv~slG~i-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 251 (322)
.. +.++||||||++ .+++++|..||.... ............... ..............++.+++.+||+.
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTF---KTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCC---SSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhcc---CcccchhhhhhcCHHHHHHHHHHhcc
Confidence 66 899999998777 777888998885320 000000011100000 00111122345677899999999997
Q ss_pred CCCCCCCHHHHH
Q 020720 252 GAHYRPTMKQVV 263 (322)
Q Consensus 252 dp~~Rps~~evl 263 (322)
| |+.|++
T Consensus 323 d-----sa~e~l 329 (336)
T 2vuw_A 323 S-----SATDLL 329 (336)
T ss_dssp S-----SHHHHH
T ss_pred C-----CHHHHH
Confidence 7 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=266.21 Aligned_cols=183 Identities=18% Similarity=0.143 Sum_probs=130.4
Q ss_pred ccCcceEEEEEEE-CCCCEEEEEEecccC----------hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 3 GGGAFGVVYRGSL-RDGTQIAIKCLSAES----------KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 3 g~G~~g~v~~~~~-~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
+.|++|.+..++. -.|+.|++|++.... ....+.+.+|+++|+++ +|+||+++++++++++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566666655533 358889999996541 23346799999999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|++|++|.+++.... +++.. .|+.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 323 yv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 323 KLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp CCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred cCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999997654 56543 58899999999999999 999999999999999999999999999866543
Q ss_pred cceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCC
Q 020720 151 VTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSS 197 (322)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p 197 (322)
.. .....+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22 2345679999999998875 456789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=235.45 Aligned_cols=180 Identities=18% Similarity=0.169 Sum_probs=145.6
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh--------hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK--------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|... ++.+++|....... ...+.+.+|+.++++++||||+++..++...+..++||||+
T Consensus 343 ~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~ 421 (540)
T 3en9_A 343 LIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYI 421 (540)
T ss_dssp -----CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECC
T ss_pred EEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECC
Confidence 4899999999999544 78899998644321 11345899999999999999997777777888889999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++.......
T Consensus 422 ~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 422 NGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999953 4689999999999999999 999999999999998 999999999997654322
Q ss_pred ee------ecccccCCCCCchHHHhh--CCCCcccceehhhHHHHHHHhCCCCC
Q 020720 153 HV------STRVAGTMGYLAPEYALL--GQLTKKADVYSFGVLLLEIISGRSSS 198 (322)
Q Consensus 153 ~~------~~~~~~t~~y~aPE~~~~--~~~~~~sDv~slG~il~ell~g~~p~ 198 (322)
.. .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 234679999999999987 57888999999998888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=191.72 Aligned_cols=139 Identities=13% Similarity=0.080 Sum_probs=114.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh------------------hcHHHHHHHHHHHhcCCCCcccccceEEEeC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK------------------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVED 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 62 (322)
.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+.++++++ | +++.+++..
T Consensus 97 ~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~- 172 (282)
T 1zar_A 97 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW- 172 (282)
T ss_dssp EEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-
T ss_pred EeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-
Confidence 3899999999999887799999999964321 13467889999999999 5 777776544
Q ss_pred CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeec
Q 020720 63 NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFG 142 (322)
Q Consensus 63 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg 142 (322)
+..++||||+++++|.+ +. . .....++.|++.||.|||+.+ ++||||||+|||++ ++.+||+|||
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 55699999999999988 41 1 234579999999999999999 99999999999999 9999999999
Q ss_pred cccccCCCcceeecccccCCCCCchHHHhh
Q 020720 143 LAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172 (322)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 172 (322)
++.. +..+.|||++..
T Consensus 238 ~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TCEE--------------TTSTTHHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHHH
Confidence 9862 356789998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.3e-21 Score=160.75 Aligned_cols=133 Identities=17% Similarity=0.152 Sum_probs=102.2
Q ss_pred CcccCcceEEEEEEE-CCCCE--EEEEEecccChh------------------------cHHHHHHHHHHHhcCCCCccc
Q 020720 1 MIGGGAFGVVYRGSL-RDGTQ--IAIKCLSAESKQ------------------------GTKEFLTEIDMIWNIRHPNLV 53 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~iv 53 (322)
.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+..+.|+++.
T Consensus 54 ~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 133 (258)
T 1zth_A 54 VISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVS 133 (258)
T ss_dssp EEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 389999999999987 57888 999997543111 113678899999999887653
Q ss_pred ccceEEEeCCeeEEEEEcCCC-C----CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeccCcccc
Q 020720 54 QLIGCCVEDNNRILVYEYLEN-N----SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH-EEADPPIVHRDIKASN 127 (322)
Q Consensus 54 ~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~~~i~h~dlkp~N 127 (322)
-..-+.. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.+ ++||||||.|
T Consensus 134 ~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~N 201 (258)
T 1zth_A 134 VPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYN 201 (258)
T ss_dssp CCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTS
T ss_pred CCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence 2222222 356899999942 3 77776532 234567889999999999999 888 9999999999
Q ss_pred eEeCCCCeEEEeeecccccc
Q 020720 128 VLLDGNFHPKIGDFGLAKLF 147 (322)
Q Consensus 128 ill~~~~~~kl~Dfg~~~~~ 147 (322)
||++. .++|+|||++...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99998 8999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.8e-19 Score=154.83 Aligned_cols=131 Identities=15% Similarity=0.153 Sum_probs=93.2
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccC--------------hhcHHH--------HHHHHHHHhcCCCCcccccceEE
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAES--------------KQGTKE--------FLTEIDMIWNIRHPNLVQLIGCC 59 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--------------~~~~~~--------~~~e~~~l~~l~h~~iv~~~~~~ 59 (322)
||+|++|.||+|...+|+.||||+++... ...... ..+|...|.++.+.++.-..-+.
T Consensus 103 IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~ 182 (397)
T 4gyi_A 103 IGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIA 182 (397)
T ss_dssp EEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEE
T ss_pred eeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeee
Confidence 89999999999998889999999976321 001111 23455556555433332211111
Q ss_pred EeCCeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-----
Q 020720 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF----- 134 (322)
Q Consensus 60 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~----- 134 (322)
.. ..++||||++|++|..+.. . .....++.||+.+|.+||+.+ ++||||||.|||+++++
T Consensus 183 ~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 183 QS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp EE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCT
T ss_pred cc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccc
Confidence 11 2369999999988865431 1 234568899999999999999 99999999999998877
Q ss_pred -----eEEEeeecccccc
Q 020720 135 -----HPKIGDFGLAKLF 147 (322)
Q Consensus 135 -----~~kl~Dfg~~~~~ 147 (322)
.+.|+||+.+...
T Consensus 248 ~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECCCTTCEET
T ss_pred cccccceEEEEeCCcccC
Confidence 4899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=116.29 Aligned_cols=134 Identities=16% Similarity=0.116 Sum_probs=104.1
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++||||++|.+|.+.
T Consensus 22 ~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 100 (263)
T 3tm0_A 22 TEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred ccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhc
Confidence 466778899999755 6889999987532223346888999999884 67788899999888899999999999999876
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA---------------------------------------------- 114 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---------------------------------------------- 114 (322)
+. +......++.+++.+|+.||+..
T Consensus 101 ~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (263)
T 3tm0_A 101 YE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp CC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred cC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence 41 11223467889999999999810
Q ss_pred ----------CCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 115 ----------DPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 115 ----------~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-12 Score=107.64 Aligned_cols=127 Identities=17% Similarity=0.138 Sum_probs=94.9
Q ss_pred cCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCc--ccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 4 GGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPN--LVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 4 ~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|. .
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred CCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 55669999997777888999997643 2245678888888885444 455888888777889999999998873 2
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEA----------------------------------------------- 114 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----------------------------------------------- 114 (322)
. ... ...++.+++..|+.||+..
T Consensus 105 ~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 S-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp S-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred C-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 1 111 2356777888888888642
Q ss_pred --------CCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 115 --------DPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 115 --------~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887777799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.2e-11 Score=107.02 Aligned_cols=138 Identities=13% Similarity=0.215 Sum_probs=101.7
Q ss_pred cccCcceEEEEEEECCCCEEEEEEec--ccC-hhcHHHHHHHHHHHhcCC--CCcccccceEEEeC---CeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLS--AES-KQGTKEFLTEIDMIWNIR--HPNLVQLIGCCVED---NNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~~~ 73 (322)
|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||||++
T Consensus 46 l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~ 124 (359)
T 3dxp_A 46 FKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVS 124 (359)
T ss_dssp CCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCC
T ss_pred cCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecC
Confidence 678999999999776 4678899875 322 122356788999999886 45577888887766 34789999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA--------------------------------------- 114 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--------------------------------------- 114 (322)
|..+.+.. ...++......++.+++.+|+.||+..
T Consensus 125 G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 125 GRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred CeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 87774311 114677788889999999999999731
Q ss_pred ----------------CCCeeeccCcccceEeCCCCe--EEEeeeccccc
Q 020720 115 ----------------DPPIVHRDIKASNVLLDGNFH--PKIGDFGLAKL 146 (322)
Q Consensus 115 ----------------~~~i~h~dlkp~Nill~~~~~--~kl~Dfg~~~~ 146 (322)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.4e-11 Score=103.28 Aligned_cols=180 Identities=18% Similarity=0.211 Sum_probs=117.0
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcC-CCCc--ccccceEEEeCC---eeEEEEEcCCCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPN--LVQLIGCCVEDN---NRILVYEYLENN 75 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~~ 75 (322)
++.|....||++. ..+++|+.... .....+.+|+..++.+ .+.. +.+++......+ ..|+||++++|.
T Consensus 28 ~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 28 SGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred cCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 5788899999863 56899986532 3456788999999887 3333 233443332222 347899999998
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA----------------------------------------- 114 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----------------------------------------- 114 (322)
+|.+... ..++......++.+++..++.||+..
T Consensus 102 ~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 102 PLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp ECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred ECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 8765332 14666777788888888888888611
Q ss_pred --------------CCCeeeccCcccceEeCC--CCeEEEeeeccccccCCCcceeecccccCCCC---CchHHHhh---
Q 020720 115 --------------DPPIVHRDIKASNVLLDG--NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGY---LAPEYALL--- 172 (322)
Q Consensus 115 --------------~~~i~h~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y---~aPE~~~~--- 172 (322)
...++|+|++|.||++++ ...+.|+||+.+....... .......+ ..|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHHHH
Confidence 134799999999999998 5668899999876432111 00011111 23332211
Q ss_pred --CCC---------CcccceehhhHHHHHHHhCCCCC
Q 020720 173 --GQL---------TKKADVYSFGVLLLEIISGRSSS 198 (322)
Q Consensus 173 --~~~---------~~~sDv~slG~il~ell~g~~p~ 198 (322)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 12358899999999999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.2e-08 Score=85.65 Aligned_cols=130 Identities=17% Similarity=0.126 Sum_probs=96.1
Q ss_pred Ccce-EEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 5 GAFG-VVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 5 G~~g-~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.++.+..
T Consensus 35 G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~ 111 (272)
T 4gkh_A 35 GQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVL 111 (272)
T ss_dssp SSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHH
T ss_pred CCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccc
Confidence 4444 68988665 467899998653 23456788999988774 334677888888899999999999998888766
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEA----------------------------------------------- 114 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----------------------------------------------- 114 (322)
... ......+..+++..|+.||...
T Consensus 112 ~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 112 EEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 322 2234456677777778887521
Q ss_pred --------CCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 115 --------DPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 115 --------~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0237999999999999988777899998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-07 Score=81.22 Aligned_cols=133 Identities=20% Similarity=0.224 Sum_probs=91.0
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCC---cccccceEEE-eCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHP---NLVQLIGCCV-EDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~L 77 (322)
++.|....||+. |..+++|+.. .......+.+|+.+|+.+.+. .+.+++.++. ..+..+++|++++|.++
T Consensus 27 l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 27 LGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred cCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 567888889988 5678899853 233456788999999998652 2455566653 34567899999999888
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA------------------------------------------- 114 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~------------------------------------------- 114 (322)
.+.... .++......++.+++..|+.||+..
T Consensus 101 ~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 101 GEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp HHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred chhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 763211 2344445555555555555555421
Q ss_pred --------------CCCeeeccCcccceEeCC---CCe-EEEeeeccccc
Q 020720 115 --------------DPPIVHRDIKASNVLLDG---NFH-PKIGDFGLAKL 146 (322)
Q Consensus 115 --------------~~~i~h~dlkp~Nill~~---~~~-~kl~Dfg~~~~ 146 (322)
...++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999997 344 58999997764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=6.7e-08 Score=84.54 Aligned_cols=76 Identities=9% Similarity=0.042 Sum_probs=50.7
Q ss_pred ccCcceEEEEEEEC-------CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCC---CcccccceEEEeC---CeeE
Q 020720 3 GGGAFGVVYRGSLR-------DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRH---PNLVQLIGCCVED---NNRI 66 (322)
Q Consensus 3 g~G~~g~v~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~---~~~~ 66 (322)
+.|..+.+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+.+++.++.+. +..+
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 67888899988654 26678999865322 0012456678888877732 3466677776554 3568
Q ss_pred EEEEcCCCCCHH
Q 020720 67 LVYEYLENNSLA 78 (322)
Q Consensus 67 lv~e~~~~~~L~ 78 (322)
+||||++|.++.
T Consensus 110 ~v~e~l~G~~l~ 121 (357)
T 3ats_A 110 FLMDYVEGVVPP 121 (357)
T ss_dssp EEEECCCCBCCC
T ss_pred EEEEecCCCChh
Confidence 999999886654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.39 E-value=2.4e-06 Score=72.30 Aligned_cols=71 Identities=23% Similarity=0.284 Sum_probs=51.3
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCC---cccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHP---NLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+|.|..+.||+....+|+.|++|+...........+..|+..|+.+... .+.+++.+ + ..+++|||++++.
T Consensus 23 ~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 23 RGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred cCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 5889999999999999999999987655444445677899988887432 23344433 2 2468999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=7.9e-07 Score=78.92 Aligned_cols=72 Identities=19% Similarity=0.204 Sum_probs=46.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccCh-------hcHHHHHHHHHHHhcCCC--Cccc-ccceEEEeCCeeEEEEE
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-------QGTKEFLTEIDMIWNIRH--PNLV-QLIGCCVEDNNRILVYE 70 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~iv-~~~~~~~~~~~~~lv~e 70 (322)
||.|..+.||++... +++.+++|....... .....+..|.++++.+.. +..+ +++.+ +.+..++|||
T Consensus 38 lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE 115 (397)
T 2olc_A 38 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 115 (397)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred CCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEE
Confidence 688999999999654 478899998653211 122456778888887632 3333 44433 4556789999
Q ss_pred cCCCC
Q 020720 71 YLENN 75 (322)
Q Consensus 71 ~~~~~ 75 (322)
++++.
T Consensus 116 ~l~g~ 120 (397)
T 2olc_A 116 DLSHL 120 (397)
T ss_dssp CCTTS
T ss_pred eCCCc
Confidence 99764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=5.9e-06 Score=71.51 Aligned_cols=30 Identities=27% Similarity=0.349 Sum_probs=26.8
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 349999999999999888899999999765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.28 E-value=9.6e-06 Score=69.25 Aligned_cols=72 Identities=14% Similarity=0.111 Sum_probs=56.9
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC---CCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR---HPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
|+.|....+|+.... +..+++|+.... ....+..|+..|+.+. ...+.+++.++...+..++||||+++..+
T Consensus 44 l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 44 LYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp ECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 578889999999764 678899987532 3567788988888873 35678888888878889999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.5e-05 Score=68.80 Aligned_cols=29 Identities=14% Similarity=0.320 Sum_probs=26.0
Q ss_pred CeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
.++|+|++|.||+++.++ +.|+||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 399999999999999876 99999988774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.98 E-value=4.4e-05 Score=60.61 Aligned_cols=103 Identities=14% Similarity=0.103 Sum_probs=67.8
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
-+|.+++...+. ++++.++|.++.|.+.+|.-+-.... -...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 389999987654 89999999999999999877632111 11233468999999999988764 1110
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSS 197 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p 197 (322)
.....+.|||... ...+.+.-|||||++||.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123566887542 3446788899999999998865444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.81 E-value=8.4e-05 Score=63.12 Aligned_cols=68 Identities=10% Similarity=0.231 Sum_probs=40.2
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcC-CCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYL-ENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~~L 77 (322)
|+.|....+|+. ..+++|+....... .....+|+..++.+....+ .+++.+ +.+..++++||+ ++.++
T Consensus 26 l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 26 RLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred cCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 567888899998 45888987643211 1123457777766643333 344433 344457899999 65443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00048 Score=59.08 Aligned_cols=71 Identities=11% Similarity=0.107 Sum_probs=45.4
Q ss_pred CcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCC--cccccceE-----EEeCCeeEEEEEcCCCCC
Q 020720 5 GAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHP--NLVQLIGC-----CVEDNNRILVYEYLENNS 76 (322)
Q Consensus 5 G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~~~~~ 76 (322)
|....||+....+|+.+++|..+... .....+..|...++.+... .+.+++.. ....+..++++++++|.+
T Consensus 36 g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 36 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCC
Confidence 67788999877667789999986331 2345566777777766321 23333332 223456688999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00026 Score=60.91 Aligned_cols=32 Identities=38% Similarity=0.305 Sum_probs=27.2
Q ss_pred CCeeeccCcccceEeCCC----CeEEEeeecccccc
Q 020720 116 PPIVHRDIKASNVLLDGN----FHPKIGDFGLAKLF 147 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 147 (322)
..++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 349999999999999875 67999999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0014 Score=56.01 Aligned_cols=141 Identities=14% Similarity=0.164 Sum_probs=74.1
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC-----CCcccccc-e--EEEeCCeeEEEEEcCC
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-----HPNLVQLI-G--CCVEDNNRILVYEYLE 73 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lv~e~~~ 73 (322)
|+.|....+|+....+| .+++|...... ....+..|+.++..+. .|.++... + +....+..+++++|++
T Consensus 30 i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 30 IAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 45677789999977655 68899886521 1234455666665552 23333211 1 1223456789999998
Q ss_pred CCCHHH-----------H---HhcC----CCCC-cCCC---HHHHHH------------HHHHHHHHHHHHhhc----CC
Q 020720 74 NNSLAN-----------A---LLGS----KSKY-VSLD---WPTRAN------------ICLGTASGLSFLHEE----AD 115 (322)
Q Consensus 74 ~~~L~~-----------~---l~~~----~~~~-~~~~---~~~~~~------------i~~qi~~~l~~lH~~----~~ 115 (322)
|..+.. . ++.. .... .... |...+. +...+...++.+... ..
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 764310 0 1110 0000 0011 111000 001133445555431 12
Q ss_pred CCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 116 ~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
..++|+|+.+.||++++++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 248999999999999987667899998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0001 Score=64.59 Aligned_cols=139 Identities=19% Similarity=0.235 Sum_probs=78.5
Q ss_pred cccCcceEEEEEEEC--------CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLR--------DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 72 (322)
|..|-...+|++... +++.+++|+.... ......+.+|..+++.+...++ .++++++. + .+|+||+
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~i 132 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQYI 132 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEECC
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEEe
Confidence 345667788998764 2578999986432 2234566789998888743333 45555543 3 2899999
Q ss_pred CCCCHHH--------------H---HhcCCCC-CcCC--CHHHHHHHHHHHHH-------------------HHHHH---
Q 020720 73 ENNSLAN--------------A---LLGSKSK-YVSL--DWPTRANICLGTAS-------------------GLSFL--- 110 (322)
Q Consensus 73 ~~~~L~~--------------~---l~~~~~~-~~~~--~~~~~~~i~~qi~~-------------------~l~~l--- 110 (322)
+|.+|.. . ++..... .... -+..+.++..++.. .+..|
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 8765421 0 1111110 0111 23445555544322 12222
Q ss_pred -hhcC-CCCeeeccCcccceEeCCC----CeEEEeeecccc
Q 020720 111 -HEEA-DPPIVHRDIKASNVLLDGN----FHPKIGDFGLAK 145 (322)
Q Consensus 111 -H~~~-~~~i~h~dlkp~Nill~~~----~~~kl~Dfg~~~ 145 (322)
.... ...++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 2348999999999999876 789999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00015 Score=64.75 Aligned_cols=69 Identities=14% Similarity=0.242 Sum_probs=45.2
Q ss_pred cccCcceEEEEEEECC--------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 72 (322)
|+.|....+|++...+ +..+++|+..... ....+..|+.+++.+...++ .++++.+. + .+|++|+
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l 154 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYI 154 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCC
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEe
Confidence 4567788999997653 5789999884321 12455578888888754344 45555442 2 2899999
Q ss_pred CCCC
Q 020720 73 ENNS 76 (322)
Q Consensus 73 ~~~~ 76 (322)
+|.+
T Consensus 155 ~G~~ 158 (429)
T 1nw1_A 155 PSRP 158 (429)
T ss_dssp CEEE
T ss_pred CCcc
Confidence 8643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00038 Score=62.63 Aligned_cols=71 Identities=13% Similarity=0.191 Sum_probs=44.1
Q ss_pred cccCcceEEEEEEECC-CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
|+.|-...+|++...+ +..+++|+....... .-...+|+.++..+...++ .++++++ .+. +|+||++|.+|
T Consensus 116 lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 116 INGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYAL 188 (458)
T ss_dssp ECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEEC
T ss_pred cCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCccC
Confidence 4567778999998774 478899987532211 1112578888888865555 4555554 232 59999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0011 Score=57.14 Aligned_cols=30 Identities=33% Similarity=0.362 Sum_probs=26.7
Q ss_pred CeeeccCcccceEeCCCCeEEEeeeccccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKL 146 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~ 146 (322)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999888899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00015 Score=63.55 Aligned_cols=70 Identities=13% Similarity=0.213 Sum_probs=40.5
Q ss_pred cccCcceEEEEEEECC---------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEc
Q 020720 2 IGGGAFGVVYRGSLRD---------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 71 (322)
|+.|....+|+....+ +..+++|+...... .......|..+++.+...++ .++++.. . -++|++|
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~ 115 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW 115 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence 4567788999987653 26889998754321 11123567777777743333 3555443 2 3689999
Q ss_pred CCCCC
Q 020720 72 LENNS 76 (322)
Q Consensus 72 ~~~~~ 76 (322)
++|.+
T Consensus 116 i~G~~ 120 (369)
T 3c5i_A 116 LYGDP 120 (369)
T ss_dssp CCSEE
T ss_pred ecCCc
Confidence 98754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0038 Score=55.43 Aligned_cols=71 Identities=14% Similarity=0.183 Sum_probs=43.5
Q ss_pred cccCcceEEEEEEECC--------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 72 (322)
|..|-...+|+....+ +..+++|+..... ...-...+|..+++.+...++ .++++.+ . -++|++|+
T Consensus 78 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 78 IFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp ECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred cCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 3457778899987653 5789999875432 111223567777777743233 4444432 2 26899999
Q ss_pred CCCCH
Q 020720 73 ENNSL 77 (322)
Q Consensus 73 ~~~~L 77 (322)
+|.+|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.01 E-value=0.021 Score=50.32 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=24.2
Q ss_pred eeeccCcccceEe------CCCCeEEEeeecccc
Q 020720 118 IVHRDIKASNVLL------DGNFHPKIGDFGLAK 145 (322)
Q Consensus 118 i~h~dlkp~Nill------~~~~~~kl~Dfg~~~ 145 (322)
++|+|+.+.||++ +++..+.++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 456779999998875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.55 E-value=0.3 Score=38.78 Aligned_cols=115 Identities=12% Similarity=0.126 Sum_probs=78.1
Q ss_pred CCCcccccceEEEeCCeeEEEEEcCCCC-CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeeccCcc
Q 020720 48 RHPNLVQLIGCCVEDNNRILVYEYLENN-SLANALLGSKSKYVSLDWPTRANICLGTASGLS-FLHEEADPPIVHRDIKA 125 (322)
Q Consensus 48 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~-~lH~~~~~~i~h~dlkp 125 (322)
.||++ -..+-.+++.+.+.++.-+++ ++..+- ..+...+++++.+|+.... +++ . -+|--|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeC
Confidence 67887 455556777777777765443 454443 5788899999999887666 444 2 57788999
Q ss_pred cceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCc
Q 020720 126 SNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKA 200 (322)
Q Consensus 126 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~ 200 (322)
+|++++.++.+++.-.|+-..+... . +.+|.+. -++=|++..++.++..|..
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lpP~------------e-~~ee~fl----------~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLPPD------------E-WDDERLL----------REVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBSSC------------S-CCHHHHH----------HHHHHHHHHHTTCSSCHHH
T ss_pred ceEEEeCCCcEEEEEcCCcccCCCC------------C-CCHHHHH----------HHHHHHHHHHHcCCCCHHH
Confidence 9999999999999887764422110 1 2333222 2566788888888777653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.00 E-value=0.22 Score=39.36 Aligned_cols=117 Identities=9% Similarity=0.065 Sum_probs=79.0
Q ss_pred CCCcccccceEEEeCCeeEEEEEcCC-CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCccc
Q 020720 48 RHPNLVQLIGCCVEDNNRILVYEYLE-NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKAS 126 (322)
Q Consensus 48 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~ 126 (322)
.||++++. .+..+.+...+.++.-+ +.++..+- ..+...+++++.+|+....+++. -+|--|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68888876 56666777666666444 22343322 57888999999999887755542 577889999
Q ss_pred ceEeCCCCeEEEeeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcc
Q 020720 127 NVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAA 201 (322)
Q Consensus 127 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~ 201 (322)
|++++.++.+++.-.|+...+... =..+|.+ .-.+=|++..+++++..|...
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~-------------~~~ee~f----------L~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPL-------------PVSEAEF----------LTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCC-------------CCCHHHH----------HHHHHHHHHHHHCTTCCHHHH
T ss_pred eEEEcCCCCEEEEEccCccCCCCC-------------CCCHHHH----------HHHHHHHHHHHHcCCCCHHHH
Confidence 999999999999877764322111 0122322 225677888999998887643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.90 E-value=0.11 Score=46.77 Aligned_cols=55 Identities=7% Similarity=0.101 Sum_probs=14.7
Q ss_pred ceEEEEEEECC-CCEEEE------EEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEe
Q 020720 7 FGVVYRGSLRD-GTQIAI------KCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61 (322)
Q Consensus 7 ~g~v~~~~~~~-~~~vai------K~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 61 (322)
||.||+|.+.. ..+||+ |..+... ......+.+|..++..++|||+++.+++...
T Consensus 152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 99999997763 467888 7665322 2233568889999999999999999888643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 322 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 8e-72
Identities = 64/271 (23%), Positives = 129/271 (47%), Gaps = 21/271 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G+FG VY+G + + ++A + Q + F E+ ++ RH N++ +G
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+V ++ E +SL + L ++K + +I TA G+ +LH I+HR
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFP-DNVTHVSTRVAGTMGYLAPEYALL---GQLTK 177
D+K++N+ L + KIGDFGLA + + +H +++G++ ++APE + +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237
++DVY+FG++L E+++G+ + + + + G L P+L++
Sbjct: 189 QSDVYAFGIVLYELMTGQL----PYSNIN--NRDQIIFMVGRGYL----SPDLSKVRSNC 238
Query: 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
++ C + RP Q++ +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-68
Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ G T++A+K L + FL E +++ ++H LV+L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
++ EY+EN SL + L L ++ A G++F+ E +HR
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D++A+N+L+ KI DFGLA+L DN + + APE G T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
+SFG+LL EI++ + +I L R++ P+
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVI-----QNLERGYRMV---------RPDNCPEEL 239
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEML 266
++ C + RPT + +L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-67
Identities = 66/267 (24%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG+V+ G + ++AIK + E ++F+ E +++ + HP LVQL G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
LV+E++E+ L++ +++ T +CL G+++L E ++HR
Sbjct: 72 QAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N L+ N K+ DFG+ + D+ ST + + +PE + + K+DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
+SFGVL+ E+ S + ++ + RL P
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVV-----EDISTGFRL---------YKPRLASTHV 231
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEMLSK 268
++ C + RP +++ L++
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 7e-67
Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 23/266 (8%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FGVV G R +AIK + E EF+ E ++ N+ H LVQL G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
++ EY+ N L N L + + +C + +L +HR
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D+ A N L++ K+ DFGL++ D+ S + + PE + + + K+D+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE-IVDPELTQFPEKEVMR 240
++FGVL+ EI S + ++ E I P +
Sbjct: 185 WAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEML 266
+ C A RPT K ++ +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-65
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 31/291 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V+RG R G ++A+K S+ ++ + EI +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 62 DNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA--- 114
DN LV +Y E+ SL + L + + L TASGL+ LH E
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 115 --DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP---DNVTHVSTRVAGTMGYLAPEY 169
P I HRD+K+ N+L+ N I D GLA D + GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 170 AL------LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDM----LILVEWTWKLREE 219
+ K+AD+Y+ G++ EI S + L+ + + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 220 GRLLEIVDPEL-TQFPEKEVMR-FIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+ + P + ++ E +R K+ C A R T ++ + LS+
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-64
Identities = 74/265 (27%), Positives = 119/265 (44%), Gaps = 21/265 (7%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
+G G FG V+ G+ T++AIK L + FL E ++ +RH LVQL
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 82
Query: 62 DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHR 121
+ +V EY+ SL + L G KY+ P ++ ASG++++ VHR
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 122 DIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADV 181
D++A+N+L+ N K+ DFGLA+L DN + + APE AL G+ T K+DV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 182 YSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241
+SFG+LL E+ + + + + V L ++ P +
Sbjct: 198 WSFGILLTELTTKG---RVPYPGMVNREV-----------LDQVERGYRMPCPPECPESL 243
Query: 242 IKVGLFCTQAGAHYRPTMKQVVEML 266
+ C + RPT + + L
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (512), Expect = 9e-64
Identities = 62/269 (23%), Positives = 120/269 (44%), Gaps = 23/269 (8%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+GGG +G VY G + +A+K L ++ + +EFL E ++ I+HPNLVQL+G C
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ ++ E++ +L + L + + + +S + +L + +H
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEK---KNFIH 138
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RD+ A N L+ N K+ DFGL++L + + + APE + + K+D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 181 VYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT-QFPEKEVM 239
V++FGVLL EI + + + ++ E+++ + + PE
Sbjct: 199 VWAFGVLLWEIATYG---------------MSPYPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+ ++ C Q RP+ ++ +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-62
Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 29/277 (10%)
Query: 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG VY G+L D A+K L+ + G +FLTE ++ + HPN++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 56 IGCCVE-DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+G C+ + + ++V Y+++ L N + L A G+ FL
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLA--- 147
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN---VTHVSTRVAGTMGYLAPEYAL 171
VHRD+ A N +LD F K+ DFGLA+ D H T + ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 172 LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231
+ T K+DV+SFGVLL E+++ + D + T L + RLL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRG---APPYPDVN--TFDITVYLLQGRRLL-------- 254
Query: 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
PE +V L C A RP+ ++V +S
Sbjct: 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 5e-62
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGT-KEFLTEIDMIWNIRHPNLVQLIGCC 59
+G G GVV++ S + G +A K + E K + + E+ ++ P +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
D + E+++ SL L K + + + GL++L E+ I+
Sbjct: 74 YSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K SN+L++ K+ DFG++ D++ GT Y++PE + ++
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 180 DVYSFGVLLLEIISGR 195
D++S G+ L+E+ GR
Sbjct: 185 DIWSMGLSLVEMAVGR 200
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 6e-62
Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 45/295 (15%)
Query: 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQ 54
IG GAFG V++ T +A+K L E S +F E ++ +PN+V+
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS--------------------LDWP 94
L+G C L++EY+ L L V L
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 95 TRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK-LFPDNVTH 153
+ I A+G+++L E VHRD+ N L+ N KI DFGL++ ++ +
Sbjct: 141 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT 213
A + ++ PE + T ++DV+++GV+L EI S ++
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG--------------LQPY 243
Query: 214 WKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+ + E + + D + PE + + C RP+ + +L +
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-61
Identities = 74/268 (27%), Positives = 113/268 (42%), Gaps = 27/268 (10%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE 61
IG G FG V G R G ++A+KC+ ++ + FL E ++ +RH NLVQL+G VE
Sbjct: 15 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 62 DNNRI-LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ + +V EY+ SL + L L L + +L VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 126
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RD+ A NVL+ + K+ DFGL K + + APE + + K+D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFSTKSD 182
Query: 181 VYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240
V+SFG+LL EI S + + L + E+G ++ P+
Sbjct: 183 VWSFGILLWEIYSFG---RVPYPRIPL---KDVVPRVEKGYKMDA--------PDGCPPA 228
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+V C A RP+ Q+ E L
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-61
Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 28/283 (9%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ-----IAIKCLSAESKQGTK-EFLTEIDMIWNIRHPNLVQ 54
+IG G FG VY+G L+ + +AIK L A + + +FL E ++ H N+++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L G + +++ EY+EN +L + K + G A+G+ +L
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLAN-- 128
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN--VTHVSTRVAGTMGYLAPEYALL 172
VHRD+ A N+L++ N K+ DFGL+++ D+ T+ ++ + + APE
Sbjct: 129 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 173 GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232
+ T +DV+SFG+++ E+++ W+L + I D
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDGFRLP 233
Query: 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEK 275
P ++ + C Q RP +V +L K + +
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-60
Identities = 67/293 (22%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGTKE-FLTEIDMIWNI-RHPNLV 53
+G GAFG V + +A+K L + +E ++E+ ++ + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS--------------LDWPTRANI 99
L+G C +++ EY L N L + ++ LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH-VSTRV 158
A G++FL + +HRD+ A N+LL KI DFGLA+ ++ + V
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE 218
+ ++APE T ++DV+S+G+ L E+ S SS +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGMPV 253
Query: 219 EGRLLEIVDPELT-QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270
+ + +++ PE + C A RPT KQ+V+++ K +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 1e-59
Identities = 69/277 (24%), Positives = 127/277 (45%), Gaps = 29/277 (10%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ----IAIKCL-SAESKQGTKEFLTEIDMIWNIRHPNLVQL 55
+IG G FG V G L+ + +AIK L S +++ ++FL+E ++ HPN++ L
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
G + +++ E++EN SL + + + G A+G+ +L D
Sbjct: 93 EGVVTKSTPVMIITEFMENGSLDSF---LRQNDGQFTVIQLVGMLRGIAAGMKYLA---D 146
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA----GTMGYLAPEYAL 171
VHRD+ A N+L++ N K+ DFGL++ D+ + + A + + APE
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206
Query: 172 LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231
+ T +DV+S+G+++ E++S + + D + + ++ RL
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYG---ERPYWDMT--NQDVINAIEQDYRL--------- 252
Query: 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P ++ L C Q ++RP Q+V L K
Sbjct: 253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-59
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 2 IGGGAFGVVYRGSLRD---GTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLI 56
+G G FG V +G + +A+K L E+ E L E +++ + +P +V++I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
G C E + +LV E E L L + + + + G+ +L +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---ES 126
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR--VAGTMGYLAPEYALLGQ 174
VHRD+ A NVLL + KI DFGL+K + + + + + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 175 LTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
+ K+DV+SFGVL+ E S G+ + G ++ ++E ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------------GC 231
Query: 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
P + C RP V L
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-59
Identities = 61/270 (22%), Positives = 119/270 (44%), Gaps = 23/270 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G++G + DG + K L S + + ++E++++ ++HPN+V+
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 59 CVEDNNRIL--VYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE--EA 114
++ N L V EY E LA+ + + LD + L H +
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
++HRD+K +NV LDG + K+GDFGLA++ + T + GT Y++PE
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMS 190
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234
+K+D++S G LL E+ + A ++ +I + + + P
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---------------AGKIREGKFRRIP 235
Query: 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
+ ++ ++RP++++++E
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-59
Identities = 64/271 (23%), Positives = 115/271 (42%), Gaps = 27/271 (9%)
Query: 2 IGGGAFGVVYRGSLR---DGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQLIG 57
+G G FG V +G R +AIK L +++ T+E + E ++ + +P +V+LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + +LV E L L+G + + + A + + G+ +L +
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLE---EKN 129
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR--VAGTMGYLAPEYALLGQL 175
VHRD+ A NVLL + KI DFGL+K + ++ + R + + APE +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 176 TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235
+ ++DV+S+GV + E +S + + E+G+ +E P
Sbjct: 190 SSRSDVWSYGVTMWEALSYG---QKPYKKMKG---PEVMAFIEQGKRMEC--------PP 235
Query: 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
+ + C RP V + +
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-59
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 30/271 (11%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G+F VY+G + ++A L +K + F E +M+ ++HPN+V+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 59 CVE----DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
+LV E + + +L L ++ + + C GL FLH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR- 131
Query: 115 DPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
PPI+HRD+K N+ + G KIGD GLA L + V GT ++APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-YEE 187
Query: 174 QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
+ + DVY+FG+ +LE+ + + + + ++ PE+ +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
E C + R ++K ++
Sbjct: 246 IEG-----------CIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-58
Identities = 70/294 (23%), Positives = 113/294 (38%), Gaps = 44/294 (14%)
Query: 1 MIGGGAFGVVYRGSLRD------GTQIAIKCLSAESKQGTKE-FLTEIDMIWNI-RHPNL 52
++G GAFG V + Q+A+K L ++ +E ++E+ M+ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS-------------------LDW 93
V L+G C L++EY L N L + K+ L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 94 PTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153
A G+ FL VHRD+ A NVL+ KI DFGLA+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 154 VS-TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEW 212
V + ++APE G T K+DV+S+G+LL EI S + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG---VNPYPGIP--VDAN 275
Query: 213 TWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
+KL + G ++ P + C + RP+ + L
Sbjct: 276 FYKLIQNGFKMDQ--------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-58
Identities = 60/269 (22%), Positives = 115/269 (42%), Gaps = 26/269 (9%)
Query: 2 IGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFG VY+ ++ A K + +S++ ++++ EID++ + HPN+V+L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+NN ++ E+ ++ + L +C T L++LH+ I+H
Sbjct: 80 YENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL----- 175
RD+KA N+L + K+ DFG++ + + + GT ++APE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 176 TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235
KADV+S G+ L+E+ + M +L++ F +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
K C + R T Q+++
Sbjct: 251 K-----------CLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 8e-58
Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 33/270 (12%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT---KEFLTEIDMIWNIRHPNLVQLIG 57
IG G+FG VY +R+ +AIK +S KQ ++ + E+ + +RHPN +Q G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
C + ++ LV EY ++ + K L A + G GL++LH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL---GQ 174
++HRD+KA N+LL K+GDFG A + + V GT ++APE L GQ
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 190
Query: 175 LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234
K DV+S G+ +E+ + L + + + ++
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSGHWSE-- 241
Query: 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
F+ C Q RPT + +++
Sbjct: 242 --YFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-57
Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 29/274 (10%)
Query: 2 IGGGAFGVVYRGSLR----DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FGVV RG +A+KCL + + +F+ E++ + ++ H NL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L G + ++ V E SL + L + T + + A G+ +L
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH--VSTRVAGTMGYLAPEYALL 172
+HRD+ A N+LL KIGDFGL + P N H + + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 173 GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232
+ +D + FGV L E+ + + + + K+ +EG L
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYG---QEPWIGLN--GSQILHKIDKEGERLPR------- 236
Query: 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEML 266
PE V + C RPT + + L
Sbjct: 237 -PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-57
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 30/292 (10%)
Query: 1 MIGGGAFGVVYRGSLRD-----GTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
++G GAFG VY+G +AIK L A S + KE L E ++ ++ +P++ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+G C+ + L+ + + L + + K N C+ A G+++L
Sbjct: 76 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGMNYLE--- 128
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALLG 173
D +VHRD+ A NVL+ H KI DFGLAKL + + + + ++A E L
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 174 QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD-PELTQ 232
T ++DV+S+GV + E+++ + + I++ E
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISSILEKGERLP 233
Query: 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLNEKALTEPGVYR 284
P + + + C A RP ++++ SK ++ L G R
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-57
Identities = 60/285 (21%), Positives = 123/285 (43%), Gaps = 33/285 (11%)
Query: 2 IGGGAFGVVYRGSLR------DGTQIAIKCLS-AESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G+FG+VY G + T++AIK ++ A S + EFL E ++ ++V+
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 55 LIGCCVEDNNRILVYEYLENNSLANAL------LGSKSKYVSLDWPTRANICLGTASGLS 108
L+G + +++ E + L + L + + + A G++
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD-NVTHVSTRVAGTMGYLAP 167
+L+ VHRD+ A N ++ +F KIGDFG+ + + + + + +++P
Sbjct: 148 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 168 EYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLE-IV 226
E G T +DV+SFGV+L EI + E ++ ++L ++
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQGLSNEQVLRFVM 249
Query: 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271
+ L P+ ++ C Q RP+ +++ + +++
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 9e-57
Identities = 64/267 (23%), Positives = 106/267 (39%), Gaps = 30/267 (11%)
Query: 2 IGGGAFGVVYRGSLR-DGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G FG VY + +A+K L E + E+++ ++RHPN+++L G
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+ L+ EY ++ L K D A A+ LS+ H +
Sbjct: 74 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 126
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
++HRDIK N+LL KI DFG + P + + GT+ YL PE +
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDE 183
Query: 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237
K D++S GVL E + G+ +A + + R E + V +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SRVEFTFPDFVTEGARDLISR- 237
Query: 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264
+ RP +++V+E
Sbjct: 238 ----------LLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-56
Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 36/285 (12%)
Query: 1 MIGGGAFGVVYRGSLRDGTQ---IAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQL 55
+IG G FG V + ++ AIK + SK ++F E++++ + HPN++ L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGS------------KSKYVSLDWPTRANICLGT 103
+G C L EY + +L + L S S +L +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 104 ASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMG 163
A G+ +L + +HRD+ A N+L+ N+ KI DFGL++ V T +
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVR 191
Query: 164 YLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223
++A E T +DV+S+GVLL EI+S + E KL + RL
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG---GTPYCGMT--CAELYEKLPQGYRL- 245
Query: 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
+ P + C + + RP+ Q++ L++
Sbjct: 246 --------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-56
Identities = 60/267 (22%), Positives = 101/267 (37%), Gaps = 24/267 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIGCC 59
+G GA+G V + +A+K + + E EI + + H N+V+ G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
E N + L EY L + + + + P +G+ +LH I
Sbjct: 73 REGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALLGQL-TK 177
HRDIK N+LLD + KI DFGLA +F +N + ++ GT+ Y+APE + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237
DV+S G++L +++G K + +D K
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALLHK- 242
Query: 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264
R T+ + +
Sbjct: 243 ----------ILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-56
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 28/274 (10%)
Query: 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQL 55
IG G FG V++G +AIK + +E FL E + HP++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
IG +N ++ E L + + + SLD + ++ L++L
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
VHRDI A NVL+ N K+GDFGL++ D+ + +++ + ++APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 176 TKKADVYSFGVLLLEII-SGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234
T +DV+ FGV + EI+ G + +D++ +E +L + P L
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PMPPNCPPTLYSLM 242
Query: 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
K C RP ++ LS
Sbjct: 243 TK-----------CWAYDPSRRPRFTELKAQLST 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-54
Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 23/264 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG GA G VY + G ++AI+ ++ + + + + EI ++ ++PN+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +V EYL SL + + + D A +C L FLH ++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 121 RDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKAD 180
RDIK+ N+LL + K+ DFG + ST V GT ++APE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 181 VYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240
++S G++ +E+I G + + L E + E + F +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLNR---- 252
Query: 241 FIKVGLFCTQAGAHYRPTMKQVVE 264
C R + K++++
Sbjct: 253 -------CLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-53
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 2 IGGGAFGVVYRGSLR--------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPN 51
+G GAFG V T++A+K L ++ +++ + ++E++M+ I +H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVS------------LDWPTRANI 99
++ L+G C +D ++ EY +L L + + L +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 100 CLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV- 158
A G+ +L +HRD+ A NVL+ + KI DFGLA+ + T
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 159 AGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE 218
+ ++APE T ++DV+SFGVLL EI + + + VE +KL +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG---GSPYPGVP---VEELFKLLK 251
Query: 219 EGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272
EG ++ P + C A RPT KQ+VE L + V L
Sbjct: 252 EGHRMDK--------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-52
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 38/289 (13%)
Query: 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESKQGT-KEFLTEID-MIWNIRHPNLV 53
+G GAFG V +A+K L + + ++E+ +I H N+V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 54 QLIGCCVEDNNRI-LVYEYLENNSLANALLGSKSKYVS------------LDWPTRANIC 100
L+G C + + ++ E+ + +L+ L ++++V L
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 101 LGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV-STRVA 159
A G+ FL +HRD+ A N+LL KI DFGLA+ + +V
Sbjct: 141 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREE 219
+ ++APE T ++DV+SFGVLL EI S +S + + E + +E
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRLKE 252
Query: 220 GRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
G + P+ + L C RPT ++VE L
Sbjct: 253 GTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (437), Expect = 8e-52
Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 23/266 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFGVV+R G A K + + + EI + +RHP LV L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+DN +++YE++ L + ++ + GL +HE VH
Sbjct: 94 DDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147
Query: 121 RDIKASNVLL--DGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
D+K N++ + K+ DFGL + T GT + APE A +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYY 205
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
D++S GVL ++SG S D+ L V + + + +++ +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISE----DG 256
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264
FI+ A + R T+ Q +E
Sbjct: 257 KDFIRK---LLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-51
Identities = 59/267 (22%), Positives = 103/267 (38%), Gaps = 28/267 (10%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G+F V L + AIK L + E D++ + HP V+L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+D Y +N L + K S D S L +LH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG---K 127
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLF-PDNVTHVSTRVAGTMGYLAPEYALLGQL 175
I+HRD+K N+LL+ + H +I DFG AK+ P++ + GT Y++PE
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 176 TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235
K +D+++ G ++ ++++G +A + + ++ E E P+ E
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-----IKLEYDFPEKFFPKARDLVE 242
Query: 236 KEVMRFIKVGLFCTQAGAHYRPTMKQV 262
K A R +++
Sbjct: 243 K-----------LLVLDATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (421), Expect = 2e-49
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 23/266 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G GAFGVV+R G K ++ EI ++ + HP L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
+ +L+ E+L L + + ++ + N GL +HE IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 121 RDIKASNVLLD--GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
DIK N++ + KI DFGLA + + T + APE +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
D+++ GVL ++SG S + L V R + E ++ E
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----KRCDWEFDEDAFSSVSP----EA 259
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264
FIK Q R T+ +E
Sbjct: 260 KDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 1e-45
Identities = 65/241 (26%), Positives = 95/241 (39%), Gaps = 20/241 (8%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLS---AESKQGTKEFLTEIDMI---WNIRHPNLV 53
+IG G FG VY D G A+KCL + KQG L E M+ P +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 54 QLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
+ + + + + L L S++ GL +H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHN- 125
Query: 114 ADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLG 173
+V+RD+K +N+LLD + H +I D GLA F H GT GY+APE G
Sbjct: 126 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKG 180
Query: 174 Q-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232
AD +S G +L +++ G S + D + T + E L + PEL
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRS 238
Query: 233 F 233
Sbjct: 239 L 239
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-45
Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 24/266 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G FG+V+R K + + EI ++ RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++++E++ + + + L+ + L FLH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 121 RDIKASNVLLD--GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
DI+ N++ + KI +FG A+ Y APE ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTA 183
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
D++S G L+ ++SG + A ++ + + E E E++ E
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNAEYTFDEEAFKEISI----EA 234
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264
M F+ R T + ++
Sbjct: 235 MDFVDR---LLVKERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 3e-45
Identities = 53/279 (18%), Positives = 100/279 (35%), Gaps = 28/279 (10%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G+FG +Y G + G ++AIK ++K + E + ++ + I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 60 VEDNNR-ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ + ++V E L + S+ T + S + ++H +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 119 VHRDIKASNVL---LDGNFHPKIGDFGLAKLFPDNVTHV------STRVAGTMGYLAPEY 169
+HRD+K N L I DFGLAK + D TH + + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229
L + +++ D+ S G +L+ G + E + + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
L + E ++ FC +P + ++
Sbjct: 240 LCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 6e-45
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 20/236 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIG 57
+G G+FG V+ S +G A+K L E + + E M+ + HP ++++ G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+ ++ +Y+E L + L S+ + A +CL L
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSKD 124
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
I++RD+K N+LLD N H KI DFG AK PD + GT Y+APE K
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
D +SFG+L+ E+++G + + + L E R + ++
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-----LNAELRFPPFFNEDVKDL 231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 6e-45
Identities = 49/266 (18%), Positives = 95/266 (35%), Gaps = 20/266 (7%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-FLTEIDMIWNIRHPNLVQLIGC 58
++G GAF V R +AIKC++ ++ +G + EI ++ I+HPN+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ L+ + + L + + + + + + +LH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+ LD + I DFGL+K+ V + GT GY+APE +K
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
D +S GV+ ++ G + + + + + + F
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LKAEYEFDSPYWDDISDSAKDFIRH-- 246
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE 264
+ R T +Q ++
Sbjct: 247 ---------LMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 2e-44
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS---------AESKQGTKEFLTEIDMIWNIR-H 49
++G G VV R + A+K + E ++ + L E+D++ + H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 50 PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSF 109
PN++QL + LV++ ++ L + L ++ V+L I +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125
Query: 110 LHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEY 169
LH+ IVHRD+K N+LLD + + K+ DFG + V GT YLAPE
Sbjct: 126 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 170 ALLGQL------TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223
K+ D++S GV++ +++G ML ++ + +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-MSGNYQFGSPEW 239
Query: 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
+ + + R T ++ +
Sbjct: 240 DDYSDTVKDLVSR-----------FLVVQPQKRYTAEEALA 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 7e-44
Identities = 57/271 (21%), Positives = 109/271 (40%), Gaps = 15/271 (5%)
Query: 2 IGGGAFGVVYRGSLRDGTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
IG G +GVVY+ G A+K + E + + EI ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 60 VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIV 119
+LV+E+L+ + + L+ T + L +G+++ H+ ++
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 120 HRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKA 179
HRD+K N+L++ KI DFGLA+ F V + + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 180 DVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239
D++S G + E+++G D L+ + R G P +T+ P+ +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRI-----FRILGTPNSKNWPNVTELPKYDPN 237
Query: 240 RFIKVGLFCTQAGAHYRPTMKQVVE-MLSKD 269
+ L + ++ ML D
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (373), Expect = 3e-43
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS---AESKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G V+ LR +A+K L A F E + HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 57 GCCVEDNNRI----LVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
+ +V EY++ +L + + + + L+F H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV--STRVAGTMGYLAPEYA 170
I+HRD+K +N+++ K+ DFG+A+ D+ V + V GT YL+PE A
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 171 LLGQLTKKADVYSFGVLLLEIISGR 195
+ ++DVYS G +L E+++G
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-43
Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 15/272 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G +GVVY+ + G +A+K + E++ + EI ++ + HPN+V+L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+N LV+E+L + S + P + GL+F H +
Sbjct: 70 IHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRV 123
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD+K N+L++ K+ DFGLA+ F V + V +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
D++S G + E+++ R+ D L + R G E+V P +T P+ +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI-----FRTLGTPDEVVWPGVTSMPDYKP 238
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE-MLSKD 269
++ + ++ ML D
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-43
Identities = 63/277 (22%), Positives = 112/277 (40%), Gaps = 22/277 (7%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE-----FLTEIDMIWNIRHPNLVQ 54
+G G F VY+ +AIK + + K+ L EI ++ + HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L+ +N LV++++E + K + L L T GL +LH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 115 DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQ 174
I+HRD+K +N+LLD N K+ DFGLAK F + +V T Y APE +
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 175 L-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
+ D+++ G +L E++ D L + G E P++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-----FETLGTPTEEQWPDMCSL 231
Query: 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE-MLSKD 269
P+ + G+ + + +++ + +
Sbjct: 232 PDYVTFKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 8e-43
Identities = 60/201 (29%), Positives = 82/201 (40%), Gaps = 13/201 (6%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLS---AESKQGTKEFLTEIDMIW-NIRHPNLVQL 55
M+G G+FG V+ + AIK L + + E ++ HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 56 IGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEAD 115
N V EYL L + D GL FLH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 116 PPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL 175
IV+RD+K N+LLD + H KI DFG+ K +T GT Y+APE L +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKY 180
Query: 176 TKKADVYSFGVLLLEIISGRS 196
D +SFGVLL E++ G+S
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQS 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 3e-42
Identities = 51/279 (18%), Positives = 102/279 (36%), Gaps = 28/279 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
IG G+FGV++ G +L + Q+AIK S + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 61 EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVH 120
++ ++ L SL + L T A + + +HE +V+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 121 RDIKASNVLLDGNFHP-----KIGDFGLAKLFPDNVTHV------STRVAGTMGYLAPEY 169
RDIK N L+ + DFG+ K + D VT ++GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 170 ALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229
L + +++ D+ + G + + + G + G + ++ E+ + + E
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQ---GLKAATNKQKYERIGEKKQSTPL--RE 239
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
L +E +++ + P + + SK
Sbjct: 240 LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-42
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQG-TKEFLTEIDMIWNIRHPNLVQLIGC 58
IG GA+G+V + ++AIK +S Q + L EI ++ RH N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ YL + L A L K L GL ++H +
Sbjct: 75 IRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS--TRVAGTMGYLAPEYALLGQL- 175
+HRD+K SN+LL+ KI DFGLA++ + H T T Y APE L +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 176 TKKADVYSFGVLLLEIISGR 195
TK D++S G +L E++S R
Sbjct: 191 TKSIDIWSVGCILAEMLSNR 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-41
Identities = 60/283 (21%), Positives = 100/283 (35%), Gaps = 25/283 (8%)
Query: 2 IGGGAFGVVYRGSLR--DGTQIAIKCLSAESKQGT--KEFLTEID---MIWNIRHPNLVQ 54
IG GA+G V++ G +A+K + ++ + + E+ + HPN+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLG--SKSKYVSLDWPTRANICLGTASGLSFLHE 112
L C L + L K + T ++ GL FLH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
+VHRD+K N+L+ + K+ DFGLA+++ + T V T+ Y APE L
Sbjct: 135 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQ 189
Query: 173 GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232
D++S G + E+ + + + D L + L E V
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 233 FPEKEVMRFIKVGLFCTQAGAHY-----------RPTMKQVVE 264
F K K + G R + +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-41
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 52/294 (17%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE------FLTEIDMIWNIR--HPN 51
++G G FG VY G + D +AIK + + E E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 52 LVQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLH 111
+++L+ ++ +L+ E E + ++ +L + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 112 EEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
++HRDIK N+L+D N K+ DFG L D V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 171 LLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229
+ + A V+S G+LL +++ G F D I +R + + V E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI----PFEHDEEI-------IRGQVFFRQRVSSE 230
Query: 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE----------MLSKDVHLN 273
C RPT +++ + ++HL+
Sbjct: 231 CQHLIRW-----------CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNI-RHPNLVQLIGC 58
++G G G V + + R + A+K L Q + E+++ W + P++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 59 C----VEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
++V E L+ L + + + + I + +LH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 115 DPPIVHRDIKASNVLLD---GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL 171
I HRD+K N+L N K+ DFG AK + + + T Y+APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 172 LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231
+ K D++S GV++ ++ G F + + + K R E +PE +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYP----PFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
+ E EV I+ + R T+ + +
Sbjct: 243 EVSE-EVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 58/274 (21%), Positives = 98/274 (35%), Gaps = 32/274 (11%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCL------SAESKQGTKEFLTEIDMIWNIRHPNLVQ 54
+G G F VV + G Q A K + S+ ++ E+ ++ I+HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 55 LIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA 114
L + IL+ E + L + ++ SL +G+ +LH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFD----FLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 115 DPPIVHRDIKASNVLLD----GNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYA 170
I H D+K N++L KI DFGLA + + GT ++APE
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIV 188
Query: 171 LLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230
L +AD++S GV+ ++SG S + L V E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-AVNYEFEDEYFSNTSALA 247
Query: 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264
F + R T++ ++
Sbjct: 248 KDFIRR-----------LLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-39
Identities = 66/237 (27%), Positives = 93/237 (39%), Gaps = 17/237 (7%)
Query: 1 MIGGGAFGVVYRG-SLRDGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLI 56
++G G FG V G A+K L E +K +TE ++ N RHP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 57 GCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADP 116
+ V EY L L S+ S L +LH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLT 176
+V+RDIK N++LD + H KI DFGL K + + T GT YLAPE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 183
Query: 177 KKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233
+ D + GV++ E++ GR + + L+ L EE R + PE
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----LMEEIRFPRTLSPEAKSL 235
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 9e-39
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 1 MIGGGAFGVVYRGSLRD-GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCC 59
+IG G+FGVVY+ L D G +AIK + Q + E+ ++ + H N+V+L
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 60 VEDNNR------ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEE 113
+ LV +Y+ A S++K +L L+++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 114 ADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
I HRDIK N+LLD + K+ DFG AK +VS + Y APE
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFG 196
Query: 173 G-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILV 210
T DV+S G +L E++ G+ G D L+ +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-38
Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 15/272 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG G +G V++ + +A+K + + + L EI ++ ++H N+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
D LV+E+ + + + + GL F H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKK 178
+HRD+K N+L++ N K+ +FGLA+ F V S V +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 179 ADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238
D++S G + E+ + G+D+ ++ ++L G E P +T+ P+ +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLL--GTPTEEQWPSMTKLPDYKP 238
Query: 239 MRFIKVGLFCTQAGAHYRPTMKQVVE-MLSKD 269
T + +++ +L +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 8e-38
Identities = 59/282 (20%), Positives = 114/282 (40%), Gaps = 27/282 (9%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGT--KEFLTEIDMIWNIRHPNLVQLIGC 58
IG G FG V++ + G ++A+K + E+++ L EI ++ ++H N+V LI
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 59 CVE--------DNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFL 110
C + LV+++ E++ + V + +GL ++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 111 HEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT---HVSTRVAGTMGYLAP 167
H I+HRD+KA+NVL+ + K+ DFGLA+ F + T T+ Y P
Sbjct: 134 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 168 EYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226
E L + D++ G ++ E+ + + L L+ + G + V
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI-----SQLCGSITPEV 245
Query: 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268
P + + E + +K + ++++ K
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-36
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCL--SAESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V R G ++AIK L +S+ K E+ ++ ++RH N++ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
D ++ LG K+ L + GL ++H I
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGI 142
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL-LGQLTK 177
+HRD+K N+ ++ + KI DFGLA+ +T T Y APE L + T+
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG----YVVTRWYRAPEVILNWMRYTQ 198
Query: 178 KADVYSFGVLLLEIISGR 195
D++S G ++ E+I+G+
Sbjct: 199 TVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (322), Expect = 4e-35
Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 20/239 (8%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKE---FLTEIDMIWNIRHPNLVQLIG 57
+G G+FG V G A+K L + K+ L E ++ + P LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 58 CCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+++N +V EY+ + + L + P +LH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---D 161
Query: 118 IVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTK 177
+++RD+K N+L+D + ++ DFG AK + GT LAPE L K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNK 217
Query: 178 KADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236
D ++ GVL+ E+ +G F D + + E + R +L
Sbjct: 218 AVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLRN 271
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 2 IGGGAFGVVYRG----SLRDGTQIAIKCLS----AESKQGTKEFLTEIDMIWNIRH-PNL 52
+G GA+G V+ G A+K L + + T+ TE ++ +IR P L
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 53 VQLIGCCVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
V L + L+ +Y+ L L + T + + + L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHL-------SQRERFTEHEVQIYVGEIVLALEH 144
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
I++RDIK N+LLD N H + DFGL+K F + T + GT+ Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 173 GQ--LTKKADVYSFGVLLLEIISGR 195
G K D +S GVL+ E+++G
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (300), Expect = 4e-32
Identities = 44/201 (21%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCC 59
+G G + V+ ++ + ++ +K L K K+ EI ++ N+R PN++ L
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99
Query: 60 VEDNNR--ILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPP 117
+ +R LV+E++ N K Y +L L + H
Sbjct: 100 KDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALDYCHSM---G 149
Query: 118 IVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQL- 175
I+HRD+K NV++D + ++ D+GLA+ + + + + PE + Q+
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207
Query: 176 TKKADVYSFGVLLLEIISGRS 196
D++S G +L +I +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-31
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLS--AESKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
+G GA+G V + G ++A+K LS +S K E+ ++ +++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 59 CVEDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPI 118
+ + L A L + K L + GL ++H I
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 119 VHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYAL-LGQLTK 177
+HRD+K SN+ ++ + KI DFGLA+ D +T T Y APE L +
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQ 198
Query: 178 KADVYSFGVLLLEIISGR 195
D++S G ++ E+++GR
Sbjct: 199 TVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-31
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGC 58
IG GA G+V +AIK LS ++ K E+ ++ + H N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 59 CV------EDNNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE 112
E + LV E ++ N + + LD + + G+ LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 113 EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALL 172
I+HRD+K SN+++ + KI DFGLA+ + + T T Y APE L
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 192
Query: 173 GQLTKKADVYSFGVLLLEIISGR 195
+ D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 2e-26
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 26/213 (12%)
Query: 2 IGGGAFGVVYRG-SLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCV 60
+G G F V+ + + T +A+K + + K T+ EI ++ + + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 61 EDNNRILVYEY------------LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLS 108
++L + E L K ++ + I GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 109 FLHEEADPPIVHRDIKASNVLLDGNFHP------KIGDFGLAKLFPDNVTHVSTRVAGTM 162
++H I+H DIK NVL++ P KI D G A + ++ T+ T
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QTR 193
Query: 163 GYLAPEYALLGQLTKKADVYSFGVLLLEIISGR 195
Y +PE L AD++S L+ E+I+G
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 4e-19
Identities = 21/159 (13%), Positives = 40/159 (25%), Gaps = 29/159 (18%)
Query: 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAES----------KQGTKEFLTEIDMIWNIRHP 50
++G G V+ + +K G F
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 51 NLVQLIGCCVED----NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASG 106
L +L G V ++ E ++ + + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILEE 115
Query: 107 LSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145
++ + IVH D+ NVL+ I DF +
Sbjct: 116 VAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 322 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.81 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-58 Score=385.19 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=193.7
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||+|.+.+++.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++
T Consensus 13 iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l 91 (263)
T d1sm2a_ 13 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 91 (263)
T ss_dssp EECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred EeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHh
Confidence 8999999999999988889999999754 344578999999999999999999999999999999999999999999998
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
..... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++..............||
T Consensus 92 ~~~~~---~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt 165 (263)
T d1sm2a_ 92 RTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165 (263)
T ss_dssp HTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------------C
T ss_pred hcccc---CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecceecC
Confidence 75532 6899999999999999999999999 99999999999999999999999999987654443333445689
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (322)
+.|+|||++.+..++.++|||||||++|||+|+..|+...... .... ..+....+ + ..+.....++
T Consensus 166 ~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~---~~i~~~~~------~---~~p~~~~~~l 231 (263)
T d1sm2a_ 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV---EDISTGFR------L---YKPRLASTHV 231 (263)
T ss_dssp TTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHH---HHHHHTCC------C---CCCTTSCHHH
T ss_pred cccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHH---HHHHhcCC------C---CCccccCHHH
Confidence 9999999999999999999999999999999965554432211 1111 11111111 1 1122233468
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 242 ~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.+++.+||+.||++|||++||++.|+++.
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=382.31 Aligned_cols=244 Identities=24% Similarity=0.312 Sum_probs=197.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||+||+|.+. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 91 (271)
T d1nvra_ 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91 (271)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGG
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHH
Confidence 4899999999999876 699999999976532 33467899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 157 (322)
+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 92 ~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 92 DRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp GGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred HHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 9996543 7999999999999999999999999 9999999999999999999999999998654322 223345
Q ss_pred cccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 158 VAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............ ..... ........
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~~~~~--------~~~~~~~~ 231 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKK--------TYLNPWKK 231 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----HHTTC--------TTSTTGGG
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCC--------CCCCcccc
Confidence 679999999999998876 57899999999999999999999765443322111 11110 00111122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...++.+++.+||+.||++|||++|+++
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2345778999999999999999999965
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=379.76 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=199.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|..+ +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 13 ~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~ 92 (263)
T d2j4za1 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92 (263)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 3899999999999876 6899999998643 23345778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 93 L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~ 162 (263)
T d2j4za1 93 VYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 162 (263)
T ss_dssp HHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---CE
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc---cc
Confidence 999997554 6999999999999999999999999 9999999999999999999999999998654332 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ ... .+. ... ..+ +..
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~-~~~------~~~---p~~ 226 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK---RIS-RVE------FTF---PDF 226 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHH-TTC------CCC---CTT
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHH---HHH-cCC------CCC---Ccc
Confidence 4569999999999999999999999999999999999999997542211 111 111 111 111 222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...++.+++.+||+.||++|||++|+++
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 3345788999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-57 Score=384.46 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=207.0
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||+||+|.+. +|+.||||+++.+ ....+.+.+|+.++++++|||||++++++.+.+..+++|||+++|+|.++
T Consensus 25 iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~ 103 (287)
T d1opja_ 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103 (287)
T ss_dssp TTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHH
Confidence 899999999999876 5889999998754 34467899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............|
T Consensus 104 l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g 178 (287)
T d1opja_ 104 LRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178 (287)
T ss_dssp HHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEE
T ss_pred hhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccc
Confidence 975432 37899999999999999999999999 9999999999999999999999999999776554444455568
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
++.|+|||++.+..++.++|||||||++|||++|..||........ . .+....+ ..+ ..+...+.+
T Consensus 179 ~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~----~~~i~~~-----~~~---~~~~~~~~~ 244 (287)
T d1opja_ 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLEKD-----YRM---ERPEGCPEK 244 (287)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H----HHHHHTT-----CCC---CCCTTCCHH
T ss_pred cccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--H----HHHHhcC-----CCC---CCCccchHH
Confidence 9999999999999999999999999999999998777654322211 1 1111111 111 222233456
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+.+++.+||+.||++|||++||++.|+.+.
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-57 Score=383.36 Aligned_cols=241 Identities=27% Similarity=0.437 Sum_probs=201.8
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||+||+|... +|+.||||+++.......+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.++
T Consensus 28 iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~ 107 (293)
T d1yhwa1 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107 (293)
T ss_dssp CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred EecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHH
Confidence 899999999999875 6999999999866555668899999999999999999999999999999999999999999998
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .....+|
T Consensus 108 ~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~g 178 (293)
T d1yhwa1 108 VTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 178 (293)
T ss_dssp HHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCS
T ss_pred hhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccccccc
Confidence 8653 5899999999999999999999999 99999999999999999999999999987643322 2344579
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMR 240 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
|+.|+|||++.+..++.++|||||||++|+|++|..||......+. . ........ +.+ ..+......
T Consensus 179 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~~~~~~~------~~~-~~~~~~s~~ 245 (293)
T d1yhwa1 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---L---YLIATNGT------PEL-QNPEKLSAI 245 (293)
T ss_dssp CGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHHHHHCS------CCC-SSGGGSCHH
T ss_pred CCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH---H---HHHHhCCC------CCC-CCcccCCHH
Confidence 9999999999999999999999999999999999999975432211 1 11111111 111 112233455
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 020720 241 FIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 241 l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 888999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=384.27 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=189.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe--CCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--DNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 75 (322)
.||+|+||+||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.+ .+..++|||||++|
T Consensus 11 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g 90 (269)
T d2java1 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90 (269)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCC
Confidence 3899999999999876 6999999998755 34445778999999999999999999999865 45689999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA--DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+|.+++.........+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++........
T Consensus 91 ~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 169 (269)
T d2java1 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS- 169 (269)
T ss_dssp EHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------
T ss_pred cHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC-
Confidence 999998654333347999999999999999999999854 23499999999999999999999999999987654322
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..+. .+ .....
T Consensus 170 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~---~~i~-~~--------~~~~~ 234 (269)
T d2java1 170 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---GKIR-EG--------KFRRI 234 (269)
T ss_dssp ------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHH-HT--------CCCCC
T ss_pred ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH---HHHH-cC--------CCCCC
Confidence 2344679999999999999999999999999999999999999997543211 11 1111 11 11222
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.....++.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 3333456889999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=382.98 Aligned_cols=251 Identities=26% Similarity=0.482 Sum_probs=198.0
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||+||+|.++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ +..++||||+++|+|.
T Consensus 15 ~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~ 91 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLY 91 (276)
T ss_dssp EEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHH
T ss_pred EEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHH
Confidence 3899999999999765 35999998754 34556789999999999999999999998754 5689999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 157 (322)
+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 92 ~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 165 (276)
T d1uwha_ 92 HHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165 (276)
T ss_dssp HHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------
T ss_pred HHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccc
Confidence 99975543 6999999999999999999999998 9999999999999999999999999998654322 223345
Q ss_pred cccCCCCCchHHHhhC---CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYALLG---QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~---~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..||+.|+|||++.+. .++.++|||||||++|||+||+.||.......... .....+. ..+.+...+
T Consensus 166 ~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~----~~p~~~~~~ 235 (276)
T d1uwha_ 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGY----LSPDLSKVR 235 (276)
T ss_dssp CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTS----CCCCGGGSC
T ss_pred cccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCC----CCCcchhcc
Confidence 6799999999999743 57899999999999999999999998653322111 1111111 112222333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 334456889999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=375.73 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=205.9
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
.||+|+||+||+|++++++.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.++
T Consensus 11 ~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~ 89 (258)
T d1k2pa_ 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89 (258)
T ss_dssp CCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHH
T ss_pred EEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHh
Confidence 489999999999999888899999998543 3457899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..............+
T Consensus 90 ~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 163 (258)
T d1k2pa_ 90 LREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163 (258)
T ss_dssp HHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCC
T ss_pred hhcccc---CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCC
Confidence 765433 6889999999999999999999998 9999999999999999999999999998765444444445668
Q ss_pred CCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHH
Q 020720 161 TMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVM 239 (322)
Q Consensus 161 t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+....+ . ..+.....
T Consensus 164 t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~i~~~~~------~---~~p~~~~~ 228 (258)
T d1k2pa_ 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLR------L---YRPHLASE 228 (258)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHHTTCC------C---CCCTTCCH
T ss_pred CCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HHHHhCCC------C---CCcccccH
Confidence 999999999999999999999999999999998 89999765322211 11111111 1 11222334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 240 RFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 240 ~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.+.+++.+||+.||++|||+++|++.|..
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 68899999999999999999999998854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=380.42 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=202.1
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||+|.+++++.||||+++.. ....+.+.+|+.++++++|||||++++++.+ +..++||||+++|+|.+++
T Consensus 21 iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~ 98 (272)
T d1qpca_ 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98 (272)
T ss_dssp EEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHT
T ss_pred EecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHH
Confidence 8999999999999988889999999754 3445789999999999999999999998754 5678999999999999988
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
.... ...+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++..............||
T Consensus 99 ~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt 173 (272)
T d1qpca_ 99 KTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173 (272)
T ss_dssp TSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCC
T ss_pred hhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccccCCc
Confidence 5432 225899999999999999999999998 99999999999999999999999999997765544444556789
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (322)
+.|+|||++....++.++|||||||++|||+||..|+....... ... ..+. .+ ..+ ..+...+.++
T Consensus 174 ~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~---~~i~-~~-----~~~---~~p~~~~~~l 239 (272)
T d1qpca_ 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI---QNLE-RG-----YRM---VRPDNCPEEL 239 (272)
T ss_dssp TTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH---HHHH-TT-----CCC---CCCTTCCHHH
T ss_pred ccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHH---HHHH-hc-----CCC---CCcccChHHH
Confidence 99999999999999999999999999999999766654432211 111 1111 11 111 1122333458
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 242 ~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.+++.+||+.||++|||++||++.|+...
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 88999999999999999999999997653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-57 Score=384.67 Aligned_cols=250 Identities=27% Similarity=0.483 Sum_probs=193.7
Q ss_pred CcccCcceEEEEEEEC-CCC---EEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT---QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~---~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||+||+|.++ +++ .||||.+... .....+.|.+|+.+|++++|||||++++++.+.+..++||||+++|
T Consensus 33 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g 112 (299)
T d1jpaa_ 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112 (299)
T ss_dssp EEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCC
Confidence 4899999999999875 333 5889988654 4445578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee-
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV- 154 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 154 (322)
+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||||+.++.+||+|||+++.........
T Consensus 113 ~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 113 SLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp EHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred cceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence 99998875432 6899999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ---ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 155 ---STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 155 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.....+|+.|+|||++.+..++.++|||||||++|||+| |..||......+ .. ..+....+
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~---~~i~~~~~--------- 251 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VI---NAIEQDYR--------- 251 (299)
T ss_dssp ---------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTTCC---------
T ss_pred eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HH---HHHHcCCC---------
Confidence 122457889999999999999999999999999999998 899997643221 11 11111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+...+..+.+++.+||+.||++|||+.||++.|++++.
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11223344568899999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=378.32 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=201.3
Q ss_pred cccCcceEEEEEEEC---CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR---DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||+||+|.++ ++..||||+++.. .....+.+.+|+.++++++|||||++++++.+ +..++||||+++|+|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 95 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence 899999999999764 3557999999754 34456789999999999999999999999865 568899999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee--e
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV--S 155 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 155 (322)
.+++..... .+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++......... .
T Consensus 96 ~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 96 HKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 999865432 6999999999999999999999999 9999999999999999999999999998765433222 2
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....||+.|+|||++....++.++|||||||++|||+| |..||......+... .+ ..+.. + ..+
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~------~i-~~~~~-----~---~~p 234 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------FI-EQGKR-----M---ECP 234 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH------HH-HTTCC-----C---CCC
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH------HH-HcCCC-----C---CCC
Confidence 23458899999999999999999999999999999998 899998654322111 11 11111 1 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 33345688999999999999999999999988754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-57 Score=382.42 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=200.5
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANA 80 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 80 (322)
||+|+||+||+|.+. +|+.||+|+++.......+.+.+|++++++++|||||++++++.+++..++||||+++|+|.++
T Consensus 20 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~ 99 (288)
T d2jfla1 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 99 (288)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred EeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHH
Confidence 899999999999876 6899999999877666678899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccccc
Q 020720 81 LLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAG 160 (322)
Q Consensus 81 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 160 (322)
+..... ++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .......|
T Consensus 100 ~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~G 172 (288)
T d2jfla1 100 MLELER---PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIG 172 (288)
T ss_dssp HHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCS
T ss_pred HHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccccc
Confidence 865432 6999999999999999999999999 9999999999999999999999999987543211 11234569
Q ss_pred CCCCCchHHHh-----hCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 161 TMGYLAPEYAL-----LGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 161 t~~y~aPE~~~-----~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
|+.|+|||++. ...++.++|||||||++|+|++|..||......+.... ..... +.....+.
T Consensus 173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~------i~~~~-------~~~~~~~~ 239 (288)
T d2jfla1 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------IAKSE-------PPTLAQPS 239 (288)
T ss_dssp CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------HHHSC-------CCCCSSGG
T ss_pred ccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH------HHcCC-------CCCCCccc
Confidence 99999999984 45688999999999999999999999986543322211 11111 01111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33456889999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-56 Score=375.86 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=197.2
Q ss_pred cccCcceEEEEEEEC---CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 2 IGGGAFGVVYRGSLR---DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 2 lg~G~~g~v~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
||+|+||+||+|.++ .++.||||+++.. .....+.+.+|+.++++++|||||++++++.+ +..++||||+++|+
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~ 93 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGP 93 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCc
Confidence 899999999999764 3567999999654 23345789999999999999999999999865 46789999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce--e
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH--V 154 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~ 154 (322)
|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++........ .
T Consensus 94 L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 94 LNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp HHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999997654 6999999999999999999999998 999999999999999999999999999876543322 2
Q ss_pred ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 155 STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+. . ..+. .+. ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~---~~i~-~~~--------~~~~ 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T---AMLE-KGE--------RMGC 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H---HHHH-TTC--------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---H---HHHH-cCC--------CCCC
Confidence 233568999999999999999999999999999999998 8999986432211 1 1111 111 1122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
+...+.++.+++.+||+.||++|||+++|++.|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 233345688999999999999999999999888654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=379.75 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||+||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 15 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~ 94 (288)
T d1uu3a_ 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94 (288)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCC
Confidence 4899999999999875 7999999998643 23345778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-ceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV-THVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 155 (322)
|.+++...+ .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ....
T Consensus 95 L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 95 LLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp HHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999987654 7999999999999999999999999 9999999999999999999999999998765332 2223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .+. .+. . .++.
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~i~-~~~------~---~~p~ 231 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQ---KII-KLE------Y---DFPE 231 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-TTC------C---CCCT
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHH---HHH-cCC------C---CCCc
Confidence 4467999999999999999999999999999999999999999754221 1111 111 111 1 1222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
....++.+++.+||+.||++|||++|++.
T Consensus 232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 232 KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 23345889999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=373.96 Aligned_cols=252 Identities=25% Similarity=0.445 Sum_probs=196.8
Q ss_pred CcccCcceEEEEEEECC-C----CEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRD-G----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||+||+|.++. + ..||||+++.. .......+.+|+.++++++|||||++++++.+.+..+++|||+.+
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~ 93 (283)
T d1mqba_ 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 93 (283)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEeccc
Confidence 58999999999997653 2 36999998755 334456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
+++.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 94 ~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 94 GALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp EEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred Ccchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 999998865533 6999999999999999999999999 999999999999999999999999999865433221
Q ss_pred -eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 -VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 -~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......||+.|+|||++.+..++.++|||||||++|||++|..|+....... ... ..+ ..+. ...
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~---~~i-~~~~--------~~~ 233 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM---KAI-NDGF--------RLP 233 (283)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHH-HTTC--------CCC
T ss_pred eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHH---HHH-hccC--------CCC
Confidence 2223458899999999999999999999999999999999776665432221 111 111 1111 112
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVHL 272 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~ 272 (322)
.+...+..+.+++.+||+.||++|||+.||++.|+++...
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 2233445688999999999999999999999999887653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=369.62 Aligned_cols=241 Identities=26% Similarity=0.423 Sum_probs=192.9
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe----CCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE----DNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~ 74 (322)
||+|+||+||+|.+. +++.||+|.+... .....+.+.+|++++++++|||||++++++.+ ....++||||+++
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~ 96 (270)
T d1t4ha_ 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS 96 (270)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCC
Confidence 899999999999876 6889999998654 34455789999999999999999999999865 3457999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC-CCCeEEEeeeccccccCCCcce
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD-GNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
|+|.+++.... .+++..++.++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||++.......
T Consensus 97 g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~-- 169 (270)
T d1t4ha_ 97 GTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-- 169 (270)
T ss_dssp CBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--
T ss_pred CcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc--
Confidence 99999997554 6999999999999999999999863 4499999999999996 57899999999998644332
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQF 233 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||........ .. ..+ ..+... +.+
T Consensus 170 -~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~---~~i-~~~~~~----~~~--- 234 (270)
T d1t4ha_ 170 -AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-TSGVKP----ASF--- 234 (270)
T ss_dssp -BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-TTTCCC----GGG---
T ss_pred -cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH---HHH-HcCCCC----ccc---
Confidence 234579999999998865 699999999999999999999999975432211 11 111 111110 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 234 PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 234 ~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+.....++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112234788999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=381.23 Aligned_cols=254 Identities=23% Similarity=0.394 Sum_probs=197.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||+||+|... +|+.||+|+++.. .....+.+.+|+.++++++|||||+++++|.+++..++||||+++|+|.
T Consensus 13 ~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~ 92 (322)
T d1s9ja_ 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92 (322)
T ss_dssp EEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHH
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHH
Confidence 3899999999999876 6899999999765 3344578899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++.... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|...... ....
T Consensus 93 ~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~ 162 (322)
T d1s9ja_ 93 QVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 162 (322)
T ss_dssp HHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC--
T ss_pred HHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC---cccc
Confidence 9997554 69999999999999999999997 58 999999999999999999999999999865321 1234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHH---------hcCc-------
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLR---------EEGR------- 221 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~------- 221 (322)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||................... ....
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 679999999999999999999999999999999999999998654332111100000000 0000
Q ss_pred -------ccc----ccCccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 222 -------LLE----IVDPELTQFPE-KEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 222 -------~~~----~~~~~~~~~~~-~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... .........+. ....++.+++.+||+.||.+|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 00000001111 12345888999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-55 Score=376.72 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=184.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC-hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES-KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
+||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||||++|+|.
T Consensus 16 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~ 95 (307)
T d1a06a_ 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95 (307)
T ss_dssp ESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 4899999999999876 68999999997553 233456889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC---CCCeEEEeeeccccccCCCcceee
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD---GNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+++.... .+++..+..++.||+.||+|||+++ ++||||||+||++. +++.+||+|||++....... ..
T Consensus 96 ~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~ 166 (307)
T d1a06a_ 96 DRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VL 166 (307)
T ss_dssp HHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred Hhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC--ee
Confidence 9997654 7999999999999999999999999 99999999999995 57899999999998654322 22
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+.. +.. . +. .....
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~-~~~-~-~~---~~~~~ 234 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFE---QILK-AEY-E-FD---SPYWD 234 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHT-TCC-C-CC---TTTTT
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-cCC-C-CC---Ccccc
Confidence 34579999999999999999999999999999999999999997542211 111 1111 110 0 00 11112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
....++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 233458899999999999999999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=372.05 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=197.9
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHHHH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLANAL 81 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 81 (322)
||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||+++|+|.+++
T Consensus 25 iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~ 102 (285)
T d1fmka3 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 102 (285)
T ss_dssp EEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred EeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhh
Confidence 8999999999999988888999999744 3456789999999999999999999999854 5678999999999999988
Q ss_pred hcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccccC
Q 020720 82 LGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVAGT 161 (322)
Q Consensus 82 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~t 161 (322)
..... ..+++..++.++.||+.||+|||+++ ++||||||+||||+.++.+||+|||+++..............||
T Consensus 103 ~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 177 (285)
T d1fmka3 103 KGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177 (285)
T ss_dssp SHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CC
T ss_pred hhccc--ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeecccccc
Confidence 65322 25899999999999999999999999 99999999999999999999999999987654443334446689
Q ss_pred CCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHHHHH
Q 020720 162 MGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEVMRF 241 (322)
Q Consensus 162 ~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (322)
+.|+|||++....++.++|||||||++|||++|..|+........ ... .+.. +. .+ +.+.....++
T Consensus 178 ~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~---~i~~-~~-----~~---~~~~~~~~~l 243 (285)
T d1fmka3 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD---QVER-GY-----RM---PCPPECPESL 243 (285)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH---HHHT-TC-----CC---CCCTTSCHHH
T ss_pred ccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHH---HHHh-cC-----CC---CCCcccCHHH
Confidence 999999999999999999999999999999997777655432211 111 1111 10 11 1222334568
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHhccccCc
Q 020720 242 IKVGLFCTQAGAHYRPTMKQVVEMLSKDVHLN 273 (322)
Q Consensus 242 ~~l~~~cl~~dp~~Rps~~evl~~L~~~~~~~ 273 (322)
.+++.+||+.||++||++++|+++|+......
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 89999999999999999999999998877543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-54 Score=378.75 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=202.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+++|+|.+
T Consensus 33 ~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~ 112 (350)
T d1koaa2 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112 (350)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHH
Confidence 3899999999999876 799999999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC--CCCeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD--GNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++........ ...
T Consensus 113 ~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~ 184 (350)
T d1koaa2 113 KVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKV 184 (350)
T ss_dssp HHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--EEE
T ss_pred HHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc--cce
Confidence 995443 26999999999999999999999999 99999999999996 467899999999987654332 234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||......+. . ..+.... . .+.. ......
T Consensus 185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~---~~i~~~~-~--~~~~---~~~~~~ 252 (350)
T d1koaa2 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---L---RNVKSCD-W--NMDD---SAFSGI 252 (350)
T ss_dssp ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHHTC-C--CSCC---GGGGGC
T ss_pred ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCC-C--CCCc---ccccCC
Confidence 5789999999999999999999999999999999999999975432211 1 1111111 0 0000 111122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..++.+++.+||+.||++|||++|+++.
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3458889999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=377.69 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=200.1
Q ss_pred CcccCcceEEEEEEECC-C-----CEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLRD-G-----TQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||+||+|.+.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+..++|||||
T Consensus 44 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~ 123 (325)
T d1rjba_ 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123 (325)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcC
Confidence 48999999999997642 2 26899998654 333446789999999998 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCC-------------------CcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC
Q 020720 73 ENNSLANALLGSKSK-------------------YVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN 133 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~ 133 (322)
++|+|.+++...... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~ 200 (325)
T d1rjba_ 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHG 200 (325)
T ss_dssp TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETT
T ss_pred CCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccC
Confidence 999999999765321 235889999999999999999999999 9999999999999999
Q ss_pred CeEEEeeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHH
Q 020720 134 FHPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVE 211 (322)
Q Consensus 134 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~ 211 (322)
+.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 201 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~--- 277 (325)
T d1rjba_ 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--- 277 (325)
T ss_dssp TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH---
T ss_pred CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 9999999999986543322 23344568999999999999999999999999999999998 899998654433221
Q ss_pred HHHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 020720 212 WTWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSK 268 (322)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~ 268 (322)
.....+. .+ +.+...+.++.++|.+||+.||++|||++||++.|..
T Consensus 278 ---~~~~~~~-----~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 278 ---KLIQNGF-----KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---HHHHTTC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHhcCC-----CC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1111111 11 1222334568899999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-55 Score=375.80 Aligned_cols=237 Identities=28% Similarity=0.443 Sum_probs=194.4
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++|||||.+|+|
T Consensus 23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 102 (309)
T d1u5ra_ 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCch
Confidence 899999999999875 68899999997553 23346789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..++.... ++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 103 ~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----~~ 170 (309)
T d1u5ra_ 103 DLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NS 170 (309)
T ss_dssp HHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CC
T ss_pred HHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-----Cc
Confidence 77765443 7999999999999999999999999 999999999999999999999999999865332 23
Q ss_pred cccCCCCCchHHHhh---CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 158 VAGTMGYLAPEYALL---GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~---~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
..||+.|+|||++.+ ..++.++|||||||++|||++|..||......+. . ....... . +.+. +
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~---~~i~~~~-~-----~~~~--~ 236 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YHIAQNE-S-----PALQ--S 236 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHHHHSC-C-----CCCS--C
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---H---HHHHhCC-C-----CCCC--C
Confidence 569999999999864 4689999999999999999999999975432111 1 1111111 1 1111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
......+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122345888999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-54 Score=378.67 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=202.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|... +|+.||||+++.........+.+|+.++++++|||||++++++.+++..++|||||++|+|.+
T Consensus 36 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~ 115 (352)
T d1koba_ 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115 (352)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHH
Confidence 3899999999999875 799999999987776667888999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeC--CCCeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLD--GNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
.+.... .++++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++........ ...
T Consensus 116 ~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~~~ 187 (352)
T d1koba_ 116 RIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKV 187 (352)
T ss_dssp HTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEE
T ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc--eee
Confidence 886543 26999999999999999999999999 99999999999998 678999999999987654322 234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..||+.|+|||++.+..++.++|||||||++|+|++|..||......+. . ..+.... . .+. .......
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~---~~i~~~~-~--~~~---~~~~~~~ 255 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---L---QNVKRCD-W--EFD---EDAFSSV 255 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HHHHHCC-C--CCC---SSTTTTS
T ss_pred ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCC-C--CCC---cccccCC
Confidence 5689999999999999999999999999999999999999975432221 1 1111111 0 001 1111223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..++.+++.+||+.||.+|||+.|+++.
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3458899999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=365.24 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=190.9
Q ss_pred CcccCcceEEEEEEECC----CCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLRD----GTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||.||+|.+.. +..||||.++.. .....+.+.+|+.++++++||||+++++++. ++..++||||+++|
T Consensus 14 ~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g 92 (273)
T d1mp8a_ 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG 92 (273)
T ss_dssp EEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTE
T ss_pred EEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCC
Confidence 48999999999997652 346889988654 3444578999999999999999999999985 56789999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++..........
T Consensus 93 ~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~ 166 (273)
T d1mp8a_ 93 ELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166 (273)
T ss_dssp EHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred cHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcceec
Confidence 99998865432 6899999999999999999999999 99999999999999999999999999987654443344
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCC
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFP 234 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
....||+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +. .+. ....+
T Consensus 167 ~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~------i~-~~~--------~~~~~ 231 (273)
T d1mp8a_ 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR------IE-NGE--------RLPMP 231 (273)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------HH-TTC--------CCCCC
T ss_pred cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH------HH-cCC--------CCCCC
Confidence 45568999999999999999999999999999999998 8888876543322211 11 111 11223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 235 EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 235 ~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+..+.+++.+||+.||++|||+.||++.|+.++
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 333456889999999999999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=372.11 Aligned_cols=240 Identities=27% Similarity=0.312 Sum_probs=200.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
+||+|+||.||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~ 91 (337)
T d1o6la_ 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCc
Confidence 4899999999999875 7999999999754 23345778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...... ....
T Consensus 92 L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~ 163 (337)
T d1o6la_ 92 LFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 163 (337)
T ss_dssp HHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBC
T ss_pred hhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-cccc
Confidence 999997654 6899999999999999999999999 9999999999999999999999999998654332 2234
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ... .+. . .++..
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~---~i~-~~~------~---~~p~~ 227 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LIL-MEE------I---RFPRT 227 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHH-HCC------C---CCCTT
T ss_pred cceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHH---HHh-cCC------C---CCCcc
Confidence 5679999999999999999999999999999999999999998653221 111 111 111 1 12222
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
...++.+++.+||+.||.+||+ ++|+++
T Consensus 228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 3345788999999999999995 788876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=367.02 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=198.1
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC------hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES------KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++|||||+
T Consensus 17 ~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (293)
T d1jksa_ 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96 (293)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3899999999999875 79999999986432 2235789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC----eEEEeeeccccccCC
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF----HPKIGDFGLAKLFPD 149 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 149 (322)
+|+|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||++.....
T Consensus 97 gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 97 GGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp SCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred Cccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 999999997654 6999999999999999999999999 99999999999998776 499999999987643
Q ss_pred CcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. ..+.. ... . +.+.
T Consensus 170 ~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~~-~~~-~-~~~~ 238 (293)
T d1jksa_ 170 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSA-VNY-E-FEDE 238 (293)
T ss_dssp SC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHT-TCC-C-CCHH
T ss_pred Cc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------HHHHh-cCC-C-CCch
Confidence 32 223456899999999999999999999999999999999999999754322111 11111 100 0 0000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. +......+.+++.+||+.||++|||++|+++
T Consensus 239 ~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 239 Y---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h---cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1112345788999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-53 Score=366.35 Aligned_cols=238 Identities=26% Similarity=0.356 Sum_probs=198.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|.++ +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++||+
T Consensus 11 ~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 90 (316)
T d1fota_ 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90 (316)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcc
Confidence 3899999999999875 6999999999743 23345788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++....... .
T Consensus 91 l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~----~ 159 (316)
T d1fota_ 91 LFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----Y 159 (316)
T ss_dssp HHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----C
T ss_pred ccccccccc----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc----c
Confidence 999997665 6888999999999999999999999 9999999999999999999999999998764332 3
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ .. ..+.. +. . ..+..
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~i~~-~~------~---~~p~~ 223 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY---EKILN-AE------L---RFPPF 223 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHH-CC------C---CCCTT
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HH---HHHHc-CC------C---CCCCC
Confidence 4679999999999999999999999999999999999999997542211 11 11111 11 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVEM 265 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~~ 265 (322)
...++.+++.+||+.||.+|+ +++++++.
T Consensus 224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 234588899999999999996 89999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=361.01 Aligned_cols=243 Identities=31% Similarity=0.451 Sum_probs=191.5
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEe-CCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE-DNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||.||+|.++ |+.||||+++.+. ..+.+.+|+.++++++||||+++++++.+ .+..++||||+++|+|.+
T Consensus 14 ~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~ 90 (262)
T d1byga_ 14 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 90 (262)
T ss_dssp EEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHH
T ss_pred EEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHH
Confidence 3899999999999986 7899999996543 34779999999999999999999999865 456899999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecccc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRVA 159 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 159 (322)
++.... ...+++..++.|+.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 91 ~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~~~~ 161 (262)
T d1byga_ 91 YLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGK 161 (262)
T ss_dssp HHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC----cccc
Confidence 996542 125899999999999999999999998 9999999999999999999999999998653322 2345
Q ss_pred cCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHHH
Q 020720 160 GTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKEV 238 (322)
Q Consensus 160 ~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
++..|+|||++.+..++.++|||||||++|||+| |..||......+.... +. .+ ..+ +.+....
T Consensus 162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~------i~-~~-----~~~---~~~~~~~ 226 (262)
T d1byga_ 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------VE-KG-----YKM---DAPDGCP 226 (262)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH------HT-TT-----CCC---CCCTTCC
T ss_pred ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH------HH-cC-----CCC---CCCccCC
Confidence 7889999999999999999999999999999998 6777765433222111 11 11 112 2233333
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 239 MRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 239 ~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 45889999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=366.23 Aligned_cols=249 Identities=27% Similarity=0.452 Sum_probs=196.1
Q ss_pred CcccCcceEEEEEEEC-CCC----EEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT----QIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||+||+|.+. +|+ .||+|.++.. .....+.+.+|+.++++++|||||++++++.++ ..+++++|+.+
T Consensus 16 ~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~ 94 (317)
T d1xkka_ 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPF 94 (317)
T ss_dssp EEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred EEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccC
Confidence 4899999999999765 444 5888988643 344567899999999999999999999999865 56788899999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
++|.+.+..... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 95 ~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 95 GCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp CBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred Cccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence 999998876533 7999999999999999999999998 999999999999999999999999999876543322
Q ss_pred eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
......||+.|+|||++.++.++.++|||||||++|||+| |..||......+.... .....+ ..
T Consensus 169 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~------i~~~~~---------~~ 233 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI------LEKGER---------LP 233 (317)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH------HHHTCC---------CC
T ss_pred cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH------HHcCCC---------CC
Confidence 2234568999999999999999999999999999999998 7888876543322111 111111 12
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||+.||.+|||+.||++.|++...
T Consensus 234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 223344568899999999999999999999999887653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-53 Score=364.76 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=201.1
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEecccCh-hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAESK-QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||+||+|+++ +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 100 (301)
T d1lufa_ 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 100 (301)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCC
Confidence 899999999999764 357899999976533 3457799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC--------------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC
Q 020720 75 NSLANALLGSKS--------------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF 134 (322)
Q Consensus 75 ~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~ 134 (322)
|+|.+++..... ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++
T Consensus 101 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~ 177 (301)
T d1lufa_ 101 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENM 177 (301)
T ss_dssp CBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred CcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCC
Confidence 999999964321 1235889999999999999999999999 99999999999999999
Q ss_pred eEEEeeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCC-CCCCcccCCCchhHHHH
Q 020720 135 HPKIGDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR-SSSKAAFGDDMLILVEW 212 (322)
Q Consensus 135 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~-~p~~~~~~~~~~~~~~~ 212 (322)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. .||......+.
T Consensus 178 ~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~------ 251 (301)
T d1lufa_ 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV------ 251 (301)
T ss_dssp CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------
T ss_pred cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH------
Confidence 999999999986543322 2223456889999999999999999999999999999999996 45654322211
Q ss_pred HHHHHhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 213 TWKLREEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+. .+. ....+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 252 ~~~v~-~~~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 252 IYYVR-DGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHH-TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHH-cCC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111 111 11223333346889999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=360.63 Aligned_cols=251 Identities=30% Similarity=0.455 Sum_probs=200.3
Q ss_pred CcccCcceEEEEEEECC--C--CEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-CeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLRD--G--TQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-NNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~--~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~ 74 (322)
+||+|+||+||+|.+.. + ..||||+++.. .....+.|.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~ 113 (311)
T d1r0pa_ 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 113 (311)
T ss_dssp EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTT
T ss_pred EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeec
Confidence 48999999999997653 2 25899998743 555568899999999999999999999998764 578999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce-
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH- 153 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 153 (322)
++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 114 g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 114 GDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred Cchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999875543 6778899999999999999999999 999999999999999999999999999865433222
Q ss_pred --eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 154 --VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 154 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
......||+.|+|||++....++.++||||||+++|||++|..||......... . ..+. .+.. +.
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~---~~i~-~g~~-----~~-- 254 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--T---VYLL-QGRR-----LL-- 254 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--H---HHHH-TTCC-----CC--
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--H---HHHH-cCCC-----CC--
Confidence 122346889999999999999999999999999999999988887654332211 1 1111 1111 11
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+......+.+++.+||+.||++||++.||++.|+++..
T Consensus 255 -~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122233458899999999999999999999999988864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.6e-53 Score=356.63 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=194.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHHHHHHHHhcCCCCcccccceEEEeCC----eeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN----NRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~ 72 (322)
.||+|+||+||+|.+. +|+.||||+++... ......+.+|+.+++.++||||+++++++...+ ..++||||+
T Consensus 14 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~ 93 (277)
T d1o6ya_ 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECC
Confidence 4899999999999875 79999999997553 334467899999999999999999999987654 378999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc-
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV- 151 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 151 (322)
++++|.+++...+ .+++.+++.++.||+.||+|||+++ ++||||||+||+++.++..+++|||.+.......
T Consensus 94 ~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 94 DGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp CEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred CCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 9999999987654 7999999999999999999999999 9999999999999999999999999887543222
Q ss_pred -ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 152 -THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 152 -~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
........||+.|+|||++.+..++.++|||||||++|+|+||+.||......+ ............. ....
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~~--~~~~ 238 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP--SARH 238 (277)
T ss_dssp ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCG--GGTS
T ss_pred cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCCC--chhc
Confidence 222344679999999999999999999999999999999999999997542211 1111112211100 0011
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccc
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRP-TMKQVVEMLSKDV 270 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~evl~~L~~~~ 270 (322)
...+ .++.+++.+||+.||++|| ++++++..|.+..
T Consensus 239 ~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 239 EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 2223 4588899999999999999 8999998887654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-53 Score=368.03 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=198.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 76 (322)
.||+|+||.||+|.++ +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+
T Consensus 48 ~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~ 127 (350)
T d1rdqe_ 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127 (350)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccc
Confidence 3899999999999876 7999999998643 22345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeec
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVST 156 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 156 (322)
|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 128 l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~ 196 (350)
T d1rdqe_ 128 MFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp HHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred hhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----cc
Confidence 999997654 6999999999999999999999999 999999999999999999999999999876432 23
Q ss_pred ccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHH
Q 020720 157 RVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEK 236 (322)
Q Consensus 157 ~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
...||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... .+.. +. . ..+..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~---~i~~-~~------~---~~p~~ 260 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KIVS-GK------V---RFPSH 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHH-CC------C---CCCTT
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHH---HHhc-CC------C---CCCcc
Confidence 45799999999999999999999999999999999999999975421 11111 1111 11 1 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 020720 237 EVMRFIKVGLFCTQAGAHYRP-----TMKQVVE 264 (322)
Q Consensus 237 ~~~~l~~l~~~cl~~dp~~Rp-----s~~evl~ 264 (322)
...++.+++.+||+.||.+|+ +++|+++
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 334588899999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-52 Score=367.41 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC---hhcHHHHH---HHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES---KQGTKEFL---TEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 73 (322)
+||+|+||.||+|... +|+.||||++.... ......+. +++.+++.++|||||++++++.+.+..++||||++
T Consensus 11 ~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~ 90 (364)
T d1omwa3 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90 (364)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecC
Confidence 4899999999999876 69999999986431 12223333 44777888899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcce
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+|+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 91 gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-- 161 (364)
T d1omwa3 91 GGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161 (364)
T ss_dssp SCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred CCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc--
Confidence 999999997654 6899999999999999999999999 9999999999999999999999999998665432
Q ss_pred eecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCC
Q 020720 154 VSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQ 232 (322)
Q Consensus 154 ~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
.....||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+...... ... .....
T Consensus 162 -~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~---------~~~~~ 227 (364)
T d1omwa3 162 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTL---------TMAVE 227 (364)
T ss_dssp -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSS---------SCCCC
T ss_pred -ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcc---------cCCCC
Confidence 234569999999999975 568999999999999999999999998765443322111 000 11111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 233 FPEKEVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 233 ~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
.+.....++.+++.+||+.||.+||| ++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 12223345888999999999999999 688875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=361.92 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=193.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhc-----HHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQG-----TKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
+||+|+||+||+|... +|+.||||+++...... .+.+.+|+.++++++|||||++++++.+++..++||||+.+
T Consensus 5 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~ 84 (299)
T d1ua2a_ 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84 (299)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred EeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcc
Confidence 5899999999999876 69999999997543221 24688999999999999999999999999999999999998
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
+++..+.... ..+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 85 DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred hHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 8777666433 26899999999999999999999999 999999999999999999999999999866543222
Q ss_pred ecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHh---cCcccccc----
Q 020720 155 STRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLRE---EGRLLEIV---- 226 (322)
Q Consensus 155 ~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---- 226 (322)
....+||+.|+|||++... .++.++|||||||++|||++|..||......+.+..+ .+... ........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhccch
Confidence 2345689999999998754 5799999999999999999999999765332222111 11100 00000000
Q ss_pred ---CccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 227 ---DPELTQFP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 227 ---~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.......+ .....++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00011111 122346889999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=356.98 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=189.2
Q ss_pred cccCcceEEEEEEEC--CC--CEEEEEEeccc---ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR--DG--TQIAIKCLSAE---SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~--~~--~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||.||+|... ++ ..||||+++.. .....+.|.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus 16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~ 94 (273)
T d1u46a_ 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPL 94 (273)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecC
Confidence 899999999999754 23 36899998654 23345789999999999999999999999965 467899999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCccee
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHV 154 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 154 (322)
+++.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++..........
T Consensus 95 ~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~ 168 (273)
T d1u46a_ 95 GSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168 (273)
T ss_dssp CBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE
T ss_pred cchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcc
Confidence 999988865432 6999999999999999999999998 9999999999999999999999999999765443322
Q ss_pred --ecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCC
Q 020720 155 --STRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELT 231 (322)
Q Consensus 155 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
.....++..|+|||++.+..++.++|||||||++|||+| |..||......+. ...+...+.. +
T Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~-----~--- 234 (273)
T d1u46a_ 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER-----L--- 234 (273)
T ss_dssp EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC-----C---
T ss_pred eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCCC-----C---
Confidence 233457889999999999999999999999999999998 8999975422211 1122222111 1
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 020720 232 QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKD 269 (322)
Q Consensus 232 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~ 269 (322)
+.+...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11222334588999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=360.42 Aligned_cols=243 Identities=18% Similarity=0.241 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLAN 79 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 79 (322)
.||+|+||+||+|.+. +|+.||+|+++.... +...+.+|+.+|+.++||||+++++++.+++..++|||||++|+|.+
T Consensus 12 ~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~ 90 (321)
T d1tkia_ 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHH
Confidence 3899999999999876 689999999976543 34668899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC--CeEEEeeeccccccCCCcceeecc
Q 020720 80 ALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN--FHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 80 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
++.... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||++....... ....
T Consensus 91 ~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~~ 162 (321)
T d1tkia_ 91 RINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRL 162 (321)
T ss_dssp HHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEE
T ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC--cccc
Confidence 996543 26899999999999999999999999 9999999999999854 479999999998764332 2234
Q ss_pred cccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCHHH
Q 020720 158 VAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPEKE 237 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
..+|+.|+|||.+.+..++.++|||||||++|+|++|..||......+. . ..+.... . ....+.....
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~---~~i~~~~-~-~~~~~~~~~~---- 230 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---I---ENIMNAE-Y-TFDEEAFKEI---- 230 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHHTC-C-CCCHHHHTTS----
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCC-C-CCChhhccCC----
Confidence 5689999999999999999999999999999999999999976532211 1 1111110 0 0000001122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 238 VMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 238 ~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..++.+++.+||+.||.+|||++|+++
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 334788999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-52 Score=351.93 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=197.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh---------hcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK---------QGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVY 69 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 69 (322)
.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++..++||
T Consensus 10 ~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivm 89 (277)
T d1phka_ 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEE
Confidence 4899999999999875 799999999875421 12246889999999997 999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCC
Q 020720 70 EYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 70 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 149 (322)
||+++|+|.+++..+. .+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 E~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 90 DLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccC
Confidence 9999999999997654 7999999999999999999999999 99999999999999999999999999987654
Q ss_pred CcceeecccccCCCCCchHHHhh------CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALL------GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLL 223 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (322)
... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||........ . ..+.. +...
T Consensus 163 ~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~---~~i~~-~~~~ 233 (277)
T d1phka_ 163 GEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---L---RMIMS-GNYQ 233 (277)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHH-TCCC
T ss_pred CCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---H---HHHHh-CCCC
Confidence 322 244679999999999874 2467899999999999999999999986532211 1 11111 1110
Q ss_pred cccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 224 EIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.. .........++.+++.+||+.||++|||++|+++.
T Consensus 234 -~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 -FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 11112233458899999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=362.52 Aligned_cols=240 Identities=27% Similarity=0.382 Sum_probs=195.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc---ChhcHHHHHHHHHHHh-cCCCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE---SKQGTKEFLTEIDMIW-NIRHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
.||+|+||+||+|.+. +|+.||||+++.. .....+.+..|..++. .++||||+++++++.+++..++||||+++|
T Consensus 9 ~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g 88 (320)
T d1xjda_ 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88 (320)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCC
Confidence 4899999999999876 6999999999743 2233456677777665 689999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceee
Q 020720 76 SLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 76 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
+|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 89 ~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~ 160 (320)
T d1xjda_ 89 DLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKT 160 (320)
T ss_dssp BHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCB
T ss_pred cHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-ccc
Confidence 9999997654 6899999999999999999999999 9999999999999999999999999998654332 223
Q ss_pred cccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccCCCCCH
Q 020720 156 TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPELTQFPE 235 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... .. ..+.. + .+.+ +.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~~i~~-~------~~~~---p~ 224 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LF---HSIRM-D------NPFY---PR 224 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-C------CCCC---CT
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HH---HHHHc-C------CCCC---Cc
Confidence 44579999999999999999999999999999999999999997543221 11 11111 1 1112 22
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 020720 236 KEVMRFIKVGLFCTQAGAHYRPTMK-QVVE 264 (322)
Q Consensus 236 ~~~~~l~~l~~~cl~~dp~~Rps~~-evl~ 264 (322)
....++.+++.+||+.||++||++. |+++
T Consensus 225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2234588899999999999999995 6754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=359.11 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=197.2
Q ss_pred CcccCcceEEEEEEEC-CCC--EEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGT--QIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 75 (322)
+||+|+||.||+|.++ +|. .||||.++.. .....+.+.+|+.+++++ +||||+++++++.+++..++||||+++|
T Consensus 17 ~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g 96 (309)
T d1fvra_ 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96 (309)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCC
Confidence 4899999999999776 444 4778887543 344557899999999999 7999999999999999999999999999
Q ss_pred CHHHHHhcCC------------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeecc
Q 020720 76 SLANALLGSK------------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGL 143 (322)
Q Consensus 76 ~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~ 143 (322)
+|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 97 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~ 173 (309)
T d1fvra_ 97 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 173 (309)
T ss_dssp BHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred cHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccc
Confidence 9999997542 22347999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCC-CCCcccCCCchhHHHHHHHHHhcCcc
Q 020720 144 AKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRS-SSKAAFGDDMLILVEWTWKLREEGRL 222 (322)
Q Consensus 144 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (322)
++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ .. ..+ ..+.
T Consensus 174 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~---~~i-~~~~- 243 (309)
T d1fvra_ 174 SRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---EKL-PQGY- 243 (309)
T ss_dssp EESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHG-GGTC-
T ss_pred ccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH---HHH-HhcC-
Confidence 975432211 223458999999999999999999999999999999999765 555432111 11 111 1111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 223 LEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.+ ..+.....++.+++.+||+.||++|||+.||++.|+++..
T Consensus 244 ----~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 244 ----RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 2223334568899999999999999999999999988764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=361.67 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=192.2
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhc-CCCCcccccceEEEe----CCeeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWN-IRHPNLVQLIGCCVE----DNNRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~ 74 (322)
+||+|+||.||+|.+. +|+.||||+++. ...+.+|+.++.+ .+||||+++++++.+ +...++|||||+|
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 4899999999999875 799999999863 2456789988765 489999999999875 3568999999999
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCc
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 151 (322)
|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 94 g~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 94 GELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp EEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC
Confidence 999999976432 26999999999999999999999999 999999999999985 5679999999998665432
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc--
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE-- 229 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (322)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .. .+....
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~~-----~i~~~~~~ 235 (335)
T d2ozaa1 169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KT-----RIRMGQYE 235 (335)
T ss_dssp C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCCSCSSS
T ss_pred c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------HH-----HHhcCCCC
Confidence 2 23457999999999999999999999999999999999999999865443321111 00 001011
Q ss_pred CC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 LT-QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~~-~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
+. ........++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 111233456889999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=356.91 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=198.4
Q ss_pred CcccCcceEEEEEEECC--------CCEEEEEEecccC-hhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEE
Q 020720 1 MIGGGAFGVVYRGSLRD--------GTQIAIKCLSAES-KQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 70 (322)
.||+|+||.||+|+... +..||||+++.+. ......+.+|...+.++ +|||||++++++.+++..++|||
T Consensus 20 ~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e 99 (299)
T d1fgka_ 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99 (299)
T ss_dssp ECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEE
Confidence 38999999999997531 2479999997654 34457888999999888 89999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 71 YLENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
|+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 100 ~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl 176 (299)
T d1fgka_ 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKI 176 (299)
T ss_dssp CCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred ccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEe
Confidence 9999999999975532 1246899999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCc-ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHh-CCCCCCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNV-THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIIS-GRSSSKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||++....... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||....... . ...
T Consensus 177 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~----~~~ 249 (299)
T d1fgka_ 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L----FKL 249 (299)
T ss_dssp CSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H----HHH
T ss_pred ccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H----HHH
Confidence 9999998654332 222344568899999999999999999999999999999998 677876433211 1 111
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
...+.. + ..+.....++.+++.+||+.||++|||+.||++.|+++..
T Consensus 250 i~~~~~-----~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 250 LKEGHR-----M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHTTCC-----C---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCC-----C---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111211 1 1122233458899999999999999999999999988753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=356.04 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=203.6
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCCeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
+||+|+||.||+|.+. +++.||||+++.. .......+.+|+.+++.+ +|||||++++++.+....+++|||+
T Consensus 30 ~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~ 109 (311)
T d1t46a_ 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC 109 (311)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcC
Confidence 3899999999999752 4568999999764 344556789999999999 6999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC--------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEE
Q 020720 73 ENNSLANALLGSKS--------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKI 138 (322)
Q Consensus 73 ~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl 138 (322)
++|+|.+++..... ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+++
T Consensus 110 ~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki 186 (311)
T d1t46a_ 110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKI 186 (311)
T ss_dssp TTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEE
T ss_pred CCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccc
Confidence 99999999975432 2236889999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCC-CCcccCCCchhHHHHHHHH
Q 020720 139 GDFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSS-SKAAFGDDMLILVEWTWKL 216 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p-~~~~~~~~~~~~~~~~~~~ 216 (322)
+|||.++....... .......||+.|+|||++....++.++|||||||++|||+|+..| |.......... ..
T Consensus 187 ~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~------~~ 260 (311)
T d1t46a_ 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------KM 260 (311)
T ss_dssp CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH------HH
T ss_pred cccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH------HH
Confidence 99999987654433 233446789999999999999999999999999999999995544 54433322211 11
Q ss_pred HhcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 217 REEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
...+. .+. .+......+.+++.+||+.||.+|||+.||+++|++.+
T Consensus 261 i~~~~-----~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 261 IKEGF-----RML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHTC-----CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC-----CCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11111 111 12223345889999999999999999999999998765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=357.00 Aligned_cols=252 Identities=24% Similarity=0.418 Sum_probs=203.2
Q ss_pred cccCcceEEEEEEEC------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCC
Q 020720 2 IGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLEN 74 (322)
Q Consensus 2 lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 74 (322)
||+|+||+||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++..+...++||||+++
T Consensus 28 lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 107 (308)
T d1p4oa_ 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 107 (308)
T ss_dssp EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCC
Confidence 899999999999763 2578999999754 344456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC------CCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 75 NSLANALLGSK------SKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 75 ~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
|+|.+++.... .....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 108 g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~ 184 (308)
T d1p4oa_ 108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184 (308)
T ss_dssp CBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred CCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceecc
Confidence 99999986431 12235788999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcce-eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCC-CCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 149 DNVTH-VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR-SSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 149 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
..... ......+|+.|+|||.+.+..++.++|||||||++|||+||. .||........+ ..+. .+
T Consensus 185 ~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------~~i~-~~------ 251 (308)
T d1p4oa_ 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFVM-EG------ 251 (308)
T ss_dssp GGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------HHHH-TT------
T ss_pred CCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------HHHH-hC------
Confidence 33222 223446899999999999999999999999999999999985 666543222111 1111 11
Q ss_pred CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 227 DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 227 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
.....+...+..+.+++.+||+.||++|||+.+|++.|++.+.
T Consensus 252 --~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 --GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1122233334568899999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=355.43 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=191.3
Q ss_pred CcccCcceEEEEEEEC------CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcC-CCCcccccceEEEeCC-eeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR------DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNI-RHPNLVQLIGCCVEDN-NRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~ 71 (322)
.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++.+.+ ..++||||
T Consensus 20 ~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~ 99 (299)
T d1ywna1 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 99 (299)
T ss_dssp EEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEEC
T ss_pred EEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEe
Confidence 3899999999999753 2468999998754 334456788888888777 6899999999987654 68999999
Q ss_pred CCCCCHHHHHhcCCC------------CCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEe
Q 020720 72 LENNSLANALLGSKS------------KYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIG 139 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~ 139 (322)
|++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~ 176 (299)
T d1ywna1 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 176 (299)
T ss_dssp CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEc
Confidence 999999999975432 1235889999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCcc-eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCC-CCCCcccCCCchhHHHHHHHHH
Q 020720 140 DFGLAKLFPDNVT-HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGR-SSSKAAFGDDMLILVEWTWKLR 217 (322)
Q Consensus 140 Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~ 217 (322)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|. .||.......... ...
T Consensus 177 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~------~~~ 250 (299)
T d1ywna1 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRL 250 (299)
T ss_dssp C------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH------HHH
T ss_pred cCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH------HHH
Confidence 9999986543322 2233456899999999999999999999999999999999975 5666543332211 111
Q ss_pred hcCccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 218 EEGRLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
..+.. + ..+.....++.+++.+||+.||++|||+.||++.|++++.
T Consensus 251 ~~~~~-----~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 251 KEGTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC-----C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 1 1222233458899999999999999999999999987753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=354.13 Aligned_cols=258 Identities=29% Similarity=0.353 Sum_probs=193.3
Q ss_pred cccCcceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC----eeEEEEEcCCCCCH
Q 020720 2 IGGGAFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN----NRILVYEYLENNSL 77 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L 77 (322)
||+|+||.||+|+.+ |+.||||+++..... ......|+..+.+++||||+++++++.+.+ ..++||||+++|+|
T Consensus 11 iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L 88 (303)
T d1vjya_ 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp EECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred EeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCH
Confidence 899999999999875 889999998654321 222334555667789999999999998754 57899999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEA-----DPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||++........
T Consensus 89 ~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~ 163 (303)
T d1vjya_ 89 FDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp HHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence 9999754 5899999999999999999999731 12299999999999999999999999999986643322
Q ss_pred e---eecccccCCCCCchHHHhhCC------CCcccceehhhHHHHHHHhCCCCCCcccCCCchh--------HHHHHHH
Q 020720 153 H---VSTRVAGTMGYLAPEYALLGQ------LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI--------LVEWTWK 215 (322)
Q Consensus 153 ~---~~~~~~~t~~y~aPE~~~~~~------~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~--------~~~~~~~ 215 (322)
. ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......... .......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T d1vjya_ 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243 (303)
T ss_dssp EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHH
Confidence 1 223467999999999987643 5679999999999999999988875433221110 0011111
Q ss_pred HHhcCccccccCccCCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 216 LREEGRLLEIVDPELTQF--PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
.. ....++|.+... .......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 244 ~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 244 VV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11 111122333221 2345667999999999999999999999999998664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=349.66 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=192.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||+||+|.+. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.++...++||||+.++.+
T Consensus 9 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~ 88 (298)
T d1gz8a_ 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88 (298)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh
Confidence 3899999999999875 799999999965432 2347889999999999999999999999999999999999976544
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+........ ....
T Consensus 89 -~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~ 161 (298)
T d1gz8a_ 89 -KFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTH 161 (298)
T ss_dssp -HHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTC
T ss_pred -hhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc-ccee
Confidence 44433222 26999999999999999999999999 99999999999999999999999999987644322 2334
Q ss_pred cccCCCCCchHHHhhCC-CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC---------
Q 020720 158 VAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD--------- 227 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~-~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 227 (322)
..||+.|+|||++.... ++.++|||||||++|+|++|+.||......+.... .... .+.......
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~---i~~~--~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR---IFRT--LGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHH--HCCCCTTTSTTGGGSTTC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH---HHHh--cCCCchhhcccccccccc
Confidence 56999999999988765 47899999999999999999999975432221111 1111 010000000
Q ss_pred -ccC---CCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 228 -PEL---TQF-----PEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 228 -~~~---~~~-----~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
... ... ......++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 000 01223468889999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-51 Score=346.66 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=194.1
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh--hcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK--QGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||+||+|.+++|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..+++++++.++.+.
T Consensus 9 ~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~ 88 (286)
T d1ob3a_ 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK 88 (286)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHH
T ss_pred EEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHH
Confidence 3899999999999998899999999976532 23478999999999999999999999999999999999999887776
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeeccc
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTRV 158 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 158 (322)
.+..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........ .....
T Consensus 89 ~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 160 (286)
T d1ob3a_ 89 LLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHE 160 (286)
T ss_dssp HHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHhhcC----CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-cccee
Confidence 6664443 7999999999999999999999999 99999999999999999999999999987654322 22334
Q ss_pred ccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCc---c---cc--ccCcc
Q 020720 159 AGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGR---L---LE--IVDPE 229 (322)
Q Consensus 159 ~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~--~~~~~ 229 (322)
.+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.... ......... . .. .....
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCChhhccchhhhhhcccc
Confidence 589999999998765 568999999999999999999999975432222111 111100000 0 00 00000
Q ss_pred C--------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 230 L--------TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 230 ~--------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
. ..........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1111222345889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=348.68 Aligned_cols=232 Identities=22% Similarity=0.361 Sum_probs=188.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccCh------hcHHHHHHHHHHHhcCC--CCcccccceEEEeCCeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESK------QGTKEFLTEIDMIWNIR--HPNLVQLIGCCVEDNNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 71 (322)
+||+|+||+||+|... +|+.||||+++.... .....+.+|+.++++++ ||||+++++++.+.+..++||||
T Consensus 11 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~ 90 (273)
T d1xwsa_ 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90 (273)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence 4899999999999875 799999999865321 11234678999999986 89999999999999999999999
Q ss_pred CCC-CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-CCeEEEeeeccccccCC
Q 020720 72 LEN-NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-NFHPKIGDFGLAKLFPD 149 (322)
Q Consensus 72 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 149 (322)
+.+ +++.+++.... .+++..++.++.||+.||+|||+++ ++||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 91 PEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp CSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred ccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccc
Confidence 976 57888886543 6999999999999999999999999 999999999999985 47999999999986543
Q ss_pred CcceeecccccCCCCCchHHHhhCCC-CcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCc
Q 020720 150 NVTHVSTRVAGTMGYLAPEYALLGQL-TKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDP 228 (322)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ... +. .
T Consensus 164 ~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~-~~------~ 221 (273)
T d1xwsa_ 164 TV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQ------V 221 (273)
T ss_dssp SC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CC------C
T ss_pred cc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhh-cc------c
Confidence 32 234579999999999998776 5778999999999999999999975310 011 10 0
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 229 ELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 229 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
.+ +.....++.+++.+||+.||++|||++|+++
T Consensus 222 ~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 FF---RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC---CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 1112345888999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=347.12 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=188.9
Q ss_pred CcccCcceEEEEEEEC-C-CCEEEEEEecccC--hhcHHHHHHHHHHHhcC---CCCcccccceEEEe-----CCeeEEE
Q 020720 1 MIGGGAFGVVYRGSLR-D-GTQIAIKCLSAES--KQGTKEFLTEIDMIWNI---RHPNLVQLIGCCVE-----DNNRILV 68 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~-~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv 68 (322)
.||+|+||+||+|.+. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++.. ....+++
T Consensus 14 ~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~ 93 (305)
T d1blxa_ 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 93 (305)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEE
T ss_pred EEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEE
Confidence 3899999999999874 4 5679999986542 22234556777766655 89999999999853 2467899
Q ss_pred EEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccC
Q 020720 69 YEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFP 148 (322)
Q Consensus 69 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 148 (322)
|||++++.+........ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~ 167 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 167 (305)
T ss_dssp EECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence 99998877655544332 26899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC------cc
Q 020720 149 DNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG------RL 222 (322)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~ 222 (322)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+.......... ..
T Consensus 168 ~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 168 FQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp GG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 32 22344679999999999999999999999999999999999999997653322221111000000000 00
Q ss_pred -cccc----CccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 223 -LEIV----DPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 223 -~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...+ ..............+.+++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000111222233457889999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-48 Score=329.81 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=201.4
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCC-CcccccceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH-PNLVQLIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||+||+|.+. +|+.||||++..... ...+.+|++.++.++| +|++.+++++.+....++||||+ +++|.
T Consensus 12 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~ 88 (293)
T d1csna_ 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 88 (293)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence 3899999999999876 689999999865432 2456788999999965 89999999999999999999999 67999
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC-----CCeEEEeeeccccccCCCcce
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG-----NFHPKIGDFGLAKLFPDNVTH 153 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~~ 153 (322)
+++..... .+++..+..++.|++.||+|||+++ ++||||||+||+++. ++.+||+|||+++........
T Consensus 89 ~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 89 DLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred HHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 98876543 6899999999999999999999999 999999999999974 578999999999865432211
Q ss_pred ------eecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccC
Q 020720 154 ------VSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVD 227 (322)
Q Consensus 154 ------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
......||+.|+|||++.+..++.++|||||||++|||++|..||.........................
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~---- 238 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR---- 238 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH----
T ss_pred cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH----
Confidence 1234569999999999999999999999999999999999999998765554443332222222111110
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 020720 228 PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDVH 271 (322)
Q Consensus 228 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~~ 271 (322)
......+ .++.+++..|++.+|++||+++.+.+.|+....
T Consensus 239 ~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 239 ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0112233 347888888999999999999999888876653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=341.40 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=187.8
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC------eeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN------NRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~ 72 (322)
||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|+.+|++++|||||+++++|...+ ..++||||+
T Consensus 26 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 105 (346)
T d1cm8a_ 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM 105 (346)
T ss_dssp C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc
Confidence 899999999999875 6999999999754 3344578899999999999999999999997654 469999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
+.+|..++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.......
T Consensus 106 -~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~- 175 (346)
T d1cm8a_ 106 -GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM- 175 (346)
T ss_dssp -SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-
T ss_pred -cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc-
Confidence 56788877543 6999999999999999999999999 9999999999999999999999999998764332
Q ss_pred eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH-----HHhcC------
Q 020720 153 HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-----LREEG------ 220 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~------ 220 (322)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+........ .....
T Consensus 176 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 176 ---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp ---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred ---ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 345689999999998864 568999999999999999999999976533222111110000 00000
Q ss_pred ----ccccccCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 221 ----RLLEIVDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 221 ----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.........+..........+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000011111122223457889999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=342.58 Aligned_cols=257 Identities=24% Similarity=0.266 Sum_probs=189.3
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc-ChhcHHHHHHHHHHHhcCCCCcccccceEEEeCC----eeEEEEEcCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE-SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDN----NRILVYEYLEN 74 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~ 74 (322)
.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.... ..+++++|+.+
T Consensus 15 ~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~ 94 (345)
T d1pmea_ 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94 (345)
T ss_dssp ECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCC
T ss_pred EEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecC
Confidence 3899999999999765 7999999999754 3444578899999999999999999999987653 23455666779
Q ss_pred CCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc--
Q 020720 75 NSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT-- 152 (322)
Q Consensus 75 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 152 (322)
++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 95 g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 95 ADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred CchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 9999999654 5899999999999999999999999 99999999999999999999999999986543221
Q ss_pred eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH-----HHhcCcc----
Q 020720 153 HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-----LREEGRL---- 222 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~---- 222 (322)
......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+.......... .......
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence 12234568999999999865 4678999999999999999999999976533222111110000 0000000
Q ss_pred -ccccCccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 223 -LEIVDPELTQFP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 223 -~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
.....+.....+ +....++.+++.+||+.||.+|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000001111 1112358899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=339.41 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=198.4
Q ss_pred cccCcceEEEEEEEC----CCCEEEEEEeccc----ChhcHHHHHHHHHHHhcCCC-CcccccceEEEeCCeeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLR----DGTQIAIKCLSAE----SKQGTKEFLTEIDMIWNIRH-PNLVQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 72 (322)
||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.++++++| |||+++++++.+....+++|||+
T Consensus 32 IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~ 111 (322)
T d1vzoa_ 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI 111 (322)
T ss_dssp EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecc
Confidence 899999999999752 4789999998643 22334668899999999976 89999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 112 ~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~ 184 (322)
T d1vzoa_ 112 NGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184 (322)
T ss_dssp CSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG
T ss_pred cccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhccccc
Confidence 9999999997665 5788999999999999999999999 99999999999999999999999999987655444
Q ss_pred eeecccccCCCCCchHHHhhC--CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCccC
Q 020720 153 HVSTRVAGTMGYLAPEYALLG--QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPEL 230 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~--~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
.......|++.|+|||.+.+. .++.++|||||||+||+|++|..||......+....+.... ... .
T Consensus 185 ~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---~~~---------~ 252 (322)
T d1vzoa_ 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKS---------E 252 (322)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHC---------C
T ss_pred ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc---ccC---------C
Confidence 444556799999999999765 46789999999999999999999998775555443322111 111 1
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 020720 231 TQFPEKEVMRFIKVGLFCTQAGAHYRPT-----MKQVVE 264 (322)
Q Consensus 231 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~evl~ 264 (322)
...+.....++.+++.+||+.||++||+ ++|+++
T Consensus 253 ~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1222334456888999999999999994 788875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=337.58 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=187.8
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEe--------CCeeEEEEE
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVE--------DNNRILVYE 70 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e 70 (322)
||+|+||+||+|.+. +|+.||||++... .......+.+|+.+|++++||||+++++++.. .+..+++||
T Consensus 18 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e 97 (318)
T d3blha1 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD 97 (318)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEE
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEe
Confidence 899999999999875 7999999998654 23334778999999999999999999999855 345799999
Q ss_pred cCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCC
Q 020720 71 YLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDN 150 (322)
Q Consensus 71 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 150 (322)
|+.++.+....... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~ 170 (318)
T d3blha1 98 FCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170 (318)
T ss_dssp CCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-
T ss_pred ccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccc
Confidence 99887666554332 37899999999999999999999999 999999999999999999999999999765432
Q ss_pred cc---eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCcccccc
Q 020720 151 VT---HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIV 226 (322)
Q Consensus 151 ~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
.. ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..... ..........
T Consensus 171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 249 (318)
T d3blha1 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEVWPNV 249 (318)
T ss_dssp ----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTTSTTC
T ss_pred cccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC-CCChhhcccc
Confidence 21 112235689999999998865 689999999999999999999999975432222211111100 0000000000
Q ss_pred C-----cc---C--CCC-CHH------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 227 D-----PE---L--TQF-PEK------EVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 227 ~-----~~---~--~~~-~~~------~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. .. . ... ... ....+++++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00 0 000 011 12346789999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=334.73 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=190.9
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccc-cceEEEeCCeeEEEEEcCCCCCHH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQ-LIGCCVEDNNRILVYEYLENNSLA 78 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~ 78 (322)
.||+|+||.||+|.+. +|+.||||++..... ...+..|+++++.++|+|++. +..++.+.+..++||||+. ++|.
T Consensus 14 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~ 90 (299)
T d1ckia_ 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLE 90 (299)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHH
T ss_pred EEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchh
Confidence 3899999999999875 689999999875433 245788999999998776555 4555677788899999994 5666
Q ss_pred HHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCC---CCeEEEeeeccccccCCCcc---
Q 020720 79 NALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDG---NFHPKIGDFGLAKLFPDNVT--- 152 (322)
Q Consensus 79 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~--- 152 (322)
+.+..... .+++..+..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||++........
T Consensus 91 ~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 91 DLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp HHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred hhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 66654332 6999999999999999999999999 999999999999864 45699999999987643221
Q ss_pred ---eeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcCccccccCcc
Q 020720 153 ---HVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEGRLLEIVDPE 229 (322)
Q Consensus 153 ---~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
.......||+.|+|||++.+..++.++|||||||++|||++|..||........................ +.
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 239 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EV 239 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-----HH
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-----hH
Confidence 1223457999999999999999999999999999999999999999876554443333222211111100 11
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 020720 230 LTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEMLSKDV 270 (322)
Q Consensus 230 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~L~~~~ 270 (322)
+ ....+.++.+++..||+.||++||+++++.+.|+...
T Consensus 240 ~---~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 240 L---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp H---TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred h---ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1 1112244888899999999999999999988887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=339.62 Aligned_cols=255 Identities=25% Similarity=0.282 Sum_probs=187.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEcCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEYLE 73 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~ 73 (322)
+||+|+||+||+|.+. +|+.||||++..+.. .+.+|+.+|++++||||+++++++... ...++||||++
T Consensus 27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~ 102 (350)
T d1q5ka_ 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102 (350)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred EEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence 4999999999999876 699999999975432 234699999999999999999998543 24789999998
Q ss_pred CCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCC-eEEEeeeccccccCCCcc
Q 020720 74 NNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNF-HPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 74 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 152 (322)
++.+..+.. .......+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++........
T Consensus 103 ~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 103 ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp EEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred CccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 764443332 1122237999999999999999999999999 99999999999999775 899999999986643322
Q ss_pred eeecccccCCCCCchHHHhh-CCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH------HHHh-cCcccc
Q 020720 153 HVSTRVAGTMGYLAPEYALL-GQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW------KLRE-EGRLLE 224 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~------~~~~-~~~~~~ 224 (322)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..||......+.+..+.... .... ......
T Consensus 179 --~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 179 --NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp --CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred --cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 234568999999998875 468999999999999999999999997654332222211100 0000 000000
Q ss_pred ccCccC------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 225 IVDPEL------TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 225 ~~~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
..-+.. .........++.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111 01112233458889999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=329.92 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=198.6
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccC--hhcHHHHHHHHHHHhcCCCCcccccceEEEeCCeeEEEEEcCCCCCH
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAES--KQGTKEFLTEIDMIWNIRHPNLVQLIGCCVEDNNRILVYEYLENNSL 77 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 77 (322)
.||+|+||+||+|.+. +|+.||||+++... ......+.+|+.+++.++||||+++++++.+....+++++++.+++|
T Consensus 9 ~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l 88 (292)
T d1unla_ 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88 (292)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHH
T ss_pred EEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccc
Confidence 3899999999999875 78999999997553 34457899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcceeecc
Q 020720 78 ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVTHVSTR 157 (322)
Q Consensus 78 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 157 (322)
..++...+ .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......... ...
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~~ 160 (292)
T d1unla_ 89 KYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSA 160 (292)
T ss_dssp HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CCS
T ss_pred cccccccc----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc-cee
Confidence 88886554 6899999999999999999999999 999999999999999999999999999876543322 223
Q ss_pred cccCCCCCchHHHhhCC-CCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHHHHhcC---cc---ccc-----
Q 020720 158 VAGTMGYLAPEYALLGQ-LTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWKLREEG---RL---LEI----- 225 (322)
Q Consensus 158 ~~~t~~y~aPE~~~~~~-~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~----- 225 (322)
..+++.|+|||++.... ++.++|||||||++|||++|..||....+... ............ .. ...
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 45678899999988665 68999999999999999999999865433221 111111111100 00 000
Q ss_pred -----cCccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 226 -----VDPELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 226 -----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
...............+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111222233455888999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=334.70 Aligned_cols=253 Identities=22% Similarity=0.253 Sum_probs=184.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC------CeeEEEEEc
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED------NNRILVYEY 71 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 71 (322)
.||+|+||+||+|.+. +|+.||||+++.. .......+.+|+.++++++||||+++++++... ...|+||||
T Consensus 24 ~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey 103 (355)
T d2b1pa1 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103 (355)
T ss_dssp ECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred EeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEec
Confidence 4899999999999876 6999999999754 344456789999999999999999999998643 578999999
Q ss_pred CCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCc
Q 020720 72 LENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNV 151 (322)
Q Consensus 72 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 151 (322)
+.++.+ +.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||++.......
T Consensus 104 ~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 104 MDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp CSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred cchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccccc
Confidence 977554 4442 15899999999999999999999999 9999999999999999999999999988654332
Q ss_pred ceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHH----------------HH
Q 020720 152 THVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWT----------------WK 215 (322)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~----------------~~ 215 (322)
......+|+.|+|||++.+..+++++||||+||++|+|++|+.||...........+... ..
T Consensus 174 --~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred --ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 234456899999999999999999999999999999999999999755322211111000 00
Q ss_pred HHhcCc------cccccCccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 LREEGR------LLEIVDPEL----TQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~~~~~~------~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
...... ....+.... ..........+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000011111 11122345678999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=332.71 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=186.8
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEeccc--ChhcHHHHHHHHHHHhcCCCCcccccceEEEeC-----CeeEEEEEcC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAE--SKQGTKEFLTEIDMIWNIRHPNLVQLIGCCVED-----NNRILVYEYL 72 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 72 (322)
.||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++... ...+++++|+
T Consensus 25 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~ 104 (348)
T d2gfsa1 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104 (348)
T ss_dssp ECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEee
Confidence 3899999999999875 7999999999754 334456789999999999999999999998643 3446677888
Q ss_pred CCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeeccccccCCCcc
Q 020720 73 ENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFGLAKLFPDNVT 152 (322)
Q Consensus 73 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 152 (322)
.+|+|.+++..+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++......
T Consensus 105 ~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-- 174 (348)
T d2gfsa1 105 MGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174 (348)
T ss_dssp CSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred cCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc--
Confidence 899999999543 5999999999999999999999999 999999999999999999999999998754322
Q ss_pred eeecccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHHH-----HHhcCc--ccc
Q 020720 153 HVSTRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTWK-----LREEGR--LLE 224 (322)
Q Consensus 153 ~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~--~~~ 224 (322)
.....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..... ...... ...
T Consensus 175 --~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp --GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred --cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 2335688999999987765 468999999999999999999999975432221111110000 000000 000
Q ss_pred ccC---ccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 225 IVD---PELTQFP-----EKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 225 ~~~---~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
... ....... ......+.+++.+||+.||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 0001110 112345788999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-46 Score=325.90 Aligned_cols=249 Identities=18% Similarity=0.244 Sum_probs=189.0
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeC--CeeEEEEEcCCCCC
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVED--NNRILVYEYLENNS 76 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~~ 76 (322)
.||+|+||+||+|... +|+.||||+++... .+.+.+|+.+|++++ ||||+++++++... ...++||||+.+++
T Consensus 42 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~ 118 (328)
T d3bqca1 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118 (328)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCB
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCc
Confidence 3899999999999875 79999999987443 467889999999995 99999999998754 46899999999999
Q ss_pred HHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCC-CeEEEeeeccccccCCCcceee
Q 020720 77 LANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGN-FHPKIGDFGLAKLFPDNVTHVS 155 (322)
Q Consensus 77 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 155 (322)
|..+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........ .
T Consensus 119 L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~ 186 (328)
T d3bqca1 119 FKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 186 (328)
T ss_dssp GGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--C
T ss_pred HHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc--c
Confidence 87654 16899999999999999999999999 9999999999999865 4699999999986643322 2
Q ss_pred cccccCCCCCchHHHhhC-CCCcccceehhhHHHHHHHhCCCCCCcccCCCchh-HHHHH------HHHHhc--Cccc--
Q 020720 156 TRVAGTMGYLAPEYALLG-QLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLI-LVEWT------WKLREE--GRLL-- 223 (322)
Q Consensus 156 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~-~~~~~------~~~~~~--~~~~-- 223 (322)
....+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.......... .+... ...... ....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 345689999999998865 47999999999999999999999997654322111 00000 000000 0000
Q ss_pred --cccCc-------c-CC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 020720 224 --EIVDP-------E-LT-QFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVE 264 (322)
Q Consensus 224 --~~~~~-------~-~~-~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~ 264 (322)
..... . .. ........++.+++.+||+.||.+|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0 00 011122345889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-41 Score=296.09 Aligned_cols=255 Identities=22% Similarity=0.241 Sum_probs=182.5
Q ss_pred CcccCcceEEEEEEEC-CCCEEEEEEecccChhcHHHHHHHHHHHhcCC-----------CCcccccceEEEeC--CeeE
Q 020720 1 MIGGGAFGVVYRGSLR-DGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-----------HPNLVQLIGCCVED--NNRI 66 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~--~~~~ 66 (322)
.||+|+||+||+|+.. +|+.||||+++.+ ....+.+.+|+.+++.++ |+||+++++++... ...+
T Consensus 20 ~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 98 (362)
T d1q8ya_ 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98 (362)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccccee
Confidence 3899999999999875 7999999999754 333467788998888775 57899999887543 4566
Q ss_pred EEEEcCCCCCH-HHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCcccceEeCCCC------eEEE
Q 020720 67 LVYEYLENNSL-ANALLGSKSKYVSLDWPTRANICLGTASGLSFLHE-EADPPIVHRDIKASNVLLDGNF------HPKI 138 (322)
Q Consensus 67 lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~~i~h~dlkp~Nill~~~~------~~kl 138 (322)
++++++..+.. ....... ....+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++ .+++
T Consensus 99 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 99 VVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred eeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeE
Confidence 66666655432 2222222 22378899999999999999999997 77 99999999999998665 3999
Q ss_pred eeeccccccCCCcceeecccccCCCCCchHHHhhCCCCcccceehhhHHHHHHHhCCCCCCcccCCCchhHHHHHH---H
Q 020720 139 GDFGLAKLFPDNVTHVSTRVAGTMGYLAPEYALLGQLTKKADVYSFGVLLLEIISGRSSSKAAFGDDMLILVEWTW---K 215 (322)
Q Consensus 139 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~---~ 215 (322)
+|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||................ .
T Consensus 174 ~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 174 ADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp CCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 999998855332 234568999999999999999999999999999999999999997653322111110000 0
Q ss_pred H--------HhcCc----------cccccC-----------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 020720 216 L--------REEGR----------LLEIVD-----------PELTQFPEKEVMRFIKVGLFCTQAGAHYRPTMKQVVEM 265 (322)
Q Consensus 216 ~--------~~~~~----------~~~~~~-----------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~evl~~ 265 (322)
. ..... ....+. +...........++.+++.+||+.||.+|||++|+|+.
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000 000000 01123445677789999999999999999999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.4e-25 Score=178.16 Aligned_cols=164 Identities=12% Similarity=0.063 Sum_probs=117.4
Q ss_pred CcccCcceEEEEEEECCCCEEEEEEecccCh------------------hcHHHHHHHHHHHhcCCCCcccccceEEEeC
Q 020720 1 MIGGGAFGVVYRGSLRDGTQIAIKCLSAESK------------------QGTKEFLTEIDMIWNIRHPNLVQLIGCCVED 62 (322)
Q Consensus 1 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 62 (322)
.||+|+||+||+|...+|+.||||+++.... .....+..|...+.++.|.+++..+++.
T Consensus 7 ~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~--- 83 (191)
T d1zara2 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--- 83 (191)
T ss_dssp EEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE---
T ss_pred EeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec---
Confidence 3899999999999888899999998753211 0113455788999999999998877653
Q ss_pred CeeEEEEEcCCCCCHHHHHhcCCCCCcCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccCcccceEeCCCCeEEEeeec
Q 020720 63 NNRILVYEYLENNSLANALLGSKSKYVSLDWPTRANICLGTASGLSFLHEEADPPIVHRDIKASNVLLDGNFHPKIGDFG 142 (322)
Q Consensus 63 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~~i~h~dlkp~Nill~~~~~~kl~Dfg 142 (322)
..+++|||+++..+. .++......++.|++.+++|||+.+ ++||||||+|||+++++ ++|+|||
T Consensus 84 -~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 84 -GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp -TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCT
T ss_pred -CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECC
Confidence 236899999876543 2444556789999999999999999 99999999999999654 8899999
Q ss_pred cccccCCCcceee-cccccCCCCCchHHHhhCCCCcccceehhhHHH
Q 020720 143 LAKLFPDNVTHVS-TRVAGTMGYLAPEYALLGQLTKKADVYSFGVLL 188 (322)
Q Consensus 143 ~~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~slG~il 188 (322)
++........... .+.+. .-.+ +....++.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~~~l~rd~~----~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWREILERDVR----NIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHHHHHHHHH----HHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHH----HHHH-HHcCCCCCcccHHHHHHHH
Confidence 9876543221100 00000 0011 2245678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.81 E-value=1.4e-08 Score=82.76 Aligned_cols=130 Identities=15% Similarity=0.098 Sum_probs=90.8
Q ss_pred cceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCC-CCcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcC
Q 020720 6 AFGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIR-HPNLVQLIGCCVEDNNRILVYEYLENNSLANALLGS 84 (322)
Q Consensus 6 ~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 84 (322)
+.+.||+.... ++.+++|+...........+.+|...+..+. +-.+.+++.+..+++..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 34689988654 6677889876554444455677888877663 334567778888888999999999998886654211
Q ss_pred CCCCcCCCHHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------------
Q 020720 85 KSKYVSLDWPTRANICLGTASGLSFLHEEAD------------------------------------------------- 115 (322)
Q Consensus 85 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~------------------------------------------------- 115 (322)
.....++.+++..++.||+...
T Consensus 105 ---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1123345556666666664210
Q ss_pred -------CCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 116 -------PPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 116 -------~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 126899999999999987777899998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.55 E-value=3.5e-07 Score=73.85 Aligned_cols=124 Identities=16% Similarity=0.118 Sum_probs=81.7
Q ss_pred ceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCC--CcccccceEEEeCCeeEEEEEcCCCCCHHHHHhcC
Q 020720 7 FGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRH--PNLVQLIGCCVEDNNRILVYEYLENNSLANALLGS 84 (322)
Q Consensus 7 ~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 84 (322)
.+.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..+++|++++|.++.+..
T Consensus 24 ~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--- 97 (255)
T d1nd4a_ 24 DAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--- 97 (255)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC---
T ss_pred CCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc---
Confidence 3678999888788899998764433 345667777766632 33566788888888899999999876543210
Q ss_pred CCCCcCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------------
Q 020720 85 KSKYVSLDWPTRANICLGTASGLSFLHEEA-------------------------------------------------- 114 (322)
Q Consensus 85 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------------------------------------------------- 114 (322)
... ..++.+++..|+.||+..
T Consensus 98 ------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 98 ------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp ------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred ------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 110 112223333444444210
Q ss_pred -----CCCeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 115 -----DPPIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 115 -----~~~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999988777899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=5.1e-06 Score=71.40 Aligned_cols=73 Identities=15% Similarity=0.095 Sum_probs=45.2
Q ss_pred cccCcceEEEEEEEC-CCCEEEEEEeccc-------ChhcHHHHHHHHHHHhcCC--CC-cccccceEEEeCCeeEEEEE
Q 020720 2 IGGGAFGVVYRGSLR-DGTQIAIKCLSAE-------SKQGTKEFLTEIDMIWNIR--HP-NLVQLIGCCVEDNNRILVYE 70 (322)
Q Consensus 2 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~e 70 (322)
||.|....||++... +++.+++|.-... .+........|+..|+.+. .| .+.+++. .+.+..+++||
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lvmE 111 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTVME 111 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEEEC
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEEEe
Confidence 688999999999765 4778999964321 1112234556777776652 23 3444443 35566789999
Q ss_pred cCCCCC
Q 020720 71 YLENNS 76 (322)
Q Consensus 71 ~~~~~~ 76 (322)
++.+..
T Consensus 112 ~L~~~~ 117 (392)
T d2pula1 112 DLSHLK 117 (392)
T ss_dssp CCTTSE
T ss_pred ccCCcc
Confidence 997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.82 E-value=4.8e-05 Score=63.39 Aligned_cols=68 Identities=12% Similarity=0.132 Sum_probs=45.2
Q ss_pred ceEEEEEEECCCCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc--cccc-----eEEEeCCeeEEEEEcCCCC
Q 020720 7 FGVVYRGSLRDGTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL--VQLI-----GCCVEDNNRILVYEYLENN 75 (322)
Q Consensus 7 ~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~ 75 (322)
-..||++...+|+.|++|+.+.. ....+.+..|...+..|....+ +... ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 35799998888999999998743 3345667788888777732221 1111 1234456778899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.48 E-value=0.0002 Score=61.25 Aligned_cols=70 Identities=16% Similarity=0.270 Sum_probs=44.9
Q ss_pred cccCcceEEEEEEECC--------CCEEEEEEecccChhcHHHHHHHHHHHhcCCCCcc-cccceEEEeCCeeEEEEEcC
Q 020720 2 IGGGAFGVVYRGSLRD--------GTQIAIKCLSAESKQGTKEFLTEIDMIWNIRHPNL-VQLIGCCVEDNNRILVYEYL 72 (322)
Q Consensus 2 lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 72 (322)
|+.|-.-.+|++...+ ...|++++.. . ........+|..+++.+.-.++ .++++++. + ++|++|+
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~efi 123 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYI 123 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCC
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEEe
Confidence 4567778899987653 3457777764 2 2233456678888888853444 45666653 2 5789999
Q ss_pred CCCCH
Q 020720 73 ENNSL 77 (322)
Q Consensus 73 ~~~~L 77 (322)
+|.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.0045 Score=50.56 Aligned_cols=29 Identities=28% Similarity=0.364 Sum_probs=26.3
Q ss_pred CeeeccCcccceEeCCCCeEEEeeecccc
Q 020720 117 PIVHRDIKASNVLLDGNFHPKIGDFGLAK 145 (322)
Q Consensus 117 ~i~h~dlkp~Nill~~~~~~kl~Dfg~~~ 145 (322)
.+||+|+.+.||+++.+...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 38999999999999998888899999776
|